Citrus Sinensis ID: 014466

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420----
Protein Sequence
MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICCVKF
Secondary Structure (PSIPRED)
ccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccccccccHHHccHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccHccEEEEEccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHEEcccccEEEEEEEcccccEEEEEEHccccccccEEEEEEEEEHHHcccHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccHHHEEEcccccEEEccccccccccccccEEEEEEEcccccccHHHHccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccccccccccccc
Coil and Loop (DISEMBL)
mshysflndqlskrtsifGLRLWVVLGICVGAGIVLVLFLISLWFTskrnsnnskrqlnaakssslcsnynsssgnptipniskeiqeiridpdsnsnsnckphsapnpdplpepepilvedspasgrnrihieigkdhriayperaagshhgsgdqtvaaaitpevshlgwghwyTLRELEvstngfadenvigeggYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNgnleqwlhgdvgphspltWEIRMNIILGTAKGLTylheglepkvvhrdikssnilldkqwnpklsdfgLAKLLGAERSYVTTRVMGtfgyvapeyastgmlnersdvySFGILIMEVIsgrnpvdysrppgevcipqmnslmtlsYCSSFFLICCVKF
Flexible Loop (DISEMBL)
MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSapnpdplpepePILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEveaigrvrhknLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSnilldkqwnpkLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICCVKF
Low Complexity Region (SEG)
MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKssslcsnynsssgnPTIPNISKEIQEIRIDPDSNSNSNCKPHSApnpdplpepepILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICCVKF
Disordered region (IsUnstruct)
**********LSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFT**************************************************************************************IEIG****I****************TVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICCV**
Disordered Region (DISOPRED)
***************SIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSN************************************************************************************************************************GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN*GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICCVKF
Disordered Region (DISEMBL)
********DQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPD***************DPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAYPER**********QTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICCVKF
Disordered Region (DISPRO)
**********LSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRN**************SLCSNYNSSSGNPTIPNISKEIQEIRIDPD***********************************************************************EVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSY*****LIC****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICCVKF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	424	2.2.26 [Sep-21-2011]
Q3EDL4	472	Probable serine/threonine	no	no	0.834	0.75	0.625	1e-138
Q6NKZ9	437	Probable receptor-like se	no	no	0.811	0.787	0.546	1e-111
Q9SJG2	494	Probable receptor-like pr	no	no	0.877	0.753	0.508	1e-110
Q8LEB6	484	Probable receptor-like pr	no	no	0.898	0.787	0.523	1e-110
Q9LRP3	467	Probable receptor-like pr	no	no	0.865	0.785	0.496	1e-106
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.556	0.327	0.518	2e-69
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.589	0.352	0.5	2e-67
Q9LV48	652	Proline-rich receptor-lik	no	no	0.504	0.328	0.532	2e-66
Q9C660	762	Proline-rich receptor-lik	no	no	0.533	0.296	0.519	9e-66
Q8GX23	670	Proline-rich receptor-lik	no	no	0.570	0.361	0.495	4e-65

>sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2

 Score =  491 bits (1263), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 255/408 (62%), Positives = 298/408 (73%), Gaps = 54/408 (13%)

Query: 1   MSHY--SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQL 58
           MS Y  +FLN +LSK TSIFGLRLWVV+GI +G+ IV+ LFL+SL  TS+R +   +   
Sbjct: 1   MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADF 60

Query: 59  NAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPI 118
            +A  ++              P ISKEI+EI                           P 
Sbjct: 61  ASAAIAT--------------PPISKEIKEI--------------------------VPA 80

Query: 119 LVEDSPASGRNRIHIEIGK-DHRIAYPER-AAGSHHGSGDQTVAAAIT------PEVSHL 170
             +  PA     I ++IGK +HR+ + +R ++G   G+   +  A+ +      PEVSHL
Sbjct: 81  QNQSVPAE----IQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHL 136

Query: 171 GWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
           GWG WYTLRELE +TNG  +ENVIGEGGYGIVY G+L D T VAVKNLLNNRGQAEKEFK
Sbjct: 137 GWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFK 196

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
           VEVE IGRVRHKNLVRLLGYC EGA+RMLVY+++DNGNLEQW+HGDVG  SPLTW+IRMN
Sbjct: 197 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMN 256

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           IILG AKGL YLHEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E SYVTTRV
Sbjct: 257 IILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRV 316

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
           MGTFGYVAPEYA TGMLNE+SD+YSFGILIME+I+GRNPVDYSRP GE
Sbjct: 317 MGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGE 364

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1

 Score =  400 bits (1029), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 213/390 (54%), Positives = 266/390 (68%), Gaps = 46/390 (11%)

Query: 12  SKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYN 71
           + + S+FGL L++V+ IC    + ++L  + ++     N  +  R++    SS       
Sbjct: 13  TTKPSVFGLNLYLVIAIC---SVFILLISLLIFLFVCLNRVSRARRMRVKHSSG------ 63

Query: 72  SSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRI 131
                 +IP +SKEI EI+                         + I  +DS     N +
Sbjct: 64  ------SIPLVSKEISEIKT----------------------VGKFINSDDSKGKIGNEV 95

Query: 132 HIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADE 191
            + +    + A       S   SGD   + A       +GWG WY+L++LE++T GF+D+
Sbjct: 96  VVVVSATSKEATSGFDTLSVASSGDVGTSEA-------MGWGKWYSLKDLEIATRGFSDD 148

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           N+IGEGGYG+VY     D +  AVKNLLNN+GQAEKEFKVEVEAIG+VRHKNLV L+GYC
Sbjct: 149 NMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYC 208

Query: 252 AEGAH--RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           A+ A   RMLVYEYIDNGNLEQWLHGDVGP SPLTW+IRM I +GTAKGL YLHEGLEPK
Sbjct: 209 ADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPK 268

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           VVHRD+KSSNILLDK+WN K+SDFGLAKLLG+E SYVTTRVMGTFGYV+PEYASTGMLNE
Sbjct: 269 VVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNE 328

Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
            SDVYSFG+L+ME+I+GR+PVDYSRPPGE+
Sbjct: 329 CSDVYSFGVLLMEIITGRSPVDYSRPPGEM 358

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1

 Score =  399 bits (1024), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 220/433 (50%), Positives = 281/433 (64%), Gaps = 61/433 (14%)

Query: 5   SFLNDQLSKRTSIFGLR---LWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAA 61
           S LN ++SK+ S FGL+   LWV + + VG  IV++L ++SLW T +R S  S  +    
Sbjct: 5   SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSKFP-- 62

Query: 62  KSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVE 121
                   +N       IP++SK+I   R+D     N              P PE + +E
Sbjct: 63  --------FNQ------IPHVSKDI---RVDRAGFQN--------------PHPESLYIE 91

Query: 122 DSPASGRNRIHIEIGKDHR-----------IAYPERAAGSHHG-------SGDQTVAAAI 163
            +  S    +   +G+              + + ERA  SH G       +G Q     +
Sbjct: 92  MNDKSTGKTMMSHLGRTKSSDNDTLSQCSSVNHHERACSSHSGEEGGFGSAGRQYGGGPV 151

Query: 164 T-------PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVK 216
           T       PE+SHLGWGHW+TLR+LE++TN FA  NV+GEGGYG+VY G L + T VAVK
Sbjct: 152 TASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVK 211

Query: 217 NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD 276
            LLNN GQAEKEF+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY+++GNLEQWLHG 
Sbjct: 212 KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGA 271

Query: 277 VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
           +  H  LTWE RM II GTA+ L YLHE +EPKVVHRDIK+SNIL+D ++N KLSDFGLA
Sbjct: 272 MRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLA 331

Query: 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
           KLL +  S++TTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+GR+PVDY RP 
Sbjct: 332 KLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPA 391

Query: 397 GEVCIPQMNSLMT 409
            EV + +   +M 
Sbjct: 392 NEVNLVEWLKMMV 404

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1

 Score =  398 bits (1022), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 213/407 (52%), Positives = 277/407 (68%), Gaps = 26/407 (6%)

Query: 5   SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
           S LND LS+  +  GL LW ++ I + A I +V+  ISLW T +R ++ S   L      
Sbjct: 3   SGLNDTLSRNYN--GLELWEIIVIVLSA-IFVVVLAISLWLTFRRKTSRSSSNLIPV--- 56

Query: 65  SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSP 124
                  S    P++P   +EI+EIR+D  S+SN      S        EPE  +  +S 
Sbjct: 57  -------SRQIPPSVP---EEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESE 106

Query: 125 ASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAIT---PEVSHLGWGHWYTLREL 181
               +R            + E+  GS   S +   A +     PE SHLGWGHW+TLR+L
Sbjct: 107 NGDSSR-------SGSFNHLEKKDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDL 159

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           +++TN F+ +N+IG+GGYG+VY G L + T VAVK LLNN GQA+K+F+VEVEAIG VRH
Sbjct: 160 QMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRH 219

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           KNLVRLLGYC EG  RMLVYEY++NGNLEQWL GD   H  LTWE R+ I++GTAK L Y
Sbjct: 220 KNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAY 279

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LHE +EPKVVHRDIKSSNIL+D ++N K+SDFGLAKLLGA++S++TTRVMGTFGYVAPEY
Sbjct: 280 LHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEY 339

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
           A++G+LNE+SDVYSFG++++E I+GR PVDY+RPP EV + +   +M
Sbjct: 340 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMM 386

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1

 Score =  384 bits (987), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 203/409 (49%), Positives = 270/409 (66%), Gaps = 42/409 (10%)

Query: 5   SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
           S L   L+KR  +  L LW ++ I + A  +++L L S+W + ++ S  S         S
Sbjct: 3   SQLKRTLTKRYGV--LELWEIIVIALFAAFIVILVL-SVWLSFRKKSKRSNATTLPVTQS 59

Query: 65  SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSP 124
                          P  ++EI+EI +D  S++N+     +          +   VED  
Sbjct: 60  ---------------PRFTEEIKEISVDHGSSNNNGTSYQTL---------DEKFVED-- 93

Query: 125 ASGRNRIHIEIGKDHRIAYPERA-AGSHHGSGDQTVAAAI----TPEVSHLGWGHWYTLR 179
                   IE G     +  ++   GSH      +  A       PEVSH+GWGHW+TLR
Sbjct: 94  --------IENGDKFSGSLEKKPLVGSHLPPSTPSTTAPSPLLGLPEVSHIGWGHWFTLR 145

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           +L+++TN F+ E++IG+GGYG+VYHG L + T VAVK LLNN GQA+K+F+VEVEAIG V
Sbjct: 146 DLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHV 205

Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           RHKNLVRLLGYC EG HRMLVYEY++NGNLEQWLHGD+     LTWE R+ +++GTAK L
Sbjct: 206 RHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKAL 265

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            YLHE +EPKVVHRDIKSSNIL+D  ++ KLSDFGLAKLLGA+ +YV+TRVMGTFGYVAP
Sbjct: 266 AYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAP 325

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
           EYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP  EV + +   LM
Sbjct: 326 EYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEWLKLM 374

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  263 bits (671), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 124/239 (51%), Positives = 171/239 (71%), Gaps = 3/239 (1%)

Query: 164 TPEVSHLGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR 222
           TP+ + LG G   ++  EL   T GFA +N++GEGG+G VY G L+D   VAVK L    
Sbjct: 346 TPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGS 405

Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
           GQ ++EFK EVE I RV H++LV L+GYC    HR+L+YEY+ N  LE  LHG   P   
Sbjct: 406 GQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV-- 463

Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           L W  R+ I +G+AKGL YLHE   PK++HRDIKS+NILLD ++  +++DFGLA+L    
Sbjct: 464 LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTT 523

Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCI 401
           +++V+TRVMGTFGY+APEYAS+G L +RSDV+SFG++++E+++GR PVD ++P GE  +
Sbjct: 524 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESL 582

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  256 bits (655), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 127/254 (50%), Positives = 174/254 (68%), Gaps = 4/254 (1%)

Query: 149 GSHHGSGDQTVAAAITPEVSHLGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYHGVL 207
           GS  G G  T + +  P+ + +G G   +T  EL   T GF+  N++GEGG+G VY G L
Sbjct: 314 GSQRGGGGYTRSGS-APDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKL 372

Query: 208 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267
            D   VAVK L    GQ ++EFK EVE I RV H++LV L+GYC   + R+L+YEY+ N 
Sbjct: 373 NDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQ 432

Query: 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327
            LE  LHG   P   L W  R+ I +G+AKGL YLHE   PK++HRDIKS+NILLD ++ 
Sbjct: 433 TLEHHLHGKGRP--VLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFE 490

Query: 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
            +++DFGLAKL  + +++V+TRVMGTFGY+APEYA +G L +RSDV+SFG++++E+I+GR
Sbjct: 491 AQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGR 550

Query: 388 NPVDYSRPPGEVCI 401
            PVD  +P GE  +
Sbjct: 551 KPVDQYQPLGEESL 564

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  253 bits (646), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 115/216 (53%), Positives = 160/216 (74%), Gaps = 2/216 (0%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA 235
           +T  EL  +TNGF++ N++G+GG+G V+ G+L     VAVK L    GQ E+EF+ EVE 
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           I RV H++LV L+GYC  G  R+LVYE++ N NLE  LHG   P   + W  R+ I LG+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP--TMEWSTRLKIALGS 385

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
           AKGL+YLHE   PK++HRDIK+SNIL+D ++  K++DFGLAK+     ++V+TRVMGTFG
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           Y+APEYA++G L E+SDV+SFG++++E+I+GR PVD
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVD 481

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  251 bits (640), Expect = 9e-66,   Method: Compositional matrix adjust.
 Identities = 120/231 (51%), Positives = 164/231 (70%), Gaps = 5/231 (2%)

Query: 171 GWGH---WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK 227
           G+G     ++  EL ++TNGF+DEN++GEGG+G VY GVL D   VAVK L    GQ ++
Sbjct: 410 GFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDR 469

Query: 228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
           EFK EV+ I RV H+NL+ ++GYC     R+L+Y+Y+ N NL   LH    P   L W  
Sbjct: 470 EFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG--LDWAT 527

Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
           R+ I  G A+GL YLHE   P+++HRDIKSSNILL+  ++  +SDFGLAKL     +++T
Sbjct: 528 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT 587

Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
           TRVMGTFGY+APEYAS+G L E+SDV+SFG++++E+I+GR PVD S+P G+
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 638

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  249 bits (635), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 172/246 (69%), Gaps = 4/246 (1%)

Query: 148 AGSHHGSGDQTVAAAI-TPEVSHLGWGH-WYTLRELEVSTNGFADENVIGEGGYGIVYHG 205
           +G H  + + T   AI +P+ + LG     +T  EL ++T GFA  N++G+GG+G V+ G
Sbjct: 270 SGPHSDASNLTGRTAIPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKG 329

Query: 206 VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265
           VL     VAVK+L    GQ E+EF+ EV+ I RV H++LV L+GYC  G  R+LVYE+I 
Sbjct: 330 VLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIP 389

Query: 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325
           N  LE  LHG   P   L W  R+ I LG+A+GL YLHE   P+++HRDIK++NILLD  
Sbjct: 390 NNTLEFHLHGKGRPV--LDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFS 447

Query: 326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           +  K++DFGLAKL     ++V+TRVMGTFGY+APEYAS+G L+++SDV+SFG++++E+I+
Sbjct: 448 FETKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELIT 507

Query: 386 GRNPVD 391
           GR P+D
Sbjct: 508 GRPPLD 513

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	424
255538254	528	Serine/threonine-protein kinase PBS1, pu	0.922	0.740	0.776	1e-180
449482676	521	PREDICTED: probable serine/threonine-pro	0.898	0.731	0.792	1e-179
225458659	519	PREDICTED: probable serine/threonine-pro	0.893	0.730	0.784	1e-177
224137574	469	predicted protein [Populus trichocarpa]	0.893	0.808	0.733	1e-163
356496904	503	PREDICTED: probable serine/threonine-pro	0.875	0.737	0.714	1e-160
359480850	516	PREDICTED: probable serine/threonine-pro	0.882	0.724	0.744	1e-159
449448310	505	PREDICTED: probable serine/threonine-pro	0.877	0.736	0.722	1e-159
356541793	499	PREDICTED: probable serine/threonine-pro	0.856	0.727	0.727	1e-156
255565232	509	BRASSINOSTEROID INSENSITIVE 1-associated	0.884	0.736	0.697	1e-156
449450231	842	PREDICTED: uncharacterized protein LOC10	0.801	0.403	0.796	1e-155

>gi|255538254|ref|XP_002510192.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223550893|gb|EEF52379.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  636 bits (1641), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 324/417 (77%), Positives = 351/417 (84%), Gaps = 26/417 (6%)

Query: 1   MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
           MS+YSFLNDQLSKRTSIFGLRLWVVLGICVGA IVLVLF+IS+WFTS+R+  N     ++
Sbjct: 1   MSNYSFLNDQLSKRTSIFGLRLWVVLGICVGAAIVLVLFIISVWFTSRRSKTNKNSTSHS 60

Query: 61  AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILV 120
            K  S   N N +  NPTIPN+SKEIQEIR+DP+ N         A +PDP+PE EP+L+
Sbjct: 61  TKFRSYLYNNNHNH-NPTIPNVSKEIQEIRLDPNPNPK-------ALSPDPVPESEPVLL 112

Query: 121 ED--SPASGRNRIHIEIGKDHRIAYPERAAGSHHGSG---------DQTVAAAITPEVSH 169
           E+  SP  GRNRIHIEIGKDHRI+YPERA GS +GSG         DQ   A + PEVSH
Sbjct: 113 EEENSPVGGRNRIHIEIGKDHRISYPERAGGSGNGSGETRSSPRSGDQAGGAIVVPEVSH 172

Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN-------R 222
           LGWGHWYTLRELEVSTN FADENVIGEGGYGIVY G+L+DNTNVAVK  L          
Sbjct: 173 LGWGHWYTLRELEVSTNCFADENVIGEGGYGIVYRGILDDNTNVAVKICLTTACTFWWCM 232

Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
           GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SP
Sbjct: 233 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSP 292

Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E
Sbjct: 293 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSE 352

Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPPGEV
Sbjct: 353 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEV 409

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449482676|ref|XP_004156368.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus]

 Score =  635 bits (1637), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 325/410 (79%), Positives = 347/410 (84%), Gaps = 29/410 (7%)

Query: 1   MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
           MS+Y+FLNDQLSKRTSIFGLRLWVVLGICVGA IV+VLFLISLWFTS+RNS         
Sbjct: 1   MSNYAFLNDQLSKRTSIFGLRLWVVLGICVGAAIVIVLFLISLWFTSRRNS--------- 51

Query: 61  AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKPHSAPNPDPLPEPEPIL 119
                  SN +  S NP IPN+SKEIQEIRID   N+ +S+ K   A NP+PLPE EP+ 
Sbjct: 52  -------SNKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEPLPEAEPLA 104

Query: 120 V-----EDSPASGRNRIHIEIGKDHRIAYPERAAGS-----HHGSGDQTVAAAITPEVSH 169
                 E SP SGR+RIHIEIGKDHRI+YPER  GS        SGDQ  A    PEVSH
Sbjct: 105 TLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQ--APMTVPEVSH 162

Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF 229
           LGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT VA+KNLLNNRGQAEKEF
Sbjct: 163 LGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEF 222

Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           KVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWLHG+VGP SPLTW+IRM
Sbjct: 223 KVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRM 282

Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
           NII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERSYVTTR
Sbjct: 283 NIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTR 342

Query: 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           VMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYSRP GEV
Sbjct: 343 VMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEV 392

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225458659|ref|XP_002282863.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera]

 Score =  627 bits (1618), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 327/417 (78%), Positives = 347/417 (83%), Gaps = 38/417 (9%)

Query: 1   MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
           M   +FLND+LSK TSIFGLRLWVV+GICVGAGIVLVLFLISLWFTS+RNS         
Sbjct: 1   MPEGAFLNDELSKHTSIFGLRLWVVVGICVGAGIVLVLFLISLWFTSRRNS--------- 51

Query: 61  AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPD---SNSNSNCKPHSAPNPDPLPEPEP 117
           AKSS            PTIPN+SKEIQEIRID     +N N + K H  PN +PLPE +P
Sbjct: 52  AKSSH----------KPTIPNVSKEIQEIRIDHSRNPANPNPDPKTHHPPNANPLPESDP 101

Query: 118 ILV--------EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAAAIT 164
                      E+SP  G  RIHIEIGKDHRI+YPER  GS HG     SGDQ   A   
Sbjct: 102 FAGAERLLQPGEESPV-GLQRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQVTIA--V 158

Query: 165 PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ 224
           PEVSHLGWGHWYTLRELE+STNGFADENVIGEGGYGIVY GVLEDNT VAVKNLLNNRGQ
Sbjct: 159 PEVSHLGWGHWYTLRELELSTNGFADENVIGEGGYGIVYRGVLEDNTQVAVKNLLNNRGQ 218

Query: 225 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
           AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGPHSPLT
Sbjct: 219 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPHSPLT 278

Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
           W+IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERS
Sbjct: 279 WDIRMNIIIGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERS 338

Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCI 401
           YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPPGEV +
Sbjct: 339 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEVNL 395

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224137574|ref|XP_002327160.1| predicted protein [Populus trichocarpa] gi|222835475|gb|EEE73910.1| predicted protein [Populus trichocarpa]

 Score =  581 bits (1498), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 309/421 (73%), Positives = 337/421 (80%), Gaps = 42/421 (9%)

Query: 1   MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
           MS+Y FLND+LSK+TSIFGLRLWVVLGICVGA IVL+LFLISLW TSKRN  ++K     
Sbjct: 1   MSNY-FLNDELSKKTSIFGLRLWVVLGICVGAAIVLLLFLISLWLTSKRNKTSNKANKPM 59

Query: 61  AKSSSLCSNYNSS-SGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPIL 119
           A +S+  + + SS + NPTIPNISKEIQEIR                             
Sbjct: 60  ATTSTATTKFVSSLNNNPTIPNISKEIQEIRTT--------------------------- 92

Query: 120 VEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSG---------DQTVAAAITPEVSHL 170
              SP  G NRIHIEIGKDHRI+YPER  G   GSG         DQ  A    PEVSHL
Sbjct: 93  ---SPVGGGNRIHIEIGKDHRISYPERVGGLGSGSGETRSGPRSGDQAGAVIAVPEVSHL 149

Query: 171 GWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
           GWGHWYTLRELE STN FADENVIGEGGYGIVY G+LEDNTNVAVKNLLNNRGQAEKEFK
Sbjct: 150 GWGHWYTLRELEESTNYFADENVIGEGGYGIVYRGLLEDNTNVAVKNLLNNRGQAEKEFK 209

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
           VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE+++NGNLEQWLHGDVGP SPLTWEIR+N
Sbjct: 210 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEFVENGNLEQWLHGDVGPCSPLTWEIRIN 269

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           II+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN K+SDFGLAKLLG+E SYVTTRV
Sbjct: 270 IIIGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSESSYVTTRV 329

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV-CIPQMNSLMT 409
           MGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRP GEV  +  + +++T
Sbjct: 330 MGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPAGEVNLVEWLKTMVT 389

Query: 410 L 410
           +
Sbjct: 390 I 390

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496904|ref|XP_003517305.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max]

 Score =  571 bits (1472), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 288/403 (71%), Positives = 319/403 (79%), Gaps = 32/403 (7%)

Query: 2   SHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAA 61
           S  + +NDQLS  TSIFGLRLWVVLG+CVGA IVL+LFLIS+W   KR+  N        
Sbjct: 6   SAAAAMNDQLSNPTSIFGLRLWVVLGVCVGAAIVLILFLISVWLAFKRSKTNPV------ 59

Query: 62  KSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPI--L 119
                           +IP++SKEIQEIR+D   N N   +P       PL EP+P+   
Sbjct: 60  ----------------SIPDVSKEIQEIRLDHAPNLNPTLQPEP-----PLSEPDPVPPT 98

Query: 120 VEDSPASGRNRIHIEIGKDHRIAYPERA---AGSHHGSGDQTVAAAITPEVSHLGWGHWY 176
            E++   G +RI  EIGK+HRI+YPER    + S+  S  +     + PEVSHLGWGHWY
Sbjct: 99  EEETTPLGYHRIQFEIGKNHRISYPERPLVRSSSNDPSSCEVQVPTVIPEVSHLGWGHWY 158

Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
           TLRELE STN FA ENVIGEGGYGIVYHG+L DNTNVA+KNLLNNRGQAEKEFKVEVEAI
Sbjct: 159 TLRELEDSTNAFAPENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAI 218

Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           GRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SPLTWEIRMNIILGTA
Sbjct: 219 GRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 278

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           KGLTYLHEGLEPKVVHRDIKSSNILL KQWN K+SDFGLAKLLG++ SY+TTRVMGTFGY
Sbjct: 279 KGLTYLHEGLEPKVVHRDIKSSNILLSKQWNAKVSDFGLAKLLGSDNSYITTRVMGTFGY 338

Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           VAPEYASTGMLNERSDVYSFGILIME+I+GRNPVDYSRPP EV
Sbjct: 339 VAPEYASTGMLNERSDVYSFGILIMELITGRNPVDYSRPPEEV 381

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359480850|ref|XP_002282732.2| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera]

 Score =  568 bits (1465), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 303/407 (74%), Positives = 329/407 (80%), Gaps = 33/407 (8%)

Query: 5   SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
           + +NDQLSK TSIFGLRLWVVLG+CVGA  VL+LFLISLW TSKRN+++  R        
Sbjct: 7   TLMNDQLSKPTSIFGLRLWVVLGVCVGAAFVLLLFLISLWLTSKRNNSSKIR-------- 58

Query: 65  SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLP--EPEPILV-- 120
                    S  PTIP +SKEIQEIRID    S     P   P  D L   E + +L+  
Sbjct: 59  --------PSQKPTIPAVSKEIQEIRIDHGHRSQIQADPF--PESDQLAGIEGQALLLPP 108

Query: 121 -EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLR 179
            E+SP  G +RIHIE+GKDHRI+YPER       + +Q  A+ + PEVSHLGWGHWYTLR
Sbjct: 109 GEESPG-GVHRIHIELGKDHRISYPERVVSGEARAVEQ--ASIVAPEVSHLGWGHWYTLR 165

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR-------GQAEKEFKVE 232
           ELE STN FAD++VIGEGGYGIVYHGVLEDNT VAVKNLLNNR       GQAEKEFKVE
Sbjct: 166 ELEASTNAFADDHVIGEGGYGIVYHGVLEDNTQVAVKNLLNNRCFLATTMGQAEKEFKVE 225

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
           VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY++NGNLEQWLHGDVGP SPLTWEIRMNII
Sbjct: 226 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSPLTWEIRMNII 285

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
           LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+E SYVTTRVMG
Sbjct: 286 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSEHSYVTTRVMG 345

Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           TFGYVAPEYASTGMLNERSDVYSFGILIME+ISGRNPVDYSRPP EV
Sbjct: 346 TFGYVAPEYASTGMLNERSDVYSFGILIMEIISGRNPVDYSRPPEEV 392

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448310|ref|XP_004141909.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] gi|449485438|ref|XP_004157168.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus]

 Score =  567 bits (1461), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 297/411 (72%), Positives = 321/411 (78%), Gaps = 39/411 (9%)

Query: 7   LNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSL 66
           + DQLSK+TSIFGLRLWVVLG+CVGA  VL LFLISLW  SKR    S++++        
Sbjct: 9   MADQLSKQTSIFGLRLWVVLGVCVGAAFVLFLFLISLWIASKR----SRKKI-------- 56

Query: 67  CSNYNSSSGNPTIPNISKEIQEIRID-PDSNSNSNCKP-HSAPNPDPLPEPEPI------ 118
                  S  PTIP +SKEIQEIRID P   +  + KP  S    DPLPEPEPI      
Sbjct: 57  -------SNRPTIPIVSKEIQEIRIDHPLPQNQEHNKPSRSHFQVDPLPEPEPIPGIERQ 109

Query: 119 --LVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG--------SGDQTVAAAITPEVS 168
             L         NRIHI+IGKDHRI+YPER   S            GDQ     + PEVS
Sbjct: 110 ALLSLPQEEERVNRIHIDIGKDHRISYPERLGRSSSSQGSGEGRCGGDQL--PMVVPEVS 167

Query: 169 HLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE 228
           HLGWGHWYTLRELE STNGF+ +NVIGEGGYGIVYHG+LED T VAVKNLLNNRGQAEKE
Sbjct: 168 HLGWGHWYTLRELEASTNGFSPDNVIGEGGYGIVYHGILEDGTQVAVKNLLNNRGQAEKE 227

Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
           FKVEVEAIGRVRHK+LVRLLGYCAEGAHRMLVYEYI+NGNLEQWLHGDVG  SPLTWEIR
Sbjct: 228 FKVEVEAIGRVRHKSLVRLLGYCAEGAHRMLVYEYINNGNLEQWLHGDVGSFSPLTWEIR 287

Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
           MNIILGTAKGL YLHEGLEPKVVHRDIKSSNILLDKQWN K+SDFGLAKLL ++ SY+TT
Sbjct: 288 MNIILGTAKGLAYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLCSDNSYITT 347

Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           RVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPP EV
Sbjct: 348 RVMGTFGYVAPEYASTGMLNERSDVYSFGILVMEIISGRNPVDYSRPPDEV 398

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356541793|ref|XP_003539357.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max]

 Score =  557 bits (1435), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 289/397 (72%), Positives = 322/397 (81%), Gaps = 34/397 (8%)

Query: 7   LNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSL 66
           +NDQLS  TSIFGLRLWVVLG+CVGA IVL+LFLIS+W   KR                 
Sbjct: 11  MNDQLSNTTSIFGLRLWVVLGVCVGAAIVLILFLISVWLAFKR----------------- 53

Query: 67  CSNYNSSSGNP-TIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPA 125
                SS  NP +IP++SKEIQEIR+D    +N   +P   P PDP+P  E    E++ +
Sbjct: 54  -----SSKTNPVSIPDVSKEIQEIRLD----TNPTLQPEPYPEPDPVPPTE----EETNS 100

Query: 126 SGRNRIHIEIGKDHRIAYPERA---AGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELE 182
            G +RI  EIGK+HRI+YPERA   + S+  S  +     + PEVSHLGWGHWYTLR+LE
Sbjct: 101 LGYHRIQFEIGKNHRISYPERALLRSSSNDPSSGEVQLPTVIPEVSHLGWGHWYTLRDLE 160

Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
            +TNGFA ENVIGEGGYGIVYHG+L DNTNVA+KNLLNNRGQAEKEFKVEVEAIGRVRHK
Sbjct: 161 DATNGFAPENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAIGRVRHK 220

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           NLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SPLTWEIRMNIILGTAKGLTYL
Sbjct: 221 NLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLTYL 280

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           HEGLEPKVVHRDIKSSNILL K+WN K+SDFGLAKLLG++ SY+TTRVMGTFGYVAPEYA
Sbjct: 281 HEGLEPKVVHRDIKSSNILLSKKWNAKVSDFGLAKLLGSDSSYITTRVMGTFGYVAPEYA 340

Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           STGMLNERSDVYSFGILIME+I+GRNPVDYSRPP EV
Sbjct: 341 STGMLNERSDVYSFGILIMELITGRNPVDYSRPPEEV 377

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565232|ref|XP_002523608.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223537170|gb|EEF38803.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  556 bits (1433), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 281/403 (69%), Positives = 319/403 (79%), Gaps = 28/403 (6%)

Query: 6   FLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSS 65
            +NDQLSK TS+FGLR+WVVLG+CVGA  VLVLFLI++W  SKR+  ++K          
Sbjct: 8   LMNDQLSKPTSVFGLRVWVVLGVCVGAAFVLVLFLITVWLASKRSKKDNK---------- 57

Query: 66  LCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLP--EPEPILV--- 120
                   +  P IP +SKEIQEIR++P   + +  + H  P+P+     E + +L+   
Sbjct: 58  --------NSKPKIPVVSKEIQEIRVEPVKPNRAQIQTHPFPDPEIAAGNERQALLLMPP 109

Query: 121 -EDSPAS---GRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWY 176
            E+SP     G   I IEIGK H I+YP  +  +  G GDQ +A  + P+VSHLGWGHWY
Sbjct: 110 EEESPMGYHHGTGNIQIEIGKGHLISYPVSSGEAPRGGGDQ-LAMVVGPDVSHLGWGHWY 168

Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
           TLRELE STNGFADENVIG+GGYGIVY+GVL DNT VAVKNLLNNRGQAEKEFKVEVEAI
Sbjct: 169 TLRELEASTNGFADENVIGQGGYGIVYYGVLVDNTQVAVKNLLNNRGQAEKEFKVEVEAI 228

Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           GRVRHKNLVRLLGYCAEG+HRMLVYEY++NGNLEQWLHGDVG  SPLTWEIRMNIILGTA
Sbjct: 229 GRVRHKNLVRLLGYCAEGSHRMLVYEYVNNGNLEQWLHGDVGSCSPLTWEIRMNIILGTA 288

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           KGLTYLHEGLEPKVVHRDIKSSNILLDK WN K+SDFGLAKLL  E SY+TTRVMGTFGY
Sbjct: 289 KGLTYLHEGLEPKVVHRDIKSSNILLDKLWNAKVSDFGLAKLLYPESSYITTRVMGTFGY 348

Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           VAPEYASTGM+NERSDV+ FGILIME+ISGRNPVDYSRPP EV
Sbjct: 349 VAPEYASTGMVNERSDVFGFGILIMEIISGRNPVDYSRPPDEV 391

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450231|ref|XP_004142867.1| PREDICTED: uncharacterized protein LOC101203008 [Cucumis sativus]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 281/353 (79%), Positives = 300/353 (84%), Gaps = 13/353 (3%)

Query: 58  LNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKPHSAPNPDPLPEPE 116
           +N   S    SN +  S NP IPN+SKEIQEIRID   N+ +S+ K   A NP+PLPE E
Sbjct: 363 INQLLSRRNSSNKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEPLPEAE 422

Query: 117 PILV-----EDSPASGRNRIHIEIGKDHRIAYPERAAGS-----HHGSGDQTVAAAITPE 166
           P+       E SP SGR+RIHIEIGKDHRI+YPER  GS        SGDQ  A    PE
Sbjct: 423 PLATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQ--APMTVPE 480

Query: 167 VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE 226
           VSHLGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT VA+KNLLNNRGQAE
Sbjct: 481 VSHLGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAE 540

Query: 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
           KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWLHG+VGP SPLTW+
Sbjct: 541 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWD 600

Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
           IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERSYV
Sbjct: 601 IRMNIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYV 660

Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           TTRVMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYSRP GEV
Sbjct: 661 TTRVMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEV 713

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	424
TAIR|locus:2132353	492	AT4G02630 [Arabidopsis thalian	0.738	0.636	0.744	2.3e-146
TAIR|locus:2025396	472	AT1G01540 [Arabidopsis thalian	0.632	0.567	0.760	5.5e-128
TAIR|locus:2045620	494	AT2G42960 [Arabidopsis thalian	0.617	0.530	0.673	4.5e-107
TAIR|locus:2139559	437	AT4G34500 [Arabidopsis thalian	0.580	0.562	0.745	1.5e-106
TAIR|locus:2146203	484	AT5G18500 [Arabidopsis thalian	0.752	0.659	0.573	1.1e-105
TAIR|locus:2027559	492	AT1G56720 [Arabidopsis thalian	0.882	0.760	0.525	7.7e-103
TAIR|locus:2077730	512	AT3G59110 [Arabidopsis thalian	0.957	0.792	0.509	9.8e-103
TAIR|locus:2093591	467	GPK1 "glyoxysomal protein kina	0.575	0.522	0.688	6.7e-100
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.877	0.798	0.506	1e-98
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.573	0.356	0.492	1.4e-66

TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)]

 Score = 1252 (445.8 bits), Expect = 2.3e-146, Sum P(2) = 2.3e-146
 Identities = 251/337 (74%), Positives = 275/337 (81%)

Query:    79 IPNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXXXXXILVEDSPASGRNRIHIEIGKD 138
             +P +SKEIQEIR  P    +   +PH                ED      N+IHIEIGKD
Sbjct:    67 VPVVSKEIQEIR--PPIQPDPTPEPHQNQQR-----------EDD-----NKIHIEIGKD 108

Query:   139 HRIAYPERA----AGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVI 194
             HRIAYPER     +GS  GSGDQ +     PEVSHLGWGHWYTLRELEVSTNGFADENVI
Sbjct:   109 HRIAYPERGGWTGSGSGSGSGDQGLLMLSGPEVSHLGWGHWYTLRELEVSTNGFADENVI 168

Query:   195 GEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254
             G+GGYGIVY GVLED + VA+KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC EG
Sbjct:   169 GQGGYGIVYRGVLEDKSMVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEG 228

Query:   255 AHRMLVYEYIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
             AHRMLVYEY+DNGNLEQW+HG  +G  SPLTWEIRMNI+LGTAKGL YLHEGLEPKVVHR
Sbjct:   229 AHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHR 288

Query:   314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
             DIKSSNILLDKQWN K+SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYASTGMLNERSDV
Sbjct:   289 DIKSSNILLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGTFGYVAPEYASTGMLNERSDV 348

Query:   374 YSFGILIMEVISGRNPVDYSRPPGEVCIPQ-MNSLMT 409
             YSFG+L+ME+ISGR+PVDYSR PGEV + + +  L+T
Sbjct:   349 YSFGVLVMEIISGRSPVDYSRAPGEVNLVEWLKRLVT 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0042546 "cell wall biogenesis" evidence=RCA

TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1121 (399.7 bits), Expect = 5.5e-128, Sum P(2) = 5.5e-128
 Identities = 210/276 (76%), Positives = 238/276 (86%)

Query:   131 IHIEIGK-DHRIAYPER-AAGSHHGSGDQTVAAAIT------PEVSHLGWGHWYTLRELE 182
             I ++IGK +HR+ + +R ++G   G+   +  A+ +      PEVSHLGWG WYTLRELE
Sbjct:    89 IQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHLGWGRWYTLRELE 148

Query:   183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
              +TNG  +ENVIGEGGYGIVY G+L D T VAVKNLLNNRGQAEKEFKVEVE IGRVRHK
Sbjct:   149 AATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK 208

Query:   243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
             NLVRLLGYC EGA+RMLVY+++DNGNLEQW+HGDVG  SPLTW+IRMNIILG AKGL YL
Sbjct:   209 NLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYL 268

Query:   303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
             HEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYA
Sbjct:   269 HEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYA 328

Query:   363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
              TGMLNE+SD+YSFGILIME+I+GRNPVDYSRP GE
Sbjct:   329 CTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGE 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)]

 Score = 968 (345.8 bits), Expect = 4.5e-107, Sum P(2) = 4.5e-107
 Identities = 177/263 (67%), Positives = 215/263 (81%)

Query:   147 AAGSHHGSGDQTVAAAI-TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHG 205
             +AG  +G G  T +  +  PE+SHLGWGHW+TLR+LE++TN FA  NV+GEGGYG+VY G
Sbjct:   141 SAGRQYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRG 200

Query:   206 VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265
              L + T VAVK LLNN GQAEKEF+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY++
Sbjct:   201 KLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 260

Query:   266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325
             +GNLEQWLHG +  H  LTWE RM II GTA+ L YLHE +EPKVVHRDIK+SNIL+D +
Sbjct:   261 SGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDE 320

Query:   326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
             +N KLSDFGLAKLL +  S++TTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+
Sbjct:   321 FNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAIT 380

Query:   386 GRNPVDYSRPPGEVCIPQMNSLM 408
             GR+PVDY RP  EV + +   +M
Sbjct:   381 GRDPVDYGRPANEVNLVEWLKMM 403

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1009 (360.2 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
 Identities = 187/251 (74%), Positives = 219/251 (87%)

Query:   154 SGDQTVAAAITPEVSH---LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN 210
             SG  T++ A + +V     +GWG WY+L++LE++T GF+D+N+IGEGGYG+VY     D 
Sbjct:   108 SGFDTLSVASSGDVGTSEAMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDG 167

Query:   211 TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVYEYIDNGN 268
             +  AVKNLLNN+GQAEKEFKVEVEAIG+VRHKNLV L+GYCA+ A   RMLVYEYIDNGN
Sbjct:   168 SVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGN 227

Query:   269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
             LEQWLHGDVGP SPLTW+IRM I +GTAKGL YLHEGLEPKVVHRD+KSSNILLDK+WN 
Sbjct:   228 LEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNA 287

Query:   329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
             K+SDFGLAKLLG+E SYVTTRVMGTFGYV+PEYASTGMLNE SDVYSFG+L+ME+I+GR+
Sbjct:   288 KVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRS 347

Query:   389 PVDYSRPPGEV 399
             PVDYSRPPGE+
Sbjct:   348 PVDYSRPPGEM 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)]

 Score = 963 (344.1 bits), Expect = 1.1e-105, Sum P(2) = 1.1e-105
 Identities = 192/335 (57%), Positives = 242/335 (72%)

Query:    80 PNISKEIQEIRIDPDSNSNS-NCKPHSAXXXXXXXXXXXILVE----DSPASGR-NRIHI 133
             P++ +EI+EIR+D  S+SN  N  P  +           I  E    DS  SG  N +  
Sbjct:    62 PSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLEK 121

Query:   134 EIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENV 193
             + G     A P  A     G           PE SHLGWGHW+TLR+L+++TN F+ +N+
Sbjct:   122 KDGSSVSSANPLTAPSPLSG----------LPEFSHLGWGHWFTLRDLQMATNQFSRDNI 171

Query:   194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
             IG+GGYG+VY G L + T VAVK LLNN GQA+K+F+VEVEAIG VRHKNLVRLLGYC E
Sbjct:   172 IGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCME 231

Query:   254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
             G  RMLVYEY++NGNLEQWL GD   H  LTWE R+ I++GTAK L YLHE +EPKVVHR
Sbjct:   232 GTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHR 291

Query:   314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
             DIKSSNIL+D ++N K+SDFGLAKLLGA++S++TTRVMGTFGYVAPEYA++G+LNE+SDV
Sbjct:   292 DIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSDV 351

Query:   374 YSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
             YSFG++++E I+GR PVDY+RPP EV + +   +M
Sbjct:   352 YSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMM 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)]

 Score = 1019 (363.8 bits), Expect = 7.7e-103, P = 7.7e-103
 Identities = 213/405 (52%), Positives = 277/405 (68%)

Query:     7 LNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKXXXX 66
             L  QLS+ + +FGL++W V+GI V   I+ +L ++S   TSK+ S  SK  L   +    
Sbjct:     5 LKSQLSRESHVFGLKVWEVIGIAVALLIIAILSVLSCCLTSKKKSRRSKTGLPVIQ---- 60

Query:    67 XXXXXXXXXXPTIPNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXX----XXXILV-- 120
                        T P +SKEI+E+R++    S SN  P                  ++V  
Sbjct:    61 -----------TPPVVSKEIREVRVE--HVSASNFAPGEGILLTIQDKNNKDSEKVMVHL 107

Query:   121 ---EDSPASGRNRI--HIEIGKDHRIAYPERAAGSH-HGSGDQTVAAAITPEVSHLGWGH 174
                +   +SGR+    H+EI   H  +  E +A S  +     +  + + PE SHLGWGH
Sbjct:   108 DMRKKRSSSGRSGSFHHLEIIDKHSDSAEEVSASSSLYNIATPSPLSGL-PE-SHLGWGH 165

Query:   175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
             W+TLR+LE +TN F+ ENVIGEGGYG+VY G L + T VAVK +LN  GQAEKEF+VEV+
Sbjct:   166 WFTLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVD 225

Query:   235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
             AIG VRHKNLVRLLGYC EG HR+LVYEY++NGNLEQWLHG +  H  LTWE RM +++G
Sbjct:   226 AIGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIG 285

Query:   295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
             T+K L YLHE +EPKVVHRDIKSSNIL++ ++N K+SDFGLAKLLGA +S+VTTRVMGTF
Sbjct:   286 TSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 345

Query:   355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
             GYVAPEYA++G+LNE+SDVYSFG++++E I+GR+PVDY RP  EV
Sbjct:   346 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEV 390

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
 Identities = 210/412 (50%), Positives = 266/412 (64%)

Query:     1 MSHYSFLNDQLSKRTSIFGLR---LWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQ 57
             MS  S L+  +SK+ S  GL+   LWV++ + VG  +VLV  ++SLW   +R S  S  +
Sbjct:     1 MSSESSLSADMSKKVSFLGLKGMKLWVLICLVVGTFVVLVFCILSLWIAFRRKSRRSSHK 60

Query:    58 LNAAKXXXXXXXXXXXXXXPTIPNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXXXXX 117
             L                      N ++ +     D  S+ NS  K  S            
Sbjct:    61 LLPFSQIPRVAKDIRVDDRVGFQNHNENLSITNADKSSDRNSG-KMMSYLGRTKSSDNDS 119

Query:   118 ILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAI-TPEVSHLGWGHWY 176
             I    S            G+D       R      G G  T +  +  PE+SHLGWGHW+
Sbjct:   120 ISQCSSVHHHERACSSHSGEDGSFGAAWRQNSLSQG-GLVTASPLVGLPEISHLGWGHWF 178

Query:   177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
             TLR+L+++TN FA ENVIGEGGYG+VY G L +  +VAVK LLNN GQAEKEF+VEVEAI
Sbjct:   179 TLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAI 238

Query:   237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             G VRHKNLVRLLGYC EG +RMLVYEY+++GNLEQWLHG +G  S LTWE RM I++GTA
Sbjct:   239 GHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGTA 298

Query:   297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
             + L YLHE +EPKVVHRDIK+SNIL+D  +N KLSDFGLAKLL +  S++TTRVMGTFGY
Sbjct:   299 QALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 358

Query:   357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
             VAPEYA+TG+LNE+SD+YSFG+L++E I+GR+PVDY RP  EV + +   +M
Sbjct:   359 VAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVEWLKMM 410

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 941 (336.3 bits), Expect = 6.7e-100, Sum P(2) = 6.7e-100
 Identities = 168/244 (68%), Positives = 210/244 (86%)

Query:   165 PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ 224
             PEVSH+GWGHW+TLR+L+++TN F+ E++IG+GGYG+VYHG L + T VAVK LLNN GQ
Sbjct:   131 PEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQ 190

Query:   225 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
             A+K+F+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY++NGNLEQWLHGD+     LT
Sbjct:   191 ADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLT 250

Query:   285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
             WE R+ +++GTAK L YLHE +EPKVVHRDIKSSNIL+D  ++ KLSDFGLAKLLGA+ +
Sbjct:   251 WEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSN 310

Query:   345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQM 404
             YV+TRVMGTFGYVAPEYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP  EV + + 
Sbjct:   311 YVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEW 370

Query:   405 NSLM 408
               LM
Sbjct:   371 LKLM 374

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=RCA

GO:0043161 "proteasomal ubiquitin-dependent protein catabolic process" evidence=RCA

GO:0043248 "proteasome assembly" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0051788 "response to misfolded protein" evidence=RCA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
 Identities = 199/393 (50%), Positives = 266/393 (67%)

Query:    19 GLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKXXXXXXXXXXXXXXPT 78
             GL++W  + I +   I++VL ++S     K+ S  SK                     P 
Sbjct:     3 GLKIWQAIFITIALIIIVVLSVLSFCLIWKKKSRRSK-----------------TLSLPI 45

Query:    79 I--PNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXXXXXILVEDSPASGRNRIHIEIG 136
             I  P +SKEI+E+RI+   +++SN  P              + +E +  +G +      G
Sbjct:    46 IQTPVVSKEIKEVRIEHVVSTSSNFDPQDENNNESDKFLLNLEMEKNRENGLSSSRSGSG 105

Query:   137 KDHRIAYPERAAGSHHGSGDQTVAAAI-TPEVSHLGWGHWYTLRELEVSTNGFADENVIG 195
             K+  +    R+  S +     + +     PE SHLGWGHW+TLR+LE++TN F+ ENVIG
Sbjct:   106 KEGYLCVANRSTSSLYEMATPSPSPLSGLPE-SHLGWGHWFTLRDLEIATNRFSKENVIG 164

Query:   196 EGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255
             EGGYG+VY G L + + VAVK +LN+ GQAEKEF+VEV+AIG VRHKNLVRLLGYC EG 
Sbjct:   165 EGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGT 224

Query:   256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315
             +R+LVYEY++NGNLE+WLHG +  H  LTWE RM ++ GT+K L YLHE +EPKVVHRDI
Sbjct:   225 NRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDI 284

Query:   316 KSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYS 375
             KSSNIL+D ++N K+SDFGLAKLLG  +S+VTTRVMGTFGYVAPEYA+TG+LNE+SDVYS
Sbjct:   285 KSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYS 344

Query:   376 FGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
             FG+L++E I+GR+PVDY+RP  EV + +   +M
Sbjct:   345 FGVLVLEAITGRDPVDYARPANEVNLVEWLKMM 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 633 (227.9 bits), Expect = 1.4e-66, Sum P(2) = 1.4e-66
 Identities = 124/252 (49%), Positives = 174/252 (69%)

Query:   150 SHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED 209
             SH GS D   A++ +  VS+     W++  EL   T+GF+++N++GEGG+G VY GVL D
Sbjct:   304 SHSGS-DYMYASSDSGMVSNQR--SWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSD 360

Query:   210 NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269
                VAVK L     Q E+EFK EVE I RV H++LV L+GYC    HR+LVY+Y+ N  L
Sbjct:   361 GREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTL 420

Query:   270 EQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
                LH    P  P +TWE R+ +  G A+G+ YLHE   P+++HRDIKSSNILLD  +  
Sbjct:   421 HYHLHA---PGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEA 477

Query:   329 KLSDFGLAKLLGAE--RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 386
              ++DFGLAK+       ++V+TRVMGTFGY+APEYA++G L+E++DVYS+G++++E+I+G
Sbjct:   478 LVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITG 537

Query:   387 RNPVDYSRPPGE 398
             R PVD S+P G+
Sbjct:   538 RKPVDTSQPLGD 549

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00014847001 SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (480 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	424
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-42
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-42
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-29
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.002
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.003
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (421), Expect = 4e-49
 Identities = 67/193 (34%), Positives = 106/193 (54%), Gaps = 11/193 (5%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +GEGG+G VY     +    VA+K +   +     +E   E+E + ++ H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +  H  LV EY + G+L+  L         L+ +  + I+L   +GL YLH      ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 312 HRDIKSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LNE 369
           HRD+K  NILLD      KL+DFGL+KLL +++S + T V GT  Y+APE        +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173

Query: 370 RSDVYSFGILIME 382
           +SD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (403), Expect = 6e-46
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 13/206 (6%)

Query: 191 ENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 244
              +GEG +G VY G L+         VAVK L  +   Q  +EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           V+LLG C E     +V EY++ G+L  +L         L+    ++  L  A+G+ YL  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
                 +HRD+ + N L+ +    K+SDFGL++ L  +  Y          ++APE    
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 365 GMLNERSDVYSFGILIMEVIS-GRNP 389
           G    +SDV+SFG+L+ E+ + G  P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (401), Expect = 1e-45
 Identities = 70/207 (33%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLL 248
            +G G +G VY          VAVK +L  R +  K+ +    E+  + R+ H N+VRL+
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVK-ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
               +  H  LV EY + G+L  +L        PL+ +    I L   +GL YLH     
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YA 362
            ++HRD+K  NILLD+    K++DFGLAK L    S +TT V GT  Y+APE        
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                  + DV+S G+++ E+++G+ P
Sbjct: 177 GP-----KVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (397), Expect = 4e-45
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 12/206 (5%)

Query: 191 ENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 244
              +GEG +G VY G L+         VAVK L  +   Q  +EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           V+LLG C E    M+V EY+  G+L  +L         L+    ++  L  A+G+ YL  
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
                 +HRD+ + N L+ +    K+SDFGL++ L  +  Y          ++APE    
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 365 GMLNERSDVYSFGILIMEVIS-GRNP 389
           G    +SDV+SFG+L+ E+ + G  P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  154 bits (391), Expect = 4e-44
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 27/216 (12%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVR 246
             +GEG +G VY G L+        VAVK L  +   +  K+F  E   + ++ H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           LLG C E     LV EY++ G+L  +L            S L+ +  ++  +  AKG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-------RVMGTF 354
           L      K VHRD+ + N L+ +    K+SDFGL++ +  +  Y          R M   
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174

Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              APE    G+   +SDV+SFG+L+ E+ + G  P
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  149 bits (378), Expect = 3e-42
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 193 VIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
            +GEG +G VY G L        T VAVK L     + E+ EF  E   + ++ H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           LLG C +G    +V EY+  G+L  +L         LT +  + + L  AKG+ YL    
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG---YVAPEYAS 363
               VHRD+ + N L+ +    K+SDFGL++ +  +  Y      G      ++APE   
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177

Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNP 389
            G    +SDV+SFG+L+ E+ + G  P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  148 bits (375), Expect = 6e-42
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           +     +GEG +G VY     +    VA+K +      +  +    E++ + +++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHE 304
           RL     +     LV EY + G+L   L         L+  E R   +      L YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
                +VHRD+K  NILLD+  + KL+DFGLA+ L       TT V GT  Y+APE    
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLG 170

Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
               +  D++S G+++ E+++G+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 2e-32
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 18/206 (8%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG+G +G V  G       VAVK L ++   A+  F  E   +  +RH NLV+LLG   +
Sbjct: 14  IGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
           G    +V EY+  G+L  +L    G    +T   ++   L   +G+ YL    E   VHR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR-GRAV-ITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D+ + N+L+ +    K+SDFGLAK          +   G     + APE       + +S
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKS 180

Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPP 396
           DV+SFGIL+ E+ S GR P  Y R P
Sbjct: 181 DVWSFGILLWEIYSFGRVP--YPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 1e-31
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 11/201 (5%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           ++IG G +G+VY G+ LE    VA+K  +L   + +A K    E++ +  ++H N+V+ +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G         ++ EY +NG+L Q +        P    +    +    +GL YLHE    
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE---Q 118

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
            V+HRDIK++NIL  K    KL+DFG+A  L        + V+GT  ++APE       +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGAS 177

Query: 369 ERSDVYSFGILIMEVISGRNP 389
             SD++S G  ++E+++G  P
Sbjct: 178 TASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (298), Expect = 8e-31
 Identities = 66/201 (32%), Positives = 117/201 (58%), Gaps = 12/201 (5%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           F  E  +G G +G V+ G+ ++   VA+K L ++    +++F+ EV+A+ R+RHK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
              C+ G    ++ E ++ G+L  +L    G V P + L     +++    A+G+ YL  
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLE- 121

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             E   +HRD+ + NIL+ +    K++DFGLA+L+  E  Y+++     + + APE AS 
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASH 178

Query: 365 GMLNERSDVYSFGILIMEVIS 385
           G  + +SDV+SFGIL+ E+ +
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  118 bits (297), Expect = 1e-30
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 17/206 (8%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN-VAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
            ++G G +G VY  + +D    +AVK   L  +  +  +  + E+  +  ++H N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 249 GYCAEGAHRML-VY-EYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHE 304
           G   +     L ++ EY+  G+L   L        P+   IR     IL   +GL YLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL---EGLAYLHS 119

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYVAPEYAS 363
                +VHRDIK +NIL+D     KL+DFG AK LG   +   T  + GT  ++APE   
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
                  +D++S G  ++E+ +G+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  117 bits (295), Expect = 2e-30
 Identities = 67/211 (31%), Positives = 112/211 (53%), Gaps = 17/211 (8%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTNV-AVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNL 244
           F   N IG+G +G+V+  V + +  V A+K + L+   + E+E  + E   + ++    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT----WEIRMNIILGTAKGLT 300
           +R      +     +V EY +NG+L + L    G   PL     W   + I+LG    L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLG----LA 115

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           +LH     K++HRDIKS N+ LD   N K+ D G+AKLL    ++  T ++GT  Y++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPE 171

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                  NE+SDV++ G+++ E  +G++P D
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (299), Expect = 4e-30
 Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 19/218 (8%)

Query: 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRH-K 242
            +     +GEG +G VY     D   VA+K L   L ++ +  + F  E++ +  + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N+V+L  +  +     LV EY+D G+LE  L   +G   PL+    + I+      L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117

Query: 303 HEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAERS-----YVTTRVMGTFGY 356
           H      ++HRDIK  NILLD+     KL DFGLAKLL    S      + +  +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 357 VAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVD 391
           +APE     S    +  SD++S GI + E+++G  P +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 9e-29
 Identities = 71/212 (33%), Positives = 107/212 (50%), Gaps = 13/212 (6%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVR 240
           E+       E  +G G +G V+ G     T VAVK L    G    E F  E + + ++R
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLR 59

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H  LV+L   C+E     +V EY+  G+L  +L    G    L   + M   +  A+G+ 
Sbjct: 60  HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMA 117

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVA 358
           YL        +HRD+ + NIL+ +    K++DFGLA+L+  +  Y T R    F   + A
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEY-TAREGAKFPIKWTA 172

Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           PE A+ G    +SDV+SFGIL+ E+++ GR P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  112 bits (282), Expect = 1e-28
 Identities = 70/218 (32%), Positives = 112/218 (51%), Gaps = 18/218 (8%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVE 234
           E+  +    + VIG G +G V+ G+L+        VA+K L    G  EK+   F  E  
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58

Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
            +G+  H N++RL G   +    M++ EY++NG L+++L    G  S       + ++ G
Sbjct: 59  IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRG 115

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMG 352
            A G+ YL    +   VHRD+ + NIL++     K+SDFGL+++L    E +Y T+    
Sbjct: 116 IAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172

Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              + APE  +       SDV+SFGI++ EV+S G  P
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  111 bits (281), Expect = 2e-28
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 9/209 (4%)

Query: 188 FADENVIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           F     IG+GG+G VY          VA+K +     + +++   E++ + + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
             G   +     +V E+   G+L+  L         LT      +     KGL YLH   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN- 117

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
              ++HRDIK++NILL      KL DFGL+  L   ++     ++GT  ++APE  +   
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKP 173

Query: 367 LNERSDVYSFGILIMEVISGRNPVDYSRP 395
            + ++D++S GI  +E+  G+ P     P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPP 202

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  112 bits (282), Expect = 3e-28
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           + +   IGEG  G VY          VA+K +   R Q ++    E+  +   +H N+V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMN------IILGTAKGL 299
                  G    +V EY+D G+L      D+     +T   +RMN      +     +GL
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLT-----DI-----ITQNFVRMNEPQIAYVCREVLQGL 129

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            YLH      V+HRDIKS NILL K  + KL+DFG A  L  E+S   + V GT  ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNP 389
           E         + D++S GI+ +E+  G  P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  109 bits (276), Expect = 1e-27
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 188 FADENVIGEGGYGIVY---HGVLEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHK 242
           +     IG+G +G VY        D     +K + L+N  + E+E  + EV+ + ++ H 
Sbjct: 2   YEIIKQIGKGSFGKVYLVRR--KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N+++      E     +V EY D G+L Q +        P   E  ++  +     L YL
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-- 360
           H     K++HRDIK  NI L      KL DFG++K+L +      T V GT  Y++PE  
Sbjct: 120 HS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175

Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGRNP 389
               Y      N +SD++S G ++ E+ + ++P
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 4e-27
 Identities = 70/213 (32%), Positives = 110/213 (51%), Gaps = 27/213 (12%)

Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 243
           E VIG G +G V  G L    +   +VA+K L    G ++K+   F  E   +G+  H N
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RL G   +    M++ EY++NG+L+++L  + G     T    + ++ G A G+ YL 
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLS 123

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG------YV 357
           E      VHRD+ + NIL++     K+SDFGL++ L    +  TT+     G      + 
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWT 175

Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  +       SDV+SFGI++ EV+S G  P
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (264), Expect = 3e-26
 Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 9/207 (4%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G+V+ G   +   VA+K +      +E++F  E + + ++ H  LV+L G C E
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
            +   LV+E++++G L  +L    G  S    E  + + L   +G+ YL       V+HR
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESS---NVIHR 124

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +SDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 374 YSFGILIMEVIS-GRNPVDYSRPPGEV 399
           +SFG+L+ EV S G+ P + +R   EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (266), Expect = 3e-26
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 32/224 (14%)

Query: 193 VIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG- 249
           V+G+G  G+VY           A+K + ++   +  K+   E++ +       +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP-----LTWEIRMNIILGTAKGLTYLHE 304
           +  EG    +V EY+D G+L   L   VG         +  +I         KGL YLH 
Sbjct: 68  FYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQI--------LKGLDYLHT 117

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----GAERSYVTTRVMGTFGYVAPE 360
                ++HRDIK SN+L++ +   K++DFG++K+L        ++V     GT  Y++PE
Sbjct: 118 KR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPE 170

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQM 404
                  +  +D++S G+ ++E   G+ P  +  PPG+    ++
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP--FL-PPGQPSFFEL 211

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 7e-26
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 21/210 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           V+G G +G VY GV + +       VA+K L      +A KE   E   +  V H ++VR
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LLG C       L+ + +  G L  ++     ++G    L W +++      AKG++YL 
Sbjct: 74  LLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
           E    ++VHRD+ + N+L+    + K++DFGLAKLL   E+ Y          ++A E  
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
              +   +SDV+S+G+ + E+++ G  P +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 2e-25
 Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 22/210 (10%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           N IG G +G VY  V L+    +AVK   + +N  +  KE   E++ +  ++H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 249 GYCAEGAHRMLVY---EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           G   E  HR  VY   EY   G LE+ L    G            + L   +GL YLH  
Sbjct: 66  G--VE-VHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH 118

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV---MGTFGYVAPEYA 362
               +VHRDIK +NI LD     KL DFG A  L    + +   V    GT  Y+APE  
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 363 STGMLNER---SDVYSFGILIMEVISGRNP 389
           + G        +D++S G +++E+ +G+ P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 38/227 (16%)

Query: 192 NVIGEGGYGIVY---HGVLEDNTN--VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
             +GEG +G V    +  L DNT   VAVK+L ++   Q   +F+ E+E +  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 246 RLLGYCAEGAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT------- 295
           +  G   E        L+ EY+ +G+L  +L      H          I L         
Sbjct: 70  KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQR----HRD-------QINLKRLLLFSSQ 117

Query: 296 -AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG-- 352
             KG+ YL      + +HRD+ + NIL++ +   K+SDFGLAK+L  ++ Y   +  G  
Sbjct: 118 ICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 353 -TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
             F Y APE   T   +  SDV+SFG+ + E+ +  +P   S PP E
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDP-SQS-PPAE 218

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 3e-25
 Identities = 69/233 (29%), Positives = 111/233 (47%), Gaps = 25/233 (10%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G V+ G+  + T VAVK L       + +F  E + + ++RH  L++L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V E +  G+L ++L G  G    L   I M   +  A G+ YL        +HR
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLE---AQNYIHR 127

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D+ + N+L+ +    K++DFGLA+++  E  Y   R    F   + APE A     + +S
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIK-EDIY-EAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 372 DVYSFGILIMEVIS-GRNP------------VD--YSRPPGEVCIPQMNSLMT 409
           DV+SFGIL+ E+++ GR P            VD  Y  P    C  ++  +M 
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 4e-25
 Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 19/201 (9%)

Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLL 248
           +G G +G V  GV    +     VAVK L      A +KEF  E   + ++ H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           G C +G   MLV E    G L ++L    ++                  A G+ YL    
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 364
               VHRD+ + N+LL  +   K+SDFG+++ LGA   Y      G +   + APE  + 
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 365 GMLNERSDVYSFGILIMEVIS 385
           G  + +SDV+S+G+ + E  S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 70/229 (30%), Positives = 115/229 (50%), Gaps = 31/229 (13%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLL-NNRGQAEKEFKVE 232
           E+ +S   F +E  +GEG +G VY G L         T+VA+K L  N   + ++EF+ E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP-------H 280
            E +  ++H N+V LLG C +     +++EY+ +G+L ++L     H DVG         
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
           S L     ++I +  A G+ YL        VHRD+ + N L+ +    K+SDFGL++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 341 AERSYVTTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           +   Y   RV         ++ PE    G     SD++SFG+++ E+ S
Sbjct: 176 SADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 43/232 (18%)

Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRV-RHK 242
           F    +IGEG +  V      E N   A+K L      + +  K  K+E E + R+  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 243 NLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
            +++L  Y  +    +  V EY  NG L Q++      +  L  +            L Y
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEY 117

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM---------- 351
           LH      ++HRD+K  NILLDK  + K++DFG AK+L    S  + +            
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 352 ---------GTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRNP 389
                    GT  YV+PE     +LNE      SD+++ G +I ++++G+ P
Sbjct: 175 NRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.0 bits (241), Expect = 5e-23
 Identities = 76/236 (32%), Positives = 113/236 (47%), Gaps = 36/236 (15%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +IGEG +G V  G       VAVKN+  +   QA   F  E   + ++ HKNLVRLLG  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 252 A-EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
              G +  +V E +  GNL  +L         +   ++ +  L  A+G+ YL      K+
Sbjct: 69  LHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLES---KKL 121

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           VHRD+ + NIL+ +    K+SDFGLA++  +G + S +  +      + APE       +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFS 175

Query: 369 ERSDVYSFGILIMEVIS-GRNPV--------------DYSRPPGEVCIPQMNSLMT 409
            +SDV+S+G+L+ EV S GR P                Y   P E C   +  LMT
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.5 bits (243), Expect = 6e-23
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 193 VIGEGGYGIVYHGVL------EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLV 245
            +GEG +G V+ G         D   VAVK L       A K+F+ E E +   +H+N+V
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL--HG--------DVGPHSPLTWEIRMNIILGT 295
           +  G C EG   ++V+EY+++G+L ++L  HG           P   LT    + I +  
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
           A G+ YL        VHRD+ + N L+      K+ DFG+++ +     Y V    M   
Sbjct: 132 ASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            ++ PE          SDV+SFG+++ E+ + G+ P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.4 bits (240), Expect = 8e-23
 Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 31/236 (13%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
           IG+G +G VY GVL+ NT VAVK   +      K  F  E E + +  H N+V+L+G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
           +     +V E +  G+L  +L       + LT +  + + L  A G+ Y    LE K  +
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEY----LESKNCI 115

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT----FGYVAPEYASTGML 367
           HRD+ + N L+ +    K+SDFG+++    E   + T   G       + APE  + G  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 368 NERSDVYSFGILIMEVISG-------------RNPVD--YSRPPGEVCIPQMNSLM 408
              SDV+S+GIL+ E  S              R  ++  Y  P  ++C  ++  LM
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  100 bits (250), Expect = 1e-22
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 16/202 (7%)

Query: 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +ENVI  G  G  Y G    N    ++ ++            E+  +G+++H N+V+L+G
Sbjct: 694 EENVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIG 750

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
            C       L++EYI+  NL + L         L+WE R  I +G AK L +LH    P 
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           VV  ++    I++D +  P L    L  LL  +     T+   +  YVAPE   T  + E
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITE 857

Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           +SD+Y FG++++E+++G++P D
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 13/216 (6%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
           E E   +   +  V+G+G YGIVY    L     +A+K +     +  +    E+     
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP--HSPLTWEIRMNIILGTA 296
           ++H+N+V+ LG  +E     +  E +  G+L   L    GP   +  T       IL   
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFG 355
           +GL YLH+    ++VHRDIK  N+L++      K+SDFG +K L A  +  T    GT  
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQ 174

Query: 356 YVAPEYASTGM--LNERSDVYSFGILIMEVISGRNP 389
           Y+APE    G       +D++S G  I+E+ +G+ P
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 75/244 (30%), Positives = 116/244 (47%), Gaps = 34/244 (13%)

Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKN 243
           E VIG G +G V  G L+        VA+K L    G  EK   +F  E   +G+  H N
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++ L G   +    M++ E+++NG L+ +L  + G  + +     + ++ G A G+ YL 
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLS 123

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TRVMG---TFGYVAP 359
              E   VHRD+ + NIL++     K+SDFGL++ L  + S  T T  +G      + AP
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNPV--------------DYSRPPGEVCIPQM 404
           E  +       SDV+S+GI++ EV+S G  P               DY  PP   C   +
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240

Query: 405 NSLM 408
           + LM
Sbjct: 241 HQLM 244

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 192 NVIGEGGYGIVYHGVL----EDNT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNL 244
             +G G +G VY G+      D     VAVK L  +   Q E +F +E   + +  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH----SPLTWEIRMNIILGTAKGLT 300
           VRL+G   E   R ++ E +  G+L+ +L  +  P     S LT +  +      AKG  
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAK-LLGAERSYVTTRVMGTFG 355
           YL E      +HRDI + N LL  +  P    K++DFG+A+ +  A       R M    
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           ++ PE    G+   ++DV+SFG+L+ E+ S G  P
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.0 bits (234), Expect = 7e-22
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAE---KEFKVEVEAIGRVRHKNLVRL 247
           +G G +G VY G+ L+D    AVK  +L ++    +   K+ + E+  + +++H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           LG   E  +  +  E +  G+L + L    G        +          GL YLH+   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAK-LLKKYGS---FPEPVIRLYTRQILLGLEYLHDR-- 121

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-ASTGM 366
              VHRDIK +NIL+D     KL+DFG+AK +            G+  ++APE  A  G 
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGG 178

Query: 367 LNERSDVYSFGILIMEVISGRNP 389
               +D++S G  ++E+ +G+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
           +G+G +G+VY G+       E  T VA+K +  N    E+ EF  E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 300
           LLG  + G   ++V E +  G+L+ +L        +     P T +  + +    A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVA 358
           YL      K VHRD+ + N ++ +    K+ DFG+ + +  E  Y     + +    ++A
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189

Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   +SDV+SFG+++ E+ +
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 8e-22
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLL 248
           IGEG YG+VY          VA+K +        +        E++ +  + H N+++LL
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                     LV+E++D  +L + +         L   +  + +    +GL + H     
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH--- 117

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GML 367
            ++HRD+K  N+L++ +   KL+DFGLA+  G+     T  V+ T  Y APE        
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176

Query: 368 NERSDVYSFGILIMEVISGR 387
           +   D++S G +  E++S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 22/212 (10%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLL 248
             IG+G +G V       D   +  K +   N  + EK+  V EV  +  ++H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63

Query: 249 GYCAEGAHRM---------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
            Y      R+         +V EY + G+L Q +         +  E    I+      L
Sbjct: 64  -YY----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 300 TYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
              H   +P   V+HRD+K +NI LD   N KL DFGLAK+LG + S+  T V GT  Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           +PE  +    +E+SD++S G LI E+ +   P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
            +GEG YG VY  +  E    VA+K +     +  +E   E+  + +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 252 AEGAHRMLVYEYIDNG------NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            +     +V EY   G       +             LT E    I+  T KGL YLH  
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHSN 118

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              K +HRDIK+ NILL+++   KL+DFG++  L    +   T V+GT  ++APE     
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             N ++D++S GI  +E+  G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVR 246
             +G G  G+V   VL   T   +AVK +       E   K    E++ + +     +V 
Sbjct: 7   GELGAGNSGVVSK-VLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVG 63

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG--PHSPLTWEIRMNIILGTAKGLTYLHE 304
             G         +  EY+D G+L++ L    G  P   L       I +   KGLTYLHE
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYA 362
               K++HRD+K SNIL++ +   KL DFG++  L     +++V     GT  Y+APE  
Sbjct: 119 KH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171

Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVD 391
                + +SD++S G+ ++E+ +GR P  
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 75/237 (31%), Positives = 115/237 (48%), Gaps = 30/237 (12%)

Query: 194 IGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
           +G G +G V  GV +      +VA+K L N   ++ + E   E E + ++ +  +VR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
            C E    MLV E    G L ++L    G    +T    + ++   + G+ YL       
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGML 367
            VHRD+ + N+LL  Q   K+SDFGL+K LGA+ SY   R  G +   + APE  +    
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV---------------CIPQMNSLM 408
           + RSDV+S+GI + E  S G+ P    + P EV               C P+M +LM
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFIEQGKRLDCPAECPPEMYALM 231

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 14/200 (7%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G +G V+ G    +T VA+K+L   +G    E F  E   + +++H  LVRL     
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
           +     ++ EY++NG+L  +L    G    +   I M   +  A+G+ ++        +H
Sbjct: 72  QEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI--AEGMAFIER---KNYIH 125

Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNER 370
           RD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + APE  + G    +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 371 SDVYSFGILIMEVIS-GRNP 389
           SDV+SFGIL+ E+++ GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)

Query: 194 IGEGGYGIV----YHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G+V    +         VAVK L +++      +F  E   +  + H+NL+RL 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT--WEIRMNIILGTAKGLTYLHEGL 306
           G        M+V E    G+L   L  D   H  ++   +  + I    A G+ YL    
Sbjct: 63  GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES-- 115

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT----RVMGTFGYVAPEYA 362
             + +HRD+ + NILL      K+ DFGL + L     +       +V   F + APE  
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNP 389
            T   +  SDV+ FG+ + E+ + G  P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 70/226 (30%), Positives = 112/226 (49%), Gaps = 30/226 (13%)

Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPL---TWEIRMNIILGTAKGLTY 301
           G C     R   LV EY+  G+L  +L  H +   H  L     +I         KG+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------CKGMEY 123

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVA 358
           L      + VHRD+ + NIL++ +   K+ DFGL K+L  ++ Y   R  G    F Y A
Sbjct: 124 LGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-A 179

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQM 404
           PE  +    +  SDV+SFG+++ E+ +     D S  P    +  M
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMM 222

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.5 bits (227), Expect = 5e-21
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLL---NNRGQAEKEFKV---EVEAIGRVRHKNLV 245
            V+G+G YG VY G+      +AVK +    +N   AEKE++    EV+ +  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           + LG C +     +  E++  G++   L+   GP     +      IL    G+ YLH  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----AERSYVTTRVMGTFGYVAPE 360
               VVHRDIK +N++L      KL DFG A+ L         S +   + GT  ++APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
             +      +SD++S G  + E+ +G+ P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 91.7 bits (227), Expect = 5e-21
 Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 12/199 (6%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G+G +G V+ G     T VA+K L       E  F  E + + ++RH+ LV+L    +E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y+        VHR
Sbjct: 73  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHR 126

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++++NIL+ +    K++DFGLA+L+  E +  T R    F   + APE A  G    +S
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV+SFGIL+ E+ + GR P
Sbjct: 185 DVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.1 bits (226), Expect = 8e-21
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 18/209 (8%)

Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 243
           E VIG G +G V  G L+        VA+K L    G  EK+   F  E   +G+  H N
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++ L G   +    M+V EY++NG+L+ +L    G  + +     + ++ G A G+ YL 
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLS 123

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEY 361
              +   VHRD+ + NIL++     K+SDFGL+++L    E +Y T        + APE 
Sbjct: 124 ---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +       SDV+S+GI++ EV+S G  P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 91.6 bits (227), Expect = 8e-21
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 22/215 (10%)

Query: 194 IGEGGYGIVY----HGVL--EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+    H +L  +D   VAVK L      A ++F+ E E +  ++H+++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLH-----------GDVGPHSPLTWEIRMNIILGTA 296
            G C EG   ++V+EY+ +G+L ++L            G+      LT    + I    A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFG 355
            G+ YL   L    VHRD+ + N L+ +    K+ DFG+++ + +   Y V  R M    
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           ++ PE          SD++SFG+++ E+ + G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 91.2 bits (226), Expect = 9e-21
 Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 40/265 (15%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEV 233
           EL +S   F +E  +GE  +G +Y G L     +    VA+K L + N  Q   EF+ E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIR 288
             +  + H N+V LLG   +     +++EY++ G+L ++L     H DVG  S     ++
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 289 --------MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
                   ++I +  A G+ YL        VH+D+ + NIL+ +Q + K+SD GL++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 341 AERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP--------- 389
           +   Y V  + +    ++ PE    G  +  SD++SFG+++ E+ S G  P         
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Query: 390 VDYSR-----PPGEVCIPQMNSLMT 409
           ++  R     P  E C P+M SLMT
Sbjct: 236 IEMVRKRQLLPCSEDCPPRMYSLMT 260

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 9e-21
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 26/205 (12%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLL 248
           +GEG YG+VY     +    VA+K +  +    E+        E+  +  ++H N+V+LL
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                     LV+EY D  +L+++L             I+ +I+    +GL Y H     
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPN-LIK-SIMYQLLRGLAYCHSH--- 117

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGML 367
           +++HRD+K  NIL+++    KL+DFGLA+  G   R+Y T  V+ T  Y APE     +L
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEI----LL 171

Query: 368 NERS-----DVYSFGILIMEVISGR 387
             +      D++S G +  E+I+G+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 9/199 (4%)

Query: 194 IGEGGYGIVYH-GVLEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGY 250
           +G+G YG VY    L DN   A+K + L +  Q E+E  V E+  +  V H N++     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             +G    +V EY   G+L + +         +  +    I +   +GL  LHE    K+
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           +HRD+KS+NILL      K+ D G++K+L   +  +    +GT  Y+APE       + +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSYK 181

Query: 371 SDVYSFGILIMEVISGRNP 389
           SD++S G L+ E+ +   P
Sbjct: 182 SDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 39/215 (18%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
           IGEG YG VY     +    VA+K +   R + EKE F +    E++ + ++RH N+VRL
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 248 LGYCAEGAHR--MLVYEYID---NGNLEQWLHGDVGPHSPLTW-EIR--MNIILGTAKGL 299
                        +V+EY+D    G L+        P    T  +I+  M  +L   +GL
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDS-------PEVKFTESQIKCYMKQLL---EGL 113

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            YLH      ++HRDIK SNIL++     KL+DFGLA+      S   T  + T  Y  P
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Query: 360 EYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           E     +L         D++S G ++ E+  G+  
Sbjct: 171 EL----LLGATRYGPEVDMWSVGCILAELFLGKPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 44/223 (19%)

Query: 190 DENVIGEGGYGIVY---HGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH-KNL 244
           D   IG G +G V    H      T +AVK +      + +K   ++++ + R      +
Sbjct: 8   DLGEIGRGAFGTVNKMLHK--PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 245 VRLLG---------YCAE------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           V+  G          C E            VYE +    + +              EI  
Sbjct: 66  VKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPE--------------EILG 110

Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
            I + T K L YL E L  K++HRD+K SNILLD+  N KL DFG++  L    S   TR
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTR 166

Query: 350 VMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRNP 389
             G   Y+APE       +    RSDV+S GI + EV +G+ P
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---------FKVEVEAIGRVRHK 242
           +IG G +G VY G+       +AVK +      A  +            E+  +  ++H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N+V+ LG   +  H  +  EY+  G++   L+        L   +R N +    KGL YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-----VMGTFGYV 357
           H      ++HRDIK +NIL+D +   K+SDFG++K L A      T      + G+  ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE         ++D++S G L++E+++G++P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 193 VIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAE-KEFKV-EVEAIGRVRHKNLVRLLG 249
           V+GEG YG+V           VA+K    +    + K+  + EV+ + ++RH+N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                    LV+EY++   L + L    G + P       +R   I    + + Y H   
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-----AVRS-YIWQLLQAIAYCHSH- 119

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAER---SYVTTRVMGTFGYVAPE- 360
              ++HRDIK  NIL+ +    KL DFG A+ L          YV TR      Y APE 
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPEL 172

Query: 361 YASTGMLNERSDVYSFGILIMEVISGR 387
                   +  DV++ G ++ E++ G 
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.4 bits (219), Expect = 8e-20
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 26/236 (11%)

Query: 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++ +G G YG VY GV +  +  VAVK L  +     +EF  E   +  ++H NLV+LLG
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
            C       ++ E++  GNL  +L         +   + + +    +  + YL +     
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---N 124

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
            +HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + 
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 370 RSDVYSFGILIMEVIS-GRNP---VDYS-------------RPPGEVCIPQMNSLM 408
           +SDV++FG+L+ E+ + G +P   +D S             RP G  C P++  LM
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEG--CPPKVYELM 238

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 8e-20
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 30/210 (14%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V+ G      +VA+K ++     +E +F  E + + ++ H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA----KGLTYLHEGLEPK 309
                +V EY+ NG L  +L    G       ++    +L       + + YL       
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESN---G 120

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT----TRVMGT---FGYVAPEYA 362
            +HRD+ + N L+ +    K+SDFGLA+       YV     T   GT     +  PE  
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLAR-------YVLDDQYTSSQGTKFPVKWAPPEVF 173

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
                + +SDV+SFG+L+ EV S G+ P +
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 15/205 (7%)

Query: 193 VIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLV 245
            +G G +G V+             T V VK L   + +  + EF+ E++   ++ HKN+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLT 300
           RLLG C E     ++ EY D G+L+Q+L       +     PL+ + ++ +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           +L      + VHRD+ + N L+  Q   K+S   L+K +     Y     +    ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 361 YASTGMLNERSDVYSFGILIMEVIS 385
                  + +SDV+SFG+L+ EV +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 68/239 (28%), Positives = 113/239 (47%), Gaps = 23/239 (9%)

Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+          +D   VAVK L +    A K+F  E E +  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGPHSPLTWEIRMNIILGTAKG 298
            G C EG   ++V+EY+ +G+L ++L  HG       +    + LT    ++I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYV 357
           + YL        VHRD+ + N L+ +    K+ DFG+++ + +   Y V    M    ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV--CIPQMNSLMTLSYC 413
            PE          SDV+S G+++ E+ + G+ P  Y     EV  CI Q   L     C
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECITQGRVLQRPRTC 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 41/236 (17%)

Query: 182 EVSTNGFADENVIGEGGYGIVYH----GVL--EDNTNVAVKNLLNNRG-QAEKEFKVEVE 234
           E   N       IG+G +G V+     G+L  E  T VAVK L        + +F+ E  
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDV----- 277
            +    H N+V+LLG CA G    L++EY+  G+L ++L            H        
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 278 -GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
                PL+   ++ I    A G+ YL E    K VHRD+ + N L+ +    K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 337 KLL-------GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           + +        +E   +  R M       PE          SDV+++G+++ E+ S
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG- 249
           VIGEG YG VY     +    VA+K +++     E+E K E   + +   H N+    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 250 YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           +  +          LV E    G++   + G       L  E    I+  T +GL YLHE
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---- 360
               KV+HRDIK  NILL K    KL DFG++  L +      T + GT  ++APE    
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIAC 187

Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNP 389
                   + RSDV+S GI  +E+  G+ P
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
             IG G YG VY    +     VA+K +    G   +  + E+  +   RH N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
                   +V EY   G+L+       GP S L  +I   +   T KGL YLHE      
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL--QIAY-VCRETLKGLAYLHE---TGK 122

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA---STGML 367
           +HRDIK +NILL +  + KL+DFG++  L A  +   + + GT  ++APE A     G  
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181

Query: 368 NERSDVYSFGILIMEVISGRNP 389
           + + D+++ GI  +E+   + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 12/211 (5%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+          +G G +G V+ G    NT VAVK L       E  F  E + + ++RH
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
             LV+L    +E     +V EY+  G+L  +L    G    L   + M   +  A G+ Y
Sbjct: 61  DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV--AAGMAY 117

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        +HRD++S+NIL+      K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172

Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+++ GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 193 VIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           V+GEG +G   +V H V  D      +  L     A ++ + E   + +++H N+V    
Sbjct: 7   VVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHEG 305
                 H  +V EY D G+L Q +    G   P    L W ++M +      G+ ++HE 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE- 118

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              +V+HRDIKS NI L +    KL DFG A+LL +  +Y  T V GT  YV PE     
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             N +SD++S G ++ E+ + ++P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.3 bits (214), Expect = 3e-19
 Identities = 62/229 (27%), Positives = 113/229 (49%), Gaps = 14/229 (6%)

Query: 193 VIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLL 248
           V+G+G +G    +   ED++ V  K + N    +EKE +    E+  +  ++H N++   
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
            +  +    ++  EY + G L   +    G       E+ +  +      ++Y+H+    
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIHKA--- 120

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
            ++HRDIK+ NI L K    KL DFG++K+LG+E S   T V+GT  Y++PE       N
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYN 179

Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC--IPQMNSLMTLSYCSS 415
            +SD+++ G ++ E+++ +   D + P   +   I Q N    +S  SS
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPL-NLVVKIVQGNYTPVVSVYSS 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.5 bits (214), Expect = 3e-19
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 21/215 (9%)

Query: 193 VIGEGGYGIVYHGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           ++G G +G V+ G+   E ++    VA+K + +  G Q  +E    + A+G + H  +VR
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LLG C  GA   LV +    G+L   +      + P   L W +++      AKG+ YL 
Sbjct: 74  LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
           E    ++VHR++ + NILL      +++DFG+A LL   ++ Y  +       ++A E  
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396
             G    +SDV+S+G+ + E++S G  P    RP 
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 12/231 (5%)

Query: 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKN 243
               + + +GEG  G V    L++   +     +      +  K+   E+E     +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 244 LVRLLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWE-IRMNIILGTAKGLT 300
           +V+  G   + +   +    EY + G+L+  ++  V        E +   I     KGL+
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           YLH     K++HRDIK SNILL ++   KL DFG++  L    S   T   GT  Y+APE
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFT-GTSFYMAPE 173

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLS 411
                  +  SDV+S G+ ++EV   R P      P    I  ++ ++ + 
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)

Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRV-RHKN 243
           +GEG +G V            + + VAVK L ++    EK+      E+E +  + +HKN
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 77

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------------GDVGPHSPLTWEIRMNI 291
           ++ LLG C +     +V EY  +GNL  +L                 P   LT +  ++ 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ +L      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 75/247 (30%), Positives = 114/247 (46%), Gaps = 42/247 (17%)

Query: 194 IGEGGYGIVYHGVLE---DNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G +G V  G+ +       VAVK L N  N    + E   E   + ++ +  +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C E    MLV E  + G L ++L    H      + L  ++ M        G+ YL E
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYA 362
                 VHRD+ + N+LL  Q   K+SDFGL+K LGA+ +Y   +  G +   + APE  
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG----------------EVCIPQMN 405
           +    + +SDV+SFG+L+ E  S G+ P  Y    G                + C P+M 
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNEVTQMIESGERMECPQRCPPEMY 228

Query: 406 SLMTLSY 412
            LM L +
Sbjct: 229 DLMKLCW 235

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 21/209 (10%)

Query: 194 IGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR-VRHKNLVRLLGYC 251
           IGEG  GIV           VAVK + + R Q  +E       I R  +H N+V +    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V E+++ G L      D+  H+ +  E    + L   K L++LH      V+
Sbjct: 86  LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVI 137

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGML 367
           HRDIKS +ILL      KLSDFG    +  E    +S V     GT  ++APE  S    
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPY 192

Query: 368 NERSDVYSFGILIMEVISGRNPVDYSRPP 396
               D++S GI+++E++ G  P  ++ PP
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPY-FNEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 86.3 bits (213), Expect = 7e-19
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 21/210 (10%)

Query: 193 VIGEGGYGIVYHGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           V+G G +G VY G+   E  T    VA+K L    G +A  EF  E   +  + H +LVR
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LLG C     + LV + + +G L  ++H    ++G    L W +++      AKG+ YL 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYA 362
           E    ++VHRD+ + N+L+    + K++DFGLA+LL G E+ Y          ++A E  
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
                  +SDV+S+G+ I E+++ G  P D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 85.7 bits (212), Expect = 7e-19
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 31/221 (14%)

Query: 192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH 241
           N +G G +G VY G   D          VAVK L   +G   Q +KEF  E   +    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG---DVGPHSPLTWEIRMNIILGTAKG 298
            N+V+LLG C     + ++ E ++ G+L  +L     +      LT +  ++I L  AKG
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 299 LTYLHEGLEPKVVHRDIKSSNILL-DKQWNP----KLSDFGLAKLLGAERSYVTTRVMG- 352
             YL    +   +HRD+ + N L+ +K ++     K+ DFGLA+ +     Y   R  G 
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172

Query: 353 ---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                 ++APE    G    +SDV+SFG+L+ E+++ G+ P
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 32/226 (14%)

Query: 193 VIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 245
            +GEG +G V              T VAVK L  N   +E ++   E   + +V H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD--VGP------------------HSPLTW 285
           +L G C++    +L+ EY   G+L  +L     VGP                     LT 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
              ++     ++G+ YL E    K+VHRD+ + N+L+ +    K+SDFGL++ +  E SY
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 346 VT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           V  ++      ++A E     +   +SDV+SFG+L+ E+++ G NP
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.0 bits (210), Expect = 9e-19
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 16/216 (7%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
              IG+G +G V  G       VAVK + N+     + F  E   + ++RH NLV+LLG 
Sbjct: 11  LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 251 CAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
             E    + +V EY+  G+L  +L       S L  +  +   L   + + YL       
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
            VHRD+ + N+L+ +    K+SDFGL K   + +      V  T    APE       + 
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178

Query: 370 RSDVYSFGILIMEVIS-GRNPVDYSRPPGEVCIPQM 404
           +SDV+SFGIL+ E+ S GR P  Y R P +  +P++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRV 212

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 52/172 (30%), Positives = 88/172 (51%), Gaps = 14/172 (8%)

Query: 194 IGEGGYGIVYH-GVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           IGEG +GIV+     E    VA+K +   R  G    +   E++A+   +H  +V+LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEGLEP 308
              G+  +LV EY+ +  L + L  +  P      +++  M ++L   KG+ Y+H     
Sbjct: 68  FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA--QVKSYMRMLL---KGVAYMHAN--- 118

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
            ++HRD+K +N+L+      K++DFGLA+L   E   + +  + T  Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 25/236 (10%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G V+ G   ++T VAVK L       +  F  E   +  ++H  LVRL     +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                ++ EY+  G+L  +L  D G    L   I  +  +  A+G+ Y+        +HR
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIER---KNYIHR 127

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++++N+L+ +    K++DFGLA+++  E +  T R    F   + APE  + G    +S
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 372 DVYSFGILIMEVIS-------GRNPVD--------YSRPPGEVCIPQMNSLMTLSY 412
           DV+SFGIL+ E+++       G +  D        Y  P  E C  ++  +M   +
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCW 241

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 31/208 (14%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 246
           IGEG YG+VY          VA+K +   R + E E  V      E+  +  + H N+VR
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           LL          LV+E++D  +L++++  D  P + L   +  + +    +G+ Y H   
Sbjct: 63  LLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE----- 360
             +V+HRD+K  N+L+D++   KL+DFGLA+  G   R+Y T  V+ T  Y APE     
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGS 174

Query: 361 -YASTGMLNERSDVYSFGILIMEVISGR 387
              ST +     D++S G +  E+++ R
Sbjct: 175 RQYSTPV-----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 13/197 (6%)

Query: 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
           IG G +G V+ G L  DNT VAVK+         K +F  E   + +  H N+VRL+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-V 310
            +     +V E +  G+   +L  + GP   +   I+M  +   A G+ YL    E K  
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQM--VENAAAGMEYL----ESKHC 115

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLN 368
           +HRD+ + N L+ ++   K+SDFG+++    +  Y +T  M      + APE  + G  +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 369 ERSDVYSFGILIMEVIS 385
             SDV+SFGIL+ E  S
Sbjct: 175 SESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +GEG Y  VY G        VA+K  +L    G      + E+  +  ++H+N+VRL   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66

Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                  MLV+EY+D  +L++++  HG  G   P T +     +L   KG+ + HE    
Sbjct: 67  IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHEN--- 119

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           +V+HRD+K  N+L++K+   KL+DFGLA+  G   +  +  V+ T  Y AP+     +L 
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV----LLG 174

Query: 369 ERS-----DVYSFGILIMEVISGR 387
            R+     D++S G ++ E+I+GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.0 bits (207), Expect = 3e-18
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G+G +G V+ G     T VA+K L       E  F  E + + ++RH  LV L    +E
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V E++  G+L  +L    G +  L   + M   +  A G+ Y+        +HR
Sbjct: 73  EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI--ADGMAYIER---MNYIHR 126

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++++NIL+      K++DFGLA+L+  E +  T R    F   + APE A  G    +S
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV+SFGIL+ E+++ GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 15/206 (7%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKN 243
           F     IG+G +G VY  +    N  VA+K +  +  +AE E +    E++ + + R   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + +  G   +G+   ++ EY   G+       D+     L       I+     GL YLH
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCL-----DLLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
           E      +HRDIK++NILL ++ + KL+DFG++  L +  S   T V GT  ++APE   
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIK 171

Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               +E++D++S GI  +E+  G  P
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 66/205 (32%), Positives = 111/205 (54%), Gaps = 19/205 (9%)

Query: 192 NVIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
            VIG+G +G VYHG L D+     + AVK+L  + +  + E+ F  E   +    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59

Query: 246 RLLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
            LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P T +  +   L  AKG+ YL 
Sbjct: 60  SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSE--THNP-TVKDLIGFGLQVAKGMEYL- 114

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPE 360
                K VHRD+ + N +LD+ +  K++DFGLA+ +  +  Y      G      ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 361 YASTGMLNERSDVYSFGILIMEVIS 385
              T     +SDV+SFG+L+ E+++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 12/202 (5%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           E  +G G +G V+      +T VAVK +       E  F  E   +  ++H  LV+L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 69

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             +     ++ E++  G+L  +L  D G   PL   I  +  +  A+G+ ++ +      
Sbjct: 70  VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQ---RNY 123

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLN 368
           +HRD++++NIL+      K++DFGLA+++  E +  T R    F   + APE  + G   
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 369 ERSDVYSFGILIMEVIS-GRNP 389
            +SDV+SFGIL+ME+++ GR P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEK---EFKVEVEAIGRVRHKNLV 245
            +G G +   Y    ++  T +AVK +    N   + E+     + E+  + R+ H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           R+LG   E +H  L  E++  G++   L    G        + +N      +GL+YLHE 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKE---AVIINYTEQLLRGLSYLHEN 122

Query: 306 LEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERS---YVTTRVMGTFGYVAPEY 361
              +++HRD+K +N+L+D      +++DFG A  L A+ +       +++GT  ++APE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
                     DV+S G +I+E+ + + P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.6 bits (204), Expect = 6e-18
 Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 14/202 (6%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V +G      +VA+K ++     +E EF  E + + ++ H+ LV+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V EY+ NG L  +L            ++ + +     +G+ YL      + +HR
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHR 124

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYASTGMLNER 370
           D+ + N L+D Q   K+SDFGL++ +  +  Y ++  +G+     +  PE       + +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSK 181

Query: 371 SDVYSFGILIMEVIS-GRNPVD 391
           SDV++FG+L+ EV S G+ P +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 51/218 (23%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------- 237
             IGEG YG VY            ++L   R  A K+ +V +   G              
Sbjct: 5   AEIGEGAYGTVYKA----------RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ 54

Query: 238 --RVRHKNLVRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                H N+VRLL  C            LV+E++D  +L  +L     P   L  E   +
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKD 111

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           ++    +G+ +LH     ++VHRD+K  NIL+      K++DFGLA++   E +   T V
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSV 166

Query: 351 MGTFGYVAPE------YASTGMLNERSDVYSFGILIME 382
           + T  Y APE      YA+        D++S G +  E
Sbjct: 167 VVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 11/211 (5%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLG 249
           V+G G +GIV+    + +  + +   +      + E    + E + +  + H N++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              E    M+V EY   G L +++      +S L  +  ++  +     L ++H  L   
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL--- 121

Query: 310 VVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           ++HRD+K+ NILLDK     K+ DFG++K+L ++    T  V+GT  Y++PE       N
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYN 179

Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           ++SD+++ G ++ E+ S +   + +  P  V
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 18/207 (8%)

Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLG 249
            IGEG +G +Y    + D+ +  +K + L      EKE  K EV  + +++H N+V    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG----PHSPLTWEIRMNIILGTAKGLTYLHEG 305
              E     +V EY D G+L + ++   G        L+W +++++      GL ++H+ 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD- 119

Query: 306 LEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
              K++HRDIKS NI L K     KL DFG+A+ L        T  +GT  Y++PE    
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQN 176

Query: 365 GMLNERSDVYSFGILIMEVISGRNPVD 391
              N ++D++S G ++ E+ + ++P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 15/216 (6%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
            VIG G   +VY  + L +N  VA+K + L     +  E + EV+A+ +  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEP 308
               G    LV  Y+  G+L   +     P   L   I   ++    KGL YLH  G   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEYASTG 365
             +HRDIK+ NILL +  + K++DFG++  L   G     V    +GT  ++APE     
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSR-PPGEV 399
              + ++D++SFGI  +E+ +G  P  YS+ PP +V
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP--YSKYPPMKV 215

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 27/240 (11%)

Query: 193 VIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRL 247
            IGEG +G VY GV      +   VAVK   N    + +E F  E   + +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           +G   E     +V E    G L  +L  +      L     +      +  L YL     
Sbjct: 73  IGVITENP-VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES--- 125

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
            + VHRDI + N+L+      KL DFGL++ L  E  Y  ++      ++APE  +    
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 368 NERSDVYSFGILIMEVIS-GRNPVDY-------------SRPP-GEVCIPQMNSLMTLSY 412
              SDV+ FG+ + E++  G  P                 R P    C P + SLMT  +
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCW 245

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH---KNLVRL 247
           +IG G YG VY G  +     VA+K + L+       + + EV  + ++R     N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
            G   +G    ++ EY + G++   +        P+  +    II      L Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-- 120

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-M 366
             V+HRDIK++NIL+    N KL DFG+A LL    S  +T V GT  ++APE  + G  
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178

Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            + ++D++S GI I E+ +G  P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 26/232 (11%)

Query: 194 IGEGGYGIVYHG------VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+          +D   VAVK L +    A K+F+ E E +  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGP---HSPLTWEIRMNIILGT 295
            G C +G   ++V+EY+ +G+L ++L  HG       D  P      L     ++I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
           A G+ YL        VHRD+ + N L+      K+ DFG+++ + +   Y V    M   
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV--CIPQ 403
            ++ PE          SDV+SFG+++ E+ + G+ P  +     EV  CI Q
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQLSNTEVIECITQ 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 31/229 (13%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVE 232
           E+ +ST  F +E  +GE  +G VY G L      E    VA+K L +   G   +EFK E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP-------H 280
                R++H N+V LLG   +     +++ Y  + +L ++L     H DVG         
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
           S L     ++I+   A G+ +L       VVH+D+ + N+L+  + N K+SD GL + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 341 AERSYVTTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           A   Y   ++MG       +++PE    G  +  SD++S+G+++ EV S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 80.6 bits (200), Expect = 3e-17
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 37/222 (16%)

Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G+G +G V   V + +T       V  K  +  R + E     E   + R+ H  +V+L
Sbjct: 1   LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKL 58

Query: 248 LGYCA--EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK-------- 297
             + A        LV EY   G L  + H                     A+        
Sbjct: 59  --HYAFQTEEKLYLVLEYAPGGEL--FSH----------LSKEGRFSEERARFYAAEIVL 104

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH      +++RD+K  NILLD   + KL+DFGLAK L +E S   T   GT  Y+
Sbjct: 105 ALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYL 160

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           APE        +  D +S G+L+ E+++G+ P  Y+    E+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 15/204 (7%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRL 247
           +G+G +G VY    ++    +AVK      +  + +KE    + E++ +  ++H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
            G   +     +  EY+  G+++  L      +  LT  +         +G+ YLH    
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN-- 123

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYASTG 365
             +VHRDIK +NIL D   N KL DFG +K L    S  T    V GT  +++PE  S  
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
               ++DV+S G  ++E+++ + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA+K + N + Q +KE  + E+  +   +H N+V  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 86  LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS NILL    + KL+DFG    +  E+S  +T V GT  ++APE  +      + 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E++ G  P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 27/220 (12%)

Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                ++APE     +   +SDV+SFG+L+ E+ + G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 26/214 (12%)

Query: 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 245
           E+VIGEG +G V   +++ +    N A+K L     + + ++F  E+E + ++  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNIIL 293
            LLG C    +  +  EY   GNL  +L              + G  S LT +  +    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
             A G+ YL E    + +HRD+ + N+L+ +    K++DFGL++    E  YV  + MG 
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMGR 179

Query: 354 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
               ++A E  +  +   +SDV+SFG+L+ E++S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 45/132 (34%), Positives = 72/132 (54%), Gaps = 9/132 (6%)

Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
           E++D G+L+           P+  EI   I +   +GLTYL+     +++HRDIK SNIL
Sbjct: 83  EFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNIL 136

Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
           ++ +   KL DFG++   G   + +    +GT  Y++PE    G    +SDV+S GI I+
Sbjct: 137 VNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISII 193

Query: 382 EVISGRNPVDYS 393
           E+  G+ P  +S
Sbjct: 194 ELALGKFPFAFS 205

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           IGEG  GIV     E +T   VAVK +   + Q  +    EV  +    H+N+V +    
Sbjct: 30  IGEGSTGIVCIAT-EKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V E+++ G L      D+  H+ +  E    + L   + L+YLH      V+
Sbjct: 89  LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVI 140

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNE 369
           HRDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S      
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPP 396
             D++S GI+++E+I G  P  ++ PP
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY-FNEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV    ++ +  +     ++ R Q  +E    EV  +   +H+N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    +V E+++ G L      D+  H+ +  E    + L   K L+ LH      V+H
Sbjct: 88  VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139

Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S       
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 371 SDVYSFGILIMEVISGRNPVDYSRPP 396
            D++S GI+++E++ G  P  ++ PP
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY-FNEPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 26/225 (11%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTN----VAVKNLLN-NRGQAEKEFKV 231
           L+E E     F    V+G G +G VY G+ + +       VA+K L      +A KE   
Sbjct: 4   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58

Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIR 288
           E   +  V + ++ RLLG C     + L+ + +  G L  ++  H D +G    L W ++
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117

Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVT 347
           +      AKG+ YL E    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y  
Sbjct: 118 I------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168

Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
                   ++A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL-GYC 251
           +G+G +G VY    ++    A   ++    + E E F VE++ +   +H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEGLEPKV 310
            E    +L+ E+ D G L+  +   +     LT  +IR  +     + L +LH     KV
Sbjct: 73  YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRY-VCRQMLEALNFLHSH---KV 124

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML--- 367
           +HRD+K+ NILL    + KL+DFG++    +      T + GT  ++APE  +       
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183

Query: 368 --NERSDVYSFGILIMEVISGRNP 389
             + ++D++S GI ++E+     P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKN 243
           F     IG+G +G V+ G+  DN     VA+K +     + E E  + E+  + +     
Sbjct: 6   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + +  G   +G    ++ EY+  G+    L    GP         +  IL   KGL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL---KGLDYLH 118

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                K +HRDIK++N+LL +Q + KL+DFG+A  L   +    T V GT  ++APE   
Sbjct: 119 S---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174

Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               + ++D++S GI  +E+  G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 8/197 (4%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V+ G       VA+K + N    +E++F  E + + ++ H  LV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V E+++NG L  +L    G  S    ++ +++     +G+ YL        +HR
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFIHR 124

Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+      K+SDFG+ + +  +    ++       +  PE  +    + +SDV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 374 YSFGILIMEVIS-GRNP 389
           +SFG+L+ EV + G+ P
Sbjct: 185 WSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 43/214 (20%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 240
           IGEG YG+VY            +N L     A K+ +++ E  G              + 
Sbjct: 8   IGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L++++  D  P S +   +  + +    +GL 
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T  Y AP
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 169

Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 170 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNL 244
           F     IG+G +G VY G+ ++ T   V   + +  +AE E    + E+  + +     +
Sbjct: 6   FTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
            R  G   +G    ++ EY+  G+       D+    PL       I+    KGL YLH 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATILREILKGLDYLHS 119

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
               + +HRDIK++N+LL +Q + KL+DFG+A  L   +    T V GT  ++APE    
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175

Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              + ++D++S GI  +E+  G  P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 57/214 (26%), Positives = 110/214 (51%), Gaps = 26/214 (12%)

Query: 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 245
           ++VIGEG +G V    ++ +    + A+K +     + + ++F  E+E + ++  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPH--------SPLTWEIRMNIIL 293
            LLG C    +  L  EY  +GNL  +L      +  P         S L+ +  ++   
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
             A+G+ YL +    + +HRD+ + NIL+ + +  K++DFGL++    +  YV  + MG 
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGR 184

Query: 354 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
               ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 26/213 (12%)

Query: 192 NVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLVR 246
           +VIGEG +G V    ++ +    + A+K +     + + ++F  E+E + ++  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNIILG 294
           LLG C    +  L  EY  +GNL  +L                   S L+ +  ++    
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
            A+G+ YL +    + +HRD+ + NIL+ + +  K++DFGL++    +  YV  + MG  
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRL 173

Query: 355 G--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
              ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 8/112 (7%)

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           I +   K L YLH  L   V+HRD+K SN+L+++    KL DFG++  L    S   T  
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163

Query: 351 MGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
            G   Y+APE  +  +     + +SDV+S GI ++E+ +GR P D  + P +
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 12/205 (5%)

Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
           E ++G G +G +  G L+        VA+  L       ++  F  E   +G+  H N+V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           RL G    G   M+V EY+ NG L+ +L    G    L     M ++ G A G+ YL E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLSE- 125

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
                VH+ + +  +L++     K+S F   +   +E  Y T        + APE     
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 366 MLNERSDVYSFGILIMEVIS-GRNP 389
             +  SDV+SFGI++ EV+S G  P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 80/305 (26%), Positives = 126/305 (41%), Gaps = 41/305 (13%)

Query: 102 KPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEI---GKDHRIAYPERAAGSHHGSGDQT 158
           KP   P   PLP         + +  R R  + +    +D  +A P         S   +
Sbjct: 2   KPIQPPPGVPLPSTAR---HTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSS 58

Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVK 216
            ++A     S        +L ELE         N IG G  G VY  V+   T    A+K
Sbjct: 59  SSSASGSAPSAA-----KSLSELERV-------NRIGSGAGGTVYK-VIHRPTGRLYALK 105

Query: 217 NLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275
            +  N      ++   E+E +  V H N+V+            ++ E++D G+LE     
Sbjct: 106 VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA 165

Query: 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335
           D    + +  +I          G+ YLH      +VHRDIK SN+L++   N K++DFG+
Sbjct: 166 DEQFLADVARQI--------LSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGV 214

Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE------RSDVYSFGILIMEVISGRNP 389
           +++L        + V GT  Y++PE  +T  LN         D++S G+ I+E   GR P
Sbjct: 215 SRILAQTMDPCNSSV-GTIAYMSPERINTD-LNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Query: 390 VDYSR 394
               R
Sbjct: 273 FGVGR 277

Length = 353

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 11/196 (5%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
           ++G+G +G V+ G L+D T VAVK    +  Q  K +F  E   + +  H N+V+L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +     +V E +  G+   +L         L  +  +   L  A G+ YL        +
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLES---KNCI 115

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           HRD+ + N L+ +    K+SDFG+++    G   S    ++     + APE  + G  + 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSS 173

Query: 370 RSDVYSFGILIMEVIS 385
            SDV+S+GIL+ E  S
Sbjct: 174 ESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKE----------FKVEVEAIGRVRH 241
           +IG+G YG VY  +      + AVK +      A +            + E+E +  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
            N+V+ LG+     +  +  EY+  G++   L      +     ++         +GL Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAY 123

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPE 360
           LH      ++HRD+K+ N+L+D     K+SDFG++K       +     + G+  ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 361 YASTGM--LNERSDVYSFGILIMEVISGRNP 389
              +     + + D++S G +++E+ +GR P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 193 VIGEGGYG--IVY-HGVLEDNTN--VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVR 246
           V+GEG +G   +Y +    D T   VAVK L    GQ     +K E+  +  + H+N+V+
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 247 LLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G C+E   +   L+ EY+  G+L  +L     P   L     +       +G+ YLH 
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 361
                 +HRD+ + N+LLD     K+ DFGLAK +     Y   R  G    F Y A E 
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
                 +  SDV+SFG+ + E+++  +      PP
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS--KQSPP 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 21/201 (10%)

Query: 194 IGEGGYG---IVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           IGEG +G   +V     ED     +K  N+     +  +E + EV  +  ++H N+V+  
Sbjct: 8   IGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHE 304
               E  +  +V +Y + G+L + ++   G   P    L W +++ +       L ++H+
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
               K++HRDIKS NI L K    KL DFG+A++L +      T  +GT  Y++PE    
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICEN 175

Query: 365 GMLNERSDVYSFGILIMEVIS 385
              N +SD+++ G ++ E+ +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 35/229 (15%)

Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKNLVRL 247
           ++GEG YG+V    H   E    VA+K  L +       K    E+  + ++RH+NLV L
Sbjct: 8   LVGEGSYGMVMKCKHK--ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 248 LGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           +          LV+E++D+    +LE++ +G       L        +    +G+ + H 
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHS 118

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPE 360
                ++HRDIK  NIL+ +    KL DFG A+ L A       YV TR      Y APE
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPE 170

Query: 361 YASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                    R+ D+++ G L+ E+++G  P+     PG+  I Q+  ++
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTG-EPL----FPGDSDIDQLYHII 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 76/258 (29%)

Query: 190 DENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA---------IGRV 239
               IG G YG+V   V       VA+K + N        F   ++A         +  +
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHL 56

Query: 240 RHKNLVRLLG-------------YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
           RH+N++ LL              Y        +V E ++  +L + +        PLT +
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVY--------IVTELMET-DLHKVIKS----PQPLTDD 103

Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-- 344
                +    +GL YLH      V+HRD+K SNIL++   + K+ DFGLA+ +  +    
Sbjct: 104 HIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160

Query: 345 -----YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSR 394
                YV TR      Y APE     +L+        D++S G +  E+++        +
Sbjct: 161 GFLTEYVVTRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTR-------K 204

Query: 395 P--PGEVCIPQMNSLMTL 410
           P  PG   I Q+N ++ +
Sbjct: 205 PLFPGRDYIDQLNLIVEV 222

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 29/215 (13%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLGY 250
            VIG+G +G V   +++       K +      A K   K +    G VR  N++     
Sbjct: 6   RVIGKGAFGKVC--IVQKRDT---KKMF-----AMKYMNKQKCVEKGSVR--NVLNERRI 53

Query: 251 CAEGAHRMLV---YEYIDNGNL----EQWLHGDVGPH----SPLTWEIRMNIILGTAKGL 299
             E  H  LV   Y + D  N+    +  L GD+  H       + E     I      L
Sbjct: 54  LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLAL 113

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            YLH      ++HRDIK  NILLD+Q +  ++DF +A  +      +TT   GT GY+AP
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAP 168

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
           E       +   D +S G+   E + G+ P     
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.7 bits (188), Expect = 1e-15
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G V+  + +     VA+K + N + Q +KE  + E+  +  +++ N+V  L   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 86  LVGDELFVVMEYLAGGSLT-----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS N+LL    + KL+DFG    +  E+S  +T V GT  ++APE  +      + 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E++ G  P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 54/182 (29%), Positives = 92/182 (50%), Gaps = 12/182 (6%)

Query: 213 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271
           VAVK L  +    A ++F  EV+ + R+   N+ RLLG C       ++ EY++NG+L Q
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 272 WLHGDVGPHS-------PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324
           +L   V   S        L++   + +    A G+ YL        VHRD+ + N L+ K
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 325 QWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 383
            +  K++DFG+++ L +   Y V  R      ++A E    G    +SDV++FG+ + E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 384 IS 385
           ++
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 28/209 (13%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKN 243
           N IGEG YGIVY     D T+   VA+K +   R   E++   +    E+  +  +RH N
Sbjct: 13  NRIGEGTYGIVYRA--RDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPN 67

Query: 244 LVRLLGYCAEGAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           +V L      G H     LV EY +  +L   L     P S    +++  ++L   +GL 
Sbjct: 68  IVELK-EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS--ESQVKC-LMLQLLRGLQ 122

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           YLHE     ++HRD+K SN+LL  +   K++DFGLA+  G     +T +V+ T  Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178

Query: 361 YASTGMLNERS--DVYSFGILIMEVISGR 387
               G     +  D+++ G ++ E+++ +
Sbjct: 179 LL-LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 193 VIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVEAIGRV-RHKNL 244
            +G G +G V     +G+ + +    VAVK L      +E+E    E++ +  +  H+N+
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           V LLG C  G   +++ EY   G+L  +L       S LT E  ++     AKG+ +L  
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---TTRVMGTFGYVAPEY 361
                 +HRD+ + N+LL      K+ DFGLA+ +  + +YV     R+     ++APE 
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPES 214

Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               +    SDV+S+GIL+ E+ S G NP
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 46/214 (21%)

Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 246
           IGEG YG+V+     +    VA+K  +    ++E +  +      E+  + +++H NLV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64

Query: 247 LLGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           L+          LV+EY D+     LE+   G       +   +   II  T + + + H
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----GAERSYVTTRVMGTFGYVAP 359
           +      +HRD+K  NIL+ KQ   KL DFG A++L         YV TR      Y AP
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169

Query: 360 E-------YASTGMLNERSDVYSFGILIMEVISG 386
           E       Y          DV++ G +  E+++G
Sbjct: 170 ELLVGDTQYGPP------VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 34/212 (16%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAE--------KEFKVEVEAIGRVRHKN 243
           +GEG Y +VY     E    VA+K + L  R +A+        +E K+  E    ++H N
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LKHPN 63

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++ LL      ++  LV+E+++  +LE+ +       +P   +I+ + +L T +GL YLH
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLEYLH 119

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--- 360
                 ++HRD+K +N+L+      KL+DFGLA+  G+    +T +V+ T  Y APE   
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175

Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGRNP 389
              +   G+     D++S G +  E++  R P
Sbjct: 176 GARHYGVGV-----DMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA+K + N + Q +KE  + E+  +   ++ N+V  L   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 86  LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS NILL    + KL+DFG    +  E+S  +T V GT  ++APE  +      + 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E++ G  P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D  N    VAVK L ++    +  +   E+E +  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVG------PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L        D        P   LT++  ++ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                ++APE     +   +SDV+SFG+L+ E+ + G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 35/232 (15%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G YGIV      E N  VA+K   N  +NR  A++  + E++ +  + H+N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71

Query: 250 YCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
                 HR       +VYE +D       LH  +     L+ +     +    +GL Y+H
Sbjct: 72  -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 V+HRD+K SN+LL+   + K+ DFGLA+    +  ++T  V+ T  Y APE   
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL-- 179

Query: 364 TGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
             +LN        DV+S G +  E++ GR P+     PG+  + Q+  +  L
Sbjct: 180 --LLNCSEYTTAIDVWSVGCIFAELL-GRKPLF----PGKDYVHQLKLITEL 224

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 23/211 (10%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
           F D   IG G +G VY    +  N  VA+K +  +  Q+ ++++    EV  + ++RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 244 LVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM-NIILGTAKGLTY 301
            +   G C    H   LV EY   G+    L  +V  H     E+ +  I  G  +GL Y
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYC-LGSASDIL--EV--HKKPLQEVEIAAICHGALQGLAY 130

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH     + +HRDIK+ NILL +    KL+DFG A L+    S+V     GT  ++APE 
Sbjct: 131 LH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182

Query: 362 ---ASTGMLNERSDVYSFGILIMEVISGRNP 389
                 G  + + DV+S GI  +E+   + P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 18/203 (8%)

Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V    +    DNT   VAVK+L   + G    + K E+E +  + H+N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 248 LGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            G C E       L+ E++ +G+L+++L  +    + +  + ++   +   KG+ YL   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS- 127

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---RVMGTFGYVAPEYA 362
              + VHRD+ + N+L++ +   K+ DFGL K +  ++ Y T         F Y APE  
Sbjct: 128 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184

Query: 363 STGMLNERSDVYSFGILIMEVIS 385
                   SDV+SFG+ + E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           V+G G +G VY G+ + D  N    VA+K L  N   +A KE   E   +  V    + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LLG C     + LV + +  G L  ++      +G    L W +++      AKG++YL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
           E    ++VHRD+ + N+L+    + K++DFGLA+LL   E  Y          ++A E  
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
                  +SDV+S+G+ + E+++ G  P D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 7e-15
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 58/228 (25%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--------EVEAIGRV-RHKN 243
           +G+G +G VY     E    VA+K +       +K+F          EV+++ ++  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +V+L     E      V+EY++ GNL Q +    G   P +  +  +II    +GL ++H
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH 116

Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS------YVTTRVMGTFGY 356
           + G      HRD+K  N+L+      K++DFGLA+ +   RS      YV+TR      Y
Sbjct: 117 KHGF----FHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTR-----WY 164

Query: 357 VAPE-------YASTGMLNERSDVYSFGILIMEVIS------GRNPVD 391
            APE       Y+S        D+++ G ++ E+ +      G + +D
Sbjct: 165 RAPEILLRSTSYSSP------VDIWALGCIMAELYTLRPLFPGSSEID 206

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)

Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
           +G+G +G+VY G+       E  T VA+K +       E+ EF  E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 300
           LLG  ++G   +++ E +  G+L+ +L        +    +P + +  + +    A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVA 358
           YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  E  Y      G     +++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMS 189

Query: 359 PEYASTGMLNERSDVYSFGILIMEV 383
           PE    G+    SDV+SFG+++ E+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)

Query: 193 VIGEGGYGIVYHGVL--EDNT--NVAVKNL-LNNRGQAE-KEFKVEVEAIGRVRHKNLVR 246
           ++GEG +G V  G L  +D +   VAVK + L+    +E +EF  E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 247 LLGYCAEGAHR------MLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTA 296
           L+G C E +        M++  ++ +G+L  +L     G +    PL  +  +  ++  A
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FG 355
            G+ YL        +HRD+ + N +L +     ++DFGL+K + +   Y   R+      
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           ++A E  +  +   +SDV++FG+ + E+ + G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 20/190 (10%)

Query: 213 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271
           VAVK L  +  + A  +F  EV+ + R++  N++RLLG C +     ++ EY++NG+L Q
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 272 WL------------HGDVGPHSPL---TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
           +L            +  V P   L   ++   +++ L  A G+ YL        VHRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165

Query: 317 SSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYS 375
           + N L+ +    K++DFG+++ L A   Y +  R +    ++A E    G     SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 376 FGILIMEVIS 385
           FG+ + E++ 
Sbjct: 226 FGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)

Query: 194 IGEGGYGIVY----HGVLE----------DNTN-VAVKNLLNN-RGQAEKEFKVEVEAIG 237
           +GEG +G V+     G+ E               VAVK L  +    A  +F  E++ + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 238 RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------HGDVGPHSPLTWEI 287
           R+++ N++RLLG C       ++ EY++NG+L Q+L          H +  P   +   +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-V 346
            M + +  A G+ YL        VHRD+ + N L+   +  K++DFG+++ L +   Y +
Sbjct: 133 YMAVQI--ASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
             R +    ++A E    G     SDV++FG+ + E+ +
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 10/210 (4%)

Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRV 239
              F  E  IG+G + +VY  + L D   VA+K +    + +    +   K E++ + ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
            H N+++ L    E     +V E  D G+L + +         +         +     L
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            ++H     +++HRDIK +N+ +      KL D GL +   ++ +   + V GT  Y++P
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNP 389
           E       N +SD++S G L+ E+ + ++P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 30/208 (14%)

Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLV 245
           IGEG YG+VY     D   N  +A+K +   R + E E        E+  +  ++H N+V
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           RL           LV+EY+D   L+   H D  P       +    +    +G+ Y H  
Sbjct: 65  RLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 306 LEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
              +V+HRD+K  N+L+D++ N  KL+DFGLA+  G      T  V+ T  Y APE    
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI--- 174

Query: 365 GMLNERS-----DVYSFGILIMEVISGR 387
            +L  R      D++S G +  E+++ +
Sbjct: 175 -LLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA++ + N + Q +KE  + E+  +   ++ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 87  LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS NILL    + KL+DFG    +  E+S   + ++GT  ++APE  +      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E+I G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)

Query: 194 IGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
           +G+G +G+VY G   D       T VAVK +  +    E+ EF  E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH-----GDVGPHSPL-TWEIRMNIILGTAKGLT 300
           LLG  ++G   ++V E + +G+L+ +L       +  P  P  T +  + +    A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVA 358
           YL+     K VHRD+ + N ++   +  K+ DFG+ + +  E  Y      G     ++A
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189

Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+    SD++SFG+++ E+ S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
           F+D   IG G +G VY    + ++  VA+K +  +  Q+ ++++    EV  + ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
            ++  G         LV EY   G+    L      H     E+ +  +  G  +GL YL
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
           H      ++HRD+K+ NILL +    KL DFG A ++     +V     GT  ++APE  
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183

Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
                G  + + DV+S GI  +E+   + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IGEG  GIV     + +   VAVK +++ R Q  +E    EV  +   +H+N+V +    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    ++ E++  G L      D+   + L  E    +     + L YLH      V+
Sbjct: 88  LVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHS---QGVI 139

Query: 312 HRDIKSSNILLDKQWNPKLSDFG----LAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           HRDIKS +ILL      KLSDFG    ++K +   +S V     GT  ++APE  S    
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPY 194

Query: 368 NERSDVYSFGILIMEVISGRNP 389
               D++S GI+++E++ G  P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 194 IGEGGYGIVY----HGVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V     +G+ +        VAVK L +N    +  +   E+E +  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   L+++  ++ 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      + +HRD+ + N+L+ +    K++DFGLA+ +     Y  T+  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                ++APE     +   +SDV+SFGIL+ E+ + G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ ++  N    VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L                 P   L+++  ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                ++APE     +   +SDV+SFG+L+ E+ + G +P
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.6 bits (179), Expect = 4e-14
 Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 80/235 (34%)

Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLN---NRGQAEKEFKVEVEAIGRVR-HKNLVRL 247
           +G+G YGIV+  + +  T   VA+K + +   N   A++ F+ E+  +  +  H N+V+L
Sbjct: 15  LGKGAYGIVWKAI-DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72

Query: 248 LGYCAEGAHRM-------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI--------- 291
           L        +        LV+EY++               + L   IR NI         
Sbjct: 73  LN-----VIKAENDKDIYLVFEYME---------------TDLHAVIRANILEDVHKRYI 112

Query: 292 ---ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---- 344
              +L   K L Y+H G    V+HRD+K SNILL+     KL+DFGLA+ L         
Sbjct: 113 MYQLL---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166

Query: 345 -----YVTTRVMGTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
                YV TR      Y APE       Y + G+     D++S G ++ E++ G+
Sbjct: 167 PVLTDYVATR-----WYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 14/202 (6%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGY 250
           IGEG YG V+     E +  VA+K + L++  +      + E+  +  ++HKN+VRL   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
                   LV+EY D  +L+++     G   P   +  M  +L   KGL + H      V
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHS---HNV 120

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTGMLNE 369
           +HRD+K  N+L++K    KL+DFGLA+  G   R Y    V  T  Y  P+      L  
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 178

Query: 370 RS-DVYSFGILIMEVISGRNPV 390
            S D++S G +  E+ +   P+
Sbjct: 179 TSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 71.7 bits (175), Expect = 9e-14
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
           F D   IG G +G VY    +  N  VA+K +  +  Q+ ++++    EV+ + R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
            +   G         LV EY   G+    L      H     E+ +  I  G  +GL YL
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 141

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
           H      ++HRDIK+ NILL +    KL+DFG A +     S+V     GT  ++APE  
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193

Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
                G  + + DV+S GI  +E+   + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 15/208 (7%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG--Y 250
           IG+G YG VY    + + ++A   +L+     ++E + E   +  +  H N+V+  G  Y
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 251 CAE---GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
            A+   G    LV E  + G++ + + G +     L   +   I+ G   GL +LH    
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM- 366
            +++HRD+K +NILL  +   KL DFG++  L + R    T V GT  ++APE  +    
Sbjct: 148 -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 205

Query: 367 ----LNERSDVYSFGILIMEVISGRNPV 390
                + R DV+S GI  +E+  G  P+
Sbjct: 206 YDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.1 bits (174), Expect = 9e-14
 Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 29/218 (13%)

Query: 194 IGEGGYGIVY-------------HGVLEDNTN----VAVKNLLNNRGQ-AEKEFKVEVEA 235
           +GEG +G V+                L+ + N    VAVK L  +  + A  +F  E++ 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR------- 288
           + R++  N++RLL  C       ++ EY++NG+L Q+L       +    ++        
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VT 347
           + +    A G+ YL        VHRD+ + N L+ K +  K++DFG+++ L +   Y + 
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
            R +    +++ E    G     SDV++FG+ + E+++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 34/215 (15%)

Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           I +G YG V+    + +T    A+K +    +  + Q + +   E + + + +   +V+L
Sbjct: 1   ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVD-QVLTERDILSQAQSPYVVKL 58

Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
             Y  +G   + LV EY+  G+L   L  +VG    L  ++    I      L YLH   
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGS---LDEDVARIYIAEIVLALEYLHSN- 112

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--------TTRVMGTFGYVA 358
              ++HRD+K  NIL+D   + KL+DFGL+K +G  R  +          R++GT  Y+A
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 359 PEYASTGMLNE----RSDVYSFGILIMEVISGRNP 389
           PE     +L +      D +S G ++ E + G  P
Sbjct: 170 PEV----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 48/128 (37%), Positives = 69/128 (53%), Gaps = 14/128 (10%)

Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
           E++D G+L+  ++  +  H      +   I +   KGLTYL   L  K++HRD+K SN+L
Sbjct: 79  EFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLW-SL--KILHRDVKPSNML 127

Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
           ++ +   KL DFG++  L    S   T V GT  Y+APE  S       SDV+S GI  M
Sbjct: 128 VNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYGIHSDVWSLGISFM 184

Query: 382 EVISGRNP 389
           E+  GR P
Sbjct: 185 ELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+G V        T    A K L   R    + E+    E + + +V     +  L
Sbjct: 1   LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSL 58

Query: 249 GYCAEG-AHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            Y  E      LV   ++ G+L+  +   G+ G            II G    L +LH+ 
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ- 113

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              ++V+RD+K  N+LLD   N ++SD GLA  L   +        GT GY+APE     
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGE 169

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
           + +   D ++ G  + E+I+GR+P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 38/214 (17%)

Query: 213 VAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLL--GYCAEGAHRMLVYEYIDNG 267
           VA+K L  +  + E +   F+ E     R+ H N+V LL  G    G     V+EY+   
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGR 64

Query: 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DK 324
            L + L  D G          M  +L     L   H      +VHRD+K  NI++     
Sbjct: 65  TLREVLAAD-GALPAGETGRLMLQVL---DALACAHNQ---GIVHRDLKPQNIMVSQTGV 117

Query: 325 QWNPKLSDFGLAKLL-GAE-----RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
           + + K+ DFG+  LL G           TT V+GT  Y APE      +   SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 379 LIMEVISGR----------------NPVDYSRPP 396
           + +E ++G+                +PVD S PP
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPP 211

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+G V   V   NT    A K L   R +    EK   +E E + +V    +V L 
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMN-IILGTAK---GLTYL 302
                  H  LV   ++ G+L+  ++  G+ G        + M  +I  +A+   G+ +L
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--------LEMERVIHYSAQITCGILHL 111

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H      +V+RD+K  N+LLD Q N +LSD GLA  L   ++   T+  GT GY+APE  
Sbjct: 112 HS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEIL 166

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                +   D ++ G  I E+++GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 45/232 (19%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKE-FKV----EVEA 235
           +   + F     IGEG YG VY    +D    VA+K +   R   EKE F +    E++ 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKI 59

Query: 236 IGRVRHKNLVRL----------LGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSP 282
           + ++ H+N+V L          L +  +     LV+EY+D+   G LE  L         
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-------VH 112

Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
            + +   + +    +GL Y H+      +HRDIK SNILL+ +   KL+DFGLA+L  +E
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Query: 343 --RSYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
             R Y T +V+ T  Y  PE     +L E       DV+S G ++ E+ + +
Sbjct: 170 ESRPY-TNKVI-TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLLGY 250
           IG+G +G V+ G+ ++ T   V   + +  +AE E    + E+  + +     + +  G 
Sbjct: 12  IGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             +     ++ EY+  G+    L        PL       I+    KGL YLH     K 
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKK 122

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           +HRDIK++N+LL +    KL+DFG+A  L  +        +GT  ++APE       + +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181

Query: 371 SDVYSFGILIMEVISGRNP 389
           +D++S GI  +E+  G  P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 18/213 (8%)

Query: 194 IGEGGYGIVYHGVLEDNT-------NVAVKNLLNNRGQAEKEFKV-----EVEAIG-RVR 240
           +G G +G VY    ++N         + V N    + + E++  +     EV  I  ++R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+VR      E     +V + I+   L +  +         T E   NI +     L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           YLH+  E ++VHRD+  +NI+L +     ++DFGLAK    E S +T+ V+GT  Y  PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTS-VVGTILYSCPE 183

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
                   E++DV++FG ++ ++ +   P  YS
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT-LQPPFYS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 44/107 (41%), Positives = 57/107 (53%), Gaps = 13/107 (12%)

Query: 292 ILG-----TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
           ILG       K L YL E  +  V+HRD+K SNILLD   N KL DFG++  L    S  
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKA 170

Query: 347 TTRVMGTFGYVAPEYASTGMLNE----RSDVYSFGILIMEVISGRNP 389
            TR  G   Y+APE       N     R+DV+S GI ++E+ +G+ P
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
           ++G+G +G VY    ++    +A K +  +    E   +V     E++ +  ++H+ +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 247 LLGYCAEGAHRMLV--YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G   + A + L    EY+  G+++  L      +  LT  +         +G++YLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS 124

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
            +   +VHRDIK +NIL D   N KL DFG +K L       T    V GT  +++PE  
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
           S      ++DV+S G  ++E+++ + P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 24/214 (11%)

Query: 194 IGEGGYGIVYHGVLEDNTN---VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V  G L  + +   VAVK +   +  R + E +F  E   +    H N++RL
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65

Query: 248 LGYCAEGAHR------MLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTAK 297
           +G C +          +++  ++ +G+L  +L     GD   + P   ++ +  +   A 
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIAS 123

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FGY 356
           G+ YL        +HRD+ + N +L++  N  ++DFGL+K +     Y   R+      +
Sbjct: 124 GMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           +A E  +  +   +SDV+SFG+ + E+ + G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 55/161 (34%), Positives = 75/161 (46%), Gaps = 19/161 (11%)

Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
           E     RH  LV L        H   V EY   G+L   +H DV    P        ++L
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVVL 112

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
           G    L YLHE    K+V+RD+K  N+LLD +   K++DFGL K  G      T+   GT
Sbjct: 113 G----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGT 164

Query: 354 FGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
             ++APE     +L E S     D +  G+LI E++ G +P
Sbjct: 165 PEFLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 19/203 (9%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAV------KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G GG+G V   V   + N         K  +   GQ ++    E E +    H  +V+L
Sbjct: 1   LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKL 58

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                +  +  ++ EY   G L   L  D G      +  R   I        YLH    
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD--EYTARF-YIACVVLAFEYLHN--- 111

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGM 366
             +++RD+K  N+LLD     KL DFG AK L   ++++      GT  YVAPE      
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKG 168

Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            +   D +S GIL+ E+++GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 40/213 (18%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 240
           IGEG YG+VY G          +N    +  A K+ ++E E  G              ++
Sbjct: 8   IGEGTYGVVYKG----------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ 57

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V L     + +   L++E++   +L+++L   +     +  E+  + +    +G+ 
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLD-SLPKGQYMDAELVKSYLYQILQGIL 115

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           + H     +V+HRD+K  N+L+D +   KL+DFGLA+  G      T  V+ T  Y APE
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPE 171

Query: 361 YA------STGMLNERSDVYSFGILIMEVISGR 387
                   ST +     D++S G +  E+ + +
Sbjct: 172 VLLGSPRYSTPV-----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 53/228 (23%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
           +GEG +G VY    ++    VA+K +L      EK+ F +    E++ + +++H N+V L
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72

Query: 248 LG----YCAEGAHRM----LVYEYID---NGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           +        +   +     +V  Y+D   +G LE        P   LT       +L   
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYMLQLL 125

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL------------GAERS 344
           +G+ YLHE     ++HRDIK++NIL+D Q   K++DFGLA+              G  R 
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
           Y  T ++ T  Y  PE     +L ER      D++  G +  E+ + R
Sbjct: 183 Y--TNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 47/235 (20%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKE-FKV----EVEA 235
           EVS   +     IG+G +G V+    +     VA+K +L      EKE F +    E++ 
Sbjct: 10  EVSK--YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKI 64

Query: 236 IGRVRHKNLVRLLGYC---AEGAHR-----MLVYEYIDN---GNLEQWLHGDVGPHSPLT 284
           +  ++H+N+V L+  C   A   +R      LV+E+ ++   G L          +   T
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-------KNVKFT 117

Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----G 340
                 ++     GL Y+H     K++HRD+K++NIL+ K    KL+DFGLA+       
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174

Query: 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
           ++ +  T RV+ T  Y  PE     +L ER      D++  G  IM  +  R+P+
Sbjct: 175 SKPNRYTNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGC-IMAEMWTRSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 33/215 (15%)

Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKEFKVEVEAIGRV---------R 240
           IGEG YG V+     D  N    VA+K +   R Q  +E  + +  I  V          
Sbjct: 9   IGEGAYGKVFKA--RDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFE 62

Query: 241 HKNLVRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           H N+VRL   C            LV+E++D  +L  +L  D  P   +  E   +++   
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQL 119

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
            +GL +LH     +VVHRD+K  NIL+      KL+DFGLA++   +     T V+ T  
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLW 174

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           Y APE           D++S G +  E+   R P+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 193 VIGEGGYGIVY----HGVLEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNL 244
           V+G G YG V+     G  +     A+K L    +  + +  +  + E + +  VR    
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYL 302
           +  L Y  +   ++ L+ +Y++ G L   L+           E  + + +      L +L
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHL 121

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H+     +++RDIK  NILLD + +  L+DFGL+K   AE         GT  Y+APE  
Sbjct: 122 HQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 363 STGML--NERSDVYSFGILIMEVISGRNP 389
             G    ++  D +S G+L  E+++G +P
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVR---HKNLVRL 247
           IG G YG VY          VA+K++     +         EV  + R+    H N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 248 LGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           +  CA           LV+E++D  +L  +L     P  P   E   +++    +GL +L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H      +VHRD+K  NIL+      KL+DFGLA++   + +   T V+ T  Y APE  
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVL 179

Query: 363 STGMLNERSDVYSFGILIMEVISGRNPV 390
                    D++S G +  E+   R P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 52/224 (23%), Positives = 111/224 (49%), Gaps = 29/224 (12%)

Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-----VAVKNLLNNRGQAEKEFKV-EVE 234
           + +S +     +++ EG +G +++G+L D        V VK + ++  + +    + E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 235 AIGRVRHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRM 289
            +  + H+N++ +L  C E G    ++Y Y++ GNL+ +L     G+      L+ +  +
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--------LLGA 341
           ++ +  A G++YLH+     V+H+DI + N ++D++   K++D  L++         LG 
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG- 176

Query: 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           +      + M      A E       +  SDV+SFG+L+ E+++
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 33/219 (15%)

Query: 189 ADENVIGEGGYGIVYHGVLEDNTN--VAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKN 243
             EN IG G YG+V   + +  +   VA+K   +  +    A++  + E++ +   +H N
Sbjct: 9   PIEN-IGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDN 65

Query: 244 LVRLLG-YCAEGAHRMLVYEYID--NGNLEQWLHGDVGPHSPLTWE-IR--MNIILGTAK 297
           ++ +       GA    VY  +D    +L   +H D     PLT E IR  +  +L   +
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQLL---R 118

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG---AERSYVTTRVMGTF 354
           GL Y+H      V+HRD+K SN+L+++    ++ DFG+A+ L     E  Y  T  + T 
Sbjct: 119 GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 355 GYVAPEYASTGMLNERS---DVYSFGILIMEVISGRNPV 390
            Y APE   +  L E +   D++S G +  E++ GR  +
Sbjct: 176 WYRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVR 240
           TN + D   +G G +G+V          NVA+K ++        A++ ++ E++ +  +R
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67

Query: 241 HKNLVRLLG-YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           H+N++ L   + +       V E +   +L + L     P      +  +  IL   +GL
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQIL---RGL 121

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVA 358
            Y+H      VVHRD+K SNIL+++  + K+ DFGLA++   + + YV+TR      Y A
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173

Query: 359 PEYASTGM-LNERSDVYSFGILIMEVISGR 387
           PE   T    +   D++S G +  E++ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 8/96 (8%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
           GL +LHE     +++RD+K  N+LLD + + K++DFG+ K  +LG      T+   GT  
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPD 161

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           Y+APE  S        D ++ G+L+ E+++G++P +
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 22/213 (10%)

Query: 194 IGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLG- 249
           +G+G YG VY  VL   T V  A+K +     +++  +  +E++ + +     +V   G 
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EGA  M + EY+D G+L++ L+        +  ++   I     KGL +L E  E  
Sbjct: 68  FFIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           ++HRD+K +N+L++     KL DFG++  L    S   T + G   Y+APE   +G  N+
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGGPNQ 180

Query: 370 R------SDVYSFGILIMEVISGRNPVDYSRPP 396
                  SDV+S G+ I+E+  GR    Y  PP
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR----YPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGY-- 250
           IG+G YG V+  + + N + A   +L+     ++E + E   +  +  H N+V+  G   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 251 ---CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                 G    LV E  + G++   + G +     +   I   I+     GL +LH    
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-- 143

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--- 364
            K +HRD+K +NILL  +   KL DFG++  L + R    T V GT  ++APE  +    
Sbjct: 144 -KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 201

Query: 365 --GMLNERSDVYSFGILIMEVISGRNPV 390
                + R DV+S GI  +E+  G  P+
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
           F   + IG G +G VY       N  VAVK +  +  Q  ++++    EV+ + +++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
            +   G   +     LV EY   G+    L      H     E+ +  I  G  +GL YL
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 137

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
           H      ++HRDIK+ NILL +    KL+DFG A       S+V     GT  ++APE  
Sbjct: 138 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189

Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
                G  + + DV+S GI  +E+   + P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 31/209 (14%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFKV-----------EVEAIGRVR 240
            +G G +G V     + +    A+K L        K  K+           E   +  +R
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKIL-------SKA-KIVKLKQVEHVLNEKRILQSIR 59

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H  LV L G   + ++  LV EY+  G L   L        P+       ++L     L 
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LE 115

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           YLH      +V+RD+K  N+LLD     K++DFG AK +   R+Y      GT  Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAPE 168

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
              +    +  D ++ GILI E+++G  P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 47/213 (22%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLG--- 249
           +G+G +G VY    ++   +A   +++ + + E E + VE++ +    H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 250 ----------YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKG 298
                     +CA GA   ++ E      LE+          PLT E ++ ++   T + 
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLE------LER----------PLT-EPQIRVVCKQTLEA 115

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR---VMGTFG 355
           L YLHE    K++HRD+K+ NIL     + KL+DFG++    A+ +    R    +GT  
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPY 168

Query: 356 YVAPEYASTGMLNER-----SDVYSFGILIMEV 383
           ++APE        +R     +DV+S GI ++E+
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 18/199 (9%)

Query: 193 VIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL- 248
           V+G+G YG   +V H        +   NL N   +  K  + E + + +++H N+V    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHE 304
            +  E     +V  + + G+L   L    G   P    + W +++      A  L YLHE
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHE 120

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
                ++HRD+K+ N+ L +    K+ D G+A++L  +    +T ++GT  Y++PE  S 
Sbjct: 121 ---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSN 176

Query: 365 GMLNERSDVYSFGILIMEV 383
              N +SDV++ G  + E+
Sbjct: 177 KPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 18/210 (8%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG-Y 250
           ++G G YG VY G       +A   +++  G  E+E K E+  + +   H+N+    G +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 251 CAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
             +    M     LV E+   G++   +    G  + L  E    I     +GL++LH+ 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH 130

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST- 364
              KV+HRDIK  N+LL +    KL DFG++  L        T  +GT  ++APE  +  
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 186

Query: 365 ----GMLNERSDVYSFGILIMEVISGRNPV 390
                  + +SD++S GI  +E+  G  P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
           ++G+G +G VY     D    +AVK +  +    E   +V     E++ +  + H+ +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 247 LLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G   +   R L    E++  G+++  L      +  LT  +         +G++YLH 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL------GAERSYVTTRVMGTFGYVA 358
            +   +VHRDIK +NIL D   N KL DFG +K L      G     VT    GT  +++
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMS 177

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           PE  S      ++D++S G  ++E+++ + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 25/202 (12%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLG-YC 251
           +G+G +G VY    ++   +A   ++  + + E E + VE+E +    H  +V+LLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 252 AEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +G   +++ E+   G ++   L  D G   P   +I++ I     + L YLH     K+
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKI 131

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLA----KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           +HRD+K+ N+LL    + KL+DFG++    K L    S++     GT  ++APE      
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186

Query: 367 LNE-----RSDVYSFGILIMEV 383
           + +     ++D++S GI ++E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 44/135 (32%), Positives = 74/135 (54%), Gaps = 13/135 (9%)

Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
           E++D G+L+Q L         +  +I   + +   KGLTYL E  + K++HRD+K SNIL
Sbjct: 83  EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 136

Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
           ++ +   KL DFG++   G     +    +GT  Y++PE       + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 382 EVISGRNPVDYSRPP 396
           E+  GR P+    PP
Sbjct: 194 EMAIGRYPI----PP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 69/212 (32%), Positives = 97/212 (45%), Gaps = 37/212 (17%)

Query: 193 VIGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
            IG G  GIV   Y  V     NVA+K L     N   A++ ++ E+  +  V HKN++ 
Sbjct: 23  PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79

Query: 247 LLGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGL 299
           LL          E     LV E +D  NL Q +  D+  H       RM+ +L     G+
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD-HE------RMSYLLYQMLCGI 131

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGY 356
            +LH      ++HRD+K SNI++      K+ DFGLA+  G       YV TR      Y
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 183

Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
            APE    GM   E  D++S G ++ E+I G 
Sbjct: 184 RAPEVI-LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)

Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   +  VL    NVAVK L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 29  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85

Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +H ++  H  +++     ++     G+ +
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD-HERMSY-----LLYQMLCGIKH 138

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+   A  +++ T  + T  Y APE 
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEV 193

Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E++ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
           ++G G +G VY     D    +AVK +  +    E   +V     E++ +  +RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 247 LLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G   +   + L    EY+  G+++  L      +  LT  +         +G++YLH 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS 124

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT----TRVMGTFGYVAPE 360
            +   +VHRDIK +NIL D   N KL DFG +K +  +   ++      V GT  +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTGTPYWMSPE 179

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
             S      ++DV+S    ++E+++ + P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 60/171 (35%), Positives = 88/171 (51%), Gaps = 17/171 (9%)

Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGP 279
           R + E+    E   +  V H  ++RL  +  E   R L  + EY+  G L  +L  + G 
Sbjct: 41  RLKQEQHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGR 97

Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
            S  T     + I+     L YLH   E  +V+RD+K  NILLDK+ + KL+DFG AK L
Sbjct: 98  FSNSTGLFYASEIVC---ALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151

Query: 340 GAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNP 389
             +R++    + GT  Y+APE   S G  N+  D ++ GILI E++ G  P
Sbjct: 152 -RDRTWT---LCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY    L      AVK +    G      + E+  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
                 +  EY   G+L+   H   GP S L       +   T +GL YLH   +   +H
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAY---VCRETLQGLAYLHSKGK---MH 129

Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGA----ERSYVTTRVMGTFGYVAPEYAS---TG 365
           RDIK +NILL    + KL+DFG+A  + A     +S++     GT  ++APE A+    G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPEVAAVEKNG 184

Query: 366 MLNERSDVYSFGILIMEVISGRNPV 390
             N+  D+++ GI  +E+   + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 45/131 (34%), Positives = 72/131 (54%), Gaps = 13/131 (9%)

Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
           E++D G+L+Q L    G    +   I   I +   +GLTYL E  + K++HRD+K SNIL
Sbjct: 79  EHMDGGSLDQVLK-KAGR---IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132

Query: 322 LDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379
           ++ +   KL DFG++  L      S+V TR      Y++PE         +SD++S G+ 
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYTVQSDIWSLGLS 187

Query: 380 IMEVISGRNPV 390
           ++E+  GR P+
Sbjct: 188 LVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 13/135 (9%)

Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
           E++D G+L+Q L         +  EI   + +   +GL YL E  + +++HRD+K SNIL
Sbjct: 83  EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136

Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
           ++ +   KL DFG++   G     +    +GT  Y++PE       + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 382 EVISGRNPVDYSRPP 396
           E+  GR P+    PP
Sbjct: 194 ELAIGRYPI----PP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 8/94 (8%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
           GL +LH      +V+RD+K  NILLD   + K++DFG+ K  +LG  +   T    GT  
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPD 161

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE       N   D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
           LV EY++ G+    L   +G   P  W  +   I     G+  LH+     ++HRDIK  
Sbjct: 74  LVMEYLNGGDCAS-LIKTLGG-LPEDW-AK-QYIAEVVLGVEDLHQR---GIIHRDIKPE 126

Query: 319 NILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
           N+L+D+  + KL+DFGL++           + +GT  Y+APE       ++ SD +S G 
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181

Query: 379 LIMEVISGRNPVDYSRP 395
           +I E + G  P     P
Sbjct: 182 VIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251
           V+G G YG VY G       +A   +++     E+E K+E+  + +   H+N+    G  
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 252 AEGA------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            + +         LV E+   G++   +    G      W     I     +GL +LH  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLHAH 140

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFG----LAKLLGAERSYVTTRVMGTFGYVAPEY 361
              KV+HRDIK  N+LL +    KL DFG    L + +G   +++     GT  ++APE 
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 192

Query: 362 AST-----GMLNERSDVYSFGILIMEVISGRNPV 390
            +         + RSD++S GI  +E+  G  P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 12/208 (5%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRH 241
           F  E  IG G +  VY    L D   VA+K     +L++   +A  +   E++ + ++ H
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
            N+++      E     +V E  D G+L + +         +  +      +     L +
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           +H     +V+HRDIK +N+ +      KL D GL +   + ++     ++GT  Y++PE 
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
                 N +SD++S G L+ E+ + ++P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 32/227 (14%)

Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL+   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 134

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                  E  D++S G ++ E++  R+ + +   PG   I Q N ++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVI 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 13/198 (6%)

Query: 194 IGEGGYGIVYHG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +GEG Y  V+ G   L +N  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
                   LV+EY+D  +L+Q++       S    +I +  IL   +GL Y H     KV
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHR---RKV 125

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNE 369
           +HRD+K  N+L++++   KL+DFGLA+         +  V+ T  Y  P+    +   + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184

Query: 370 RSDVYSFGILIMEVISGR 387
           + D++  G +  E+ SGR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           YLH      +++RD+K  N+LLD + + K++DFG AK +  +R++    + GT  Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPE 185

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
              +    +  D ++ G+L+ E I+G  P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 4/92 (4%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL +LH+     +++RD+K  N+LLDK  + K++DFG+ K          +   GT  Y+
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYI 163

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE       NE  D +SFG+L+ E++ G++P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 49/225 (21%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK-------NLLNNRGQAEKEFKVEVEAIGRV 239
           + + + IGEG YG+V           VA+K            R    +E K+    + R 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR--TLREIKI----LRRF 60

Query: 240 RHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
           +H+N++ +L               +V E      +E  L+  +     L+ +     +  
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY-KLIKTQHLSNDHIQYFLYQ 114

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER-------SYVT 347
             +GL Y+H      V+HRD+K SN+LL+   + K+ DFGLA++   E         YV 
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 348 TRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
           TR      Y APE     MLN +      D++S G ++ E++S R
Sbjct: 172 TR-----WYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 16/203 (7%)

Query: 194 IGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G V  G          V VK L  +    E+  F  EV+    + H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEGLEP 308
            C E    +LV E+   G+L+ +L  + G  + +   ++   +    A GL +LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FGYVAPEYAS---- 363
             +H D+   N  L    + K+ D+GLA     E  Y+T         ++APE       
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 364 ---TGMLNERSDVYSFGILIMEV 383
                   ++S+++S G+ + E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 8/206 (3%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKN 243
           F  E  IG G +  VY    L D   VA+K +        +A ++   E++ + ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +++ L    E     +V E  D G+L Q +         +         +     + ++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                +V+HRDIK +N+ +      KL D GL +   ++ +   + V GT  Y++PE   
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179

Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               N +SD++S G L+ E+ + ++P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 27/206 (13%)

Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196

Query: 362 ASTGMLNERSDVYSFGILIMEVISGR 387
                  E  D++S G ++ E+I G 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)

Query: 194 IGEGGYGIVYHGVLEDN---TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G V  G +        V VK L  +   Q + +F  E +    ++H NL++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            C E    +LV E+   G+L+ +L      ++    P T + RM   +  A GL +LH+ 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLHLHKN 119

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYAST 364
                +H D+   N LL      K+ D+GL+     E  YVT  ++     ++APE    
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 365 GMLN-------ERSDVYSFGILIMEV 383
              N       + S+V+S G+ I E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 19/224 (8%)

Query: 186 NGFADENVIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAE-KEFKV-EVEAIGRVR 240
           N F    V+GEG YG+V    H   E    VA+K   ++    E KE  + E++ +  ++
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHK--ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
            +N+V L           LV+EY++   LE     +  P+     ++R + I    K + 
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKAIH 114

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           + H+     +VHRDIK  N+L+      KL DFG A+ L    +   T  + T  Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQM 404
                   +  D++S G ++ E+  G+ P+     PGE  I Q+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ-PLF----PGESEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 194 IGEGGYGIVYHG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +GEG Y  VY G   L DN  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
                   LV+EY+D  +L+Q+L  D G +S     +++  +    +GL Y H     KV
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLD-DCG-NSINMHNVKL-FLFQLLRGLNYCHR---RKV 125

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLN 368
           +HRD+K  N+L++++   KL+DFGLA+         +  V+ T  Y  P+    ST   +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY-S 183

Query: 369 ERSDVYSFGILIMEVISGR 387
            + D++  G +  E+ +GR
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 44/224 (19%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
           N I EG YG+VY    +  T   VA+K L   +   EKE F +    E+  + +++H N+
Sbjct: 11  NRIEEGTYGVVYRA-RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNI 66

Query: 245 VRLLGYCAE---GAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           V +     E   G++     +V EY+++ +L+  +  +      L  E++  ++L    G
Sbjct: 67  VTV----KEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVK-CLMLQLLSG 118

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           + +LH+     ++HRD+K+SN+LL+ +   K+ DFGLA+  G+     T  V+ T  Y A
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174

Query: 359 PEYASTGMLNERS-----DVYSFGILIMEVIS------GRNPVD 391
           PE     +L  +      D++S G +  E+++      G++ +D
Sbjct: 175 PEL----LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)

Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +GEG Y  V+ G  +   N VA+K + L +   A      EV  +  ++H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                  LV+EY+D+ +L+Q+L       S    +I M  +L   +GL+Y H+    K++
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHK---RKIL 125

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP-------EYAST 364
           HRD+K  N+L++++   KL+DFGLA+         +  V+ T  Y  P       EY++ 
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184

Query: 365 GMLNERSDVYSFGILIMEVISGR 387
                  D++  G ++ E+ +GR
Sbjct: 185 ------IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 16/204 (7%)

Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLG 249
           +G+GG+G V    +     + A K L   R +  K ++   VE   + +V H   +  L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 250 YCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK---GLTYLHEG 305
           Y  +    + LV   ++ G+L   ++ +V   +P   E R      TA+   GL +LH+ 
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRA--CFYTAQIISGLEHLHQR 116

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              ++++RD+K  N+LLD   N ++SD GLA  L   +S  T    GT G++APE     
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGE 172

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             +   D ++ G+ + E+I+ R P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 70/216 (32%), Positives = 98/216 (45%), Gaps = 22/216 (10%)

Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAEKEFK-VEVEA---IGRVRHKNLV 245
           VIG+G +G V    H    D    AVK L       +KE K +  E    +  V+H  LV
Sbjct: 2   VIGKGSFGKVLLAKHK--ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 246 RLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYLH 303
            L  Y  + A ++  V +Y++ G L  + H       P   E R        A  L YLH
Sbjct: 60  GL-HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLH 113

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  NILLD Q +  L+DFGL K  G E S  T+   GT  Y+APE   
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
               +   D +  G ++ E++ G  P  YSR   E+
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 194 IGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G YG VY      N N     A+K +    G+     + E+  +   +H N+V   G
Sbjct: 17  IGSGTYGDVYKA---RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                    +  E+   G+L+   H   GP S         +   T +GL YLH   +  
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAY---VSRETLQGLYYLHSKGK-- 127

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST---GM 366
            +HRDIK +NILL    + KL+DFG++  + A  +   +  +GT  ++APE A+    G 
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGG 185

Query: 367 LNERSDVYSFGILIMEVISGRNPV 390
            N+  D+++ GI  +E+   + P+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 1/94 (1%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYV 357
           L  +H      ++HRDIKS+NILL      KL DFG +K+  A  S    R   GT  YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           APE       ++++D++S G+L+ E+++ + P D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 4/94 (4%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLHE     +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+
Sbjct: 108 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 163

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           APE           D ++ G+L+ E+++GR+P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 10/99 (10%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-G 352
           A GL +LH      +++RD+K  N++LD + + K++DFG+ K    E  +   TTR   G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCG 163

Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           T  Y+APE  +     +  D ++FG+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 33/85 (38%), Positives = 48/85 (56%), Gaps = 6/85 (7%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST------ 364
           VHRDIK  N+L+D+  + KL+DFG A  L A +   +   +GT  Y+APE  +T      
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
           G      D +S G++  E+I GR+P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 40/122 (32%), Positives = 61/122 (50%), Gaps = 27/122 (22%)

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFG 355
           +GL Y+H      ++HRD+K SNI +++    K+ DFGLA+    E + YV TR      
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180

Query: 356 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMNSLM 408
           Y APE     MLN        D++S G ++ E+++G       +   PG   I Q+  +M
Sbjct: 181 YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTG-------KTLFPGSDHIDQLKRIM 229

Query: 409 TL 410
            L
Sbjct: 230 NL 231

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL  LH+    ++V+RD+K  NILLD   + ++SD GLA  +  E   +  RV GT GY+
Sbjct: 114 GLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 168

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D ++ G L+ E+I+G++P
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 7/120 (5%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL ++H      VV+RD+K +NILLD+  + ++SD GLA     ++ + +   +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 358 APEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSF 416
           APE    G   + S D +S G ++ +++ G +P    +   +  I +M   + +    SF
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSF 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNLVR 246
           VIG+G +G V     + D +  AVK +L  +   +K+ +  + A     +  ++H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 247 LLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           L  Y  + A ++  V +Y++ G L   L  +     P        +    A  + YLH  
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV----ASAIGYLHS- 114

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               +++RD+K  NILLD Q +  L+DFGL K  G E    T+   GT  Y+APE     
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSR 394
             +   D +  G ++ E++ G  P  YSR
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF-YSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 25/153 (16%)

Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVG----PHSPL-TWEIRMNIILGTAKGLTY 301
           L  C +   R+  V EY++ G+L   +   VG    PH+     EI + +    +KG   
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-GTFGYVA 358
                   +++RD+K  N++LD + + K++DFG+ K    E  +  VTT+   GT  Y+A
Sbjct: 122 --------IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIA 169

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           PE  +     +  D ++FG+L+ E+++G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 10/99 (10%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-G 352
           + GL +LH      +++RD+K  N++LD + + K++DFG+ K    E     VTTR   G
Sbjct: 111 SVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCG 163

Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           T  Y+APE  +     +  D +++G+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 31/212 (14%)

Query: 194 IGEGGYGIVYHGVLEDNTN-------VAVKNLLNNRGQAEKEFKVEVEAIG---RVRHKN 243
           +G+G +  +Y GVL   ++         V  +L   G   ++     E      ++ HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L G C    + M V EY+  G L+ +LH +   +  L W  ++++    A  L YL 
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHRE-KNNVSLHW--KLDVAKQLASALHYLE 118

Query: 304 EGLEPKVVHRDIKSSNILL-----DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           +    K+VH ++   NIL+     ++ + P  KLSD G+   + + R     R+     +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI----PW 170

Query: 357 VAPEYASTGMLNERS--DVYSFGILIMEVISG 386
           +APE    G  +     D +SFG  ++E+ S 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL  LH     ++V+RD+K  NILLD   + ++SD GLA  +  E   +  RV GT GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYM 168

Query: 358 APEYASTGMLNER----SDVYSFGILIMEVISGRNP 389
           APE       NER     D +  G LI E+I G++P
Sbjct: 169 APEVVK----NERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 193 VIGEGGYGIVY--HGVLEDNTN------VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           V+G G YG V+    V   +T       V  K  L  + +  +  + E   +  VR    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM---NIILGTAKGLT 300
           +  L Y  +   ++ L+ +Y+  G +   L+           E+R     IIL     L 
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA----LE 119

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           +LH+     +V+RDIK  NILLD + +  L+DFGL+K   +E    T    GT  Y+APE
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176

Query: 361 YA-STGMLNERSDVYSFGILIMEVISGRNP 389
                G   +  D +S GILI E+++G +P
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 38/216 (17%)

Query: 193 VIGEGGYGIVYHGVLEDNTN----VAVKNL------LNNRGQAEKEFKVEVEAIGRVRHK 242
           V+G+GGYG V+        +     A+K L       N +  A    K E   +  V+H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT--KAERNILEAVKHP 60

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAK---- 297
            +V L+     G    L+ EY+  G L   L              R  I +  TA     
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-------------REGIFMEDTACFYLS 107

Query: 298 ----GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
                L +LH+     +++RD+K  NILLD Q + KL+DFGL K    E + VT    GT
Sbjct: 108 EISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGT 163

Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
             Y+APE        +  D +S G L+ ++++G  P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 35/96 (36%), Positives = 59/96 (61%), Gaps = 8/96 (8%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGT 353
           A  L +LH  L   +++RD+K  NILLD++ + KL+DFGL+K  +   +++Y      GT
Sbjct: 108 ALALDHLH-SL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGT 161

Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
             Y+APE  +     + +D +SFG+L+ E+++G  P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 4/93 (4%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L +LHE     +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+A
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           PE           D ++ G+L+ E+++GR+P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 43/225 (19%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           N+IG G +G+VY  + ++ +  VA+K +L +     +E  +    +  + H N++ L  Y
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127

Query: 251 CAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII----LGTAKG 298
                 +         +V E+I      Q +H  +  ++     + + ++        + 
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFI-----PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAK-LLGAER--SYVTTRVMGTF 354
           L Y+H      + HRD+K  N+L+D   +  KL DFG AK LL  +R  SY+ +R     
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---- 235

Query: 355 GYVAPEYASTGMLNERS--DVYSFGILIMEVI------SGRNPVD 391
            Y APE    G  N  +  D++S G +I E+I      SG++ VD
Sbjct: 236 -YRAPELM-LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278

Length = 440

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 28/206 (13%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V   +       VA+K L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 250 Y--CAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
               A          LV  Y+   +L++ +        PL+ +    ++     GL Y+H
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH 134

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYA 362
                 ++HRD+K  N+ +++    K+ DFGLA+   AE + YV TR      Y APE  
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 186

Query: 363 STGM-LNERSDVYSFGILIMEVISGR 387
              M  N+  D++S G ++ E+++G+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 13/204 (6%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           VIG G Y  V    L+ N  +     VK  L +  +     + E     +      +  L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             C +   R+ LV EY++ G+L    H  +     L  E            L +LHE   
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDL--MFH--MQRQRKLPEEHARFYAAEICIALNFLHE--- 114

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
             +++RD+K  N+LLD   + KL+D+G+ K  G      T+   GT  Y+APE       
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
               D ++ G+L+ E+++GR+P D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 29/209 (13%)

Query: 194 IGEGGYGIVYHGVLEDNTNVA---VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G V    +  +T VA   VK L  N    E+ EF  + +    ++H N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 250 YCAEGAHRMLVYEYIDNGNL------EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
            C E    +LV+EY + G+L      EQW   +    S L    RM   +  A G+T++H
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEY 361
              +   +H D+   N  L      K+ D+G+      E  Y+ T         ++APE 
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172

Query: 362 AST---GML----NERSDVYSFGILIMEV 383
                 G++     + S+V++ G+ + E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 37/124 (29%), Positives = 65/124 (52%), Gaps = 7/124 (5%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL ++H      VV+RD+K +NILLD+  + ++SD GLA     ++ + +   +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 358 APEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSF 416
           APE    G+  + S D +S G ++ +++ G +P    +   +  I +M   M +    SF
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222

Query: 417 FLIC 420
               
Sbjct: 223 SPEL 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 5/96 (5%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L YLH      VV+RD+K  N++LDK  + K++DFGL K  G           GT  Y+A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
           PE           D +  G+++ E++ GR P  Y++
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL  LH       V+RD+K  NILLD   + ++SD GLA  +  E   +  RV GT GY+
Sbjct: 114 GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRV-GTVGYM 168

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE  +        D +  G LI E+I G++P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 51/205 (24%)

Query: 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------------ 234
            +  E  IG G YG VY            KN  + +  A K+FK + E            
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKR--------KNGKDGKEYAIKKFKGDKEQYTGISQSACRE 52

Query: 235 -AIGR-VRHKNLVRLLGYCAEGAHRM--LVYEYI--DNGNLEQWLHGDVGPHS------- 281
            A+ R ++H+N+V L+    E A +   L+++Y   D   + ++ H      S       
Sbjct: 53  IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVK 111

Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLAK 337
            L W+I +N       G+ YLH      V+HRD+K +NIL+     ++   K+ D GLA+
Sbjct: 112 SLLWQI-LN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Query: 338 LLGA--ERSYVTTRVMGTFGYVAPE 360
           L  A  +       V+ T  Y APE
Sbjct: 161 LFNAPLKPLADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 5/104 (4%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
           A  L YLH      +V+RD+K  NILLD Q +  L+DFGL K  G  +S  TT   GT  
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPE 161

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           Y+APE       +   D +  G ++ E++ G  P  Y R   E+
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 5/92 (5%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL  L      ++V+RD+K  NILLD + + ++SD GLA  +  E   V  RV GT GY+
Sbjct: 114 GLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYM 168

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE  +        D +  G LI E+I G++P
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH G   K+V+RD+K  N++LDK  + K++DFGL K  G   +       GT  Y+
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYL 162

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D +  G+++ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 27/212 (12%)

Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNL-------LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           +G+GGYG V+    +D    VA+K +       LN       E  +        + + LV
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT----KSEWLV 64

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +LL    +  +  L  EY+  G+    L+  G +       +   M   +     L Y  
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY-- 122

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                  +HRD+K  N L+D   + KL+DFGL+K      +Y  + V+G+  Y+APE   
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS-VVGSPDYMAPEVLR 171

Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
               +   D +S G ++ E + G  P   S P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 4/93 (4%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L +LH+     +++RD+K  N+LLD + + KL+DFG+ K  G      T+   GT  Y+A
Sbjct: 109 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIA 164

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           PE     +     D ++ G+L+ E++ G  P +
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 61/253 (24%), Positives = 95/253 (37%), Gaps = 87/253 (34%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAV-------KNLLNNRGQ-----AEKEFKVEVEAIGRVR 240
           VIG G +G V+  ++ D     V       K+ +  R Q     AE++   +  A     
Sbjct: 8   VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD--ADSPW- 62

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAK-- 297
              +V+L     +  H  LV EY+  G+L             +   IR ++    TA+  
Sbjct: 63  ---IVKLYYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETARFY 106

Query: 298 ------GLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTT 348
                  L  +H+ G     +HRDIK  NIL+D   + KL+DFGL K +    +R Y   
Sbjct: 107 IAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 349 R--------------------------VMGTFGYVAPE------YASTGMLNERSDVYSF 376
                                       +GT  Y+APE      Y          D +S 
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY------GLECDWWSL 216

Query: 377 GILIMEVISGRNP 389
           G+++ E++ G  P
Sbjct: 217 GVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 29/157 (18%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGRV------R 240
            +GEG Y  VY G          ++ L  +  A KE ++E E      AI         +
Sbjct: 12  KLGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V L           LV+EY+D  +L+Q++    G  S     + +  +L   +GL 
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
           Y H+    +V+HRD+K  N+L+ ++   KL+DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 32/234 (13%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           + VIG+G YG+V   +       VA+K   ++  +   A +  + E++ +  +RH ++V 
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           +       + R     Y+    +E  LH  +  +  LT E     +    + L Y+H   
Sbjct: 64  IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA- 122

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-------RSYVTTRVMGTFGYVAP 359
              V HRD+K  NIL +     K+ DFGLA++   +         YV TR      Y AP
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-----WYRAP 175

Query: 360 EYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMNSLMT 409
           E   +         D++S G +  EV++G       +P  PG+  + Q++ L+T
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTG-------KPLFPGKNVVHQLD-LIT 221

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L +LH      V++RD+K  NILLD + + KL+DFG+ K  G      TT   GT  Y+A
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIA 164

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           PE           D ++ G+L+ E+++G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 28/227 (12%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
                       E  ++  L   L G    ++     LT +    +I    +GL Y+H  
Sbjct: 84  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 191

Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 233

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 39/113 (34%), Positives = 62/113 (54%), Gaps = 9/113 (7%)

Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
           SPLT E  +      A+G+ +L      K +HRD+ + NILL +    K+ DFGLA+ + 
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225

Query: 341 AERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +  YV   + R+     ++APE     +   +SDV+SFG+L+ E+ S G +P
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
           + D   +G G YG V   +       VA+K L     +   A++ ++ E+  +  ++H+N
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---HSPLTWEIRMNIILGTAKGLT 300
           ++ LL           +  + D   +  ++  D+G    H  L+ +    ++    KGL 
Sbjct: 76  VIGLLDVFTPDLS---LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAP 359
           Y+H      ++HRD+K  N+ +++    K+ DFGLA+   +E + YV TR      Y AP
Sbjct: 133 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAP 184

Query: 360 EYASTGM-LNERSDVYSFGILIMEVISGR 387
           E     M   +  D++S G ++ E+++G+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 8/94 (8%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
           GL +LH      +++RD+K  N++LD+  + K++DFG+ K  + G  R+   +   GT  
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPD 161

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE           D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 43/221 (19%)

Query: 194 IGEGGYGIV----YHGVLEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVR-HKNLV 245
           +G+G YGIV          +   VA+K   N+ + +  A++  + E++ +   R HKN+ 
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNIT 65

Query: 246 RL--LGYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
            L  +     G    L +YE +   +L Q +        PLT     + I     GL Y+
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYI 121

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA--------KLLGAERSYVTTRVMGTF 354
           H      V+HRD+K  N+L++     K+ DFGLA        +  G    YV TR     
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR----- 173

Query: 355 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
            Y APE     ML+ +S     DV+S G ++ E++ GR PV
Sbjct: 174 WYRAPEI----MLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 37/155 (23%), Positives = 74/155 (47%), Gaps = 9/155 (5%)

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
           +E   +  V H +++R+      GA   +V  +  + +L  +L     P   L  +  + 
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP---LPIDQALI 161

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           I     +GL YLH     +++HRD+K+ NI ++      + D G A+      +++   +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
            GT    APE  +    N ++D++S GI++ E+++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 194 IGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           +G+G +  ++ G+  +         T V +K L  +     + F      + ++ HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
              G C  G   ++V EY+  G+L+ +L  +      ++W+      L  AK L +    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAKQLAWALHF 115

Query: 306 LEPK-VVHRDIKSSNILL-----DKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           LE K + H ++ + N+LL      K  NP   KLSD G++  +   +  +  R+     +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-KEILLERI----PW 170

Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGRN 388
           V PE       L+  +D +SFG  + E+ SG +
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 9/113 (7%)

Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
            PLT E  ++     A+G+ +L      K +HRD+ + NILL +    K+ DFGLA+ + 
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 341 AERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +  YV     R+     ++APE     +   +SDV+SFG+L+ E+ S G +P
Sbjct: 225 KDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L  LH+     V++RD+K  NILLD Q +  L DFGL K L  +    T    GT  Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLA 161

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           PE        +  D ++ G+L+ E+++G  P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH   E  VV+RD+K  N++LDK  + K++DFGL K  G +         GT  Y+
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D +  G+++ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 49/231 (21%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE------------------KEFKVE 232
             +GEG YG V           VA+K +       +                  +E K+ 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
            E    ++H+N++ L+    EG    LV + +   +L++ +   +     LT      I+
Sbjct: 75  NE----IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCIL 125

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG------------ 340
           L    GL  LH+      +HRD+  +NI ++ +   K++DFGLA+  G            
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 341 --AERSYVTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
               R  +T++V+ T  Y APE    +    +   D++S G +  E+++G+
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 21/172 (12%)

Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           + +V H +L  + G C  G+  ++V E++++G L+  L  + G   P+ W+I +   L +
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLAS 128

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NP--KLSDFGLAKLLGAERSYVTT 348
           A  L+YL    +  +VH ++ + NILL +       +P  KLSD G++      R     
Sbjct: 129 A--LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVE 182

Query: 349 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV-ISGRNPVDYSRPPGE 398
           R+     ++APE       L+  +D +SFG  ++E+   G  P+   R P E
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-ERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 16/213 (7%)

Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGR-VRHKNLVRL 247
           VIG+G +G V     + +    AVK L      + + EK    E   + + V+H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
             +  + A ++  V +YI+ G L   L  +     P        I    A  L YLH   
Sbjct: 62  -HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS-- 114

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
              +V+RD+K  NILLD Q +  L+DFGL K    E +  T+   GT  Y+APE      
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 367 LNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
            +   D +  G ++ E++ G  P  YSR   E+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 23/202 (11%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYC 251
           +GEG Y  VY G  + N  +    ++  + +    F    EA  +  ++H N+V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                  LV+EY+ + +L Q++    G   P   ++ +  +L   +GL+Y+H+     ++
Sbjct: 73  HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---IL 125

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP-------EYAST 364
           HRD+K  N+L+      KL+DFGLA+         +  V+ T  Y  P       EY++ 
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTC 184

Query: 365 GMLNERSDVYSFGILIMEVISG 386
                  D++  G + +E+I G
Sbjct: 185 ------LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 32/215 (14%)

Query: 193 VIGEGGYGIVY--HGVLEDNT------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           V+G G YG V+    V   ++       V  K  +  + +  +  + E + +  +R    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNL-------EQWLHGDVGPHSPLTWEIRMNIILGTA 296
           +  L Y  +   ++ L+ +YI+ G L       E++   +V  +S         I+L   
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-------EIVLA-- 117

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
             L +LH+     +++RDIK  NILLD   +  L+DFGL+K    +         GT  Y
Sbjct: 118 --LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 357 VAPEYASTGML--NERSDVYSFGILIMEVISGRNP 389
           +AP+    G    ++  D +S G+L+ E+++G +P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 37/215 (17%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKN-LVRL 247
           IGEG YG VY     D     +  L   R + ++E        E+  +  +     +VRL
Sbjct: 9   IGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 248 LGYCAEGAHR-------MLVYEYIDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGL 299
           L    E            LV+EY+D+ +L++++  +  GP  PL  +   + +    KG+
Sbjct: 67  L--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAE-RSYVTTRVMGTFGYV 357
            + H+     V+HRD+K  N+L+DKQ    K++D GL +      +SY  T  + T  Y 
Sbjct: 124 AHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYR 178

Query: 358 APE------YASTGMLNERSDVYSFGILIMEVISG 386
           APE      + ST +     D++S G +  E+   
Sbjct: 179 APEVLLGSTHYSTPV-----DIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           + D   +G G  G+V+  V  D +  VAVK ++    Q+ K    E++ I R+ H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 247 LLGYCAEGAHRM--------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
           +          +              +V EY++  +L   L        PL+ E     +
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLSEEHARLFM 120

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERS---YVTT 348
               +GL Y+H      V+HRD+K +N+ ++ +    K+ DFGLA+++    S   Y++ 
Sbjct: 121 YQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 349 RVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGR 387
            ++  + Y +P    S     +  D+++ G +  E+++G+
Sbjct: 178 GLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 30/224 (13%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLGY 250
           IG G +G V+    +          ++ RG  E+E     +EV  +  ++HKN+VR +  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 251 CAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE- 307
               A++ L  + E+ D G+L + +         +     ++I       L Y H   + 
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 308 ---PKVVHRDIKSSNILLDK----------QWN-------PKLSDFGLAKLLGAERSYVT 347
               +V+HRD+K  NI L            Q N        K+ DFGL+K +G E   + 
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MA 198

Query: 348 TRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRNP 389
              +GT  Y +PE     T   +++SD+++ G +I E+ SG+ P
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 30/214 (14%)

Query: 194 IGEGGYGIVYHGVL--EDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLL 248
           +G G +G V       ED   VA+K    ++   +K+      E + +  + H   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLH------GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           G   + ++  LV E++  G    +L        DVG                 A  +  +
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--------------YAAQIVLI 143

Query: 303 HEGLEP-KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
            E L+   +V+RD+K  N+LLDK    K++DFG AK++   R+Y    + GT  Y+APE 
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT---LCGTPEYIAPEI 199

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
                  + +D ++ GI I E++ G  P   + P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 9/112 (8%)

Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
            LT E  +      AKG+ +L      K +HRD+ + NILL +    K+ DFGLA+ +  
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 342 ERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           +  YV     R+     ++APE     +   +SDV+SFG+L+ E+ S G +P
Sbjct: 232 DPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYC 251
           +GEG Y  VY G+   N  +    +++ + +    F    EA  +  ++H N+V L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                   V+EY+   +L Q++    G   P    + M  +L   +GL Y+H      ++
Sbjct: 73  HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYIHG---QHIL 125

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+K  N+L+      KL+DFGLA+         ++ V+ T  Y  P+    G  +  S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDYSS 183

Query: 372 --DVYSFGILIMEVISGR 387
             D++  G + +E++ G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  Y+A
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           PE           D +  G+++ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 4/83 (4%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY----ASTGM 366
           +HRD+K  N+LLDK  + KL+DFG    + A         +GT  Y++PE        G 
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 367 LNERSDVYSFGILIMEVISGRNP 389
                D +S G+ + E++ G  P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 15/114 (13%)

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFG 355
           +GL Y+H      ++HRD+K SN+ +++    ++ DFGLA+    E + YV TR      
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180

Query: 356 YVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
           Y APE     M  N+  D++S G ++ E++ G+     +  PG   I Q+  +M
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK-----ALFPGNDYIDQLKRIM 229

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 19/179 (10%)

Query: 215 VKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL--------LGYCAEGAHRMLVYEYIDN 266
           +   +    +A  + + E+ A+GR+ H+N++++          Y     +   +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326
                W         PL  + R  I+      + Y+H+    K++HRDIK  NI L+   
Sbjct: 256 EAF-DW------KDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304

Query: 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
              L DFG A     ER       +GT    +PE  +     E +D++S G+++++++S
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 63/263 (23%), Positives = 99/263 (37%), Gaps = 46/263 (17%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
           F    VIG G +G V     +D  +V    +L      EKE     + E + +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +V++     +  +  L+ E++  G++   L         LT E     I  T   +  +H
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIH 118

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL---------------------------- 335
           +      +HRDIK  N+LLD + + KLSDFGL                            
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 336 ------AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
                 A+     R  +    +GT  Y+APE       N+  D +S G+++ E++ G  P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 390 VDYSRPPGEVCIPQMNSLMTLSY 412
              S  P E     MN   TL +
Sbjct: 236 F-CSETPQETYKKVMNWKETLIF 257

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 43/215 (20%), Positives = 95/215 (44%), Gaps = 34/215 (15%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-------EVEAIGRVRHKNLV 245
           +I E     +Y G+  +N  V ++       +  K  KV       E++ + R+   N++
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTF----KKFHKGHKVLIDITENEIKNLRRIDSNNIL 81

Query: 246 RLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           ++ G+      +     L+ EY   G L + L  +      L+++ ++++ +   KGL  
Sbjct: 82  KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYN 137

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY----- 356
           L++       ++++ S + L+ + +  K+   GL K+L +   +     M  F Y     
Sbjct: 138 LYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLND 194

Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           +  EY        + D+YS G+++ E+ +G+ P +
Sbjct: 195 IFSEY------TIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           +I  G YG VY   H   E     A+K +    L  R Q ++ F VE + +    +  +V
Sbjct: 8   LISNGAYGAVYLVRHK--ETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVV 64

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            +        H  +V EY++ G+    L  ++G    L  ++       T   L YLH  
Sbjct: 65  SMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGA---LPVDMARMYFAETVLALEYLHN- 119

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL-------LGAE-------RSYVTTRVM 351
               +VHRD+K  N+L+    + KL+DFGL+K+          E       R ++  +V 
Sbjct: 120 --YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           GT  Y+APE        +  D ++ GI++ E + G  P
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           +GL YLH      ++HRDIK  N+L++     K+ DFGLA++   + S   T+ + T  Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 357 VAPEYASTGMLNERS--DVYSFGILIMEVISGR 387
            APE    G  +  S  D++S G +  E++  R
Sbjct: 171 RAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 18/221 (8%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
           +R+L++    +    VIG G +G V     + +  V    LL+     ++     F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAK----- 145

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             TA+ +  L       ++HRD+K  N+LLDK  + KL+DFG    +           +G
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205

Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
           T  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 13/177 (7%)

Query: 218 LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
           +LN+  QA    + E+  +    H  +V+           +L+ EY   G+L + +   +
Sbjct: 102 MLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL 160

Query: 278 GPHSPLT-WEIRM---NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333
             H P   +E+ +    I+L        L E    K++HRD+KS+NI L      KL DF
Sbjct: 161 KEHLPFQEYEVGLLFYQIVLA-------LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF 213

Query: 334 GLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           G +K      S  V +   GT  Y+APE       ++++D++S G+++ E+++   P
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 5/86 (5%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           G+ Y+H+    +++HRD+K+ NI L      K+ DFG+++LL       TT   GT  Y+
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYM 172

Query: 358 APEYASTGMLNERSDVYSFGILIMEV 383
           +PE       + +SD++S G ++ E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 42/216 (19%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------------- 237
           +G G    +Y G+L    +       ++    EKE KV ++ +                 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDE-----DDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57

Query: 238 --RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
             +V HK++V L G C      ++V E+++ G L+ ++H        LT   +  +    
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQL 114

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILL-----DKQWNP--KLSDFGLAKLLGAERSYVTT 348
           A  L+YL    +  +VH ++ + NILL     D +  P  KLSD G+  +    R     
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVE 170

Query: 349 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV 383
           R+     ++APE    +  L+  +D +SFG  + E+
Sbjct: 171 RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 64/237 (27%), Positives = 91/237 (38%), Gaps = 53/237 (22%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
           ++G+G  G V+  V    T    A+K L     +  K  KV     E E +  + H  L 
Sbjct: 8   LLGKGDVGRVFL-VRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLP 64

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE-IRM---NIILGTAKGLTY 301
            L        +  LV +Y   G L + L     P   L+ E  R     ++L     L Y
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLA----LEY 118

Query: 302 LH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-------------- 346
           LH  G    +V+RD+K  NILL +  +  LSDF L+K    E   V              
Sbjct: 119 LHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 347 -----------TTRVM---GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
                      + R     GT  Y+APE  S        D ++ GIL+ E++ G  P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L +LH+     +V+RD+K  NILLD   +  L DFGL+K      +  T    GT  Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLA 164

Query: 359 PEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           PE     +L+E+      D +S G+L+ E+  G +P
Sbjct: 165 PEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 5/84 (5%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-----ASTG 365
           VHRDIK  N+LLDK  + +L+DFG    L A+ +  +   +GT  Y++PE         G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
                 D +S G+ + E++ G  P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 18/221 (8%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
           +R+L +    +    VIG G +G V     +    V    LL+     ++     F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWAR----- 145

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             TA+ +  L        +HRD+K  N+LLDK  + KL+DFG    +  E        +G
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205

Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
           T  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 21/214 (9%)

Query: 193 VIGEGGYGIVYHGVL--EDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           ++G+G +G V    L  ED +   VAVK L   + +    E EF  E   +    H N++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVI 64

Query: 246 RLLGYCAEGAHR------MLVYEYIDNGNLEQWLHGDVGPHSPLTW--EIRMNIILGTAK 297
           +L+G       +      M++  ++ +G+L  +L        P T   +  +  ++  A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG-TFGY 356
           G+ YL        +HRD+ + N +L++     ++DFGL+K + +   Y           +
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           +A E  +  +    SDV++FG+ + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.3 bits (121), Expect = 7e-07
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)

Query: 194 IGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVR-HKNLVRLLG- 249
           IGEG +  V      +     A+K +  +    E+   + E++A+ R+  H N++RL+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 250 -YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
            +  +     LV+E +D  NL + + G   P      +  M  +L   K L ++H     
Sbjct: 67  LFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL---KSLDHMHRN--- 119

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGML 367
            + HRDIK  NIL+ K    KL+DFG  + + ++  Y  T  + T  Y APE   + G  
Sbjct: 120 GIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYY 176

Query: 368 NERSDVYSFGILIMEVIS------GRNPVD 391
             + D+++ G +  E++S      G N +D
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELD 206

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 63/264 (23%), Positives = 102/264 (38%), Gaps = 48/264 (18%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
           F    VIG G +G V     +D  ++    +L      EKE     + E + +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +V++     +  +  L+ E++  G++   L         L+ E     I  T   +  +H
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIH 118

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL---------------------------- 335
           +      +HRDIK  N+LLD + + KLSDFGL                            
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 336 ------AKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRN 388
                 A+     R  +    +GT  Y+APE +  TG  N+  D +S G+++ E++ G  
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYP 234

Query: 389 PVDYSRPPGEVCIPQMNSLMTLSY 412
           P   S  P E     MN   TL +
Sbjct: 235 PF-CSETPQETYRKVMNWKETLVF 257

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 11/99 (11%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-- 353
           A+G+ +L        +HRD+ + N+LL      K+ DFGLA+ +  + +YV   V G   
Sbjct: 222 AQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNAR 275

Query: 354 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               ++APE     +   +SDV+S+GIL+ E+ S G++P
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 8/93 (8%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF- 354
           A+G+ +L        VHRD+ + N+LL +    K+ DFGLA+ +  + +YV+     TF 
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301

Query: 355 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
              ++APE     +    SDV+S+GIL+ E+ S
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 13/106 (12%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-- 353
           AKG+++L        +HRD+ + NILL      K+ DFGLA+ +  + +YV   V G   
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277

Query: 354 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396
               ++APE     +    SDV+S+GIL+ E+ S G +P  Y   P
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGMP 321

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 41/140 (29%), Positives = 59/140 (42%), Gaps = 44/140 (31%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---------------------- 348
           +HRDIK  N+LLD + + KLSDFGL    G ++S+ T                       
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 349 ------------RVM-----GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPV 390
                       R +     GT  Y+APE +  TG  N+  D +S G+++ E++ G  P 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239

Query: 391 DYSRPPGEVCIPQMNSLMTL 410
             S  P E     +N   TL
Sbjct: 240 -CSDNPQETYRKIINWKETL 258

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 5/84 (5%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----G 365
           VHRDIK  NIL+D   + +L+DFG    L  + +  ++  +GT  Y++PE         G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
                 D +S G+ + E++ G  P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----G 365
           VHRDIK  N+LLD   + +L+DFG    +  + +  ++  +GT  Y++PE         G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
                 D +S G+ + E++ G  P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 34/193 (17%)

Query: 208 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV------- 260
           E    V VK          K    E++ +  + H+ ++ L+      +   +V       
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171

Query: 261 -YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319
            + Y+D                PL  E  + I     + L YLH      ++HRD+K+ N
Sbjct: 172 LFTYVDR-------------SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTEN 215

Query: 320 ILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV---APEYASTGMLNERSDVYSF 376
           I LD+  N  L DFG A  L A     T +  G  G +   +PE  +      ++D++S 
Sbjct: 216 IFLDEPENAVLGDFGAACKLDA--HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273

Query: 377 GILIMEVISGRNP 389
           G+++ E+      
Sbjct: 274 GLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 25/115 (21%)

Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
           NI+ G  +GL YLH+      +HR+IK+S+IL+       LS  GL+ L    R+    +
Sbjct: 105 NILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159

Query: 350 VMGTFGYVAPEYASTGML---------------NERSDVYSFGILIMEVISGRNP 389
           V+  F    P++ ST +L               N +SD+YS GI   E+ +GR P
Sbjct: 160 VVYDF----PQF-STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF- 354
           A G+ +L        VHRD+ + N+L+ +    K+ DFGLA+ +  + +Y++     TF 
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFL 303

Query: 355 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
              ++APE     +    SDV+SFGIL+ E+ +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 19/105 (18%)

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER---------------SYVTT--RVMG 352
           V+HRD+K  NILL       + D+G A     E                S +T   +++G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193

Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
           T  Y+APE       +E +D+Y+ G+++ ++++   P  Y R  G
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKG 236

Length = 932

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 9/95 (9%)

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL---LGAERSYVTTRVMGT 353
           + + YLHE    +++HRDIK+ NI ++   +  L DFG A     + A + Y      GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA---GT 246

Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
               APE  +        D++S GI++ E+ +  +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281

Length = 391

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.1 bits (105), Expect = 6e-05
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 11/106 (10%)

Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTT 348
            II    + L  LH+     ++H DIK  N+L D  +    L D+GL K++G    Y   
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--- 166

Query: 349 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
              GT  Y +PE    G   + S D ++ G+L  E+++G++P    
Sbjct: 167 --DGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKED 209

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 7/80 (8%)

Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
           LV EY+  G+++  LH     +     E+ +  I   A  L YLH      ++HRD+K  
Sbjct: 81  LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPD 133

Query: 319 NILLDKQWNPKLSDFGLAKL 338
           N+L+  + + KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 25/195 (12%)

Query: 210 NTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266
           NT VAVK + N    ++++ K+   E+    +++H N++  +      +   +V   +  
Sbjct: 25  NTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83

Query: 267 GNLEQWL--HGDVG-PHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVVHRDIKSSNILL 322
           G+ E  L  H   G P   +       I+      L Y+H +G     +HR +K+S+ILL
Sbjct: 84  GSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIHSKGF----IHRSVKASHILL 134

Query: 323 DKQWNPKLSDFGLAKLL--GAERSYV----TTRVMGTFGYVAPEYASTGML--NERSDVY 374
                  LS    +  +    +R  V        +    +++PE     +   NE+SD+Y
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194

Query: 375 SFGILIMEVISGRNP 389
           S GI   E+ +G  P
Sbjct: 195 SVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 31/121 (25%), Positives = 47/121 (38%), Gaps = 42/121 (34%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGL----------------------------------- 335
           +HRDIK  NIL+D+  + KL+DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 336 AKLLGAERSYVT--TRVM-----GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
            +L   ER       R +     GT  Y+APE        +  D +S G+++ E++ G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 389 P 389
           P
Sbjct: 243 P 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 16/26 (61%), Positives = 21/26 (80%)

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLA 336
           +HRDIK  NIL+D+  + KLSDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.1 bits (96), Expect = 9e-04
 Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 26/235 (11%)

Query: 173 GHWYTL--RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
           GH+Y +   +++VST  F   +++GEG +G V               ++ N  +  ++ K
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173

Query: 231 VEVEAIGRVRHKN------LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
           +E++ + +VR  +      L+++  Y       M +        L  W+      H P +
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIM----KHGPFS 229

Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-----------KQWNPKLSDF 333
                 II  T   L Y H   E  ++H D+K  NIL++           +   P     
Sbjct: 230 HRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 334 GLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
            +  L G  +  +  T ++ T  Y +PE          +D++S G +I E+ +G+
Sbjct: 288 RICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 301 YLH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVA 358
           Y+H EG    ++HRDIK+ N+L++   +  L DFG A    G+  +     + GT    A
Sbjct: 275 YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330

Query: 359 PEYASTGMLNERSDVYSFGILIME 382
           PE  +        D++S G++I E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 51/232 (21%), Positives = 99/232 (42%), Gaps = 52/232 (22%)

Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV--------------EVEAIGRV 239
           +G G YG VY    +D             G+ EKE+ +              E+  +  +
Sbjct: 9   VGRGTYGHVYKAKRKD-------------GKDEKEYALKQIEGTGISMSACREIALLREL 55

Query: 240 RHKNLVRLLGYCAEGAHRM--LVYEYIDNG--NLEQWLHGDVGPHSPLTWEIRM--NIIL 293
           +H N++ L       + R   L+++Y ++   ++ ++         P+     M  +++ 
Sbjct: 56  KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVT-- 347
               G+ YLH      V+HRD+K +NIL+     ++   K++D G A+L  +    +   
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 348 TRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSR 394
             V+ TF Y APE     +L  R      D+++ G +  E+++   P+ + R
Sbjct: 173 DPVVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)

Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +G G YG VY    +D   + + A+K +    G +    + E+  +  ++H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKV 66

Query: 251 CAEGAHRM--LVYEYIDNG--NLEQWLHGDVGPHSPLTWEIRM--NIILGTAKGLTYLHE 304
               A R   L+++Y ++   ++ ++         P+     M  +++     G+ YLH 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 305 GLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVA 358
                V+HRD+K +NIL+     ++   K++D G A+L  +    +     V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 359 PEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSR 394
           PE     +L  R      D+++ G +  E+++   P+ + R
Sbjct: 184 PEL----LLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 30/120 (25%), Positives = 43/120 (35%), Gaps = 21/120 (17%)

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           + L     L  LH         R  KS NILL   W+  L   G       E+S      
Sbjct: 22  VCLQCLGALRELH---------RQAKSGNILL--TWDGLLKLDGSVAFKTPEQSRPDPYF 70

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M      APE        E++D+YS GI + E +     + Y+    E+    +  L+  
Sbjct: 71  M------APEVIQGQSYTEKADIYSLGITLYEALDYE--LPYNEER-ELS-AILEILLNG 120

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	424
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.29
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.89
PRK09902	216	hypothetical protein; Provisional	98.85
COG4248	637	Uncharacterized protein with protein kinase and he	98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.6
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.58
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.49
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.41
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.39
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.36
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.35
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.35
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.17
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.15
PLN02876	822	acyl-CoA dehydrogenase	98.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.04
PRK10593	297	hypothetical protein; Provisional	98.02
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.94
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.76
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.68
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.6
PRK05231	319	homoserine kinase; Provisional	97.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.6
PLN02236	344	choline kinase	97.35
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.34
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.29
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.26
KOG2270	520	consensus Serine/threonine protein kinase involved	97.02
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.0
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.96
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.91
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.9
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.85
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.74
COG2334	331	Putative homoserine kinase type II (protein kinase	96.69
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.66
PLN02756	418	S-methyl-5-thioribose kinase	96.46
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.41
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.29
PRK11768	325	serine/threonine protein kinase; Provisional	96.21
PRK06148	1013	hypothetical protein; Provisional	96.15
PTZ00384	383	choline kinase; Provisional	96.01
PRK12396	409	5-methylribose kinase; Reviewed	95.81
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	95.73
PTZ00382	96	Variant-specific surface protein (VSP); Provisiona	95.57
PF13908	179	Shisa: Wnt and FGF inhibitory regulator	95.53

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=372.21  Aligned_cols=198  Identities=27%  Similarity=0.520  Sum_probs=180.5

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .+|...+.||+|.||+||+|+++ ++..||||.+.+.  .....+-+..|+++|+.++|||||++++++++++.+|||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            47888888999999999999965 5788999999776  45556678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC------CceEEEecCCc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ------WNPKLSDFGLA  336 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~------~~~kL~DfG~a  336 (424)
                      ||+||+|.+|++++    +.+++..+..++.|+|.||++||++   +||||||||.||||+..      -.+||+|||+|
T Consensus        90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999987    5899999999999999999999999   99999999999999764      45899999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +.+..  .......||+|.|||||++...+|+.|+|+||+|++||+|++|+.||+.
T Consensus       163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            98753  3345668999999999999999999999999999999999999999983

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-49  Score=383.68  Aligned_cols=242  Identities=57%  Similarity=0.942  Sum_probs=212.5

Q ss_pred             CCcceeeeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEe
Q 014466          172 WGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC  251 (424)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  251 (424)
                      ....|++.++..++++|...+.||+|+||.||+|...+++.||||++.....+..++|..|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45678999999999999999999999999999999998899999988665443155699999999999999999999999


Q ss_pred             eeCC-eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEE
Q 014466          252 AEGA-HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL  330 (424)
Q Consensus       252 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL  330 (424)
                      .+.+ +.+||||||++|+|.++|+.....  +++|..+++|+.++|+||+|||+.+.|.|||||||++|||||+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9988 599999999999999999987432  8899999999999999999999998889999999999999999999999


Q ss_pred             EecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHHh
Q 014466          331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL  410 (424)
Q Consensus       331 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  410 (424)
                      +|||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+..++..+..+.+|.+....
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999976543111111111799999999999999999999999999999999999999999888888888999876665


Q ss_pred             hhccc
Q 014466          411 SYCSS  415 (424)
Q Consensus       411 ~~~~~  415 (424)
                      .....
T Consensus       299 ~~~~~  303 (361)
T KOG1187|consen  299 EGKLR  303 (361)
T ss_pred             Ccchh
Confidence            54333

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=355.36  Aligned_cols=231  Identities=27%  Similarity=0.448  Sum_probs=194.8

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC-eeeEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRMLV  260 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lv  260 (424)
                      ..++++.++.||+|..|+||++.++ +++-+|+|.+..+ .....+++.+|++++++.+|||||.+||.|..+. ...++
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            3446777899999999999999977 5777899999443 4556678999999999999999999999999988 49999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      ||||++|+|.+++...    +.+++....+++.++++||.|||+.  ++||||||||+||||+..|++||||||.+..+.
T Consensus       157 mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             hhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999999999865    5789999999999999999999963  299999999999999999999999999998764


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHH----------h
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMT----------L  410 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------~  410 (424)
                      ..   ....++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+.......-+..+..          .
T Consensus       231 nS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  231 NS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             hh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence            33   5567899999999999999999999999999999999999999997654333333333333332          2


Q ss_pred             hhccceeeeeeec
Q 014466          411 SYCSSFFLICCVK  423 (424)
Q Consensus       411 ~~~~~~~l~~c~~  423 (424)
                      +-+.+-|+.||++
T Consensus       308 S~ef~~FV~~CL~  320 (364)
T KOG0581|consen  308 SPEFRSFVSCCLR  320 (364)
T ss_pred             CHHHHHHHHHHhc
Confidence            3336678888874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-47  Score=350.20  Aligned_cols=203  Identities=28%  Similarity=0.402  Sum_probs=182.1

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ..++|+++++||+|+||+||+++.+ +++.+|+|++.+..-   ...+....|..+|.+++||+||+++-.|++.+++||
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3458999999999999999999965 577899999876532   334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |+||+.||.|...|++.    +.+++..+..++.+|+.||.|||++   +||||||||+|||||.+|+++|+|||+++..
T Consensus       103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999999876    6889999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . .....+..+|||+.|||||++.+..|+..+|+||||+++|||++|..||....
T Consensus       176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            2 23344566899999999999999999999999999999999999999997543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=357.76  Aligned_cols=227  Identities=35%  Similarity=0.621  Sum_probs=196.2

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC-ee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HR  257 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~  257 (424)
                      ..+....+.+.+.||+|+||+||+|.+.+...||+|++.....  ...+.|.+|+.+|.+++|||||+++|++.+.. ..
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            3455566777888999999999999998544499999976532  22568999999999999999999999999887 78


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeeCCCCCCCEEEcCCC-ceEEEecCC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQW-NPKLSDFGL  335 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-ivHrDlkp~NILl~~~~-~~kL~DfG~  335 (424)
                      ++||||+++|+|.+++++.  ....+++..++.++.+||+|++|||++   + ||||||||+|||++.++ ++||+|||+
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            9999999999999999874  246899999999999999999999998   7 99999999999999998 999999999


Q ss_pred             ccccCCCcceeeeccccccccccccccc--CCCCCCccchHHHHHHHHHHHcCCCCCCCCC--------------CC-CC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRNPVDYSR--------------PP-GE  398 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~--------------~~-~~  398 (424)
                      ++...... ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||....              |. +.
T Consensus       191 sr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  191 SREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             ceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            98764332 3344478999999999999  6799999999999999999999999998433              33 44


Q ss_pred             ccHHHHHHHHHhhhc
Q 014466          399 VCIPQMNSLMTLSYC  413 (424)
Q Consensus       399 ~~~~~~~~~~~~~~~  413 (424)
                      .+...|..+|..||.
T Consensus       270 ~~~~~l~~l~~~CW~  284 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWL  284 (362)
T ss_pred             cCCHHHHHHHHHhCC
Confidence            488899999999997

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=361.26  Aligned_cols=200  Identities=26%  Similarity=0.459  Sum_probs=183.4

Q ss_pred             CCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .+|...+.||+|||..||.+++ ..|..||+|++.+.   +....+.+.+||++.+.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 78999999999663   4455667888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |+|+.++|..+++++    .++++.+++.+++||+.||.|||++   +|+|||||..|+|++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999999855    7899999999999999999999999   999999999999999999999999999998754


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... ...+.||||.|.|||++....++..+||||+||+||-|++|++||+..
T Consensus       171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            433 344589999999999999999999999999999999999999999843

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=355.38  Aligned_cols=231  Identities=29%  Similarity=0.513  Sum_probs=207.0

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ...+++....+..++.||+|.||.||.|.++....||+|.+... ....++|.+|+++|++|+|+|||+++++|..+..+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            34457888889999999999999999999998889999998765 34457788999999999999999999999998899


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      +||||||+.|+|.+||+...  ...+.....+.++.|||+|++||+++   ++|||||...||||++++.+||+|||+|+
T Consensus       277 yIVtE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEEEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence            99999999999999998732  35677888899999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC--------------CCCCCCCccHH
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD--------------YSRPPGEVCIP  402 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~--------------~~~~~~~~~~~  402 (424)
                      .+.++.........-...|.|||.+....++.|||||||||+||||+| |+.||.              ++.|.++.|..
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~  431 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPD  431 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCH
Confidence            765555444444455668999999999999999999999999999999 999987              77899999999


Q ss_pred             HHHHHHHhhhcc
Q 014466          403 QMNSLMTLSYCS  414 (424)
Q Consensus       403 ~~~~~~~~~~~~  414 (424)
                      ++.++|..||..
T Consensus       432 ~vY~lM~~CW~~  443 (468)
T KOG0197|consen  432 EVYELMKSCWHE  443 (468)
T ss_pred             HHHHHHHHHhhC
Confidence            999999999974

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-47  Score=336.72  Aligned_cols=207  Identities=26%  Similarity=0.380  Sum_probs=181.9

Q ss_pred             CCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEee-EeeeCCe-eeE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLG-YCAEGAH-RML  259 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~-~~~~~~~-~~l  259 (424)
                      ..+|+++++||+|.||.||++.+ .+|..+|.|.+.-.  +......+..|+.+|++|+|||||++++ .+.++.. ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            34799999999999999999994 57889999988643  3344567888999999999999999999 4545454 789


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |||||..|+|.+.++........+++..+++++.|+++||..+|.. .+.  |+||||||.||+|+.+|.+||+|||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999988777778899999999999999999999984 235  9999999999999999999999999999


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .+..... .....+|||+||+||.+.+..|+.+|||||+||++|||+.-+.||.+.
T Consensus       177 ~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  177 FLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             HhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            8865433 345688999999999999999999999999999999999999999854

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=326.74  Aligned_cols=200  Identities=27%  Similarity=0.401  Sum_probs=182.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|++.+.||.|+||+|.+++.+ +|..+|+|.+.+..-   ...+....|..+|+.+.||+++++++.+.+.+.++||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            457899999999999999999976 577789999976533   3445677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||++||.|..+|++.    +.+++..+..++.||+.||+|||+.   +|++|||||+|||||.+|.+||+|||+|+.+.
T Consensus       123 meyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            9999999999999876    6889999999999999999999999   99999999999999999999999999999764


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ..    +...||||.|+|||++..+.|+.++|+|+|||++|||+.|.+||...+|
T Consensus       196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            32    5668999999999999999999999999999999999999999988776

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-45  Score=344.83  Aligned_cols=203  Identities=26%  Similarity=0.450  Sum_probs=176.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCch-------hHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQ-------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+....       ......+|+++|++|+|||||+++++|++.+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            455788899999999999999995 47999999999765221       1234568999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC---CceEEEe
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSD  332 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kL~D  332 (424)
                      ..||||||++||+|.+++-.+    ..+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999999776    5677788899999999999999999   99999999999999766   6799999


Q ss_pred             cCCccccCCCcceeeecccccccccccccccCCC---CCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ||+|+..+  ....+.++||||.|.|||++.++.   +..++|+||+||+||-+++|.+||.....
T Consensus       323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~  386 (475)
T KOG0615|consen  323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT  386 (475)
T ss_pred             cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence            99999865  344567799999999999997654   33478999999999999999999986653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-44  Score=340.78  Aligned_cols=216  Identities=28%  Similarity=0.390  Sum_probs=190.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Ceee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~  258 (424)
                      ..+.|+.+++||+|.||.||+|++ .+|+.||+|++....  ........+||.+|++|.||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            446799999999999999999994 578899999996543  45556778899999999999999999998876  6899


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ||+|||+. ||.-++...   .-.+++..+..++.|++.||+|+|.+   +|+|||||.+|||||++|.+||+|||+|+.
T Consensus       195 lVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence            99999998 999888764   35799999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHHhh
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLS  411 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  411 (424)
                      +........+..+-|.+|.|||++.+ ..|+..+|+||.||||.||++|++.|.+     ...++|+.++...|
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G-----~tEveQl~kIfklc  336 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG-----RTEVEQLHKIFKLC  336 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC-----ccHHHHHHHHHHHh
Confidence            87777666777778999999998765 5699999999999999999999999954     55677888777665

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=341.56  Aligned_cols=219  Identities=26%  Similarity=0.407  Sum_probs=189.8

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      ...++|.+++.||+|+|++|++|+.. .++.||||++.+.   +....+.+..|-++|.+| .||.|++|+-.|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34568999999999999999999955 6889999998665   334456688899999999 899999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |+|+||+++|+|.+++++.    +.+++..+..++.+|+.||+|||+.   |||||||||+|||||.++++||+|||.|+
T Consensus       150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999987    7899999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCcce----------e--eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHH
Q 014466          338 LLGAERSY----------V--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMN  405 (424)
Q Consensus       338 ~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~  405 (424)
                      .+.+....          .  ...++||..|.+||++.....++.+|+|+|||+||.|+.|.+||....     .-..+.
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliFq  297 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIFQ  297 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHHH
Confidence            87543211          1  145899999999999999999999999999999999999999996433     334445


Q ss_pred             HHHHhhhc
Q 014466          406 SLMTLSYC  413 (424)
Q Consensus       406 ~~~~~~~~  413 (424)
                      ++|...+.
T Consensus       298 kI~~l~y~  305 (604)
T KOG0592|consen  298 KIQALDYE  305 (604)
T ss_pred             HHHHhccc
Confidence            55555544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.9e-44  Score=321.18  Aligned_cols=210  Identities=26%  Similarity=0.396  Sum_probs=182.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +.|+.+.++|+|+||+||+|+.+ +|+.||||++....  +...+-..+||++|++++|+|+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888999999999999999976 58889999997653  3344557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ||+. ++.+-|.+.   ...++...+..++.|+++|+.|+|++   ++|||||||+||||+.+|.+||||||+|+.+.. 
T Consensus        82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            9998 555556655   46788899999999999999999999   999999999999999999999999999998864 


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM  408 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  408 (424)
                      .....+..+.|.+|.|||.+.+ ..|+..+|||++||++.||++|.+-|     ++...+.|+..++
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~-----PG~SDiDQLy~I~  215 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW-----PGRSDIDQLYLIR  215 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC-----CCcchHHHHHHHH
Confidence            3344566788999999998877 78999999999999999999999999     4555666666544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4e-43  Score=338.24  Aligned_cols=212  Identities=26%  Similarity=0.357  Sum_probs=185.1

Q ss_pred             eeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEee
Q 014466          177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA  252 (424)
Q Consensus       177 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  252 (424)
                      .++...+..++|+++.+||+|+||.||+|+-+ +|..+|+|++.+..   ....+.++.|-.+|....+|.||+|+-.|+
T Consensus       132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            34555778889999999999999999999955 58889999997763   334566888999999999999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                      +.+++||||||++||++..+|.+.    ..+++..+..++.+++-|++.||+.   |+|||||||+|+|||..|++||+|
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence            999999999999999999999876    7899999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCC-----------------------Ccc----ee-------------------eecccccccccccccccCCC
Q 014466          333 FGLAKLLGA-----------------------ERS----YV-------------------TTRVMGTFGYVAPEYASTGM  366 (424)
Q Consensus       333 fG~a~~~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~  366 (424)
                      ||++.-+..                       +..    ..                   ....+|||.|+|||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            999853211                       000    00                   01247999999999999999


Q ss_pred             CCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          367 LNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       367 ~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      |+..+|+||||||+|||+.|.+||...+|
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp  393 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETP  393 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999999999976664

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=331.92  Aligned_cols=229  Identities=29%  Similarity=0.459  Sum_probs=198.0

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+++.....+.++||+|-||.|.+|....+..||+|++...... ...+|.+|+++|.+++||||++++|+|..++.++|
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            36778889999999999999999999988899999999776444 45899999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |+|||++|+|.+|+..+..+.  +.......|+.||+.|++||.+.   ++|||||.+.|+|++.++++||+|||+++-+
T Consensus       613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence            999999999999998874332  45556677999999999999998   9999999999999999999999999999955


Q ss_pred             CCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc--CCCCCCCC---------------------CC
Q 014466          340 GAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYS---------------------RP  395 (424)
Q Consensus       340 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt--g~~Pf~~~---------------------~~  395 (424)
                      -....+ ...+.+-...|||+|.+..++++.++|+|+||+++||+++  ...||...                     .+
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence            444333 3345566789999999999999999999999999999876  88898721                     12


Q ss_pred             CCCccHHHHHHHHHhhhcc
Q 014466          396 PGEVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~  414 (424)
                      .+..|...+.++|..||..
T Consensus       768 ~P~~cp~~lyelml~Cw~~  786 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRR  786 (807)
T ss_pred             CCCcCcHHHHHHHHHHhch
Confidence            5566888999999999974

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=336.47  Aligned_cols=204  Identities=29%  Similarity=0.453  Sum_probs=180.2

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC----Cc-hhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCC
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN----RG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA  255 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~  255 (424)
                      ...+.|.+.+.||+|.||+|++|... ++..||+|.+.+.    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            45568999999999999999999854 6799999966543    12 23456778999999999 999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEEEecC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFG  334 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DfG  334 (424)
                      .+++||||+.||+|.+++...    +.+.+..+..+++|++.|++|||+.   +|+||||||+|||++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            999999999999999999874    6788899999999999999999999   99999999999999999 999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCC-CC-CccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LN-ERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~  227 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN  227 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence            999763 3344566789999999999999877 86 68999999999999999999998743

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=343.90  Aligned_cols=231  Identities=27%  Similarity=0.417  Sum_probs=199.5

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +...|....+||+|+.|.||.+.. .+++.||||++........+-+..|+.+|+..+|+|||++++.|..++++|+|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            345688889999999999999994 4688899999988777777788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++||+|.+.+...     .+++..+..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus       351 ym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             ecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999999998765     589999999999999999999999   9999999999999999999999999999887655


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCc------cHHHHHHHHHhhhccce
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV------CIPQMNSLMTLSYCSSF  416 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~  416 (424)
                      .. .....+|||+|||||++..+.|+++.||||||++++||+-|.+||-..+|.-..      ...++...-..+-..+.
T Consensus       423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD  501 (550)
T ss_pred             cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence            44 455678999999999999999999999999999999999999999876652222      11233333444555778


Q ss_pred             eeeeeec
Q 014466          417 FLICCVK  423 (424)
Q Consensus       417 ~l~~c~~  423 (424)
                      ||..||.
T Consensus       502 FL~~cL~  508 (550)
T KOG0578|consen  502 FLDRCLV  508 (550)
T ss_pred             HHHHHhh
Confidence            8888875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.3e-43  Score=338.32  Aligned_cols=197  Identities=32%  Similarity=0.487  Sum_probs=180.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+...  ...+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57889999999999999999966 467789999866533  345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+.| +|..+|...    ..++++.+..++.+++.||.|||+.   +|+|||+||.|||++..|.+|+||||+|+.++. 
T Consensus        82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9987 999999876    7899999999999999999999999   999999999999999999999999999998754 


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      .....+...|||.|||||++.+..|+..+|+||+||+||||++|++||.
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence            3445677889999999999999999999999999999999999999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.3e-42  Score=304.06  Aligned_cols=210  Identities=26%  Similarity=0.430  Sum_probs=182.4

Q ss_pred             CCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .+|...+.||+|.||.||+|++ ++|+.||||++....  ........+||+.|+.++|+||+.++++|-..+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4788899999999999999995 479999999996542  2234467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++. +|...++..   ...++...+..++.++++||+|||++   .|+||||||.|+|++.+|.+||+|||+|+.++..
T Consensus        82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9987 999999876   46788999999999999999999999   9999999999999999999999999999998765


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM  408 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  408 (424)
                      ..... ..+-|.+|.|||.+.+ +.|+...||||.||++.||+-|.+-|     +++.+++|+..+.
T Consensus       155 ~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f-----pG~sDidQL~~If  215 (318)
T KOG0659|consen  155 NRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF-----PGDSDIDQLSKIF  215 (318)
T ss_pred             Ccccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC-----CCCchHHHHHHHH
Confidence            44333 3367999999998865 66999999999999999999998888     5566677766654

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=335.55  Aligned_cols=205  Identities=26%  Similarity=0.392  Sum_probs=179.9

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCC
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGA  255 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  255 (424)
                      ..+..++|.++++||+|.||+|+++..+ +++.+|||.+.+..   .+..+....|..++... +||.+++++.+|++.+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3566678999999999999999999976 56778999998763   34556677788887777 5999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ++|+||||+.||++..+.+.     ..+++..+..++..++.||.|||++   +|||||||.+|||||.+|++||+|||+
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             eEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence            99999999999995554442     5789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.--. ....+.++||||.|||||++.+..|+..+|+|||||+||||+.|..||....
T Consensus       515 cKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd  572 (694)
T KOG0694|consen  515 CKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD  572 (694)
T ss_pred             ccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            986432 3335678999999999999999999999999999999999999999997543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.4e-42  Score=347.13  Aligned_cols=233  Identities=31%  Similarity=0.529  Sum_probs=202.6

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEe
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYC  251 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~  251 (424)
                      +-.++.+.+.+..+.||+|+||+||+|+..      +..-||||.++..... ...+|++|+++++.++|||||+|+|+|
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            445777888889999999999999999853      2345899999877665 778999999999999999999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEE
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------P----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL  321 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NIL  321 (424)
                      .+++..+||+|||..|||.+||.....      .    ..+++..+.+.|+.|||.|++||-++   .+|||||-..|+|
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL  635 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence            999999999999999999999975431      1    33488889999999999999999999   9999999999999


Q ss_pred             EcCCCceEEEecCCccccCCCcceeee-cccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC------
Q 014466          322 LDKQWNPKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS------  393 (424)
Q Consensus       322 l~~~~~~kL~DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~------  393 (424)
                      |.++..|||+|||+++.+-+...+... ...-...|||||.|..++|+.+||||||||+|||+++ |+.||.+.      
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            999999999999999976554444332 3334668999999999999999999999999999999 99999843      


Q ss_pred             --------CCCCCccHHHHHHHHHhhhcc
Q 014466          394 --------RPPGEVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       394 --------~~~~~~~~~~~~~~~~~~~~~  414 (424)
                              .+.++.|..++..+|..||..
T Consensus       716 e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~  744 (774)
T KOG1026|consen  716 ECIRAGQLLSCPENCPTEVYSLMLECWNE  744 (774)
T ss_pred             HHHHcCCcccCCCCCCHHHHHHHHHHhhc
Confidence                    357888999999999999973

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=320.93  Aligned_cols=201  Identities=29%  Similarity=0.486  Sum_probs=174.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC--eeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lv~e  262 (424)
                      .++...+.||+|.||.||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|.....+  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            357788999999999999999764 7889999987664444677899999999999999999999855444  5889999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCccccCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~~~~~  341 (424)
                      |+++|+|.+++.+..   ..+++..+..+.+|+++||+|||++   +|+||||||+|||++. ++.+||+|||++.....
T Consensus        97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999998873   2799999999999999999999999   9999999999999999 79999999999987653


Q ss_pred             --CcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          342 --ERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       342 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                        ..........||+.|||||++..+ ....++|||||||++.||+||+.||..
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence              222334457899999999999863 333589999999999999999999986

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=316.15  Aligned_cols=201  Identities=24%  Similarity=0.431  Sum_probs=182.8

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ...+|++.+.||+|.||.|-+|+. ..|+.||||.+.+..   .+..-.+++||++|..|+||||++++.+|++.+...|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            345899999999999999999995 679999999997654   3444568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||..+|.|++|+.+.    +.+++..+..+++||..|+.|+|.+   +++|||||.+|||+|.++++||+|||++.++
T Consensus       131 vMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  131 VMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999999876    6899999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCcceeeecccccccccccccccCCCCC-CccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..  ....+.+||+|.|.+||++++..|. +.+|-|||||+||-|+.|.+|||+.
T Consensus       204 ~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~  256 (668)
T KOG0611|consen  204 AD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR  256 (668)
T ss_pred             cc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence            43  3345779999999999999999885 6899999999999999999999943

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7e-42  Score=329.91  Aligned_cols=218  Identities=28%  Similarity=0.512  Sum_probs=194.8

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .++++.+.+.-++-||.|+.|.||+|+++ +..||||++..-+       ..+|+-|++|+||||+.|.|+|.....++|
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            35788888888999999999999999987 6789999874322       237888999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |||||..|.|.+.|+..    .+++......+..+||.|+.|||.+   +|||||||.-||||..+..+||+|||-++..
T Consensus       190 iMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             eeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence            99999999999999876    5788888999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC---------------CCCCCCccHHHH
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY---------------SRPPGEVCIPQM  404 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~---------------~~~~~~~~~~~~  404 (424)
                      ...  .....++||..|||||++++...++|+||||||||||||+||..||.+               ..|.+..|...+
T Consensus       263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF  340 (904)
T ss_pred             hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence            433  334468999999999999999999999999999999999999999973               447888899999


Q ss_pred             HHHHHhhhcc
Q 014466          405 NSLMTLSYCS  414 (424)
Q Consensus       405 ~~~~~~~~~~  414 (424)
                      .-++.+||-.
T Consensus       341 klL~Kqcw~s  350 (904)
T KOG4721|consen  341 KLLLKQCWNS  350 (904)
T ss_pred             HHHHHHHHhc
Confidence            9999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=322.00  Aligned_cols=229  Identities=28%  Similarity=0.482  Sum_probs=193.5

Q ss_pred             eeeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       177 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ..+++++..+.+.+...||+|.||+||+|.+.  ..||||.+...  ..+..+.|+.|+..+++.+|.||+-|.|+|.+.
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34778999999999999999999999999986  35999998654  455678999999999999999999999999998


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      .. .||..+|+|-+|+.+++-..   ..++....+.|++|+++|+.|||.+   +|||||||..|||+.+++.|||+|||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            76 89999999999999998773   6788899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCC-CcceeeecccccccccccccccC---CCCCCccchHHHHHHHHHHHcCCCCCCCCCC---------------
Q 014466          335 LAKLLGA-ERSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRP---------------  395 (424)
Q Consensus       335 ~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~---------------  395 (424)
                      ++..... ..........|...|||||+++.   ..|++++||||||+++|||+||..||.....               
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd  613 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD  613 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence            9864211 11111223457779999999864   5689999999999999999999999983322               


Q ss_pred             ---CCCccHHHHHHHHHhhhcc
Q 014466          396 ---PGEVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       396 ---~~~~~~~~~~~~~~~~~~~  414 (424)
                         ....|..++-+++..||.+
T Consensus       614 ~s~~~s~~pk~mk~Ll~~C~~~  635 (678)
T KOG0193|consen  614 LSKIRSNCPKAMKRLLSDCWKF  635 (678)
T ss_pred             chhhhccCHHHHHHHHHHHHhc
Confidence               2233666888888888874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.7e-41  Score=304.82  Aligned_cols=211  Identities=26%  Similarity=0.390  Sum_probs=178.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCceeeEeeEeeeC--CeeeE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML  259 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l  259 (424)
                      .+.|+.++.|++|.||.||+|+++ ++..||+|++......  ---.-.+||.+|.+++|||||.+..+....  +.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            357999999999999999999976 5778999999654321  122356799999999999999999988654  47899


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |||||+. +|...+....   .++....+..+..|+++|++|||.+   .|+|||||++|+|+++.|.+||+|||+|+.+
T Consensus       155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999998 9999998763   6788899999999999999999999   9999999999999999999999999999998


Q ss_pred             CCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM  408 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  408 (424)
                      +.... ..+..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++-|.+     ...+.|+.++.
T Consensus       228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G-----~sE~dQl~~If  291 (419)
T KOG0663|consen  228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG-----KSEIDQLDKIF  291 (419)
T ss_pred             cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC-----CchHHHHHHHH
Confidence            76533 3455667999999998765 6699999999999999999999999954     44455554443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=322.53  Aligned_cols=202  Identities=25%  Similarity=0.358  Sum_probs=177.8

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHH-HHHHHHHHHhcCC-CCceeeEeeEeeeCC-eeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVR-HKNLVRLLGYCAEGA-HRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~-~~~l  259 (424)
                      ..++|.+.+.||.|.||.||+|+. .+|..||||+.++.-....+ .=.+|++.|++++ |||||++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            456899999999999999999994 46888999998765433332 3457999999998 999999999998887 8999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |||||+. +|+++++.+   ...+++..++.|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+||.+
T Consensus        88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            9999987 999999887   47899999999999999999999999   9999999999999998889999999999987


Q ss_pred             CCCcceeeecccccccccccccc-cCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .+...  .+..+.|.+|.|||++ +...|+.+.|+|++||+++|+.+-++-|.+..
T Consensus       161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s  214 (538)
T KOG0661|consen  161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS  214 (538)
T ss_pred             ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence            55443  4567889999999976 67789999999999999999999999995443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=310.74  Aligned_cols=208  Identities=25%  Similarity=0.356  Sum_probs=181.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ....+.|++.++||.|..++||+|++. .+..||||++.-. .....+.+.+|+..|+.++||||++++..|..+..+|+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            345568999999999999999999954 6788999999544 33446889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||.||.+|++.++++...  ...+.+..+..|++++++||.|||++   |.||||||+.||||+.+|.+||+|||.+..+
T Consensus       102 VmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             eehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999998774  45699999999999999999999999   9999999999999999999999999987655


Q ss_pred             CCCcc--eee-eccccccccccccccc--CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERS--YVT-TRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~--~~~-~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....  ... +.++||++|||||++.  ...|+.|+||||||++..||.+|..||....
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence            33322  222 5578999999999964  4569999999999999999999999998543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.3e-40  Score=324.14  Aligned_cols=202  Identities=26%  Similarity=0.348  Sum_probs=175.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||+||+|... +++.||+|++.+..   ......+..|++++..++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999865 57889999986532   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999999765    5789999999999999999999998   999999999999999999999999999875432


Q ss_pred             Ccc----------------------------------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCC
Q 014466          342 ERS----------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  387 (424)
Q Consensus       342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~  387 (424)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            100                                  0112457999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 014466          388 NPVDYSR  394 (424)
Q Consensus       388 ~Pf~~~~  394 (424)
                      .||....
T Consensus       234 ~Pf~~~~  240 (363)
T cd05628         234 PPFCSET  240 (363)
T ss_pred             CCCCCCC
Confidence            9997544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-40  Score=326.33  Aligned_cols=197  Identities=27%  Similarity=0.428  Sum_probs=176.9

Q ss_pred             CcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      -|+.++.||+|+.|.|-+|++ .+|+.+|||.+.+..   ......+.+||-+|+.+.||||+++|+++++..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            367789999999999999995 479999999996652   2334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|.|.+++-+.    +++++..+..++.||+.|+.|+|..   +|+||||||+|+|||.++++||+|||+|.+--  
T Consensus        93 yv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   93 YVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             ecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            99999999999876    7899999999999999999999998   99999999999999999999999999998642  


Q ss_pred             cceeeecccccccccccccccCCCCC-CccchHHHHHHHHHHHcCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ........||+|+|.+||++++..|+ .++||||.|||||.|+||+.||++
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD  214 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD  214 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence            33345567999999999999999886 589999999999999999999984

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-39  Score=322.93  Aligned_cols=201  Identities=23%  Similarity=0.329  Sum_probs=174.1

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .|++++.||+|+||+||+|+.. +++.||+|++....   ......+..|+++++.++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999965 57889999986542   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+++.+.    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999999765    4688888999999999999999998   9999999999999999999999999997543110


Q ss_pred             cc----------------------------------------------eeeecccccccccccccccCCCCCCccchHHH
Q 014466          343 RS----------------------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSF  376 (424)
Q Consensus       343 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSl  376 (424)
                      ..                                              ......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              01123579999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCC
Q 014466          377 GILIMEVISGRNPVDYSR  394 (424)
Q Consensus       377 Gv~l~elltg~~Pf~~~~  394 (424)
                      ||++|||++|+.||....
T Consensus       235 G~il~elltG~~Pf~~~~  252 (381)
T cd05626         235 GVILFEMLVGQPPFLAPT  252 (381)
T ss_pred             hhHHHHHHhCCCCCcCCC
Confidence            999999999999997544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=322.39  Aligned_cols=201  Identities=26%  Similarity=0.365  Sum_probs=175.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+++++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999975 57889999986532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999875422


Q ss_pred             Ccce-------------------------------------eeecccccccccccccccCCCCCCccchHHHHHHHHHHH
Q 014466          342 ERSY-------------------------------------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  384 (424)
Q Consensus       342 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ell  384 (424)
                      ....                                     .....+||+.|+|||++....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     111346999999999999999999999999999999999


Q ss_pred             cCCCCCCCC
Q 014466          385 SGRNPVDYS  393 (424)
Q Consensus       385 tg~~Pf~~~  393 (424)
                      +|+.||...
T Consensus       234 ~G~~Pf~~~  242 (364)
T cd05599         234 VGYPPFCSD  242 (364)
T ss_pred             cCCCCCCCC
Confidence            999999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-41  Score=292.69  Aligned_cols=203  Identities=29%  Similarity=0.442  Sum_probs=181.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ..++|++++.||+|.||.||+|+.+ ++..||+|++.+..   .+....+.+|+++-+.|+||||+++|++|.++...||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4568999999999999999999965 56678999997652   3445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ++||...|+|...|+...  ...+++.....++.|+|.||.|+|..   +|+||||||+|+|++.++.+||+|||.+..-
T Consensus       100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            999999999999998553  35688888999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .   .......|||..|++||...+..++..+|+|++|++.||++.|..||+...
T Consensus       175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            2   444566899999999999999999999999999999999999999998544

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.2e-40  Score=322.33  Aligned_cols=207  Identities=23%  Similarity=0.331  Sum_probs=178.8

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      +.+....++|++.+.||+|+||.||+++.. +++.+|+|.+.+.   .......+.+|+++++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            445667789999999999999999999976 4778999988643   222345678899999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence            9999999999999999999643     578888999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCC----CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++..............+||+.|+|||++.+.    .++.++|+|||||++|||++|+.||...
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            9987644333333456799999999998654    3788999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=323.00  Aligned_cols=202  Identities=24%  Similarity=0.349  Sum_probs=174.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||++... +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999865 68889999986532   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999999764    5688899999999999999999998   999999999999999999999999999863311


Q ss_pred             Ccc----------------------------------------------eeeecccccccccccccccCCCCCCccchHH
Q 014466          342 ERS----------------------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYS  375 (424)
Q Consensus       342 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwS  375 (424)
                      ...                                              ......+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000                                              0001246999999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCC
Q 014466          376 FGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       376 lGv~l~elltg~~Pf~~~~  394 (424)
                      |||++|||++|+.||....
T Consensus       234 lGvil~elltG~~Pf~~~~  252 (377)
T cd05629         234 LGAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             cchhhhhhhcCCCCCCCCC
Confidence            9999999999999997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-39  Score=313.88  Aligned_cols=210  Identities=30%  Similarity=0.468  Sum_probs=174.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCceeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  253 (424)
                      +++.++|++.+.||+|+||.||+|.+.      ++..||+|++..... ...+.+..|++++..+ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            567789999999999999999999742      245799999865432 3345788999999999 89999999998876


Q ss_pred             C-CeeeEEEEecCCCCHHHHHccCCCC-----------------------------------------------------
Q 014466          254 G-AHRMLVYEYIDNGNLEQWLHGDVGP-----------------------------------------------------  279 (424)
Q Consensus       254 ~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  279 (424)
                      . ...++||||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4578999999999999999754210                                                     


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce-eeeccccc
Q 014466          280 -----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGT  353 (424)
Q Consensus       280 -----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt  353 (424)
                           ..++++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 13477888899999999999999998   9999999999999999999999999999865332222 12234467


Q ss_pred             ccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          354 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       354 ~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      +.|+|||++.+..++.++|||||||+||||++ |..||....
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            78999999999999999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-39  Score=315.42  Aligned_cols=199  Identities=23%  Similarity=0.345  Sum_probs=176.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357889999999999999999976 57889999986532   23345688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            9999999999999765    4678889999999999999999999   99999999999999999999999999998653


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       170 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  219 (329)
T PTZ00263        170 DR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT  219 (329)
T ss_pred             CC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence            32    223579999999999999999999999999999999999999997543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-39  Score=316.62  Aligned_cols=202  Identities=24%  Similarity=0.366  Sum_probs=177.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC--CCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      .+..++|++.+.||+|+||.||+|.+..  +..||+|++....   ....+.+.+|+++++.++||||+++++++.++..
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            3455689999999999999999998653  3579999886532   2334568889999999999999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence            99999999999999999765    4688999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ......    .....||+.|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus       179 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        179 KVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             eecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            865322    234579999999999999999999999999999999999999997644

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-39  Score=322.39  Aligned_cols=201  Identities=23%  Similarity=0.335  Sum_probs=173.4

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999965 57789999986542   2334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+++.+.    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999999765    4678899999999999999999998   9999999999999999999999999997532100


Q ss_pred             c----------------------------------------------ceeeecccccccccccccccCCCCCCccchHHH
Q 014466          343 R----------------------------------------------SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSF  376 (424)
Q Consensus       343 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSl  376 (424)
                      .                                              .......+||+.|+|||++.+..|+.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              001123579999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCC
Q 014466          377 GILIMEVISGRNPVDYSR  394 (424)
Q Consensus       377 Gv~l~elltg~~Pf~~~~  394 (424)
                      ||++|||++|+.||....
T Consensus       235 Gvil~elltG~~Pf~~~~  252 (382)
T cd05625         235 GVILYEMLVGQPPFLAQT  252 (382)
T ss_pred             hHHHHHHHhCCCCCCCCC
Confidence            999999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=309.90  Aligned_cols=198  Identities=28%  Similarity=0.378  Sum_probs=175.5

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 58889999986432   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999999765    4688899999999999999999999   999999999999999999999999999986532


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2    223568999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-39  Score=298.64  Aligned_cols=205  Identities=25%  Similarity=0.381  Sum_probs=175.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCc-eeeEeeEeeeCC-----
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGA-----  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~-----  255 (424)
                      ...|+..++||+|.||+||+|+.. +|+.||+|++.-...  .......+|+.++++++|+| ||++++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            346888899999999999999954 688999999965433  23455678999999999999 999999998877     


Q ss_pred             -eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       256 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                       ..++|+||++. +|..++.........++...+..++.||++||+|||++   +|+||||||.||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             78899999987 99999987643224577788999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +|+...-.. ...+..++|.+|.|||++.+. .|+...||||+||+++||++++.-|.+..
T Consensus       166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s  225 (323)
T KOG0594|consen  166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS  225 (323)
T ss_pred             hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence            999654332 224456789999999998776 79999999999999999999999996544

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-39  Score=322.54  Aligned_cols=202  Identities=24%  Similarity=0.335  Sum_probs=174.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+.+..   ......+.+|++++++++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999965 57889999985432   223456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999999765    4678888899999999999999998   999999999999999999999999999753210


Q ss_pred             C------------------------------------------cceeeecccccccccccccccCCCCCCccchHHHHHH
Q 014466          342 E------------------------------------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL  379 (424)
Q Consensus       342 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~  379 (424)
                      .                                          ........+||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            0                                          0001123579999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCC
Q 014466          380 IMEVISGRNPVDYSR  394 (424)
Q Consensus       380 l~elltg~~Pf~~~~  394 (424)
                      +|||++|+.||....
T Consensus       234 lyell~G~~Pf~~~~  248 (376)
T cd05598         234 LYEMLVGQPPFLADT  248 (376)
T ss_pred             eeehhhCCCCCCCCC
Confidence            999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=318.26  Aligned_cols=229  Identities=26%  Similarity=0.401  Sum_probs=192.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ...|+..+.||+|.||.||+|.+. .++.||+|.+.-. .....+++.+|+.++..++++||.++|+.|..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            346777899999999999999965 5778999998543 44556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ||.||++.+.|+..    ..+.+..+.-++++++.||.|||.+   +.+|||||+.|||+..+|.+||+|||++..+...
T Consensus        92 y~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999999765    3447777788999999999999999   9999999999999999999999999999876554


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC------ccHHHHHHHHHhhhccce
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE------VCIPQMNSLMTLSYCSSF  416 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~~  416 (424)
                      .... ..++|||.|||||++....|+.|+||||||++.+||.+|.+|+....|...      ....++..  ..+...+.
T Consensus       165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~--~~S~~~kE  241 (467)
T KOG0201|consen  165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG--DFSPPFKE  241 (467)
T ss_pred             hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc--ccCHHHHH
Confidence            4433 678999999999999999999999999999999999999999987766221      12222222  33334566


Q ss_pred             eeeeeec
Q 014466          417 FLICCVK  423 (424)
Q Consensus       417 ~l~~c~~  423 (424)
                      |+.+|++
T Consensus       242 FV~~CL~  248 (467)
T KOG0201|consen  242 FVEACLD  248 (467)
T ss_pred             HHHHHhh
Confidence            7777875

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-39  Score=319.61  Aligned_cols=208  Identities=23%  Similarity=0.328  Sum_probs=179.7

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      ++.+++..++|++.+.||+|+||.||+|... +++.+|+|.+.+.   .......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4556777789999999999999999999976 5778999988542   22234557789999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      +...++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998653     478888899999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCC----CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++.............+||+.|+|||++.+.    .++.++|||||||++|||++|+.||...
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            99987654333333456799999999998654    3889999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=314.64  Aligned_cols=198  Identities=26%  Similarity=0.366  Sum_probs=176.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ......+..|++++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999976 47889999986542   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999999754    4688999999999999999999998   999999999999999999999999999986432


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  202 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST  202 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence                2344679999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-38  Score=303.29  Aligned_cols=201  Identities=26%  Similarity=0.357  Sum_probs=174.5

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .|+..+.||+|+||.||+|... +++.||+|.+....   ......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677899999999999999964 68899999886542   2233457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            999999998886432  24688999999999999999999998   9999999999999999999999999999865332


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence            2  2234578999999999999999999999999999999999999998644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.9e-40  Score=303.91  Aligned_cols=197  Identities=26%  Similarity=0.412  Sum_probs=164.7

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC---ee--eEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA---HR--MLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---~~--~lv  260 (424)
                      .|+-.+++|.|.||.||+|... +++.+|||++.....-    -.+|+++|+.+.|||||+++-+|....   ..  .+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5667899999999999999965 4688999999766542    234899999999999999998886432   23  389


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEEEecCCcccc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLL  339 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DfG~a~~~  339 (424)
                      ||||+. +|.+.++........++...+.-+..||++||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 99999986544456777788888999999999999998   99999999999999976 99999999999987


Q ss_pred             CCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......  .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~  229 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD  229 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence            544332  33445889999998865 56999999999999999999999999653

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.7e-39  Score=318.16  Aligned_cols=206  Identities=23%  Similarity=0.325  Sum_probs=177.4

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ..++..++|++.+.||+|+||.||+++.. +++.||+|.+.+.   .....+.+..|+++++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34566778999999999999999999975 5788999998643   2233445778999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            999999999999999998653     577888889999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCC----CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +..............+||+.|+|||++.+.    .++.++|+|||||++|||++|+.||...
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  250 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence            987644333233456799999999988653    4889999999999999999999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.4e-39  Score=311.33  Aligned_cols=194  Identities=25%  Similarity=0.311  Sum_probs=169.8

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|++++++++||||+++++++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68889999986542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceee
Q 014466          268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT  347 (424)
Q Consensus       268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~  347 (424)
                      +|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~  152 (323)
T cd05571          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence            999999765    5788999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             ecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       348 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  198 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence            3467999999999999999999999999999999999999999643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-39  Score=317.18  Aligned_cols=202  Identities=25%  Similarity=0.352  Sum_probs=175.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|++++..++||||+++++.+.++...++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999975 57889999986432   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999999765    4688999999999999999999998   999999999999999999999999999875422


Q ss_pred             Ccc----------------------------------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCC
Q 014466          342 ERS----------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  387 (424)
Q Consensus       342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~  387 (424)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0112357999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 014466          388 NPVDYSR  394 (424)
Q Consensus       388 ~Pf~~~~  394 (424)
                      .||....
T Consensus       234 ~Pf~~~~  240 (360)
T cd05627         234 PPFCSET  240 (360)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=305.35  Aligned_cols=203  Identities=28%  Similarity=0.407  Sum_probs=168.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--------------hhHHHHHHHHHHHhcCCCCceee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------------QAEKEFKVEVEAIGRVRHKNLVR  246 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~hpnIv~  246 (424)
                      ..-.|+|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            455689999999999999999999955 688899999855311              12357889999999999999999


Q ss_pred             EeeEeeeC--CeeeEEEEecCCCCHHHHHccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc
Q 014466          247 LLGYCAEG--AHRMLVYEYIDNGNLEQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD  323 (424)
Q Consensus       247 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~  323 (424)
                      |+.+..+.  +.+|||+|||..|.+...-     ...+ +++.++++++++++.||+|||.+   +||||||||+|+||+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence            99999764  5789999999998875422     2234 89999999999999999999999   999999999999999


Q ss_pred             CCCceEEEecCCccccCCC----cceeeecccccccccccccccCC---C-CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          324 KQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTG---M-LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       324 ~~~~~kL~DfG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~---~-~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .+|++||+|||.+......    ........+|||.|+|||...++   . .+.+.||||+||+||.|+.|+.||-.
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            9999999999998865211    11122347899999999988662   2 34578999999999999999999964

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=309.71  Aligned_cols=202  Identities=25%  Similarity=0.331  Sum_probs=174.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999965 5788999998642   2233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++.+.   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999999764   24688999999999999999999999   999999999999999999999999999876544


Q ss_pred             CcceeeecccccccccccccccC-----CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..........||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            33333334569999999999863     56788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.1e-39  Score=311.16  Aligned_cols=202  Identities=24%  Similarity=0.318  Sum_probs=175.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+.+.   .......+..|+.++..++|+||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 5778999988643   2223445788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999764   24688899999999999999999998   999999999999999999999999999987654


Q ss_pred             CcceeeecccccccccccccccC-----CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..........||+.|+|||++.+     ..++.++|+|||||+||||++|+.||...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            43333344679999999998865     56888999999999999999999999643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=305.19  Aligned_cols=196  Identities=28%  Similarity=0.453  Sum_probs=166.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|+..+.||+|+||.||+|++. +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++.+++..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            356788899999999999999965 688999999865433 345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+.        ....+..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            9999998642        2345677788999999999999998   9999999999999999999999999999865432


Q ss_pred             cceeeecccccccccccccccC-----CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      . .......||..|+|||++..     ...+.++|||||||++|||++|+.||..
T Consensus       222 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        222 M-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             c-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            2 12234579999999998743     3345689999999999999999999974

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-38  Score=308.28  Aligned_cols=194  Identities=27%  Similarity=0.319  Sum_probs=169.4

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +.||+|+||.||++... +|+.||+|.+....   ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 68889999986542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceee
Q 014466          268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT  347 (424)
Q Consensus       268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~  347 (424)
                      +|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~  152 (323)
T cd05595          81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence            999988765    4688999999999999999999998   9999999999999999999999999998753221 1222


Q ss_pred             ecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       348 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  198 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence            3467999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=335.02  Aligned_cols=229  Identities=31%  Similarity=0.530  Sum_probs=198.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC--CC----EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED--NT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      +++....+..+.||+|+||.||.|.+.+  +.    .||||.+.+. +.+...+|.+|..+|+.++|||||+++|++.+.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            3557778889999999999999999653  33    3899999765 456677899999999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS  331 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~  331 (424)
                      ...++++|||++|+|..||++.+.   ....++....+.++.+||+|..||+++   ++|||||..+|+||+....+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence            999999999999999999987632   246788999999999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCcceeeecc-cccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC--------------CCCC
Q 014466          332 DFGLAKLLGAERSYVTTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD--------------YSRP  395 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~--------------~~~~  395 (424)
                      |||+|+.+-....+..... .-...|||||.+....++.|+|||||||+|||++| |..||.              .+.+
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~  924 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD  924 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence            9999995533333322222 33458999999999999999999999999999999 999998              4557


Q ss_pred             CCCccHHHHHHHHHhhhc
Q 014466          396 PGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~  413 (424)
                      ++.+|.+.+.++|..||.
T Consensus       925 ~P~~CP~~ly~lM~~CW~  942 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWK  942 (1025)
T ss_pred             CCCCCChHHHHHHHHHcc
Confidence            889999999999999997

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=322.57  Aligned_cols=230  Identities=25%  Similarity=0.361  Sum_probs=189.7

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEcCC-CEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEee-Eeee--
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLG-YCAE--  253 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~-~~~~--  253 (424)
                      .-+++...++++.++|.+|||+.||+|.+..+ .+||+|++.-.+....+.+++||++|+.|+ |+|||.++| ....  
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            55678888999999999999999999998766 999999998888888999999999999996 999999999 3321  


Q ss_pred             ----CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          254 ----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       254 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                          .-+++|+||||.||.|-+++..+..  ..|++.++++|+.++++|+++||.. .|+|||||||-+||||+.+++.|
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence                1256799999999999999987643  4499999999999999999999975 78899999999999999999999


Q ss_pred             EEecCCccccCCCc--ceee------ecccccccccccccc---cCCCCCCccchHHHHHHHHHHHcCCCCCCCC-----
Q 014466          330 LSDFGLAKLLGAER--SYVT------TRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYS-----  393 (424)
Q Consensus       330 L~DfG~a~~~~~~~--~~~~------~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~-----  393 (424)
                      |||||.|.-.....  ....      -...-|+.|+|||.+   .+...++|+|||+|||+||-||....||+..     
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI  266 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI  266 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE
Confidence            99999986431111  0000      012358999999976   5788999999999999999999999999954     


Q ss_pred             ------CCCCCccHHHHHHHHHhh
Q 014466          394 ------RPPGEVCIPQMNSLMTLS  411 (424)
Q Consensus       394 ------~~~~~~~~~~~~~~~~~~  411 (424)
                            -|+.......+..++..+
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~m  290 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTM  290 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHH
Confidence                  344444555555555544

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=320.66  Aligned_cols=204  Identities=22%  Similarity=0.326  Sum_probs=178.0

Q ss_pred             CcccceeEcccCcEEEEEEEEc-C-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-D-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      .|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+++++.++|||||++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999854 3 5678888776555555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++|+|.+++........++++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998875443346788999999999999999999998   999999999999999999999999999987643322


Q ss_pred             -eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 -YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence             2234567999999999999999999999999999999999999999753

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=323.31  Aligned_cols=227  Identities=31%  Similarity=0.515  Sum_probs=198.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-C---CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-N---TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ++..+...+.++||.|.||.|++|+++- |   ..||||.++... .....+|..|..+|.++.||||++|.|+......
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            4556677889999999999999999763 2   358999997664 3455689999999999999999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .+||.|||++|+|+.||+.+.   +.+++.+....+++|+.|+.||-+.   ++|||||...||||+.+...|++|||++
T Consensus       705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999999884   5688888899999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecc--cccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC--------------CCCCCCCc
Q 014466          337 KLLGAERSYVTTRV--MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD--------------YSRPPGEV  399 (424)
Q Consensus       337 ~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~--------------~~~~~~~~  399 (424)
                      +.+.++.....+..  .-...|.|||.+...+++.++||||||++|||.++ |..||=              |+.|++..
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD  858 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD  858 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC
Confidence            98754432222222  22468999999999999999999999999999998 999964              78899999


Q ss_pred             cHHHHHHHHHhhhcc
Q 014466          400 CIPQMNSLMTLSYCS  414 (424)
Q Consensus       400 ~~~~~~~~~~~~~~~  414 (424)
                      |...++.+|.-||.+
T Consensus       859 CP~aL~qLMldCWqk  873 (996)
T KOG0196|consen  859 CPAALYQLMLDCWQK  873 (996)
T ss_pred             CcHHHHHHHHHHHHH
Confidence            999999999999985

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-38  Score=308.40  Aligned_cols=194  Identities=26%  Similarity=0.341  Sum_probs=170.0

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +.||+|+||.||++... +++.||+|++.+..   ......+.+|+++++.++||||+++++++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 58889999986542   234456788999999999999999999999999999999999999


Q ss_pred             CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceee
Q 014466          268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT  347 (424)
Q Consensus       268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~  347 (424)
                      +|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  152 (328)
T cd05593          81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM  152 (328)
T ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence            999998764    4688999999999999999999998   9999999999999999999999999998753221 2223


Q ss_pred             ecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       348 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence            3467999999999999999999999999999999999999999654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=295.72  Aligned_cols=203  Identities=28%  Similarity=0.443  Sum_probs=175.0

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeec--CCchhHHHHHHHHHHHhcCCCCceeeEeeEeee-----CC
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-----GA  255 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~  255 (424)
                      ....|...+.||+|+||.|+.+.+. +|..||||++.+  ......++..+|+++|++++|+||+.+++++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3446666899999999999999965 689999999974  345566778889999999999999999999865     34


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      .+|+|+|+|+. +|.+.++.+    ..+++..+..+++|+++||.|+|+.   +|+||||||+|+|++.+..+||+|||+
T Consensus       100 DvYiV~elMet-DL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELMET-DLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             eeEEehhHHhh-HHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            68999999965 999999876    4599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC-cceeeecccccccccccccc-cCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAE-RSYVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |+..+.. .....+..+-|.+|.|||++ ....|+...||||.||++.||++|+.-|.+..
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d  232 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD  232 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence            9977432 22334667789999999976 56789999999999999999999999996543

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.3e-38  Score=308.03  Aligned_cols=200  Identities=28%  Similarity=0.336  Sum_probs=172.8

Q ss_pred             CcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +|++.+.||+|+||.||+++..    +++.||+|.+.+..    ....+.+..|+++++.+ +||||+++++++.++...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999853    57889999986432    23345678899999999 599999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999999764    4688999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            6543333334456799999999998765 4888999999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-39  Score=313.80  Aligned_cols=202  Identities=26%  Similarity=0.362  Sum_probs=178.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|+++++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47889999999999999999976 68889999986542   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999765    5788999999999999999999998   999999999999999999999999999986543


Q ss_pred             Cc----------------------------ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ER----------------------------SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            11223457999999999999999999999999999999999999999754


Q ss_pred             C
Q 014466          394 R  394 (424)
Q Consensus       394 ~  394 (424)
                      .
T Consensus       234 ~  234 (350)
T cd05573         234 T  234 (350)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.4e-38  Score=296.31  Aligned_cols=225  Identities=28%  Similarity=0.446  Sum_probs=185.0

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      +..++|++.+.||+|+||.||+|+++    .+..||+|.+.... ......+.+|++.++.++||||+++++++..+...
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            34567899999999999999999854    35578999886553 23345788999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+|++|||.+.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            9999999999999999765   24688999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHH
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIP  402 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~  402 (424)
                      ..............++..|+|||.+.+..++.++|||||||++||+++ |+.||....              |.+..+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN  235 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            543222222223345678999999999999999999999999999875 999996432              23334455


Q ss_pred             HHHHHHHhhhc
Q 014466          403 QMNSLMTLSYC  413 (424)
Q Consensus       403 ~~~~~~~~~~~  413 (424)
                      .+.+++..||.
T Consensus       236 ~~~~li~~c~~  246 (266)
T cd05064         236 LLHQLMLDCWQ  246 (266)
T ss_pred             HHHHHHHHHcC
Confidence            66667776665

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.2e-38  Score=308.16  Aligned_cols=202  Identities=24%  Similarity=0.327  Sum_probs=173.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+++.+ +++.+|+|.+.+.   .......+..|+.++..++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999976 4677899988542   1223345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++.+.   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999764   24688899999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .........+||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            3333334467999999999885     356889999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.9e-38  Score=300.57  Aligned_cols=201  Identities=25%  Similarity=0.357  Sum_probs=173.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||.||+|+++ +++.+|+|++....  ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999976 57789999986542  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++++.+..+...    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9998776655432    24688999999999999999999998   9999999999999999999999999999876433


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .........||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            333334457899999999999989999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=305.42  Aligned_cols=192  Identities=26%  Similarity=0.310  Sum_probs=168.8

Q ss_pred             EcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       194 LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      ||+|+||.||+|+.. +++.||+|.+...   .......+..|++++++++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999976 5778999998653   233445678899999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeec
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR  349 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~  349 (424)
                      .+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~  152 (312)
T cd05585          81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT  152 (312)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence            9999764    4688999999999999999999998   9999999999999999999999999999754222 222344


Q ss_pred             ccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       350 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~  196 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE  196 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence            67999999999999999999999999999999999999999643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=297.11  Aligned_cols=208  Identities=25%  Similarity=0.291  Sum_probs=180.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .+..+.|+.++.||+|.-|+||+++..+ +..+|+|++.+..-   ....+...|-++|+.+.||.++.||..|+.+...
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            4556689999999999999999999875 57789999976533   3344567799999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |++||||+||+|..+++++.  ...+++..+..++.+++-||+|||-.   |||+|||||+||||.++|++-|+||.++.
T Consensus       153 cl~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEEEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            99999999999999998873  57899999999999999999999998   99999999999999999999999998864


Q ss_pred             ccCC---------------------------------C-c---------------------ceeeecccccccccccccc
Q 014466          338 LLGA---------------------------------E-R---------------------SYVTTRVMGTFGYVAPEYA  362 (424)
Q Consensus       338 ~~~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~  362 (424)
                      ....                                 . .                     ...+..++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            2210                                 0 0                     0112346899999999999


Q ss_pred             cCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       363 ~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .+...+.++|+|+|||+||||+.|..||.+..
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~  339 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN  339 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence            99999999999999999999999999997543

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.9e-39  Score=310.32  Aligned_cols=202  Identities=25%  Similarity=0.341  Sum_probs=177.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999965 57889999986542   234456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++.+.   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999999765   24789999999999999999999998   999999999999999999999999999987654


Q ss_pred             Ccceeeeccccccccccccccc------CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..........||+.|+|||++.      ...++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            4443444567999999999886      566889999999999999999999999643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.5e-38  Score=304.34  Aligned_cols=201  Identities=25%  Similarity=0.399  Sum_probs=176.6

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      +..++|++.+.||+|+||.||++++. ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            34578999999999999999999976 5777889988654 334456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++...    ..+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++....
T Consensus        82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          82 MEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             eecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            9999999999999765    46889999999999999999999752  69999999999999999999999999987653


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       156 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             cc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            22   22345789999999999999999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4e-38  Score=311.24  Aligned_cols=218  Identities=24%  Similarity=0.360  Sum_probs=182.2

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-C-----CceeeEe
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-H-----KNLVRLL  248 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~l~  248 (424)
                      |.+...+...-+|+++++||+|.||.|.+|++. +++.||||++.+.. .....-..|+.+|..++ |     -|+|+++
T Consensus       176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            445444444458999999999999999999965 58889999886654 33445566999999997 4     3899999


Q ss_pred             eEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC--
Q 014466          249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW--  326 (424)
Q Consensus       249 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~--  326 (424)
                      ++|...++.|||+|.+.. +|+++++.+.  ...++...++.++.||++||.+||+.   +|||+||||+||||.+-+  
T Consensus       255 d~F~fr~HlciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             eccccccceeeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcC
Confidence            999999999999999976 9999999874  46789999999999999999999998   999999999999996543  


Q ss_pred             ceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 014466          327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNS  406 (424)
Q Consensus       327 ~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~  406 (424)
                      .+||+|||.+...+..-    ...+.+..|.|||++.+.+|+.+.||||||||+.||++|.+-|     +++.+.+|+..
T Consensus       329 ~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf-----pG~ne~DQl~~  399 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF-----PGDNEYDQLAR  399 (586)
T ss_pred             ceeEEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc-----CCCCHHHHHHH
Confidence            69999999998653221    2445678999999999999999999999999999999998888     55556666666


Q ss_pred             HHH
Q 014466          407 LMT  409 (424)
Q Consensus       407 ~~~  409 (424)
                      ++.
T Consensus       400 I~e  402 (586)
T KOG0667|consen  400 IIE  402 (586)
T ss_pred             HHH
Confidence            543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-37  Score=299.11  Aligned_cols=206  Identities=28%  Similarity=0.471  Sum_probs=172.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcC-----------------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCcee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV  245 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv  245 (424)
                      ..++|.+.+.||+|+||.||+|.+++                 +..||+|.+.... .....+|.+|++++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            45688999999999999999998542                 2358999886543 33456789999999999999999


Q ss_pred             eEeeEeeeCCeeeEEEEecCCCCHHHHHccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 014466          246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV  310 (424)
Q Consensus       246 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i  310 (424)
                      ++++++.+.+..++||||+++|+|.+++.....               ....+++..++.++.|++.||+|||+.   +|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            999999999999999999999999999865321               123467888899999999999999998   99


Q ss_pred             eeCCCCCCCEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc--CC
Q 014466          311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GR  387 (424)
Q Consensus       311 vHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt--g~  387 (424)
                      +||||||+|||++.++.+||+|||+++.+...... ......++..|+|||++.+..++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999999865433222 2233456789999999988899999999999999999987  56


Q ss_pred             CCCCC
Q 014466          388 NPVDY  392 (424)
Q Consensus       388 ~Pf~~  392 (424)
                      .||..
T Consensus       240 ~p~~~  244 (304)
T cd05096         240 QPYGE  244 (304)
T ss_pred             CCCCc
Confidence            77764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.9e-38  Score=303.71  Aligned_cols=199  Identities=25%  Similarity=0.335  Sum_probs=171.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCC-ceeeEeeEeeeCCeeeEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lv~  261 (424)
                      +|++.+.||+|+||.||+|... +++.||+|++.+..   ....+.+..|++++..+.|+ +|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999976 46789999986542   23445677899999999765 5889999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999998765    4678899999999999999999998   999999999999999999999999999874322


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. .......||+.|+|||++.+..++.++|+|||||++|||+||+.||...
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (324)
T cd05587         154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  204 (324)
T ss_pred             CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            11 2233467999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.1e-38  Score=303.95  Aligned_cols=200  Identities=24%  Similarity=0.342  Sum_probs=171.8

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999976 46789999986542   22334566688888777 5899999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999998765    4688899999999999999999998   999999999999999999999999999875422


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ........||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence            2 222345679999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-38  Score=304.72  Aligned_cols=194  Identities=29%  Similarity=0.411  Sum_probs=168.4

Q ss_pred             eeEcccCcEEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +.||+|+||.||+++..    +++.||+|.+....    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999853    47789999986532    22334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++...    ..+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999765    4678888889999999999999998   99999999999999999999999999987532222


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~  203 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE  203 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence             2233467999999999999989999999999999999999999999754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-39  Score=310.31  Aligned_cols=202  Identities=28%  Similarity=0.429  Sum_probs=181.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe-eeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-RMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~~lv~  261 (424)
                      ++|..++.+|+|+||.+++++.+ +++.+++|++.-.+  ....+....|+.++++++|||||.+++.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57899999999999999999965 57789999985442  3333467789999999999999999999999888 89999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      +||+||+|.+.+.+..  ...++++.+..++.|++.|+.|||++   .|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998874  35789999999999999999999998   999999999999999999999999999998866


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... .....+||+.|+.||.+.+..|+.|+|||||||++|||++-+.+|...
T Consensus       159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~  209 (426)
T KOG0589|consen  159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS  209 (426)
T ss_pred             chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence            543 345678999999999999999999999999999999999999999854

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-37  Score=300.77  Aligned_cols=194  Identities=28%  Similarity=0.404  Sum_probs=166.0

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhc-CCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|++. +++.||+|.+....   ....+.+..|.+++.. .+||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 47789999986542   2233445556677665 4899999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            9999998764    4688899999999999999999998   99999999999999999999999999997543222 23


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            34567999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.4e-38  Score=303.50  Aligned_cols=197  Identities=28%  Similarity=0.383  Sum_probs=168.7

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHH---hcCCCCceeeEeeEeeeCCeeeEE
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAI---GRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      |++.+.||+|+||.||+|.+. +++.||+|.+.+..   ....+.+..|++++   +.++||||+++++++.++...++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567899999999999999965 57889999986542   22334566665554   567899999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|..+++.     ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999988864     3689999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... ......+||+.|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence            221 2234467999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.4e-38  Score=305.96  Aligned_cols=194  Identities=25%  Similarity=0.306  Sum_probs=168.7

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +.||+|+||.||++... +++.||+|.+.+..   ......+..|+++++.++||||+++++++.++...++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68889999986542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      +|..++...    ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~  152 (325)
T cd05594          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT  152 (325)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence            999988765    468899999999999999999997 6   89999999999999999999999999987532221 22


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            23457999999999999999999999999999999999999999654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-37  Score=299.35  Aligned_cols=201  Identities=24%  Similarity=0.365  Sum_probs=171.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            357999999999999999999976 678899999864432 233457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++ ++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 5888888654   24678888999999999999999999   9999999999999999999999999998754322


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      . .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2 22234568999999998765 56889999999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=310.68  Aligned_cols=228  Identities=30%  Similarity=0.491  Sum_probs=194.6

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcC--C--CE-EEEEEeec---CCchhHHHHHHHHHHHhcCCCCceeeEee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED--N--TN-VAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG  249 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~  249 (424)
                      ...+++..++....++||+|+||.||+|++..  +  .. ||+|....   .......+|..|.++|+.++|||||++||
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            34567888888889999999999999999653  2  23 79998864   23556778999999999999999999999


Q ss_pred             EeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       250 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                      ++..+..+++|||+|.||+|.++|+++.   ..++....+.++.+.|.||+|||++   +++||||-.+|+|++.++.+|
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence            9999999999999999999999999873   3689999999999999999999999   999999999999999999999


Q ss_pred             EEecCCccccCCCcceeeec-c-cccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC---------------
Q 014466          330 LSDFGLAKLLGAERSYVTTR-V-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD---------------  391 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~~~~~-~-~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~---------------  391 (424)
                      |+|||+++.-.   .+.... . .-...|+|||.+....|++++|||||||++||+++ |..||.               
T Consensus       303 ISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~  379 (474)
T KOG0194|consen  303 ISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG  379 (474)
T ss_pred             eCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence            99999987532   122111 1 23458999999999999999999999999999999 888987               


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcc
Q 014466          392 YSRPPGEVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~  414 (424)
                      ++.+.+......+..+|..||..
T Consensus       380 ~r~~~~~~~p~~~~~~~~~c~~~  402 (474)
T KOG0194|consen  380 YRMPIPSKTPKELAKVMKQCWKK  402 (474)
T ss_pred             ccCCCCCCCHHHHHHHHHHhccC
Confidence            44566677788888888888863

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=304.81  Aligned_cols=201  Identities=27%  Similarity=0.396  Sum_probs=180.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCch---hHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~  258 (424)
                      ....|++.+.||+|.||.||+|+.+. |+.+|+|.+.+....   ..+.+.+|+++|+++. |||||+++++|++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34578889999999999999999764 899999999766442   3468999999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC----CceEEEecC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ----WNPKLSDFG  334 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kL~DfG  334 (424)
                      +|||++.||.|.+.+...     .+++..+..++.|++.+++|||+.   +|+||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999765     289999999999999999999998   99999999999999543    479999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.....  .......+||+.|+|||++....|+..+||||+||++|.|++|..||...+
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            9998755  445677899999999999999999999999999999999999999997654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-37  Score=297.40  Aligned_cols=201  Identities=25%  Similarity=0.403  Sum_probs=171.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            47899999999999999999965 57889999886442 23345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            985 999988654   24578889999999999999999998   99999999999999999999999999997643222


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       .......|++.|+|||++.+ ..++.++||||+||++|||+||+.||....
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             12233568999999998865 568999999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-37  Score=294.38  Aligned_cols=191  Identities=19%  Similarity=0.391  Sum_probs=165.6

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchh---HHHHHHHHHHHhcCCCCceeeEeeEeee----CCeeeEEEEec
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA---EKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLVYEYI  264 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lv~e~~  264 (424)
                      ..||+|++|.||+|.+. |+.||||++.......   .+.+.+|+++|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            78999999999999984 8899999986543322   4678899999999999999999999876    34678999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++|+|.+++...    ..+++.....++.+++.||.|||+..  +++||||||+|||+++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999765    46788899999999999999999732  78899999999999999999999999998653321 


Q ss_pred             eeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                         ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~  225 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL  225 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence               23468899999999976  68999999999999999999999999854

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.8e-37  Score=301.46  Aligned_cols=193  Identities=27%  Similarity=0.383  Sum_probs=168.0

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|+.. +++.+|+|.+.+.   .....+.+..|+.++.++ +||||+++++++.++...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 5778999998754   223445677888888776 899999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~  152 (329)
T cd05618          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence            9999988754    5689999999999999999999998   9999999999999999999999999998753222 122


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|+.||+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            3446799999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-37  Score=301.76  Aligned_cols=195  Identities=24%  Similarity=0.361  Sum_probs=168.6

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|+.+ +++.||+|.+.+..   ....+.+..|++++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 57889999986532   23345667788888876 699999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~  152 (320)
T cd05590          81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT  152 (320)
T ss_pred             chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence            9999998765    4688999999999999999999998   9999999999999999999999999998753222 222


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN  200 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            344679999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-37  Score=302.80  Aligned_cols=193  Identities=26%  Similarity=0.365  Sum_probs=168.8

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      ++||+|+||.||+|+.. +++.||+|.+.+..   ....+.+..|..++..+ +||||+++++++.++...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999965 57889999987542   23345678899999988 799999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            9999988754    5789999999999999999999999   9999999999999999999999999998742111 222


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            3446799999999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-37  Score=307.42  Aligned_cols=197  Identities=20%  Similarity=0.296  Sum_probs=171.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      +..++|++.+.||+|+||.||+|.+. +++.||+|...      ...+.+|++++++++||||+++++++..+...++|+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            44568999999999999999999965 57889999643      234678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |++. ++|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       163 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        163 PRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             ecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            9996 5898888654    4678899999999999999999998   999999999999999999999999999975433


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~  286 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK  286 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence            2222334567999999999999999999999999999999999999887543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-37  Score=301.37  Aligned_cols=202  Identities=26%  Similarity=0.415  Sum_probs=176.2

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      +..++|++.+.||+|+||.||++.+. ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            45578999999999999999999976 5777888887654 334456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++...    ..+++..+..++.+++.||.|||+..  +|+||||||+|||++.++.+||+|||++....
T Consensus        82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          82 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            9999999999999764    46788999999999999999999741  69999999999999999999999999987553


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..   ......||..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            22   223456899999999999989999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.2e-38  Score=302.43  Aligned_cols=195  Identities=26%  Similarity=0.355  Sum_probs=168.4

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      ++||+|+||.||+|+.. +++.||+|.+....   ....+.+..|.+++..+ +||||+++++++.++...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 47789999986542   23345567788888866 799999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...... ...
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~  152 (321)
T cd05591          81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVT  152 (321)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC-Ccc
Confidence            9999998765    4688899999999999999999999   9999999999999999999999999998754222 222


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence            344679999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.5e-37  Score=288.20  Aligned_cols=201  Identities=25%  Similarity=0.469  Sum_probs=174.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      ++|++.+.||+|+||.||++.++++..+|+|.+.... ...+.+..|++++++++||||+++++++.++...++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            5688899999999999999998877889999875432 334678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +|+|.++++...   ..+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||.++........
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            999999997642   4588999999999999999999998   9999999999999999999999999998865433222


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            2223345668999999998899999999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-37  Score=301.19  Aligned_cols=200  Identities=24%  Similarity=0.346  Sum_probs=171.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      +|++.+.||+|+||.||+|... +++.||+|++.+..   ....+.+..|+++++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999965 57889999986532   233456777888988885 577889999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999998765    5688999999999999999999998   999999999999999999999999999875422


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ........||+.|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         154 D-GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             C-CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence            2 122334569999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.4e-37  Score=314.51  Aligned_cols=209  Identities=25%  Similarity=0.321  Sum_probs=178.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC---
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA---  255 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  255 (424)
                      +...++|.+.+.||+|+||+||+|+.. +++.||||.+...  .......+.+|+..+..++|+||+++++.+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            345568999999999999999999854 6889999998654  2344556888999999999999999988775332   


Q ss_pred             -----eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEE
Q 014466          256 -----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL  330 (424)
Q Consensus       256 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL  330 (424)
                           ..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 35799999999999999976544456789999999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          331 SDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       331 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +|||+++.+.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~  248 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE  248 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            9999998654322 22234567999999999999999999999999999999999999999743

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.9e-37  Score=299.76  Aligned_cols=195  Identities=27%  Similarity=0.370  Sum_probs=169.5

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|... +++.+|+|.+.+..   ....+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 56789999987542   23345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  152 (327)
T cd05617          81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT  152 (327)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence            9999988754    4689999999999999999999998   9999999999999999999999999998753221 122


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~  200 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT  200 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence            345679999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-37  Score=293.68  Aligned_cols=196  Identities=26%  Similarity=0.349  Sum_probs=169.8

Q ss_pred             EcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       194 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      ||+|+||+||++.+. +++.+|+|.+.....   ...+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 678899999865422   2235677899999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeec
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR  349 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~  349 (424)
                      ..++.........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..+..... ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988865433345789999999999999999999998   999999999999999999999999999986543322 2334


Q ss_pred             ccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       350 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            57899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.7e-37  Score=305.48  Aligned_cols=210  Identities=29%  Similarity=0.452  Sum_probs=175.6

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEE------cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  252 (424)
                      +.++.++|++.+.||+|+||.||+|+.      .++..||+|++.... ....+.+.+|+++++.+ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            356677899999999999999999973      235579999886443 33456788899999999 8999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCC------------------------------------------------------
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------  278 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  278 (424)
                      +++..++||||+++|+|.++++....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999999965321                                                      


Q ss_pred             -----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          279 -----------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       279 -----------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                                       ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             012578888999999999999999998   999999999999999999999999999986643


Q ss_pred             Cccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..... .....++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            32221 122335667999999999999999999999999999998 89999653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.7e-37  Score=288.79  Aligned_cols=205  Identities=26%  Similarity=0.475  Sum_probs=178.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.+.||+|+||.||+|...+++.+|+|.+.... ...+.+.+|+++++.++|+||+++++++.+++..+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            35567899999999999999999998888889999876543 33567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++.+..  ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          81 EYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999999999997652  34678888899999999999999998   999999999999999999999999999987644


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ..........++..|+|||++.+..++.++|+|||||++|||++ |+.||..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  207 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG  207 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence            32222233445678999999998899999999999999999998 9999964

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-37  Score=301.22  Aligned_cols=194  Identities=29%  Similarity=0.368  Sum_probs=165.7

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHH-HHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||+||+|+.. +++.||+|.+....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68889999986532   122234444544 56889999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (323)
T cd05575          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT  152 (323)
T ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence            9999999764    4688899999999999999999998   9999999999999999999999999998753221 223


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  199 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence            34567999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-37  Score=300.83  Aligned_cols=199  Identities=25%  Similarity=0.413  Sum_probs=168.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----Ceee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM  258 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~  258 (424)
                      +|++.+.||+|+||.||+|+.. ++..||+|++...  .......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788999999999999999965 6889999998643  223345688899999999999999999988543     2478


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+. ++|.+++...    ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999996 5899988754    4688999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCcc--eeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERS--YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            432211  12234579999999999866  67899999999999999999999999654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-37  Score=301.86  Aligned_cols=194  Identities=30%  Similarity=0.371  Sum_probs=166.1

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHH-HHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||+||+|+.. +|+.+|+|++.+..   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 68889999986542   223344555554 57789999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~  152 (325)
T cd05604          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT  152 (325)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence            9999988754    5788999999999999999999998   9999999999999999999999999998753221 222


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence            34567999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.9e-37  Score=298.31  Aligned_cols=194  Identities=25%  Similarity=0.369  Sum_probs=166.8

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|++. +++.||+|.+....   ......+..|..++... +||||+++++++.+++..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 57889999986542   22344566677787754 899999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence            9999998764    4678899999999999999999998   9999999999999999999999999998743211 222


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            34567999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-37  Score=299.63  Aligned_cols=194  Identities=27%  Similarity=0.341  Sum_probs=164.8

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHH-HHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      ++||+|+||.||+|+.. +++.||+|.+.+...   .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 578899999865421   2233444454 467889999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (321)
T cd05603          81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET  152 (321)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence            9999888654    4678888899999999999999998   9999999999999999999999999998753221 222


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence            34567999999999999999999999999999999999999999654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.2e-37  Score=297.19  Aligned_cols=195  Identities=27%  Similarity=0.383  Sum_probs=166.7

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhc-CCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|.+. +++.||+|.+....   ......+..|..++.. ++||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 46789999986542   2233456667777775 4999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05619          81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCc
Confidence            9999999754    4678889999999999999999998   9999999999999999999999999998753221 122


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD  200 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence            344679999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-37  Score=300.05  Aligned_cols=194  Identities=29%  Similarity=0.350  Sum_probs=164.2

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHH-HHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||+||+|++. +++.||+|.+....   ......+..|. .+++.++||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 46779999986532   12223344444 457889999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.+++...    ..+.+..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~  152 (325)
T cd05602          81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT  152 (325)
T ss_pred             CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence            9999999764    4677888888999999999999999   9999999999999999999999999998754222 222


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence            34567999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.3e-37  Score=303.28  Aligned_cols=211  Identities=28%  Similarity=0.449  Sum_probs=176.8

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCC-CCceeeEeeEe
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYC  251 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~  251 (424)
                      .++++.++|++.+.||+|+||.||+|++..      +..||+|++..... ...+.+.+|+++++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            456778899999999999999999998531      34699999865433 33467889999999996 99999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCC-----------------------------------------------------
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVG-----------------------------------------------------  278 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  278 (424)
                      .+....+|||||+++|+|.+++..+..                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999999865321                                                     


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          279 ---------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       279 ---------------------------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                                                             ....+++..+..++.|+++||+|||+.   +|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence                                                   012477888899999999999999998   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            99999999999999999865432222 1223456788999999999999999999999999999997 99999653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.1e-37  Score=303.31  Aligned_cols=210  Identities=28%  Similarity=0.465  Sum_probs=175.0

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  253 (424)
                      ..+.++|++.+.||+|+||.||+|+..      ++..||+|.+.... ....+.+.+|+++++.+ +|+||+++++++.+
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            456678999999999999999999842      23469999986543 33445688899999999 89999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCC-------------------------------------------------------
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVG-------------------------------------------------------  278 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  278 (424)
                      ....++||||+++|+|.+++.....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999999864311                                                       


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee-
Q 014466          279 -----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-  346 (424)
Q Consensus       279 -----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~-  346 (424)
                                 ....+++..++.++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++.+....... 
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       113478888999999999999999998   99999999999999999999999999998654332221 


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            122335668999999999999999999999999999997 999997543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=290.32  Aligned_cols=196  Identities=32%  Similarity=0.530  Sum_probs=164.9

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC--CCCceeeEeeEeeeCC----eeeEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV--RHKNLVRLLGYCAEGA----HRMLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~l~~~~~~~~----~~~lv  260 (424)
                      ..++.++||+|.||.||+|.+. ++.||||++.   .+....|..|-++.+..  +|+||++|++.-....    .++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            4456789999999999999987 5889999984   34456677787777755  8999999999876555    78999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------EPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ++|.+.|+|.+||+.+     .++|....+++..+++||+|||+..      +|.|+|||||++||||.+|++.-|+|||
T Consensus       287 t~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            9999999999999876     7899999999999999999999754      6799999999999999999999999999


Q ss_pred             CccccCCCcc-eeeecccccccccccccccCCC-CC-----CccchHHHHHHHHHHHcCCCCCC
Q 014466          335 LAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM-LN-----ERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       335 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      +|..+..... ......+||..|||||++.+.. +.     .+.||||+|.|||||++...-++
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~  425 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD  425 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            9998764432 2234478999999999997643 22     25899999999999999766554

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-37  Score=301.15  Aligned_cols=195  Identities=27%  Similarity=0.366  Sum_probs=169.9

Q ss_pred             eeEcccCcEEEEEEEE----cCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          192 NVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      +.||+|+||.||+++.    .+++.+|+|++.....  .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999885    2578899999865422  233456779999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence            99999999764    4689999999999999999999998   99999999999999999999999999988653321 2


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence            2344679999999999999899999999999999999999999997543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=329.04  Aligned_cols=208  Identities=26%  Similarity=0.337  Sum_probs=189.3

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      ++++++..++|+++++||+|+||.|.+++.+ +++.||+|++.+.   +......|..|-.+|..-+.+=|+++.-.|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            5677888999999999999999999999976 5777899998763   33445679999999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      +.++||||||++||+|..++.+.    ..++++.+..++..|+-||+-||+.   |+|||||||+|||||..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999999876    4799999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeeccccccccccccccc----C-CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS----T-GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      |.+-.++.+........+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||..
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            999988877777788889999999999884    3 6799999999999999999999999973

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.5e-37  Score=291.29  Aligned_cols=201  Identities=28%  Similarity=0.413  Sum_probs=167.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc--CCCEEEEEEeecCC--chhHHHHHHHHHHHhcC---CCCceeeEeeEee-----e
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV---RHKNLVRLLGYCA-----E  253 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~-----~  253 (424)
                      .+|++.+.||+|+||.||+|+..  +++.||+|.+....  ......+.+|+++++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46779999886432  22233455677776665   6999999999885     2


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ....++||||++ ++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            446789999997 59999987652  24588999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            999865432  22344678999999999988899999999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-36  Score=284.96  Aligned_cols=201  Identities=27%  Similarity=0.451  Sum_probs=174.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+++++.++||||+++++++.+....+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4678899999999999999998777779999876443 334678899999999999999999999998888999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +|+|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||.++........
T Consensus        83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            999999997652   3688999999999999999999998   9999999999999999999999999998865433322


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |..||...
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            2223345678999999988889999999999999999999 99999743

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-36  Score=293.89  Aligned_cols=223  Identities=28%  Similarity=0.492  Sum_probs=182.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCC----EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ...+|+..+.||+|+||.||+|.+. ++.    .||+|.+.... ....+++..|+.+++.++||||+++++++..+ ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            3457899999999999999999854 333    38999886543 34456788999999999999999999999875 56


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++++||+++|+|.+++...   ...+++...+.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          84 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            7999999999999999865   24578888999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccH
Q 014466          338 LLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCI  401 (424)
Q Consensus       338 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~  401 (424)
                      .+....... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||+...              |....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  237 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence            765432222 222334678999999999999999999999999999998 999997532              2233345


Q ss_pred             HHHHHHHHhhhc
Q 014466          402 PQMNSLMTLSYC  413 (424)
Q Consensus       402 ~~~~~~~~~~~~  413 (424)
                      .++..++..||.
T Consensus       238 ~~~~~li~~cl~  249 (316)
T cd05108         238 IDVYMIMVKCWM  249 (316)
T ss_pred             HHHHHHHHHHcc
Confidence            567777777765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-36  Score=301.32  Aligned_cols=194  Identities=24%  Similarity=0.295  Sum_probs=167.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ...|.+.+.||+|+||.||+|.+. .++.||+|...      ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999976 47789999642      22356799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +. ++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 6999888654   24789999999999999999999998   99999999999999999999999999998654322


Q ss_pred             ce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          344 SY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       344 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      .. ......||+.|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            21 2234579999999999999999999999999999999999887653

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-37  Score=290.21  Aligned_cols=201  Identities=27%  Similarity=0.366  Sum_probs=174.0

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999965 57889999986532   2223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999998886542  24688999999999999999999998   9999999999999999999999999999865322


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .  ......|++.|+|||++.+..++.++|+||+||++|||++|+.||....
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~  205 (285)
T cd05605         156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK  205 (285)
T ss_pred             C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence            2  2234578999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=283.92  Aligned_cols=206  Identities=28%  Similarity=0.481  Sum_probs=177.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+.+.+|++++++++||||+++++++..+...+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            45677899999999999999999998778889999886543 33567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999999997653  24688999999999999999999998   999999999999999999999999999987653


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ...........+..|+|||++.+..++.++|+||||+++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  208 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM  208 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            22221222223457999999999999999999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.7e-37  Score=296.03  Aligned_cols=194  Identities=26%  Similarity=0.384  Sum_probs=168.1

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||+||+|++. +++.||+|.+.+..   ......+..|+++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 47789999987542   23345677788898888 799999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~  152 (318)
T cd05570          81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT  152 (318)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence            9999988765    4689999999999999999999998   9999999999999999999999999998743221 122


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence            33457899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=286.87  Aligned_cols=204  Identities=26%  Similarity=0.310  Sum_probs=180.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchh---HHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA---EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .+-.++|..+++||+|.||+|.+|+.+ +++.+|+|++.+...-.   ...-..|-++|+..+||.+..+.-.|+..+++
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            455678999999999999999999965 68889999987763332   33445688999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |+||||..||.|.-.|.+.    ..+++.....+-.+|+.||.|||++   +||+||||.+|.|+|.+|++||+|||+++
T Consensus       244 CFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence            9999999999999888765    5688888888999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .- ......+..+||||.|+|||++....|+..+|+|.+||++|||++|+.||...
T Consensus       317 E~-I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  317 EE-IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             hc-ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            53 23344567899999999999999999999999999999999999999999754

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.2e-37  Score=302.22  Aligned_cols=200  Identities=25%  Similarity=0.364  Sum_probs=171.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC-----eee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM  258 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~  258 (424)
                      +|++.+.||+|+||.||++... +++.||+|++...  .....+.+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 6889999998643  2234467888999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +|+||+. ++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999997 4888887654    5688999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .............+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            54333333344568999999998876 458999999999999999999999997654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=283.34  Aligned_cols=201  Identities=27%  Similarity=0.460  Sum_probs=172.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .+|++.+.||+|+||.||++.++++..+|+|.+.+.. .....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4688899999999999999998877789999875433 234568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999997652   3688999999999999999999998   9999999999999999999999999999865432222


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||+..
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  205 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF  205 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence            2222234457999999999999999999999999999999 89999754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-36  Score=287.26  Aligned_cols=227  Identities=29%  Similarity=0.500  Sum_probs=184.9

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCC------CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDN------TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ..++|++.+.||+|+||.||+|.....      ..+|+|.+.... ......+.+|+++++.++||||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            345788999999999999999986432      468999886543 3345678999999999999999999999999889


Q ss_pred             eeEEEEecCCCCHHHHHccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK  324 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~  324 (424)
                      .+++|||+++++|.+++......            ...+++..++.++.|++.||+|||+.   +++|+||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence            99999999999999999764211            14578889999999999999999998   9999999999999999


Q ss_pred             CCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCCC-------
Q 014466          325 QWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP-------  395 (424)
Q Consensus       325 ~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~~-------  395 (424)
                      ++.+||+|||+++....... .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||....+       
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999986533221 22234456889999999988899999999999999999998 9999974322       


Q ss_pred             -------CCCccHHHHHHHHHhhhc
Q 014466          396 -------PGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       396 -------~~~~~~~~~~~~~~~~~~  413 (424)
                             ....+..++.+++..||.
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~  264 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWN  264 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHcc
Confidence                   122334566666666664

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-37  Score=289.31  Aligned_cols=218  Identities=28%  Similarity=0.467  Sum_probs=176.0

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC--CCCceeeEeeEeeeCC----eeeEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV--RHKNLVRLLGYCAEGA----HRMLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~l~~~~~~~~----~~~lv  260 (424)
                      +..+.+.||+|.||.||+|.++ |..||||++...   .++.+.+|.++.+.+  +|+||+.|++.-..+.    ++|||
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            5677899999999999999998 788999998543   345566778877754  9999999998765433    67899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-----LEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      .+|.+.|+|++||.++     .++.+..+++++.+|.||++||-.     .+|.|.|||||+.||||..++..-|+|+|+
T Consensus       288 TdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             eecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            9999999999999875     788999999999999999999953     478999999999999999999999999999


Q ss_pred             ccccCCCcc---eeeecccccccccccccccCCC----CC--CccchHHHHHHHHHHHcC----------CCCCCCCCCC
Q 014466          336 AKLLGAERS---YVTTRVMGTFGYVAPEYASTGM----LN--ERSDVYSFGILIMEVISG----------RNPVDYSRPP  396 (424)
Q Consensus       336 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~--~~sDiwSlGv~l~elltg----------~~Pf~~~~~~  396 (424)
                      |........   ...+..+||..|||||++....    +.  ..+||||||+++||+.-.          +.||..--|.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            987654422   2234578999999999986532    22  258999999999998652          4577643331


Q ss_pred             C-------------------------CccHHHHHHHHHhhhc
Q 014466          397 G-------------------------EVCIPQMNSLMTLSYC  413 (424)
Q Consensus       397 ~-------------------------~~~~~~~~~~~~~~~~  413 (424)
                      +                         ...+..+.++|..||-
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~  484 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWY  484 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhc
Confidence            1                         1156788999999996

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=301.82  Aligned_cols=202  Identities=25%  Similarity=0.364  Sum_probs=166.7

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC------CceeeEeeEee
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH------KNLVRLLGYCA  252 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~  252 (424)
                      +++...++|++.+.||+|+||+||+|++. .++.||||++.... ....++..|+++++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            44566789999999999999999999965 57789999985432 223445667777776654      45899999987


Q ss_pred             eC-CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCC----
Q 014466          253 EG-AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQW----  326 (424)
Q Consensus       253 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~----  326 (424)
                      .+ .+.++|||++ +++|.+++.+.    ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++    
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            65 4678999988 67899988764    578899999999999999999996 5   899999999999998765    


Q ss_pred             ------------ceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          327 ------------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       327 ------------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                                  .+||+|||.+....    ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        49999999876421    22345679999999999999999999999999999999999999997644

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=270.59  Aligned_cols=211  Identities=26%  Similarity=0.349  Sum_probs=181.0

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC----
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----  255 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----  255 (424)
                      +.+..++|.+.+.||+|||+-||++. ..++..+|+|++.-...+..+...+|++..++++|||+++++++...+.    
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            45778899999999999999999999 5567889999998887777888999999999999999999999875433    


Q ss_pred             -eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       256 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                       ..|++++|...|+|.+.+.........+++..++.|+.++++||++||+. .+.+.||||||.|||+.+.+.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence             48999999999999999987766667899999999999999999999987 5569999999999999999999999999


Q ss_pred             CccccCCCcce--------eeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          335 LAKLLGAERSY--------VTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .+....-.-..        .-.....|..|.|||.+.   +...++++|||||||+||+|+.|..||+.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            98754321100        011234688999999774   56688999999999999999999999983

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=280.10  Aligned_cols=200  Identities=27%  Similarity=0.427  Sum_probs=173.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-----hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-----QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ++|++.+.||+|++|.||+|... ++..+|+|.+.....     ...+.+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999964 588899998854321     223568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |+||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999998765    4678899999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcceee--ecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          340 GAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ........  ....|+..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            43222111  335678899999999998999999999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.8e-36  Score=281.90  Aligned_cols=205  Identities=30%  Similarity=0.488  Sum_probs=175.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.+ ...+++|
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT   79 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence            355678999999999999999999988888899999865433 34578899999999999999999998854 5678999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++....  ...+++..++.++.+++.||+|||+.   +++||||||+||++++++.+||+|||++..+..
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          80 EYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            9999999999997642  24578999999999999999999998   999999999999999999999999999986543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..........++..|+|||++.+..++.++|+||||+++|||++ |..||...
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  207 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            32222223345668999999988899999999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=305.99  Aligned_cols=202  Identities=28%  Similarity=0.430  Sum_probs=173.1

Q ss_pred             ccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------eeeEE
Q 014466          189 ADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRMLV  260 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~~~lv  260 (424)
                      ...+.||+||||.||+++. .+|..||||.+.+.. ....+...+|+++|++++|||||+++++-++..      ...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            4467899999999999994 579999999986643 334456778999999999999999999876544      45799


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc--CCCc--eEEEecCCc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWN--PKLSDFGLA  336 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~--~~~~--~kL~DfG~a  336 (424)
                      ||||.+|+|...|++..+ ...+++...+.++.++..|+.|||++   +|+||||||.||++-  .+|+  .||+|||.|
T Consensus        96 mEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999987643 46799999999999999999999999   999999999999993  3343  899999999


Q ss_pred             cccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPP  396 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~  396 (424)
                      +.++...  ..+.++||..|++||+... +.|+..+|.|||||++|++.||..||.....+
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9875443  5677899999999999984 88999999999999999999999999866544

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-36  Score=283.79  Aligned_cols=205  Identities=31%  Similarity=0.549  Sum_probs=180.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .+..+|++.+.||+|+||.||+|...++..+++|.+..........+..|+++++.++||||+++++++.+....++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            44567999999999999999999988888899999877665566778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            999999999997653  24678999999999999999999998   9999999999999999999999999999865432


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .. ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...
T Consensus       158 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         158 VY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             cc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence            22 1223446778999999988899999999999999999998 89999653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-36  Score=285.84  Aligned_cols=205  Identities=30%  Similarity=0.544  Sum_probs=175.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..+|.+.+.||+|+||.||+|...+      +..+|+|.+...... ..+.+.+|+++++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4578999999999999999998643      467999998665443 457899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVG----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN  327 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~  327 (424)
                      ++||||+++++|.+++.....          ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            999999999999999976421          234578889999999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          328 PKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       328 ~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      +||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999765332211 1223345788999999999999999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.8e-36  Score=281.20  Aligned_cols=205  Identities=28%  Similarity=0.491  Sum_probs=176.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.++||+|+||.||+|..++++.+|+|.+..... ....+.+|++++++++|+||+++++++.. +..+++|
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIIT   79 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEE
Confidence            466778999999999999999999988889999999865443 34578889999999999999999998754 5689999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++....  ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            9999999999987542  34688899999999999999999998   999999999999999999999999999986543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..........++..|+|||++....++.++|+||||+++|||++ |+.||...
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  207 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM  207 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            22222233445678999999998899999999999999999999 99999643

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.5e-36  Score=285.91  Aligned_cols=207  Identities=28%  Similarity=0.493  Sum_probs=176.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++..+...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3567899999999999999999852      2345889988766556667899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          258 MLVYEYIDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      ++||||+++++|.+++....         .....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            99999999999999997542         1223589999999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||+|||+++....... .......++..|+|||++.+..++.++|+|||||++|||++ |..||...
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999986533222 11223445778999999999999999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=305.45  Aligned_cols=202  Identities=25%  Similarity=0.370  Sum_probs=166.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-------
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-------  254 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-------  254 (424)
                      ....+|++.+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...       
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            34567999999999999999999975 57889999886543    2234699999999999999999987432       


Q ss_pred             -CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEe
Q 014466          255 -AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSD  332 (424)
Q Consensus       255 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~D  332 (424)
                       ..+++||||+++ +|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             245689999985 78777764433346789999999999999999999998   999999999999998665 699999


Q ss_pred             cCCccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ||+++.+....  ......||+.|+|||++.+ ..|+.++|||||||++|||++|..||....
T Consensus       215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99998654322  2234568999999998765 469999999999999999999999997643

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-37  Score=277.46  Aligned_cols=200  Identities=26%  Similarity=0.414  Sum_probs=174.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-----c---hhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----G---QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG  254 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  254 (424)
                      .+.|.-.++||.|..++|-+|..+ +|+++|+|++....     .   ...+.-.+|+.+|+++ .||||+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            456777899999999999999855 68889999885321     1   1234566799999999 699999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...++|+|.|+.|.|.++|...    -.++++....|++|+..|++|||..   +||||||||+|||++++.++||+|||
T Consensus        96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999876    5789999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeeccccccccccccccc------CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++..+..  .......||||+|+|||.+.      ...|+...|+|++||++|.|+.|..||-.+
T Consensus       169 Fa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR  231 (411)
T KOG0599|consen  169 FACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR  231 (411)
T ss_pred             eeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence            9997643  33456789999999999873      356888999999999999999999999643

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-36  Score=280.74  Aligned_cols=202  Identities=33%  Similarity=0.526  Sum_probs=173.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .++|++.+.||+|+||.||+|.+..    ...+|+|.+.... .....+|..|+.+++.++||||+++++++.++...++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4578999999999999999999752    3468999886543 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      +|||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||+++..
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999997652   4788999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          340 GAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       340 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ..... .......++..|+|||.+.+..++.++|+||||+++|||++ |..||..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~  211 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence            52222 22223345678999999999999999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-36  Score=280.10  Aligned_cols=206  Identities=31%  Similarity=0.522  Sum_probs=178.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.+.||+|+||.||+|.++++..+|+|.+.... ...+++.+|++++++++|+||+++++++.++...++||
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            45678999999999999999999998888889999886543 33467889999999999999999999999988999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++....  ...+++..+..++.+++.|++|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999999997652  24688999999999999999999999   999999999999999999999999999986643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..........++..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            22222222334668999999998899999999999999999999 99999643

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.9e-36  Score=281.78  Aligned_cols=204  Identities=30%  Similarity=0.495  Sum_probs=173.9

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+ ...++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            45568999999999999999999987777899998865332 34578899999999999999999998754 55789999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+++....  ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||.++.+...
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999997642  24578899999999999999999998   9999999999999999999999999999866433


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .........++..|+|||++.+..++.++|+||||+++|||+| |..||...
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~  207 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  207 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            3222223446678999999988899999999999999999999 88899754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=279.36  Aligned_cols=201  Identities=23%  Similarity=0.360  Sum_probs=174.7

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ...+.|++-++||+|.|+.|+++... +|+++|+|.+..+  +....+++.+|+.+-+.|+|||||++.+.+.+....||
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            34568999999999999999999854 6888999987433  33456789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCCc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLA  336 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~a  336 (424)
                      |+|+|+|++|..-+-.+    .-+++..+-.+++||++||+|+|.+   +|||||+||+|+|+-.   ..-+||+|||+|
T Consensus        88 vFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             EEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceE
Confidence            99999999996544332    3567888888999999999999999   9999999999999944   334999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..++  .......++|||.|||||++...+|+..+|||+.||+||-|+.|++||-+
T Consensus       161 i~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  161 IEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             EEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            9876  33445668899999999999999999999999999999999999999975

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.3e-36  Score=283.44  Aligned_cols=193  Identities=30%  Similarity=0.393  Sum_probs=166.7

Q ss_pred             EcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       194 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      ||+|+||.||+++.+ +|+.+|+|++....   ......+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999965 58889999986432   22234556799999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeec
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR  349 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~  349 (424)
                      .+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            98886542  24578888899999999999999998   99999999999999999999999999988654322  2234


Q ss_pred             ccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       350 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..|+..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            56899999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-36  Score=316.85  Aligned_cols=205  Identities=23%  Similarity=0.359  Sum_probs=174.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47899999999999999999975 58889999986532   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          262 EYIDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ||++||+|.+++.....       .....++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864311       123456677889999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCcc-----------------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERS-----------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +++.......                 ......+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            9986521110                 0112356999999999999999999999999999999999999999753

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.3e-36  Score=280.56  Aligned_cols=204  Identities=26%  Similarity=0.473  Sum_probs=175.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      +...+|++.+.||+|+||.||+|.+. .++.+|+|.+... ....+++.+|+++++.++||||+++++++..+...+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            44557888999999999999999965 4778999987644 334567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++....  ...+++..++.++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          82 EFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999999997642  24688899999999999999999998   999999999999999999999999999987644


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ..........++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            32222222334668999999999999999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.2e-36  Score=280.87  Aligned_cols=203  Identities=24%  Similarity=0.379  Sum_probs=175.5

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+...   .......+..|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47899999999999999999965 6889999987542   2344457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++.........+++..++.++.|+++||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998865433345688899999999999999999998   999999999999999999999999999886643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            221 22235688899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.2e-36  Score=282.76  Aligned_cols=209  Identities=25%  Similarity=0.489  Sum_probs=174.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ++..++|++.+.||+|+||.||+|.+.      .+..||+|++.... .....++.+|+.+++.++||||+++++++.++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456678999999999999999999854      24569999885432 23445688999999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGP------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      ...++||||+++++|.+++......      ...+++..+..++.|+++||+|||+.   +++|+||||+|||++.++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            9999999999999999999754221      23467788899999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||+|||+++......... .....+++.|+|||++.+..++.++|+|||||++|||++ |..||...
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999987653322211 122345778999999999999999999999999999999 78898654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-35  Score=282.53  Aligned_cols=207  Identities=28%  Similarity=0.454  Sum_probs=173.8

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..++|++.+.||+|+||+||+|..     .++..+++|.+.... ......+.+|+++++.++||||+++++++..+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            345788899999999999999984     245679999986533 34446788999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVG-------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK  324 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~  324 (424)
                      ++||||+++++|.+++.....             ....+++...+.++.|++.||+|||++   +++||||||+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence            999999999999999854321             123578888999999999999999998   9999999999999999


Q ss_pred             CCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          325 QWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       325 ~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ++.+||+|||++........ .......++..|+|||++.+..++.++|+||||+++|||++ |..||...
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999986533221 22233445778999999988889999999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.5e-36  Score=293.52  Aligned_cols=197  Identities=29%  Similarity=0.373  Sum_probs=168.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      .++|++.+.||+|+||.||++.+. ++..||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            358999999999999999999965 5888999998643  2334567788999999999999999999986543      


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++ +|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            46899999976 6766664      2467888889999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9754322  2234457899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-36  Score=282.98  Aligned_cols=220  Identities=34%  Similarity=0.605  Sum_probs=179.7

Q ss_pred             ccceeEcccCcEEEEEEEEc-----CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          189 ADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++.+.||.|.||.||+|.+.     .+..|+||.+.... ....+.|.+|++.+++++||||++++|++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            34678999999999999977     25668999995543 3446789999999999999999999999998888999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.++|...  ....+++..++.++.|+++||.|||+.   +++|+||+++|||++.++.+||+|||++......
T Consensus        82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999999876  235789999999999999999999999   9999999999999999999999999999876322


Q ss_pred             c-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHHHHHH
Q 014466          343 R-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIPQMNS  406 (424)
Q Consensus       343 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~~~~~  406 (424)
                      . ........+...|+|||.+....++.++||||||+++|||++ |+.||....              +....+...+..
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYS  236 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHH
Confidence            2 222233456779999999998889999999999999999999 789987432              223345667888


Q ss_pred             HHHhhhc
Q 014466          407 LMTLSYC  413 (424)
Q Consensus       407 ~~~~~~~  413 (424)
                      ++..||.
T Consensus       237 li~~C~~  243 (259)
T PF07714_consen  237 LIQQCWS  243 (259)
T ss_dssp             HHHHHT-
T ss_pred             HHHHHcC
Confidence            8888886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-36  Score=282.25  Aligned_cols=208  Identities=26%  Similarity=0.472  Sum_probs=176.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ++..++|++.+.||+|+||.||+|...+      +..+|+|.+.... ......+.+|+++++.++||||+++++++..+
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            4566789999999999999999998642      3579999986543 34455788999999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGP------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      ...++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            9999999999999999999754321      23478888999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          329 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ||+|||+++.+..... .......++..|+|||.+.+..++.++|+|||||++|||++ |..||..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  224 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG  224 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence            9999999986543322 12233456789999999988889999999999999999998 9999964

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-36  Score=283.92  Aligned_cols=200  Identities=26%  Similarity=0.370  Sum_probs=172.8

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      |+..+.||+|+||.||++.+. +++.+|+|.+....   ......+..|+.+++.++|+||+.+++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999965 57889999886542   22234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++....  ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999986542  24588899999999999999999998   99999999999999999999999999987653222


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                        ......|+..|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence              1233478999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-35  Score=276.10  Aligned_cols=201  Identities=30%  Similarity=0.492  Sum_probs=175.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||+|... +++.|++|.+...  .....+.+..|+++++.++||||+++++++.++...++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999975 5788999988643  334556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++....  ...+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999997652  35688899999999999999999998   99999999999999999999999999988664332


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      . ......|++.|+|||+..+..++.++|+||||+++|||++|+.||...
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  204 (256)
T cd08529         156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN  204 (256)
T ss_pred             c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence            2 223456889999999999999999999999999999999999999744

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=288.51  Aligned_cols=200  Identities=30%  Similarity=0.450  Sum_probs=179.2

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      -|.++.+||+|.||.||++.++ .|+.+|||.+.-  .....++..|+.+|+++..|++|++||.|.....+|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            5788999999999999999965 688899998743  3456788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      .|++.+.++.+   +.++++..+..+++..++||+|||..   .-+|||||..|||++.+|..||+|||+|-.+.... .
T Consensus       112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A  184 (502)
T KOG0574|consen  112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A  184 (502)
T ss_pred             CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence            99999999876   47899999999999999999999998   88999999999999999999999999997654322 2


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ..+.+.|||.|||||++..-.|+.++||||||++..||..|++||.+-.|
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence            34567899999999999999999999999999999999999999986444

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.3e-36  Score=292.06  Aligned_cols=210  Identities=30%  Similarity=0.475  Sum_probs=174.0

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCceeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  253 (424)
                      +++.++|++.+.||+|+||.||+|+..      +++.||+|++..... ...+.+..|++++.++ +|+||+++++++..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            567779999999999999999999742      246799998865432 3345677899999999 89999999998864


Q ss_pred             -CCeeeEEEEecCCCCHHHHHccCCCC-----------------------------------------------------
Q 014466          254 -GAHRMLVYEYIDNGNLEQWLHGDVGP-----------------------------------------------------  279 (424)
Q Consensus       254 -~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  279 (424)
                       +...+++|||+++++|.+++......                                                     
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             45678999999999999998643210                                                     


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce-eeecccccc
Q 014466          280 ----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF  354 (424)
Q Consensus       280 ----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~  354 (424)
                          ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... ......++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                13678999999999999999999998   9999999999999999999999999999876433222 122345677


Q ss_pred             cccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       355 ~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      .|+|||++.+..++.++|||||||+||||++ |..||....
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            8999999999999999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-35  Score=282.12  Aligned_cols=203  Identities=30%  Similarity=0.476  Sum_probs=169.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCC----EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      .++|++.+.||+|+||+||+|.+. ++.    .+++|.+..... ....++..|+..+++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            357888999999999999999964 344    367777654332 334677888999999999999999998864 4577


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            899999999999999765   24688999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          339 LGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      ..... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  216 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR  216 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            54322 222234557788999999998899999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.8e-36  Score=288.13  Aligned_cols=201  Identities=26%  Similarity=0.408  Sum_probs=170.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|.+.+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57889999999999999999975 57789999986443 22334677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            986 888888654   24578888999999999999999998   99999999999999999999999999997643322


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1 2223467899999998754 568999999999999999999999997544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.2e-36  Score=283.51  Aligned_cols=200  Identities=27%  Similarity=0.349  Sum_probs=173.1

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      |+..+.||+|+||+||++.+. +++.+|+|.+.....   .....+.+|+++++.++|+||+.+.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999965 578899999865432   2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999998886542  24689999999999999999999998   99999999999999999999999999987653222


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                        ......|+..|+|||++.+..++.++|+||||+++|||++|..||....
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~  205 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK  205 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence              1234578999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=295.79  Aligned_cols=231  Identities=29%  Similarity=0.485  Sum_probs=204.5

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcC---CC--EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEe
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED---NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC  251 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  251 (424)
                      .+.+++.+...+..+.||+|-||.||+|++.+   |.  .||||..+.+ .....+.|..|.-+|+.++|||||+++|+|
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence            34567777888889999999999999999653   32  3789988764 455677899999999999999999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS  331 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~  331 (424)
                      .+. ..|+|||.++.|.|..||+.+   ...++......++.||+.||+|||+.   ++|||||...|||+....-+||+
T Consensus       461 ~e~-P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  461 VEQ-PMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             ecc-ceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence            874 589999999999999999987   36788888899999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC--------------CCCCC
Q 014466          332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD--------------YSRPP  396 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~--------------~~~~~  396 (424)
                      |||+++.+..+..+..+...-...|||||.++-..++.++|||-|||.+||++. |..||.              .+.|.
T Consensus       534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~  613 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC  613 (974)
T ss_pred             ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC
Confidence            999999998777766665556778999999999999999999999999999987 999998              35578


Q ss_pred             CCccHHHHHHHHHhhhccc
Q 014466          397 GEVCIPQMNSLMTLSYCSS  415 (424)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~  415 (424)
                      +..|...+..+|..||.+.
T Consensus       614 P~nCPp~LYslmskcWaye  632 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYE  632 (974)
T ss_pred             CCCCChHHHHHHHHHhccC
Confidence            8999999999999999863

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-35  Score=283.13  Aligned_cols=206  Identities=27%  Similarity=0.485  Sum_probs=175.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ..+|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|++.+++++||||+++++++.++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            346788899999999999999843      24458888887666666678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC
Q 014466          259 LVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW  326 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~  326 (424)
                      +||||+++++|.+++.....            ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999975421            123588999999999999999999999   999999999999999999


Q ss_pred             ceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          327 NPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       327 ~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999976543221 12233456789999999999999999999999999999999 99998643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.7e-36  Score=315.64  Aligned_cols=212  Identities=25%  Similarity=0.410  Sum_probs=174.2

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee--
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--  253 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--  253 (424)
                      ...+...++|++.+.||+|+||+||+|.+. ++..+|+|.+...  .......|..|+.+++.++|||||+++++|.+  
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            344566779999999999999999999976 4667888887543  23345678899999999999999999998854  


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeeeCCCCCCCEEEcC-----
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE----PKVVHRDIKSSNILLDK-----  324 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~----~~ivHrDlkp~NILl~~-----  324 (424)
                      ...+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+...    .+||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            356889999999999999997654334679999999999999999999998410    25999999999999964     


Q ss_pred             ------------CCceEEEecCCccccCCCcceeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          325 ------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       325 ------------~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                                  .+.+||+|||++..+....  ......||+.|+|||++.+  ..++.++|||||||+||||+||+.||
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                        2348999999998654322  2234579999999998854  55899999999999999999999999


Q ss_pred             CC
Q 014466          391 DY  392 (424)
Q Consensus       391 ~~  392 (424)
                      ..
T Consensus       244 ~~  245 (1021)
T PTZ00266        244 HK  245 (1021)
T ss_pred             Cc
Confidence            64

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=298.13  Aligned_cols=231  Identities=27%  Similarity=0.475  Sum_probs=204.7

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      +.+++.+.++...++||-|.||.||.|+|+. .-.||||.++.. ....++|..|..+|+.++|||+|+|+|+|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            5678888888999999999999999999874 456899987544 45567899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |||.|||..|+|.+||++..  ...++....++.+.||..|++||..+   ++|||||...|+|+.++..+|++|||+++
T Consensus       339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999998763  46678888899999999999999998   99999999999999999999999999999


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC--------------CCCCCCCccHH
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD--------------YSRPPGEVCIP  402 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~--------------~~~~~~~~~~~  402 (424)
                      ++..+.........-...|.|||-+....++.|+|||+|||+|||+.| |..||.              |++..++.|..
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCH
Confidence            987654443333444668999999999999999999999999999999 999987              56678899999


Q ss_pred             HHHHHHHhhhccc
Q 014466          403 QMNSLMTLSYCSS  415 (424)
Q Consensus       403 ~~~~~~~~~~~~~  415 (424)
                      ...++|..||-|+
T Consensus       494 kVYeLMraCW~Ws  506 (1157)
T KOG4278|consen  494 KVYELMRACWNWS  506 (1157)
T ss_pred             HHHHHHHHHhcCC
Confidence            9999999999875

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-35  Score=292.99  Aligned_cols=198  Identities=22%  Similarity=0.301  Sum_probs=171.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc---CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..+|++.+.||+|+||.||+|...   .+..||+|.+...     +.+.+|+++++.++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999754   3567899987543     23457999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |++. ++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       166 e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9996 5899988433    5789999999999999999999998   999999999999999999999999999986543


Q ss_pred             Ccc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          342 ERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       342 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~  292 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV  292 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence            322 122346799999999999999999999999999999999999999976543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-35  Score=281.31  Aligned_cols=203  Identities=24%  Similarity=0.341  Sum_probs=175.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +.+.|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..+...++|||
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            4467999999999999999999976 478899999877666667788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|..++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++++||+|||++......
T Consensus        90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            99999999887654   24688999999999999999999998   9999999999999999999999999998754322


Q ss_pred             cceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ........+++.|+|||++.     ...++.++|+|||||++|||++|+.||...
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence             11223456888999999884     345788999999999999999999999654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-35  Score=294.53  Aligned_cols=230  Identities=25%  Similarity=0.428  Sum_probs=186.5

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~  252 (424)
                      ++++.++|.+.+.||+|+||.||+|++.      .+..||+|++.... ....+.+..|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4677788999999999999999999864      24579999996543 233457889999999997 999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCC------------------------------------------------------
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------  278 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  278 (424)
                      .....++||||+++|+|.+++++...                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999975421                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCC
Q 014466          279 ----------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       279 ----------------------------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~  318 (424)
                                                              ....+++...+.++.|+++||+|||+.   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                    112466777888999999999999998   9999999999


Q ss_pred             CEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCCC-
Q 014466          319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP-  395 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~~-  395 (424)
                      |||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|||++ |..||..... 
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            999999999999999999865322211 1223456788999999998889999999999999999998 8999964321 


Q ss_pred             --------------CCCccHHHHHHHHHhhhc
Q 014466          396 --------------PGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       396 --------------~~~~~~~~~~~~~~~~~~  413 (424)
                                    .+..+..++.+++..||.
T Consensus       349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~  380 (401)
T cd05107         349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE  380 (401)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence                          122234566777777776

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.7e-36  Score=280.41  Aligned_cols=202  Identities=28%  Similarity=0.389  Sum_probs=174.8

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ..++|++.+.||+|+||.||+|+.. +++.+|+|++..........+.+|+.+++.++||||+++++++..+...++|||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            3457999999999999999999964 678899999876555555678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.++++..    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999998754    4688999999999999999999998   9999999999999999999999999999865322


Q ss_pred             cceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. ......|++.|+|||.+.   ...++.++|+|||||++|||++|+.||...
T Consensus       160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            11 123356889999999874   445788999999999999999999998644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-35  Score=285.35  Aligned_cols=198  Identities=26%  Similarity=0.408  Sum_probs=172.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999965 5677888887544 333445688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.++++..    ..+++..+..++.|+++||.|||+..  +++|+||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999999765    56889999999999999999999732  8999999999999999999999999998754322 


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                        ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence              22345789999999999888899999999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-35  Score=276.67  Aligned_cols=204  Identities=28%  Similarity=0.469  Sum_probs=173.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +..++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+++++.++|||++++++++.. ...+++||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence            4456788999999999999999998877789999875443 334668889999999999999999998854 56789999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++....  ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          81 FMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            999999999997642  24578899999999999999999998   9999999999999999999999999999865433


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .........++..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2222223346778999999998899999999999999999999 99999753

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=289.17  Aligned_cols=200  Identities=24%  Similarity=0.387  Sum_probs=177.6

Q ss_pred             CcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      -|...+.||+|.|.+|-+|++ -+|..||||++.+.+-.  ....+.+|+..|+.++|||||++|.+......+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            577889999999999999984 36999999999776443  334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE-cCCCceEEEecCCccccCCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kL~DfG~a~~~~~~  342 (424)
                      -++|+|.+|+-+.   ...+.++.+.+++.||+.|+.|+|+.   .+|||||||+||.. ..-|-+||+|||++..+.+.
T Consensus        99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999877   36789999999999999999999998   99999999999987 45788999999999876443


Q ss_pred             cceeeecccccccccccccccCCCCCC-ccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNE-RSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                        ...+..||+..|.|||++.+..|+. ++|||||||+||.|++|+.||+...
T Consensus       173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN  223 (864)
T KOG4717|consen  173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN  223 (864)
T ss_pred             --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence              3456789999999999999999885 6799999999999999999997544

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.1e-35  Score=275.56  Aligned_cols=215  Identities=32%  Similarity=0.537  Sum_probs=176.3

Q ss_pred             eEcccCcEEEEEEEEc---CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCC
Q 014466          193 VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      .||+|+||.||+|.+.   ++..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999864   345689998865533 334678999999999999999999999864 56789999999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeee
Q 014466          269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT  348 (424)
Q Consensus       269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~  348 (424)
                      |.+++...   ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||++............
T Consensus        81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99999754   25789999999999999999999998   9999999999999999999999999999865443322221


Q ss_pred             --cccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCCC--------------CCCccHHHHHHHHHhh
Q 014466          349 --RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP--------------PGEVCIPQMNSLMTLS  411 (424)
Q Consensus       349 --~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~~--------------~~~~~~~~~~~~~~~~  411 (424)
                        ...++..|+|||.+....++.++|+||||+++|||++ |..||....+              .+..+..++.+++..|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC  234 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence              2233578999999988889999999999999999996 9999964322              2234456777888888


Q ss_pred             hcc
Q 014466          412 YCS  414 (424)
Q Consensus       412 ~~~  414 (424)
                      |..
T Consensus       235 ~~~  237 (257)
T cd05115         235 WIY  237 (257)
T ss_pred             cCC
Confidence            864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=295.06  Aligned_cols=192  Identities=27%  Similarity=0.324  Sum_probs=161.8

Q ss_pred             EcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcC---CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       194 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      ||+|+||+||+|+.. +++.||+|++.+...   .....+..|..++...   .||||+++++++.++...++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 588899999865322   1223344566666655   699999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.+++...    ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~  152 (330)
T cd05586          81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKT  152 (330)
T ss_pred             ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCC
Confidence            9999998754    5688999999999999999999999   9999999999999999999999999998753222 222


Q ss_pred             eecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~  200 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE  200 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence            3456799999999988654 5899999999999999999999999654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.8e-35  Score=275.65  Aligned_cols=203  Identities=24%  Similarity=0.397  Sum_probs=177.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+...   .....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999976 7889999988532   2233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++.........+++..++.++.++++||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999876443345688999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            221 12334688899999999998999999999999999999999999954

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-35  Score=273.96  Aligned_cols=196  Identities=28%  Similarity=0.471  Sum_probs=168.5

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHH
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE  270 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~  270 (424)
                      ++||+|+||.||+|...+++.+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988888999998865543 33456889999999999999999999999999999999999999999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeecc
Q 014466          271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV  350 (424)
Q Consensus       271 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~  350 (424)
                      +++...   ...+++..++.++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            998754   24578999999999999999999998   999999999999999999999999999875433222222223


Q ss_pred             cccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       351 ~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .++..|+|||++.+..++.++|+||||+++||+++ |..||...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            34667999999998899999999999999999998 99999643

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-35  Score=282.46  Aligned_cols=207  Identities=26%  Similarity=0.457  Sum_probs=172.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-----------------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCce
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-----------------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL  244 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnI  244 (424)
                      ++.++|++.+.||+|+||.||++...                 ++..+|+|.+.... ......+.+|+++++.++|+||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence            35568999999999999999998643                 23358899886543 3445678999999999999999


Q ss_pred             eeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCC
Q 014466          245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP-------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS  317 (424)
Q Consensus       245 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp  317 (424)
                      +++++++..++..+++|||+++++|.+++......       ...+++..+..++.|++.||+|||+.   +++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence            99999999999999999999999999999764321       23477888999999999999999998   999999999


Q ss_pred             CCEEEcCCCceEEEecCCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc--CCCCCCC
Q 014466          318 SNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDY  392 (424)
Q Consensus       318 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt--g~~Pf~~  392 (424)
                      +|||++.++.++|+|||+++.+....... .....++..|++||......++.++|+|||||++|||++  |..||..
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999998653322211 222344678999999888889999999999999999998  7788864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.1e-36  Score=280.30  Aligned_cols=202  Identities=28%  Similarity=0.387  Sum_probs=175.9

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ..++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            4458999999999999999999865 578899998866555555668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          87 FCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            99999999998754    5788999999999999999999998   9999999999999999999999999998765322


Q ss_pred             cceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ........|++.|+|||++.   ...++.++|+|||||++|||++|..||...
T Consensus       160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~  212 (267)
T cd06645         160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence             22223457899999999874   456889999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.1e-35  Score=281.49  Aligned_cols=201  Identities=25%  Similarity=0.430  Sum_probs=177.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ..+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            34688999999999999999985 46889999998766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|..++...     .+++..+..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            9999999998643     578999999999999999999999   99999999999999999999999999987654332


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2 2233568899999999999899999999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-37  Score=289.56  Aligned_cols=210  Identities=27%  Similarity=0.359  Sum_probs=182.6

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      ++...+..+.|..-++||+||||.||-|..+ +|+-+|.|++.+.+.   ..+.-...|-++|.+++.+.||.+--.|++
T Consensus       177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            3344566788999999999999999999855 688899998865432   233446679999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      .+.+++|+..|.||+|.-.|....  ...+++..+..++.+|+-||++||+.   +||+||+||+|||+|+.|+++|+|+
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence            999999999999999988776543  25799999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |+|..+.....  ....+||.+|||||++.+..|+...|+|||||+||||+.|+.||....
T Consensus       332 GLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  332 GLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             ceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            99998754433  344589999999999999999999999999999999999999998655

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-35  Score=282.82  Aligned_cols=200  Identities=26%  Similarity=0.414  Sum_probs=176.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      .+|++.+.||+|+||.||+|+.. +++.+++|.+........+.+.+|+++++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            47889999999999999999964 67889999987665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999998643     578889999999999999999998   999999999999999999999999999876533221


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       ......|++.|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence             1233468899999999998889999999999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-35  Score=277.13  Aligned_cols=205  Identities=28%  Similarity=0.432  Sum_probs=173.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCC----CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ++..++|.+.+.||+|+||.||+|.+.+.    ..+++|...... ....+.+.+|+++++.++||||+++++++.+ ..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            45566789999999999999999986432    458899886554 4455688999999999999999999999876 45


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...   ...+++..++.++.+++.||+|||+.   +++|+||||+|||++.++.+||+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence            78999999999999999765   24588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +..........+...++..|+|||.+....++.++|+||||+++|||++ |..||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  212 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV  212 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            8664443222333345568999999988899999999999999999986 99999643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.7e-36  Score=292.61  Aligned_cols=198  Identities=28%  Similarity=0.360  Sum_probs=169.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------C
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~  255 (424)
                      .++|++.+.||+|+||.||++... .++.+|+|++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            468999999999999999999865 5788999998654  233446677899999999999999999988643      3


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++ +|.+++..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence            46899999976 77777642      477888899999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865332  22344578999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=306.70  Aligned_cols=205  Identities=22%  Similarity=0.368  Sum_probs=178.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCCCEE-EEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~v-avK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +.+.|+++-.||.|+||.||+|..++...+ |.|.+........+++..||++|+.+.||+||+|++.|..++.++|+.|
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            455688899999999999999997754444 6777777777778899999999999999999999999998899999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ||.||-....+-.-   ...+++..+..+++|++.||.|||++   +|||||||..|||++-+|.++|+|||++..... 
T Consensus       110 FC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-  182 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-  182 (1187)
T ss_pred             ecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-
Confidence            99999998887554   46899999999999999999999999   999999999999999999999999998764322 


Q ss_pred             cceeeecccccccccccccc-----cCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      .......+.|||+|||||++     ...+|+.++||||||++|.||..+.+|-....|
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp  240 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP  240 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence            12234568899999999976     356799999999999999999999999876554

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-35  Score=278.12  Aligned_cols=198  Identities=33%  Similarity=0.540  Sum_probs=174.3

Q ss_pred             cccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHH--HHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEK--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      |++.+.||+|+||+||++.... ++.+|+|.+.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999875 557999999776544332  3456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++...    ..+++..++.++.|+++||++||+.   +++|+||||+||+++.++.++|+|||.+... ....
T Consensus        81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENN  152 (260)
T ss_dssp             TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTT
T ss_pred             cccccccccccc----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence            999999999833    5789999999999999999999999   9999999999999999999999999999754 2223


Q ss_pred             eeeeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .......++..|+|||++. +..++.++|+||+|+++|+|++|..||...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3445567899999999998 889999999999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.3e-35  Score=278.49  Aligned_cols=202  Identities=29%  Similarity=0.477  Sum_probs=170.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCC----EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..++|++.+.||+|+||+||+|.+. ++.    .||+|.+... ......++.+|+.+++.+.||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            3467889999999999999999854 344    3799988654 334456788999999999999999999999764 46


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++++||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++
T Consensus        84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            7999999999999999765   24688999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          338 LLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       338 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            764332221 122335678999999998899999999999999999998 9999975

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-35  Score=281.54  Aligned_cols=210  Identities=29%  Similarity=0.485  Sum_probs=177.0

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  252 (424)
                      +++..++|++.+.||+|+||.||++...+      ...+|+|.+.... .....++.+|+++++++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            45677789999999999999999998642      3568999886542 33445688899999999 8999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCE
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI  320 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NI  320 (424)
                      .+...+++|||+++|+|.++++...            .....+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            9999999999999999999997532            2245688999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          321 LLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       321 Ll~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      |++.++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            99999999999999998764332211 222345678999999999999999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.1e-35  Score=274.95  Aligned_cols=205  Identities=26%  Similarity=0.473  Sum_probs=175.7

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.+.||+|+||.||++.+.++..+++|.+.... ...+.+.+|+++++.++|+||+++++++.+ ...+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            45667899999999999999999998777889999876432 345678889999999999999999999887 6789999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++.+..  ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+.....
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999999997652  24578888999999999999999998   999999999999999999999999999986543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..........++..|+|||++....++.++|+|||||++|++++ |+.||...
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence            32222223345678999999998899999999999999999999 99999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-35  Score=292.21  Aligned_cols=198  Identities=29%  Similarity=0.368  Sum_probs=169.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------C
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~  255 (424)
                      .++|++.+.||+|+||.||+|... .++.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            458999999999999999999965 5788999998653  233446678899999999999999999987543      3


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++ +|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            57899999976 78777742      467888899999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            9865332  22334578999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.8e-35  Score=283.09  Aligned_cols=208  Identities=30%  Similarity=0.490  Sum_probs=174.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC--------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC  251 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  251 (424)
                      ++..++|.+.+.||+|+||.||++....        ...+|+|.+.... .....++..|+++++.+ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            5667789999999999999999998531        2468999886542 33456788899999999 799999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      ..++..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999976532            123588899999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ||++.++.+||+|||.++........ ......++..|+|||.+.+..++.++|+|||||++|||++ |..||..
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            99999999999999998765322111 1122234568999999998899999999999999999998 8889864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-35  Score=276.87  Aligned_cols=203  Identities=31%  Similarity=0.488  Sum_probs=172.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-C---CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-D---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ..+|++.+.||+|+||.||+|.+. +   +..+|+|.+.... ....+.+..|+++++.++||||+++++++.+++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            347888999999999999999864 2   2368999886543 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..+
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            999999999999997652   4678899999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCcceee--ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          340 GAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ........  ....++..|+|||.+.+..++.++|+||||+++||+++ |..||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            44322222  12233568999999998899999999999999999887 99999654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.9e-35  Score=280.70  Aligned_cols=198  Identities=28%  Similarity=0.380  Sum_probs=175.5

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||++.+. +++.+|+|.+.+..   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999965 57889999886542   234466888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999999765    5788999999999999999999998   999999999999999999999999999986543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .    .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            3    234568999999999988889999999999999999999999996543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-35  Score=277.61  Aligned_cols=203  Identities=24%  Similarity=0.376  Sum_probs=176.3

Q ss_pred             CCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||++.. .++..+++|.+....   .....++.+|+++++.++||||+++++++.++...+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4788999999999999999995 478899999876432   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++.........+++..++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999875433345789999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ... ......|+..|+|||.+.+..++.++|+||||+++|||++|..||..
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  208 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence            222 22345688999999999998999999999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.9e-35  Score=280.89  Aligned_cols=200  Identities=26%  Similarity=0.415  Sum_probs=177.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      .+|++.+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++||||+++++++..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            57899999999999999999964 68899999997665555677888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++.+.     .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999998643     578889999999999999999998   999999999999999999999999999876543322


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~  219 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             1233468899999999999899999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.4e-35  Score=278.59  Aligned_cols=193  Identities=28%  Similarity=0.433  Sum_probs=169.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|++++++++||||+++++++..+...++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999964 6788999988654 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|..+.        .+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999997642        457888889999999999999998   9999999999999999999999999999865322 


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                        ......||..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence              22345789999999999999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=275.48  Aligned_cols=203  Identities=29%  Similarity=0.405  Sum_probs=178.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+++++.++||||+++++++.++...+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            468899999999999999999965 5778999998776656677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            9999999998765   25688999999999999999999998   99999999999999999999999999988654321


Q ss_pred             ceeeecccccccccccccccCC---CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       .......++..|+|||.+.+.   .++.++|+||||+++|||++|+.||....
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~  208 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH  208 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence             122345688899999998776   88999999999999999999999997543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.8e-35  Score=278.11  Aligned_cols=209  Identities=24%  Similarity=0.401  Sum_probs=175.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeee-C
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-G  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~  254 (424)
                      .+..++|++.+.||+|+||.||+|.+.+     +..|++|.+.... ....+.+.+|+++++.++||||+++++++.. +
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3456789999999999999999999765     6778899876543 3445678899999999999999999998765 4


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEE
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGP----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL  330 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL  330 (424)
                      ...++++||+++++|.+++......    ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6788999999999999999764321    14688999999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          331 SDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       331 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence            999999865433222 1223345778999999998899999999999999999999 99999753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-35  Score=277.23  Aligned_cols=197  Identities=29%  Similarity=0.455  Sum_probs=167.1

Q ss_pred             cccceeEcccCcEEEEEEEE-----cCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--CeeeE
Q 014466          188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML  259 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l  259 (424)
                      |++.+.||+|+||+||++.+     .++..||+|.+..... .....+.+|+++++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38899999999999988753     2567899998865432 3456788999999999999999999988653  35789


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      +|||+++++|.+++...     .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999999653     589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCcce--eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          340 GAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       340 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            432221  11223456779999999888899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.5e-35  Score=274.65  Aligned_cols=199  Identities=29%  Similarity=0.488  Sum_probs=173.1

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCC------chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++.+++++|+||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998788899999885432      12234688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      +||+++++|.+++.+.    ..+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999764    4678899999999999999999998   99999999999999999999999999987643


Q ss_pred             CC-----cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          341 AE-----RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       341 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..     .........|+..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            21     11122335689999999999998999999999999999999999999964

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=279.10  Aligned_cols=203  Identities=24%  Similarity=0.359  Sum_probs=177.0

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +.++|++.+.||+|+||.||++... ++..+|+|.+........+.+..|++++++++||||+++++++.++...++|||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            4568999999999999999999975 578899999876666666789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999998764   24689999999999999999999999   9999999999999999999999999998764332


Q ss_pred             cceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. ......|++.|+|||.+.     ...++.++|+||||+++|||++|+.||...
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            21 223356899999999874     345778999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.7e-35  Score=285.86  Aligned_cols=198  Identities=22%  Similarity=0.377  Sum_probs=162.1

Q ss_pred             ceeEcccCcEEEEEEEEc---CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee--CCeeeEEEEecC
Q 014466          191 ENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYID  265 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~  265 (424)
                      .+.||+|+||+||+|+..   +++.+|+|.+....  ....+.+|++++++++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999965   45779999886442  23456789999999999999999999854  456789999996


Q ss_pred             CCCHHHHHccCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE----cCCCceEEEecCCc
Q 014466          266 NGNLEQWLHGDVG-----PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLA  336 (424)
Q Consensus       266 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DfG~a  336 (424)
                      + +|.+++.....     ....+++..+..++.|++.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 88888754321     123588999999999999999999999   99999999999999    45678999999999


Q ss_pred             cccCCCcc--eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87643321  12234678999999998876 468999999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-35  Score=277.61  Aligned_cols=201  Identities=27%  Similarity=0.447  Sum_probs=170.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-----CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee--CCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  257 (424)
                      ..+|++.+.||+|+||.||+|...     ++..||+|++........+.+.+|+++++.++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            347888999999999999999743     477899999877666667789999999999999999999998753  3467


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++|+||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            89999999999999997642   4688999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcceee--ecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          338 LLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       338 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ..........  ....++..|+|||++.+..++.++|+|||||++|||++|..|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            7643322211  12233456999999998899999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.3e-35  Score=280.48  Aligned_cols=203  Identities=29%  Similarity=0.468  Sum_probs=168.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEcC-CC--EEEEEEeecC-CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ++|++.+.||+|+||.||+|+.++ +.  .+++|.+... .....+.+..|+++++++ +||||+++++++.+....+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998753 33  4688877643 334456788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          261 YEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      +||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999975421            123588899999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||+|||++.....  .........+..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999864321  111111223557999999998899999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=299.12  Aligned_cols=194  Identities=30%  Similarity=0.453  Sum_probs=172.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..|..++.||.|.||.||-|++. +...||||+..-..   .....++..|+.+|++++|||++.+.|+|..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            36888999999999999999965 56778999986443   344567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |||-| +-.+++.-.   ..++.+..+..|+.+.+.||+|||+.   +.||||||..|||+++.|.+||+|||.|....+
T Consensus       106 EYClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHHhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            99965 888887655   36788999999999999999999999   999999999999999999999999999986543


Q ss_pred             Ccceeeecccccccccccccc---cCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                           .+.++|||+|||||++   ..+.|+-++||||||++..||.-.++|+-
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence                 4568899999999987   46889999999999999999999999975

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.9e-35  Score=279.20  Aligned_cols=206  Identities=29%  Similarity=0.509  Sum_probs=175.0

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ...+|+..++||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            3457888999999999999999742      3456889988766666677899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW  326 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~  326 (424)
                      +++|||+++++|.+++.....           ....+++..++.++.|++.|++|||+.   +++||||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence            999999999999999975421           113578899999999999999999998   999999999999999999


Q ss_pred             ceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          327 NPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       327 ~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      .+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            9999999998765332211 1222345778999999999999999999999999999998 9999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.2e-35  Score=280.17  Aligned_cols=206  Identities=27%  Similarity=0.407  Sum_probs=172.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..+|++.+.||+|+||.||+|...+      +..||+|++..... ...+.+..|+.+++.++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            3468889999999999999998642      46799999865433 3346688999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          258 MLVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      ++++||+.+++|.+++....            .....+++..++.++.|++.||+|||+.   +|+||||||+|||++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            99999999999999985321            1123578888999999999999999998   99999999999999999


Q ss_pred             CceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          326 WNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999886533222 12233456789999999988889999999999999999998 88898643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.2e-35  Score=273.22  Aligned_cols=201  Identities=27%  Similarity=0.404  Sum_probs=175.0

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      +|++.+.||+|+||.||++... +++.+|+|.+... .....+.+..|+++++.++||||+++++.+.++...+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999965 5788999988543 3344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++....  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||.+........
T Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            9999999986542  24578899999999999999999998   999999999999999999999999999976543222


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||+..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  203 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN  203 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence             223456899999999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4e-35  Score=273.74  Aligned_cols=201  Identities=30%  Similarity=0.457  Sum_probs=177.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++.+.||+|+||.||+|...+ ++.+++|.+.....  .+.+.+|+++++.++||||+++++++.++...++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            4689999999999999999999764 78899998865432  67899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            9999999999754   25789999999999999999999998   99999999999999999999999999988664332


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~  203 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH  203 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            1 2233557889999999999999999999999999999999999997544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.3e-35  Score=275.25  Aligned_cols=203  Identities=30%  Similarity=0.528  Sum_probs=172.0

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcC-CC---EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLED-NT---NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ..++|+..+.||+|+||.||+|+... ++   .+|+|.+... .....+.+..|+++++.++||||+++++++.+.+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            45678889999999999999999752 32   6899988654 2334567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++++|.+++...   ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        83 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          83 IITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence            999999999999999764   25688999999999999999999998   999999999999999999999999999886


Q ss_pred             cCCCcceee--ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          339 LGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      .........  .....+..|+|||++.+..++.++|+|||||++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~  213 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD  213 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence            543222111  11223457999999998889999999999999999998 9999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.2e-35  Score=277.05  Aligned_cols=200  Identities=25%  Similarity=0.370  Sum_probs=172.7

Q ss_pred             CcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            46888999999999999999764 66778888866655666778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|..++.+.   ..++++..++.++.|+++||.|||+.   +++||||||+|||++.++.+||+|||++....... .
T Consensus        86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~  158 (282)
T cd06643          86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  158 (282)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence            99999988653   25789999999999999999999998   99999999999999999999999999987643221 2


Q ss_pred             eeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......|++.|+|||++.     +..++.++|+|||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  211 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL  211 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence            223456899999999873     455788999999999999999999999743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6e-35  Score=273.36  Aligned_cols=214  Identities=32%  Similarity=0.541  Sum_probs=175.9

Q ss_pred             eEcccCcEEEEEEEEc---CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          193 VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +||+|+||.||+|.++   ++..+|+|++....  ....+++..|+.+++.+.||||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   46789999885443  3345678899999999999999999998864 4678999999999


Q ss_pred             CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceee
Q 014466          268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT  347 (424)
Q Consensus       268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~  347 (424)
                      +|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||.|||++.++.+||+|||+++.+........
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999754    4688999999999999999999998   999999999999999999999999999987654432211


Q ss_pred             --ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHHHHHHHHHh
Q 014466          348 --TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIPQMNSLMTL  410 (424)
Q Consensus       348 --~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~~~~~~~~~  410 (424)
                        ....++..|+|||.+....++.++|+|||||++|||++ |+.||....              +.+..+..++.+++..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKL  233 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence              22334678999999988889999999999999999998 999997532              2233445667777777


Q ss_pred             hhcc
Q 014466          411 SYCS  414 (424)
Q Consensus       411 ~~~~  414 (424)
                      ||..
T Consensus       234 ~~~~  237 (257)
T cd05116         234 CWTY  237 (257)
T ss_pred             Hhcc
Confidence            7753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-36  Score=292.75  Aligned_cols=203  Identities=25%  Similarity=0.400  Sum_probs=179.9

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .....|.+...||+|.|+.|.++++. ++.+||||.+.+...  .....+.+|+++|+.++|||||+++.+.+....+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34567899999999999999999955 688999999876533  333458889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+.+|.+.+|+..+    +...+..+..++.|+.+|++|||++   .|||||||.+||||+.+.++||+|||++..+
T Consensus       133 V~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            99999999999999876    4555688888999999999999999   9999999999999999999999999999987


Q ss_pred             CCCcceeeecccccccccccccccCCCCC-CccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .  ........+|++.|.|||+..+..|+ +++|+||+|++||-|+.|.+|||+..
T Consensus       206 ~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~  259 (596)
T KOG0586|consen  206 D--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN  259 (596)
T ss_pred             c--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence            5  34456678999999999999887765 68999999999999999999999543

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.7e-35  Score=272.51  Aligned_cols=195  Identities=30%  Similarity=0.480  Sum_probs=165.6

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      +.||+|+||.||+|.+. +++.+|+|.+.... ......+.+|+++++.++||||+++++++..+...++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999965 68889999876543 34456789999999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceee-e
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-T  348 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~-~  348 (424)
                      .+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........... .
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9999754   24578999999999999999999998   999999999999999999999999999876432211110 1


Q ss_pred             cccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       349 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ...++..|+|||.+.+..++.++|+||||+++|||++ |..||..
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~  199 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN  199 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            1122456999999999899999999999999999998 9999964

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.6e-35  Score=281.91  Aligned_cols=206  Identities=28%  Similarity=0.469  Sum_probs=170.5

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCE--EEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTN--VAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +..++|++.+.||+|+||.||+|.+. ++..  +++|.+.... ......+.+|++++.++ +||||+++++++.+++..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            34568899999999999999999965 3443  5777765432 33456788899999999 899999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      ++||||+++++|.++++....            ....+++..++.++.|++.||+|||+.   +++||||||+|||++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            999999999999999975431            123578999999999999999999998   99999999999999999


Q ss_pred             CceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +.+||+|||+++....  ........++..|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus       161 ~~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         161 YVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             CcEEeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            9999999999864211  111112234667999999988889999999999999999998 99999643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.1e-35  Score=276.38  Aligned_cols=199  Identities=27%  Similarity=0.402  Sum_probs=163.6

Q ss_pred             eeEcccCcEEEEEEEEcC---CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +.||+|+||.||+|...+   +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   35689998865432 34457888999999999999999999999988999999999999


Q ss_pred             CHHHHHccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          268 NLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       268 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      +|.+++..... .....++..+..++.|+++|++|||+.   +++||||||+||+++.++++||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432 123456777888999999999999998   99999999999999999999999999997543322211


Q ss_pred             -eecccccccccccccccCC-------CCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          347 -TTRVMGTFGYVAPEYASTG-------MLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       347 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                       .....++..|+|||++.+.       .++.++|+||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence             2235678889999988542       35789999999999999996 99999753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.6e-35  Score=276.73  Aligned_cols=209  Identities=31%  Similarity=0.503  Sum_probs=173.0

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      +..++|.+.+.||+|+||.||+|.+.+      +..|++|.+.... ......+..|+.+++.++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345688999999999999999999753      4568888875443 334567888999999999999999999999888


Q ss_pred             eeeEEEEecCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC---ceE
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPK  329 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~---~~k  329 (424)
                      ..++||||+++++|.+++.....   ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence            89999999999999999976532   123588999999999999999999998   999999999999998755   599


Q ss_pred             EEecCCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          330 LSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      |+|||+++.+....... ......+..|+|||++.+..++.++|||||||++|||++ |+.||+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999998763222111 112233568999999998999999999999999999997 999997543

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.3e-35  Score=272.70  Aligned_cols=202  Identities=28%  Similarity=0.536  Sum_probs=173.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ..+|++.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+++++.++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            34678889999999999999998777889999876443 23456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++....   ..+++..++.++.+++.|++|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            9999999997652   4678899999999999999999998   999999999999999999999999999886543322


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  205 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR  205 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            11222335678999999998899999999999999999998 99999743

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.2e-35  Score=275.55  Aligned_cols=201  Identities=31%  Similarity=0.512  Sum_probs=170.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEcC-C---CEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLED-N---TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ..|++.+.||+|+||.||+|.+.. +   ..||+|.+... .......|..|+++++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357889999999999999999653 3   35899988654 334456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999765   24688999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccee--eeccc--ccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          341 AERSYV--TTRVM--GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       341 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ......  .....  .+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~  214 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  214 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence            322111  11111  2457999999999999999999999999999987 9999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.7e-35  Score=278.33  Aligned_cols=208  Identities=28%  Similarity=0.490  Sum_probs=172.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ++..++|++.+.||+|+||.||+|..++      +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4567789999999999999999997542      4468999875443 23345678899999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVG------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      ...++||||+++|+|.+++.....      .....+...+..++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999975321      123456777889999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ||+|||+++........ ......++..|+|||.+.+..++.++|+|||||++|||++ |..||..
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~  224 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG  224 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999998865332211 1122345678999999998899999999999999999998 7889864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-35  Score=281.06  Aligned_cols=208  Identities=29%  Similarity=0.494  Sum_probs=174.8

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC  251 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  251 (424)
                      ++..++|++.+.||+|+||.||+|+..        ++..+|+|.+.... ....+++.+|+++++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            456678999999999999999999742        23468999886543 34456788999999999 899999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      ......+++|||+++|+|.+++.....            ....+++..++.++.|+++||.|||++   +++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            999999999999999999999976432            124578888999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999876433222 1223445778999999998899999999999999999998 8888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.9e-35  Score=279.95  Aligned_cols=199  Identities=29%  Similarity=0.418  Sum_probs=165.2

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCceeeEeeEeee-----CC
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAE-----GA  255 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~-----~~  255 (424)
                      +|++.+.||+|+||+||+|++. +++.||+|.+.....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788999999999999999976 578899998864321  2223455677766655   79999999998864     24


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..+++|||+.+ +|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999985 8999887652  24588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++......  ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            98654321  223456899999999999889999999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.6e-35  Score=274.24  Aligned_cols=200  Identities=25%  Similarity=0.390  Sum_probs=170.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Cee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  257 (424)
                      ++|++.+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999965 58889999875321     22345788899999999999999999998764  467


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      +++|||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            7999999999999998754    4578888899999999999999998   99999999999999999999999999988


Q ss_pred             ccCCCcc--eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          338 LLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       338 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .......  .......|+..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            6532111  112335688999999999888899999999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=298.11  Aligned_cols=217  Identities=30%  Similarity=0.483  Sum_probs=182.5

Q ss_pred             eeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHH
Q 014466          192 NVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE  270 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~  270 (424)
                      -+||+|.||+||-|++.+ ....|||.+.....+....+.+||.+-++++|.|||+++|.+.+++.+-+.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            369999999999999765 4457999997777777788999999999999999999999999999989999999999999


Q ss_pred             HHHccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCccccCCCcceee
Q 014466          271 QWLHGDVGPHSPL--TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGAERSYVT  347 (424)
Q Consensus       271 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~~~~~~~~~~~  347 (424)
                      ++|+..=   +++  .+.+.-.+.+||++||.|||++   .|||||||-+|+||+. .|.+||+|||-++.+..... .+
T Consensus       661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~T  733 (1226)
T KOG4279|consen  661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CT  733 (1226)
T ss_pred             HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cc
Confidence            9998763   455  6777788999999999999999   9999999999999965 78999999999988755433 34


Q ss_pred             ecccccccccccccccCC--CCCCccchHHHHHHHHHHHcCCCCCCC----------------CCCCCCccHHHHHHHHH
Q 014466          348 TRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDY----------------SRPPGEVCIPQMNSLMT  409 (424)
Q Consensus       348 ~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~elltg~~Pf~~----------------~~~~~~~~~~~~~~~~~  409 (424)
                      ..+-||..|||||++..+  .|+..+|||||||++.||.||++||..                ..|.++.-..+....+.
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence            567899999999999754  588999999999999999999999862                22333434445555666


Q ss_pred             hhhccc
Q 014466          410 LSYCSS  415 (424)
Q Consensus       410 ~~~~~~  415 (424)
                      .||...
T Consensus       814 rcFepd  819 (1226)
T KOG4279|consen  814 RCFEPD  819 (1226)
T ss_pred             HHcCCC
Confidence            666543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-35  Score=300.54  Aligned_cols=204  Identities=21%  Similarity=0.310  Sum_probs=162.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcC--CCEEEEEE--------------e---ecCCchhHHHHHHHHHHHhcCCCCc
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLED--NTNVAVKN--------------L---LNNRGQAEKEFKVEVEAIGRVRHKN  243 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~--~~~vavK~--------------~---~~~~~~~~~~~~~Ei~~l~~l~hpn  243 (424)
                      ...++|++.+.||+|+||+||+|..+.  +...+.|.              +   ..........+.+|++++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345689999999999999999987542  11112220              1   1112233456888999999999999


Q ss_pred             eeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       244 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      |+++++++.+.+..|+|+|++.+ +|.+++..... .........+..++.|++.||+|||++   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            99999999999999999999965 78777754321 112234566778999999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          323 DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                      +.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999876544433344567999999999999999999999999999999999987543

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.1e-35  Score=275.01  Aligned_cols=205  Identities=29%  Similarity=0.504  Sum_probs=174.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .++|++.+.||+|+||.||+|+.+      +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            457889999999999999999964      2356889988655443 456799999999999999999999999998899


Q ss_pred             eEEEEecCCCCHHHHHccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                      ++||||+++|+|.+++......     ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999999765321     12689999999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            99987543332223334456778999999988889999999999999999999 8889964

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-35  Score=279.73  Aligned_cols=207  Identities=27%  Similarity=0.451  Sum_probs=171.7

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCC---------------CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDN---------------TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVR  246 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~---------------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~  246 (424)
                      .+.++|++.+.||+|+||.||+|+..+.               ..||+|.+.... ......+.+|++++++++||||++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            3456899999999999999999986421               248999886543 334457899999999999999999


Q ss_pred             EeeEeeeCCeeeEEEEecCCCCHHHHHccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCC
Q 014466          247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG--------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       247 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~  318 (424)
                      +++++..+...++||||+++++|.+++.....        ....+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            99999999999999999999999999865321        112467888999999999999999998   9999999999


Q ss_pred             CEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc--CCCCCCC
Q 014466          319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDY  392 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt--g~~Pf~~  392 (424)
                      |||++.++.+||+|||++......... ......++..|+|||++.+..++.++|+|||||++|||++  |..||..
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999999999999999765332211 1223345778999999988899999999999999999998  6678764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=273.37  Aligned_cols=196  Identities=24%  Similarity=0.421  Sum_probs=171.1

Q ss_pred             ceeEcccCcEEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCCCC
Q 014466          191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      .+.||+|+|+.|--|+ ..++.+||||++.+........+.+|++++.+. .|+||++++++|+++..+|||||.|.||.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            4789999999999998 668999999999888888888899999999998 59999999999999999999999999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc---eEEEecCCccccCCCc--
Q 014466          269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAER--  343 (424)
Q Consensus       269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DfG~a~~~~~~~--  343 (424)
                      |.+.++++    ..+++..+..+.++|+.||.|||.+   +|.||||||+|||...-..   +|||||.+..-+....  
T Consensus       163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            99999876    5789999999999999999999999   9999999999999965443   8999998876432211  


Q ss_pred             ----ceeeecccccccccccccc-----cCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 ----SYVTTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ----~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                          .......+|+..|||||+.     ....|+.+.|.|||||+||-|+.|..||-+.
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence                1122346789999999976     3457999999999999999999999999854

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-34  Score=272.94  Aligned_cols=205  Identities=29%  Similarity=0.472  Sum_probs=174.8

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ++..++.+.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+++++.++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4556677777789999999999999965 567799999877666667789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPL--TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLA  336 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a  336 (424)
                      |+||+++++|.+++....   ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999997642   234  7788888999999999999998   9999999999999976 678999999998


Q ss_pred             cccCCCcceeeecccccccccccccccCC--CCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ........ ......|++.|+|||++.+.  .++.++|+||||+++|+|++|+.||..
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence            76533221 22234578999999988654  378899999999999999999999964

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-35  Score=273.75  Aligned_cols=203  Identities=25%  Similarity=0.442  Sum_probs=168.6

Q ss_pred             cccceeEcccCcEEEEEEEEcC----CCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe-----
Q 014466          188 FADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  256 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-----  256 (424)
                      |.+.+.||+|+||.||+|....    +..+|+|++....  ......+..|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3569999986542  3345678899999999999999999998866554     


Q ss_pred             -eeEEEEecCCCCHHHHHccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          257 -RMLVYEYIDNGNLEQWLHGDVG--PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       257 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                       .++++||+++|+|..++.....  ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             6899999999999999855421  234688999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          334 GLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      |+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            9998664332221 122335678999999998999999999999999999999 99998653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.4e-35  Score=277.04  Aligned_cols=205  Identities=29%  Similarity=0.463  Sum_probs=171.4

Q ss_pred             CcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+..|+++++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678899999999999999853      224688888765533 345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          260 VYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      ++||+.+++|.+++.....                    ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999865321                    123578899999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999865332221 1223345778999999988899999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-34  Score=272.96  Aligned_cols=199  Identities=28%  Similarity=0.501  Sum_probs=171.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch---------hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      +|.+...||+|+||.||+|... +++.+|+|.+......         ..+.+.+|+++++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999865 5788999988543221         23568889999999999999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++++||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999765    4678888999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcc-----eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          337 KLLGAERS-----YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       337 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +.......     .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            87642211     111234588899999999988899999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.5e-35  Score=271.50  Aligned_cols=202  Identities=24%  Similarity=0.396  Sum_probs=176.3

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||.++.. ++..+++|++...  .....+.+.+|++++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788999999999999999854 5788999988544  334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++....  ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999997653  24678899999999999999999998   99999999999999999999999999998664333


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ......|++.|+|||.+.+..++.++|+||||+++|||++|..||+...
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN  205 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence            2 2334568999999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.1e-35  Score=280.43  Aligned_cols=202  Identities=26%  Similarity=0.402  Sum_probs=171.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357889999999999999999975 57889999886432 2334467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++ ++|.+++...   ...+++..++.++.|+++||+|||+.   +|+|+||||+|||++.++.+||+|||++......
T Consensus        85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            997 4999988764   24678899999999999999999998   9999999999999999999999999999764322


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            21 1223457889999998765 458889999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.2e-35  Score=274.81  Aligned_cols=203  Identities=28%  Similarity=0.415  Sum_probs=171.6

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC------
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG------  254 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~------  254 (424)
                      .+.+.|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+++++++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35568999999999999999999965 57788999886543 3445788899999998 799999999998753      


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...+++|||+.+++|.+++....  ...+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            45789999999999999997642  34688999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCcceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ++....... .......|+..|+|||++.     ...++.++|+|||||++|||++|+.||+.
T Consensus       157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            998653221 1233456899999999885     34688899999999999999999999964

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-34  Score=272.82  Aligned_cols=202  Identities=25%  Similarity=0.452  Sum_probs=165.7

Q ss_pred             cccceeEcccCcEEEEEEEEcCCC---EEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------Ce
Q 014466          188 FADENVIGEGGYGIVYHGVLEDNT---NVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AH  256 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~  256 (424)
                      |.+.+.||+|+||.||+|.+.++.   .+|+|.+...  .....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            356789999999999999976433   5899987543  234456788899999999999999999987432      24


Q ss_pred             eeEEEEecCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          257 RMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      .+++|||+++|+|.+++....  .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            679999999999999874322  1234588999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          335 LAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      +++.+....... .....+++.|+|||.+.+..++.++|+||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  217 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG  217 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            998764332211 122345678999999999999999999999999999999 8999964

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-35  Score=288.12  Aligned_cols=196  Identities=25%  Similarity=0.387  Sum_probs=167.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------C
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~  255 (424)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+++++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            358999999999999999999964 577899999865422  2345677899999999999999999988643      3


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++++|++ +++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence            468999988 6799988853     3688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            9865332    234568999999998876 57899999999999999999999999654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-34  Score=272.60  Aligned_cols=192  Identities=26%  Similarity=0.431  Sum_probs=161.6

Q ss_pred             eeEcccCcEEEEEEEEcC-------------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          192 NVIGEGGYGIVYHGVLED-------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +.||+|+||.||+|+..+             ...+++|.+..........+.+|+.+++.++||||+++++++.++...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2247888876555555567888999999999999999999999998999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc-------eEEE
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-------PKLS  331 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~-------~kL~  331 (424)
                      +||||+++|+|..++...   ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.       +|++
T Consensus        81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999998754   24688999999999999999999998   9999999999999987664       8999


Q ss_pred             ecCCccccCCCcceeeeccccccccccccccc-CCCCCCccchHHHHHHHHHHH-cCCCCCCCCC
Q 014466          332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI-SGRNPVDYSR  394 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~ell-tg~~Pf~~~~  394 (424)
                      |||++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|..||....
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            99998754221     2345788999999886 567899999999999999998 5899986543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=282.76  Aligned_cols=205  Identities=24%  Similarity=0.359  Sum_probs=175.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  256 (424)
                      .+...+|.++.+||+|+||.|.++..++ ...+|||++.+..   ....+.-..|-++|+.. +-|.++++..+|++-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            3455689999999999999999999774 4458999886652   23334445577777777 57899999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      +|+||||+.||+|.-.++..    +.+.+..+..++.+|+-||-|||++   +|++||||.+|||+|.+|++||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999888765    6777888889999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +.- .-....+..++|||.|+|||++..++|+..+|+||+||+||||+.|+.||++..
T Consensus       498 KEn-i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  498 KEN-IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             ccc-ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            842 223345567999999999999999999999999999999999999999998654

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-34  Score=280.07  Aligned_cols=209  Identities=29%  Similarity=0.484  Sum_probs=174.2

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC  251 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  251 (424)
                      +++.++|.+.+.||+|+||.||+|...        ....+|+|.+.... .....++..|+++++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            566778999999999999999999742        23458899876543 34456788899999999 699999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      .++...+++|||+++|+|.+++.....            ....+++..+..++.|++.||.|||++   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            998899999999999999999976421            124588899999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||...
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999998654322111 122234567999999999999999999999999999999 89998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.7e-35  Score=279.20  Aligned_cols=207  Identities=30%  Similarity=0.462  Sum_probs=175.2

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  253 (424)
                      .+..++|.+.+.||+|+||.||++...      .+..+|+|.+.... ....+.+.+|+++++++ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            455678999999999999999999742      24468999886543 33446788999999999 79999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      .+..+++|||+.+|+|.++++...  ...+++..++.++.+++.||+|||++   +|+|+||||+|||++.++.+||+||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence            999999999999999999997643  23489999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          334 GLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      |+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~  247 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM  247 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence            999865433221 1222346778999999999999999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-35  Score=280.59  Aligned_cols=203  Identities=28%  Similarity=0.341  Sum_probs=175.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch---hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+......   ..+.+..|+++++.++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999976 4888999998765322   4457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+.+++|.+++....  ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999997542  35689999999999999999999998   999999999999999999999999999875432


Q ss_pred             Ccc----------------------------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERS----------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...                            .......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            111                            0112346889999999999989999999999999999999999999644

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.8e-35  Score=322.69  Aligned_cols=190  Identities=33%  Similarity=0.626  Sum_probs=161.5

Q ss_pred             CcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .|...++||+|+||.||+|+. .++..||+|++.......    ..|++.+++++|||||++++++.++...++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            355678899999999999997 468899999886543222    236888999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +|+|.++++       .+++..+..++.|+++|++|||..++++|+||||||+||+++.++..++. ||.......    
T Consensus       767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            999999995       36889999999999999999996556699999999999999999888875 665543211    


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       .....||+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence             12236789999999999999999999999999999999999999643

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.9e-35  Score=285.68  Aligned_cols=192  Identities=22%  Similarity=0.348  Sum_probs=164.1

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ...+|++.+.||+|+||.||+|+.. ++..||+|.....      ....|+.++++++||||+++++++..+...++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999976 4667888864332      23458999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+. ++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       138 ~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        138 HYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             ccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            995 5898888654   35689999999999999999999998   9999999999999999999999999999753221


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                        .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1223456899999999999999999999999999999999855554

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-34  Score=275.03  Aligned_cols=214  Identities=27%  Similarity=0.415  Sum_probs=177.1

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEee-
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA-  252 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~-  252 (424)
                      ..++.+....++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            345566678889999999999999999999965 57789999875432 2345678899999999 6999999999874 


Q ss_pred             ----eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          253 ----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       253 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                          ++...++||||+++++|.+++.........+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                34568999999999999998865433345688899999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCcceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ||+|||+++.+.... .......|++.|+|||++.     +..++.++|+|||||++|||++|+.||....
T Consensus       164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999999988654322 1223346899999999875     3458889999999999999999999987543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-36  Score=294.61  Aligned_cols=233  Identities=22%  Similarity=0.336  Sum_probs=191.1

Q ss_pred             cceeeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEee
Q 014466          174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLG  249 (424)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~  249 (424)
                      ++..++.-.+...-|..++.||-|+||.|.+++-. +...||+|.+.+.+   .......+.|..+|+.-..+-||+||-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            34445555666777899999999999999999844 45668999886653   234456788999999999999999999


Q ss_pred             EeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       250 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                      .|++++.+|+||||++||++..+|-+.    +-+.+..+..++.++.-|+++.|..   |+|||||||+|||||.+|++|
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCcee
Confidence            999999999999999999999999876    6788899999999999999999998   999999999999999999999


Q ss_pred             EEecCCcccc---------CCCc--------------------------------ceeeecccccccccccccccCCCCC
Q 014466          330 LSDFGLAKLL---------GAER--------------------------------SYVTTRVMGTFGYVAPEYASTGMLN  368 (424)
Q Consensus       330 L~DfG~a~~~---------~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~  368 (424)
                      |+|||++.-+         ....                                .......+||+.|+|||++....|+
T Consensus       770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~  849 (1034)
T KOG0608|consen  770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT  849 (1034)
T ss_pred             eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence            9999998522         0000                                0011235799999999999999999


Q ss_pred             CccchHHHHHHHHHHHcCCCCCCCCCCCCCc-cHHHHHHHHHhhhc
Q 014466          369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEV-CIPQMNSLMTLSYC  413 (424)
Q Consensus       369 ~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~  413 (424)
                      ..+|+||.|||||||+.|+.||...+|.+.. .+..|...+...++
T Consensus       850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~  895 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQ  895 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccc
Confidence            9999999999999999999999998875443 34455555544444

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=274.02  Aligned_cols=204  Identities=29%  Similarity=0.488  Sum_probs=172.5

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcC-CC----EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLED-NT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ...+|++.+.||+|+||.||+|.+.+ +.    .+|+|.+..... ....++.+|++.+++++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            34578889999999999999998653 32    478888765543 345678899999999999999999999987 778


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++|+||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            99999999999999997652   4588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          338 LLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       338 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      ......... .....++..|+|||.+....++.++|+||||+++||+++ |+.||+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  216 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP  216 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence            764332221 112234568999999988899999999999999999999 999998643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.4e-35  Score=276.20  Aligned_cols=199  Identities=27%  Similarity=0.485  Sum_probs=169.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-----CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Cee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  257 (424)
                      ..|++.+.||+|+||.||+|.+.     ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            45788999999999999999842     46789999986543 34456789999999999999999999998775  567


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++++|.+++.+.   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999999765   23578999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcce--eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          338 LLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                      .+......  ......++..|+|||++.+..++.++|+||||+++|||++++.|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            76433221  122345677899999998888999999999999999999987765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-34  Score=275.44  Aligned_cols=201  Identities=27%  Similarity=0.401  Sum_probs=172.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999976 58889999886542  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++++.|..++...    ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99998888877543    4689999999999999999999998   9999999999999999999999999999876433


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            21 2223457889999998865 568899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.5e-34  Score=272.50  Aligned_cols=199  Identities=25%  Similarity=0.414  Sum_probs=161.5

Q ss_pred             eeEcccCcEEEEEEEEcC---CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|++.++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999997543   3457888765443 333456888999999999999999999999999999999999999


Q ss_pred             CHHHHHccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          268 NLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       268 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      +|.+++...... ....++...+.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999775422 23356778889999999999999998   99999999999999999999999999987543222111


Q ss_pred             -eecccccccccccccccC-------CCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          347 -TTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       347 -~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                       .....++..|+|||++..       ..++.++|||||||++|||++ |..||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence             123345778999998743       457889999999999999999 88898654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.9e-34  Score=268.26  Aligned_cols=201  Identities=24%  Similarity=0.379  Sum_probs=172.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeee-CCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e  262 (424)
                      +|++.+.||+|++|.||++... +++.+|+|++....  ....+.+..|++++++++|+|++++++.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999965 46789999986432  3345678889999999999999999998764 446789999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++....  ...+++..++.++.+++.|++|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            999999999997642  24688999999999999999999998   9999999999999999999999999999866432


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. ......|++.|+|||++.+..++.++|+||||+++|||++|+.||+..
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  205 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK  205 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            22 223456899999999999999999999999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-35  Score=274.67  Aligned_cols=200  Identities=28%  Similarity=0.434  Sum_probs=176.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||.|+||.||+|.+. +++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888999999999999999965 57889999886543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++...     .+++..++.++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||+++......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999998753     788999999999999999999998   99999999999999999999999999998765432


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       .......|++.|+|||++.+..++.++|+||||+++|||+||+.||....
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence             22334568889999999998889999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.3e-35  Score=284.37  Aligned_cols=209  Identities=29%  Similarity=0.455  Sum_probs=171.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEE------cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  253 (424)
                      +++.++|++.+.||+|+||.||+|.+      .+++.||||.+.... ......+.+|++++.++ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            55677899999999999999999974      246789999986543 23345688899999999 68999999998865


Q ss_pred             C-CeeeEEEEecCCCCHHHHHccCCCC-----------------------------------------------------
Q 014466          254 G-AHRMLVYEYIDNGNLEQWLHGDVGP-----------------------------------------------------  279 (424)
Q Consensus       254 ~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  279 (424)
                      . ...+++|||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 4678999999999999998653210                                                     


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce-eee
Q 014466          280 ----------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTT  348 (424)
Q Consensus       280 ----------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~  348 (424)
                                ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++......... ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      12467788889999999999999998   9999999999999999999999999999865322221 112


Q ss_pred             cccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       349 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ...++..|+|||.+.+..++.++|+||||+++|||++ |..||...
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            2345678999999999999999999999999999997 99999653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=267.87  Aligned_cols=203  Identities=26%  Similarity=0.360  Sum_probs=178.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  256 (424)
                      .+..++|..+++||+|.|.+|.+++++ +.+.+|+|++++.   ..+..+....|-.+...- +||.+|.+..+|++++.
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            345678999999999999999999965 4667899988654   344455666777777665 79999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      +++|.||++||+|.-.++++    .+++++.+..+..+|..||.|||+.   +|++||||.+|+|+|.+|++||+|+|++
T Consensus       326 lffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             EEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence            99999999999998877766    6899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +.- -.....+..++|||.|.|||++++..|+...|+|+|||+++||+.|+.||+.
T Consensus       399 ke~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  399 KEG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             hcC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            852 3344566789999999999999999999999999999999999999999994

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-36  Score=293.30  Aligned_cols=194  Identities=26%  Similarity=0.470  Sum_probs=165.9

Q ss_pred             ccceeEcccCcEEEEEEEEc-CCCEEEEE--Eee--cCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe--eeEEE
Q 014466          189 ADENVIGEGGYGIVYHGVLE-DNTNVAVK--NLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVY  261 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~-~~~~vavK--~~~--~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--~~lv~  261 (424)
                      ++..+||+|+|-+||+|.+. +|-+||=-  ++.  .......+.|..|+.+|+.|+||||+++|+++.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44678999999999999965 46666521  121  1234455789999999999999999999999987665  56899


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCccccC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLG  340 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~~~~  340 (424)
                      |.+..|+|..|+++.    ..........|++||++||.|||++ .|+|||||||.+||+|+. .|.+||+|+|+|..+.
T Consensus       123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999999987    5778889999999999999999997 889999999999999974 7899999999999763


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ..   ....+.|||.|||||+.. ..|++.+||||||+.++||+|+..||.
T Consensus       198 ~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  198 KS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             cc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence            32   233478999999999887 889999999999999999999999995

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-34  Score=278.04  Aligned_cols=201  Identities=26%  Similarity=0.396  Sum_probs=172.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999976 46789999886543   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...    ..+++..+..++.++++||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            999999999999765    4688999999999999999999998   999999999999999999999999998863211


Q ss_pred             C--------------cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 E--------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .              .........|+..|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            0              001112245788999999998889999999999999999999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-34  Score=267.55  Aligned_cols=196  Identities=32%  Similarity=0.500  Sum_probs=168.3

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHH
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE  270 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~  270 (424)
                      ++||+|+||.||++.+.+++.|++|.+...... ..+.+..|+++++.++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877899999988665433 5567899999999999999999999999999999999999999999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceee-ec
Q 014466          271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TR  349 (424)
Q Consensus       271 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~-~~  349 (424)
                      +++...   ...+++..++.++.+++.||+|||++   +++||||||+|||++.++.+||+|||++........... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            999764   24678888999999999999999999   999999999999999999999999999986542211111 12


Q ss_pred             ccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       350 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..++..|+|||.+.+..++.++|+||||+++|||+| |..||...
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~  199 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM  199 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence            233567999999988899999999999999999999 89998653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-34  Score=275.92  Aligned_cols=207  Identities=29%  Similarity=0.485  Sum_probs=173.6

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      +..++|++.+.||+|+||.||+|...      ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.++.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            35678999999999999999999864      35678999886543 344567889999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVG------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS  317 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp  317 (424)
                      ..+++|||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+.   +++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            99999999999999999974321                  123478888999999999999999998   999999999


Q ss_pred             CCEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          318 SNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       318 ~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      +|||++.++.+||+|||++..+...... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||..
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999998755332211 1122334667999999998999999999999999999998 8889853

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.6e-35  Score=272.62  Aligned_cols=199  Identities=27%  Similarity=0.362  Sum_probs=176.8

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +|++.+.||.|+||.||+|.+. +++.+|+|.+.+..   ....+.+.+|++.+++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999976 58889999986543   2345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+.+++|.+++...    .++++..+..++.|+++||.|||++   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999765    4788999999999999999999998   9999999999999999999999999998865433


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            2  2234568889999999988889999999999999999999999998655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-34  Score=279.54  Aligned_cols=198  Identities=22%  Similarity=0.371  Sum_probs=161.1

Q ss_pred             ceeEcccCcEEEEEEEEcC---CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee--CCeeeEEEEecC
Q 014466          191 ENVIGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYID  265 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~  265 (424)
                      ...||+|+||.||+|+..+   +..+|+|.+....  ....+.+|+++++.++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3679999999999999653   4679999886442  23457789999999999999999998853  457789999997


Q ss_pred             CCCHHHHHccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE----cCCCceEEEecCCc
Q 014466          266 NGNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLA  336 (424)
Q Consensus       266 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DfG~a  336 (424)
                      + +|.+++....     .....+++..+..++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 8888775321     1224588899999999999999999998   99999999999999    56678999999999


Q ss_pred             cccCCCcc--eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +.......  .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            87643321  12234578999999998876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=256.01  Aligned_cols=213  Identities=26%  Similarity=0.377  Sum_probs=178.1

Q ss_pred             eeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcC-CCCceeeEeeEeee
Q 014466          177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE  253 (424)
Q Consensus       177 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  253 (424)
                      ..+.++++.+....+..||+|+||.|=+-++. +|+..|+|++... +.+..+.+.+|+.+..+. .+|.+|.++|.+..
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            34556788888888999999999999888854 6888899999654 345556777888887665 79999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ....++.||.|+. +|..+.++-......+++...-+|+..+.+||.|||++.  .++|||+||+||||+.+|++|+|||
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence            9999999999976 898887665555678999999999999999999999986  9999999999999999999999999


Q ss_pred             CCccccCCCcceeeeccccccccccccccc----CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS----TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |++-.+-+.  ...+-..|...|||||.+.    ...|+-++||||||+.+.||.+++.||+.-.
T Consensus       194 GIsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  194 GISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ccceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            998755322  2223345788999999874    3479999999999999999999999998544

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.8e-34  Score=271.99  Aligned_cols=198  Identities=27%  Similarity=0.455  Sum_probs=173.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      .|+..+.||+|+||.||+|.+. ++..+|+|.+.... ......+.+|++++++++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            5778899999999999999975 57889999886543 345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++..     .++++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999864     3578888899999999999999998   999999999999999999999999999976643322


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ......++..|+|||++.+..++.++|+|||||++|||++|..||...
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence             223346788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-34  Score=268.42  Aligned_cols=194  Identities=31%  Similarity=0.510  Sum_probs=164.6

Q ss_pred             eeEcccCcEEEEEEEEcC----CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      ++||+|+||.||+|.+..    +..+|+|.+..... ...+.+..|+++++.+.||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999998542    25799998865543 345678899999999999999999998764 567899999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.+++...    ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999865    3688999999999999999999998   99999999999999999999999999998764433222


Q ss_pred             ee--cccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          347 TT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       347 ~~--~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..  ...++..|+|||.+.+..++.++|+||||+++|||++ |..||...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence            11  1223567999999999999999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.9e-34  Score=269.66  Aligned_cols=195  Identities=28%  Similarity=0.456  Sum_probs=168.9

Q ss_pred             eeEcccCcEEEEEEEEcC--CC--EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLED--NT--NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|++|.||+|.+.+  ++  .+|+|.+..... ...+.+..|++.+++++||||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  22  589999877655 566789999999999999999999999988 888999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce-
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-  345 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-  345 (424)
                      ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.+...... 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999987532  4688999999999999999999998   9999999999999999999999999999876442221 


Q ss_pred             -eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          346 -VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       346 -~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                       ......++..|+|||.+.+..++.++|+|||||++|||++ |+.||+.
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  203 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG  203 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence             1123456789999999999999999999999999999999 9999964

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-34  Score=269.32  Aligned_cols=197  Identities=31%  Similarity=0.488  Sum_probs=168.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEee-eCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e  262 (424)
                      ..++|++.+.||+|+||.||++... +..+|+|.+....  ..+.+.+|+.++++++|+|++++++++. +++..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            3457889999999999999999876 7779999875432  3457889999999999999999999764 5567899999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++....  ...+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            999999999997652  23578899999999999999999998   9999999999999999999999999998754322


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      .    ....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            1    22334568999999999999999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-34  Score=274.27  Aligned_cols=201  Identities=25%  Similarity=0.401  Sum_probs=170.5

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||+|+.. ++..||+|++....  ....+.+..|+++++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999975 68889999885432  23346788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      ++ ++|.+++..... ...+++..++.++.|+++||+|||+.   +++|+||||+|||++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 589998865432 35688999999999999999999998   99999999999999999999999999987653322


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       .......+++.|+|||++.+ ..++.++|+||||+++|||+||+.||...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             12233457889999998765 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-34  Score=268.13  Aligned_cols=199  Identities=34%  Similarity=0.572  Sum_probs=172.6

Q ss_pred             eeEcccCcEEEEEEEEcC----CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|....    +..+++|.+...... ..+.+..|++.++.++|+||+++++++.++...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999764    778999998665433 367889999999999999999999999999999999999999


Q ss_pred             CCHHHHHccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          267 GNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       267 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ++|.+++......     ...+++..++.++.|+++||+|||++   +++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875211     36789999999999999999999998   999999999999999999999999999987654


Q ss_pred             Ccc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ... .......++..|+|||.+....++.++|+||||+++|||++ |..||...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            321 22234557889999999988899999999999999999999 69999754

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-34  Score=274.82  Aligned_cols=206  Identities=28%  Similarity=0.476  Sum_probs=174.1

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcC-----------------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCcee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV  245 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv  245 (424)
                      ...+|++.+.||+|+||.||+|...+                 +..+|+|.+.... ....+.+.+|+++++.++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            34688999999999999999998642                 2357899886543 34566789999999999999999


Q ss_pred             eEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCC
Q 014466          246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP-------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       246 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~  318 (424)
                      ++++++..+...+++|||+++++|.+++......       ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence            9999999999999999999999999999765311       23689999999999999999999998   9999999999


Q ss_pred             CEEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc--CCCCCCC
Q 014466          319 NILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDY  392 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt--g~~Pf~~  392 (424)
                      ||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++  |..||..
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999886533221 22234456788999999988889999999999999999998  7778864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=269.63  Aligned_cols=200  Identities=33%  Similarity=0.519  Sum_probs=175.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +..++|++.+.||.|+||.||+|... ++.+|+|.+..... ..+.+..|+.+++.++|+||+++++++.++...++|||
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            34568899999999999999999876 78899999876544 56778899999999999999999999998889999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.++.....
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          81 YMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            999999999997652  23689999999999999999999998   9999999999999999999999999999865322


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .    ....++..|+|||.+....++.++|+||||+++|||++ |+.||...
T Consensus       156 ~----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         156 Q----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             c----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence            1    12334668999999988899999999999999999997 99998644

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=262.38  Aligned_cols=204  Identities=27%  Similarity=0.437  Sum_probs=172.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~  258 (424)
                      ....++.+++..||.|..|.||+++.+ .|...|||...+. +.+..+++...+.++..-. .|+||+.+|+|..+...+
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            455667788899999999999999976 4778899998665 3445567777888776654 899999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +.||.|.. .+..++++.   ..++++..+-++...+.+||.||-++.  +|+|||+||+|||+|+.|++||||||++-.
T Consensus       168 IcMelMs~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  168 ICMELMST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccce
Confidence            99999854 677777665   367999999999999999999999864  999999999999999999999999999876


Q ss_pred             cCCCcceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +-..  ...+...|.+.|||||.+.   ...|+.++||||||+.|+||.||+.||...
T Consensus       242 lvdS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c  297 (391)
T KOG0983|consen  242 LVDS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC  297 (391)
T ss_pred             eecc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence            5433  3345567899999999885   457999999999999999999999999864

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-34  Score=280.61  Aligned_cols=209  Identities=30%  Similarity=0.484  Sum_probs=174.1

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcC--------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGY  250 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  250 (424)
                      +++...+|++.+.||+|+||.||+|....        ...+|+|.+.... ....+++.+|+++++++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            35666789999999999999999997421        2358999876443 33456788999999999 89999999999


Q ss_pred             eeeCCeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCC
Q 014466          251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       251 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~  318 (424)
                      +..+...++++||+++|+|.+++.....            ....+++..++.++.|++.||+|||++   +++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence            9999999999999999999999976421            224578888999999999999999998   9999999999


Q ss_pred             CEEEcCCCceEEEecCCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          319 NILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      |||++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            9999999999999999998654322211 122334567999999999999999999999999999998 8899864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-34  Score=269.36  Aligned_cols=198  Identities=28%  Similarity=0.436  Sum_probs=173.4

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      +|+..+.||+|+||+||+|... ++..|++|.+....     .+..+.+.+|+++++.++|+||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 68899999885533     23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      +||+++++|.+++...    ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999765    4578899999999999999999998   99999999999999999999999999988653


Q ss_pred             CCcceeeecccccccccccccccCCC-CCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...  ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||...
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            332  233456889999999887766 899999999999999999999999654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-35  Score=276.36  Aligned_cols=202  Identities=28%  Similarity=0.426  Sum_probs=176.1

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..++|++.+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++.....+++||
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            4468999999999999999999965 57889999876543 344577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...    ..+++..+..++.+++.||.|||+..  +++||||||+||++++++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          83 EFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             ecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            999999999998764    46889999999999999999999631  899999999999999999999999999875422


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .   ......|+..|+|||++.+..++.++|+|||||++|||++|+.||+...
T Consensus       157 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         157 S---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             h---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            1   1234578999999999988899999999999999999999999998544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-34  Score=270.49  Aligned_cols=201  Identities=25%  Similarity=0.409  Sum_probs=170.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Cee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  257 (424)
                      .+|+..+.||+|+||.||+|... ++..+++|++....     ....+.+.+|+++++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999965 58889999885432     12345688899999999999999999998753  567


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++++||+++++|.+++...    ..+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            8999999999999999754    4578888899999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCc--ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAER--SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......  ........++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            653211  11122345888999999999988999999999999999999999999743

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.6e-34  Score=280.46  Aligned_cols=198  Identities=20%  Similarity=0.239  Sum_probs=165.7

Q ss_pred             cceeEccc--CcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          190 DENVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       190 ~~~~LG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ++++||+|  +||+||++... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999865 68889999986542  334456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999997542  24588999999999999999999998   999999999999999999999999986543321111


Q ss_pred             e------eeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          345 Y------VTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       345 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            0      1112346778999999876  4689999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-34  Score=273.37  Aligned_cols=191  Identities=24%  Similarity=0.405  Sum_probs=159.7

Q ss_pred             eEcccCcEEEEEEEEcC-------------------------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeE
Q 014466          193 VIGEGGYGIVYHGVLED-------------------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL  247 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l  247 (424)
                      .||+|+||.||+|....                         ...|++|.+.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         12478888865555555678889999999999999999


Q ss_pred             eeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-
Q 014466          248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-  326 (424)
Q Consensus       248 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-  326 (424)
                      ++++.++...++||||+++|+|..++...   ...+++..++.++.|+++||+|||+.   +|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            99999999999999999999999998754   24678899999999999999999998   999999999999997654 


Q ss_pred             ------ceEEEecCCccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHH-cCCCCCCCCC
Q 014466          327 ------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVI-SGRNPVDYSR  394 (424)
Q Consensus       327 ------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~ell-tg~~Pf~~~~  394 (424)
                            .+|++|||++......     ....++..|+|||.+.+ ..++.++|+||||+++|||+ +|+.||....
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence                  3899999987643221     22357788999998865 66899999999999999995 6999997654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-34  Score=277.69  Aligned_cols=204  Identities=24%  Similarity=0.365  Sum_probs=173.7

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeec--CCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +.+....|++++.||+||.+.||++...+.+.+|+|++..  .+.+....|..|+++|.+| .|.+||+|++|-..++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            4567778999999999999999999988888899988743  3556678899999999999 599999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ||||||=+. +|..+|+...   ...+.-.++.++.|++.|+.++|+.   +|||.||||.|+|+-. |.+||+|||+|.
T Consensus       436 YmvmE~Gd~-DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  436 YMVMECGDI-DLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             EEEeecccc-cHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence            999998765 9999998773   2333237788999999999999999   9999999999999865 589999999999


Q ss_pred             ccCCCc-ceeeecccccccccccccccCC-----------CCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          338 LLGAER-SYVTTRVMGTFGYVAPEYASTG-----------MLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       338 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .+..+. +......+||+.||+||.+...           +.+.++|||||||+||+|+.|+.||..
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            876543 3344568899999999977432           256789999999999999999999974

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-34  Score=274.22  Aligned_cols=198  Identities=28%  Similarity=0.467  Sum_probs=172.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            5778899999999999999865 46789999876443 344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++..     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            99999998864     3678899999999999999999998   99999999999999999999999999997654322 


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .......|+..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL  204 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence            1222346888999999999989999999999999999999999998643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.9e-34  Score=273.74  Aligned_cols=202  Identities=22%  Similarity=0.348  Sum_probs=169.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            457899999999999999999865 58889999986543 2233467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+. ++|.+++...   ...+.+..+..++.|++.||+|||+.   +|+|+||||+|||++.++++||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            996 6887777544   24567888888999999999999998   9999999999999999999999999998754322


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . .......+++.|+|||.+.+ ..++.++|+|||||++|||++|+.||+...
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         157 S-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             C-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            1 11233457889999998865 458889999999999999999999997544

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.9e-34  Score=266.70  Aligned_cols=201  Identities=24%  Similarity=0.421  Sum_probs=174.4

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||++... +++.+|+|++...  .....+++.+|+++++.++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999965 6788999998643  233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++....  ...+++..++.++.|++.|++|||+.   +++|+||+|+|||++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999987542  23578889999999999999999998   99999999999999999999999999998654322


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      . ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08218         156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG  204 (256)
T ss_pred             h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence            1 122345888999999999989999999999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-34  Score=269.55  Aligned_cols=196  Identities=28%  Similarity=0.491  Sum_probs=162.7

Q ss_pred             eeEcccCcEEEEEEEEcC-CC--EEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLED-NT--NVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|.+.+ +.  .+++|.+.... ....+.+..|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 33  46888776433 34456788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          267 GNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       267 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      |+|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999975431            123578899999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ++.....  .........+..|+|||++....++.++|+||||+++|||++ |..||..
T Consensus       158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  214 (270)
T cd05047         158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  214 (270)
T ss_pred             Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            9863211  111111233567999999998999999999999999999997 9999964

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-34  Score=267.55  Aligned_cols=200  Identities=31%  Similarity=0.466  Sum_probs=174.5

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||+|... +++.+++|.+.....  ...+.+..|+++++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999965 678899999876544  3567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++...    ..+++..++.++.++++||.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999999764    3578888999999999999999998   99999999999999999999999999988764432


Q ss_pred             ceee---ecccccccccccccccCCC---CCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVT---TRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....   ....++..|+|||++.+..   ++.++|+||||+++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            2221   1356788999999988766   889999999999999999999999643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-34  Score=273.25  Aligned_cols=200  Identities=27%  Similarity=0.426  Sum_probs=173.3

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||+|.+. +++.+|+|++....  ....+.+.+|++++++++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 68889999986543  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      + +++|.+++....   ..+++..++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999987652   5689999999999999999999998   99999999999999999999999999998764433


Q ss_pred             ceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ........|+..|+|||.+.+. .++.++||||+|+++|||++|..||...
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            2223345689999999988654 4689999999999999999998888643

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=294.22  Aligned_cols=220  Identities=29%  Similarity=0.469  Sum_probs=189.9

Q ss_pred             cccceeEcccCcEEEEEEEE-cCCC----EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          188 FADENVIGEGGYGIVYHGVL-EDNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .+..++||.|+||+||+|.+ ..|+    +||||++... ..+..+++.+|+-.|.+++|||++++++++..+. ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            45578999999999999985 3343    4799988655 3455678999999999999999999999998765 77999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      +|+++|+|.+|++.++   ..+.....+.|..|||+|+.|||++   +++||||-..||||..-..+||.|||+++.+..
T Consensus       777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            9999999999998874   6788888999999999999999999   999999999999999999999999999998865


Q ss_pred             Ccceee-ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC--------------CCCCCCccHHHHH
Q 014466          342 ERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY--------------SRPPGEVCIPQMN  405 (424)
Q Consensus       342 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~--------------~~~~~~~~~~~~~  405 (424)
                      ...... ....-.+.|||-|.+....|+.++|||||||++||++| |..|++.              +.+.+..|..+..
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy  930 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY  930 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence            544333 23333568999999999999999999999999999999 9999983              4457788999999


Q ss_pred             HHHHhhhcc
Q 014466          406 SLMTLSYCS  414 (424)
Q Consensus       406 ~~~~~~~~~  414 (424)
                      ..|..||+.
T Consensus       931 ~~mvkCwmi  939 (1177)
T KOG1025|consen  931 MVMVKCWMI  939 (1177)
T ss_pred             HHHHHHhcc
Confidence            999999984

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.7e-34  Score=268.65  Aligned_cols=190  Identities=27%  Similarity=0.490  Sum_probs=161.5

Q ss_pred             eeEcccCcEEEEEEEEcCCC-----------EEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          192 NVIGEGGYGIVYHGVLEDNT-----------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+++++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999976433           4677766544333 6788899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-------ceEEEec
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-------NPKLSDF  333 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kL~Df  333 (424)
                      |||+++|+|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++       .+||+||
T Consensus        79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999998752   3688899999999999999999998   999999999999999887       7999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCC--CCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      |++.....     .....++..|+|||++...  .++.++|+||||+++|||++ |..||....
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            99986533     2234467789999998776  78999999999999999999 688886553

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.9e-35  Score=273.31  Aligned_cols=199  Identities=28%  Similarity=0.440  Sum_probs=175.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||++.+. +++.+++|.+.... ....+.+.+|++++++++||||+++++.+..+...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788999999999999999976 57889999886653 34556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      +++++|.+++....   ..+++.....++.|++.||+|||+ .   +++|+||||+||++++++.+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999997652   578889999999999999999999 7   9999999999999999999999999998765322


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..   ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            11   1266888999999999999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.8e-34  Score=272.08  Aligned_cols=199  Identities=26%  Similarity=0.349  Sum_probs=170.8

Q ss_pred             CcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +|++.+.||+|+||.||+++..    +|..||+|.+....    ....+.+..|+++++.+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999863    67889999986532    22345678899999999 599999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++|+||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999999764    4678888899999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..............|+..|+|||.+.+  ..++.++|+||||+++|+|++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            654433333334568999999998865  3478899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.8e-34  Score=274.46  Aligned_cols=202  Identities=27%  Similarity=0.432  Sum_probs=176.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++.+.||+|+||.||++... +++.+++|.+........+.+..|+.+++.++||||+++++++..++..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            358899999999999999999864 5788999998655545556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++.+.     .+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999998653     567888999999999999999999   99999999999999999999999999887654332


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      . ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++
T Consensus       170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~  220 (293)
T cd06647         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (293)
T ss_pred             c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            2 22334688899999999888899999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-34  Score=269.30  Aligned_cols=200  Identities=26%  Similarity=0.404  Sum_probs=171.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-----CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Cee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  257 (424)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+...     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999965 5888999987432     223446788999999999999999999998764  457


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++++||+++++|.+++...    ..+++.....++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            8999999999999998754    4578888999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCc--ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          338 LLGAER--SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       338 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ......  ........|+..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            653211  1112335689999999999988899999999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5e-34  Score=270.64  Aligned_cols=202  Identities=28%  Similarity=0.412  Sum_probs=167.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHH-HhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||.||++.+. +|+.||+|++.... ......+..|+.. ++.++||||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999976 58899999886543 2333445556664 667799999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++ |+|.+++.........+++..++.++.|++.||+|||++.  +++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 5898888765434467899999999999999999999753  7999999999999999999999999999865322


Q ss_pred             cceeeecccccccccccccccC----CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .  ..+...|+..|+|||.+.+    ..++.++|+||||+++|||++|+.||..
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            1  2233468889999998754    4578899999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.1e-35  Score=278.44  Aligned_cols=200  Identities=30%  Similarity=0.413  Sum_probs=174.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      +.|.....||+|+||.||++... ++..||||.+........+.+.+|+..++.++||||+++++.+..++..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            35565678999999999999965 57889999986655556677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++........
T Consensus       102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            99999998854     3578889999999999999999998   999999999999999999999999999876533222


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  222 (292)
T cd06658         174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP  222 (292)
T ss_pred             -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             1233568999999999988889999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-34  Score=274.41  Aligned_cols=202  Identities=26%  Similarity=0.457  Sum_probs=172.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++.+..+...++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36889999999999999999976 6888999988654 333456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+..  +|+|+||||+||+++.++.+||+|||++..+... 
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999999987642 1246899999999999999999999632  8999999999999999999999999998765322 


Q ss_pred             ceeeecccccccccccccccCC------CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                        ......+++.|+|||.+.+.      .++.++|+|||||++|||++|+.||...
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence              22334578899999988543      3588999999999999999999999643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6e-34  Score=271.54  Aligned_cols=212  Identities=29%  Similarity=0.422  Sum_probs=175.8

Q ss_pred             eeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC
Q 014466          177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG  254 (424)
Q Consensus       177 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  254 (424)
                      .+..+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+..|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34555667889999999999999999999975 57889999885432 2345677899999999 899999999998753


Q ss_pred             -----CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          255 -----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       255 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                           ...++||||+++++|.++++........+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence                 357899999999999999875433345788999999999999999999998   999999999999999999999


Q ss_pred             EEecCCccccCCCcceeeecccccccccccccccCC-----CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+|||++........ ......|+..|+|||.+...     .++.++|+|||||++|||++|+.||...
T Consensus       169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            999999886543221 12234688999999987543     3688999999999999999999999654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-34  Score=271.08  Aligned_cols=201  Identities=26%  Similarity=0.491  Sum_probs=172.9

Q ss_pred             CcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC------chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+....      ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 468889999886432      1234678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKL  338 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~~  338 (424)
                      |+||+++++|.+++.+.    .++++..+..++.|++.||.|||++   +++|+||||+||+++.++ .+||+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            99999999999999764    4688899999999999999999999   999999999999998776 599999999876


Q ss_pred             cCCCc---ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          339 LGAER---SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....   ........|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            64321   111223468899999999988899999999999999999999999997543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-34  Score=267.80  Aligned_cols=194  Identities=32%  Similarity=0.521  Sum_probs=159.5

Q ss_pred             eeEcccCcEEEEEEEEcC----CCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEee-eCCeeeEEEEecC
Q 014466          192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYEYID  265 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~~~  265 (424)
                      +.||+|+||.||+|.+.+    ...+|+|.+... .....+.+..|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998542    346899988543 3344567888999999999999999999775 4556789999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +|+|.+++....   ...++.....++.|+++||+|||+.   +++||||||+|||++.++.+||+|||+++.+......
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999997652   3456777888999999999999998   9999999999999999999999999999865332111


Q ss_pred             ---eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcC-CCCCC
Q 014466          346 ---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVD  391 (424)
Q Consensus       346 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg-~~Pf~  391 (424)
                         ......++..|+|||.+.+..++.++||||||+++|||++| ..||.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  204 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  204 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence               11233467789999999888999999999999999999994 56665

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.6e-34  Score=267.04  Aligned_cols=205  Identities=29%  Similarity=0.457  Sum_probs=176.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+..+...++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999965 57789999886443 33567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++..... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999976421 24688999999999999999999998   99999999999999999999999999987664432


Q ss_pred             ce---eeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..   ......|+..|+|||++... .++.++|+||||+++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  211 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP  211 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence            22   22345689999999998776 78999999999999999999999997543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=273.99  Aligned_cols=201  Identities=25%  Similarity=0.391  Sum_probs=170.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+++++.++|+||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999976 678899999865432 2234567799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +.+ +|.+++....   ..+++..++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            985 9999987652   4678899999999999999999998   99999999999999999999999999987543221


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       .......++..|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus       158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence             11222346889999998865 558899999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-34  Score=277.68  Aligned_cols=198  Identities=28%  Similarity=0.390  Sum_probs=172.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .|.....||+|+||.||++... +++.||+|.+........+.+.+|+..++.++||||+++++++..+...++++||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            4455668999999999999965 688899999865554555678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++..     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....... .
T Consensus       102 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~  172 (297)
T cd06659         102 GGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-P  172 (297)
T ss_pred             CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-c
Confidence            9999998754     3578999999999999999999998   99999999999999999999999999987553322 1


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......|+..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  220 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD  220 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            223456899999999999888999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.9e-34  Score=268.82  Aligned_cols=202  Identities=28%  Similarity=0.434  Sum_probs=171.7

Q ss_pred             CcccceeEcccCcEEEEEEEEcC--CCEEEEEEeecC----------CchhHHHHHHHHHHHhc-CCCCceeeEeeEeee
Q 014466          187 GFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNN----------RGQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAE  253 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~  253 (424)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  677999987532          12233456778888865 799999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                      ++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||||+|||++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999886533334568899999999999999999996 5   899999999999999999999999


Q ss_pred             cCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ||++.......  ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~  216 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST  216 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence            99998754332  334456899999999999888999999999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.7e-34  Score=266.79  Aligned_cols=203  Identities=29%  Similarity=0.431  Sum_probs=174.3

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee--CCeeeEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVY  261 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~  261 (424)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .....+.+..|+++++.++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999864 6788999988643  23345678889999999999999999998754  45678999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-----EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-----~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      ||+++++|.+++.........+++..++.++.+++.||+|||     +.   +++|+||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999765444567899999999999999999999     66   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            876443321 23356899999999999888999999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.6e-34  Score=275.00  Aligned_cols=202  Identities=31%  Similarity=0.522  Sum_probs=168.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCC----EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..++|+..+.||+|+||.||+|.+. ++.    .+|+|.+..... ....++.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            3457888999999999999999864 343    468887765432 3344688899999999999999999998764 46


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            7999999999999998765   24678889999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          338 LLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       338 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~  214 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG  214 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            76433221 1223445778999999999999999999999999999997 9999964

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-34  Score=270.39  Aligned_cols=209  Identities=29%  Similarity=0.433  Sum_probs=173.8

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeee--
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE--  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--  253 (424)
                      +.++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+.... ....++..|+.+++++ +|+||+++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            4445556778999999999999999999975 57788999875443 3345688899999998 79999999999853  


Q ss_pred             ----CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          254 ----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       254 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                          ....+++|||+++|+|.+++....  ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence                457889999999999999997653  24578888899999999999999998   999999999999999999999


Q ss_pred             EEecCCccccCCCcceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+|||++........ ......|++.|+|||.+.     ...++.++|+|||||++|||++|+.||...
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            999999876532211 223356899999999875     356888999999999999999999999654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.6e-34  Score=265.07  Aligned_cols=200  Identities=32%  Similarity=0.572  Sum_probs=172.3

Q ss_pred             cccceeEcccCcEEEEEEEEcC-----CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          188 FADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      +++.+.||.|+||.||++...+     +..+|+|.+...... ..+.+..|++.++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999764     377999998655433 5678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999976521  1289999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ..........+++.|+|||.+.+..++.++|+||||+++|||++ |+.||+.
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            42222222346789999999988889999999999999999998 8889864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=272.93  Aligned_cols=201  Identities=28%  Similarity=0.395  Sum_probs=173.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+++++.++|+||+++++++.+++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999976 5778999988543  23344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |++++.+..+....    ..+++..++.++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99987776665443    4588999999999999999999998   9999999999999999999999999999876544


Q ss_pred             cceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .........++..|+|||++.+. .++.++|+||||+++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            33233445688999999999887 8899999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.2e-34  Score=267.27  Aligned_cols=201  Identities=25%  Similarity=0.429  Sum_probs=178.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|++|.||+|... +++.+++|++..... ...+.+..|++.+.+++|+||+++++++..+...++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999976 488899999866544 4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      +++++|.+++...    ..+++..++.++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999765    578999999999999999999999 8   9999999999999999999999999999876433


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            222 224467889999999999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-34  Score=274.42  Aligned_cols=200  Identities=27%  Similarity=0.425  Sum_probs=171.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||.||+|.+. +++.+|+|++.....  ...+.+.+|+++++.++||||+++++++.++...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999976 578899998754322  234568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|..+....    ..+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99999998877543    3588999999999999999999998   9999999999999999999999999998865433


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      . .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~  204 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD  204 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence            2 22233567889999998865 45788999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.5e-34  Score=270.09  Aligned_cols=197  Identities=23%  Similarity=0.389  Sum_probs=159.6

Q ss_pred             eEcccCcEEEEEEEEcCCC---EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCC
Q 014466          193 VIGEGGYGIVYHGVLEDNT---NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      .||+|+||.||++...++.   .+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999854333   35566665433 3345678999999999999999999999999999999999999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc-ceee
Q 014466          269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER-SYVT  347 (424)
Q Consensus       269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~  347 (424)
                      |.++++.........++..++.++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999986543334567777889999999999999998   99999999999999999999999999986422111 1122


Q ss_pred             ecccccccccccccccC-------CCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          348 TRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       348 ~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  211 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH  211 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence            34567889999998743       345789999999999999997 6778864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-33  Score=269.23  Aligned_cols=202  Identities=28%  Similarity=0.375  Sum_probs=173.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--CeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lv~  261 (424)
                      ++|+..+.||.|++|.||+|.+. +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788999999999999999975 57788999886543 24456788999999999999999999998653  4688999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998765433345688899999999999999999998   999999999999999999999999999875432


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..   .....++..|+|||.+.+..++.++|+||||+++|||++|+.||+..
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            21   12345788999999999999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=245.39  Aligned_cols=198  Identities=27%  Similarity=0.427  Sum_probs=169.7

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .|...++||+|.||+||+|+.. ++..||+|++.-.  .........+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4667789999999999999954 5777999988533  333345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      |+. +|..|...-   ++.++.+.+..++.|+++||.|+|++   ++.|||+||.|.||+.+|++||+|||+++-++..-
T Consensus        83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            977 898888765   47889999999999999999999999   99999999999999999999999999999876554


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ...+. .+-|.+|.+|.++.+ +-|+...|+||-||++.|+.. |++-|.+
T Consensus       156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence            34333 345899999998876 458899999999999999988 6666744

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-34  Score=274.02  Aligned_cols=197  Identities=27%  Similarity=0.439  Sum_probs=167.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||+|++. +|+.+|+|++....  ......+.+|++++++++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999975 58889999885432  22335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++ +|.+++...   ...+++..++.++.|+++||.|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            975 888887654   24689999999999999999999998   99999999999999999999999999998654322


Q ss_pred             ceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      . ......+++.|+|||.+.+. .++.++|+|||||++|||+||..||.
T Consensus       154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            1 12234578899999988664 47899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.4e-34  Score=274.02  Aligned_cols=204  Identities=19%  Similarity=0.248  Sum_probs=156.8

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCC----CEEEEEEeecCCchh--H---------HHHHHHHHHHhcCCCCceee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQA--E---------KEFKVEVEAIGRVRHKNLVR  246 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~Ei~~l~~l~hpnIv~  246 (424)
                      ++..++|++.+.||+|+||+||+|.+.++    ..+|+|.........  +         .....+...+..+.|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            45567899999999999999999997643    345565432222111  0         11223344566778999999


Q ss_pred             EeeEeeeCC----eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          247 LLGYCAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       247 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      +++++....    ..++++|++.. ++.+.+...    ...++..+..++.|+++||+|||+.   +|+||||||+|||+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            999765543    34678887754 677766543    2356788889999999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCcc------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          323 DKQWNPKLSDFGLAKLLGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +.++.+||+|||+++.+.....      .......||+.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999986632211      1122346999999999999999999999999999999999999999765

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-33  Score=265.21  Aligned_cols=192  Identities=28%  Similarity=0.372  Sum_probs=169.4

Q ss_pred             EcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       194 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      ||.|+||.||+|+.. +++.+++|.+.+..   ....+.+..|+++++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 47889999986543   23456789999999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeec
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR  349 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~  349 (424)
                      .+++.+.    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            9999765    4578899999999999999999998   99999999999999999999999999998764332  2233


Q ss_pred             ccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       350 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..|++.|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            568899999999988889999999999999999999999997554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-33  Score=259.80  Aligned_cols=199  Identities=29%  Similarity=0.466  Sum_probs=177.7

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      +|+..+.||+|++|.||++... ++..+++|++........+.+.+|+++++.++|+||+++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677899999999999999976 678899999876655566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++....   ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999987652   5789999999999999999999998   999999999999999999999999999987644332 


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             33456889999999998888999999999999999999999999765

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.8e-34  Score=269.16  Aligned_cols=202  Identities=28%  Similarity=0.482  Sum_probs=172.5

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-----CCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeee--CCee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  257 (424)
                      ..|++.+.||+|+||.||++.+.     ++..+|+|.+...... ..+.+..|++.++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999854     3577999998765443 56789999999999999999999999877  5578


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      +++|||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            99999999999999997652   3588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCccee--eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .........  .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            765332211  11233456799999998889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-33  Score=265.39  Aligned_cols=198  Identities=27%  Similarity=0.449  Sum_probs=172.4

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      -|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++.+++++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677899999999999999865 57889999875433 334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++++|.+++..     ..+++..+..++.+++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            99999999864     3578999999999999999999998   99999999999999999999999999987654322 


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  204 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL  204 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            1223356888999999998888999999999999999999999999743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-34  Score=274.47  Aligned_cols=205  Identities=23%  Similarity=0.362  Sum_probs=171.1

Q ss_pred             CcccceeEcccCcEEEEEEEEcC---CCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Ceee
Q 014466          187 GFADENVIGEGGYGIVYHGVLED---NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  258 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~  258 (424)
                      +|++.+.||+|+||.||+|....   +..||+|.+....   ....+.+.+|+++++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999753   6889999987633   33345677899999999999999999999988  7899


Q ss_pred             EEEEecCCCCHHHHHccCCCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC----CCceEEEec
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPH-SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSDF  333 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kL~Df  333 (424)
                      +||||+++ +|.+++....... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 7777775443222 3788999999999999999999998   9999999999999999    899999999


Q ss_pred             CCccccCCCcc--eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          334 GLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       334 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      |++........  .......+++.|+|||++.+ ..++.++|+||||+++|||++|+.||.....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            99986543322  12234567899999998765 4588999999999999999999999986553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.1e-34  Score=272.33  Aligned_cols=200  Identities=26%  Similarity=0.374  Sum_probs=170.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch-----hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      +|++.+.||+|+||.||+|... +++.||+|++......     ....+..|+++++.++|+||+++++++.++...++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999965 5889999998654322     345577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+ +++|.+++....   ..+++..++.++.|+++||.|||++   +++|+||||+|||++.++.+||+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 889999997652   3689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .... ......+++.|+|||.+.+ ..++.++|+|||||++|||++|..||....
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence            3322 2223456888999998854 567899999999999999999988886543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=283.62  Aligned_cols=194  Identities=30%  Similarity=0.469  Sum_probs=169.5

Q ss_pred             ceeEcccCcEEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      .++||.|.||+||-|.. ++|+.||||.+.+.+  ...+..++.|+.+|+.+.||.||.+-.-|++.+..+.|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            58999999999999995 479999999996642  344577999999999999999999999999999999999999774


Q ss_pred             CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC---CceEEEecCCccccCCCcc
Q 014466          268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DfG~a~~~~~~~~  344 (424)
                      -|.-.|...   .+.+++.....++.||+-||+|||.+   +|+|+||||+|||+...   -++||||||+|+.++... 
T Consensus       649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence            455555443   46789999999999999999999999   99999999999999654   469999999999875432 


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                       ....++|||.|+|||+++++.|+..-|+||.||++|--++|..||..
T Consensus       722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence             34568899999999999999999999999999999999999999964

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.1e-34  Score=268.03  Aligned_cols=199  Identities=32%  Similarity=0.520  Sum_probs=165.6

Q ss_pred             eeEcccCcEEEEEEEEcC-------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +.||+|+||.||+|+..+       +..+++|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998643       2468899875543 23456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-----ceEEEecCC
Q 014466          264 IDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGL  335 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kL~DfG~  335 (424)
                      +++++|.+++.....   ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999975422   124478889999999999999999998   999999999999999877     899999999


Q ss_pred             ccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          336 AKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            876532211 11122345678999999999999999999999999999998 99999643

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.2e-33  Score=262.05  Aligned_cols=201  Identities=25%  Similarity=0.438  Sum_probs=173.5

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||++... +++.+|+|.+...  .......+..|+++++.++||||+++++.+..+...++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788999999999999999964 5788999988654  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEEEecCCccccCCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DfG~a~~~~~~  342 (424)
                      +++++|.+++....  ...+++..++.++.+++.||+|||++   +++|+||||+||+++.+ +.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999997652  24578999999999999999999998   99999999999999865 45899999999876433


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||+...
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  205 (256)
T cd08220         156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN  205 (256)
T ss_pred             c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence            2  2223568889999999998889999999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.2e-34  Score=269.49  Aligned_cols=192  Identities=25%  Similarity=0.354  Sum_probs=160.2

Q ss_pred             eEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHH---HHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVE---VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E---i~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .||+|+||.||++... +++.||+|.+.+...   .....+..|   ++.++...||||+++++++.++...++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 578899998865421   112223333   344555689999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +|+|.+++...    ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.......  
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            99999988654    5689999999999999999999998   99999999999999999999999999987553221  


Q ss_pred             eeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       .....|+..|+|||++.+ ..++.++|+||+|+++|||++|+.||....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~  200 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence             223468999999999874 468999999999999999999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=286.54  Aligned_cols=225  Identities=26%  Similarity=0.444  Sum_probs=194.5

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcC--CC--EEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLED--NT--NVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ++.++....++||+|.||.|++|.|..  |+  .||||.+...... ...+|.+|+.+|.+|+|||+++|||+..+ ...
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            455677888999999999999999763  44  4799999765443 67899999999999999999999999988 667


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      .||+|.++.|+|.+.|++.  ....+.....-.++.|||.|+.||.++   ++|||||...|+||-..-.+||+|||+.+
T Consensus       186 mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccccee
Confidence            8999999999999999883  356777888889999999999999999   99999999999999998899999999999


Q ss_pred             ccCCCcceee-ec-ccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC--------------CCCCCCcc
Q 014466          338 LLGAERSYVT-TR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY--------------SRPPGEVC  400 (424)
Q Consensus       338 ~~~~~~~~~~-~~-~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~--------------~~~~~~~~  400 (424)
                      -++....... .. ..-...|.|||.++...++.++|+|+|||+||||+| |..||-+              +.|.+..|
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~c  340 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYC  340 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCC
Confidence            8866544332 21 223567999999999999999999999999999999 9999974              33577889


Q ss_pred             HHHHHHHHHhhhc
Q 014466          401 IPQMNSLMTLSYC  413 (424)
Q Consensus       401 ~~~~~~~~~~~~~  413 (424)
                      .+.+..+|..||.
T Consensus       341 sedIY~imk~cWa  353 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWA  353 (1039)
T ss_pred             hHHHHHHHHHhcc
Confidence            9999999999997

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-34  Score=270.28  Aligned_cols=190  Identities=24%  Similarity=0.438  Sum_probs=160.4

Q ss_pred             eeEcccCcEEEEEEEEcC--------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +.||+|+||.||+|....        ...+++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998642        223778877555445556788899999999999999999999998999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc--------eEEEecCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--------PKLSDFGL  335 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kL~DfG~  335 (424)
                      +++|+|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999998652   3678899999999999999999998   9999999999999987765        69999998


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCC-CCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGR-NPVDY  392 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~-~Pf~~  392 (424)
                      +......     ....++..|+|||++.+ ..++.++|+||||+++|||++|. .||..
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            8754321     23457889999999876 45899999999999999999984 66654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=266.91  Aligned_cols=199  Identities=29%  Similarity=0.489  Sum_probs=171.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCC---CCceeeEeeEeeeCCeeeEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .|+..+.||+|+||.||+|.+. +++.+|+|.+... .....+++.+|+++++.++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5788899999999999999964 6888999988654 3344567888999999996   999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999998643     688999999999999999999998   999999999999999999999999999987644


Q ss_pred             CcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            332 2233568999999998764 457899999999999999999999997543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-33  Score=266.68  Aligned_cols=199  Identities=26%  Similarity=0.430  Sum_probs=169.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc----------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG----------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      +|...+.||+|+||.||+|... +++.+|+|.+.....          ...+.+..|+++++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677899999999999999865 578899998753211          11346788999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++++|.+++.+.    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999999765    5788899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcc-eeeecccccccccccccccCCC--CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          336 AKLLGAERS-YVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       336 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +........ .......|+..|+|||.+....  ++.++|+||||+++|||++|..||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            976532211 1223456889999999887654  88999999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-34  Score=267.32  Aligned_cols=205  Identities=34%  Similarity=0.453  Sum_probs=173.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCC------
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~------  255 (424)
                      ++++|++.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ .|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5678999999999999999999975 567899998765433 346788999999999 7999999999997644      


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            48899999999999999876543346789999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-----CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +....... .......|+..|+|||++..     ..++.++||||||+++|+|++|+.||...
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            87653322 22233568999999998753     35788999999999999999999999743

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.3e-33  Score=267.87  Aligned_cols=192  Identities=25%  Similarity=0.348  Sum_probs=159.5

Q ss_pred             eEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHH---HHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVE---AIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~---~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .||+|+||.||++... +++.+|+|.+.+...   .....+.+|..   ++...+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 578899998865421   22223334443   3344579999999999999899999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......  
T Consensus        81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            99999998754    5689999999999999999999998   99999999999999999999999999987553221  


Q ss_pred             eeeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       .....||..|+|||.+. +..++.++|+|||||++|||++|+.||....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence             22346899999999886 4668999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.3e-33  Score=268.74  Aligned_cols=198  Identities=31%  Similarity=0.435  Sum_probs=169.7

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      .+...|++.+.||+|+||.||+|... +++.||+|.+....   ....+++.+|+++++.++||||+++++++.++...+
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            34457999999999999999999965 58889999885432   233457889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +|+||+++ +|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        92 lv~e~~~g-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~  164 (307)
T cd06607          92 LVMEYCLG-SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL  164 (307)
T ss_pred             EEHHhhCC-CHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence            99999974 787777543   24688999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCcceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ....     ....+++.|+|||++.   ...++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         165 VSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             cCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence            4322     2346788999999874   46688999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-33  Score=266.35  Aligned_cols=194  Identities=26%  Similarity=0.361  Sum_probs=167.0

Q ss_pred             EcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       194 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      ||+|+||+||+|... +++.+|+|.+....   ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 57889999886532   22344567899999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeec
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR  349 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~  349 (424)
                      .+++....  ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......  .....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence            99997653  24688999999999999999999998   9999999999999999999999999998765332  12233


Q ss_pred             ccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       350 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence            457889999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-33  Score=263.78  Aligned_cols=195  Identities=33%  Similarity=0.514  Sum_probs=166.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .+|++.+.||+|+||.||++.. .++.+|+|.+....  ..+.+.+|+.+++.++||||+++++++..+ ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688999999999999999975 47789999885432  335788899999999999999999998764 4789999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++....  ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            999999997652  24678899999999999999999998   9999999999999999999999999998754221   


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                       ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence             122334568999999988899999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-33  Score=267.50  Aligned_cols=198  Identities=29%  Similarity=0.414  Sum_probs=172.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++..++..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4555689999999999999964 678899998865555556678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++..     ..+++..++.++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+........ 
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            9999999875     3578889999999999999999998   999999999999999999999999998875433221 


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~  218 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE  218 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence            223356899999999998888999999999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.9e-33  Score=267.48  Aligned_cols=203  Identities=30%  Similarity=0.439  Sum_probs=178.3

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ..+.|++.+.||+|+||.||+|.+. ++..+++|.+..... ..+.+..|++.++.++|+||+++++++..+...++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            5567899999999999999999976 688899999876544 55678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++....   ..+++..+..++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999998752   3789999999999999999999998   9999999999999999999999999988755332


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .. ......++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~  220 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP  220 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            21 2233457889999999988889999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-36  Score=285.32  Aligned_cols=209  Identities=25%  Similarity=0.326  Sum_probs=184.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCC-EEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNT-NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +...+++.+..||-||||+|=++..+... .+|+|.+.+.   .....+.+..|-.+|...+.|.||++|..|.++...|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            44556778889999999999999876433 3788877554   3444567788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      |+||-|-||.|+..|+.+    +.+++..+..++..+++|++|||++   +||+|||||+|.+++.+|-+||.|||+|+.
T Consensus       497 mLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999999876    6788889999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCcc
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVC  400 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~  400 (424)
                      ++..  ..+.++||||.|.|||++.++..+.++|.||||+++|||++|.+||....|.-.++
T Consensus       570 i~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn  629 (732)
T KOG0614|consen  570 IGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN  629 (732)
T ss_pred             hccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence            7544  35667999999999999999999999999999999999999999998877755443

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-33  Score=276.03  Aligned_cols=197  Identities=29%  Similarity=0.361  Sum_probs=168.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------C
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~  255 (424)
                      .++|+..+.||+|+||.||+|... +++.||+|.+...  .....+.+.+|++++++++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            468999999999999999999965 6889999998643  233445677899999999999999999988643      3


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+.+ +|.+++..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            56899999965 88888753      277888899999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++......  ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...
T Consensus       165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            98754322  223346789999999999999999999999999999999999999654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.3e-33  Score=258.49  Aligned_cols=203  Identities=27%  Similarity=0.432  Sum_probs=178.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||++.+. ++..+++|++.....  ...+.+..|+++++.++|||++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999975 578899999865433  4556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++.........+++..+..++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999987643346789999999999999999999998   99999999999999999999999999998764432


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       .......|++.|+|||...+..++.++|+||+|+++++|++|+.||+..
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence             2233456899999999998888999999999999999999999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-33  Score=267.31  Aligned_cols=200  Identities=26%  Similarity=0.440  Sum_probs=169.4

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|+..+.||+|++|.||+|+.. +++.+|+|++....  ......+..|++++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999975 58889999885432  22345788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +. ++|.+++....  ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 58999886542  35688999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      . ......+++.|+|||++.+. .++.++|+||||+++|||+||+.||...
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            1 12233568899999987654 4688999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-34  Score=262.04  Aligned_cols=205  Identities=23%  Similarity=0.358  Sum_probs=170.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEcC-----CCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeee-CCee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~  257 (424)
                      ..|+....||+|.||.||+|...+     ++.+|||++...+.  .......+|+.+++.++||||+.+..++.+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            368889999999999999996432     23689999865422  222346679999999999999999999877 7788


Q ss_pred             eEEEEecCCCCHHHHHccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC----CceEEEe
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ----WNPKLSD  332 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kL~D  332 (424)
                      +|++||.+. +|.+.++-.+.. ...++...+..|+.||+.|+.|||++   -|+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999998 999998765432 34688899999999999999999999   89999999999999877    8999999


Q ss_pred             cCCccccCCCcce--eeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          333 FGLAKLLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       333 fG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ||+++.+...-..  ....++-|.+|.|||.+.+ ..|+.+.|+|++||++.||+|-.+-|....
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            9999988554222  2345677999999998765 569999999999999999999999887654

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-33  Score=262.03  Aligned_cols=193  Identities=27%  Similarity=0.401  Sum_probs=168.3

Q ss_pred             EcccCcEEEEEEEEcC-CCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          194 IGEGGYGIVYHGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       194 LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      ||+|+||.||++++.+ ++.+++|.+.....   ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 88899998865433   3456788899999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc-----
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-----  344 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-----  344 (424)
                      .+++.+.    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9999765    3789999999999999999999998   999999999999999999999999999875432211     


Q ss_pred             --eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 --YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                        .......++..|+|||......++.++|+||||+++|||++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  204 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE  204 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence              1223456788999999998888999999999999999999999999744

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=265.25  Aligned_cols=200  Identities=29%  Similarity=0.397  Sum_probs=171.3

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--CeeeEEEE
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYE  262 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e  262 (424)
                      |++.+.||+|+||.||+|... +++.+|+|++....  ......+.+|+++++.++|||++++++++.+.  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999976 47889999997653  33446788899999999999999999999887  78999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++ +|.+++...   ...+++..++.++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 899888654   24788999999999999999999998   9999999999999999999999999999876544


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||+...
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            3222334457889999997754 468899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-33  Score=267.19  Aligned_cols=200  Identities=25%  Similarity=0.375  Sum_probs=170.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--CeeeEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLV  260 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lv  260 (424)
                      ++|++.+.||+|+||.||+|.+. +++.+++|.+.....  .....+.+|++++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47899999999999999999976 578899999864432  2234567899999999999999999998877  789999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      +||+++ +|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||++....
T Consensus        85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999975 9999887652   3689999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus       158 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         158 SPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             CCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            432 122334578899999988654 4688999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=313.57  Aligned_cols=199  Identities=30%  Similarity=0.401  Sum_probs=169.4

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++.-..+||.|.||.||-|... +|.-.|+|.+.-.  .....+.+.+|+.++..++|||+|+++|+-.+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            4566789999999999999954 5777899987543  233345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      |++|+|.+.+...    .-.++.....+..|++.|++|||++   +||||||||.||||+.+|.+|++|||.|..+....
T Consensus      1316 C~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             hccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999765    3456666777888999999999999   99999999999999999999999999999875542


Q ss_pred             ce---eeecccccccccccccccC---CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          344 SY---VTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       344 ~~---~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..   .....+||+.|||||++.+   +....++||||+|||+.||+||+.||..
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence            11   1234689999999999965   3466789999999999999999999973

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.8e-33  Score=266.32  Aligned_cols=203  Identities=25%  Similarity=0.336  Sum_probs=167.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCe-----
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAH-----  256 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~-----  256 (424)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+++++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999965 58889999875432  223356788999999995 6999999999887665     


Q ss_pred             eeEEEEecCCCCHHHHHccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecC
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFG  334 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG  334 (424)
                      .++||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 898888654322 35689999999999999999999998   9999999999999998 8899999999


Q ss_pred             CccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +++.+..... ......+++.|+|||.+.+ ..++.++|+||||+++|||++|..||...
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9886533211 1122356889999998754 56799999999999999999999999754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=273.85  Aligned_cols=200  Identities=26%  Similarity=0.417  Sum_probs=167.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----Cee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~  257 (424)
                      .++|++.+.||+|+||.||+|... +++.||+|.+... .......+..|+++++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            358999999999999999999864 6888999998643 233445678899999999999999999987644     357


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++++||+.+ +|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            899999975 88887754     3688999999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCcce--eeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ........  ......||+.|+|||.+.+ ..++.++|+|||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            65432211  1233568999999998654 56899999999999999999999999653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.1e-33  Score=259.66  Aligned_cols=201  Identities=26%  Similarity=0.466  Sum_probs=172.8

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||+|..+ ++..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+.++...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999976 57889999886532  23445788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc-eEEEecCCccccCCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAE  342 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kL~DfG~a~~~~~~  342 (424)
                      +++++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||||+||++++++. +||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999997652  23578999999999999999999998   9999999999999998864 699999999876433


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. ......|++.|+|||+..+..++.++|+||||+++|||++|..||...
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            22 223345899999999998888999999999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.9e-33  Score=269.25  Aligned_cols=203  Identities=29%  Similarity=0.410  Sum_probs=169.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Ceee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~  258 (424)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++.....  .....+.+|++++++++|+||+++++++.+.  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            3457899999999999999999975 588899998864322  2233456799999999999999999998765  4678


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+.+ +|.+++...   ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            99999975 898888764   25689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ...... ......+++.|+|||.+.+ ..++.++|+|||||++|||++|+.||....
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~  213 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS  213 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            643321 1223345788999998865 568899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.9e-33  Score=260.86  Aligned_cols=191  Identities=23%  Similarity=0.329  Sum_probs=159.9

Q ss_pred             CCcccceeE--cccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVI--GEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~L--G~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      +.|++.+.+  |+|+||.||++... ++..+|+|.+........     |+.....+ +||||+++++++..++..++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            355565555  99999999999965 577788888754322211     22222222 7999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCccccC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLG  340 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~~~~  340 (424)
                      ||+++++|.+++...    ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||++....
T Consensus        89 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         89 DYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999765    3789999999999999999999998   999999999999999988 99999999988654


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..     ....|+..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus       162 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        162 TP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             CC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            32     2245789999999999999999999999999999999999999744

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.9e-33  Score=265.09  Aligned_cols=202  Identities=26%  Similarity=0.422  Sum_probs=168.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|++|.||+|... +++.||+|++....  ....+.+..|++++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            47889999999999999999975 67889999885432  2334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCccccCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~~~~~  341 (424)
                      |+++ +|.+++....  ....++..+..++.|++.||+|||++   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLDL-DLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             cccc-cHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9964 8888876542  23467888889999999999999998   9999999999999985 55799999999976543


Q ss_pred             CcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ... ......+++.|+|||++.+ ..++.++|+||||+++|+|+||+.||....
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            211 1223457889999998865 468899999999999999999999997543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.4e-33  Score=263.66  Aligned_cols=202  Identities=28%  Similarity=0.454  Sum_probs=171.2

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      +|++.+.||+|++|.||+|+.. ++..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999975 578899998865432 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++ +|.+++..... ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 89988865432 34689999999999999999999998   999999999999999999999999999976533221


Q ss_pred             eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       ......++..|++||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             1223457889999998755 457889999999999999999999997544

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=258.57  Aligned_cols=196  Identities=24%  Similarity=0.333  Sum_probs=164.4

Q ss_pred             CCccc-ceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC----Ceee
Q 014466          186 NGFAD-ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG----AHRM  258 (424)
Q Consensus       186 ~~~~~-~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~----~~~~  258 (424)
                      ++|.+ -++||-|-.|.|..|..+ +++++|+|.+.+.     ...++|+++--.. .|||||.++++|++.    ..++
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            34444 368999999999999965 6888999988543     2344577765444 699999999998653    4567


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL  335 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~  335 (424)
                      +|||.++||.|.+.++.+.  ...+++..+..|+.||+.|+.|||+.   +|.||||||+|+|...   +..+||+|||+
T Consensus       136 iVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            9999999999999998874  36799999999999999999999998   9999999999999964   44699999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+....  .......+-||+|.|||++...+|+...|+||+||++|-|++|.+||...
T Consensus       211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence            996432  34455677899999999999999999999999999999999999999743

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-32  Score=255.99  Aligned_cols=201  Identities=28%  Similarity=0.431  Sum_probs=176.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--CeeeEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY  261 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lv~  261 (424)
                      +|...+.||+|++|.||+|... +++.+++|.+.....  ...+.+.+|++++++++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999976 688899998865542  4567889999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...    ..+++..++.++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999999765    3789999999999999999999998   999999999999999999999999999987654


Q ss_pred             Ccce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            3321 1234568889999999988889999999999999999999999997653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.6e-33  Score=260.40  Aligned_cols=202  Identities=27%  Similarity=0.390  Sum_probs=176.1

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|+||.||++... +++.+++|.+....  .....++..|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 67889999986542  33345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++.........+++..++.++.+++.||+|||+.   +++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999877443346789999999999999999999998   9999999999999999999999999999876443 


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                        ......+++.|++||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  205 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS  205 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence              2223457889999999999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8e-33  Score=260.97  Aligned_cols=203  Identities=24%  Similarity=0.428  Sum_probs=166.2

Q ss_pred             cccceeEcccCcEEEEEEEEc----CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          188 FADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      |.+.+.||+|+||.||+|.+.    ++..+|+|.+...  .....+++.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999854    3578999988654  2344567888999999999999999999886432      


Q ss_pred             eeeEEEEecCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ..++++||+.+|+|.+++....  .....+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999998875332  1223578889999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          334 GLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      |+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            999865432211 1223345678999999999899999999999999999999 88998643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.2e-33  Score=264.14  Aligned_cols=199  Identities=29%  Similarity=0.367  Sum_probs=169.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +|++.+.||+|+||.||+++..    ++..+|+|.+.+..    ....+.+..|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3778899999999999999843    46789999886432    22345678899999999 599999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++|+|.+++...    ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999998754    4678888999999999999999998   99999999999999999999999999988


Q ss_pred             ccCCCcceeeecccccccccccccccCCC--CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..............|+..|+|||.+.+..  ++.++|+||||+++|||++|..||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            65443333333456899999999987655  78899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.5e-33  Score=266.81  Aligned_cols=197  Identities=29%  Similarity=0.419  Sum_probs=171.4

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      |....+||+|+||.||++... ++..+|+|++........+.+.+|+.+++.++|+||+++++++..++..++||||+++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            344578999999999999874 6888999988655555566788999999999999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      ++|.+++..     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus       102 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~  172 (292)
T cd06657         102 GALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  172 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence            999998754     3578889999999999999999998   999999999999999999999999999876533221 2


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....|++.|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            23356889999999998888999999999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=254.70  Aligned_cols=199  Identities=30%  Similarity=0.497  Sum_probs=175.7

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +|++.+.||+|++|.||++... +++.+++|.+.....  ...+.+.+|++++++++|||++++++++.++...+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 577899999876543  4556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999999765    5789999999999999999999998   99999999999999999999999999998764433


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. .....++..|+|||...+..++.++|+||+|+++|+|++|+.||...
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~  202 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL  202 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence            21 23456888999999998888999999999999999999999999643

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-33  Score=290.42  Aligned_cols=231  Identities=29%  Similarity=0.484  Sum_probs=197.9

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEc----C----CCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCceeeEee
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLE----D----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLG  249 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~  249 (424)
                      .+++..++.++.+.||+|.||.|++|...    .    ...||||.+..... ...+.+..|+++|+.+ .|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            56788888888899999999999999843    1    34589999876533 4567899999999999 6999999999


Q ss_pred             EeeeCCeeeEEEEecCCCCHHHHHccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCC
Q 014466          250 YCAEGAHRMLVYEYIDNGNLEQWLHGDV---GP-------H--SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS  317 (424)
Q Consensus       250 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp  317 (424)
                      ++.+++..++|+||+..|+|..+|+..+   ..       .  ..++....+.++.|||.|++||++.   ++|||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998775   11       1  2388899999999999999999999   999999999


Q ss_pred             CCEEEcCCCceEEEecCCccccCCCcceeeeccccc--ccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC--
Q 014466          318 SNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY--  392 (424)
Q Consensus       318 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt--~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~--  392 (424)
                      .|||++.+..+||+|||+|+.......+......|+  ..|||||.+....|+.++|||||||+|||++| |..||..  
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            999999999999999999997655555543433333  34999999999999999999999999999999 9999985  


Q ss_pred             -------------CCCCCCccHHHHHHHHHhhhc
Q 014466          393 -------------SRPPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       393 -------------~~~~~~~~~~~~~~~~~~~~~  413 (424)
                                   +...++.|..++..+|..||.
T Consensus       527 ~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~  560 (609)
T KOG0200|consen  527 PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWN  560 (609)
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhC
Confidence                         345778899999999999994

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=263.51  Aligned_cols=199  Identities=27%  Similarity=0.436  Sum_probs=169.1

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      |++.+.||+|++|.||+|.+. +|..||+|++....  ....+.+.+|++.++.++||||+++++++.++...+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567899999999999999965 68899999886543  223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      + ++|.+++....  ...+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 59999987653  24689999999999999999999998   999999999999999999999999999976543221


Q ss_pred             eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      . .....+++.|+|||++.+ ..++.++|+||||+++|||++|+.||...
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1 122356889999998765 45788999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.8e-33  Score=266.52  Aligned_cols=204  Identities=28%  Similarity=0.385  Sum_probs=170.4

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC----
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----  255 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----  255 (424)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|.+....  ......+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            44568999999999999999999976 57889999986432  233456778999999999999999999987654    


Q ss_pred             ------eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          256 ------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       256 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                            ..++|+||+++ ++..++...   ...+++..++.++.|++.||+|||+.   +|+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78899999986 777777654   34689999999999999999999998   999999999999999999999


Q ss_pred             EEecCCccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999998664333222223446788999998764 45788999999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=259.52  Aligned_cols=190  Identities=26%  Similarity=0.342  Sum_probs=161.3

Q ss_pred             eeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHH-hcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAI-GRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|... +++.||+|.+.+...   .....+..|..++ ...+|+||+++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999965 578899998865422   2223344455444 455899999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++....     
T Consensus        82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            9999999764    4688899999999999999999998   999999999999999999999999999875432     


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....|+..|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            22346888999999998888999999999999999999999999643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.1e-33  Score=264.34  Aligned_cols=201  Identities=30%  Similarity=0.465  Sum_probs=176.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ++|.+.+.||+|+||.||+|... +++.+|+|.+.+.   .....+.+..|++++++++ ||||+++++++.++...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999965 6888999988653   2334467888999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999999765    4789999999999999999999998   99999999999999999999999999988654


Q ss_pred             CCcc-------------------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERS-------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....                   .......|+..|+|||......++.++|+||||++++++++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            3321                   1223356789999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.4e-33  Score=265.92  Aligned_cols=203  Identities=25%  Similarity=0.381  Sum_probs=167.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            347899999999999999999975 58889999886432  222345667999999999999999999987654      


Q ss_pred             --eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          256 --HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       256 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                        ..++||||+.+ +|.+++...   ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              34899999975 888888654   24688999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCcce---eeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          334 GLAKLLGAERSY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |++.........   ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            999865432211   12234578899999987654 47889999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.9e-32  Score=263.44  Aligned_cols=195  Identities=31%  Similarity=0.453  Sum_probs=167.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..|+..+.||+|+||.||+++.. ++..+|+|.+....   ......+..|+++++.++|||++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            35788999999999999999965 57889999886432   233457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+.+ +|.+++...   ..++++..+..++.+++.||.|||+.   +|+||||+|+||+++.++.+||+|||++.....
T Consensus       105 e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         105 EYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             eCCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            99975 888877544   25688999999999999999999998   999999999999999999999999999875432


Q ss_pred             Ccceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                           .....|++.|+|||++.   ...++.++|+|||||++|||++|+.||..
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  226 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  226 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                 22346888999999873   46788999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.7e-33  Score=271.68  Aligned_cols=200  Identities=25%  Similarity=0.429  Sum_probs=169.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeee----CCeee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM  258 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~  258 (424)
                      ++|++.+.||+|+||.||+|... ++..||+|++....  ....+.+..|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            57889999999999999999965 58899999986542  2344567789999999999999999998763    34678


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+. ++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999996 5899998754    4589999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCcc---eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERS---YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......   .......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~  215 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK  215 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence            533221   11234578999999998755 56899999999999999999999999654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.2e-33  Score=270.41  Aligned_cols=200  Identities=29%  Similarity=0.442  Sum_probs=168.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC--Ceee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG--AHRM  258 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--~~~~  258 (424)
                      .++|++.+.||+|+||.||+|.+. +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            458999999999999999999976 5788999988543  223345677899999999 999999999998643  3678


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++ +|.+++...     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999975 999988653     677888899999999999999998   999999999999999999999999999986


Q ss_pred             cCCCcc----eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERS----YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......    .......||..|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            643322    12234568999999997754 56888999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-32  Score=261.90  Aligned_cols=202  Identities=29%  Similarity=0.465  Sum_probs=168.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~  258 (424)
                      .+..++|++.+.||+|+||.||+|.+++ ++.+|+|.+.... .....++..|++++.... ||||+++++++.++...+
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            4556789999999999999999999874 8889999986543 233455666777776664 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++|||+.+ +|.+++...   ...+++..+..++.|+++|++|||+ .   +|+||||+|+||++++++.+||+|||++.
T Consensus        91 ~v~e~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          91 ICMELMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             EEeeccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence            99999864 787777653   2478899999999999999999996 5   89999999999999999999999999987


Q ss_pred             ccCCCcceeeecccccccccccccccCCC----CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .+.....  .....++..|+|||.+.+..    ++.++|+||||+++|||++|+.||..
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            6543222  22345788999999987554    88899999999999999999999964

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-32  Score=261.03  Aligned_cols=197  Identities=25%  Similarity=0.352  Sum_probs=164.3

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCceeeEeeEeeeC--CeeeEEEE
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRMLVYE  262 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~e  262 (424)
                      |++.+.||+|+||.||+|... +++.+|+|++.... .........|+..++++. |+||+++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999965 57889999886542 222233456888999885 99999999999987  88999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++ +|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++. +.+||+|||+++.....
T Consensus        81 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMDM-NLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCCc-cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9975 888888654   24689999999999999999999998   9999999999999999 99999999999866433


Q ss_pred             cceeeeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..  .....++..|+|||.+. +..++.++|+|||||++|||++|..||....
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence            22  12345789999999764 4567889999999999999999999997543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.5e-34  Score=295.76  Aligned_cols=194  Identities=29%  Similarity=0.449  Sum_probs=157.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC---------
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG---------  254 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---------  254 (424)
                      ++|+.++.||+||||.||+++.+ ||+.||||++.-+ .......+.+|+.++++|+|||||+++..+.+.         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            57889999999999999999976 8999999999544 333445688899999999999999986522000         


Q ss_pred             --------------------------------------------------------------------------------
Q 014466          255 --------------------------------------------------------------------------------  254 (424)
Q Consensus       255 --------------------------------------------------------------------------------  254 (424)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------------------CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 014466          255 ------------------------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE  304 (424)
Q Consensus       255 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~  304 (424)
                                                    ..+||-||||+...|.++++++.   ..-.....++++++|+.||+|+|+
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHh
Confidence                                          11468899999977777777652   111467789999999999999999


Q ss_pred             CCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC-----------------CCcceeeecccccccccccccccCC--
Q 014466          305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----------------AERSYVTTRVMGTFGYVAPEYASTG--  365 (424)
Q Consensus       305 ~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~--  365 (424)
                      +   +||||||||.||+++++..+||+|||+|....                 .......+..+||.-|+|||++.+.  
T Consensus       716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            9   99999999999999999999999999998621                 1122245667899999999998654  


Q ss_pred             -CCCCccchHHHHHHHHHHHc
Q 014466          366 -MLNERSDVYSFGILIMEVIS  385 (424)
Q Consensus       366 -~~~~~sDiwSlGv~l~ellt  385 (424)
                       .|+.|+|+|||||||+||+.
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc
Confidence             59999999999999999974

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-32  Score=268.93  Aligned_cols=199  Identities=27%  Similarity=0.411  Sum_probs=168.5

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----Cee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~  257 (424)
                      ++|.+.+.||+|+||+||+|+.. +++.||+|.+...  .......+..|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            47899999999999999999965 5888999998653  223345677899999999999999999988654     347


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++|+||+. ++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            89999996 5899988754    5689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...... .......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||...
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            654322 22234567889999998764 56899999999999999999999999654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.5e-33  Score=265.32  Aligned_cols=203  Identities=27%  Similarity=0.382  Sum_probs=167.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      .++|++.+.||+|+||.||+|... +++.+|+|++.....  .....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 578899998864422  22345678999999999999999999875433      


Q ss_pred             --eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          256 --HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       256 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                        ..++|+||+.+ +|..++...   ...+++..+..++.|+++||+|||+.   +|+|+||||+|||+++++.+||+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46899999975 787777654   24689999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCcce----------eeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          334 GLAKLLGAERSY----------VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |+++........          ..+...|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            999865332111          1123457889999998765 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.7e-33  Score=263.40  Aligned_cols=203  Identities=32%  Similarity=0.440  Sum_probs=166.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            46777899999999999999965 57889999986543 344567888999999996 9999999999999889999999


Q ss_pred             ecCCCCHHHHHccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          263 YIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       263 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |+.. ++.++.... ......+++..+..++.++++||+|||+..  +++||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9865 665543211 011256899999999999999999999632  899999999999999999999999999976532


Q ss_pred             CcceeeecccccccccccccccCC---CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..  ......|+..|+|||++.+.   .++.++|+|||||++|||++|+.||...
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            21  22334688999999998765   6899999999999999999999999643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-33  Score=268.66  Aligned_cols=200  Identities=27%  Similarity=0.417  Sum_probs=173.1

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC-----eee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM  258 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~  258 (424)
                      +|++.+.||.|+||.||+|... +++.+|+|++....  ....+.+.+|++.++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788999999999999999975 48889999986643  344567889999999999999999999988765     789


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ++|||+++ +|.+++...    ..+++..++.++.+++.||+|||+.   +|+|+||||+|||++.++.++|+|||++..
T Consensus        81 lv~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999985 899988764    4789999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCcc--eeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          339 LGAERS--YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ......  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            644321  123345678999999999877 89999999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-32  Score=265.71  Aligned_cols=200  Identities=28%  Similarity=0.427  Sum_probs=169.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee-CCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~  257 (424)
                      ....++|++.+.||+|+||.||+|... +++.+|+|++.+.  .....+.+..|+++++.++||||+++++++.. +...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446778999999999999999999965 6888999988543  22344667889999999999999999999865 5578


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++++||+ +++|.++++.     ..+++..+..++.|+++||+|||+.   +|+||||+|+|||++.++.+||+|||++.
T Consensus        86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            8999998 4589988864     3577888889999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....    .....+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~  210 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD  210 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            54321    223457889999998765 678999999999999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-32  Score=267.78  Aligned_cols=200  Identities=26%  Similarity=0.375  Sum_probs=168.1

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC---
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG---  254 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---  254 (424)
                      +....++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++...   
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            3455678999999999999999999854 68889999986542  22345677899999999999999999988643   


Q ss_pred             ---CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE
Q 014466          255 ---AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS  331 (424)
Q Consensus       255 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~  331 (424)
                         ...+++++++ +++|.+++...     .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence               3467888877 67999888643     578999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |||+++....    ......|+..|+|||++.+ ..++.++|+|||||++|||++|+.||...
T Consensus       163 dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         163 DFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             cccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999886432    2233567899999998765 56889999999999999999999999654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=260.75  Aligned_cols=207  Identities=30%  Similarity=0.418  Sum_probs=167.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHh-cCCCCceeeEeeEeeeCCeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIG-RVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ++..++.+.+..||.|+||+|++-.++ .|+..|||++..... ...+++..|.+... .-+.||||++||.+..++..|
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            344556777889999999999998865 688899999966544 44567777877654 457999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          259 LVYEYIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      +.||.|+- +|..+.+.- .-....+++...-.|...++.||.||-+..  +|||||+||+|||++..|.+||||||++-
T Consensus       140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchH
Confidence            99999975 776654321 112357888988899999999999999764  99999999999999999999999999986


Q ss_pred             ccCCCcceeeeccccccccccccccc--CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .+-  .+...+.-.|...|||||.+.  ...|+.+||+||||++|||+.||+.||...
T Consensus       217 qLv--~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w  272 (361)
T KOG1006|consen  217 QLV--DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW  272 (361)
T ss_pred             hHH--HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence            542  233344456888999999884  345999999999999999999999999743

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.5e-32  Score=264.16  Aligned_cols=197  Identities=24%  Similarity=0.313  Sum_probs=162.3

Q ss_pred             eeEccc--CcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      ..||+|  +||+||++.+. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457777  99999999975 68999999886432  33456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      ++|.+++....  ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+|++||+.+..........
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999998653  23588899999999999999999998   99999999999999999999999998654321111000


Q ss_pred             ------eecccccccccccccccCC--CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 ------TTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                            .....++..|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                  0112346679999998764  4789999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-32  Score=265.99  Aligned_cols=200  Identities=25%  Similarity=0.327  Sum_probs=166.5

Q ss_pred             Ccc-cceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchh--------------HHHHHHHHHHHhcCCCCceeeEeeE
Q 014466          187 GFA-DENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA--------------EKEFKVEVEAIGRVRHKNLVRLLGY  250 (424)
Q Consensus       187 ~~~-~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~hpnIv~l~~~  250 (424)
                      +|. +.+.||+|+||+||+|.+. +++.||+|++.......              ...+.+|+++++.++||||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            454 4678999999999999965 68889999885432211              1246789999999999999999999


Q ss_pred             eeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEE
Q 014466          251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL  330 (424)
Q Consensus       251 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL  330 (424)
                      +..++..++||||+. |+|.+++...    ..+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            999999999999997 5999998654    4688899999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCc-------------ceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          331 SDFGLAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       331 ~DfG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +|||++.......             ........+++.|+|||.+.+. .++.++|+|||||++|||++|+.||....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999998654111             1111223568899999988764 47889999999999999999999997543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-32  Score=266.41  Aligned_cols=197  Identities=24%  Similarity=0.400  Sum_probs=167.5

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC-----
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----  255 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----  255 (424)
                      ..++|++.+.||+|+||.||++... ++..||+|++....  ....+.+..|+++++.++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3567999999999999999999854 68889999985432  223456788999999999999999999987654     


Q ss_pred             -eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       256 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                       ..++||||+ +++|.+++..     ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999999 6799988864     3688999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++......    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99865322    223457889999998865 46889999999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-32  Score=268.63  Aligned_cols=200  Identities=25%  Similarity=0.418  Sum_probs=167.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC----------
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG----------  254 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----------  254 (424)
                      .+|++.+.||.|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            58899999999999999999965 5788999998766656667788999999999999999999876543          


Q ss_pred             ----CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceE
Q 014466          255 ----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPK  329 (424)
Q Consensus       255 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~k  329 (424)
                          ...++||||+++ +|.+++..     ..+++..++.++.|++.||.|||+.   +|+||||||+||+++. ++.+|
T Consensus        85 ~~~~~~~~lv~e~~~~-~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYMET-DLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeecccc-cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence                357899999974 99888854     3578899999999999999999998   9999999999999974 56789


Q ss_pred             EEecCCccccCCCcce--eeeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          330 LSDFGLAKLLGAERSY--VTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |+|||+++........  ......++..|+|||.+. +..++.++|+|||||++|||++|+.||....
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999765332111  112345788999999764 4668889999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-32  Score=256.61  Aligned_cols=199  Identities=29%  Similarity=0.425  Sum_probs=166.9

Q ss_pred             cccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCceeeEeeEeeeCCe-----
Q 014466          188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAH-----  256 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~-----  256 (424)
                      |++.+.||+|+||.||+|+.+. ++.+|+|++.....  .....+..|+++++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678999999999999999764 88999999864322  2234566677777666   59999999999988776     


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .+++|||+.+ +|.+++....  ...+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 8999887642  23588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ........  .....++..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            87643322  223457889999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.5e-32  Score=259.42  Aligned_cols=194  Identities=31%  Similarity=0.457  Sum_probs=165.9

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      |...+.||+|+||+||+|+.. +++.+++|++....   ......+..|+++++.++|||++++++++.++...++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999965 57889999886432   23345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +. |+|.+++...   ..++++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....  
T Consensus       103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 5888877654   24688999999999999999999998   999999999999999999999999998864321  


Q ss_pred             ceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                         .....|+..|+|||++.   ...++.++|+|||||++|||++|..||...
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence               23456889999999874   466888999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=265.50  Aligned_cols=207  Identities=26%  Similarity=0.438  Sum_probs=172.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCch-------hHHHHHHHHHHHhcCCCCceeeEeeEee-
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQ-------AEKEFKVEVEAIGRVRHKNLVRLLGYCA-  252 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-  252 (424)
                      ....++|-.++.||+|||+.||+|.+ ..++.||+|+-.-++..       ..+...+|..+-+.|.||.||++|++|. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            44556899999999999999999984 45677888875433222       1234567999999999999999999996 


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceE
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPK  329 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~k  329 (424)
                      +.+.+|-|+|||+|.+|.-||+.+    ..+++..+..|+.||+.||.||.+. +++|||-||||.|||+   +.-|.+|
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence            445678899999999999999876    5789999999999999999999985 8899999999999999   4568899


Q ss_pred             EEecCCccccCCCcc------eeeeccccccccccccccc----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          330 LSDFGLAKLLGAERS------YVTTRVMGTFGYVAPEYAS----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       330 L~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+|||+++.++++..      ..+....||.+|++||.+.    ....+.|+||||+||++|..+.|+.||...
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            999999998865432      2345678999999999653    235778999999999999999999999854

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3e-32  Score=262.69  Aligned_cols=199  Identities=21%  Similarity=0.221  Sum_probs=164.1

Q ss_pred             ccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      .+.+.+|.|+++.|+++.. +++.||+|++...  .....+.+..|+++++.++||||+++++++.+++..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            4455555566666655554 5889999998654  344567899999999999999999999999999999999999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc--
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS--  344 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--  344 (424)
                      |+|.+++....  ...+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||.+........  
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          84 GSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            99999998653  24588899999999999999999999   999999999999999999999999998875432111  


Q ss_pred             ----eeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 ----YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                          .......++..|+|||++..  ..++.++|+|||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence                11223457788999999866  45889999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-32  Score=258.36  Aligned_cols=199  Identities=26%  Similarity=0.399  Sum_probs=170.8

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      |++.+.||+|++|.||+|... +++.+++|++.....  .....+..|+++++.++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999965 688899998865432  34567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++ +|.+++...   ...+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            76 888888764   25788999999999999999999998   99999999999999999999999999998764433 


Q ss_pred             eeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||....
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            122234578899999988776 78999999999999999999999996533

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-32  Score=250.50  Aligned_cols=193  Identities=29%  Similarity=0.372  Sum_probs=169.0

Q ss_pred             EcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCH
Q 014466          194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       194 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      ||+|+||.||++... +++.+++|.+.....   ...+.+..|+++++.++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 478899998865432   2456788899999999999999999999999999999999999999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeec
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR  349 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~  349 (424)
                      .+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            9999765    3688999999999999999999998   99999999999999999999999999998654322 12334


Q ss_pred             ccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       350 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..++..|++||...+..++.++|+||||+++|||++|+.||....
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            567889999999988889999999999999999999999996543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7e-32  Score=259.72  Aligned_cols=197  Identities=29%  Similarity=0.456  Sum_probs=167.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      +.+.|+..+.||+|+||.||+|+.. ++..+|+|.+...   ......++.+|+++++.++|+|++++++++..+...++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            3456888899999999999999965 5778999988542   22334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+. |+|.+++...   ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            999997 5888877544   24678899999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ...     ....|++.|+|||.+.   ...++.++|||||||++|||++|+.||..
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  216 (308)
T cd06634         166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (308)
T ss_pred             cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence            322     2345788999999874   45688899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.7e-32  Score=284.66  Aligned_cols=145  Identities=28%  Similarity=0.416  Sum_probs=130.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|.+.+.||+|+||.||+|++. +++.||||++....   ......+..|+++++.++||||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999976 57889999986532   233467888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ||+.+++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999764    4678889999999999999999998   99999999999999999999999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.3e-32  Score=253.12  Aligned_cols=201  Identities=21%  Similarity=0.334  Sum_probs=167.1

Q ss_pred             CcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecC-----CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      +|.+.+.||+|+||.||+++... +..+++|.+...     .......+..|+++++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998653 334555554321     222334567799999999999999999999998999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      +||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++. +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999999876433346789999999999999999999998   9999999999999975 569999999987653


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ... .......|++.|+|||...+..++.++|+||||+++|+|++|..||..
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            322 222345688899999999888899999999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-32  Score=263.68  Aligned_cols=196  Identities=26%  Similarity=0.421  Sum_probs=165.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+++++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            357899999999999999999964 68899999986532  223456788999999999999999999986542      


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++|+||+.. +|..++.      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46899999975 7877652      3578899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.....    .....+++.|+|||.+.+ ..++.++|+|||||++|||++|+.||....
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~  219 (342)
T cd07879         164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  219 (342)
T ss_pred             CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9864322    223457889999998866 568899999999999999999999997543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=9.3e-32  Score=261.59  Aligned_cols=200  Identities=26%  Similarity=0.364  Sum_probs=164.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc-C--CCEEEEEEeecC--CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC----Ce
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-D--NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG----AH  256 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~----~~  256 (424)
                      +|++.+.||+|+||.||+++.. .  +..+|+|++...  .....+.+.+|+++++++ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999965 3  678999988643  222345677899999999 599999999875432    45


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++++||+. ++|.+++...    ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            678889886 5899998654    5688999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcc---eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERS---YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +.......   .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||....
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            86543221   11234578999999998765 568999999999999999999999997643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=9.7e-32  Score=254.91  Aligned_cols=199  Identities=26%  Similarity=0.379  Sum_probs=168.5

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEec
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      |++.+.||+|+||.||+|... +++.+++|++..... .......+|+..+++++ ||||+++++++.++...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567899999999999999976 477899998865432 22234556899999999 999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                       +|+|.+++....  ...+++..++.++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             779999887653  24678999999999999999999998   999999999999999999999999999986543222


Q ss_pred             eeeeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                        .....++..|+|||++. ...++.++|+||||++++||++|+.||....
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence              23346788999999874 4568899999999999999999999996554

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=254.28  Aligned_cols=199  Identities=29%  Similarity=0.472  Sum_probs=170.4

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      |+..+.||+|+||.||+|... +++.+|+|.+....  ....+.+..|+++++.++|+||+++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999976 48889999987653  333456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++ +|.+++....   ..+++..++.++.+++.||+|||+.   +|+||||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            85 9999997652   4688999999999999999999999   999999999999999999999999999986543322


Q ss_pred             eeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence             22234467789999988766 88999999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=8.3e-32  Score=263.20  Aligned_cols=198  Identities=25%  Similarity=0.396  Sum_probs=168.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe----
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH----  256 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~----  256 (424)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999975 57889999886432  2334567789999999999999999998876554    


Q ss_pred             --eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          257 --RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       257 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                        .++|+||+ +++|.+++..     ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              88999999 5699998864     3689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++......    .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~  220 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD  220 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99865322    233467889999998865 468899999999999999999999997543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=2.6e-31  Score=246.04  Aligned_cols=181  Identities=22%  Similarity=0.226  Sum_probs=155.1

Q ss_pred             cCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHHHHHcc
Q 014466          197 GGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG  275 (424)
Q Consensus       197 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  275 (424)
                      |.||.||++++. +++.+|+|++....     .+..|...+....||||+++++++.+....+++|||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999965 67889999986542     233455555666799999999999999999999999999999999876


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeeccccccc
Q 014466          276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG  355 (424)
Q Consensus       276 ~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~  355 (424)
                      .    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+......    .....++..
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence            5    3588999999999999999999998   9999999999999999999999999987654322    223446778


Q ss_pred             ccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       356 y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+|||.+.+..++.++|+||+|+++|||++|+.||+..
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~  185 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH  185 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence            99999998888999999999999999999999887643

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-32  Score=250.73  Aligned_cols=208  Identities=22%  Similarity=0.337  Sum_probs=175.4

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCC--CCc----eeeEe
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR--HKN----LVRLL  248 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--hpn----Iv~l~  248 (424)
                      +-+...+...++|++...+|+|.||.|-.|++.. +..||+|++..- ....+...-|++++.++.  .|+    +|++.
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            5566677889999999999999999999999664 577899977543 233345566999999993  233    88999


Q ss_pred             eEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC----
Q 014466          249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----  324 (424)
Q Consensus       249 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~----  324 (424)
                      +||.-.++.++|+|.+ |-++.++|..+.  ..+++...+..+..|++++++|||+.   +++|.||||+|||+.+    
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence            9999999999999988 559999998873  56788899999999999999999999   9999999999999921    


Q ss_pred             ----------------CCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCC
Q 014466          325 ----------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN  388 (424)
Q Consensus       325 ----------------~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~  388 (424)
                                      +..+||+|||.|.......    ...+.|..|.|||++.+-.++..+||||+||||+||.||..
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                            2348999999998643332    44667999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 014466          389 PVDYSR  394 (424)
Q Consensus       389 Pf~~~~  394 (424)
                      -|....
T Consensus       308 LFqtHe  313 (415)
T KOG0671|consen  308 LFQTHE  313 (415)
T ss_pred             ecccCC
Confidence            997654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=265.69  Aligned_cols=196  Identities=24%  Similarity=0.395  Sum_probs=169.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhH--------HHHHHHHHHHhcCC---CCceeeEeeEeee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAE--------KEFKVEVEAIGRVR---HKNLVRLLGYCAE  253 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~--------~~~~~Ei~~l~~l~---hpnIv~l~~~~~~  253 (424)
                      .+|+..+.+|+|+||.|++|.++. ...|+||.+.+.+--..        -.+-.||++|+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            468999999999999999999774 56688998876542211        12446999999997   9999999999999


Q ss_pred             CCeeeEEEEec-CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          254 GAHRMLVYEYI-DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       254 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                      ++.+||+||-. ++.+|.+++...    ..+++..+..|++|++-|+++||++   +|||||||-+|+.++.+|-+||+|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            99999999975 456899999765    5789999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCcceeeecccccccccccccccCCCCCC-ccchHHHHHHHHHHHcCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE-RSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ||.+....+.   .-..++||..|.|||++.+..|-- .-|||++|++||.++....||.
T Consensus       714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999865332   334578999999999999988754 5799999999999999999985

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=270.79  Aligned_cols=210  Identities=30%  Similarity=0.445  Sum_probs=178.5

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEee---
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA---  252 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~---  252 (424)
                      +..+..+++-|++.++||.|.+|.||+++. ++++..|+|+.... ....+++..|.++++.. .|||++.++|+|.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            444556778899999999999999999994 46777888876544 34446677889999888 6999999999985   


Q ss_pred             --eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEE
Q 014466          253 --EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL  330 (424)
Q Consensus       253 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL  330 (424)
                        .++.+|||||||.+|+..++++...  ...+.|..+..|++.++.||.+||.+   .++|||||-.|||++.++.+||
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence              4568999999999999999998775  46789999999999999999999999   9999999999999999999999


Q ss_pred             EecCCccccCCCcceeeecccccccccccccccC-----CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       331 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +|||++..++.... ......|||.|||||++.-     ..|+..+|+||||++..||--|.+|+.+-.
T Consensus       165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH  232 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH  232 (953)
T ss_pred             eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence            99999987654433 3456789999999998843     347788999999999999999999987433

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-32  Score=249.94  Aligned_cols=233  Identities=24%  Similarity=0.324  Sum_probs=189.1

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeE
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGY  250 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~  250 (424)
                      +.++.+...+++....+-+|.||+||+|.+.      +.+.|.+|.+.+... -....+..|.-++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4566777888999999999999999999643      344567787765533 345668889889999999999999998


Q ss_pred             eee-CCeeeEEEEecCCCCHHHHHccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          251 CAE-GAHRMLVYEYIDNGNLEQWLHGDVG----PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       251 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      +.+ ....+.++.++.-|+|..||..-++    ....++.......+.|++.|++|||+.   +|||.||...|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            865 4567888999999999999972221    234566667778899999999999999   99999999999999999


Q ss_pred             CceEEEecCCccccCCCc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC-----------
Q 014466          326 WNPKLSDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY-----------  392 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~-----------  392 (424)
                      .++||+|=.+++.+-+.. ............||+||.+.+..|+..+|+|||||+||||+| |+.||..           
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            999999999988653322 222222334568999999999999999999999999999999 9999873           


Q ss_pred             ---CCCCCCccHHHHHHHHHhhhc
Q 014466          393 ---SRPPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       393 ---~~~~~~~~~~~~~~~~~~~~~  413 (424)
                         +...+-+|..++...|.-||.
T Consensus       513 dGyRlaQP~NCPDeLf~vMacCWa  536 (563)
T KOG1024|consen  513 DGYRLAQPFNCPDELFTVMACCWA  536 (563)
T ss_pred             ccceecCCCCCcHHHHHHHHHHHh
Confidence               334677899999999999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=4.6e-31  Score=266.21  Aligned_cols=208  Identities=24%  Similarity=0.395  Sum_probs=157.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEE-----------------cCCCEEEEEEeecCCchhHHH--------------HH
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVL-----------------EDNTNVAVKNLLNNRGQAEKE--------------FK  230 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~  230 (424)
                      +...++|++.++||+|+||+||+|.+                 ..++.||||++........++              ..
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            34678999999999999999999964                 234679999986543332222              33


Q ss_pred             HHHHHHhcCCCCce-----eeEeeEeee--------CCeeeEEEEecCCCCHHHHHccCCC-------------------
Q 014466          231 VEVEAIGRVRHKNL-----VRLLGYCAE--------GAHRMLVYEYIDNGNLEQWLHGDVG-------------------  278 (424)
Q Consensus       231 ~Ei~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------  278 (424)
                      .|+.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...+                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46777777766654     677777653        3567999999999999999875321                   


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeeccccccccc
Q 014466          279 -PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV  357 (424)
Q Consensus       279 -~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~  357 (424)
                       ....+++..+..++.|++.+|.|||+.   +|+||||||+|||++.++.+||+|||++..+............+|+.|+
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence             112356778889999999999999998   9999999999999999999999999999765433222222334588999


Q ss_pred             ccccccCCC--------------------CC--CccchHHHHHHHHHHHcCCC-CCCC
Q 014466          358 APEYASTGM--------------------LN--ERSDVYSFGILIMEVISGRN-PVDY  392 (424)
Q Consensus       358 aPE~~~~~~--------------------~~--~~sDiwSlGv~l~elltg~~-Pf~~  392 (424)
                      |||.+....                    |+  .+.|+||+||++|+|++|.. ||..
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            999875322                    22  24799999999999999886 7753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.5e-30  Score=237.40  Aligned_cols=199  Identities=32%  Similarity=0.486  Sum_probs=173.5

Q ss_pred             cccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      |.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+..|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999775 788999998766554 66789999999999999999999999999889999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++.....   .+++.....++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999999987521   178899999999999999999998   9999999999999999999999999999876443211


Q ss_pred             eeecccccccccccccc-cCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ......++..|++||.. ....++.++|+|+||++++||++|+.||+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22345678899999988 777788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-33  Score=248.67  Aligned_cols=202  Identities=24%  Similarity=0.366  Sum_probs=169.9

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC-----eee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM  258 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~  258 (424)
                      +.+-.+.||.|+||+||.+++. +|+.||+|++.+-  +-...+.+.+|+++|..++|.|++..++..+-..     ++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3455688999999999999854 7999999998543  3334567888999999999999999988765432     356


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      .+.|.+.. +|...+-.    ...++.+.+.-+++||++||.|||+.   +|.||||||.|.|++.+..+||||||+++.
T Consensus       134 V~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            78888754 77666543    36788888889999999999999999   999999999999999999999999999998


Q ss_pred             cCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPP  396 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~  396 (424)
                      ...+....++..+-|-+|.|||++++ ..|+...||||.||++.||+..+.-|....|.
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi  264 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI  264 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence            77666666777777999999998876 56999999999999999999999999876653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.4e-31  Score=231.56  Aligned_cols=194  Identities=24%  Similarity=0.438  Sum_probs=165.6

Q ss_pred             CCCcccceeEcccCcEEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCe--eeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAH--RMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~--~~lv  260 (424)
                      .++|++.+.+|+|.|+.||.|. ..++.+++||.+.+   -..+.+.+|+++|..|+ ||||++++++..+...  ..||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4679999999999999999998 45678899998864   34567889999999997 9999999999987653  4599


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEEEecCCcccc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLL  339 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DfG~a~~~  339 (424)
                      +||+++.+...+.       ..++...+..++.++++||.|+|+.   ||+|||+||.|++||.. -.++|+|+|+|..+
T Consensus       114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence            9999998877655       4677788889999999999999999   99999999999999975 45999999999988


Q ss_pred             CCCcceeeecccccccccccccc-cCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....+..  .+.+.+|--||.+ .-..|+..-|+|||||+|..|+..+-||-..
T Consensus       184 Hp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG  236 (338)
T KOG0668|consen  184 HPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  236 (338)
T ss_pred             CCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence            66655433  3457789999977 5577999999999999999999999998654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=261.35  Aligned_cols=194  Identities=27%  Similarity=0.360  Sum_probs=163.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .+..|++...+|.|+|+.|-.+... +++..++|++.+...+    ..+|+.++... +||||+++.+.+.++.+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3567888888999999999999855 5788999999766322    33366665555 7999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE-cCCCceEEEecCCccccC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kL~DfG~a~~~~  340 (424)
                      |.+.|+-+.+-+...     +.....+..|+.+|+.|+.|||++   ++|||||||+|||+ +..++++|+|||.++...
T Consensus       396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999887776554     222256678999999999999999   99999999999999 689999999999998764


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..    ....+-|..|.|||++....|++++||||||++||+|++|+.||...
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~  516 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH  516 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence            43    22234588999999999999999999999999999999999999754

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.6e-32  Score=241.94  Aligned_cols=203  Identities=24%  Similarity=0.408  Sum_probs=166.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee--------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------  253 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------  253 (424)
                      .+.|+-..+||+|.||.||+|+.+ +|+.||+|++...  +...-....+|+++|..++|+|++.++..|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            346888899999999999999965 5777898877542  22233455679999999999999999987742        


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ...+||||++|+. +|.-+|...   ...++...+.+++.++..||.|+|..   .|+|||+|+.|+||+.+|.+||+||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence            2357899999988 999988655   35688889999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcce---eeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          334 GLAKLLGAERSY---VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |+++.+......   ..+..+-|.+|.+||.+.+ ..|+++.|+|.-||++.||+||..-|...+
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            999866432221   1233456999999997765 669999999999999999999999886544

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-29  Score=241.89  Aligned_cols=147  Identities=24%  Similarity=0.325  Sum_probs=122.6

Q ss_pred             CCCCcceeeeeeeecC-CCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----C-
Q 014466          170 LGWGHWYTLRELEVST-NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----H-  241 (424)
Q Consensus       170 ~~~~~~~~~~~~~~~~-~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h-  241 (424)
                      ...|++.+++-.+... .+|.+.++||.|.|++||+|++.. .+.||+|+.. ......+....||++|++++     | 
T Consensus        61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             hhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            4456677777777777 899999999999999999999764 5567888653 34445566777999999884     3 


Q ss_pred             --CceeeEeeEee----eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCC
Q 014466          242 --KNLVRLLGYCA----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI  315 (424)
Q Consensus       242 --pnIv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDl  315 (424)
                        .+||+|++.|.    ++.+++||+|++ |.+|..++....  ...++...+..|++|++.||.|||..|  +|||.||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDl  214 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDL  214 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCC
Confidence              36999999996    456899999999 669999998763  567888999999999999999999988  9999999


Q ss_pred             CCCCEEE
Q 014466          316 KSSNILL  322 (424)
Q Consensus       316 kp~NILl  322 (424)
                      ||+|||+
T Consensus       215 KPENvLl  221 (590)
T KOG1290|consen  215 KPENVLL  221 (590)
T ss_pred             Ccceeee
Confidence            9999999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=3.6e-30  Score=265.50  Aligned_cols=202  Identities=22%  Similarity=0.312  Sum_probs=146.2

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcC-----CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeE------e
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY------C  251 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~------~  251 (424)
                      ...++|++.+.||+|+||.||+|++.+     +..||+|++......  +....|  .+....+.++..++..      .
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            466789999999999999999999754     578999987543221  111111  1222222233222221      2


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVGP----------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI  315 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDl  315 (424)
                      .++...++|+||+++++|.+++......                ........+..++.|++.||+|||+.   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            4566789999999999999998754210                00112334567999999999999998   9999999


Q ss_pred             CCCCEEEcC-CCceEEEecCCccccCCCcceeeecccccccccccccccCC----------------------CCCCccc
Q 014466          316 KSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----------------------MLNERSD  372 (424)
Q Consensus       316 kp~NILl~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD  372 (424)
                      ||+|||++. ++.+||+|||+++.+............+|+.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 67999999999987654444445567899999999965322                      2345679


Q ss_pred             hHHHHHHHHHHHcCCCCCC
Q 014466          373 VYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       373 iwSlGv~l~elltg~~Pf~  391 (424)
                      ||||||+||||+++..|++
T Consensus       362 VwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc
Confidence            9999999999999887765

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=5.8e-29  Score=228.96  Aligned_cols=186  Identities=30%  Similarity=0.473  Sum_probs=165.5

Q ss_pred             CcEEEEEEEEcC-CCEEEEEEeecCCchh-HHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHHHHHcc
Q 014466          198 GYGIVYHGVLED-NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG  275 (424)
Q Consensus       198 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  275 (424)
                      +||.||+|...+ ++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999764 8889999987655444 67899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeeccccccc
Q 014466          276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG  355 (424)
Q Consensus       276 ~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~  355 (424)
                      .    ..+++..++.++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            5    2388899999999999999999998   99999999999999999999999999998764332  3344568889


Q ss_pred             ccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       356 y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      |++||...+..++.++|+||||+++++|++|..||+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999888899999999999999999999999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.9e-30  Score=248.80  Aligned_cols=213  Identities=23%  Similarity=0.241  Sum_probs=180.6

Q ss_pred             CcceeeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC------CCcee
Q 014466          173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR------HKNLV  245 (424)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------hpnIv  245 (424)
                      .++|.++-.++...+|.+.-..|+|-|++|.+|.+. .|+.||||+|.++.. ..+.=..|+++|++|+      .-|++
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            677888888999999999999999999999999965 477999999876533 3344556999999996      34899


Q ss_pred             eEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       246 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      +|+..|...+++|||+|-+. .+|.+.|++... ...+....+..+++|+..||..|-..   +|+|.||||+||||++.
T Consensus       498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence            99999999999999999885 499999987643 45677888899999999999999987   99999999999999875


Q ss_pred             -CceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          326 -WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       326 -~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       ..+||||||.|...+...   .+...-+..|.|||++.+..|+...|+||.||+||||.||+..|.+.+
T Consensus       573 k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             cceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence             569999999997653321   222333567999999999999999999999999999999999997654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-30  Score=231.80  Aligned_cols=207  Identities=29%  Similarity=0.371  Sum_probs=174.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------Ce
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AH  256 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~  256 (424)
                      .+|.-++.+|.|.- .|..+.+. .++.||+|++...  .....+...+|..++..++|+||++++.+|.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            36777888999998 55555543 5788999998654  234456677899999999999999999998533      35


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .|+|||+|.. +|.+.+.      -.++-+...+|+.|++.|+.|||+.   +|+||||||+||++..+..+||.|||+|
T Consensus        96 ~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            7899999976 8988886      2467788899999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHHh
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL  410 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  410 (424)
                      +.-+..  ...+..+.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|.     ++..+.||.++...
T Consensus       166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~-----g~d~idQ~~ki~~~  232 (369)
T KOG0665|consen  166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP-----GKDHIDQWNKIIEQ  232 (369)
T ss_pred             cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec-----CchHHHHHHHHHHH
Confidence            864332  45677788999999999988889999999999999999999999994     67778888887654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=6.5e-29  Score=250.34  Aligned_cols=200  Identities=28%  Similarity=0.407  Sum_probs=164.1

Q ss_pred             CcccceeEcccCcE-EEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEec
Q 014466          187 GFADENVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       187 ~~~~~~~LG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      -|...+++|.|..| .||+|.+. ++.||||++...   ..+-..+|+..|+.- .|||||++++.-.+....|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            45557889999997 57899987 789999998643   234456799999888 6999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---C--CceEEEecCCcccc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---Q--WNPKLSDFGLAKLL  339 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~--~~~kL~DfG~a~~~  339 (424)
                      .. +|.+++...............+.+..|+++||++||+.   +||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            76 99999987411111122244577888999999999997   9999999999999975   3  46999999999998


Q ss_pred             CCCcceee--ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          340 GAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      +...+...  ....||.+|+|||++....-+..+||+|+||++|+.++ |..||....
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~  719 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL  719 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence            76654433  35679999999999999888889999999999999999 599998654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=219.66  Aligned_cols=195  Identities=21%  Similarity=0.382  Sum_probs=157.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeE-eeeCCeeeEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGY-CAEGAHRMLVY  261 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~-~~~~~~~~lv~  261 (424)
                      .+.|.+.+.||+|.||.+-+|+++. ++.+++|.+... ....++|.+|...--.| .|.||+.-|++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3579999999999999999999774 667888876543 34457788888776666 58999998875 56667777999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc--CCCceEEEecCCcccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLL  339 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DfG~a~~~  339 (424)
                      ||++.|+|.+-+..     ..+.+.....++.|+++|+.|||++   ++||||||.+||||-  +...+||||||+.+..
T Consensus       102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999886643     4678888899999999999999999   999999999999993  3347999999999865


Q ss_pred             CCCcceeeecccccccccccccccCC-----CCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +..-.    ...-+..|.+||.....     ..++.+|+|.||+++|.++||+.||..
T Consensus       174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            43322    22235578999966432     256789999999999999999999974

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=5e-29  Score=245.39  Aligned_cols=200  Identities=29%  Similarity=0.417  Sum_probs=178.0

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      -+.++|+.+..+|.|.||.||++++. .+...|+|.++-.......-+..|+-+++..+|||||.+++.|......++.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            45678999999999999999999965 57778999998777777788889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |||.+|+|++..+..    +++++..+...+++.++||+|||+.   +=+|||||-.|||+++.|.+|+.|||.+-.++.
T Consensus        92 EycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            999999999988765    7899999999999999999999999   889999999999999999999999999876543


Q ss_pred             Ccceeeecccccccccccccc---cCCCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                      . -.....+.||++|||||+.   +.+.|+.++|||++|+...|+---+.|-
T Consensus       165 t-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  165 T-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             h-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            2 2234568899999999965   5678999999999999999988777774

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=5.5e-26  Score=203.85  Aligned_cols=183  Identities=36%  Similarity=0.633  Sum_probs=158.9

Q ss_pred             EcccCcEEEEEEEEcC-CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHHH
Q 014466          194 IGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ  271 (424)
Q Consensus       194 LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~  271 (424)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 888999998665433 45678899999999999999999999999899999999999999999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCccccCCCcceeeecc
Q 014466          272 WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRV  350 (424)
Q Consensus       272 ~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~~~~~~~~~~~~~~  350 (424)
                      ++....   ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987542   4678899999999999999999998   9999999999999999 89999999999986543321 12334


Q ss_pred             cccccccccccccCC-CCCCccchHHHHHHHHHH
Q 014466          351 MGTFGYVAPEYASTG-MLNERSDVYSFGILIMEV  383 (424)
Q Consensus       351 ~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el  383 (424)
                      .+...|++||..... .++.+.|+|++|+++++|
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            578899999998877 888999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.4e-26  Score=220.99  Aligned_cols=164  Identities=20%  Similarity=0.235  Sum_probs=128.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc--CCCEEEEEEeecC-----CchhHHHHHHHHHHHhcCCCCceee-EeeEeeeCC
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVR-LLGYCAEGA  255 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~~  255 (424)
                      ..++|.+.+.||+|+||+||+|.+.  +++.+|||++...     .....+.|.+|+++|++++|+|++. ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            4457999999999999999999865  4677899987533     2223556899999999999999985 5432    4


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCC-CCCCEEEcCCCceEEEecC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI-KSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kL~DfG  334 (424)
                      ..++||||++|++|.. +..       ..   ...++.++++||.|||+.   +|+|||| ||+|||++.++++||+|||
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            5799999999999963 211       11   135778999999999998   9999999 9999999999999999999


Q ss_pred             CccccCCCcce-------eeecccccccccccccccCC
Q 014466          335 LAKLLGAERSY-------VTTRVMGTFGYVAPEYASTG  365 (424)
Q Consensus       335 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  365 (424)
                      +++.+......       ..+...+++.|+|||.+...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99976433211       11356789999999988543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.1e-25  Score=212.10  Aligned_cols=210  Identities=25%  Similarity=0.388  Sum_probs=168.0

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  258 (424)
                      -.+.|..+++||+|.|++||++.+.    ....||+|.+....  ....+..|+++|..+ .+.||+++.+++..++...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3457889999999999999999843    35679999986542  234578899999999 5899999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCcc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAK  337 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~  337 (424)
                      +|+||++..+..+++.       .++...+..+++.+++||.++|.+   |||||||||+|+|.+. .+.-.|+|||+|.
T Consensus       112 ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence            9999999988888875       345677888999999999999999   9999999999999975 4668999999997


Q ss_pred             ccCCC---------------------------------cce----------eeecccccccccccccccC-CCCCCccch
Q 014466          338 LLGAE---------------------------------RSY----------VTTRVMGTFGYVAPEYAST-GMLNERSDV  373 (424)
Q Consensus       338 ~~~~~---------------------------------~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  373 (424)
                      .....                                 ..+          ......||++|.|||++.. ..-+.++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            21100                                 000          0112459999999998865 456789999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 014466          374 YSFGILIMEVISGRNPVDYSRPPGEVCIPQMNS  406 (424)
Q Consensus       374 wSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~  406 (424)
                      ||.||++.-+++++.||-... .+...+.++..
T Consensus       262 ws~GVI~Lslls~~~PFf~a~-dd~~al~ei~t  293 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAK-DDADALAEIAT  293 (418)
T ss_pred             eeccceeehhhccccccccCc-cccchHHHHHH
Confidence            999999999999999997654 33334444443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-24  Score=208.93  Aligned_cols=202  Identities=21%  Similarity=0.314  Sum_probs=166.6

Q ss_pred             CcccceeEcccCcEEEEEEEEcCC--CEEEEEEeecCCchhHHHHHHHHHHHhcCCC----CceeeEeeEe-eeCCeeeE
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDN--TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH----KNLVRLLGYC-AEGAHRML  259 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----pnIv~l~~~~-~~~~~~~l  259 (424)
                      +|.+.+.||+|+||.||.|.....  ..+|+|............+..|+.++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  3678887765433322267778888888863    6899999999 57778899


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-----CceEEEecC
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-----WNPKLSDFG  334 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kL~DfG  334 (424)
                      ||+.+ |.+|.++.....  ...++..+...|+.|++.+|++||+.   +++||||||.|+++...     -.+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 679999876653  46899999999999999999999998   99999999999999765     359999999


Q ss_pred             Ccc--ccCCCcc-----e-e-eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAK--LLGAERS-----Y-V-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +++  .+.....     . . ...+.||..|.++....+...+++.|+||++.++.|+..|..||....
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            998  4321111     1 1 233569999999999999999999999999999999999999996554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=2.6e-23  Score=198.53  Aligned_cols=201  Identities=34%  Similarity=0.521  Sum_probs=171.4

Q ss_pred             cccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCch---hHHHHHHHHHHHhcCCCC-ceeeEeeEeeeCCeeeEEEEe
Q 014466          188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e~  263 (424)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667889999999999999986  77899988655332   467899999999999988 799999999877778999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCccccCCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAE  342 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~~~~~~  342 (424)
                      +.++++.+++...... ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999777654211 3688889999999999999999999   999999999999999988 7999999999865443


Q ss_pred             cce-----eeecccccccccccccccC---CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSY-----VTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ...     ......||..|+|||.+.+   ..++...|+||+|++++++++|..||....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            322     2456789999999999987   678889999999999999999999976554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=4.3e-25  Score=238.18  Aligned_cols=148  Identities=18%  Similarity=0.223  Sum_probs=114.7

Q ss_pred             cCCC-CceeeEeeEe-------eeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 014466          238 RVRH-KNLVRLLGYC-------AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK  309 (424)
Q Consensus       238 ~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~  309 (424)
                      .++| +||++++++|       .+...+++++||+ +++|.++|...   ...+++..++.++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4455 5888888887       2334567788987 45999999754   35689999999999999999999998   9


Q ss_pred             eeeCCCCCCCEEEcCCC-------------------ceEEEecCCccccCCCc---------------ceeeeccccccc
Q 014466          310 VVHRDIKSSNILLDKQW-------------------NPKLSDFGLAKLLGAER---------------SYVTTRVMGTFG  355 (424)
Q Consensus       310 ivHrDlkp~NILl~~~~-------------------~~kL~DfG~a~~~~~~~---------------~~~~~~~~gt~~  355 (424)
                      |+||||||+||||+..+                   .+|++|||+++......               .......+||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            99999999999996544                   45566666655321100               000112468999


Q ss_pred             ccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       356 y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      |+|||++.+..|+.++|||||||+||||++|..|+..
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            9999999999999999999999999999999998763

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=4.1e-24  Score=193.40  Aligned_cols=172  Identities=13%  Similarity=0.151  Sum_probs=133.8

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHH---H------HHHHHHHHhcCCCCceeeEeeEeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK---E------FKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      +..++|...++||.|+||.||+... ++..+|+|.+.+.......   .      +.+|++.+.+++|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4567899999999999999999766 5778999998654332222   2      6789999999999999999988664


Q ss_pred             C--------CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          254 G--------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       254 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      .        ...+|+|||++|.+|.++..        +++    ....+++.++..+|+.   +++|||+||+||+++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            3        34789999999999988732        222    2355899999999999   99999999999999999


Q ss_pred             CceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHH
Q 014466          326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  384 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ell  384 (424)
                      + ++|+|||...........             ..+.....|+.++|+|+||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8 999999987644211111             11445556778999999999876543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=6.7e-23  Score=182.81  Aligned_cols=139  Identities=17%  Similarity=0.174  Sum_probs=108.0

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCch--h------------------------HHHHHHHHHHHhcCCCCce
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--A------------------------EKEFKVEVEAIGRVRHKNL  244 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~Ei~~l~~l~hpnI  244 (424)
                      ...||+|+||.||+|...+|+.||+|++......  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998654211  0                        1122349999999988776


Q ss_pred             eeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeeCCCCCCCEEEc
Q 014466          245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-HEGLEPKVVHRDIKSSNILLD  323 (424)
Q Consensus       245 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~ivHrDlkp~NILl~  323 (424)
                      .....+...  ..+|||||++++++.......    ..++......++.|++.+|.++ |+.   +|+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            443333222  238999999988776543222    4678888999999999999999 687   999999999999998


Q ss_pred             CCCceEEEecCCcccc
Q 014466          324 KQWNPKLSDFGLAKLL  339 (424)
Q Consensus       324 ~~~~~kL~DfG~a~~~  339 (424)
                       ++.++|+|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-22  Score=183.11  Aligned_cols=200  Identities=22%  Similarity=0.315  Sum_probs=165.0

Q ss_pred             CCcccceeEcccCcEEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      -.|.++++||+|.||+.+.|+ +-++..||||.-.  .......++.|....+.| ..++|.+.+-+..++-+..||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478999999999999999999 4468999999532  223345677788888888 468999999888898889999998


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-----ceEEEecCCccc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGLAKL  338 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kL~DfG~a~~  338 (424)
                      + |-+|.++..--   ...++.+++.-++.|++.-++|+|++   .+|+|||||+|+||..-+     .+.|+|||+|+.
T Consensus       106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            8 56777766443   35788899999999999999999999   999999999999995433     489999999997


Q ss_pred             cCCCcc------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          339 LGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +.+...      ......-||..||+--...+..-+.+.|+-|||-+++..+-|.+||.+-.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            754321      12234679999999988888889999999999999999999999998654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-22  Score=178.98  Aligned_cols=207  Identities=21%  Similarity=0.273  Sum_probs=166.7

Q ss_pred             ecCCCcccceeEcccCcEEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC-CceeeEeeEeeeCCeeeEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lv  260 (424)
                      +-...|.+++.||.|+||.+|.|. ..+|.+||||.-......  ..+..|.++.+.|++ ..|..+.-+..+.....||
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            345689999999999999999999 567999999976443222  346668889998975 6788888888888889999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCCcc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLAK  337 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~a~  337 (424)
                      ||.. |-+|.++.+--   ...++..+.+-++-|++.-++|+|..   +++||||||+|+|+.-   ...+.|+|||+++
T Consensus        90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            9988 66888877543   35678888999999999999999998   9999999999999954   3459999999999


Q ss_pred             ccCCCcce------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q 014466          338 LLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE  398 (424)
Q Consensus       338 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~  398 (424)
                      .+-+....      ......||..|.+--...+..-+.+.|+-|+|.+|..+.-|..||.+-.+...
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence            76443221      12345689999887766666777889999999999999999999998775443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=6.5e-22  Score=176.83  Aligned_cols=139  Identities=22%  Similarity=0.205  Sum_probs=110.6

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCch--------------------------hHHHHHHHHHHHhcCCCCce
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------------------------AEKEFKVEVEAIGRVRHKNL  244 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~hpnI  244 (424)
                      ...||+|+||.||+|.+.+|+.||||.+......                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999999878999999998654211                          01234578999999999987


Q ss_pred             eeEeeEeeeCCeeeEEEEecCCCCHHHH-HccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEE
Q 014466          245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW-LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       245 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl  322 (424)
                      .....+...  ..+|||||++++++... +..     ..++......++.+++.++.+||+ .   +|+||||||+|||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            554444333  24899999998755433 332     356778889999999999999999 8   99999999999999


Q ss_pred             cCCCceEEEecCCccccC
Q 014466          323 DKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~  340 (424)
                      + ++.++|+|||++....
T Consensus       152 ~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         152 H-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             E-CCCEEEEEcccceecC
Confidence            9 8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=7.8e-22  Score=174.96  Aligned_cols=187  Identities=17%  Similarity=0.131  Sum_probs=138.3

Q ss_pred             ccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCch----hHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEe
Q 014466          189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ----AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .+...|++|+||+||.+.. .+.+++.+.+......    ....+.+|+++|+++. |++|++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997766 5677777776543221    1225788999999995 5889999886    346899999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCC-CCCCEEEcCCCceEEEecCCccccCCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI-KSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ++|.+|.+.+..     .      ...++.|++.+|.++|++   +|+|||| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999998754321     1      134677899999999999   9999999 799999999999999999999854432


Q ss_pred             cce----e--------eecccccccccccccccC-CCCC-CccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSY----V--------TTRVMGTFGYVAPEYAST-GMLN-ERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~----~--------~~~~~gt~~y~aPE~~~~-~~~~-~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..-    .        ......++.|++|+-..- ...+ ...++++.|.-+|.++|++.|+-...
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            210    0        111235778888874321 1222 46799999999999999999875433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.87  E-value=6.2e-22  Score=174.38  Aligned_cols=108  Identities=29%  Similarity=0.293  Sum_probs=95.3

Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.++++.+   ...+++..++.++.|+++||+|||+.   +      ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6899999764   24699999999999999999999988   5      999999999999999  99988654322   


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                         ..||+.|+|||++.+..|+.++|||||||++|||+||+.||....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~  108 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER  108 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence               258999999999999999999999999999999999999997543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.2e-21  Score=171.94  Aligned_cols=138  Identities=16%  Similarity=0.295  Sum_probs=107.2

Q ss_pred             ccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-----CCCceeeEeeEeeeCC---eee-E
Q 014466          189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-----RHKNLVRLLGYCAEGA---HRM-L  259 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~hpnIv~l~~~~~~~~---~~~-l  259 (424)
                      .-.+.||+|+||.||.  +......+||++........+.+.+|+++++.+     .||||++++|+++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  433333479988765455567899999999999     5799999999998873   334 7


Q ss_pred             EEEe--cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeeeCCCCCCCEEEcC----CCceEEEe
Q 014466          260 VYEY--IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL-TYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSD  332 (424)
Q Consensus       260 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al-~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kL~D  332 (424)
                      |+||  +.+|+|.+++.+.     .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +++++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  5579999999653     24444  34567788777 999999   9999999999999974    34799999


Q ss_pred             -cCCccc
Q 014466          333 -FGLAKL  338 (424)
Q Consensus       333 -fG~a~~  338 (424)
                       ||....
T Consensus       153 g~G~~~~  159 (210)
T PRK10345        153 NIGESTF  159 (210)
T ss_pred             CCCCcce
Confidence             554443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=9.4e-23  Score=201.60  Aligned_cols=186  Identities=27%  Similarity=0.317  Sum_probs=155.7

Q ss_pred             eEcccCcEEEEEEEE----cCCCEEEEEEeecCCch--hHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEecC
Q 014466          193 VIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      ++|+|.||.|++++-    ..+.-+|+|.+.+....  .......|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999998762    23666888887654221  1114555888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +|+|...+...    ..+++.....+...++-+++.+|+.   +++|||+|++||+++.+|++|+.|||+++..-.... 
T Consensus        81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99998877655    5677777777888999999999998   999999999999999999999999999986432221 


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                          .|||..|||||+++  .....+|.||||++++||+||..||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                18999999999998  567789999999999999999999965

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=6.1e-21  Score=200.96  Aligned_cols=204  Identities=21%  Similarity=0.215  Sum_probs=164.7

Q ss_pred             eeeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC---CCceeeEeeEeee
Q 014466          177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAE  253 (424)
Q Consensus       177 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~  253 (424)
                      +..+.++....|.+.+.||+|+||.||+|...+|+.||+|.-.+....   +|.--.+++.+|+   -+-|..+...+.-
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence            346678888899999999999999999999888999999987665543   2222344555555   2345555555555


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-------CC
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-------QW  326 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-------~~  326 (424)
                      .+..++|+||.+.|+|.++++..    ..+++...+.++.|+++.++.||..   +|||+||||+|.||..       .-
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             CCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence            66678999999999999999844    6788999999999999999999998   9999999999999942       22


Q ss_pred             ceEEEecCCccccCCCc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          327 NPKLSDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       327 ~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                      -++|+|||.+..+.--. ...-...++|-.+-.+|...++.|++++|.|.|+.+++-|+.|+.-=
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q  903 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME  903 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence            49999999987553222 23445678899999999999999999999999999999999997653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=9.8e-22  Score=202.70  Aligned_cols=199  Identities=24%  Similarity=0.311  Sum_probs=158.3

Q ss_pred             ccceeEcccCcEEEEEEEEc-CCCEEEEEEeec---CCchh---HHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLN---NRGQA---EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~---~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ...+++|.|++|.|+.+... ....++.|....   .....   ...+..|..+-..+.|||++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45788999999977777633 333344443221   11111   112556777788899999998888887766666669


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |||++ +|..++.+.    ..+....+-.++.|++.|++|||+.   +|.|||+|++|++++.+|.+||+|||.+.....
T Consensus       401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 999999765    4677788889999999999999999   999999999999999999999999999886643


Q ss_pred             Ccc---eeeecccccccccccccccCCCCCCc-cchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          342 ERS---YVTTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       342 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ...   ......+|+..|+|||++.+..|++. .||||.|+++..|.+|+.||.....
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~  530 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK  530 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence            322   45567889999999999999999985 7999999999999999999986554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1e-20  Score=169.14  Aligned_cols=200  Identities=20%  Similarity=0.356  Sum_probs=158.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeec--CCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .+..+..+|.+...|..|+|+++.+ .+++|++.-  -.....++|..|.-.|+.+.||||+.+++.|....+..++..|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3455677899999999999999854 456666532  2334456899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE--ecCCccccCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS--DFGLAKLLGA  341 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~--DfG~a~~~~~  341 (424)
                      |+.|+|+..|++..  .--.+..++.+++.++++|++|||+. +|-|.---|.+..++||++.+.+|.  |--++     
T Consensus       269 mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs-----  340 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS-----  340 (448)
T ss_pred             ccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee-----
Confidence            99999999999874  23466678889999999999999986 6555555789999999999988775  21111     


Q ss_pred             CcceeeecccccccccccccccCCCCC---CccchHHHHHHHHHHHcCCCCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLN---ERSDVYSFGILIMEVISGRNPVDYSRPPG  397 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDiwSlGv~l~elltg~~Pf~~~~~~~  397 (424)
                         .......-.|.||+||.+..++-+   ..+|+|||+++||||.|...||..-.|.+
T Consensus       341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme  396 (448)
T KOG0195|consen  341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME  396 (448)
T ss_pred             ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence               111222346789999999776543   46899999999999999999998766633

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.1e-19  Score=167.73  Aligned_cols=142  Identities=19%  Similarity=0.158  Sum_probs=110.4

Q ss_pred             CcccceeEcccCcEEEEEEE--EcCCCEEEEEEeecCCch------------------------hHHHHHHHHHHHhcCC
Q 014466          187 GFADENVIGEGGYGIVYHGV--LEDNTNVAVKNLLNNRGQ------------------------AEKEFKVEVEAIGRVR  240 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~  240 (424)
                      .|++.+.||+|+||.||+|+  ..+|+.||+|.+......                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999999999998  457899999988643210                        1123567999999997


Q ss_pred             CCc--eeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeeCCCCC
Q 014466          241 HKN--LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKS  317 (424)
Q Consensus       241 hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-ivHrDlkp  317 (424)
                      +.+  +.+++++    ...++||||+++++|..+....    ..........++.|++.++.+||+.   + |+||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            533  3444433    2348999999998887654322    2445556678999999999999998   8 99999999


Q ss_pred             CCEEEcCCCceEEEecCCccccC
Q 014466          318 SNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       318 ~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      +||+++ +++++|+|||.+...+
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4.4e-19  Score=161.07  Aligned_cols=134  Identities=21%  Similarity=0.345  Sum_probs=113.0

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCch--------hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      +.||+|++|.||+|.. ++..+++|+.......        ....+.+|++++..++|++|.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 5778999976543211        123577899999999999988877777777788999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ++|++|.+++...    .   . ....++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998643    1   1 6778899999999999998   999999999999999 78899999999875

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=2.1e-19  Score=167.61  Aligned_cols=200  Identities=25%  Similarity=0.372  Sum_probs=131.6

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCC----------CceeeEeeEe--
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRH----------KNLVRLLGYC--  251 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h----------pnIv~l~~~~--  251 (424)
                      +...+.||.|+++.||.+++. +++.+|+|...-..   ....+.+++|.-....+.+          -.++-.++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            455789999999999999987 48889999885432   2345667777666655432          1222222221  


Q ss_pred             -------eeC---C-----eeeEEEEecCCCCHHHHHc---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeC
Q 014466          252 -------AEG---A-----HRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR  313 (424)
Q Consensus       252 -------~~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHr  313 (424)
                             ...   .     +.+++|+-+.+ +|.+++.   ........+....++.+..|+++.+++||..   +++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                   111   1     23678887754 8877753   2211122344455677778999999999999   99999


Q ss_pred             CCCCCCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccC--------CCCCCccchHHHHHHHHHHHc
Q 014466          314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVIS  385 (424)
Q Consensus       314 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlGv~l~ellt  385 (424)
                      ||||+|+|++.+|.++|+||+.....+...   .. ...+..|.+||....        -.++.+.|.|+||+++|.|++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999999877643221   11 334578999996633        247888999999999999999


Q ss_pred             CCCCCCCCCC
Q 014466          386 GRNPVDYSRP  395 (424)
Q Consensus       386 g~~Pf~~~~~  395 (424)
                      |+.||+...+
T Consensus       246 ~~lPf~~~~~  255 (288)
T PF14531_consen  246 GRLPFGLSSP  255 (288)
T ss_dssp             SS-STCCCGG
T ss_pred             ccCCCCCCCc
Confidence            9999996654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=7.6e-19  Score=158.04  Aligned_cols=131  Identities=22%  Similarity=0.355  Sum_probs=106.9

Q ss_pred             eEcccCcEEEEEEEEcCCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      .||+|+||.||+|.+. +..+++|.......        ...+.+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999864 67899998654321        11356778999999999887665555555666778999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      +|++|.+++....    .       .++.+++++|.+||+.   +++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999875431    1       6788999999999998   999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.3e-18  Score=179.51  Aligned_cols=137  Identities=20%  Similarity=0.319  Sum_probs=112.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--Cc------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..|...+.||+|+||+||+|.+.+.. +++|+....  ..      ...+.+.+|+++++.++|++++....++.+....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34566899999999999999876444 444443221  11      1235688899999999999999888888777778


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++++|.+++.            ....++.+++++|.+||+.   +++||||||+|||+ .++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999999885            2467888999999999998   99999999999999 57789999999998


Q ss_pred             cc
Q 014466          338 LL  339 (424)
Q Consensus       338 ~~  339 (424)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.8e-18  Score=155.65  Aligned_cols=137  Identities=20%  Similarity=0.163  Sum_probs=107.7

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCch----------------------hHHHHHHHHHHHhcCCCCc-
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ----------------------AEKEFKVEVEAIGRVRHKN-  243 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~~l~hpn-  243 (424)
                      .|.+.+.||+|+||.||++...+|+.+|||++......                      ....+..|..++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            37778999999999999999888999999986543210                      1123567888898888774 


Q ss_pred             -eeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          244 -LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       244 -Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                       +...++.    ...++||||+++++|......          .....++.+++.++.++|+.   +|+||||||+||++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill  158 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV  158 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence             4444442    345899999999998765421          22356788999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccC
Q 014466          323 DKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~  340 (424)
                      ++++.++|+|||++....
T Consensus       159 ~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCcEEEEECCccccCC
Confidence            999999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=4.3e-19  Score=183.98  Aligned_cols=166  Identities=27%  Similarity=0.408  Sum_probs=122.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ++|..++.|..|+||.||.++++. .+.+|+| +.+++.-     .+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee-------------------
Confidence            478889999999999999999764 5667884 4332211     100  23333344333                   


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC---
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA---  341 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~---  341 (424)
                        |+=...++..    ++++...        +.+++|||+-   +|+|||+||+|.+|+.-|++|++|||+.+....   
T Consensus       136 --gDc~tllk~~----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 --GDCATLLKNI----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             --chhhhhcccC----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence              3434444332    3444332        6789999998   999999999999999999999999999874311   


Q ss_pred             -----------CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          342 -----------ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       342 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                                 ........++|||.|.|||++..+.|+..+|+|++|+++||.+.|..||+..+|
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp  263 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  263 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence                       112223457899999999999999999999999999999999999999998865

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=2.7e-19  Score=185.66  Aligned_cols=196  Identities=23%  Similarity=0.247  Sum_probs=149.7

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc-hhHHHHHHHHHH--HhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~--l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .+...+.||.+.|=+|.+|+++.|. |+||++.+..+ -..+.|.++++-  ....+|||.+.+.-+-..+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677889999999999999988776 89999977653 334444443333  5556899999999888777778899999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc--CC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GA  341 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~--~~  341 (424)
                      +.. +|++.|..+    .-+...+.+-|+.|+++||..+|..   +|+|+|||.+||||+.=.=+.|+||..-+..  ..
T Consensus       103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            976 999988765    3456667778999999999999999   9999999999999998666899999866532  11


Q ss_pred             Cc--ce--eeecccccccccccccccC----------C-CCCCccchHHHHHHHHHHHc-CCCCCC
Q 014466          342 ER--SY--VTTRVMGTFGYVAPEYAST----------G-MLNERSDVYSFGILIMEVIS-GRNPVD  391 (424)
Q Consensus       342 ~~--~~--~~~~~~gt~~y~aPE~~~~----------~-~~~~~sDiwSlGv~l~ellt-g~~Pf~  391 (424)
                      +.  ..  .-.+...-..|.|||.+..          . ..+++.||||+||++.||++ |++||+
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            11  10  0011112237999995532          1 26788999999999999999 899998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=8.3e-17  Score=137.06  Aligned_cols=135  Identities=19%  Similarity=0.174  Sum_probs=113.2

Q ss_pred             cceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC--CceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+.+++.++|  .++.+++.+...++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35789999999999999864 7799998755433  5678889999999976  58999999988888899999999987


Q ss_pred             CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      .+..+           +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            66543           4456677888999999999986334799999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.1e-17  Score=157.12  Aligned_cols=144  Identities=27%  Similarity=0.367  Sum_probs=108.1

Q ss_pred             CCCceeeEeeEeeeC---------------------------CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHH
Q 014466          240 RHKNLVRLLGYCAEG---------------------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII  292 (424)
Q Consensus       240 ~hpnIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  292 (424)
                      +|||||++.++|.++                           ...|+||.-.+. +|.+|+..+     ..+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence            599999998876322                           246899988876 999999765     34555666688


Q ss_pred             HHHHHHHHHHHcCCCCCeeeCCCCCCCEEE--cCCC--ceEEEecCCccccCCCc---cee--eeccccccccccccccc
Q 014466          293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQW--NPKLSDFGLAKLLGAER---SYV--TTRVMGTFGYVAPEYAS  363 (424)
Q Consensus       293 ~~i~~al~~LH~~~~~~ivHrDlkp~NILl--~~~~--~~kL~DfG~a~~~~~~~---~~~--~~~~~gt~~y~aPE~~~  363 (424)
                      .|+++|+.|||++   +|.|||+|++||||  |+|+  .+.|+|||++---+...   .+.  .....|.-..||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            8999999999999   99999999999999  3333  37889999875322110   111  11234666789999875


Q ss_pred             CCC------CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          364 TGM------LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       364 ~~~------~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ...      --.|+|.|+.|.+.||+++...||..
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            432      12489999999999999999999975

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=6.7e-17  Score=143.86  Aligned_cols=135  Identities=23%  Similarity=0.235  Sum_probs=96.9

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchh--HHH----------------------HHHHHHHHhcCCCCc--e
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA--EKE----------------------FKVEVEAIGRVRHKN--L  244 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~Ei~~l~~l~hpn--I  244 (424)
                      .+.||+|+||+||+|...+++.||||++.......  ...                      ...|.+.+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999886532211  111                      134555666654432  4


Q ss_pred             eeEeeEeeeCCeeeEEEEecCCCCHHH-HHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEE
Q 014466          245 VRLLGYCAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       245 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl  322 (424)
                      .+++++    ...++||||++++.+.. .+...     ... ..+..++.+++.++.++|. .   +|+|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            444443    23589999999954321 11111     001 4567889999999999998 7   99999999999999


Q ss_pred             cCCCceEEEecCCcccc
Q 014466          323 DKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~  339 (424)
                      + ++.++|+|||.+...
T Consensus       149 ~-~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E-CCcEEEEECcccccc
Confidence            9 889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.9e-16  Score=146.33  Aligned_cols=135  Identities=21%  Similarity=0.270  Sum_probs=105.6

Q ss_pred             ceeEc-ccCcEEEEEEEEcCCCEEEEEEeecCC-------------chhHHHHHHHHHHHhcCCCCce--eeEeeEeeeC
Q 014466          191 ENVIG-EGGYGIVYHGVLEDNTNVAVKNLLNNR-------------GQAEKEFKVEVEAIGRVRHKNL--VRLLGYCAEG  254 (424)
Q Consensus       191 ~~~LG-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~~  254 (424)
                      ...|| .||.|+||.+... +..+++|.+....             ......+.+|++++.+++|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999876 6779999874321             1223457889999999998885  6777765433


Q ss_pred             C-e---eeEEEEecCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          255 A-H---RMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       255 ~-~---~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                      . .   .++|||+++| .+|.+++...     .++..    .+.+++.+|.+||+.   +|+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2 2   2499999997 6899988642     34443    356899999999999   999999999999999999999


Q ss_pred             EEecCCccc
Q 014466          330 LSDFGLAKL  338 (424)
Q Consensus       330 L~DfG~a~~  338 (424)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.69  E-value=6.2e-18  Score=164.65  Aligned_cols=123  Identities=24%  Similarity=0.462  Sum_probs=106.8

Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..|+.|++|...+|.+||.++.. ....++...+.++.|++.|++|   +   +.+|||+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            46799999999999999976542 3456777889999999999999   5   899999999999999999999999999


Q ss_pred             ccccCCCc-----ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc
Q 014466          336 AKLLGAER-----SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS  385 (424)
Q Consensus       336 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt  385 (424)
                      ........     ....+...||..||+||.+.+..|+.++|||+||++|+||++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            87654433     223456789999999999999999999999999999999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.66  E-value=2.7e-16  Score=155.80  Aligned_cols=152  Identities=31%  Similarity=0.607  Sum_probs=126.4

Q ss_pred             HhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-eeCC
Q 014466          236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV-VHRD  314 (424)
Q Consensus       236 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i-vHrD  314 (424)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+...   ...+++.....+++++++|++|||..   .| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            46789999999999999999999999999999999999774   46789999999999999999999976   44 9999


Q ss_pred             CCCCCEEEcCCCceEEEecCCccccCCC-cceeeecccccccccccccccCCC-------CCCccchHHHHHHHHHHHcC
Q 014466          315 IKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISG  386 (424)
Q Consensus       315 lkp~NILl~~~~~~kL~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDiwSlGv~l~elltg  386 (424)
                      +++.|.++|..+.+||+|||+....... .........-...|.|||.+....       .+.+.|+||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998765321 001111112345799999887632       46679999999999999999


Q ss_pred             CCCCCCC
Q 014466          387 RNPVDYS  393 (424)
Q Consensus       387 ~~Pf~~~  393 (424)
                      ..||+..
T Consensus       155 ~~~~~~~  161 (484)
T KOG1023|consen  155 SGPFDLR  161 (484)
T ss_pred             cCccccc
Confidence            9999863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=7.6e-17  Score=166.58  Aligned_cols=204  Identities=26%  Similarity=0.367  Sum_probs=162.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCC--CEEEEEEeecCC--chhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDN--TNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~--~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ..|.+.+.||+|.|+.|-.......  ..+|.|.+....  ....+....|..+-+.+. |.|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            3567778899999999988875433  335666554432  223344555777777776 99999999999999999999


Q ss_pred             EEecCCCCHHHHH-ccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCcc
Q 014466          261 YEYIDNGNLEQWL-HGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAK  337 (424)
Q Consensus       261 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~  337 (424)
                      ++|.+++++.+.+ +...   ...+...+..++.|+..++.|+| ..   ++.|||+||+|.+++..+ .+|+.|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999998877 3321   14555666788999999999999 77   999999999999999999 99999999998


Q ss_pred             ccCC--Ccceeeecccc-cccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          338 LLGA--ERSYVTTRVMG-TFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       338 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      .+..  .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            7755  33344455678 9999999988774 566789999999999999999999986543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=1.9e-14  Score=144.22  Aligned_cols=142  Identities=22%  Similarity=0.218  Sum_probs=99.5

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhH----------------------------------------HHHH
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE----------------------------------------KEFK  230 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  230 (424)
                      .+.||.|++|.||+|++.+|+.||||+..+......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999855421100                                        0233


Q ss_pred             HHHHHHhcC----CCCceeeEeeEeee-CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHc
Q 014466          231 VEVEAIGRV----RHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK-GLTYLHE  304 (424)
Q Consensus       231 ~Ei~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-al~~LH~  304 (424)
                      .|.+.+.++    +|.+-+.+-.++.+ ....+|||||++|++|.++.....   ...+   ...++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence            455555544    23333344334432 345789999999999988764321   1122   2345555555 4778898


Q ss_pred             CCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       305 ~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      .   +++|+|+||.||+++.+++++++|||++..++.
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=4.5e-14  Score=143.37  Aligned_cols=144  Identities=16%  Similarity=0.129  Sum_probs=95.0

Q ss_pred             CcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCch----------------------------------hHH----
Q 014466          187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ----------------------------------AEK----  227 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~----  227 (424)
                      .|+. +.||.|++|.||+|++++ |+.||||++.+.-..                                  ..+    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 789999999999999887 999999998654211                                  011    


Q ss_pred             --HHHHHHHHHhcCC----CCceeeEeeEeee-CCeeeEEEEecCCCCHHHHH--ccCCCCCCCCCHHHHHHHHHHHHHH
Q 014466          228 --EFKVEVEAIGRVR----HKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKG  298 (424)
Q Consensus       228 --~~~~Ei~~l~~l~----hpnIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~~a  298 (424)
                        ++.+|...+.+++    +.+.+.+-.++++ ....+|||||++|+.+.++-  .........+....+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence              1333444444442    4444555555544 34568999999999998742  2211001123333333333333   


Q ss_pred             HHHHHcCCCCCeeeCCCCCCCEEEcCCC----ceEEEecCCccccCC
Q 014466          299 LTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFGLAKLLGA  341 (424)
Q Consensus       299 l~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DfG~a~~~~~  341 (424)
                          ...   +++|+|+||.||+++.++    +++++|||++..++.
T Consensus       277 ----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                345   999999999999999988    999999999886643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=4e-13  Score=117.40  Aligned_cols=131  Identities=21%  Similarity=0.144  Sum_probs=94.9

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCcee-eEeeEeeeCCeeeEEEEecCCCCH
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEYIDNGNL  269 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~~gsL  269 (424)
                      .+.|+.|.++.||++... ++.+++|....... ....+..|.++++.+.+.+++ +++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            356889999999999876 67899998754432 223466788888888655543 4554433  345799999999877


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ...   .         .....++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~---~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE---D---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc---c---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            542   0         011235678999999999871  11259999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=2e-12  Score=129.85  Aligned_cols=166  Identities=20%  Similarity=0.224  Sum_probs=126.5

Q ss_pred             EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHH
Q 014466          207 LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE  286 (424)
Q Consensus       207 ~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~  286 (424)
                      ..++..|.|...............+-++.|+.+|||||+++++.++.+...|+|+|-+.  .|..++++.       ...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence            34577888887776665445567778999999999999999999999999999999885  677777654       256


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccCCC
Q 014466          287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM  366 (424)
Q Consensus       287 ~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  366 (424)
                      .....+.||+.||.|||+.+  +++|++|.-..|+++..|+.||++|-++........ ......---.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            66678889999999999665  999999999999999999999999987764322211 001111112456666544333


Q ss_pred             CCCccchHHHHHHHHHHHcC
Q 014466          367 LNERSDVYSFGILIMEVISG  386 (424)
Q Consensus       367 ~~~~sDiwSlGv~l~elltg  386 (424)
                        -..|.|-||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              236999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=2.6e-11  Score=107.62  Aligned_cols=135  Identities=19%  Similarity=0.183  Sum_probs=96.4

Q ss_pred             eeEcccCcEEEEEEEEcC-------CCEEEEEEeecCC----------------------chhHHHH----HHHHHHHhc
Q 014466          192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNR----------------------GQAEKEF----KVEVEAIGR  238 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~Ei~~l~~  238 (424)
                      ..||.|--+.||.|...+       +..+|||......                      ....+.+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       4789999663210                      0011222    378999988


Q ss_pred             CCC--CceeeEeeEeeeCCeeeEEEEecCCCCHHH-HHccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeeCC
Q 014466          239 VRH--KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-HEGLEPKVVHRD  314 (424)
Q Consensus       239 l~h--pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~ivHrD  314 (424)
                      +..  -++.+++++    ...++||||+.++.+.. .++.     ..++......+..+++.++..| |+.   +++|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            853  455666654    34589999997754422 2221     2344455667788999999998 888   999999


Q ss_pred             CCCCCEEEcCCCceEEEecCCcccc
Q 014466          315 IKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       315 lkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |++.|||++ ++.++|+|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 467999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=6.2e-12  Score=125.13  Aligned_cols=200  Identities=25%  Similarity=0.287  Sum_probs=154.2

Q ss_pred             cCCCcccceeEcc--cCcEEEEEEEE---cCCCEEEEEEeecC--CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCC
Q 014466          184 STNGFADENVIGE--GGYGIVYHGVL---EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGA  255 (424)
Q Consensus       184 ~~~~~~~~~~LG~--G~~g~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  255 (424)
                      ....|.+...+|.  |.+|.||.+..   .++..+|+|+-...  .+.....=.+|....+.+ .|+|.++.+..++.++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3345677788999  99999999986   35777888874322  122222333466666666 5999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEE
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKL  330 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL  330 (424)
                      ..++-+|+|. .+|.++.+...   .-++....+.++.+...    ||..+|..   .++|-|+||.||++..+ ...++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cceeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence            9999999996 58888887652   34667777778888888    99999998   99999999999999999 88999


Q ss_pred             EecCCccccCCCcc----eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          331 SDFGLAKLLGAERS----YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       331 ~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      +|||+...++...-    ....+..|...|++||..+ ..++...|+|++|.+..+-.++..+.-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence            99999988765431    1122335777899999764 467888999999999999888766544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=3.4e-11  Score=103.18  Aligned_cols=143  Identities=21%  Similarity=0.290  Sum_probs=108.0

Q ss_pred             cceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ....|-+|+-+.|+++.+. |+.+.||.-..+..        -..+...+|++++.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999986 67777775433211        12345778999999987666665555666666778999


Q ss_pred             EecCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc---eEEEecCCcc
Q 014466          262 EYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAK  337 (424)
Q Consensus       262 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DfG~a~  337 (424)
                      ||++| -++.+++.....  ..........+++.+-+.+.-||.+   +|+|+||..+||++..++.   +.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 478888876643  2233333467888999999999999   9999999999999966553   6899999986


Q ss_pred             c
Q 014466          338 L  338 (424)
Q Consensus       338 ~  338 (424)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.29  E-value=3.2e-11  Score=109.85  Aligned_cols=142  Identities=19%  Similarity=0.246  Sum_probs=107.7

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCC--ceeeEeeEeeeCC---eeeEEEEecC
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHK--NLVRLLGYCAEGA---HRMLVYEYID  265 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~~~~---~~~lv~e~~~  265 (424)
                      +.|+.|.++.||+++..+|..+++|....... .....+..|.++++.+++.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987667899998754332 1345678899999999763  4577777766542   5689999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL---------------------------------------  306 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~---------------------------------------  306 (424)
                      |.++.+.+..     ..++......++.+++++|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9877664421     24566677778888888888888521                                       


Q ss_pred             --------------CCCeeeCCCCCCCEEEcC--CCceEEEecCCccc
Q 014466          307 --------------EPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKL  338 (424)
Q Consensus       307 --------------~~~ivHrDlkp~NILl~~--~~~~kL~DfG~a~~  338 (424)
                                    ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          246799999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=4.9e-11  Score=102.70  Aligned_cols=131  Identities=23%  Similarity=0.373  Sum_probs=100.5

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCc---h-----hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG---Q-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ..+++|+-+.+|.+.+. |..+++|.=.++..   +     ..+...+|..++++++--.|...+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 44466665433311   1     123456799999998766666555566666777899999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ++|..|.+++...           ...++..+-..+.-||..   +|+|+||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888654           145667788889999999   999999999999998875 99999999974

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=8.9e-12  Score=115.17  Aligned_cols=152  Identities=21%  Similarity=0.336  Sum_probs=117.9

Q ss_pred             HhcCCCCceeeEeeEeeeC-----CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 014466          236 IGRVRHKNLVRLLGYCAEG-----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV  310 (424)
Q Consensus       236 l~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i  310 (424)
                      |-.+.|.|||++..|+.+.     ....++.|||..|++.++|++.......+......+++.||+.||.|||+ +.|.|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            4455799999999987643     35678999999999999999876666778888889999999999999998 58999


Q ss_pred             eeCCCCCCCEEEcCCCceEEEecCCccccCC----CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcC
Q 014466          311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGA----ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG  386 (424)
Q Consensus       311 vHrDlkp~NILl~~~~~~kL~DfG~a~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg  386 (424)
                      +|+++..+.|++..+|-+|+.- +.-.....    ..........+-++|.+||.=.....+..+|||+||....||..+
T Consensus       200 ihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999998888742 11111100    001111123467899999987777778889999999999999887


Q ss_pred             CCC
Q 014466          387 RNP  389 (424)
Q Consensus       387 ~~P  389 (424)
                      ..-
T Consensus       279 Eiq  281 (458)
T KOG1266|consen  279 EIQ  281 (458)
T ss_pred             eec
Confidence            654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=1e-11  Score=123.67  Aligned_cols=198  Identities=21%  Similarity=0.217  Sum_probs=149.1

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc--CCCEEEEEEeecCCchhHHHH--HHHHHHHhcC-CCCceeeEeeEeeeCC
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNRGQAEKEF--KVEVEAIGRV-RHKNLVRLLGYCAEGA  255 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~hpnIv~l~~~~~~~~  255 (424)
                      ......+|..+..||.|.|+.|+.+..+  ++..|++|.+.+.......++  ..|+-+...+ .|.++++++..+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3455567888999999999999998743  577899998877644433332  2355555555 5889999888777777


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEEEecC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFG  334 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DfG  334 (424)
                      ..|+-.|||+++++...+..    ...+++...+.+..|++.++.++|+.   .++|+|+||+||++..+ +.-++.|||
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence            78899999999988766522    24567777888999999999999988   99999999999999886 788999999


Q ss_pred             CccccCCCcceeeecccccccc-cccccccCCCCCCccchHHHHHHHHHHHcCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGY-VAPEYASTGMLNERSDVYSFGILIMEVISGRN  388 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~  388 (424)
                      ++..+....   ......+..| .+++......+..+.|++|||.-+.|.+++..
T Consensus       413 ~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  413 CWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cccccceec---ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            886432111   1111123334 35556667778899999999999999998765

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.18  E-value=4.4e-12  Score=132.58  Aligned_cols=207  Identities=23%  Similarity=0.283  Sum_probs=153.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      +...+.+.+.+-+-.|.++.++.+.-. .|...++|.....   .....+....+-.++-..++|.+++..--+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            456677888889999999999988743 2333344433211   112233334444444445677777666556666778


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      +|+++|..+++|...|+..    ...+.+.....+..+..+++|||..   .+.|||++|.|+|+..+++.++.|||...
T Consensus       880 ~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             chhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence            9999999999999998765    3566666666777889999999987   79999999999999999999999998443


Q ss_pred             ccCCC------------------------------cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCC
Q 014466          338 LLGAE------------------------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  387 (424)
Q Consensus       338 ~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~  387 (424)
                      ..+..                              .........||+.|.+||.+.+......+|+|+.|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            22100                              001122357899999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 014466          388 NPVDYSRP  395 (424)
Q Consensus       388 ~Pf~~~~~  395 (424)
                      .||...+|
T Consensus      1033 pp~na~tp 1040 (1205)
T KOG0606|consen 1033 PPFNAETP 1040 (1205)
T ss_pred             CCCCCcch
Confidence            99987765

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.09  E-value=1.4e-09  Score=106.55  Aligned_cols=169  Identities=18%  Similarity=0.280  Sum_probs=128.1

Q ss_pred             cEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEee----eCCeeeEEEEecCC-CCHHHH
Q 014466          199 YGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----EGAHRMLVYEYIDN-GNLEQW  272 (424)
Q Consensus       199 ~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~  272 (424)
                      ..+.|++.. .||..|++|++...+.+.......-++.++++.|+|||++.++|.    .+..+++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            367888884 479999999995443333322334688899999999999999887    34567899999986 577776


Q ss_pred             HccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          273 LHGDV-----------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       273 l~~~~-----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      .....           ......++...|.++.|++.||.++|+.   |+.-+-|.+.+||++.+.+++|...|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            53221           1234578899999999999999999999   999999999999999999999988887765543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN  388 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~  388 (424)
                      +..               |.+..   -.+-|.=-||.++..|.||..
T Consensus       446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            320               11111   235699999999999999843

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=2.8e-09  Score=99.79  Aligned_cols=135  Identities=15%  Similarity=0.094  Sum_probs=95.3

Q ss_pred             CcEEEEEEEEcCCCEEEEEEeecCCch-hH----------HHHHHHHHHHhcCCCCce--eeEeeEeee-----CCeeeE
Q 014466          198 GYGIVYHGVLEDNTNVAVKNLLNNRGQ-AE----------KEFKVEVEAIGRVRHKNL--VRLLGYCAE-----GAHRML  259 (424)
Q Consensus       198 ~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~Ei~~l~~l~hpnI--v~l~~~~~~-----~~~~~l  259 (424)
                      ....|+++.. +|+.+.||......-. ..          ..+.+|...+.++...+|  ..++++.+.     ....++
T Consensus        34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            3344667665 4677889976433211 11          136788888888854333  334445432     234679


Q ss_pred             EEEecCCC-CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-------CCceEEE
Q 014466          260 VYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-------QWNPKLS  331 (424)
Q Consensus       260 v~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-------~~~~kL~  331 (424)
                      |+|++++- +|.+++....  ..+.+......++.+++..+.-||+.   +|+|+|++++|||++.       ++.+.|+
T Consensus       113 Vte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             EEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            99999885 7999885421  13445667778999999999999999   9999999999999975       4679999


Q ss_pred             ecCCccc
Q 014466          332 DFGLAKL  338 (424)
Q Consensus       332 DfG~a~~  338 (424)
                      ||+.++.
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=1.7e-09  Score=95.63  Aligned_cols=125  Identities=27%  Similarity=0.322  Sum_probs=80.8

Q ss_pred             EEEEEEEcCCCEEEEEEeecCCc--------------------------hhHHHHHHHHHHHhcCCCC--ceeeEeeEee
Q 014466          201 IVYHGVLEDNTNVAVKNLLNNRG--------------------------QAEKEFKVEVEAIGRVRHK--NLVRLLGYCA  252 (424)
Q Consensus       201 ~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~  252 (424)
                      .||.|...+|..+|+|.......                          .......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999988899999997632100                          0123466799999999766  456666552 


Q ss_pred             eCCeeeEEEEecC--CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          253 EGAHRMLVYEYID--NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY-LHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       253 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~-LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                         ...+||||++  |..+..+....      ++......++.+++..+.. +|..   +|+|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  65554433221      1123345566677775544 5787   99999999999999988 899


Q ss_pred             EEecCCcccc
Q 014466          330 LSDFGLAKLL  339 (424)
Q Consensus       330 L~DfG~a~~~  339 (424)
                      |+|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.89  E-value=1.2e-08  Score=93.24  Aligned_cols=135  Identities=23%  Similarity=0.205  Sum_probs=93.8

Q ss_pred             cccceeEcccCcEEEEEEEEcCCCEEEEEEeecC----------Cch------------hHHHHHHHHHHHhcCCCC--c
Q 014466          188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN----------RGQ------------AEKEFKVEVEAIGRVRHK--N  243 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~----------~~~------------~~~~~~~Ei~~l~~l~hp--n  243 (424)
                      ..+.+.||-|--+.||.|....|.++|||.=.-.          +..            ......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4567899999999999999999999999932111          000            122356799999999654  6


Q ss_pred             eeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc
Q 014466          244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD  323 (424)
Q Consensus       244 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~  323 (424)
                      +.+.+++    +...+||||++|-.|...-         ++.+..-.++..|+.-+.-+-..   ||||+|+.+-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            6666665    4557999999996664321         11222233333444443333345   999999999999999


Q ss_pred             CCCceEEEecCCccc
Q 014466          324 KQWNPKLSDFGLAKL  338 (424)
Q Consensus       324 ~~~~~kL~DfG~a~~  338 (424)
                      ++|.+.++||--+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999965543

>PRK09902 hypothetical protein; Provisional

Probab=98.85  E-value=4.7e-08  Score=87.19  Aligned_cols=137  Identities=15%  Similarity=0.175  Sum_probs=101.8

Q ss_pred             EcccCcEEEEEEEEcCCCEEEEEEeecCC------chhHHHHHHHHHHHhcCCCCc--eeeEeeEee---eC--CeeeEE
Q 014466          194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKN--LVRLLGYCA---EG--AHRMLV  260 (424)
Q Consensus       194 LG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~---~~--~~~~lv  260 (424)
                      -|+||.+-|++..+. |+.+-+|+-.+..      +.....|.+|...|.++...+  +.++. ++.   .+  -..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            456899999988776 4568888764221      334567999999999885432  44444 322   11  235699


Q ss_pred             EEecCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc--eEEEecCCcc
Q 014466          261 YEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDFGLAK  337 (424)
Q Consensus       261 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DfG~a~  337 (424)
                      +|-+++ -+|.+++....  ..+.+......++.+++++++-||+.   ++.|+|+.+.|||++.++.  ++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 58999986542  24567777889999999999999999   9999999999999986667  9999997665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.84  E-value=7.6e-08  Score=92.44  Aligned_cols=194  Identities=14%  Similarity=0.178  Sum_probs=129.4

Q ss_pred             ccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeE----ee--eCCe-eeEE
Q 014466          189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGY----CA--EGAH-RMLV  260 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~----~~--~~~~-~~lv  260 (424)
                      ...+.||+|+-+.+|-.-.- +. .+.|+...........   .++.|... .||-+-.-+.|    .+  +.+. .-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            34678999999999954322 22 3557776654433322   23334444 45533321222    11  2222 4578


Q ss_pred             EEecCCCC-HHHHHc--cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          261 YEYIDNGN-LEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       261 ~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |..+.+.. +..++.  .++.......|...++.++.++.+.+.||+.   |.+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            88887642 333332  1122345688999999999999999999999   99999999999999999999999854333


Q ss_pred             ccCCCcceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcC-CCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISG-RNPVDY  392 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg-~~Pf~~  392 (424)
                      .-  .........+|.+.|++||.-.     +-.-+...|.|.|||++++|+.| +.||.+
T Consensus       166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            21  1122223456899999999654     33456779999999999999986 999984

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=4.3e-08  Score=88.61  Aligned_cols=105  Identities=22%  Similarity=0.258  Sum_probs=80.8

Q ss_pred             HHHHHHHHHHhcCCCCc--eeeEeeEeeeC----CeeeEEEEecCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 014466          227 KEFKVEVEAIGRVRHKN--LVRLLGYCAEG----AHRMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL  299 (424)
Q Consensus       227 ~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al  299 (424)
                      ....+|...+..+..-+  +.+.+++.+..    ...++|+|++++ .+|.+++....    ..+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            34666777777775333  34555555442    245799999987 47999987642    255566788999999999


Q ss_pred             HHHHcCCCCCeeeCCCCCCCEEEcCCC---ceEEEecCCccc
Q 014466          300 TYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAKL  338 (424)
Q Consensus       300 ~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DfG~a~~  338 (424)
                      +-||+.   +|+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=4.8e-08  Score=99.07  Aligned_cols=141  Identities=21%  Similarity=0.213  Sum_probs=91.0

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchh------------------------------HH----------HHHH
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA------------------------------EK----------EFKV  231 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~  231 (424)
                      +.|+.++-|.||+|++++|+.||||+..+.-...                              .+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999876542110                              01          1233


Q ss_pred             HHHHHhcCC----CCceeeEeeEeee-CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHH-HHHHHcC
Q 014466          232 EVEAIGRVR----HKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG-LTYLHEG  305 (424)
Q Consensus       232 Ei~~l~~l~----hpnIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~a-l~~LH~~  305 (424)
                      |...+.+++    ...=+++-.+|++ .+...|+|||++|-.+.+......   ...+...   ++..++++ +..+=..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~---ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKE---LAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHH---HHHHHHHHHHHHHHhc
Confidence            444444442    2223334445543 456789999999988877742221   2233222   22222222 1122223


Q ss_pred             CCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       306 ~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                         +++|.|..|.||+++.+|++.+.|||+...++.
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               899999999999999999999999999876643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.60  E-value=1.1e-06  Score=80.65  Aligned_cols=139  Identities=19%  Similarity=0.178  Sum_probs=84.8

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEeeEeeeCCeeeEEEEecCCCC-
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYIDNGN-  268 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~gs-  268 (424)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-+  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   25567788765432  3345688999998886443  4677777777777889999999863 


Q ss_pred             HHHH---------------------HccCCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHcC-CCCCeeeCCC
Q 014466          269 LEQW---------------------LHGDVGPHSPLTWEIRMNIILG----------TAK-GLTYLHEG-LEPKVVHRDI  315 (424)
Q Consensus       269 L~~~---------------------l~~~~~~~~~l~~~~~~~i~~~----------i~~-al~~LH~~-~~~~ivHrDl  315 (424)
                      +...                     ++........++... ..+..+          +.. ...+|.+. ..+.++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            1111                     111100011111100 001000          001 12222211 1346789999


Q ss_pred             CCCCEEEcCCCceEEEecCCcc
Q 014466          316 KSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       316 kp~NILl~~~~~~kL~DfG~a~  337 (424)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999988 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.58  E-value=1.1e-06  Score=78.72  Aligned_cols=139  Identities=14%  Similarity=0.173  Sum_probs=90.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHH---------HHHHHHHhcCCCC---ceeeEeeE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---------KVEVEAIGRVRHK---NLVRLLGY  250 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~hp---nIv~l~~~  250 (424)
                      +..++|...+++-......|.+-..+ |+.+++|..........+.|         .+++..+.+++..   ....++-+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            34567777888887777777766664 68899998765433322222         2344444444322   22222222


Q ss_pred             ee-----eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          251 CA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       251 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      .+     -....+|+|||++|..|.++..        +++.    +...+..++.-||+.   |+.|+|..|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e~----~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDED----LAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCHH----HHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            22     2234568999999987765432        2222    334567789999999   99999999999999966


Q ss_pred             CceEEEecCCccc
Q 014466          326 WNPKLSDFGLAKL  338 (424)
Q Consensus       326 ~~~kL~DfG~a~~  338 (424)
                      + ++++||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            5 99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.57  E-value=7.1e-09  Score=104.04  Aligned_cols=189  Identities=18%  Similarity=0.124  Sum_probs=136.9

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc-eeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e  262 (424)
                      .+.-+..-+.+++|+++++++.+....+....+.+...     ....-++++|.+++||| .+..++-++.+...+++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            33445666788999999999988544444445544332     44556899999999999 7777888888888899999


Q ss_pred             ecCCC-CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          263 YIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       263 ~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ++.++ +-......   ....+.......+.+.-++++++||+.   .=+|+|    ||+..+ +..|..||+....+..
T Consensus       315 i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  315 ICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhcCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCc
Confidence            99886 21111100   012233344456677778899999976   458998    777766 5789999999876543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                      ..  ......+|+.|+|||+.....+..+.|.|++|+--.++--|-.|-
T Consensus       384 ~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  384 TM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            32  445677999999999999999999999999998666666666654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.49  E-value=1.5e-06  Score=79.39  Aligned_cols=145  Identities=22%  Similarity=0.259  Sum_probs=84.8

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC--ceeeEeeEee---eCCeeeEEEEecC
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLLGYCA---EGAHRMLVYEYID  265 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~---~~~~~~lv~e~~~  265 (424)
                      ++.|+.|..+.||++...+ ..+++|.....  .....+..|..+++.+...  .+.+++.+..   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4679999999999999886 68999986544  4556777888888888533  3456665443   2334689999999


Q ss_pred             CCCHHH----------------HH---ccCCCCCCCCCHHHH--H-------HH------------HHHHHH-HHHHHHc
Q 014466          266 NGNLEQ----------------WL---HGDVGPHSPLTWEIR--M-------NI------------ILGTAK-GLTYLHE  304 (424)
Q Consensus       266 ~gsL~~----------------~l---~~~~~~~~~l~~~~~--~-------~i------------~~~i~~-al~~LH~  304 (424)
                      |..+..                .+   +..............  .       ..            ...+.. .++.+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987776                11   111001111111110  0       00            011222 2333332


Q ss_pred             C----CCCCeeeCCCCCCCEEEc-CCCceEEEecCCccc
Q 014466          305 G----LEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKL  338 (424)
Q Consensus       305 ~----~~~~ivHrDlkp~NILl~-~~~~~kL~DfG~a~~  338 (424)
                      .    ....++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1    234799999999999999 666678999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.4e-06  Score=88.28  Aligned_cols=140  Identities=21%  Similarity=0.262  Sum_probs=88.5

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchh-------------------------------HH------HHHHHH
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA-------------------------------EK------EFKVEV  233 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~Ei  233 (424)
                      .+.||.-..|.||+|+.++|+.||||+-.+.-...                               .+      +|..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999765431110                               00      133344


Q ss_pred             HHHhcC----CCCc---eeeEeeEeeeC-CeeeEEEEecCCCCHHHH--HccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014466          234 EAIGRV----RHKN---LVRLLGYCAEG-AHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYLH  303 (424)
Q Consensus       234 ~~l~~l----~hpn---Iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH  303 (424)
                      +-..++    .|-+   -|.+-.++++- ....|+||||+|..+.+.  +.+.     .++...   ++..+.++  |++
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~~---i~~~l~~~--~~~  315 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-----GISPHD---ILNKLVEA--YLE  315 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-----CCCHHH---HHHHHHHH--HHH
Confidence            433333    3555   23344555543 467899999999866443  3333     333332   22223322  222


Q ss_pred             cCCCCCeeeCCCCCCCEEEcC----CCceEEEecCCccccC
Q 014466          304 EGLEPKVVHRDIKSSNILLDK----QWNPKLSDFGLAKLLG  340 (424)
Q Consensus       304 ~~~~~~ivHrDlkp~NILl~~----~~~~kL~DfG~a~~~~  340 (424)
                      .-...|++|+|-.|.||+++.    ++++.+.|||+...+.
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            112228999999999999984    6789999999987653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.39  E-value=4.8e-06  Score=75.57  Aligned_cols=136  Identities=22%  Similarity=0.254  Sum_probs=91.8

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchh------------------------HHHHHHHHHHHhcCC--CCcee
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA------------------------EKEFKVEVEAIGRVR--HKNLV  245 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~Ei~~l~~l~--hpnIv  245 (424)
                      -.|++|--..||+|...++..+|+|+........                        ......|..-|+++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            3688888999999998889999999885432111                        012334666677663  33344


Q ss_pred             eEeeEeeeCCeeeEEEEecCCCCH-HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEc
Q 014466          246 RLLGYCAEGAHRMLVYEYIDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLD  323 (424)
Q Consensus       246 ~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~  323 (424)
                      +.+++..    ..|||||+....+ .=.|+.     -++..+....+..++++.+.-|-. .   ++||+||..=|||+.
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH  201 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE
Confidence            5555543    3799999965311 111111     122333566677778888777776 5   999999999999999


Q ss_pred             CCCceEEEecCCccccC
Q 014466          324 KQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       324 ~~~~~kL~DfG~a~~~~  340 (424)
                       ++.+.++|||-|....
T Consensus       202 -~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 -DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CCeEEEEECccccccC
Confidence             8899999999887543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.36  E-value=4.5e-08  Score=99.37  Aligned_cols=96  Identities=28%  Similarity=0.497  Sum_probs=74.7

Q ss_pred             HHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee--------eecccccccccccccccCC
Q 014466          294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--------TTRVMGTFGYVAPEYASTG  365 (424)
Q Consensus       294 ~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~  365 (424)
                      +++.|+.|+|..  +++||++|.|++|.++..+..||+.|+.+....+...+.        ..-..-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            455899999975  599999999999999999999999999876443311110        0012235689999999998


Q ss_pred             CCCCccchHHHHHHHHHHHc-CCCCCC
Q 014466          366 MLNERSDVYSFGILIMEVIS-GRNPVD  391 (424)
Q Consensus       366 ~~~~~sDiwSlGv~l~ellt-g~~Pf~  391 (424)
                      ..+.++|+||+|+++|.+.. |+.-+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~  211 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIA  211 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhh
Confidence            89999999999999999984 554444

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.35  E-value=5.8e-06  Score=76.66  Aligned_cols=140  Identities=16%  Similarity=0.144  Sum_probs=83.7

Q ss_pred             EcccCc-EEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEecCCCCHHH
Q 014466          194 IGEGGY-GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ  271 (424)
Q Consensus       194 LG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~  271 (424)
                      |..|.+ ..||+.... +..+.+|......   ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 788988765 4667788764332   335667888887773 3446677877776667789999999977654


Q ss_pred             HH-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHcC----C
Q 014466          272 WL-------------------HGDVGPHSPLTWE--IRMNIIL--------------------GTAKGLTYLHEG----L  306 (424)
Q Consensus       272 ~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~al~~LH~~----~  306 (424)
                      ..                   +.......++...  .......                    .+...+..|-..    .
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            31                   1110001111100  0000000                    011112222111    1


Q ss_pred             CCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       307 ~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3569999999999999998778999999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.35  E-value=1.3e-05  Score=71.62  Aligned_cols=131  Identities=23%  Similarity=0.335  Sum_probs=92.7

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCC----------------chhHHHHHHHHHHHhcCC------CCceeeEe
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----------------GQAEKEFKVEVEAIGRVR------HKNLVRLL  248 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------hpnIv~l~  248 (424)
                      ...||+|+.-.||.  +.++...+||+.....                ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999999995  4445567889886554                122455666766666655      78899999


Q ss_pred             eEeeeCCeeeEEEEecCC------CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          249 GYCAEGAHRMLVYEYIDN------GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       249 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      |+.+++.-.-+|+|.+..      -+|.+++...     .++. .   +...+-+-..||-++   .|+.+|++|.||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence            999999888899998743      2688888543     4554 2   223344456677777   89999999999999


Q ss_pred             cCCC----ceEEEe-cCC
Q 014466          323 DKQW----NPKLSD-FGL  335 (424)
Q Consensus       323 ~~~~----~~kL~D-fG~  335 (424)
                      ....    .+.|+| ||.
T Consensus       152 ~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EecCCCceEEEEEeCCCC
Confidence            5432    477887 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=6.6e-06  Score=70.78  Aligned_cols=133  Identities=17%  Similarity=0.236  Sum_probs=90.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCcee-eEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~  263 (424)
                      .......+.|++|.+|.||+|.+. |..+|+|+-..  ......+..|.++|..+.-.++- +++.|-.+    ++.|||
T Consensus        21 ~~~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          21 KYELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             chhhhhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            334566789999999999999997 55788886533  33446788899999988766553 45555433    456999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCC-CCCEEEcCCCceEEEecCCccc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK-SSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlk-p~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ++|-.|.++-...       +...    +..+++.---|-..   +|-|..|. |..++|-.++.+.|+||..|..
T Consensus        94 i~G~~L~~~~~~~-------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG-------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc-------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9998887754321       2222    23445554444455   88888886 4445555555899999998874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.17  E-value=3.2e-05  Score=68.70  Aligned_cols=125  Identities=26%  Similarity=0.397  Sum_probs=89.0

Q ss_pred             CCcccceeEcccCc-EEEEEEEEcCCCEEEEEEeec---CC--------c----------hhHHHHHHHHHHHhcCC---
Q 014466          186 NGFADENVIGEGGY-GIVYHGVLEDNTNVAVKNLLN---NR--------G----------QAEKEFKVEVEAIGRVR---  240 (424)
Q Consensus       186 ~~~~~~~~LG~G~~-g~V~~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~Ei~~l~~l~---  240 (424)
                      .+++.++.||.|.- |.||+++.. |+.+|+|.+..   ..        .          .....|..|.++..+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            57888999999999 999999986 67899998321   00        0          11235778888887774   


Q ss_pred             CCce--eeEeeEeeeC------------------CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 014466          241 HKNL--VRLLGYCAEG------------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT  300 (424)
Q Consensus       241 hpnI--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~  300 (424)
                      +.++  |+++||..-.                  ....||.||++...             .+.    ..-+.+|.+-+.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence            4456  9999997321                  01247888776522             222    233446777789


Q ss_pred             HHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       301 ~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .+|..   +|+-+|+++.|..   +  -||+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc---C--CEEEecccC
Confidence            99998   9999999999986   3  399999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.15  E-value=1.3e-05  Score=71.17  Aligned_cols=104  Identities=22%  Similarity=0.241  Sum_probs=81.1

Q ss_pred             HHHHHHhcCCC-CceeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 014466          231 VEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK  309 (424)
Q Consensus       231 ~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~  309 (424)
                      .|.-+++.+++ +++.+++|+|-.    ++|.||...+++... ..........+|..+.+|+.++++.+.+|+......
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            47778888866 699999999954    678999987665421 000001135689999999999999999999854446


Q ss_pred             eeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       310 ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=3.8e-05  Score=83.70  Aligned_cols=148  Identities=13%  Similarity=0.204  Sum_probs=91.1

Q ss_pred             ceeEcccCcEEEEEEEEcCC---CEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCce--eeEeeEeeeC---CeeeEE
Q 014466          191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNL--VRLLGYCAEG---AHRMLV  260 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnI--v~l~~~~~~~---~~~~lv  260 (424)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |.++  .+++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999887654   357777653322 123356888999999995 6665  7788887664   357899


Q ss_pred             EEecCCCCHHH--------------------H---HccCCCC-------CCCCC--HHHHHHHH---------------H
Q 014466          261 YEYIDNGNLEQ--------------------W---LHGDVGP-------HSPLT--WEIRMNII---------------L  293 (424)
Q Consensus       261 ~e~~~~gsL~~--------------------~---l~~~~~~-------~~~l~--~~~~~~i~---------------~  293 (424)
                      |||++|..+.+                    .   |+.....       ..+..  ......+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998854211                    1   1211000       00101  11111111               1


Q ss_pred             HHHHHHHHHHcCCC--------CCeeeCCCCCCCEEEcCC-Cc-eEEEecCCccc
Q 014466          294 GTAKGLTYLHEGLE--------PKVVHRDIKSSNILLDKQ-WN-PKLSDFGLAKL  338 (424)
Q Consensus       294 ~i~~al~~LH~~~~--------~~ivHrDlkp~NILl~~~-~~-~kL~DfG~a~~  338 (424)
                      .+.+.+++|..+..        +.+||+|+++.|||++.+ +. .-|.||.++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            13344667755432        359999999999999853 33 57999988764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=2.9e-05  Score=71.64  Aligned_cols=72  Identities=14%  Similarity=0.224  Sum_probs=44.5

Q ss_pred             eeEcccCcE-EEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC---ceeeEeeEeeeC---CeeeEEEEec
Q 014466          192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCAEG---AHRMLVYEYI  264 (424)
Q Consensus       192 ~~LG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~---~~~~lv~e~~  264 (424)
                      +.|+.||.. .||+.    +..+++|....  ......+.+|.++++.+...   .+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777776 58875    33567775433  22345788899999877532   234444443322   2347899999


Q ss_pred             CCCCH
Q 014466          265 DNGNL  269 (424)
Q Consensus       265 ~~gsL  269 (424)
                      +|.++
T Consensus        77 ~G~~l   81 (235)
T cd05155          77 EGETA   81 (235)
T ss_pred             cCCCC
Confidence            98665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.04  E-value=7.6e-05  Score=68.66  Aligned_cols=73  Identities=15%  Similarity=0.116  Sum_probs=46.9

Q ss_pred             eeEcccCcEEEEEEEEcC--CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc-eeeEeeEeeeCCeeeEEEEecCCCC
Q 014466          192 NVIGEGGYGIVYHGVLED--NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      +.|..|-...+|++...+  +..+++|....... ..-...+|+.+++.+...+ ..++++....    .++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence            567778888999998664  56788886643322 1123346888888885433 3444444332    48999999865


Q ss_pred             H
Q 014466          269 L  269 (424)
Q Consensus       269 L  269 (424)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.02  E-value=9.7e-05  Score=70.65  Aligned_cols=77  Identities=10%  Similarity=0.053  Sum_probs=54.6

Q ss_pred             cceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC---CceeeEeeEeee---CCeeeEEEEe
Q 014466          190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH---KNLVRLLGYCAE---GAHRMLVYEY  263 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~---~~~~~lv~e~  263 (424)
                      -.+.||.|..+.||+....++ .+.+|.. +. ......+..|.+.++.+..   -.+.++++++..   .+..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~-~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMA-RS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEe-cc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            356799999999999876655 4566653 22 1123567889888888843   357778877754   3567999999


Q ss_pred             cCCCCH
Q 014466          264 IDNGNL  269 (424)
Q Consensus       264 ~~~gsL  269 (424)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.94  E-value=5.3e-05  Score=70.78  Aligned_cols=139  Identities=14%  Similarity=0.095  Sum_probs=76.9

Q ss_pred             EcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEEecCCCCHHH-
Q 014466          194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDNGNLEQ-  271 (424)
Q Consensus       194 LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~gsL~~-  271 (424)
                      +..|-.+.+|+... ++..+++|..........-...+|.++++.+...++ .+++....    -++|+||++|..+.. 
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            45677789998874 466788886543322211234668888888854333 33343332    368999999865432 


Q ss_pred             -------------H---HccCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHcC-----CCCCeeeCCCCCCCE
Q 014466          272 -------------W---LHGDVGPHSPLTWEI-RMNIILGT---------AKGLTYLHEG-----LEPKVVHRDIKSSNI  320 (424)
Q Consensus       272 -------------~---l~~~~~~~~~l~~~~-~~~i~~~i---------~~al~~LH~~-----~~~~ivHrDlkp~NI  320 (424)
                                   .   ++.......+++... ...+..++         ...+..+-..     ..+.++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                         1   122111111222111 11111111         1112222111     123689999999999


Q ss_pred             EEcCCCceEEEecCCccc
Q 014466          321 LLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       321 Ll~~~~~~kL~DfG~a~~  338 (424)
                      ++++++ +.|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 79999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.76  E-value=0.00018  Score=68.70  Aligned_cols=144  Identities=17%  Similarity=0.174  Sum_probs=84.3

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEeeE------eeeCCeeeEEEE
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE  262 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~e  262 (424)
                      .+.|..|....+|+....+ ..+++|....   .....+..|++++..+.+.+  +.+++..      ...++..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            5667778888999987654 4688887654   22345666788877774332  4444432      123445689999


Q ss_pred             ecCCCCHHH-----------H---HccCC----CC---CCCCCHHHHH----------HHHHHHHHHHHHHHc----CCC
Q 014466          263 YIDNGNLEQ-----------W---LHGDV----GP---HSPLTWEIRM----------NIILGTAKGLTYLHE----GLE  307 (424)
Q Consensus       263 ~~~~gsL~~-----------~---l~~~~----~~---~~~l~~~~~~----------~i~~~i~~al~~LH~----~~~  307 (424)
                      |++|..+..           .   ++...    ..   .....|....          .....+..++.++.+    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999865421           0   11100    00   0011111110          011112334444443    123


Q ss_pred             CCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       308 ~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      .+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999987778999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.68  E-value=0.00035  Score=66.95  Aligned_cols=142  Identities=26%  Similarity=0.311  Sum_probs=81.9

Q ss_pred             eeEcccCcEEEEEEEEcC-------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~  263 (424)
                      +.|..|-...+|+....+       ++.+++|...... .......+|.++++.+...++ .++++++.+    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667777999988654       4678888865433 222345668888877753333 345555542    368999


Q ss_pred             cCCCCHHHH-----------------HccCCCCC-----CCCC--HHHHHH--------------------------HHH
Q 014466          264 IDNGNLEQW-----------------LHGDVGPH-----SPLT--WEIRMN--------------------------IIL  293 (424)
Q Consensus       264 ~~~gsL~~~-----------------l~~~~~~~-----~~l~--~~~~~~--------------------------i~~  293 (424)
                      ++|..+...                 ++......     ...+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988665321                 11111110     0111  111100                          111


Q ss_pred             HHHHHHHHHHc------CCCCCeeeCCCCCCCEEEcCC----CceEEEecCCccc
Q 014466          294 GTAKGLTYLHE------GLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL  338 (424)
Q Consensus       294 ~i~~al~~LH~------~~~~~ivHrDlkp~NILl~~~----~~~kL~DfG~a~~  338 (424)
                      .+.+.+.+|-.      .....++|+|+.+.|||++++    +.++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22223334432      234589999999999999985    8899999988763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.60  E-value=0.0016  Score=64.52  Aligned_cols=75  Identities=19%  Similarity=0.239  Sum_probs=53.2

Q ss_pred             ceeEcccCcEEEEEEEEcCC-CEEEEEEeecC-----C--chhHHHHHHHHHHHhcCC---CCceeeEeeEeeeCCeeeE
Q 014466          191 ENVIGEGGYGIVYHGVLEDN-TNVAVKNLLNN-----R--GQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+.||.|.+..||++...+| +.++||.-.+.     .  +...+.+..|.+.|+.+.   ..++.+++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            35799999999999998876 47999975321     1  123456667888887762   345777777733  55789


Q ss_pred             EEEecCCC
Q 014466          260 VYEYIDNG  267 (424)
Q Consensus       260 v~e~~~~g  267 (424)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>PRK05231 homoserine kinase; Provisional

Probab=97.60  E-value=0.0012  Score=63.85  Aligned_cols=143  Identities=13%  Similarity=0.156  Sum_probs=76.6

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEee------EeeeCCeeeEEEE
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLG------YCAEGAHRMLVYE  262 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~------~~~~~~~~~lv~e  262 (424)
                      .+.|+.|....+|+....+| .+++|+.. .  ...+.+..|+++++.|...+  +.+.+.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35577787789999887655 58888764 1  12233444555555553211  223332      1223456789999


Q ss_pred             ecCCCCHH-----------HH---HccCCCC-------CCCCCH-HHHHH------------HHHH-HHHHHHHHHc---
Q 014466          263 YIDNGNLE-----------QW---LHGDVGP-------HSPLTW-EIRMN------------IILG-TAKGLTYLHE---  304 (424)
Q Consensus       263 ~~~~gsL~-----------~~---l~~~~~~-------~~~l~~-~~~~~------------i~~~-i~~al~~LH~---  304 (424)
                      |++|..+.           +.   ++.....       ...+.+ .....            .+.+ +...++.+.+   
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99986431           11   1111100       001111 11110            1111 1112233321   


Q ss_pred             -CCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          305 -GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       305 -~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                       ....++||+|+.+.|||++.+...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             134589999999999999976556899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.60  E-value=0.0014  Score=62.94  Aligned_cols=145  Identities=17%  Similarity=0.205  Sum_probs=82.3

Q ss_pred             cceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEeeE------eeeCCeeeEEE
Q 014466          190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVY  261 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~  261 (424)
                      ..+.++.|-...+|+....++ .+++|......  ..+.+..|++++..|...+  +.+++..      ...++..++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            356677777789999876544 57788764422  1234555677777664222  3343331      12245678999


Q ss_pred             EecCCCCHH-----H---------HHccCCCC---C--C---CCCHHHHH------------HHHHHHHHHHHHHHc---
Q 014466          262 EYIDNGNLE-----Q---------WLHGDVGP---H--S---PLTWEIRM------------NIILGTAKGLTYLHE---  304 (424)
Q Consensus       262 e~~~~gsL~-----~---------~l~~~~~~---~--~---~l~~~~~~------------~i~~~i~~al~~LH~---  304 (424)
                      ||++|..+.     .         .++.....   .  .   ...|....            .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885431     1         11211100   0  0   00111000            001123334555542   


Q ss_pred             -CCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          305 -GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       305 -~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                       ....+++|+|+.+.||+++.++...|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             224589999999999999998777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.35  E-value=0.0022  Score=62.61  Aligned_cols=142  Identities=19%  Similarity=0.201  Sum_probs=80.0

Q ss_pred             eeEcccCcEEEEEEEEcC-----CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEEecC
Q 014466          192 NVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~  265 (424)
                      ..|..|-.-.+|++...+     ++.+++|.......... ....|..+++.+..-++ .++++.+.++    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345557888999987542     35788887755432222 23568888887754443 3455665433    5789998


Q ss_pred             CCCHHHH-----------------HccCCCCCC--CCCHHHHHHHHHH-----------------HHHHHHHH----Hc-
Q 014466          266 NGNLEQW-----------------LHGDVGPHS--PLTWEIRMNIILG-----------------TAKGLTYL----HE-  304 (424)
Q Consensus       266 ~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~-----------------i~~al~~L----H~-  304 (424)
                      +.+|...                 ++.......  ...+.....+..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665311                 122110111  1112222222211                 11112222    21 


Q ss_pred             CCCCCeeeCCCCCCCEEEcC-CCceEEEecCCccc
Q 014466          305 GLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKL  338 (424)
Q Consensus       305 ~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~~  338 (424)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12347899999999999986 46799999988764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.34  E-value=3.4e-05  Score=84.91  Aligned_cols=162  Identities=13%  Similarity=0.017  Sum_probs=118.8

Q ss_pred             HHHHHHHHhcCCCCceeeEeeEeee--CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 014466          229 FKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL  306 (424)
Q Consensus       229 ~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~  306 (424)
                      ...|...++...|+++.....-...  +...+.+++|+.+|.+.+.+-+......++....+...-.+...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3345556667789998877665543  33567899999999999998776655555655554444444355555555432


Q ss_pred             --CCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHH
Q 014466          307 --EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  384 (424)
Q Consensus       307 --~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ell  384 (424)
                        ..-.+|+++|+-|.+|..+.++|+.++|+.+....... ......+++.|+.|+..+.-.++.++|+|..|+.+|++.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence              12468999999999999999999999999983222222 223456788999999999999999999999999999998


Q ss_pred             cCCCCCC
Q 014466          385 SGRNPVD  391 (424)
Q Consensus       385 tg~~Pf~  391 (424)
                      .|..+|-
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            8888864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.29  E-value=0.0028  Score=60.16  Aligned_cols=75  Identities=15%  Similarity=0.233  Sum_probs=45.9

Q ss_pred             ccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC---CCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      +..+.++-|....+|+.. .+++.+.+|.-..   .....|..|.+-|+.|   .--.+.+++++...++..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            335678889899999877 5677899997652   2234566677777666   34557788888877777799999998


Q ss_pred             CC
Q 014466          266 NG  267 (424)
Q Consensus       266 ~g  267 (424)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.26  E-value=0.0034  Score=59.32  Aligned_cols=31  Identities=32%  Similarity=0.496  Sum_probs=26.2

Q ss_pred             CCeeeCCCCCCCEEEcCCCc-eEEEecCCccc
Q 014466          308 PKVVHRDIKSSNILLDKQWN-PKLSDFGLAKL  338 (424)
Q Consensus       308 ~~ivHrDlkp~NILl~~~~~-~kL~DfG~a~~  338 (424)
                      +.++|+|+++.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            46899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.02  E-value=0.0059  Score=58.86  Aligned_cols=139  Identities=17%  Similarity=0.206  Sum_probs=92.3

Q ss_pred             cceeEcccCcEEEEEEEEcCCCEEEEEEeecC------Cch--------------------hHHHHHHHHHHHhcCCCCc
Q 014466          190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN------RGQ--------------------AEKEFKVEVEAIGRVRHKN  243 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~------~~~--------------------~~~~~~~Ei~~l~~l~hpn  243 (424)
                      +.-.|..|--..||.+...+|..+|||+....      +..                    ..-....|+.-|++++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34578889999999999999999999976321      000                    0112345777788876544


Q ss_pred             eeeEeeEeeeCCeeeEEEEecCCCCHH-HHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          244 LVRLLGYCAEGAHRMLVYEYIDNGNLE-QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       244 Iv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      |.-.--....  ...|||+|+...... -.|+     ...++...+..+-++++.-+.-|-+.|  ++||.||.-=|+|+
T Consensus       228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCceeee--cceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            3321111111  236999999642221 1122     234555566677778888888887777  99999999999998


Q ss_pred             cCCCceEEEecCCccc
Q 014466          323 DKQWNPKLSDFGLAKL  338 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~  338 (424)
                      .+ |.+.++|.+-+..
T Consensus       299 hd-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSVE  313 (520)
T ss_pred             EC-CEEEEEEcccccc
Confidence            65 5799999887654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.00  E-value=0.00073  Score=63.84  Aligned_cols=134  Identities=16%  Similarity=0.107  Sum_probs=87.4

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEee---------cCCch-------------hHHHHHHHHHHHhcCCC--C
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLL---------NNRGQ-------------AEKEFKVEVEAIGRVRH--K  242 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~---------~~~~~-------------~~~~~~~Ei~~l~~l~h--p  242 (424)
                      -+.+++.||-|--+-+|.+.+..|++.++|.-.         +++..             ..-...+|...|+.|..  -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            356789999999999999999989998888321         00000             01123457777777742  1


Q ss_pred             ceeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       243 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      -+.+.+++    +..++|||++.|-.|.+.-+-.       +...   +...+..-+--|..+   |+||+|..-=||++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------DPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeecC-------ChHH---HHHHHHHHHHHHHHc---CceecccchheeEE
Confidence            24444444    4568999999887765533211       1121   222223334445556   99999999999999


Q ss_pred             cCCCceEEEecCCcc
Q 014466          323 DKQWNPKLSDFGLAK  337 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~  337 (424)
                      ++++.++++||--..
T Consensus       236 ~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMV  250 (465)
T ss_pred             ecCCCEEEeechHhh
Confidence            999999999996443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.96  E-value=0.0077  Score=58.52  Aligned_cols=142  Identities=20%  Similarity=0.285  Sum_probs=77.5

Q ss_pred             eeEcccCcEEEEEEEEcC----CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.|..|-...+|+....+    +..|++|........ .-.-.+|..+++.+..-++ .++++++..+    +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            345447778899887543    236888877554332 2233558888888765444 3556665332    58899877


Q ss_pred             CCHHH--------------H---HccCCCCCC--CCCHHHHHHHHHH----------------------HHHHHHHHHc-
Q 014466          267 GNLEQ--------------W---LHGDVGPHS--PLTWEIRMNIILG----------------------TAKGLTYLHE-  304 (424)
Q Consensus       267 gsL~~--------------~---l~~~~~~~~--~l~~~~~~~i~~~----------------------i~~al~~LH~-  304 (424)
                      ..|..              .   ++.......  +-.+.....+..+                      +..-+..+.+ 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65421              1   122110101  1112222222211                      1111222111 


Q ss_pred             ----CCCCCeeeCCCCCCCEEEcC-CCceEEEecCCccc
Q 014466          305 ----GLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKL  338 (424)
Q Consensus       305 ----~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~~  338 (424)
                          ..+.-++|.|+.+.|||+++ ++.++++||..|-.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11234899999999999975 57899999987753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.94  E-value=0.014  Score=56.16  Aligned_cols=31  Identities=23%  Similarity=0.327  Sum_probs=28.0

Q ss_pred             CCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       308 ~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      .+++|+|+.++|+|++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999987764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.91  E-value=0.0031  Score=68.62  Aligned_cols=156  Identities=20%  Similarity=0.248  Sum_probs=112.3

Q ss_pred             HHHHHHHHHhcCCCCceeeEeeEeeeCCee----eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014466          228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH  303 (424)
Q Consensus       228 ~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH  303 (424)
                      ....|++.+..+.|+|++.++.|-.+....    .+..+++..-++...+..-    ..++....+.+..++.+||+|+|
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence            345578888899999999999987654322    2456788888888877654    57788888889999999999999


Q ss_pred             cCCCCCeeeCCCCCC---CEEEcCCCceEEE--ecCCccccCCCcceeeecccccccccccccccCCCCCCc--cchHHH
Q 014466          304 EGLEPKVVHRDIKSS---NILLDKQWNPKLS--DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER--SDVYSF  376 (424)
Q Consensus       304 ~~~~~~ivHrDlkp~---NILl~~~~~~kL~--DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDiwSl  376 (424)
                      +.   ...|.-+..+   +-.++.++...++  ||+..+.........  ...-+..|.++|......+..+  .|+|.+
T Consensus       304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHH
Confidence            87   5555555444   4444566667776  898887654332221  1223556788888877666654  799999


Q ss_pred             HHHHHHHHcCCCCCCC
Q 014466          377 GILIMEVISGRNPVDY  392 (424)
Q Consensus       377 Gv~l~elltg~~Pf~~  392 (424)
                      |.++..+..|..+-.+
T Consensus       379 gll~~~~~~~~~i~~~  394 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEK  394 (1351)
T ss_pred             HHHHhhhhhcCccccc
Confidence            9999999988776544

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.90  E-value=0.011  Score=56.65  Aligned_cols=29  Identities=28%  Similarity=0.343  Sum_probs=25.7

Q ss_pred             CCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       308 ~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999988 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.85  E-value=0.018  Score=55.26  Aligned_cols=148  Identities=19%  Similarity=0.259  Sum_probs=79.9

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEee-cCCchhHHHHHHHHHHHhcCCC--CceeeEeeEeeeCC--eeeEEEEecC
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLL-NNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGA--HRMLVYEYID  265 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~--~~~lv~e~~~  265 (424)
                      .+.+..|-.-.+|..... ++++++.+-. ...........+|.++|+.+.-  --+...+++|.++.  ..+.||+|++
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            344433444455555443 6677777211 1122334556678888877743  22344566666655  6689999999


Q ss_pred             CCCHHHHHccC---------------------C-------C-----CCCCCC-HHHHHHH--------HHHHHHHHHHHH
Q 014466          266 NGNLEQWLHGD---------------------V-------G-----PHSPLT-WEIRMNI--------ILGTAKGLTYLH  303 (424)
Q Consensus       266 ~gsL~~~l~~~---------------------~-------~-----~~~~l~-~~~~~~i--------~~~i~~al~~LH  303 (424)
                      |..+.+.+...                     .       +     ....+. +...+..        .-.......||+
T Consensus       109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            84222111100                     0       0     000000 0000000        001122244444


Q ss_pred             cCC-----CCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          304 EGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       304 ~~~-----~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ++.     .+.++|+|+.+.||+++.+..+-++||+++.+-
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            432     357999999999999999888999999998753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.74  E-value=0.017  Score=56.15  Aligned_cols=72  Identities=18%  Similarity=0.267  Sum_probs=46.2

Q ss_pred             eEcccCcEEEEEEEEcCC-CEEEEEEeecC-------CchhHHHHHHHHHHHhcCC--CC-ceeeEeeEeeeCCeeeEEE
Q 014466          193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNN-------RGQAEKEFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       193 ~LG~G~~g~V~~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lv~  261 (424)
                      .||.|....||++...+| +.++||.-.+.       -+-..++...|.+.|+...  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999997654 57899864321       1222344455777776653  23 45555544  444567999


Q ss_pred             EecCC
Q 014466          262 EYIDN  266 (424)
Q Consensus       262 e~~~~  266 (424)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.69  E-value=0.018  Score=55.61  Aligned_cols=142  Identities=21%  Similarity=0.306  Sum_probs=82.7

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc------eeeEee----EeeeCCeeeEEE
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLLG----YCAEGAHRMLVY  261 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~----~~~~~~~~~lv~  261 (424)
                      ..|.+ .-..+|+....+|+. ++|.....  ....++..|++++..+.-.+      +..+=|    ........+-++
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            33444 556889998877665 66765443  45566777888888884222      222222    122223667899


Q ss_pred             EecCCCCHHH------------H---Hc----cCC----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHcC
Q 014466          262 EYIDNGNLEQ------------W---LH----GDV----GPHSPLTWEI-------------RMNIILGTAKGLTYLHEG  305 (424)
Q Consensus       262 e~~~~gsL~~------------~---l~----~~~----~~~~~l~~~~-------------~~~i~~~i~~al~~LH~~  305 (424)
                      +|++|..+..            +   |+    ...    .......|..             ......++...++.+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999877662            1   11    110    0111223320             011233344445555543


Q ss_pred             C----CCC---eeeCCCCCCCEEEcCCCc-eEEEecCCcc
Q 014466          306 L----EPK---VVHRDIKSSNILLDKQWN-PKLSDFGLAK  337 (424)
Q Consensus       306 ~----~~~---ivHrDlkp~NILl~~~~~-~kL~DfG~a~  337 (424)
                      .    ...   +||+|+.|.|||++.+.. ..++|||-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2    113   899999999999999885 8899999775

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.66  E-value=0.011  Score=56.91  Aligned_cols=73  Identities=22%  Similarity=0.261  Sum_probs=56.2

Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...|++|++- |++|.. +       ....+++...++.+.+..++-+..+.  ..-|||+.-.||||+ +|++-|+||-
T Consensus       299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence            3456777765 444432 1       23456788889999888888888665  889999999999999 9999999999


Q ss_pred             Ccccc
Q 014466          335 LAKLL  339 (424)
Q Consensus       335 ~a~~~  339 (424)
                      ++++-
T Consensus       367 lsRl~  371 (488)
T COG5072         367 LSRLS  371 (488)
T ss_pred             eeecc
Confidence            99953

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.46  E-value=0.087  Score=52.27  Aligned_cols=73  Identities=14%  Similarity=0.219  Sum_probs=49.2

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecC----Cc---hhHHHHHHHHHHHhcCC---CCceeeEeeEeeeCCeeeEE
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN----RG---QAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .+.||.|....||+.... ++.++||.-...    ..   .....-..|.+.|+.+.   ..++.+++.++.+.  .+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            467899999999998875 456889875421    10   12233334566666553   35788888888743  5788


Q ss_pred             EEecCC
Q 014466          261 YEYIDN  266 (424)
Q Consensus       261 ~e~~~~  266 (424)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.41  E-value=0.011  Score=53.33  Aligned_cols=29  Identities=38%  Similarity=0.546  Sum_probs=20.9

Q ss_pred             CeeeCCCCCCCEEE-cCCCceEEEecCCcc
Q 014466          309 KVVHRDIKSSNILL-DKQWNPKLSDFGLAK  337 (424)
Q Consensus       309 ~ivHrDlkp~NILl-~~~~~~kL~DfG~a~  337 (424)
                      -++|.|+.+.|||+ +.++.++|+||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            68999999999999 888999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.29  E-value=0.024  Score=50.99  Aligned_cols=117  Identities=18%  Similarity=0.129  Sum_probs=76.1

Q ss_pred             cCcEEEEEEEEcCCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCCHHHHHcc
Q 014466          197 GGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG  275 (424)
Q Consensus       197 G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  275 (424)
                      ||.++.-.+..+-| ...+|++....-. ...-|..+..+++++.  .|+++..=  +.-.+-+++|+|..-.       
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------  140 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence            45566666655443 3566766433222 3345677788888876  67887722  3334459999995411       


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       276 ~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                            -..    ..++..=+++|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+..
T Consensus       141 ------i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 ------INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ------cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence                  111    22222225678889954 458999999999999999999999997643

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.21  E-value=0.12  Score=50.03  Aligned_cols=71  Identities=15%  Similarity=0.072  Sum_probs=43.3

Q ss_pred             cCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEe---e--EeeeCCeeeEEEEecCCCC
Q 014466          197 GGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLL---G--YCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       197 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~---~--~~~~~~~~~lv~e~~~~gs  268 (424)
                      +.-..||+....+++.+++|..... ......+..|++.+..|....  ++...   |  +...++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            4456899998877888888876432 234456667777777663211  22211   1  1223456778999998753

>PRK06148 hypothetical protein; Provisional

Probab=96.15  E-value=0.087  Score=58.88  Aligned_cols=142  Identities=18%  Similarity=0.280  Sum_probs=78.6

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-------CCCceeeEee-----Eeee-CC--e
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-------RHKNLVRLLG-----YCAE-GA--H  256 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-------~hpnIv~l~~-----~~~~-~~--~  256 (424)
                      +.|+ |..-.+|+....+|..+++|+.....  ....+..|.++|..|       .-|.+++-.+     .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 45678898887778889999876542  223344455566544       2334443221     1111 22  4


Q ss_pred             eeEEEEecCCCCHHHH---------------------HccCCC--CCCCCCHHH-----------------HHHHHHHHH
Q 014466          257 RMLVYEYIDNGNLEQW---------------------LHGDVG--PHSPLTWEI-----------------RMNIILGTA  296 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~---------------------l~~~~~--~~~~l~~~~-----------------~~~i~~~i~  296 (424)
                      .+-+++|++|..+.+.                     ++....  ....+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            5678999999776541                     011100  011122211                 112222333


Q ss_pred             HHHH-----HHHcCCCCCeeeCCCCCCCEEEcCCC--ceE-EEecCCcc
Q 014466          297 KGLT-----YLHEGLEPKVVHRDIKSSNILLDKQW--NPK-LSDFGLAK  337 (424)
Q Consensus       297 ~al~-----~LH~~~~~~ivHrDlkp~NILl~~~~--~~k-L~DfG~a~  337 (424)
                      ..+.     .+. ....++||+|+.+.|||++.++  ++. |+|||-+.
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            2222     122 2345899999999999999875  555 99999775

>PTZ00384 choline kinase; Provisional

Probab=96.01  E-value=0.095  Score=51.92  Aligned_cols=73  Identities=14%  Similarity=0.299  Sum_probs=43.7

Q ss_pred             eeEcccCcEEEEEEEEcCC--CE-----EEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLEDN--TN-----VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~  263 (424)
                      +.|..|-...+|++...++  ..     |.++.. .......-+-.+|+++++.+...++ .++++.+..    +++.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            3455588899999976533  22     333322 1111111233558889988865544 456666653    599999


Q ss_pred             cCCCCH
Q 014466          264 IDNGNL  269 (424)
Q Consensus       264 ~~~gsL  269 (424)
                      ++|..|
T Consensus       131 IeGr~l  136 (383)
T PTZ00384        131 VEGNTM  136 (383)
T ss_pred             eccccC
Confidence            998765

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.81  E-value=0.065  Score=52.87  Aligned_cols=74  Identities=16%  Similarity=0.215  Sum_probs=48.4

Q ss_pred             ceeEcccCcEEEEEEEEcC-CCEEEEEEeecC------CchhHHHHHHHHHHHhcCC--CC-ceeeEeeEeeeCCeeeEE
Q 014466          191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNN------RGQAEKEFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lv  260 (424)
                      .+.||.|.-.-||++...+ ++.++||.-.+.      -+-..++...|.+.|+...  -| ++.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999753 567899864321      1223455566777777663  23 45566655  34455788


Q ss_pred             EEecCC
Q 014466          261 YEYIDN  266 (424)
Q Consensus       261 ~e~~~~  266 (424)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=95.73  E-value=0.0074  Score=48.93  Aligned_cols=32  Identities=22%  Similarity=0.320  Sum_probs=16.8

Q ss_pred             chhhHHHHHHHHHHHHHH--HHHHHHhhhhcccc
Q 014466           19 GLRLWVVLGICVGAGIVL--VLFLISLWFTSKRN   50 (424)
Q Consensus        19 gl~~~~ii~I~~g~~~v~--~l~~~~~~~~~rr~   50 (424)
                      +|.-..|++|++|+.+.+  ++++|+||++||||
T Consensus        60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~K   93 (122)
T PF01102_consen   60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRK   93 (122)
T ss_dssp             SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS-
T ss_pred             CccccceeehhHHHHHHHHHHHHHHHHHHHHHhc
Confidence            566667777777754433  33344555555444

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>PTZ00382 Variant-specific surface protein (VSP); Provisional

Probab=95.57  E-value=0.0016  Score=50.74  Aligned_cols=36  Identities=25%  Similarity=0.370  Sum_probs=23.4

Q ss_pred             cccccchhhHHHHHHHHHHHHHH-HHHH-HHhhhhccc
Q 014466           14 RTSIFGLRLWVVLGICVGAGIVL-VLFL-ISLWFTSKR   49 (424)
Q Consensus        14 ~~~~~gl~~~~ii~I~~g~~~v~-~l~~-~~~~~~~rr   49 (424)
                      .+...||....|+||+||+++++ +|++ ++||+.+||
T Consensus        57 st~~~~ls~gaiagi~vg~~~~v~~lv~~l~w~f~~r~   94 (96)
T PTZ00382         57 GANRSGLSTGAIAGISVAVVAVVGGLVGFLCWWFVCRG   94 (96)
T ss_pred             ccCCCCcccccEEEEEeehhhHHHHHHHHHhheeEEee
Confidence            45567999999999999876554 3333 334444443

>PF13908 Shisa: Wnt and FGF inhibitory regulator

Probab=95.53  E-value=0.042  Score=48.29  Aligned_cols=27  Identities=15%  Similarity=0.224  Sum_probs=20.2

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHhh
Q 014466           18 FGLRLWVVLGICVGAGIVLVLFLISLW   44 (424)
Q Consensus        18 ~gl~~~~ii~I~~g~~~v~~l~~~~~~   44 (424)
                      .++..+++++|++|+++|+++++++++
T Consensus        74 ~~~~~~iivgvi~~Vi~Iv~~Iv~~~C  100 (179)
T PF13908_consen   74 IYFITGIIVGVICGVIAIVVLIVCFCC  100 (179)
T ss_pred             ccceeeeeeehhhHHHHHHHhHhhhee
Confidence            467788999999988777666666553

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	424
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-56
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-54
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-43
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-38
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-26
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-19
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-19
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-19
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-19
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-19
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-19
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-19
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-19
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-18
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-17
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-17
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		5e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  215 bits (547), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 105/237 (44%), Positives = 157/237 (66%), Gaps = 2/237 (0%)
Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL 218
           V A   PEV HLG    ++LREL+V+++ F+++N++G GG+G VY G L D T VAVK L
Sbjct: 12  VPAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 70
Query: 219 LNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
              R Q  E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L    
Sbjct: 71  KEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 130
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
               PL W  R  I LG+A+GL YLH+  +PK++HRD+K++NILLD+++   + DFGLAK
Sbjct: 131 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
           L+  +  +V   V GT G++APEY STG  +E++DV+ +G++++E+I+G+   D +R
Sbjct: 191 LMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 247

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 103/237 (43%), Positives = 154/237 (64%), Gaps = 2/237 (0%)
Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL 218
           V A   PEV HLG    ++LREL+V+++ F ++N++G GG+G VY G L D   VAVK L
Sbjct: 4   VPAEEDPEV-HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL 62
Query: 219 LNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
              R Q  E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L    
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
               PL W  R  I LG+A+GL YLH+  +PK++HRD+K++NILLD+++   + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
           L+  +  +V   V G  G++APEY STG  +E++DV+ +G++++E+I+G+   D +R
Sbjct: 183 LMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 94/220 (42%), Positives = 141/220 (64%), Gaps = 6/220 (2%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG 237
           L +LE +TN F  + +IG G +G VY GVL D   VA+K       Q  +EF+ E+E + 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 238 RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
             RH +LV L+G+C E    +L+Y+Y++NGNL++ L+G   P   ++WE R+ I +G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE--RSYVTTRVMGTFG 355
           GL YLH      ++HRD+KS NILLD+ + PK++DFG++K  G E  ++++   V GT G
Sbjct: 151 GLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK-KGTELGQTHLXXVVKGTLG 206
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           Y+ PEY   G L E+SDVYSFG+++ EV+  R+ +  S P
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 94/220 (42%), Positives = 141/220 (64%), Gaps = 6/220 (2%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG 237
           L +LE +TN F  + +IG G +G VY GVL D   VA+K       Q  +EF+ E+E + 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 238 RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
             RH +LV L+G+C E    +L+Y+Y++NGNL++ L+G   P   ++WE R+ I +G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE--RSYVTTRVMGTFG 355
           GL YLH      ++HRD+KS NILLD+ + PK++DFG++K  G E  ++++   V GT G
Sbjct: 151 GLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLXXVVKGTLG 206
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           Y+ PEY   G L E+SDVYSFG+++ EV+  R+ +  S P
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  160 bits (406), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 93/236 (39%), Positives = 144/236 (61%), Gaps = 21/236 (8%)
Query: 174 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLN----NRG 223
           H ++  EL+  TN F +       N +GEGG+G+VY G + +NT VAVK L         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
           + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+ NG+L   L    G   PL
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPL 130
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           +W +R  I  G A G+ +LHE      +HRDIKS+NILLD+ +  K+SDFGLA+   +E+
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEK 185
Query: 344 ---SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
              + + +R++GT  Y+APE A  G +  +SD+YSFG++++E+I+G   VD  R P
Sbjct: 186 FAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/237 (39%), Positives = 141/237 (59%), Gaps = 23/237 (9%)
Query: 174 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLN----NRG 223
           H ++  EL+  TN F +       N +GEGG+G+VY G + +NT VAVK L         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
           + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+ NG+L   L    G   PL
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPL 130
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           +W +R  I  G A G+ +LHE      +HRDIKS+NILLD+ +  K+SDFGLA+   A  
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR---ASE 184
Query: 344 SYVTT----RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
            +  T    R++GT  Y+APE A  G +  +SD+YSFG++++E+I+G   VD  R P
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/236 (39%), Positives = 142/236 (60%), Gaps = 21/236 (8%)
Query: 174 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLN----NRG 223
           H ++  EL+  TN F +       N +GEGG+G+VY G + +NT VAVK L         
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 65
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
           + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+ NG+L   L    G   PL
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPL 124
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           +W +R  I  G A G+ +LHE      +HRDIKS+NILLD+ +  K+SDFGLA+   +E+
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEK 179
Query: 344 ---SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
                +  R++GT  Y+APE A  G +  +SD+YSFG++++E+I+G   VD  R P
Sbjct: 180 FAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 234

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 93/234 (39%), Positives = 135/234 (57%), Gaps = 17/234 (7%)
Query: 174 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLN----NRG 223
           H ++  EL+  TN F +       N  GEGG+G+VY G + +NT VAVK L         
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 62
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
           + +++F  E++   + +H+NLV LLG+ ++G    LVY Y  NG+L   L    G   PL
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT-PPL 121
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           +W  R  I  G A G+ +LHE      +HRDIKS+NILLD+ +  K+SDFGLA+      
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 344 SYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
             V  +R++GT  Y APE A  G +  +SD+YSFG++++E+I+G   VD  R P
Sbjct: 179 QXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 231

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 74/202 (36%), Positives = 113/202 (55%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIV----YHGVLEDNTNVAVKNLLNNRGQAEK--EFKVEVEAIGRVRHKNLVRL 247
           IG G +G V    +HG     ++VAVK L+     AE+  EF  EV  + R+RH N+V  
Sbjct: 45  IGAGSFGTVHRAEWHG-----SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           +G   +  +  +V EY+  G+L + LH   G    L    R+++    AKG+ YLH    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           P +VHRD+KS N+L+DK++  K+ DFGL++ L A     +    GT  ++APE       
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 368 NERSDVYSFGILIMEVISGRNP 389
           NE+SDVYSFG+++ E+ + + P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 118/203 (58%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIV----YHGVLEDNTNVAVKNLLNNRGQAEK--EFKVEVEAIGRVRHKNLVRL 247
           IG G +G V    +HG     ++VAVK L+     AE+  EF  EV  + R+RH N+V  
Sbjct: 45  IGAGSFGTVHRAEWHG-----SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           +G   +  +  +V EY+  G+L + LH   G    L    R+++    AKG+ YLH    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-VMGTFGYVAPEYASTGM 366
           P +VHR++KS N+L+DK++  K+ DFGL++L  +  ++++++   GT  ++APE      
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            NE+SDVYSFG+++ E+ + + P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQP 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G GG   VY  + ED   N  VA+K +      + +  K F+ EV    ++ H+N+V +
Sbjct: 19  LGGGGMSTVY--LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           +    E     LV EYI+   L +++      H PL+ +  +N       G+ + H+   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
            ++VHRDIK  NIL+D     K+ DFG+AK L       T  V+GT  Y +PE A     
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 368 NERSDVYSFGILIMEVISGRNP 389
           +E +D+YS GI++ E++ G  P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G+V+ G   +   VA+K +      +E++F  E E + ++ H  LV+L G C E
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
            A   LV+E++++G L  +L    G  +    E  + + L   +G+ YL E     V+HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEA---SVIHR 127
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +SDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 374 YSFGILIMEVIS-GRNPVD 391
           +SFG+L+ EV S G+ P +
Sbjct: 188 WSFGVLMWEVFSEGKIPYE 206

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G+V+ G   +   VA+K +      +E++F  E E + ++ H  LV+L G C E
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
            A   LV+E++++G L  +L    G  +    E  + + L   +G+ YL E     V+HR
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +SDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 374 YSFGILIMEVIS-GRNPVD 391
           +SFG+L+ EV S G+ P +
Sbjct: 186 WSFGVLMWEVFSEGKIPYE 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G+V+ G   +   VA+K +      +E++F  E E + ++ H  LV+L G C E
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
            A   LV+E++++G L  +L    G  +    E  + + L   +G+ YL E     V+HR
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +SDV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 374 YSFGILIMEVIS-GRNPVD 391
           +SFG+L+ EV S G+ P +
Sbjct: 191 WSFGVLMWEVFSEGKIPYE 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G+V+ G   +   VA+K +      +E++F  E E + ++ H  LV+L G C E
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
            A   LV+E++++G L  +L    G  +    E  + + L   +G+ YL E     V+HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +SDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 374 YSFGILIMEVIS-GRNPVD 391
           +SFG+L+ EV S G+ P +
Sbjct: 188 WSFGVLMWEVFSEGKIPYE 206

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 8/199 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G+V+ G   +   VA+K +      +E +F  E E + ++ H  LV+L G C E
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
            A   LV+E++++G L  +L    G  +    E  + + L   +G+ YL E     V+HR
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +SDV
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 374 YSFGILIMEVIS-GRNPVD 391
           +SFG+L+ EV S G+ P +
Sbjct: 208 WSFGVLMWEVFSEGKIPYE 226

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 128/237 (54%), Gaps = 25/237 (10%)
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHG-VLEDNTNVAVKNLL--NNRGQAE 226
           +G   +   R   ++ N    E  IG+GG+G+V+ G +++D + VA+K+L+  ++ G+ E
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 227 -----KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
                +EF+ EV  +  + H N+V+L G       RM V E++  G+L    H  +    
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAH 117
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-----DKQWNPKLSDFGLA 336
           P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI L     +     K++DFGL+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 337 KLLGAERSYVTTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           +    +  +  + ++G F ++APE   A      E++D YSF +++  +++G  P D
Sbjct: 177 Q----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 8/199 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G+V+ G   +   VA+K +      +E++F  E E + ++ H  LV+L G C E
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
            A   LV E++++G L  +L    G  +    E  + + L   +G+ YL E     V+HR
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           D+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +SDV
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 374 YSFGILIMEVIS-GRNPVD 391
           +SFG+L+ EV S G+ P +
Sbjct: 189 WSFGVLMWEVFSEGKIPYE 207

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 115/219 (52%), Gaps = 19/219 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN-----VAVKNLLNNRGQAEKE---FKVEV 233
           E+  +    + VIG G +G VY G+L+ ++      VA+K L    G  EK+   F  E 
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEA 97
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
             +G+  H N++RL G  ++    M++ EY++NG L+++L    G  S L     + ++ 
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLR 154
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVM 351
           G A G+ YL        VHRD+ + NIL++     K+SDFGL+++L    E +Y T+   
Sbjct: 155 GIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               + APE  S       SDV+SFGI++ EV++ G  P
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 127/237 (53%), Gaps = 25/237 (10%)
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHG-VLEDNTNVAVKNLL--NNRGQAE 226
           +G   +   R   ++ N    E  IG+GG+G+V+ G +++D + VA+K+L+  ++ G+ E
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 227 -----KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
                +EF+ EV  +  + H N+V+L G       RM V E++  G+L    H  +    
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAH 117
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-----DKQWNPKLSDFGLA 336
           P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI L     +     K++DFG +
Sbjct: 118 PIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS 176
Query: 337 KLLGAERSYVTTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           +    +  +  + ++G F ++APE   A      E++D YSF +++  +++G  P D
Sbjct: 177 Q----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 127/237 (53%), Gaps = 25/237 (10%)
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHG-VLEDNTNVAVKNLL--NNRGQAE 226
           +G   +   R   ++ N    E  IG+GG+G+V+ G +++D + VA+K+L+  ++ G+ E
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 227 -----KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
                +EF+ EV  +  + H N+V+L G       RM V E++  G+L    H  +    
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAH 117
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-----DKQWNPKLSDFGLA 336
           P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI L     +     K++DF L+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS 176
Query: 337 KLLGAERSYVTTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           +    +  +  + ++G F ++APE   A      E++D YSF +++  +++G  P D
Sbjct: 177 Q----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 114/223 (51%), Gaps = 25/223 (11%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----GQAEKEFKVEVEAI 236
           LE+       E +IG GG+G VY      +  VAVK   ++      Q  +  + E +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             ++H N++ L G C +  +  LV E+   G L + L G   P      +I +N  +  A
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP-----DILVNWAVQIA 115
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNIL-LDKQWNP-------KLSDFGLAKLLGAERSYVTT 348
           +G+ YLH+     ++HRD+KSSNIL L K  N        K++DFGLA+       + TT
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTT 170
Query: 349 RV--MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           ++   G + ++APE     M ++ SDV+S+G+L+ E+++G  P
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEV 233
           H    +E+EV       E V+G G +G+V         +VA+K + +      K F VE+
Sbjct: 3   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAK-DVAIKQIESE--SERKAFIVEL 52
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
             + RV H N+V+L G C       LV EY + G+L   LHG   P    T    M+  L
Sbjct: 53  RQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCL 109
Query: 294 GTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVM 351
             ++G+ YLH  ++PK ++HRD+K  N+LL       K+ DFG A  +        T   
Sbjct: 110 QCSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNK 164
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           G+  ++APE       +E+ DV+S+GI++ EVI+ R P D
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEV 233
           H    +E+EV       E V+G G +G+V         +VA+K + +      K F VE+
Sbjct: 4   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAK-DVAIKQIESE--SERKAFIVEL 53
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
             + RV H N+V+L G C       LV EY + G+L   LHG   P    T    M+  L
Sbjct: 54  RQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCL 110
Query: 294 GTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVM 351
             ++G+ YLH  ++PK ++HRD+K  N+LL       K+ DFG A  +        T   
Sbjct: 111 QCSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNK 165
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           G+  ++APE       +E+ DV+S+GI++ EVI+ R P D
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/238 (32%), Positives = 117/238 (49%), Gaps = 24/238 (10%)
Query: 158 TVAAAITPEVSHLGWGHWYTLRE---LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVA 214
           TV     P+   L    W   RE   LEV          +G+G +G V+ G     T VA
Sbjct: 245 TVCPTSKPQTQGLAKDAWEIPRESLRLEVK---------LGQGCFGEVWMGTWNGTTRVA 295
Query: 215 VKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH 274
           +K L       E  F  E + + ++RH+ LV+L    +E     +V EY+  G+L  +L 
Sbjct: 296 IKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLK 353
Query: 275 GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
           G+ G +  L   + M   +  A G+ Y+        VHRD++++NIL+ +    K++DFG
Sbjct: 354 GETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 408
Query: 335 LAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           LA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 409 LARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 115/235 (48%), Gaps = 18/235 (7%)
Query: 158 TVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKN 217
           TV     P+   L    W      E+       E  +G+G +G V+ G     T VA+K 
Sbjct: 162 TVCPTSKPQTQGLAKDAW------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 215
Query: 218 LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
           L       E  F  E + + ++RH+ LV+L    +E     +V EY+  G+L  +L G+ 
Sbjct: 216 LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET 273
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
           G +  L   + M   +  A G+ Y+        VHRD++++NIL+ +    K++DFGLA+
Sbjct: 274 GKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 338 LLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 329 LI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 115/235 (48%), Gaps = 18/235 (7%)
Query: 158 TVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKN 217
           TV     P+   L    W      E+       E  +G+G +G V+ G     T VA+K 
Sbjct: 162 TVCPTSKPQTQGLAKDAW------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 215
Query: 218 LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
           L       E  F  E + + ++RH+ LV+L    +E     +V EY+  G+L  +L G+ 
Sbjct: 216 LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET 273
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
           G +  L   + M   +  A G+ Y+        VHRD++++NIL+ +    K++DFGLA+
Sbjct: 274 GKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 338 LLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 329 LI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 123/261 (47%), Gaps = 32/261 (12%)
Query: 172 WGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEK 227
           WG     +E++VS      E VIG G +G V  G L+      + VA+K L     + ++
Sbjct: 2   WGSMEFAKEIDVSYVKI--EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR 59
Query: 228 -EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
            EF  E   +G+  H N++RL G        M++ E+++NG L+ +L  + G  + +   
Sbjct: 60  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL- 118
Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
             + ++ G A G+ YL E      VHRD+ + NIL++     K+SDFGL++ L    S  
Sbjct: 119 --VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 173
Query: 347 T-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPV----------- 390
           T T  +G      + APE  +       SD +S+GI++ EV+S G  P            
Sbjct: 174 TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINA 233
Query: 391 ---DYSRPPGEVCIPQMNSLM 408
              DY  PP   C   ++ LM
Sbjct: 234 IEQDYRLPPPPDCPTSLHQLM 254

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 115/235 (48%), Gaps = 18/235 (7%)
Query: 158 TVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKN 217
           TV     P+   L    W      E+       E  +G+G +G V+ G     T VA+K 
Sbjct: 162 TVCPTSKPQTQGLAKDAW------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 215
Query: 218 LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
           L       E  F  E + + ++RH+ LV+L    +E     +V EY+  G+L  +L G+ 
Sbjct: 216 LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGET 273
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
           G +  L   + M   +  A G+ Y+        VHRD++++NIL+ +    K++DFGLA+
Sbjct: 274 GKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 338 LLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 329 LI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 24/216 (11%)
Query: 194 IGEGGYGIVY----HGVL--EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+    H +L  +D   VAVK L      A ++F+ E E +  ++H+++VR 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG----------DVGPHSPLTWEIRMNIILGT 295
            G C EG   ++V+EY+ +G+L ++L  HG          DV P  PL     + +    
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQV 144
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
           A G+ YL  GL    VHRD+ + N L+ +    K+ DFG+++ + +   Y V  R M   
Sbjct: 145 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            ++ PE          SDV+SFG+++ E+ + G+ P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 24/216 (11%)
Query: 194 IGEGGYGIVY----HGVL--EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+    H +L  +D   VAVK L      A ++F+ E E +  ++H+++VR 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG----------DVGPHSPLTWEIRMNIILGT 295
            G C EG   ++V+EY+ +G+L ++L  HG          DV P  PL     + +    
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQV 138
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
           A G+ YL  GL    VHRD+ + N L+ +    K+ DFG+++ + +   Y V  R M   
Sbjct: 139 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            ++ PE          SDV+SFG+++ E+ + G+ P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 24/216 (11%)
Query: 194 IGEGGYGIVY----HGVL--EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+    H +L  +D   VAVK L      A ++F+ E E +  ++H+++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG----------DVGPHSPLTWEIRMNIILGT 295
            G C EG   ++V+EY+ +G+L ++L  HG          DV P  PL     + +    
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQV 167
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
           A G+ YL  GL    VHRD+ + N L+ +    K+ DFG+++ + +   Y V  R M   
Sbjct: 168 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            ++ PE          SDV+SFG+++ E+ + G+ P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 111/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 69
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY++ G+L  +L G+ G +  L   + M+  +  A G+ Y
Sbjct: 70  EKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAY 126
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 127 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 181
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 182 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 111/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 69
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY++ G+L  +L G+ G +  L   + M+  +  A G+ Y
Sbjct: 70  EKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAY 126
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 127 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAP 181
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 182 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 61
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 62  EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 118
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 119 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 173
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 174 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 62
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G+ G +  L   + M   +  A G+ Y
Sbjct: 63  EKLVQLYAVVSEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAY 119
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 120 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAP 174
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 175 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 63
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 64  EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 120
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 121 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 175
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 114/219 (52%), Gaps = 16/219 (7%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEV 233
           RE+E S      E +IG G  G V +G L    + +  VA+K L     + ++ +F  E 
Sbjct: 44  REIEASRIHI--EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
             +G+  H N++RL G    G   M+V EY++NG+L+ +L    G  + +     + ++ 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLR 158
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVM 351
           G   G+ YL    +   VHRD+ + N+L+D     K+SDFGL+++L    + +Y TT   
Sbjct: 159 GVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               + APE  +    +  SDV+SFG+++ EV++ G  P
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 65
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G+ G +  L   + M   +  A G+ Y
Sbjct: 66  EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAY 122
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 123 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 177
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 178 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G+G +G V+ G     T VA+K L       E  F  E + + ++RH
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 72
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + LV+L    +E     +V EY+  G+L  +L G++G +  L   + M   +  A G+ Y
Sbjct: 73  EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 129
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           +        VHRD+ ++NIL+ +    K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 130 VERM---NYVHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 114
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 115 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYLAS 170
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 171 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
             T     +SDV+SFG+L+ E+++   P
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 113
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 114 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYLAS 169
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 170 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
             T     +SDV+SFG+L+ E+++   P
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 87
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 88  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYLAS 143
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 144 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
             T     +SDV+SFG+L+ E+++   P
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 94  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYL-- 147
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 260

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 96  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYLAS 151
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 95  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYL-- 148
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 114/234 (48%), Gaps = 18/234 (7%)
Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL 218
           V     P+   L    W      E+       E  +G+G +G V+ G     T VA+K L
Sbjct: 164 VCPTSKPQTQGLAKDAW------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL 217
Query: 219 LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG 278
                  E  F  E + + ++RH+ LV+L    +E     +V EY+  G+L  +L G++G
Sbjct: 218 KPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMG 275
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
            +  L   + M   +  A G+ Y+        VHRD++++NIL+ +    K++DFGL +L
Sbjct: 276 KYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLGRL 330
Query: 339 LGAERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           +  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + GR P
Sbjct: 331 I--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 96  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYL-- 149
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
             T     +SDV+SFG+L+ E+++   P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 92
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 93  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYLAS 148
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 149 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
             T     +SDV+SFG+L+ E+++   P
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 90
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 91  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYL-- 144
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y      G      ++A E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 118/251 (47%), Gaps = 30/251 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEK-EFKVEVEAI 236
           E+  +    E VIG G +G V  G L+      + VA+K L     + ++ EF  E   +
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 71
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G        M++ E+++NG L+ +L  + G  + +     + ++ G A
Sbjct: 72  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIA 128
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TRVMG--- 352
            G+ YL E      VHRD+ + NIL++     K+SDFGL++ L    S  T T  +G   
Sbjct: 129 SGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPV--------------DYSRPPG 397
              + APE  +       SD +S+GI++ EV+S G  P               DY  PP 
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPP 245
Query: 398 EVCIPQMNSLM 408
             C   ++ LM
Sbjct: 246 PDCPTSLHQLM 256

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEV 233
           RE+E S      E +IG G  G V +G L    + +  VA+K L     + ++ +F  E 
Sbjct: 44  REIEASRIHI--EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
             +G+  H N++RL G    G   M+V EY++NG+L+ +L    G  + +     + ++ 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLR 158
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
           G   G+ YL    +   VHRD+ + N+L+D     K+SDFGL+++L  +     T   G 
Sbjct: 159 GVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 354 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               + APE  +    +  SDV+SFG+++ EV++ G  P
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 74
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 75  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 131
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 132 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 187 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 71
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 128
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 129 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 183
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 184 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 122
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 177
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 67
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 68  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 124
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 125 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 179
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 180 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 71
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 128
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 129 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT 183
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 184 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 15  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 73
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 74  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 130
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 131 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 185
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 186 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 8   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 66
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 67  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 123
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 124 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 178
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 179 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 12  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 70
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 71  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 127
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 128 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT 182
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 183 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 122
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 177
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 17  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 75
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 76  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 132
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 133 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT 187
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 188 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 122
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HRD++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT 177
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G V+ G    +T VAVK+L      +   F  E   + +++H+ LVRL     +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                ++ EY++NG+L  +L    G    LT    +++    A+G+ ++ E      +HR
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++++NIL+    + K++DFGLA+L+  E +  T R    F   + APE  + G    +S
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV+SFGIL+ E+++ GR P
Sbjct: 187 DVWSFGILLTEIVTHGRIP 205

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 122/234 (52%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ +L  
Sbjct: 97  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKFL-- 150
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +L  E   V  +        ++A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 263

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEGLEPKVV 311
                +V ++ +  +L   LH      S   +E++  ++I   TA+G+ YLH      ++
Sbjct: 80  -PQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE- 369
           HRD+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N  
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 370 --RSDVYSFGILIMEVISGRNP 389
             +SDVY+FGI++ E+++G+ P
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLP 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGLA++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 30/251 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEK-EFKVEVEAI 236
           E+  +    E VIG G +G V  G L+        VA+K L +   + ++ +F  E   +
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 88
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++ L G   +    M++ E+++NG+L+ +L  + G  + +     + ++ G A
Sbjct: 89  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIA 145
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TRVMG--- 352
            G+ YL +      VHRD+ + NIL++     K+SDFGL++ L  + S  T T  +G   
Sbjct: 146 AGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 202
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPV--------------DYSRPPG 397
              + APE          SDV+S+GI++ EV+S G  P               DY  PP 
Sbjct: 203 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 262
Query: 398 EVCIPQMNSLM 408
             C   ++ LM
Sbjct: 263 MDCPSALHQLM 273

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ YL  
Sbjct: 95  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKYLAS 150
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +   E   V  +        ++A E 
Sbjct: 151 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 261

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 117/237 (49%), Gaps = 28/237 (11%)
Query: 194 IGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLG 249
           +G G +G V  GV    +   +VA+K L     +A+ +E   E + + ++ +  +VRL+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
            C   A  MLV E    G L ++L   VG    +       ++   + G+ YL E     
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEE---KN 130
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGML 367
            VHRD+ + N+LL  +   K+SDFGL+K LGA+ SY T R  G +   + APE  +    
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV--------------CIPQMNSLMT 409
           + RSDV+S+G+ + E +S G+ P    + P  +              C P++ +LM+
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 247

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 128
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 129 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 245
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 246 CPAALYQLM 254

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 145
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 146 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 262
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 263 CPAALYQLM 271

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G  G V+ G    +T VAVK+L      +   F  E   + +++H+ LVRL     +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                ++ EY++NG+L  +L    G    LT    +++    A+G+ ++ E      +HR
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++++NIL+    + K++DFGLA+L+  E +  T R    F   + APE  + G    +S
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV+SFGIL+ E+++ GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 114/239 (47%), Gaps = 23/239 (9%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+          +D   VAVK L +    A K+F  E E +  ++H+++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGPHSPLTWEIRMNIILGTAKG 298
            G C EG   ++V+EY+ +G+L ++L  HG       +  P + LT    ++I    A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYV 357
           + YL        VHRD+ + N L+ +    K+ DFG+++ + +   Y V    M    ++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV--CIPQMNSLMTLSYC 413
            PE          SDV+S G+++ E+ + G+ P  Y     EV  CI Q   L     C
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECITQGRVLQRPRTC 255

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 155
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 156 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 272
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 273 CPAALYQLM 281

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEGLEPKVV 311
                +V ++ +  +L   LH      S   +E++  ++I   TA+G+ YLH      ++
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE- 369
           HRD+KS+NI L +    K+ DFGLA        S+   ++ G+  ++APE       N  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 370 --RSDVYSFGILIMEVISGRNP 389
             +SDVY+FGI++ E+++G+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEGLEPKVV 311
                +V ++ +  +L   LH      S   +E++  ++I   TA+G+ YLH      ++
Sbjct: 92  -PQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE- 369
           HRD+KS+NI L +    K+ DFGLA        S+   ++ G+  ++APE       N  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 370 --RSDVYSFGILIMEVISGRNP 389
             +SDVY+FGI++ E+++G+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK+L      +   F  E   + ++
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 61
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 62  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGM 118
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYV 357
            ++ E      +HR+++++NIL+    + K++DFGLA+L+  E +  T R    F   + 
Sbjct: 119 AFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT 173
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ E+++ GR P
Sbjct: 174 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ +L  
Sbjct: 96  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKFL-- 149
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +   E   V  +        ++A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 100
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ +L  
Sbjct: 101 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKFL-- 154
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +   E   V  +        ++A E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 267

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
           + E   NG  D  V+G+G YGIVY G  L +   +A+K +     +  +    E+     
Sbjct: 18  DYEYDENG--DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 75
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP--HSPLTWEIRMNIILGTA 296
           ++HKN+V+ LG  +E     +  E +  G+L   L    GP   +  T       IL   
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL--- 132
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFG 355
           +GL YLH+    ++VHRDIK  N+L++      K+SDFG +K L A  +  T    GT  
Sbjct: 133 EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQ 188
Query: 356 YVAPEYASTGM--LNERSDVYSFGILIMEVISGRNP 389
           Y+APE    G     + +D++S G  I+E+ +G+ P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 154
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ +L  
Sbjct: 155 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKFLAS 210
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +   E   V  +        ++A E 
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
             T     +SDV+SFG+L+ E+++   P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ +L  
Sbjct: 96  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKFL-- 149
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +   E   V  +        ++A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ +L  
Sbjct: 94  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKFL-- 147
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +   E   V  +        ++A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 260

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 121/234 (51%), Gaps = 21/234 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG G +G VYHG L DN     + AVK+L  + + G+   +F  E   +    H N++ 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 247 LLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           LLG C  +EG+  ++V  Y+ +G+L  ++  +   H+P   ++ +   L  AKG+ +L  
Sbjct: 97  LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNET--HNPTVKDL-IGFGLQVAKGMKFL-- 150
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRVMGTF--GYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +   E   V  +        ++A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP--VDYSRPPGEVCIPQMNSLMTLSYC 413
             T     +SDV+SFG+L+ E+++   P   D +     V + Q   L+   YC
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 263

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+  +    E VIG G +G V  G L+     +  VA+K L +    +  ++F  E   +
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM 98
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N+V L G    G   M+V E+++NG L+ +L    G  + +     + ++ G A
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL---VGMLRGIA 155
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL++++    E  Y TT      
Sbjct: 156 AGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV 212
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE          SDV+S+GI++ EV+S G  P
Sbjct: 213 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+  +    E VIG G +G V  G L+        VA+K L +    +  ++F  E   +
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++ L G   +    M+V EY++NG+L+ +L  + G  + +     + ++ G +
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL---VGMLRGIS 134
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 135 AGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 191
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE  +       SDV+S+GI++ EV+S G  P
Sbjct: 192 RWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 118/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V EY++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL ++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
           + E   NG  D  V+G+G YGIVY G  L +   +A+K +     +  +    E+     
Sbjct: 4   DYEYDENG--DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 61
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP--HSPLTWEIRMNIILGTA 296
           ++HKN+V+ LG  +E     +  E +  G+L   L    GP   +  T       IL   
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL--- 118
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFG 355
           +GL YLH+    ++VHRDIK  N+L++      K+SDFG +K L A  +  T    GT  
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQ 174
Query: 356 YVAPEYASTGM--LNERSDVYSFGILIMEVISGRNP 389
           Y+APE    G     + +D++S G  I+E+ +G+ P
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V  G  +   +VAVK ++     +E EF  E + + ++ H  LV+  G C++
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 254 GAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                +V EYI NG L  +L  HG     S L     + +     +G+ +L      + +
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QFI 126
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+D+    K+SDFG+ + +  ++   +        + APE       + +S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 372 DVYSFGILIMEVIS-GRNPVD 391
           DV++FGIL+ EV S G+ P D
Sbjct: 187 DVWAFGILMWEVFSLGKMPYD 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G G +G V+      +T VAVK +       E  F  E   +  ++H
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 69
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
             LV+L     +     ++ E++  G+L  +L  D G   PL   I  +  +  A+G+ +
Sbjct: 70  DKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAF 126
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           + +      +HRD++++NIL+      K++DFGLA+++  E +  T R    F   + AP
Sbjct: 127 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 181
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E  + G    +SDV+SFGIL+ME+++ GR P
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 117/237 (49%), Gaps = 28/237 (11%)
Query: 194 IGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLG 249
           +G G +G V  GV    +   +VA+K L     +A+ +E   E + + ++ +  +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
            C   A  MLV E    G L ++L   VG    +       ++   + G+ YL E     
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGML 367
            VHR++ + N+LL  +   K+SDFGL+K LGA+ SY T R  G +   + APE  +    
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV--------------CIPQMNSLMT 409
           + RSDV+S+G+ + E +S G+ P    + P  +              C P++ +LM+
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 573

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 119/251 (47%), Gaps = 30/251 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEK-EFKVEVEAI 236
           E+  +    E VIG G +G V  G L+        VA+K L +   + ++ +F  E   +
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 62
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++ L G   +    M++ E+++NG+L+ +L  + G  + +     + ++ G A
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIA 119
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TRVMG--- 352
            G+ YL +      VHR + + NIL++     K+SDFGL++ L  + S  T T  +G   
Sbjct: 120 AGMKYLADM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPV--------------DYSRPPG 397
              + APE          SDV+S+GI++ EV+S G  P               DY  PP 
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 236
Query: 398 EVCIPQMNSLM 408
             C   ++ LM
Sbjct: 237 MDCPSALHQLM 247

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 10/216 (4%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEA 235
           +L + E+       ++ +G G YG VY GV +  +  VAVK L  +  + E EF  E   
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           +  ++H NLV+LLG C       ++ E++  GNL  +L            E+   ++L  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL------RECNRQEVSAVVLLYM 114
Query: 296 AKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
           A  ++   E LE K  +HRD+ + N L+ +    K++DFGL++L+  +            
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE  +    + +SDV++FG+L+ E+ + G +P
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G G +G V+      +T VAVK +       E  F  E   +  ++H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 242
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
             LV+L     +     ++ E++  G+L  +L  D G   PL   I  +  +  A+G+ +
Sbjct: 243 DKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAF 299
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
           + +      +HRD++++NIL+      K++DFGLA+++  E +  T R    F   + AP
Sbjct: 300 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 354
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E  + G    +SDV+SFGIL+ME+++ GR P
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 78  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 130
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N    
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 191 QSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 133
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N    
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 133
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N    
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 128
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+  +    E VIG G +G V  G L+        VA+K L      +  ++F  E   +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++ L G   +    M++ EY++NG+L+ +L  + G  + +     + ++ G  
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIG 141
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFG++++L    E +Y T       
Sbjct: 142 SGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE  +       SDV+S+GI++ EV+S G  P
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 118/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V E ++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 128
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 21/230 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G V+ G    NT VA+K L       E  F  E + + +++H  LV+L    +E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V EY++ G+L  +L    G    L     +++    A G+ Y+        +HR
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 129
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++S+NIL+      K++DFGLA+L+  E +  T R    F   + APE A  G    +S
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFFLICC 421
           DV+SFGIL+ E+++           G V  P MN+   L      + + C
Sbjct: 188 DVWSFGILLTELVTK----------GRVPYPGMNNREVLEQVERGYRMPC 227

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 103 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 155
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N    
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 216 QSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 156
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++APE       N    
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 192 NVIGEGGYGIVYHG--VLEDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
            V+G G +G VY G  V E  T    VA+K L    G +A  EF  E   +  + H +LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           RLLG C     + LV + + +G L +++H    ++G    L W +++      AKG+ YL
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 156
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPEY 361
            E    ++VHRD+ + N+L+    + K++DFGLA+LL G E+ Y          ++A E 
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
                   +SDV+S+G+ I E+++ G  P D
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+  +    E VIG G +G V  G L+        VA+K L      +  ++F  E   +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++ L G   +    M++ EY++NG+L+ +L  + G  + +     + ++ G  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIG 126
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFG++++L    E +Y T       
Sbjct: 127 SGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE  +       SDV+S+GI++ EV+S G  P
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 118/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V E ++NG+L+ +L       + +     + ++ G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 128
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 129 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 245
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 246 CPAALYQLM 254

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFK 230
           L+E+ +S   F +E  +GE  +G VY G L      E    VA+K L +   G   +EF+
Sbjct: 20  LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP------ 279
            E     R++H N+V LLG   +     +++ Y  +G+L ++L     H DVG       
Sbjct: 78  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 280 -HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
             S L     ++++   A G+ YL       VVH+D+ + N+L+  + N K+SD GL + 
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 339 LGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           + A   Y +    +    ++APE    G  +  SD++S+G+++ EV S
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+  +    E VIG G +G V  G L+        VA+K L      +  ++F  E   +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++ L G   +    M++ EY++NG+L+ +L  + G  + +     + ++ G  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIG 120
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFG++++L    E +Y T       
Sbjct: 121 SGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE  +       SDV+S+GI++ EV+S G  P
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 10/216 (4%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEA 235
           +L + E+       ++ +G G YG VY GV +  +  VAVK L  +  + E EF  E   
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           +  ++H NLV+LLG C       ++ E++  GNL  +L            E+   ++L  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL------RECNRQEVSAVVLLYM 114
Query: 296 AKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
           A  ++   E LE K  +HRD+ + N L+ +    K++DFGL++L+  +            
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE  +    + +SDV++FG+L+ E+ + G +P
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 192 NVIGEGGYGIVYHG--VLEDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
            V+G G +G VY G  V E  T    VA+K L    G +A  EF  E   +  + H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           RLLG C     + LV + + +G L +++H    ++G    L W +++      AKG+ YL
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 133
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPEY 361
            E    ++VHRD+ + N+L+    + K++DFGLA+LL G E+ Y          ++A E 
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
                   +SDV+S+G+ I E+++ G  P D
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 118/249 (47%), Gaps = 28/249 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           E+     + + V+G G +G V  G L+       +VA+K L +    +  ++F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           G+  H N++RL G   +    M+V E ++NG+L+ +L       + +     + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTF 354
            G+ YL +      VHRD+ + NIL++     K+SDFGL+++L    E +Y T       
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP------------VD--YSRPPGEV 399
            + +PE  +       SDV+S+GI++ EV+S G  P            VD  Y  PP   
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 400 CIPQMNSLM 408
           C   +  LM
Sbjct: 275 CPAALYQLM 283

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFK 230
           L+E+ +S   F +E  +GE  +G VY G L      E    VA+K L +   G   +EF+
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP------ 279
            E     R++H N+V LLG   +     +++ Y  +G+L ++L     H DVG       
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 280 -HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
             S L     ++++   A G+ YL       VVH+D+ + N+L+  + N K+SD GL + 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 339 LGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           + A   Y +    +    ++APE    G  +  SD++S+G+++ EV S
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 85  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 81  REPPFYIIIEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 195 DVWAFGVLLWEIATYGMSP 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVE 232
           ++ ++ + E+       ++ +G G YG VY GV +  +  VAVK L  +  + E EF  E
Sbjct: 20  YFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 78
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
              +  ++H NLV+LLG C       +V EY+  GNL  +L            E+   ++
Sbjct: 79  AAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVL 132
Query: 293 LGTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
           L  A  ++   E LE K  +HRD+ + N L+ +    K++DFGL++L+  +         
Sbjct: 133 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAK 192
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               + APE  +    + +SDV++FG+L+ E+ + G +P
Sbjct: 193 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 85  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 85  REPPFYIIIEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 81  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 195 DVWAFGVLLWEIATYGMSP 213

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 82  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 196 DVWAFGVLLWEIATYGMSP 214

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 25/236 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G V+ G   ++T VAVK L       +  F  E   +  ++H  LVRL      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                ++ EY+  G+L  +L  D G    L   I  +  +  A+G+ Y+        +HR
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIERK---NYIHR 134
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++++N+L+ +    K++DFGLA+++  E +  T R    F   + APE  + G    +S
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 372 DVYSFGILIMEVIS-------GRNPVD--------YSRPPGEVCIPQMNSLMTLSY 412
           DV+SFGIL+ E+++       GR   D        Y  P  E C  ++  +M + +
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCW 248

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 132
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++ +   +  G     + APE  
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 223

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 85  REPPFYIITEFMTYGNLLDYL------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 80  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 80  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 85  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 199 DVWAFGVLLWEIATYGMSP 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 80  REPPFYIIIEFMTYGNLLDYL------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 80  REPPFYIITEFMTYGNLLDYL------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 80  REPPFYIIIEFMTYGNLLDYL------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 84  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 198 DVWAFGVLLWEIATYGMSP 216

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 128
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA        S+   ++ G+  ++APE       N    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 16/230 (6%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG 223
            P  + LG+G W    E++     F  E  +G G +G+V +G      +VA+K ++    
Sbjct: 8   APSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
            +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L         +
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
               +   +L   K +    E LE K  +HRD+ + N L++ Q   K+SDFGL++ +  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
               +        +  PE       + +SD+++FG+L+ E+ S G+ P +
Sbjct: 174 EETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 10/216 (4%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEA 235
           +L + E+       ++ +G G +G VY GV +  +  VAVK L  +  + E EF  E   
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           +  ++H NLV+LLG C       ++ E++  GNL  +L            E+   ++L  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL------RECNRQEVSAVVLLYM 114
Query: 296 AKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
           A  ++   E LE K  +HRD+ + N L+ +    K++DFGL++L+  +            
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + APE  +    + +SDV++FG+L+ E+ + G +P
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 80  REPPFYIITEFMTYGNLLDYL------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 93  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 146
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 207 DVWAFGVLLWEIATYGMSP 225

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 82  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 196 DVWAFGVLLWEIATYGMSP 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 96  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 148
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA        S+   ++ G+  ++APE       N    
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 209 QSDVYAFGIVLYELMTGQLP 228

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 82  REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 196 DVWAFGVLLWEIATYGMSP 214

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V + N+     Q  + FK EV  + + RH N++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V ++ +  +L   LH        +     ++I   TA+G+ YLH      ++HR
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 156
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNE--- 369
           D+KS+NI L +    K+ DFGLA        S+   ++ G+  ++APE       N    
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVY+FGI++ E+++G+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 81  YFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +  + A  S  TT + GT  Y+ PE     M +E
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDE 190
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 123
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 213

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 215

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 20/232 (8%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG 223
            P  + LG+G W    E++     F  E  +G G +G+V +G      +VA+K ++    
Sbjct: 8   APSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
            +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L         +
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
               +   +L   K +    E LE K  +HRD+ + N L++ Q   K+SDFGL++ +  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 343 RSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
               T+ V   F   +  PE       + +SD+++FG+L+ E+ S G+ P +
Sbjct: 174 E--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 133
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HR++ + NIL++ +   K+ DFGL K+L  ++ Y   +  G     + APE  
Sbjct: 134 K---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 191 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 224

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 188 FADENVIGEGGYGIVY-----HGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
           F   N++G+G +  VY     H  LE    +  K  +   G  ++  + EV+   +++H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHP 71
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           +++ L  Y  +  +  LV E   NG + ++L   V P S       M+ I+    G+ YL
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII---TGMLYL 128
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA--ERSYVTTRVMGTFGYVAPE 360
           H      ++HRD+  SN+LL +  N K++DFGLA  L    E+ Y    + GT  Y++PE
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPE 182
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
            A+       SDV+S G +   ++ GR P D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKNLVRLL 248
           ++G GG   V+    L D+ +VAVK L  +  +       F+ E +    + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                    G    +V EY+D   L   +H +     P+T +  + +I    + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPEYA 362
                ++HRD+K +NIL+      K+ DFG+A+ +    + V  T  V+GT  Y++PE A
Sbjct: 135 N---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
               ++ RSDVYS G ++ EV++G  P     P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGMEYLGT 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 226

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVD 391
            E  DV+S GI++  +++G  P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 21/228 (9%)
Query: 168 SHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRG 223
           SH+     + L + E+          +G+G +G VY    + +  + A+K L      + 
Sbjct: 2   SHMSKKRQWALEDFEIG-------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA 54
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
             E + + EVE    +RH N++RL GY  +     L+ EY   G +    + ++   S  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKF 110
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
             +     I   A  L+Y H     +V+HRDIK  N+LL      K++DFG +    + R
Sbjct: 111 DEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
               T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 168 R---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDYLPPEMIEGRMHDE 185
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 131
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 132 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 189 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 222

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 136
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 137 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 194 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 227

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 185
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 163
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 254

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 130
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 131 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 188 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 221

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 132
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 223

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 188
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 132
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 223

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 102 YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 154
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +  + A  S  TT + GT  Y+ PE     M +E
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDE 211
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 212 KVDLWSLGVLCYEFLVGKPPFE 233

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 137
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 138 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 195 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 228

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKNLVRLL 248
           ++G GG   V+    L D+ +VAVK L  +  +       F+ E +    + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                    G    +V EY+D   L   +H +     P+T +  + +I    + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
                ++HRD+K +NI++      K+ DFG+A+ +    + VT    V+GT  Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
               ++ RSDVYS G ++ EV++G  P     P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDE 185
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 226

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDE 186
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 138
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 139 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 196 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDE 185
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 81  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 190
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKNLVRLL 248
           ++G GG   V+    L D+ +VAVK L  +  +       F+ E +    + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                    G    +V EY+D   L   +H +     P+T +  + +I    + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
                ++HRD+K +NI++      K+ DFG+A+ +    + VT    V+GT  Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
               ++ RSDVYS G ++ EV++G  P     P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDYLPPEMIEGRMHDE 185
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 139
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 140 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 197 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 230

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 93  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 145
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +  + A  S  TT + GT  Y+ PE     M +E
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDE 202
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 203 KVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 75  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 127
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 184
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 185 KVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 150
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 151 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 241

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ E++  G+L ++L  H +   H  L     +       KG+ YL  
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 226

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 287 REPPFYIITEFMTYGNLLDYL------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HR++ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 401 DVWAFGVLLWEIATYGMSP 419

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 188
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG G +G VY G    +  V +  +++   +  + F+ EV  + + RH N++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
             +  +V ++ +  +L + LH      +       ++I   TA+G+ YLH      ++HR
Sbjct: 104 D-NLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE---YASTGMLNE 369
           D+KS+NI L +    K+ DFGLA +      S    +  G+  ++APE          + 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SDVYS+GI++ E+++G  P
Sbjct: 217 QSDVYSYGIVLYELMTGELP 236

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNT-NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
                 ++ E++  GNL  +L            E+   ++L  A  ++   E LE K  +
Sbjct: 326 REPPFYIITEFMTYGNLLDYL------RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 379
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HR++ + N L+ +    K++DFGL++L+  +             + APE  +    + +S
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 372 DVYSFGILIMEVIS-GRNP 389
           DV++FG+L+ E+ + G +P
Sbjct: 440 DVWAFGVLLWEIATYGMSP 458

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 132
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 189
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 190 KVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TTLSGTLDYLPPEMIEGRMHDE 186
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G V    +  L+DNT   VAVK L ++  +  ++F+ E+E +  ++H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           G C     R   L+ EY+  G+L  +L  H +   H  L     +       KG+ YL  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 150
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + +HRD+ + NIL++ +   K+ DFGL K+L  ++     +  G     + APE  
Sbjct: 151 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGE 398
           +    +  SDV+SFG+++ E+ +    ++ S+ PP E
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAE 241

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    +    + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 73  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 125
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 182
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 183 KVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G     ++ ++   S    +     I   A  L+Y H     +
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGTLDYLPPEMIEGRMHDE 190
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 25/236 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G V+ G   ++T VAVK L      + + F  E   +  ++H  LVRL     +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                ++ E++  G+L  +L  D G    L   I  +  +  A+G+ Y+        +HR
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIERK---NYIHR 133
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
           D++++N+L+ +    K++DFGLA+++  E +  T R    F   + APE  + G    +S
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 372 DVYSFGILIMEVIS-------GRNPVD--------YSRPPGEVCIPQMNSLMTLSY 412
           +V+SFGIL+ E+++       GR   D        Y  P  E C  ++  +M + +
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMKMCW 247

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G VY    E N+   +A+K L      +   E + + EVE    +RH N++RL 
Sbjct: 16  LGKGKFGNVYLAR-EKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           GY  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     
Sbjct: 75  GYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK--- 127
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           KV+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +
Sbjct: 128 KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHD 184
Query: 369 ERSDVYSFGILIMEVISGRNPVD 391
           E+ D++S G+L  E + G+ P +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
           E+       E  +G G +G V+      +T VAVK +       E  F  E   +  ++H
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 236
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
             LV+L     +     ++ E++  G+L  +L  D G   PL   I  +  +  A+G+ +
Sbjct: 237 DKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAF 293
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           + +      +HRD++++NIL+      K++DFGLA++ GA+             + APE 
Sbjct: 294 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARV-GAK---------FPIKWTAPEA 340
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            + G    +SDV+SFGIL+ME+++ GR P
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 114/238 (47%), Gaps = 23/238 (9%)
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF 229
           LG G    ++EL++          IG+G +G V  G    N  VAVK + N+     + F
Sbjct: 3   LGSGWALNMKELKLL-------QTIGKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAF 52
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
             E   + ++RH NLV+LLG   E    + +V EY+  G+L  +L       S L  +  
Sbjct: 53  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCL 110
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
           +   L   + + YL EG     VHRD+ + N+L+ +    K+SDFGL K    E S    
Sbjct: 111 LKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQD 163
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVCIPQMN 405
                  + APE       + +SDV+SFGIL+ E+ S GR P  Y R P +  +P++ 
Sbjct: 164 TGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVE 219

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V+          +D   VAVK L +    A K+F+ E E +  ++H+++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGPHSP---LTWEIRMNIILGT 295
            G C +G   ++V+EY+ +G+L ++L  HG       D  P      L     ++I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
           A G+ YL        VHRD+ + N L+      K+ DFG+++ + +   Y V    M   
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            ++ PE          SDV+SFG+++ E+ + G+ P
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 20/226 (8%)
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF 229
           LG+G W    E++     F  E  +G G +G+V +G      +VA+K ++     +E EF
Sbjct: 5   LGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEF 57
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
             E + +  + H+ LV+L G C +     ++ EY+ NG L  +L         +    + 
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EMRHRFQT 110
Query: 290 NIILGTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
             +L   K +    E LE K  +HRD+ + N L++ Q   K+SDFGL++ +  +    T+
Sbjct: 111 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTS 168
Query: 349 RVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
            V   F   +  PE       + +SD+++FG+L+ E+ S G+ P +
Sbjct: 169 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 194 IGEGGYG---IVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G   +  +  L DNT   VAVK L ++    +++F+ E++ +  +    +V+  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 249 GYCAEGAHRM---LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGLTYLHE 304
           G  + G  R    LV EY+ +G L  +L      H       R+ +      KG+ YL  
Sbjct: 79  GV-SYGPGRQSLRLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGS 133
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + VHRD+ + NIL++ + + K++DFGLAKLL  ++ Y   R  G     + APE  
Sbjct: 134 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 363 STGMLNERSDVYSFGILIMEVIS 385
           S  + + +SDV+SFG+++ E+ +
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG  G V   V       VAVK +   R     +  K E+     + H+N+V+  G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +  D+G   P        ++     G+ YLH G+   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
            E  DV+S GI++  +++G  P D    P + C
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSC 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 194 IGEGGYG---IVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G   +  +  L DNT   VAVK L ++    +++F+ E++ +  +    +V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 249 GYCAEGAHRM---LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGLTYLHE 304
           G  + G  R    LV EY+ +G L  +L      H       R+ +      KG+ YL  
Sbjct: 91  GV-SYGPGRQSLRLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGS 145
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYA 362
               + VHRD+ + NIL++ + + K++DFGLAKLL  ++ Y   R  G     + APE  
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 363 STGMLNERSDVYSFGILIMEVIS 385
           S  + + +SDV+SFG+++ E+ +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 78  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 130
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDE 187
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 188 KVDLWSLGVLCYEFLVGKPPFE 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 194 IGEGGYG---IVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G   +  +  L DNT   VAVK L ++    +++F+ E++ +  +    +V+  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 249 G--YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGLTYLHEG 305
           G  Y        LV EY+ +G L  +L      H       R+ +      KG+ YL   
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYAS 363
              + VHRD+ + NIL++ + + K++DFGLAKLL  ++ Y   R  G     + APE  S
Sbjct: 134 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 364 TGMLNERSDVYSFGILIMEVIS 385
             + + +SDV+SFG+++ E+ +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDE 188
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 78  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 130
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K+++FG +    + R    T + GT  Y+ PE     M +E
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 187
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 188 KVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K+++FG +    + R    T + GT  Y+ PE     M +E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 188
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 105/216 (48%), Gaps = 16/216 (7%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
             IG+G +G V  G    N  VAVK + N+     + F  E   + ++RH NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 252 AEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            E    + +V EY+  G+L  +L       S L  +  +   L   + + YL EG     
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNF 138
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           VHRD+ + N+L+ +    K+SDFGL K    E S           + APE       + +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVCIPQMN 405
           SDV+SFGIL+ E+ S GR P  Y R P +  +P++ 
Sbjct: 195 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVE 228

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DTLCGTLDYLPPEMIEGRMHDE 186
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDE 185
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
             IG+G +G V  G    N  VAVK + N+     + F  E   + ++RH NLV+LLG  
Sbjct: 12  QTIGKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 252 AEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            E    + +V EY+  G+L  +L       S L  +  +   L   + + YL EG     
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNF 123
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           VHRD+ + N+L+ +    K+SDFGL K    E S           + APE       + +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVCIPQMNS 406
           SDV+SFGIL+ E+ S GR P  Y R P +  +P++  
Sbjct: 180 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEK 214

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDE 185
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           IGEG  GIV     E +T   VAVK +   + Q  +    EV  +    H N+V +    
Sbjct: 53  IGEGSTGIVCIAT-EKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V E+++ G L      D+  H+ +  E    + L   + L+YLH      V+
Sbjct: 112 LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVI 163
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNE 369
           HRDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S      
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPP 396
             D++S GI+++E+I G  P  ++ PP
Sbjct: 221 EVDIWSLGIMVIEMIDGEPPY-FNEPP 246

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDE 188
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 102 YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 154
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPPEMIEGRMHDE 211
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 212 KVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY      +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYCHSK---R 132
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE     M +E
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDE 189
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G  P +
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G +    + ++   S    +     I   A  L+Y H     +
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPPEMIEGRMHDE 188
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
             IG+G +G V  G    N  VAVK + N+     + F  E   + ++RH NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 252 AEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            E    + +V EY+  G+L  +L       S L  +  +   L   + + YL EG     
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNF 310
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           VHRD+ + N+L+ +    K+SDFGL K    E S           + APE       + +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVCIPQMNS 406
           SDV+SFGIL+ E+ S GR P  Y R P +  +P++  
Sbjct: 367 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEK 401

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 38/254 (14%)
Query: 149 GSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL- 207
           GSH  SG+    A +              L+E E     F    V+G G +G VY G+  
Sbjct: 1   GSHMASGEAPNQALLR------------ILKETE-----FKKIKVLGSGAFGTVYKGLWI 43
Query: 208 ----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262
               +    VA+K L      +A KE   E   +  V + ++ RLLG C     + L+ +
Sbjct: 44  PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQ 102
Query: 263 YIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319
            +  G L  ++  H D +G    L W +++      AKG+ YL +    ++VHRD+ + N
Sbjct: 103 LMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARN 153
Query: 320 ILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
           +L+    + K++DFGLAKLLGA E+ Y          ++A E     +   +SDV+S+G+
Sbjct: 154 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 213
Query: 379 LIMEVIS-GRNPVD 391
            + E+++ G  P D
Sbjct: 214 TVWELMTFGSKPYD 227

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY    + +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G     ++ ++   S    +     I   A  L+Y H     +
Sbjct: 81  YFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R    T + GT  Y+ PE       +E
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEXIEGRXHDE 190
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G+ P +
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           V H  ++R+ G   +     ++ +YI+ G L   L       +P+       + L     
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA---- 118
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L YLH      +++RD+K  NILLDK  + K++DFG AK +      VT  + GT  Y+A
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIA 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           PE  ST   N+  D +SFGILI E+++G  P
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKG 130
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 133
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 194 IGEGGYGIVYH----GVL--EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVR 246
           IGEG +G V+     G+L  E  T VAVK L        + +F+ E   +    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS---------------------PLTW 285
           LLG CA G    L++EY+  G+L ++L   + PH+                     PL+ 
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRS-MSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERS 344
             ++ I    A G+ YL E    K VHRD+ + N L+ +    K++DFGL++ +  A+  
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                      ++ PE          SDV+++G+++ E+ S
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 23/247 (9%)
Query: 155 GDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL------E 208
           G+  + A++ PE  +      Y   E EV+         +G+G +G+VY GV       E
Sbjct: 18  GNGVLYASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDE 75
Query: 209 DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267
             T VA+K +       E+ EF  E   +      ++VRLLG  ++G   +++ E +  G
Sbjct: 76  PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG 135
Query: 268 NLEQWLHGDVGPH-------SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
           +L+ +L   + P        +P +    + +    A G+ YL+     K VHRD+ + N 
Sbjct: 136 DLKSYLRS-LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 191
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGI 378
           ++ + +  K+ DFG+ + +  E  Y      G     +++PE    G+    SDV+SFG+
Sbjct: 192 MVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 250
Query: 379 LIMEVIS 385
           ++ E+ +
Sbjct: 251 VLWEIAT 257

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 130
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 123
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 139
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 140 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 8/204 (3%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKV-EVEAIGRVRHKNLVRLLG 249
            IG G YG       + +  + V   L+  +  +AEK+  V EV  +  ++H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 250 YCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
              +  +  L  V EY + G+L   +         L  E  + ++      L   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 308 --PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               V+HRD+K +N+ LD + N KL DFGLA++L  + S+  T V GT  Y++PE  +  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             NE+SD++S G L+ E+ +   P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 19/243 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKN 243
           F     IG+G +G V+ G+  DN     VA+K + L       ++ + E+  + +     
Sbjct: 25  FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + +  G   +G+   ++ EY+  G+    L    GP         +  IL   KGL YLH
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL---KGLDYLH 137
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                K +HRDIK++N+LL +Q + KL+DFG+A  L   +    T V GT  ++APE   
Sbjct: 138 S---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 193
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL--SYCSSF--FLI 419
               + ++D++S GI  +E+  G  P     P   + +   N+  TL   +  SF  F+ 
Sbjct: 194 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFID 253
Query: 420 CCV 422
            C+
Sbjct: 254 ACL 256

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 23/241 (9%)
Query: 161 AAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVA 214
           A++ PE  +      Y   E EV+         +G+G +G+VY GV       E  T VA
Sbjct: 2   ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 215 VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL 273
           +K +       E+ EF  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L
Sbjct: 60  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 274 HGDVGPH-------SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326
              + P        +P +    + +    A G+ YL+     K VHRD+ + N ++ + +
Sbjct: 120 RS-LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175
Query: 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVI 384
             K+ DFG+ + +  E  Y      G     +++PE    G+    SDV+SFG+++ E+ 
Sbjct: 176 TVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 385 S 385
           +
Sbjct: 235 T 235

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 154
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 155 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKNLVRLL 248
           ++G GG   V+    L  + +VAVK L  +  +       F+ E +    + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 249 GY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                    G    +V EY+D   L   +H +     P+T +  + +I    + L + H+
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
                ++HRD+K +NI++      K+ DFG+A+ +    + VT    V+GT  Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
               ++ RSDVYS G ++ EV++G  P     P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 17/229 (7%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLL--NNRGQAEKEFKVEVEAIGRVR 240
           S   + +  ++GEG YG+V     +D    VA+K  L  ++    +K    E++ + ++R
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H+NLV LL  C +     LV+E++D+  L+     ++ P+  L +++    +     G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNG-LDYQVVQKYLFQIINGIG 138
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           + H      ++HRDIK  NIL+ +    KL DFG A+ L A        V  T  Y APE
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPE 194
Query: 361 YASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                +   ++ DV++ G L+ E+  G         PG+  I Q+  +M
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-----PGDSDIDQLYHIM 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 110/239 (46%), Gaps = 33/239 (13%)
Query: 163 ITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNN 221
           I+PE       HW      + +     D   IG G YG V   V + +  + AVK + + 
Sbjct: 11  ISPE------QHW------DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 222 RGQAE-KEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYEYIDNG--NLEQWLHG-- 275
             + E K+  ++++ + R      +V+  G         +  E +        ++++   
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 276 -DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
            DV P      EI   I L T K L +L E L  K++HRDIK SNILLD+  N KL DFG
Sbjct: 119 DDVIPE-----EILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171
Query: 335 LAKLLGAERSYVTTRVMGTFGYVAPEY----ASTGMLNERSDVYSFGILIMEVISGRNP 389
           ++  L    S   TR  G   Y+APE     AS    + RSDV+S GI + E+ +GR P
Sbjct: 172 ISGQLVD--SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKNLVRLL 248
           ++G GG   V+    L  + +VAVK L  +  +       F+ E +    + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                    G    +V EY+D   L   +H +     P+T +  + +I    + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
                ++HRD+K +NI++      K+ DFG+A+ +    + VT    V+GT  Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
               ++ RSDVYS G ++ EV++G  P     P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 194 IGEGGYG---IVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +G   +  +  L DNT   VAVK L ++    +++F+ E++ +  +    +V+  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 249 G--YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGLTYLHEG 305
           G  Y        LV EY+ +G L  +L      H       R+ +      KG+ YL   
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGYVAPEYAS 363
              + VHRD+ + NIL++ + + K++DFGLAKLL  ++     R  G     + APE  S
Sbjct: 131 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 364 TGMLNERSDVYSFGILIMEVIS 385
             + + +SDV+SFG+++ E+ +
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV    +  +  +     ++ R Q  +E    EV  +   +H+N+V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    +V E+++ G L      D+  H+ +  E    + L   + L+ LH      V+H
Sbjct: 92  VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 143
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S       
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPP 396
            D++S GI+++E++ G  P  ++ PP
Sbjct: 201 VDIWSLGIMVIEMVDGEPPY-FNEPP 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV    +  +  +     ++ R Q  +E    EV  +   +H+N+V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    +V E+++ G L      D+  H+ +  E    + L   + L+ LH      V+H
Sbjct: 88  VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 139
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S       
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPP 396
            D++S GI+++E++ G  P  ++ PP
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY-FNEPP 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV    +  +  +     ++ R Q  +E    EV  +   +H+N+V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    +V E+++ G L      D+  H+ +  E    + L   + L+ LH      V+H
Sbjct: 97  VGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 148
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S       
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPP 396
            D++S GI+++E++ G  P  ++ PP
Sbjct: 206 VDIWSLGIMVIEMVDGEPPY-FNEPP 230

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 23/241 (9%)
Query: 161 AAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVA 214
           A++ PE  +      Y   E EV+         +G+G +G+VY GV       E  T VA
Sbjct: 2   ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 215 VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL 273
           +K +       E+ EF  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L
Sbjct: 60  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 274 HGDVGPH-------SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326
              + P        +P +    + +    A G+ YL+     K VHRD+ + N ++ + +
Sbjct: 120 RS-LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175
Query: 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVI 384
             K+ DFG+ + +  E  Y      G     +++PE    G+    SDV+SFG+++ E+ 
Sbjct: 176 TVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 385 S 385
           +
Sbjct: 235 T 235

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV    +  +  +     ++ R Q  +E    EV  +   +H+N+V +     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    +V E+++ G L      D+  H+ +  E    + L   + L+ LH      V+H
Sbjct: 99  VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 150
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S       
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPP 396
            D++S GI+++E++ G  P  ++ PP
Sbjct: 208 VDIWSLGIMVIEMVDGEPPY-FNEPP 232

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKNLVRLL 248
           ++G GG   V+    L  + +VAVK L  +  +       F+ E +    + H  +V + 
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                    G    +V EY+D   L   +H +     P+T +  + +I    + L + H+
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 151
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
                ++HRD+K +NI++      K+ DFG+A+ +    + VT    V+GT  Y++PE A
Sbjct: 152 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
               ++ RSDVYS G ++ EV++G  P     P
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVE 232
           E EVS         +G+G +G+VY G   D       T VAVK +  +    E+ EF  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-------PLTW 285
              +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       P T 
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTL 129
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
           +  + +    A G+ YL+     K VHRD+ + N ++   +  K+ DFG+ + +  E +Y
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAY 185
Query: 346 VTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                 G     ++APE    G+    SD++SFG+++ E+ S
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V +G      +VA+K ++     +E EF  E + +  + H+ LV+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVH 312
                ++ EY+ NG L  +L         +    +   +L   K +    E LE K  +H
Sbjct: 71  QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNER 370
           RD+ + N L++ Q   K+SDFGL++ +  +    T+ V   F   +  PE       + +
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 371 SDVYSFGILIMEVIS-GRNPVD 391
           SD+++FG+L+ E+ S G+ P +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V +G      +VA+K ++     +E EF  E + +  + H+ LV+L G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVH 312
                ++ EY+ NG L  +L         +    +   +L   K +    E LE K  +H
Sbjct: 75  QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNER 370
           RD+ + N L++ Q   K+SDFGL++ +  +    T+ V   F   +  PE       + +
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 371 SDVYSFGILIMEVIS-GRNPVD 391
           SD+++FG+L+ E+ S G+ P +
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V +G      +VA+K ++     +E EF  E + +  + H+ LV+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVH 312
                ++ EY+ NG L  +L         +    +   +L   K +    E LE K  +H
Sbjct: 76  QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-VMGTFGYVAPEYASTGMLNERS 371
           RD+ + N L++ Q   K+SDFGL++ +  +  Y ++R       +  PE       + +S
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 372 DVYSFGILIMEVIS-GRNPVD 391
           D+++FG+L+ E+ S G+ P +
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYE 208

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +G+V +G      +VA+K ++     +E EF  E + +  + H+ LV+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVH 312
                ++ EY+ NG L  +L         +    +   +L   K +    E LE K  +H
Sbjct: 76  QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNER 370
           RD+ + N L++ Q   K+SDFGL++ +  +    T+ V   F   +  PE       + +
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 371 SDVYSFGILIMEVIS-GRNPVD 391
           SD+++FG+L+ E+ S G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G+G +G VY      +  + A+K L      +   E + + EVE    +RH N++RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           Y  +     L+ EY   G     ++ ++   S    +     I   A  L+Y H     +
Sbjct: 80  YFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSYCHSK---R 132
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRDIK  N+LL      K++DFG +    + R      + GT  Y+ PE     M +E
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR---DTLCGTLDYLPPEMIEGRMHDE 189
Query: 370 RSDVYSFGILIMEVISGRNPVD 391
           + D++S G+L  E + G  P +
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +   +    TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-E 228
           Y   E EVS         +G+G +G+VY G   D       T VAVK +  +    E+ E
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS------- 281
           F  E   +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRP 125
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLG 340
           P T +  + +    A G+ YL+     K VHRD+ + N ++   +  K+ DFG+ + +  
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
            +      + +    ++APE    G+    SD++SFG+++ E+ S
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +   +    TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV    +  +  +     ++ R Q  +E    EV  +   +H+N+V +     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    +V E+++ G L      D+  H+ +  E    + L   + L+ LH      V+H
Sbjct: 219 VGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 270
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S       
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPP 396
            D++S GI+++E++ G  P  ++ PP
Sbjct: 328 VDIWSLGIMVIEMVDGEPPY-FNEPP 352

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      A+G
Sbjct: 74  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEG 126
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAV-KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           V+G+G +G        +   V V K L+    + ++ F  EV+ +  + H N+++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +      + EYI  G L   +       S   W  R++     A G+ YLH      ++
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-------------TRVMGTFGYVA 358
           HRD+ S N L+ +  N  ++DFGLA+L+  E++                  V+G   ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRN 388
           PE  +    +E+ DV+SFGI++ E+I   N
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           F +  +IG GG+G V+      D     +K +  N  +AE+E    V+A+ ++ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 247 LLG------YCAEGAHR----------MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
             G      Y  E + +           +  E+ D G LEQW+    G    L   + + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALE 126
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           +     KG+ Y+H     K+++RD+K SNI L      K+ DFGL   L  +      R 
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RXRS 181
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384
            GT  Y++PE  S+    +  D+Y+ G+++ E++
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV    +  +  +     ++ R Q  +E    EV  +   +H+N+V +     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    +V E+++ G L      D+  H+ +  E    + L   + L+ LH      V+H
Sbjct: 142 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 193
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  E   V  R  ++GT  ++APE  S       
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPP 396
            D++S GI+++E++ G  P  ++ PP
Sbjct: 251 VDIWSLGIMVIEMVDGEPPY-FNEPP 275

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D     T VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVE 232
           E EVS         +G+G +G+VY G   D       T VAVK +  +    E+ EF  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-------PLTW 285
              +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       P T 
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTL 129
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
           +  + +    A G+ YL+     K VHRD+ + N ++   +  K+ DFG+ + +  E  Y
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDY 185
Query: 346 VTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                 G     ++APE    G+    SD++SFG+++ E+ S
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D  N    VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERSYVTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +   +    TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRV 239
           S++ F     +G G Y  VY G L   T V V      L +  G      + E+  +  +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG--TAK 297
           +H+N+VRL           LV+E++DN +L++++      ++P   E+ +         +
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL + HE    K++HRD+K  N+L++K+   KL DFGLA+  G   +  ++ V+ T  Y 
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYR 175
Query: 358 APEYASTGMLNERS-DVYSFGILIMEVISGR 387
           AP+          S D++S G ++ E+I+G+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+  G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D     T VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D     T VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D     T VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 133
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFG AKLLGA E+ Y          ++
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKV-EVEAIGRVRHKNLVRLLG 249
            IG G YG       + +  + V   L+  +  +AEK+  V EV  +  ++H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 250 YCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
              +  +  L  V EY + G+L   +         L  E  + ++      L   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 308 --PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               V+HRD+K +N+ LD + N KL DFGLA++L  + S+    V GT  Y++PE  +  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRM 191
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             NE+SD++S G L+ E+ +   P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+  G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D     T VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D     T VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFG AKLLGA E+ Y          ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D     T VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+  G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL--EDNTN--VAVKNL-LNNRGQAE-KEFKV 231
           L ++ +  N      ++GEG +G V  G L  ED T+  VAVK + L+N  Q E +EF  
Sbjct: 26  LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHR-----MLVYEYIDNGNLEQWL---HGDVGP-HSP 282
           E   +    H N++RLLG C E + +     M++  ++  G+L  +L     + GP H P
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           L  +  +  ++  A G+ YL        +HRD+ + N +L       ++DFGL+K + + 
Sbjct: 146 L--QTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200
Query: 343 RSYVTTRVMGT-FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
             Y   R+      ++A E  +  +   +SDV++FG+ + E+ + G  P
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+  L      +A KE   E   +  V +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 111 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 163
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++
Sbjct: 164 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    +++DFGLA+ +     Y  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA++ + N + Q +KE  + E+  +   ++ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 87  LVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS NILL    + KL+DFG    +  E+S  +T V GT  ++APE  +      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E+I G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTN----VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLV 245
           + VIG+G +G+VYHG   D        A+K+L      Q  + F  E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 246 RLLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
            L+G     EG   +L+  Y+ +G+L Q++     P    T +  ++  L  A+G+ YL 
Sbjct: 86  ALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLA 141
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR----VMGTFGYVAP 359
           E    K VHRD+ + N +LD+ +  K++DFGLA+ +  +R Y + +          + A 
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTAL 197
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNP 389
           E   T     +SDV+SFG+L+ E+++   P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFG AKLLGA E+ Y          ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVE 232
           E EVS         +G+G +G+VY G   D       T VAVK +  +    E+ EF  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-------PLTW 285
              +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       P T 
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTL 129
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERS 344
           +  + +    A G+ YL+     K VHRD+ + N ++   +  K+ DFG+ + +   +  
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 186
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
               + +    ++APE    G+    SD++SFG+++ E+ S
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFG AKLLGA E+ Y          ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFG AKLLGA E+ Y          ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 21/226 (9%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
           Y   E EV+         +G+G +G+VY GV       E  T VA+K +       E+ E
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------S 281
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLA 126
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P +    + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-Y 182
Query: 342 ERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           E  Y      G     +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 21/226 (9%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
           Y   E EV+         +G+G +G+VY GV       E  T VA+K +       E+ E
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------S 281
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLA 126
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P +    + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-Y 182
Query: 342 ERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           E  Y      G     +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVE 232
           E EVS         +G+G +G+VY G   D       T VAVK +  +    E+ EF  E
Sbjct: 8   EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 67
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-------PLTW 285
              +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       P T 
Sbjct: 68  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTL 126
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERS 344
           +  + +    A G+ YL+     K VHRD+ + N ++   +  K+ DFG+ + +   +  
Sbjct: 127 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX 183
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
               + +    ++APE    G+    SD++SFG+++ E+ S
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+      +    VA+K L      +A KE   E   +  V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIRMNIILGTAKG 298
            ++ RLLG C     + L+ + +  G L  ++  H D +G    L W +++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYV 357
           + YL +    ++VHRD+ + N+L+    + K++DFG AKLLGA E+ Y          ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
           A E     +   +SDV+S+G+ + E+++ G  P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 21/226 (9%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
           Y   E EV+         +G+G +G+VY GV       E  T VA+K +       E+ E
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------S 281
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLA 127
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P +    + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-Y 183
Query: 342 ERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           E  Y      G     +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 184 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D  N    VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP---LTWEIRMNI 291
           ++ LLG C +     ++ EY   GNL ++L     P         H+P   L+ +  ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 113/238 (47%), Gaps = 30/238 (12%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
            V   G +G V+   L  N  VAVK   + ++   + E+  EV ++  ++H+N+++ +G 
Sbjct: 30  EVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGA 86
Query: 251 CAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 304
              G        L+  + + G+L  +L  +V     ++W    +I    A+GL YLHE  
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDI 141
Query: 305 -----GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
                G +P + HRDIKS N+LL       ++DFGLA    A +S   T   +GT  Y+A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 359 PEYASTGMLNERS-----DVYSFGILIMEVIS----GRNPVDYSRPPGEVCIPQMNSL 407
           PE     +  +R      D+Y+ G+++ E+ S       PVD    P E  I Q  SL
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
           IG G +G V+ G L  DNT VAVK+         K +F  E   + +  H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +     +V E +  G+   +L  +    + L  +  + ++   A G+ YL        +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNE 369
           HRD+ + N L+ ++   K+SDFG+++   A+  Y  +  +      + APE  + G  + 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 370 RSDVYSFGILIMEVIS-GRNP 389
            SDV+SFGIL+ E  S G +P
Sbjct: 295 ESDVWSFGILLWETFSLGASP 315

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
           IG G +G V+ G L  DNT VAVK+         K +F  E   + +  H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +     +V E +  G+   +L  +    + L  +  + ++   A G+ YL        +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG----TFGYVAPEYASTGML 367
           HRD+ + N L+ ++   K+SDFG+++    E   V     G       + APE  + G  
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 368 NERSDVYSFGILIMEVIS-GRNP 389
           +  SDV+SFGIL+ E  S G +P
Sbjct: 293 SSESDVWSFGILLWETFSLGASP 315

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-E 228
           Y   E EVS         +G+G +G+VY G   D       T VAVK +  +    E+ E
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS------- 281
           F  E   +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRP 125
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P T +  + +    A G+ YL+     K VHR++ + N ++   +  K+ DFG+ + +  
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-Y 181
Query: 342 ERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           E  Y      G     ++APE    G+    SD++SFG+++ E+ S
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 21/226 (9%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
           Y   E EV+         +G+G +G+VY GV       E  T VA+K +       E+ E
Sbjct: 5   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------S 281
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPAMANNPVLA 123
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P +    + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-Y 179
Query: 342 ERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           E  Y      G     +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 34/228 (14%)
Query: 192 NVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNL 244
             +GEG +G V              T VAVK L  N   +E ++   E   + +V H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD--VGP------------------HSPLT 284
           ++L G C++    +L+ EY   G+L  +L     VGP                     LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
               ++     ++G+ YL E    K+VHRD+ + NIL+ +    K+SDFGL++ +  E S
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 345 YVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           YV  R  G     ++A E     +   +SDV+SFG+L+ E+++ G NP
Sbjct: 206 YV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 19/225 (8%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
           Y   E EV+         +G+G +G+VY GV       E  T VA+K +       E+ E
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------S 281
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLA 127
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLG 340
           P +    + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
            +      + +    +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 185 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 192 NVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
            V+G G +G V+ GV           V +K + +  G Q+ +     + AIG + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           RLLG C  G+   LV +Y+  G+L   +    G +GP   L W +++      AKG+ YL
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEY 361
            E     +VHR++ + N+LL      +++DFG+A LL   ++  + +       ++A E 
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
              G    +SDV+S+G+ + E+++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-E 228
           Y   E EVS         +G+G +G+VY G   D       T VAVK +  +    E+ E
Sbjct: 8   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS------- 281
           F  E   +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       
Sbjct: 68  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRP 126
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P T +  + +    A G+ YL+     K VHR++ + N ++   +  K+ DFG+ + +  
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-Y 182
Query: 342 ERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           E  Y      G     ++APE    G+    SD++SFG+++ E+ S
Sbjct: 183 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 192 NVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
            V+G G +G V+ GV           V +K + +  G Q+ +     + AIG + H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           RLLG C  G+   LV +Y+  G+L   +    G +GP   L W +++      AKG+ YL
Sbjct: 97  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEY 361
            E     +VHR++ + N+LL      +++DFG+A LL   ++  + +       ++A E 
Sbjct: 150 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
              G    +SDV+S+G+ + E+++
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           F +  +IG GG+G V+      D     ++ +  N  +AE+E    V+A+ ++ H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVH 69
Query: 247 LLG--------------------YCAEGAHR---------MLVYEYIDNGNLEQWLHGDV 277
             G                    Y  E +            +  E+ D G LEQW+    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
           G    L   + + +     KG+ Y+H     K++HRD+K SNI L      K+ DFGL  
Sbjct: 130 G--EKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384
            L  +     TR  GT  Y++PE  S+    +  D+Y+ G+++ E++
Sbjct: 185 SLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVEVE 234
           EVS         +G+G +G+VY G   D       T VAVK +  +    E+ EF  E  
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-------PLTWEI 287
            +      ++VRLLG  ++G   ++V E + +G+L+ +L   + P +       P T + 
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTLQE 130
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
            + +    A G+ YL+     K VHRD+ + N ++   +  K+ DFG+ + +  E  Y  
Sbjct: 131 MIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYR 186
Query: 348 TRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
               G     ++APE    G+    SD++SFG+++ E+ S
Sbjct: 187 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKV-EVEAIGRVRHKNLVRLLG 249
            IG G YG       + +  + V   L+  +  +AEK+  V EV  +  ++H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 250 YCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
              +  +  L  V EY + G+L   +         L  E  + ++      L   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 308 --PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               V+HRD+K +N+ LD + N KL DFGLA++L  +  +    V GT  Y++PE  +  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRM 191
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             NE+SD++S G L+ E+ +   P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVE 232
           E EV+         +G+G +G+VY GV       E  T VA+K +       E+ EF  E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------SPLTW 285
              +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +P + 
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPSL 128
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
              + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  E  Y
Sbjct: 129 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 184
Query: 346 VTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                 G     +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 185 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 111/219 (50%), Gaps = 26/219 (11%)
Query: 186 NGFADENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-R 240
           N    ++VIGEG +G V    ++ +    + A+K +     + + ++F  E+E + ++  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPH--------SPLTWEIR 288
           H N++ LLG C    +  L  EY  +GNL  +L      +  P         S L+ +  
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
           ++     A+G+ YL +    + +HRD+ + NIL+ + +  K++DFGL++    +  YV  
Sbjct: 135 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-K 187
Query: 349 RVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVE 232
           E EV+         +G+G +G+VY GV       E  T VA+K +       E+ EF  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------SPLTW 285
              +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +P + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPSL 124
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
              + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  E  Y
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDY 180
Query: 346 VTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                 G     +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 31/243 (12%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
            +   G +G V+   L  N  VAVK   L ++   + E   E+ +   ++H+NL++ +  
Sbjct: 21  EIKARGRFGCVWKAQLM-NDFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQFIAA 77
Query: 251 CAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 304
              G++      L+  + D G+L  +L G++     +TW    ++    ++GL+YLHE  
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHEDV 132
Query: 305 ------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA-KLLGAERSYVTTRVMGTFGYV 357
                 G +P + HRD KS N+LL       L+DFGLA +    +    T   +GT  Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVIS----GRNPVDYSRPPGEVCIPQMNSLM 408
           APE     +  +R      D+Y+ G+++ E++S       PVD    P E  I Q  SL 
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLE 252
Query: 409 TLS 411
            L 
Sbjct: 253 ELQ 255

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++  Y   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 111/219 (50%), Gaps = 26/219 (11%)
Query: 186 NGFADENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-R 240
           N    ++VIGEG +G V    ++ +    + A+K +     + + ++F  E+E + ++  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPH--------SPLTWEIR 288
           H N++ LLG C    +  L  EY  +GNL  +L      +  P         S L+ +  
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
           ++     A+G+ YL +    + +HRD+ + NIL+ + +  K++DFGL++    +  YV  
Sbjct: 145 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-K 197
Query: 349 RVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPY 431
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+   + +G    + YL 
Sbjct: 432 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE 486
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 487 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 543
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNT-----NVAVKNLLNNRGQAEKEFKVEVEAI 236
           + + + F     +G+G +G VY    + N       V  K+ L   G  E + + E+E  
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQ 68
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             +RH N++R+  Y  +     L+ E+   G L    + ++  H     +     +   A
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELA 124
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFG 355
             L Y HE    KV+HRDIK  N+L+  +   K++DFG +         +  R M GT  
Sbjct: 125 DALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLD 177
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           Y+ PE       +E+ D++  G+L  E + G  P D
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPY 432
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+   + +G    + YL 
Sbjct: 433 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE 487
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 488 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 544
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
           Y   E EV+         +G+G +G+VY GV       E  T VA+K +       E+ E
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------S 281
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLA 120
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P +    + +    A G+ YL+     K VHRD+ + N  + + +  K+ DFG+ + +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDI-Y 176
Query: 342 ERSYVTTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           E  Y      G     +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 105/221 (47%), Gaps = 19/221 (8%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVE 232
           E EV+         +G+G +G+VY GV       E  T VA+K +       E+ EF  E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH-------SPLTW 285
              +      ++VRLLG  ++G   +++ E +  G+L+ +L   + P        +P + 
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPSL 122
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK-LLGAERS 344
              + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +   +  
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
               + +    +++PE    G+    SDV+SFG+++ E+ +
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNT-----NVAVKNLLNNRGQAEKEFKVEVEAI 236
           + + + F     +G+G +G VY    + N       V  K+ L   G  E + + E+E  
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQ 69
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             +RH N++R+  Y  +     L+ E+   G L    + ++  H     +     +   A
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELA 125
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFG 355
             L Y HE    KV+HRDIK  N+L+  +   K++DFG +         +  R M GT  
Sbjct: 126 DALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLD 178
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           Y+ PE       +E+ D++  G+L  E + G  P D
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA++ + N + Q +KE  + E+  +   ++ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 87  LVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS NILL    + KL+DFG    +  E+S   + ++GT  ++APE  +      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E+I G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 87
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 88  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 142
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 143 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 199
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
           +GEG +G V      G+ +D       VAVK L ++  + +  +   E+E +  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
           ++ LLG C +     ++  Y   GNL ++L            D+   P   +T++  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
               A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
                ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA++ + N + Q +KE  + E+  +   ++ N+V  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 88  LVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS NILL    + KL+DFG    +  E+S  +  V GT  ++APE  +      + 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E+I G  P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 89
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 144
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 145 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 89
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 144
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 145 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA++ + N + Q +KE  + E+  +   ++ N+V  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 88  LVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HR+IKS NILL    + KL+DFG    +  E+S  +T V GT  ++APE  +      + 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E+I G  P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
           IG+G  G VY  + +     VA++ + N + Q +KE  + E+  +   ++ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 87  LVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRDIKS NILL    + KL+DFG    +  E+S  +  V GT  ++APE  +      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 372 DVYSFGILIMEVISGRNP 389
           D++S GI+ +E+I G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 69
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 124
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 79
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 134
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKN 243
           F   + IG+G +G VY G+  DN     VA+K + L       ++ + E+  + +     
Sbjct: 21  FTKLDRIGKGSFGEVYKGI--DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + R  G   +     ++ EY+  G+       D+    PL       I+    KGL YLH
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATILREILKGLDYLH 133
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                + +HRDIK++N+LL +Q + KL+DFG+A  L  +        +GT  ++APE   
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIK 189
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               + ++D++S GI  +E+  G  P
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 73
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 128
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 129 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 185
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 67
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 68  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 122
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE 
Sbjct: 123 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 179
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 17/224 (7%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGR 238
           +E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
                +V   G         +  E++D G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           LTYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPV------DYSRPP 396
           PE       + +SD++S G+ ++E+  GR P+      + SRPP
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPP 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRV-RHKNLVRLLG 249
            V+    YGI   GV   +  VAVK L      +E+E    E++ + ++  H+N+V LLG
Sbjct: 60  KVMNATAYGISKTGV---SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP-------------------LTWEIRMN 290
            C       L++EY   G+L  +L       S                    LT+E  + 
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-R 349
                AKG+ +L        VHRD+ + N+L+      K+ DFGLA+ + ++ +YV    
Sbjct: 177 FAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 233
Query: 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                 ++APE    G+   +SDV+S+GIL+ E+ S G NP
Sbjct: 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 194 IGEGGYG-IVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           IGEG +G  +     ED     +K  N+     +  +E + EV  +  ++H N+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG----PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
             E     +V +Y + G+L + ++   G        L W +++ +       L ++H+  
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL------ALKHVHDR- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
             K++HRDIKS NI L K    +L DFG+A++L +    +    +GT  Y++PE      
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACIGTPYYLSPEICENKP 201
Query: 367 LNERSDVYSFGILIMEVIS 385
            N +SD+++ G ++ E+ +
Sbjct: 202 YNNKSDIWALGCVLYELCT 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 26/219 (11%)
Query: 186 NGFADENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-R 240
           N    ++VIGEG +G V    ++ +    + A+K +     + + ++F  E+E + ++  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGP--------HSPLTWEIR 288
           H N++ LLG C    +  L  EY  +GNL  +L      +  P         S L+ +  
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
           ++     A+G+ YL    + + +HR++ + NIL+ + +  K++DFGL++    +  YV  
Sbjct: 142 LHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYV-K 194
Query: 349 RVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
           + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I ++ H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I ++ H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 34/228 (14%)
Query: 192 NVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNL 244
             +GEG +G V              T VAVK L  N   +E ++   E   + +V H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD--VGP------------------HSPLT 284
           ++L G C++    +L+ EY   G+L  +L     VGP                     LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
               ++     ++G+ YL E    K+VHRD+ + NIL+ +    K+SDFGL++ +  E S
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 345 YVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            V  R  G     ++A E     +   +SDV+SFG+L+ E+++ G NP
Sbjct: 206 XV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 149 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGRV 239
           E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
               +V   G         +  E++D G+L+Q L         +  +I   + +   KGL
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGL 120
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           TYL E  + K++HRD+K SNIL++ +   KL DFG++  L  E   +    +GT  Y++P
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRSYMSP 175
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
           E       + +SD++S G+ ++E+  GR    Y RPP
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR----YPRPP 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 194 IGEGGYGIV---YHGVLEDNT--NVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V    +    DNT   VAVK+L    G     + K E+E +  + H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 248 LGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            G C E  G    L+ E++ +G+L+++L  +    + +  + ++   +   KG+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---RVMGTFGYVAPEYA 362
              + VHRD+ + N+L++ +   K+ DFGL K +  ++   T    R    F Y APE  
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 363 STGMLNERSDVYSFGILIMEVIS 385
                   SDV+SFG+ + E+++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 194 IGEGGYGIV---YHGVLEDNT--NVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRL 247
           +GEG +G V    +    DNT   VAVK+L    G     + K E+E +  + H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 248 LGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            G C E  G    L+ E++ +G+L+++L  +    + +  + ++   +   KG+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---RVMGTFGYVAPEYA 362
              + VHRD+ + N+L++ +   K+ DFGL K +  ++   T    R    F Y APE  
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 363 STGMLNERSDVYSFGILIMEVIS 385
                   SDV+SFG+ + E+++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 164 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 174 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL-----EDNT-NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N       +G G +G V          ED    VAVK L +     EKE    E++
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIR- 288
            +  + +H+N+V LLG C  G   +++ EY   G+L  +L      D+        E+R 
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 289 -MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
            ++     A+G+ +L        +HRD+ + N+LL      K+ DFGLA+ +  + +Y+ 
Sbjct: 154 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 348 T-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                    ++APE     +   +SDV+S+GIL+ E+ S G NP
Sbjct: 211 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 254

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 184 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL-----EDNT-NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N       +G G +G V          ED    VAVK L +     EKE    E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIR- 288
            +  + +H+N+V LLG C  G   +++ EY   G+L  +L      D+        E+R 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 289 -MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
            ++     A+G+ +L        +HRD+ + N+LL      K+ DFGLA+ +  + +Y+ 
Sbjct: 162 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 348 T-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                    ++APE     +   +SDV+S+GIL+ E+ S G NP
Sbjct: 219 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 262

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +G G +G+V H V E  T  N A K ++      ++  + E++ +  +RH  LV L    
Sbjct: 59  LGTGAFGVV-HRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +    +++YE++  G L + +  +   H+ ++ +  +  +    KGL ++HE      V
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 171
Query: 312 HRDIKSSNILL-DKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           H D+K  NI+   K+ N  KL DFGL   L  ++S   T   GT  + APE A    +  
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 229
Query: 370 RSDVYSFGILIMEVISGRNP 389
            +D++S G+L   ++SG +P
Sbjct: 230 YTDMWSVGVLSYILLSGLSP 249

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +G G +G+V H V E  T  N A K ++      ++  + E++ +  +RH  LV L    
Sbjct: 165 LGTGAFGVV-HRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +    +++YE++  G L + +  +   H+ ++ +  +  +    KGL ++HE      V
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 277
Query: 312 HRDIKSSNILL-DKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           H D+K  NI+   K+ N  KL DFGL   L  ++S   T   GT  + APE A    +  
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 335
Query: 370 RSDVYSFGILIMEVISGRNP 389
            +D++S G+L   ++SG +P
Sbjct: 336 YTDMWSVGVLSYILLSGLSP 355

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 175 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G G +G VY G +    N      VAVK L      Q E +F +E   I +  H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYL 302
            +G   +   R ++ E +  G+L+ +L  +  P       + M  +L  A+    G  YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTR-VMGTFGYVA 358
            E      +HRDI + N LL         K+ DFG+A+ +     Y      M    ++ 
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
           PE    G+   ++D +SFG+L+ E+ S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQA--EKEFKVEVEAIGRVRHKNLVRLLGY 250
           IGEG YG+V+     D    VA+K  L +      +K    E+  + +++H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 251 CAEGAHRMLVYEYIDNG---NLEQWLHGDVGPH--SPLTWEIRMNIILGTAKGLTYLHEG 305
                   LV+EY D+     L+++  G V  H    +TW+        T + + + H+ 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRG-VPEHLVKSITWQ--------TLQAVNFCHKH 121
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YAST 364
                +HRD+K  NIL+ K    KL DFG A+LL     Y    V  T  Y +PE     
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGD 177
Query: 365 GMLNERSDVYSFGILIMEVISG 386
                  DV++ G +  E++SG
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSG 199

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 190 DENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
           ++  +G G +G V  G  +            +KN  N+    + E   E   + ++ +  
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPY 73
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +VR++G C E    MLV E  + G L ++L  +         E+    +   + G+ YL 
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL----VHQVSMGMKYLE 128
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
           E      VHRD+ + N+LL  Q   K+SDFGL+K L A+ +    +  G +   + APE 
Sbjct: 129 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPEC 185
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            +    + +SDV+SFG+L+ E  S G+ P
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGR 238
           +E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
                +V   G         +  E++D G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           LTYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           PE       + +SD++S G+ ++E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +GEG YG VY  + ++   +     +      ++  K E+  + +    ++V+  G   +
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-EISIMQQCDSPHVVKYYGSYFK 95
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
                +V EY   G++   +      +  LT +    I+  T KGL YLH     + +HR
Sbjct: 96  NTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHR 149
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           DIK+ NILL+ + + KL+DFG+A  L  +       V+GT  ++APE       N  +D+
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADI 208
Query: 374 YSFGILIMEVISGRNP 389
           +S GI  +E+  G+ P
Sbjct: 209 WSLGITAIEMAEGKPP 224

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGR 238
           +E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
                +V   G         +  E++D G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           LTYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           PE       + +SD++S G+ ++E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGR 238
           +E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
                +V   G         +  E++D G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           LTYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           PE       + +SD++S G+ ++E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGR 238
           +E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
                +V   G         +  E++D G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           LTYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           PE       + +SD++S G+ ++E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-R 240
           V ++G+  +  IG G Y      V +  N   AVK +     +++++   E+E + R  +
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQ 79
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGL 299
           H N++ L     +G H  LV E +  G L      D         E   + +L T  K +
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELL-----DKILRQKFFSEREASFVLHTIGKTV 134
Query: 300 TYLHEGLEPKVVHRDIKSSNIL-LDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG 355
            YLH      VVHRD+K SNIL +D+  NP   ++ DFG AK L AE   + T    T  
Sbjct: 135 EYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           +VAPE       +E  D++S GIL+  +++G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 192 NVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNL 244
             +GEG +G V              T VAVK L  N   +E ++   E   + +V H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD--VGP------------------HSPLT 284
           ++L G C++    +L+ EY   G+L  +L     VGP                     LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
               ++     ++G+ YL E     +VHRD+ + NIL+ +    K+SDFGL++ +  E S
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 345 YVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            V  R  G     ++A E     +   +SDV+SFG+L+ E+++ G NP
Sbjct: 206 XV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           IGEG YG V+     E +  VA+K +    ++ G      + E+  +  ++HKN+VRL  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                    LV+E+ D  +L+++    +GD+ P      EI  + +    KGL + H   
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP------EIVKSFLFQLLKGLGFCHSR- 120
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
              V+HRD+K  N+L+++    KL+DFGLA+  G      +  V+ T  Y  P+      
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 177
Query: 367 LNERS-DVYSFGILIMEVISGRNPV 390
           L   S D++S G +  E+ +   P+
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
           IGEG  GIV     + +       +++ R Q  +E    EV  +   +H N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
            G    ++ E++  G L      D+     L  E    +     + L YLH      V+H
Sbjct: 113 VGEELWVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIH 164
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
           RDIKS +ILL      KLSDFG    +  +   V  R  ++GT  ++APE  S  +    
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 371 SDVYSFGILIMEVISGRNP 389
            D++S GI+++E++ G  P
Sbjct: 222 VDIWSLGIMVIEMVDGEPP 240

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNV----AVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
            V+G G +G VY G+ + D  NV    A+K L  N   +A KE   E   +  V    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           RLLG C     + LV + +  G L   +    G +G    L W +++      AKG++YL
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYL 135
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEY 361
            +    ++VHRD+ + N+L+    + K++DFGLA+LL   E  Y          ++A E 
Sbjct: 136 EDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
                   +SDV+S+G+ + E+++ G  P D
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-R 240
           V ++G+  +  IG G Y      V +  N   AVK +     +++++   E+E + R  +
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQ 79
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGL 299
           H N++ L     +G H  LV E +  G L      D         E   + +L T  K +
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELL-----DKILRQKFFSEREASFVLHTIGKTV 134
Query: 300 TYLHEGLEPKVVHRDIKSSNIL-LDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG 355
            YLH      VVHRD+K SNIL +D+  NP   ++ DFG AK L AE   + T    T  
Sbjct: 135 EYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           +VAPE       +E  D++S GIL+  +++G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G+G +G VY    ++ + +A   +++ + + E +++ VE++ +    H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
              +  ++ E+   G ++  +   +    PLT      +   T   L YLH+    K++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR---VMGTFGYVAPEYASTGMLNE 369
           RD+K+ NIL     + KL+DFG++    A+ +    R    +GT  ++APE        +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 370 R-----SDVYSFGILIMEVISGRNP 389
           R     +DV+S GI ++E+     P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 91
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP--------LTWEIRMNIIL 293
           N+V LLG C + G   M++ E+   GNL  +L        P        LT E  +    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-RVMG 352
             AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV       
Sbjct: 152 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
              ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 257

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++D  +L++++        PL   +  + +    +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLP--LIKSYLFQLLQGLA 120
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 176 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRL---- 247
           +G GG+G V   + +D    VA+K          +E + +E++ + ++ H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 248 --LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
             L   A     +L  EY + G+L ++L+            IR  ++   +  L YLHE 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 140
Query: 306 LEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
              +++HRD+K  NI+L    ++   K+ D G AK L  ++  + T  +GT  Y+APE  
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELL 195
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                    D +SFG L  E I+G  P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRL---- 247
           +G GG+G V   + +D    VA+K          +E + +E++ + ++ H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 248 --LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
             L   A     +L  EY + G+L ++L+            IR  ++   +  L YLHE 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 141
Query: 306 LEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
              +++HRD+K  NI+L    ++   K+ D G AK L  ++  + T  +GT  Y+APE  
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELL 196
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                    D +SFG L  E I+G  P
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 25/230 (10%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL-----EDNT-NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N       +G G +G V          ED    VAVK L +     EKE    E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---------HSP-- 282
            +  + +H+N+V LLG C  G   +++ EY   G+L  +L     P         H+P  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 283 -LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
            L+    ++     A+G+ +L        +HRD+ + N+LL      K+ DFGLA+ +  
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 342 ERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           + +Y+          ++APE     +   +SDV+S+GIL+ E+ S G NP
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 268

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G+G +G VY    ++ + +A   +++ + + E +++ VE++ +    H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
              +  ++ E+   G ++  +   +    PLT      +   T   L YLH+    K++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR---VMGTFGYVAPEYASTGMLNE 369
           RD+K+ NIL     + KL+DFG++    A+ +    R    +GT  ++APE        +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 370 R-----SDVYSFGILIMEVISGRNP 389
           R     +DV+S GI ++E+     P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G+G +G VY    ++ + +A   +++ + + E +++ VE++ +    H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
              +  ++ E+   G ++  +   +    PLT      +   T   L YLH+    K++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR---VMGTFGYVAPEYASTGMLNE 369
           RD+K+ NIL     + KL+DFG++    A+ +    R    +GT  ++APE        +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 370 R-----SDVYSFGILIMEVISGRNP 389
           R     +DV+S GI ++E+     P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++ +   ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELD-HERMSYLLYQMLV-----GIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G+++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++ +   ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELD-HERMSYLLYQMLV-----GIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G+++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 91
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV   
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 11/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGRV 239
           E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +   
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
               +V   G         +  E++D G+L+Q L         +  +I   + +   KGL
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGL 136
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           TYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++P
Sbjct: 137 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 191
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           E       + +SD++S G+ ++E+  GR P+
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 91
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP--------LTWEIRMNIIL 293
           N+V LLG C + G   M++ E+   GNL  +L        P        LT E  +    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-RVMG 352
             AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV       
Sbjct: 152 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              ++APE     +   +SDV+SFG+L+ E+ S G +P
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 11/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGRV 239
           E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +   
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
               +V   G         +  E++D G+L+Q L         +  +I   + +   KGL
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGL 179
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           TYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++P
Sbjct: 180 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 234
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           E       + +SD++S G+ ++E+  GR P+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 105/248 (42%), Gaps = 32/248 (12%)
Query: 187 GFADENVI-----GEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE-FKVEVEAI 236
           G A E+V+     GEG +G VY GV      +  NVAVK    +     KE F  E   +
Sbjct: 20  GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 79
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             + H ++V+L+G   E     ++ E    G L  +L  +      LT  +     L   
Sbjct: 80  KNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQIC 135
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           K + YL        VHRDI   NIL+      KL DFGL++ +  E  Y  +       +
Sbjct: 136 KAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 192
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCI 401
           ++PE  +       SDV+ F + + E++S G+ P  +                P  ++C 
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 252
Query: 402 PQMNSLMT 409
           P + +LMT
Sbjct: 253 PVLYTLMT 260

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 11/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGRV 239
           E+  + F   + +G G  G+V+    + +  V  + L  L  +     +   E++ +   
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
               +V   G         +  E++D G+L+Q L         +  +I   + +   KGL
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGL 144
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           TYL E  + K++HRD+K SNIL++ +   KL DFG++   G     +    +GT  Y++P
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 199
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           E       + +SD++S G+ ++E+  GR P+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 105/248 (42%), Gaps = 32/248 (12%)
Query: 187 GFADENVI-----GEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE-FKVEVEAI 236
           G A E+V+     GEG +G VY GV      +  NVAVK    +     KE F  E   +
Sbjct: 4   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 63
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             + H ++V+L+G   E     ++ E    G L  +L  +      LT  +     L   
Sbjct: 64  KNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQIC 119
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           K + YL        VHRDI   NIL+      KL DFGL++ +  E  Y  +       +
Sbjct: 120 KAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 176
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCI 401
           ++PE  +       SDV+ F + + E++S G+ P  +                P  ++C 
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 236
Query: 402 PQMNSLMT 409
           P + +LMT
Sbjct: 237 PVLYTLMT 244

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 82
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV   
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 93
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV   
Sbjct: 154 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 263

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 41/228 (17%)
Query: 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           F     +G GG+G+V+    + D+ N A+K + L NR  A ++   EV+A+ ++ H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 246 RLL-GYCAEGAHRML------VYEYID-----NGNLEQWLHGDVGPHSPLTWEIR----- 288
           R    +  +     L      VY YI        NL+ W++G        T E R     
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC------TIEERERSVC 120
Query: 289 MNIILGTAKGLTYLH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
           ++I L  A+ + +LH +GL    +HRD+K SNI        K+ DFGL   +  +    T
Sbjct: 121 LHIFLQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 348 -----------TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384
                      T  +GT  Y++PE       + + D++S G+++ E++
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 105/248 (42%), Gaps = 32/248 (12%)
Query: 187 GFADENVI-----GEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE-FKVEVEAI 236
           G A E+V+     GEG +G VY GV      +  NVAVK    +     KE F  E   +
Sbjct: 8   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             + H ++V+L+G   E     ++ E    G L  +L  +      LT  +     L   
Sbjct: 68  KNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQIC 123
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           K + YL        VHRDI   NIL+      KL DFGL++ +  E  Y  +       +
Sbjct: 124 KAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCI 401
           ++PE  +       SDV+ F + + E++S G+ P  +                P  ++C 
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 240
Query: 402 PQMNSLMT 409
           P + +LMT
Sbjct: 241 PVLYTLMT 248

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 128
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV   
Sbjct: 189 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 82
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV   
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG----- 237
           V    F     IGEG YG+VY            +N L     A K+ +++ E  G     
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTA 53
Query: 238 --------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
                    + H N+V+LL          LV+E++ + +L++++        PL   +  
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIK 110
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTT 348
           + +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T
Sbjct: 111 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--T 165
Query: 349 RVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             + T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 HEVVTLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL-----EDNT-NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N       +G G +G V          ED    VAVK L +     EKE    E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-----DVGP-----HSPL 283
            +  + +H+N+V LLG C  G   +++ EY   G+L  +L       +  P     +S L
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           +    ++     A+G+ +L        +HRD+ + N+LL      K+ DFGLA+ +  + 
Sbjct: 162 STRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 344 SYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           +Y+          ++APE     +   +SDV+S+GIL+ E+ S G NP
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKN 243
           F     IG+G +G V+ G+  DN     VA+K + L       ++ + E+  + +     
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + +  G   +     ++ EY+  G+    L        PL       I+    KGL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH 121
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                K +HRDIK++N+LL +    KL+DFG+A  L   +    T V GT  ++APE   
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 177
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               + ++D++S GI  +E+  G  P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 51
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 108
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T 
Sbjct: 109 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--TH 163
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
            + T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 93
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHG---DVGPHSP-------LTWEIRMNI 291
           N+V LLG C + G   M++ E+   GNL  +L     +  P+ P       LT E  +  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-RV 350
               AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +   V     
Sbjct: 154 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKN 243
           F     IG+G +G V+ G+  DN     VA+K + L       ++ + E+  + +     
Sbjct: 29  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + +  G   +     ++ EY+  G+    L        PL       I+    KGL YLH
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH 141
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                K +HRDIK++N+LL +    KL+DFG+A  L   +    T V GT  ++APE   
Sbjct: 142 S---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 197
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               + ++D++S GI  +E+  G  P
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKN 243
           F     IG+G +G V+ G+  DN     VA+K + L       ++ + E+  + +     
Sbjct: 24  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + +  G   +     ++ EY+  G+    L        PL       I+    KGL YLH
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH 136
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                K +HRDIK++N+LL +    KL+DFG+A  L  +        +GT  ++APE   
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIK 192
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               + ++D++S GI  +E+  G  P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 110/249 (44%), Gaps = 24/249 (9%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG-Y 250
           ++G G YG VY G       +A   +++  G  E+E K E+  + +   H+N+    G +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 251 CAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
             +    M     LV E+   G++   +    G  + L  E    I     +GL++LH+ 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH 148
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-- 363
              KV+HRDIK  N+LL +    KL DFG++  L        T  +GT  ++APE  +  
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 204
Query: 364 ---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCI------PQMNSLMTLSYCS 414
                  + +SD++S GI  +E+  G  P+    P   + +      P++ S        
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 264
Query: 415 SFFLICCVK 423
           SF   C VK
Sbjct: 265 SFIESCLVK 273

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNL 244
           IGEG YG V+     D  N    VA+K +    G+         E      +    H N+
Sbjct: 19  IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 245 VRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           VRL   C            LV+E++D  +L  +L  D  P   +  E   +++    +GL
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLRGL 133
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            +LH     +VVHRD+K  NIL+      KL+DFGLA++   + +   T V+ T  Y AP
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAP 188
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           E           D++S G +  E+   R P+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 5   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 111
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL++ H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 112 LLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNL 244
           IGEG YG V+     D  N    VA+K +    G+         E      +    H N+
Sbjct: 19  IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 245 VRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           VRL   C            LV+E++D  +L  +L  D  P   +  E   +++    +GL
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLRGL 133
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            +LH     +VVHRD+K  NIL+      KL+DFGLA++   + +   T V+ T  Y AP
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAP 188
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           E           D++S G +  E+   R P+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKN 243
           F     IG+G +G V+ G+  DN     VA+K + L       ++ + E+  + +     
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           + +  G   +     ++ EY+  G+    L        PL       I+    KGL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH 121
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                K +HRDIK++N+LL +    KL+DFG+A  L  +        +GT  ++APE   
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIK 177
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
               + ++D++S GI  +E+  G  P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNL 244
           IGEG YG V+     D  N    VA+K +    G+         E      +    H N+
Sbjct: 19  IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 245 VRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           VRL   C            LV+E++D  +L  +L  D  P   +  E   +++    +GL
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLRGL 133
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            +LH     +VVHRD+K  NIL+      KL+DFGLA++   + +   T V+ T  Y AP
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAP 188
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPV 390
           E           D++S G +  E+   R P+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 50
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 107
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 108 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 50
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 107
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 108 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++ +   ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELD-HERMSYLLYQMLV-----GIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 50
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 107
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 108 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 50
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 107
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 108 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLVRLL 248
           IGEG YG+VY          A+K +   R + E E        E+  +  ++H N+V+L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                    +LV+E++D  +L++ L    G    +T +   + +L    G+ Y H+    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SFLLQLLNGIAYCHDR--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGML 367
           +V+HRD+K  N+L++++   K++DFGLA+  G      T  V+ T  Y AP+    +   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 368 NERSDVYSFGILIMEVISG 386
           +   D++S G +  E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 32/237 (13%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL-----EDNT-NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N       +G G +G V          ED    VAVK L +     EKE    E++
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPH--------- 280
            +  + +H+N+V LLG C  G   +++ EY   G+L  +L       +GP          
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 281 ------SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
                  PL     ++     A+G+ +L        +HRD+ + N+LL      K+ DFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 335 LAKLLGAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           LA+ +  + +Y+          ++APE     +   +SDV+S+GIL+ E+ S G NP
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 260

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLVRLL 248
           IGEG YG+VY          A+K +   R + E E        E+  +  ++H N+V+L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                    +LV+E++D  +L++ L    G    +T +   + +L    G+ Y H+    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SFLLQLLNGIAYCHDR--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGML 367
           +V+HRD+K  N+L++++   K++DFGLA+  G      T  V+ T  Y AP+    +   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 368 NERSDVYSFGILIMEVISG 386
           +   D++S G +  E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLA 119
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 175 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 51
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 108
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 109 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLA 120
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 176 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLA 119
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 175 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHK 242
           F     IGEG YG+VY     +     V  L   R   E E        E+  +  + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKA--RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFC 119
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE- 360
           H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T  Y APE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEI 174
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGR 387
                Y ST +     D++S G +  E+++ R
Sbjct: 175 LLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHK 242
           F     IGEG YG+VY     +     V  L   R   E E        E+  +  + H 
Sbjct: 4   FQKVEKIGEGTYGVVYKA--RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFC 118
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE- 360
           H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEI 173
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGR 387
                Y ST +     D++S G +  E+++ R
Sbjct: 174 LLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           IGEG YG V+     E +  VA+K +    ++ G      + E+  +  ++HKN+VRL  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                    LV+E+ D  +L+++    +GD+ P      EI  + +    KGL + H   
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP------EIVKSFLFQLLKGLGFCHSR- 120
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
              V+HRD+K  N+L+++    KL++FGLA+  G      +  V+ T  Y  P+      
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 177
Query: 367 LNERS-DVYSFGILIMEVISGRNPV 390
           L   S D++S G +  E+ +   P+
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLA 120
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 176 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 4   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 110
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 54
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 55  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 111
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 112 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 168
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLA 119
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 175 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 5   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 111
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 4   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 110
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
           F+D   IG G +G VY      N+ V A+K +  +  Q+ ++++    EV  + ++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
            ++  G         LV EY   G+    L      H     E+ +  +  G  +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYL 170
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
           H      ++HRD+K+ NILL +    KL DFG A ++     +V     GT  ++APE  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 222
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
                G  + + DV+S GI  +E+   + P+
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELD-HERMSY-----LLYQMLXGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 51
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKS 108
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 109 YLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 12  FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 61
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 118
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 174 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L++++        PL   +  + +    +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLP--LIKSYLFQLLQGLA 120
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 176 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 5   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 111
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 LWYRAPEILLGXKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
           F+D   IG G +G VY      N+ V A+K +  +  Q+ ++++    EV  + ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
            ++  G         LV EY   G+    L      H     E+ +  +  G  +GL YL
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC-LGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
           H      ++HRD+K+ NILL +    KL DFG A ++     +V     GT  ++APE  
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
                G  + + DV+S GI  +E+   + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 51
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L++++        PL   +  +
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLP--LIKS 108
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 109 YLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           +GEG +G V      D TN      VAVK L  + G Q    +K E++ +  + H+++++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 247 LLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G C +   +   LV EY+  G+L  +L     P   +     +       +G+ YLH 
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 361
                 +HR++ + N+LLD     K+ DFGLAK +     Y   R  G    F Y APE 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
                    SDV+SFG+ + E+++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 5   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 111
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLVRLL 248
           IGEG YG+VY          A+K +   R + E E        E+  +  ++H N+V+L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                    +LV+E++D  +L++ L    G    +T +   + +L    G+ Y H+    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SFLLQLLNGIAYCHDR--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGML 367
           +V+HRD+K  N+L++++   K++DFGLA+  G      T  ++ T  Y AP+    +   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178
Query: 368 NERSDVYSFGILIMEVISG 386
           +   D++S G +  E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           +GEG +G V      D TN      VAVK L  + G Q    +K E++ +  + H+++++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 247 LLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G C +   +   LV EY+  G+L  +L     P   +     +       +G+ YLH 
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 361
                 +HR++ + N+LLD     K+ DFGLAK +     Y   R  G    F Y APE 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
                    SDV+SFG+ + E+++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 50
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L+ ++        PL   +  +
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLP--LIKS 107
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 108 YLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKV--EVEAIGRV 239
           ++T+ +     IG G YG VY      + + VA+K++    G+         EV  + R+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 240 R---HKNLVRLLGYCAEGAHR-----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
               H N+VRL+  CA           LV+E++D  +L  +L  D  P   L  E   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDL 117
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
           +    +GL +LH      +VHRD+K  NIL+      KL+DFGLA++   + +     V+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP--VV 172
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
            T  Y APE           D++S G +  E+   R P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 12  FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 61
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 118
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 174 LWYRAPEILLGXKYYSTAV-----DIWSLGCIFAEMVTRR 208

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 53
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L+ ++        PL   +  +
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLP--LIKS 110
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 111 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGR 238
           + + F     +G+G +G VY    E  ++  V   +  + Q EKE      + E+E    
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLA-REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAH 79
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           + H N++RL  Y  +     L+ EY   G L + L          T      I+   A  
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRT----ATIMEELADA 135
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L Y H     KV+HRDIK  N+LL  +   K++DFG +    + R      + GT  Y+ 
Sbjct: 136 LMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT---MCGTLDYLP 189
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           PE     M NE+ D++  G+L  E++ G  P +
Sbjct: 190 PEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 23/222 (10%)
Query: 183 VSTNGFADENVIGEGGYGIVYH------GVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
           ++T+ +     IG G YG VY       G      +V V N     G        EV  +
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 237 GRVR---HKNLVRLLGYCAEG-----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
            R+    H N+VRL+  CA           LV+E++D  +L  +L  D  P   L  E  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETI 122
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
            +++    +GL +LH      +VHRD+K  NIL+      KL+DFGLA++   + +   T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--T 177
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
            V+ T  Y APE           D++S G +  E+   R P+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG------ 237
           S   F     IGEG YG+VY            +N L     A K+ +++ E  G      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAI 52
Query: 238 -------RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
                   + H N+V+LL          LV+E++ + +L+ ++        PL   +  +
Sbjct: 53  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLP--LIKS 109
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTR 349
            +    +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    
Sbjct: 110 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 166
Query: 350 VMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           V  T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 V--TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKV--EVEAIGRV 239
           ++T+ +     IG G YG VY      + + VA+K++    G+         EV  + R+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 240 R---HKNLVRLLGYCAEGAHR-----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
               H N+VRL+  CA           LV+E++D  +L  +L  D  P   L  E   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDL 117
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
           +    +GL +LH      +VHRD+K  NIL+      KL+DFGLA++   + +     V+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP--VV 172
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
            T  Y APE           D++S G +  E+   R P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 31/232 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 92
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP-----------LTWEIRMN 290
           N+V LLG C + G   M++ E+   GNL  +L        P           LT E  + 
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-R 349
                AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +   V    
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                 ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 31/227 (13%)
Query: 181 LEVSTNGFADENV-----------IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRG 223
           LEV   G  D  V           +GEG +G V      D TN      VAVK L  + G
Sbjct: 15  LEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAG 73
Query: 224 -QAEKEFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPH 280
            Q    +K E++ +  + H+++++  G C  A  A   LV EY+  G+L  +L     P 
Sbjct: 74  PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PR 128
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL- 339
             +     +       +G+ YLH       +HRD+ + N+LLD     K+ DFGLAK + 
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 340 -GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
            G E   V         + APE          SDV+SFG+ + E+++
Sbjct: 186 EGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVR 240
           S   F     IGEG YG+VY    +     VA+K + L+   +      + E+  +  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H N+V+LL          LV+E++ + +L+ ++        PL   +  + +    +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLP--LIKSYLFQLLQGLA 120
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
           E      Y ST +     D++S G +  E+++ R
Sbjct: 176 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 145 ERAAGSHHGSGDQTVAAAITPEVSHLGWG---------------HWYTLRELEVSTNGFA 189
           E  A +  G+GD      +   ++HLG                  W  L    +  + F 
Sbjct: 129 ETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFL 188
Query: 190 DENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLV 245
           D  V+G GG+G V+   ++    + A K L   R +  K ++   VE + + +V H   +
Sbjct: 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFI 247
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK---GLTYL 302
             L Y  E    + +   I NG   ++   +V   +P   E R   I  TA+   GL +L
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA--IFYTAQIVSGLEHL 305
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H+     +++RD+K  N+LLD   N ++SD GLA  L A ++  T    GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                +   D ++ G+ + E+I+ R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 4   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 110
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELD-HERMSY-----LLYQMLXGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 82
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +   V   
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 4   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 110
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 32/227 (14%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 248 LGYCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                  E  D++S G ++ E++  R+ + +   PG   I Q N ++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVI 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELD-HERMSY-----LLYQMLXGIKH 134
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 82
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +   V   
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 91
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +   V   
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL-----EDNT-NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N       +G G +G V          ED    VAVK L +     EKE    E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-----DVGP-----HSPL 283
            +  + +H+N+V LLG C  G   +++ EY   G+L  +L       +  P     +S  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           +    ++     A+G+ +L        +HRD+ + N+LL      K+ DFGLA+ +  + 
Sbjct: 162 STRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 344 SYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           +Y+          ++APE     +   +SDV+S+GIL+ E+ S G NP
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 145 ERAAGSHHGSGDQTVAAAITPEVSHLGWG---------------HWYTLRELEVSTNGFA 189
           E  A +  G+GD      +   ++HLG                  W  L    +  + F 
Sbjct: 129 ETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSKYFLRFLQWKWLEAQPMGEDWFL 188
Query: 190 DENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLV 245
           D  V+G GG+G V+   ++    + A K L   R +  K ++   VE + + +V H   +
Sbjct: 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFI 247
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK---GLTYL 302
             L Y  E    + +   I NG   ++   +V   +P   E R   I  TA+   GL +L
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA--IFYTAQIVSGLEHL 305
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H+     +++RD+K  N+LLD   N ++SD GLA  L A ++  T    GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                +   D ++ G+ + E+I+ R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 145 ERAAGSHHGSGDQTVAAAITPEVSHLGWG---------------HWYTLRELEVSTNGFA 189
           E  A +  G+GD      +   ++HLG                  W  L    +  + F 
Sbjct: 129 ETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFL 188
Query: 190 DENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLV 245
           D  V+G GG+G V+   ++    + A K L   R +  K ++   VE + + +V H   +
Sbjct: 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFI 247
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK---GLTYL 302
             L Y  E    + +   I NG   ++   +V   +P   E R   I  TA+   GL +L
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA--IFYTAQIVSGLEHL 305
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H+     +++RD+K  N+LLD   N ++SD GLA  L A ++  T    GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                +   D ++ G+ + E+I+ R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 145 ERAAGSHHGSGDQTVAAAITPEVSHLGWG---------------HWYTLRELEVSTNGFA 189
           E  A +  G+GD      +   ++HLG                  W  L    +  + F 
Sbjct: 129 ETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFL 188
Query: 190 DENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLV 245
           D  V+G GG+G V+   ++    + A K L   R +  K ++   VE + + +V H   +
Sbjct: 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFI 247
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK---GLTYL 302
             L Y  E    + +   I NG   ++   +V   +P   E R   I  TA+   GL +L
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA--IFYTAQIVSGLEHL 305
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H+     +++RD+K  N+LLD   N ++SD GLA  L A ++  T    GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                +   D ++ G+ + E+I+ R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 55/238 (23%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK----------VEVE 234
            + F +  V+G+G +G V          V  +N L++R  A K+ +           EV 
Sbjct: 5   ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVM 54
Query: 235 AIGRVRH-------------KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD-VGPH 280
            +  + H             +N V+ +    + +   +  EY +NG L   +H + +   
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--- 337
               W +   I+    + L+Y+H      ++HRD+K  NI +D+  N K+ DFGLAK   
Sbjct: 115 RDEYWRLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 338 ----LLGAERSYV------TTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI 384
               +L  +   +       T  +GT  YVA E    TG  NE+ D+YS GI+  E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 6   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L++++        PL   +  + +  
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP--LIKSYLFQ 112
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y    V  T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 167
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKV--EVEAIGRV 239
           ++T+ +     IG G YG VY      + + VA+K++    G+         EV  + R+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 240 R---HKNLVRLLGYCAEGAHR-----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
               H N+VRL+  CA           LV+E++D  +L  +L  D  P   L  E   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDL 117
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
           +    +GL +LH      +VHRD+K  NIL+      KL+DFGLA++   + +     V+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--DPVV 172
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
            T  Y APE           D++S G +  E+   R P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 142
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 197
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------- 237
           F     IGEG YG+VY            +N L     A K+ +++ E  G          
Sbjct: 4   FQKVEKIGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 238 ---RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               + H N+V+LL          LV+E++ + +L+ ++        PL   +  + +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLP--LIKSYLFQ 110
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGT 353
             +GL + H     +V+HRD+K  N+L++ +   KL+DFGLA+  G   R+Y  T  + T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 354 FGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
             Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 194 IGEGGYGIVYH----GVLEDNT--NVAVKNLLNNRGQAE-----KEFKVEVEAIGRVRHK 242
           +G G +G V      G+ +  T   VAVK L      +E      E K+ +  IG   H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGH--HL 91
Query: 243 NLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP------------LTWEIRM 289
           N+V LLG C + G   M++ E+   GNL  +L        P            LT E  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT- 348
                 AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +   V   
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
                  ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           IGEG YG+V   Y  V    T VA+K +    ++   ++  + E++ + R RH+N++ + 
Sbjct: 51  IGEGAYGMVSSAYDHV--RKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIR 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                     +   YI    +E  L+  +     L+ +     +    +GL Y+H     
Sbjct: 108 DILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRGLKYIHSA--- 163
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPEYASTGM 366
            V+HRD+K SN+L++   + K+ DFGLA++   E  +    T  + T  Y APE     M
Sbjct: 164 NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI----M 219
Query: 367 LNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
           LN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 261

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPEVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 184 STNGFAD----ENVIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEA 235
           ST  F+D    + V+G+G +G   +    +      V V +    + + +KE  + EV+ 
Sbjct: 26  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 85
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           + ++ H N+++L  +  +  +  LV E    G L      ++      +      II   
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQV 141
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             G+TY+H+    K+VHRD+K  N+LL+   K  N ++ DFGL+    A +       +G
Sbjct: 142 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IG 196
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           T  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 197 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           +GEG +G V      D TN      VAVK L    G Q    ++ E+E +  + H+++V+
Sbjct: 16  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 247 LLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G C +   +   LV EY+  G+L  +L     P   +     +       +G+ YLH 
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLHA 129
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 361
                 +HR + + N+LLD     K+ DFGLAK +     Y   R  G    F Y APE 
Sbjct: 130 Q---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 185
Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
                    SDV+SFG+ + E+++
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
           +GEG +G V      D TN      VAVK L    G Q    ++ E+E +  + H+++V+
Sbjct: 17  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 247 LLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
             G C +   +   LV EY+  G+L  +L     P   +     +       +G+ YLH 
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLHA 130
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 361
                 +HR + + N+LLD     K+ DFGLAK +     Y   R  G    F Y APE 
Sbjct: 131 Q---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 186
Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
                    SDV+SFG+ + E+++
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 179
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 180 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 234
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 32/227 (14%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 248 LGYCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                  E  D++S G ++ E++  R+ + +   PG   I Q N ++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVI 238

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 248 LGYCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 193 VIGEGGYGIVYH--GVLEDNT------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           V+G+GGYG V+    V   NT       V  K ++    +     K E   +  V+H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           V L+     G    L+ EY+  G L   L   G     +   +   +++ LG      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H+     +++RD+K  NI+L+ Q + KL+DFGL K        VT    GT  Y+APE  
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                N   D +S G L+ ++++G  P
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 110/255 (43%), Gaps = 41/255 (16%)
Query: 194 IGEGGYGIV--YHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +GEGG+  V    G L D    A+K +L +  Q  +E + E +      H N++RL+ YC
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 252 --AEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
               GA     L+  +   G L   +       + LT +  + ++LG  +GL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL----LGAERSYVTTRVMG----TFGYVAP 359
               HRD+K +NILL  +  P L D G        +   R  +T +       T  Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 360 EYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSRPPG---------EVCIPQ---- 403
           E  S     +++ER+DV+S G ++  ++ G  P D     G         ++ IPQ    
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272
Query: 404 -------MNSLMTLS 411
                  +NS+MT+ 
Sbjct: 273 SSALWQLLNSMMTVD 287

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 140
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 141 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 195
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 196 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 231

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 193 VIGEGGYGIVYH--GVLEDNT------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           V+G+GGYG V+    V   NT       V  K ++    +     K E   +  V+H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           V L+     G    L+ EY+  G L   L   G     +   +   +++ LG      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H+     +++RD+K  NI+L+ Q + KL+DFGL K        VT    GT  Y+APE  
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPEIL 193
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                N   D +S G L+ ++++G  P
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 19/202 (9%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNL-LNNRGQAE----KEFKVEVEAIGRVRHKNL 244
           + +GEG +  VY    + NTN  VA+K + L +R +A+    +    E++ +  + H N+
Sbjct: 16  DFLGEGQFATVYKAR-DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           + LL      ++  LV+++++  +LE  +  +    +P   +  M   L T +GL YLH+
Sbjct: 75  IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM---LMTLQGLEYLHQ 130
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA- 362
                ++HRD+K +N+LLD+    KL+DFGLAK  G+  R+Y    V  T  Y APE   
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLF 185
Query: 363 STGMLNERSDVYSFGILIMEVI 384
              M     D+++ G ++ E++
Sbjct: 186 GARMYGVGVDMWAVGCILAELL 207

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 140
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 198 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 241

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 248 LGYCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 142
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 197
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 27  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 83
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 142
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 200 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 243

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 248 LGYCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 179
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 180 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 234
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 142
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 197
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   +  VL    NVAVK L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 30  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 86
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +H ++  H  +++     ++     G+ +
Sbjct: 87  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELD-HERMSY-----LLYQMLCGIKH 139
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+   A  +++ T  + T  Y APE 
Sbjct: 140 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPEV 194
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E++ G
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 187 GFADENVIGEGGYG-IVYHGVLEDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNL 244
            F  ++V+G G  G IVY G+  DN +VAVK +L      A++E ++  E+     H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRESD---EHPNV 80
Query: 245 VRLLGYCAEGAHRMLVYEYID--NGNLEQWLHGDVGPH---SPLTWEIRMNIILGTAKGL 299
           +R   +C E   R   Y  I+     L++++      H    P+T      ++  T  GL
Sbjct: 81  IRY--FCTE-KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT------LLQQTTSGL 131
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDK-----QWNPKLSDFGLAKLLGAERSYVTTR--VMG 352
            +LH      +VHRD+K  NIL+       +    +SDFGL K L   R   + R  V G
Sbjct: 132 AHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 353 TFGYVAPEYASTGMLNERS---DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
           T G++APE  S       +   D++S G +   VIS     + S P G+    Q N L+
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS-----EGSHPFGKSLQRQANILL 242

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 140
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 198 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 241

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLN------NRGQAEKEFKVEVEAIGRVRHKNL 244
             IG G YG+V           VA+K + N      N  +  +E K+    +   +H N+
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI----LKHFKHDNI 116
Query: 245 VRL---LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + +   L           VY  +D   +E  LH  +    PLT E     +    +GL Y
Sbjct: 117 IAIKDILRPTVPYGEFKSVYVVLDL--MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVA 358
           +H     +V+HRD+K SN+L+++    K+ DFG+A+ L    AE  Y  T  + T  Y A
Sbjct: 175 MHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 359 PEYA-STGMLNERSDVYSFGILIMEVISGRN 388
           PE   S     +  D++S G +  E+++ R 
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 33  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 89
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 148
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 149 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 206 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 140
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 198 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 241

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 28/233 (12%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLN------NRGQAEKEFKVEVEAIGRVRHKNL 244
             IG G YG+V           VA+K + N      N  +  +E K+    +   +H N+
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI----LKHFKHDNI 115
Query: 245 VRL---LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + +   L           VY  +D   +E  LH  +    PLT E     +    +GL Y
Sbjct: 116 IAIKDILRPTVPYGEFKSVYVVLDL--MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVA 358
           +H     +V+HRD+K SN+L+++    K+ DFG+A+ L    AE  Y  T  + T  Y A
Sbjct: 174 MHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 359 PEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           PE   S     +  D++S G +  E+++ R        PG+  + Q+  +M +
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-----PGKNYVHQLQLIMMV 278

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 134
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 248 LGYCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 135
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 136 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 190
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  VL  + NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 135
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 136 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 190
Query: 362 ASTGMLNERSDVYSFGILIMEVI------SGRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
           +G+G +G VY    ++   +A   ++  + + E E + VE+E +    H  +V+LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 253 EGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                 ++ E+   G ++   L  D G   P    +   ++    + L +LH     +++
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RII 131
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLA----KLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           HRD+K+ N+L+  + + +L+DFG++    K L    S++     GT  ++APE      +
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETM 186
Query: 368 NE-----RSDVYSFGILIMEVISGRNP 389
            +     ++D++S GI ++E+     P
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVY--- 203
           AAG+  G GD   A   TP +        +      + ++ +  + V+G+G +G V    
Sbjct: 21  AAGTSGGPGDHLHA---TPGM--------FVQHSTAIFSDRYKGQRVLGKGSFGEVILCK 69
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262
             +      V V +    + + +KE  + EV+ + ++ H N+++L  +  +  +  LV E
Sbjct: 70  DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 129
Query: 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322
               G L      ++      +      II     G+TY+H+    K+VHRD+K  N+LL
Sbjct: 130 VYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLL 182
Query: 323 D---KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379
           +   K  N ++ DFGL+    A +       +GT  Y+APE    G  +E+ DV+S G++
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVI 239
Query: 380 IMEVISGRNP 389
           +  ++SG  P
Sbjct: 240 LYILLSGCPP 249

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 140
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 198 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 241

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 45  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 101
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 160
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 161 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 218 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 261

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 36/251 (14%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG 237
           L+E ++         +IG+G +G VYHG       + + ++  +     K FK EV A  
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 238 RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-----DVGPHSPLTWEIRMNII 292
           + RH+N+V  +G C    H  ++        L   +       DV     +  EI     
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI----- 139
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGL---AKLLGAERSYVT 347
               KG+ YLH      ++H+D+KS N+  D   N K  ++DFGL   + +L A R    
Sbjct: 140 ---VKGMGYLH---AKGILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDK 190
Query: 348 TRVM-GTFGYVAPEY---------ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
            R+  G   ++APE                ++ SDV++ G +  E+ +   P  +   P 
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPA 248
Query: 398 EVCIPQMNSLM 408
           E  I QM + M
Sbjct: 249 EAIIWQMGTGM 259

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVY--- 203
           AAG+  G GD   A   TP +        +      + ++ +  + V+G+G +G V    
Sbjct: 22  AAGTSGGPGDHLHA---TPGM--------FVQHSTAIFSDRYKGQRVLGKGSFGEVILCK 70
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262
             +      V V +    + + +KE  + EV+ + ++ H N+++L  +  +  +  LV E
Sbjct: 71  DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 130
Query: 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322
               G L      ++      +      II     G+TY+H+    K+VHRD+K  N+LL
Sbjct: 131 VYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLL 183
Query: 323 D---KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379
           +   K  N ++ DFGL+    A +       +GT  Y+APE    G  +E+ DV+S G++
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVI 240
Query: 380 IMEVISGRNP 389
           +  ++SG  P
Sbjct: 241 LYILLSGCPP 250

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 72/132 (54%), Gaps = 9/132 (6%)
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
           +  E++D G+L+Q L         +  EI   + +   +GL YL E  + +++HRD+K S
Sbjct: 91  ICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPS 144
Query: 319 NILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
           NIL++ +   KL DFG++   G     +    +GT  Y+APE       + +SD++S G+
Sbjct: 145 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGL 201
Query: 379 LIMEVISGRNPV 390
            ++E+  GR P+
Sbjct: 202 SLVELAVGRYPI 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
           +G+G +G VY    ++   +A   ++  + + E E + VE+E +    H  +V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 253 EGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                 ++ E+   G ++   L  D G   P    +   ++    + L +LH     +++
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RII 139
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLA----KLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           HRD+K+ N+L+  + + +L+DFG++    K L    S++     GT  ++APE      +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETM 194
Query: 368 NE-----RSDVYSFGILIMEVISGRNP 389
            +     ++D++S GI ++E+     P
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 193 VIGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++G+G +G V      + +    V V N  + + +       EVE + ++ H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              + +   +V E    G L      ++      +      II     G+TY+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 310 VVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           +VHRD+K  NILL   +K  + K+ DFGL+     + + +  R+ GT  Y+APE    G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTAYYIAPE-VLRGT 198
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            +E+ DV+S G+++  ++SG  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 184 STNGFAD----ENVIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEA 235
           ST  F+D    + V+G+G +G V      +      V V +    + + +KE  + EV+ 
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           + ++ H N+++L  +  +  +  LV E    G L      ++      +      II   
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQV 135
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             G+TY+H+    K+VHRD+K  N+LL+   K  N ++ DFGL+    A +       +G
Sbjct: 136 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IG 190
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           T  Y+APE    G  +E+ DV+S G+++  ++SG  P
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHK 242
           T+G+  +  IG G Y +    + +  N   AVK +     +++++   E+E + R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHP 76
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGLTY 301
           N++ L     +G +  +V E +  G L      D         E   + +L T  K + Y
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELL-----DKILRQKFFSEREASAVLFTITKTVEY 131
Query: 302 LHEGLEPKVVHRDIKSSNIL-LDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           LH      VVHRD+K SNIL +D+  NP   ++ DFG AK L AE   + T    T  +V
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFV 187
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE       +   D++S G+L+  +++G  P
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 23  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 79
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 138
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 139 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 196 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 239

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 193 VIGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++G+G +G V      + +    V V N  + + +       EVE + ++ H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              + +   +V E    G L      ++      +      II     G+TY+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 310 VVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           +VHRD+K  NILL   +K  + K+ DFGL+     + + +  R+ GT  Y+APE    G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTAYYIAPE-VLRGT 198
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            +E+ DV+S G+++  ++SG  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 30  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 86
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 145
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 146 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 203 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 246

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 31  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 87
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 146
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 147 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 204 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 22  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 78
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 137
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 138 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 195 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 85
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 144
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 202 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 140
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 198 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 241

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 23  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 79
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 138
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 139 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 196 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 239

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 143
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++    + T  Y APE 
Sbjct: 144 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMVPFVVTRYYRAPEV 198
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                  E  D++S G ++ E+I G
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 26/232 (11%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKN 243
           + + + IGEG YG+V      DN N   VA+K +     Q   +  + E++ + R RH+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 145
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPEY 361
                 V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE 
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 362 ASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
               MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 203 ----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 85
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 144
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 202 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-----EFKVEVEAIGRVRHKNLV 245
           + +G G +G V  G  +     VAVK L  NR +        + K E++ +   RH +++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +L    +      +V EY+  G L  ++  HG V        E R  +       + Y H
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYCH 128
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
             +   VVHRD+K  N+LLD   N K++DFGL+ ++ ++  ++ T   G+  Y APE  S
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEVIS 183
Query: 364 TGML-NERSDVYSFGILIMEVISGRNPVDYSRPP 396
             +      D++S G+++  ++ G  P D    P
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 85
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH-LSNDHICYFLYQILRGLKYI 144
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 202 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 194 IGEGGYGIVYHGVLE----DNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G+G +G+V  G  +       +VAVK L   + ++ +A  +F  EV A+  + H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--------AKG 298
           L G       +M V E    G+L   L    G           + +LGT        A+G
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGY 356
           + YL      + +HRD+ + N+LL  +   K+ DFGL + L     +   +      F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            APE   T   +  SD + FG+ + E+ + G+ P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 193 VIGEGGYGIVYH---GVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++G+G +G V      + +    V V N  + + +       EVE + ++ H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              + +   +V E    G L      ++      +      II     G+TY+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 310 VVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           +VHRD+K  NILL   +K  + K+ DFGL+     + + +  R+ GT  Y+APE    G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTAYYIAPEVLR-GT 198
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            +E+ DV+S G+++  ++SG  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           E+  +  + H N+++L     +  +  LV E+ + G L + +   +  H     +   NI
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDA-ANI 151
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKLLGAERSYVTT 348
           +     G+ YLH+     +VHRDIK  NILL+ +    N K+ DFGL+      + Y   
Sbjct: 152 MKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLR 206
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
             +GT  Y+APE       NE+ DV+S G+++  ++ G  P
Sbjct: 207 DRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPP 246

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 23/235 (9%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 246 RLLGYCAEGAHRMLV-YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH- 303
           +L  +C +   ++     Y  NG L +++   +G             I+     L YLH 
Sbjct: 101 KLY-FCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHG 155
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYA 362
           +G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  
Sbjct: 156 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
           +     + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 212 TEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 263

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFK---VEVEA 235
           ++++    F    ++G+G +G V+    +  N   A+K L  +    + + +   VE   
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 236 IGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPHSPLTWEIRMN 290
           +     H  L  +        +   V EY++ G+L   +      D+   +    EI + 
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL- 130
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTT 348
                  GL +LH      +V+RD+K  NILLDK  + K++DFG+ K  +LG  +   T 
Sbjct: 131 -------GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TN 177
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
              GT  Y+APE       N   D +SFG+L+ E++ G++P 
Sbjct: 178 EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 194 IGEGGYGIVYHGVLE----DNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G+G +G+V  G  +       +VAVK L   + ++ +A  +F  EV A+  + H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--------AKG 298
           L G       +M V E    G+L   L    G           + +LGT        A+G
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 133
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT--FGY 356
           + YL      + +HRD+ + N+LL  +   K+ DFGL + L     +   +      F +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            APE   T   +  SD + FG+ + E+ + G+ P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 194 IGEGGYGIVYHGVLE----DNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G+G +G+V  G  +       +VAVK L   + ++ +A  +F  EV A+  + H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--------AKG 298
           L G       +M V E    G+L   L    G           + +LGT        A+G
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT-FGY 356
           + YL      + +HRD+ + N+LL  +   K+ DFGL + L   +  YV        F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            APE   T   +  SD + FG+ + E+ + G+ P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRH 241
           F  E  IG G +  VY    L D   VA+K     +L++ + +A+     E++ + ++ H
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLNH 91
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
            N+++      E     +V E  D G+L + +         +         +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           +H     +V+HRDIK +N+ +      KL D GL +   + ++     ++GT  Y++PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 207
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
                 N +SD++S G L+ E+ + ++P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 194 IGEGGYGIVYHGVLE----DNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G+G +G+V  G  +       +VAVK L   + ++ +A  +F  EV A+  + H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--------AKG 298
           L G       +M V E    G+L   L    G           + +LGT        A+G
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT-FGY 356
           + YL      + +HRD+ + N+LL  +   K+ DFGL + L   +  YV        F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            APE   T   +  SD + FG+ + E+ + G+ P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFK---VEVEA 235
           ++++    F    ++G+G +G V+    +  N   A+K L  +    + + +   VE   
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 236 IGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPHSPLTWEIRMN 290
           +     H  L  +        +   V EY++ G+L   +      D+   +    EI + 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL- 129
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTT 348
                  GL +LH      +V+RD+K  NILLDK  + K++DFG+ K  +LG  +   T 
Sbjct: 130 -------GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TN 176
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
              GT  Y+APE       N   D +SFG+L+ E++ G++P 
Sbjct: 177 XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA++ +    ++   ++  + E++ + R RH+
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHE 85
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 144
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 202 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 245

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 194 IGEGGYGIVYHGVLE----DNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G+G +G+V  G  +       +VAVK L   + ++ +A  +F  EV A+  + H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--------AKG 298
           L G       +M V E    G+L   L    G           + +LGT        A+G
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 127
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT-FGY 356
           + YL      + +HRD+ + N+LL  +   K+ DFGL + L   +  YV        F +
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            APE   T   +  SD + FG+ + E+ + G+ P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 194 IGEGGYGIVYHGVLE----DNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G+G +G+V  G  +       +VAVK L   + ++ +A  +F  EV A+  + H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--------AKG 298
           L G       +M V E    G+L   L    G           + +LGT        A+G
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 133
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT-FGY 356
           + YL      + +HRD+ + N+LL  +   K+ DFGL + L   +  YV        F +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            APE   T   +  SD + FG+ + E+ + G+ P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 194 IGEGGYGIVYHGVLE----DNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +G+G +G+V  G  +       +VAVK L   + ++ +A  +F  EV A+  + H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--------AKG 298
           L G       +M V E    G+L   L    G           + +LGT        A+G
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 127
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT-FGY 356
           + YL      + +HRD+ + N+LL  +   K+ DFGL + L   +  YV        F +
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            APE   T   +  SD + FG+ + E+ + G+ P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 19/233 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +L     +         Y  NG L +++   +G             I+     L YLH  
Sbjct: 99  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 154
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAST 364
               ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  + 
Sbjct: 155 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
               + SD+++ G +I ++++G  P    R   E  I Q    +   + ++FF
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPAAFF 261

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 42/222 (18%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV---RHKNLVRLL- 248
           +IG G YG VY G L D   VAVK        A ++  +  + I RV    H N+ R + 
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 249 ---GYCAEG-AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                 A+G    +LV EY  NG+L ++L           W     +     +GL YLH 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHT 129
Query: 305 GL------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--------GAERSYVTTRV 350
            L      +P + HRD+ S N+L+       +SDFGL+  L        G E +   + V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 351 MGTFGYVAPEYASTGMLNERS--------DVYSFGILIMEVI 384
            GT  Y+APE    G +N R         D+Y+ G++  E+ 
Sbjct: 190 -GTIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 119/293 (40%), Gaps = 37/293 (12%)
Query: 144 PERAAGSHHGSGDQTVAAAITPEVSHL-GWGHWYTL---RELEVSTNGFADENVIGEGGY 199
           P+ A     G    TV+ + T + + +      YT+   R+ E+          IGEG +
Sbjct: 344 PKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQF 403
Query: 200 GIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCAEG 254
           G V+ G+     N    VA+K   N    + +E F  E   + +  H ++V+L+G   E 
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463
Query: 255 AHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
               ++ E    G L  +L   V   S  L   I     L TA  L YL      + VHR
Sbjct: 464 P-VWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTA--LAYLESK---RFVHR 515
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           DI + N+L+      KL DFGL++ +     Y  ++      ++APE  +       SDV
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 374 YSFGILIMEVI-SGRNPVD----------------YSRPPGEVCIPQMNSLMT 409
           + FG+ + E++  G  P                     PP   C P + SLMT
Sbjct: 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMT 626

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 124 PASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEV 183
           P SGR R      +  +      A GS   S D+   + +T  V+  G G     R  EV
Sbjct: 2   PMSGRPRT-TSFAESCKPVQQPSAFGSMKVSRDKD-GSKVTTVVATPGQGPD---RPQEV 56
Query: 184 STNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFK-VEVEAIGRVRH 241
           S   + D  VIG G +G+VY   L D+   VA+K +L      +K FK  E++ + ++ H
Sbjct: 57  S---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDH 108
Query: 242 KNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
            N+VRL  +      +       LV +Y+         H      +     +++  +   
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQL 167
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLL---GAERSYVTTRVM 351
            + L Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ +R  
Sbjct: 168 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 223
Query: 352 GTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
               Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 224 ----YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 106/256 (41%), Gaps = 33/256 (12%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKV 231
           + R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMN 290
           E   + +  H ++V+L+G   E     ++ E    G L  +L   V  +S  L   I   
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKYSLDLASLILYA 117
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
             L TA  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++ 
Sbjct: 118 YQLSTA--LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD----------------YS 393
                ++APE  +       SDV+ FG+ + E++  G  P                    
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232
Query: 394 RPPGEVCIPQMNSLMT 409
            PP   C P + SLMT
Sbjct: 233 MPPN--CPPTLYSLMT 246

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 135
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 136 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 190
Query: 362 ASTGMLNERSDVYSFGILIMEVIS------GRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 37/293 (12%)
Query: 144 PERAAGSHHGSGDQTVAAAITPEVSHL-GWGHWYTL---RELEVSTNGFADENVIGEGGY 199
           P+ A     G    TV+ + T + + +      YT+   R+ E+          IGEG +
Sbjct: 344 PKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQF 403
Query: 200 GIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCAEG 254
           G V+ G+     N    VA+K   N    + +E F  E   + +  H ++V+L+G   E 
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463
Query: 255 AHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
               ++ E    G L  +L   V   S  L   I     L TA  L YL      + VHR
Sbjct: 464 P-VWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTA--LAYLESK---RFVHR 515
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           DI + N+L+      KL DFGL++ +     Y  ++      ++APE  +       SDV
Sbjct: 516 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 374 YSFGILIMEVI-SGRNPVDYSR----------------PPGEVCIPQMNSLMT 409
           + FG+ + E++  G  P    +                PP   C P + SLMT
Sbjct: 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMT 626

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-----EFKVEVEAIGRVRHKNLV 245
           + +G G +G V  G  E     VAVK L  NR +        + + E++ +   RH +++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKIL--NRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +L    +  +   +V EY+  G L  +    +  +  L  +    +      G+ Y H  
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDY----ICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
           +   VVHRD+K  N+LLD   N K++DFGL+ ++ ++  ++     G+  Y APE  S  
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSC-GSPNYAAPEVISGR 190
Query: 366 ML-NERSDVYSFGILIMEVISGRNPVDYSRPP 396
           +      D++S G+++  ++ G  P D    P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 146
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE 
Sbjct: 147 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 201
Query: 362 ASTGMLNERSDVYSFGILIMEVIS------GRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 237

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHK 242
           T+G+  +  IG G Y +    + +  N   AVK +     +++++   E+E + R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKII----DKSKRDPTEEIEILLRYGQHP 76
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT-AKGLTY 301
           N++ L     +G +  +V E    G L      D         E   + +L T  K + Y
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELL-----DKILRQKFFSEREASAVLFTITKTVEY 131
Query: 302 LHEGLEPKVVHRDIKSSNIL-LDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           LH      VVHRD+K SNIL +D+  NP   ++ DFG AK L AE   + T    T  +V
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFV 187
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE       +   D++S G+L+   ++G  P
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 106/256 (41%), Gaps = 33/256 (12%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKV 231
           + R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMN 290
           E   + +  H ++V+L+G   E     ++ E    G L  +L   V  +S  L   I   
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKYSLDLASLILYA 119
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
             L TA  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++ 
Sbjct: 120 YQLSTA--LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 174
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD----------------YS 393
                ++APE  +       SDV+ FG+ + E++  G  P                    
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 234
Query: 394 RPPGEVCIPQMNSLMT 409
            PP   C P + SLMT
Sbjct: 235 MPPN--CPPTLYSLMT 248

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 105/254 (41%), Gaps = 33/254 (12%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEV 233
           R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMNII 292
             + +  H ++V+L+G   E     ++ E    G L  +L   V  +S  L   I     
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQ 119
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
           L TA  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++   
Sbjct: 120 LSTA--LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD----------------YSRP 395
              ++APE  +       SDV+ FG+ + E++  G  P                     P
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 234
Query: 396 PGEVCIPQMNSLMT 409
           P   C P + SLMT
Sbjct: 235 PN--CPPTLYSLMT 246

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 55/238 (23%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK----------VEVE 234
            + F +  V+G+G +G V          V  +N L++R  A K+ +           EV 
Sbjct: 5   ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVM 54
Query: 235 AIGRVRH-------------KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD-VGPH 280
            +  + H             +N V+ +    + +   +  EY +N  L   +H + +   
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ 114
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--- 337
               W +   I+    + L+Y+H      ++HRD+K  NI +D+  N K+ DFGLAK   
Sbjct: 115 RDEYWRLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 338 ----LLGAERSYV------TTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI 384
               +L  +   +       T  +GT  YVA E    TG  NE+ D+YS GI+  E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 15/230 (6%)
Query: 183 VSTNGFADENVIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVR 240
           ++ + +  + VIG G   +V           VA+K +   + Q    E   E++A+ +  
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV--GPHSP--LTWEIRMNIILGTA 296
           H N+V             LV + +  G++   +   V  G H    L       I+    
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA----ERSYVTTRVMG 352
           +GL YLH+  +   +HRD+K+ NILL +  + +++DFG++  L       R+ V    +G
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 353 TFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCI 401
           T  ++APE        + ++D++SFGI  +E+ +G  P  +  PP +V +
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYPPMKVLM 232

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 106/256 (41%), Gaps = 33/256 (12%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKV 231
           + R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMN 290
           E   + +  H ++V+L+G   E     ++ E    G L  +L   V  +S  L   I   
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKYSLDLASLILYA 122
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
             L TA  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++ 
Sbjct: 123 YQLSTA--LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD----------------YS 393
                ++APE  +       SDV+ FG+ + E++  G  P                    
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237
Query: 394 RPPGEVCIPQMNSLMT 409
            PP   C P + SLMT
Sbjct: 238 MPPN--CPPTLYSLMT 251

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 106/256 (41%), Gaps = 33/256 (12%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKV 231
           + R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMN 290
           E   + +  H ++V+L+G   E     ++ E    G L  +L   V  +S  L   I   
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKYSLDLASLILYA 145
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
             L TA  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++ 
Sbjct: 146 YQLSTA--LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 200
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD----------------YS 393
                ++APE  +       SDV+ FG+ + E++  G  P                    
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 260
Query: 394 RPPGEVCIPQMNSLMT 409
            PP   C P + SLMT
Sbjct: 261 MPPN--CPPTLYSLMT 274

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 72
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 73  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 128
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 129 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 235

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 127
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 128 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 70
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 71  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 126
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 127 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 233

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 15/230 (6%)
Query: 183 VSTNGFADENVIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVR 240
           ++ + +  + VIG G   +V           VA+K +   + Q    E   E++A+ +  
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV--GPHSP--LTWEIRMNIILGTA 296
           H N+V             LV + +  G++   +   V  G H    L       I+    
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA----ERSYVTTRVMG 352
           +GL YLH+  +   +HRD+K+ NILL +  + +++DFG++  L       R+ V    +G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 353 TFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCI 401
           T  ++APE        + ++D++SFGI  +E+ +G  P  +  PP +V +
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYPPMKVLM 237

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 77
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 78  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 133
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 134 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 240

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 73
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 74  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 129
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 130 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 236

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 106/256 (41%), Gaps = 33/256 (12%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKV 231
           + R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMN 290
           E   + +  H ++V+L+G   E     ++ E    G L  +L   V  +S  L   I   
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKYSLDLASLILYA 120
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
             L TA  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++ 
Sbjct: 121 YQLSTA--LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 175
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI-SGRNPVD----------------YS 393
                ++APE  +       SDV+ FG+ + E++  G  P                    
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 235
Query: 394 RPPGEVCIPQMNSLMT 409
            PP   C P + SLMT
Sbjct: 236 MPPN--CPPTLYSLMT 249

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 148
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 255

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
               ++ SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 258

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 256

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 148
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 255

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 256

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 152
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 153 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 259

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 256

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 258

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 152
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 153 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 259

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G+G YG V+ G  +   NVAVK + ++R +     + E+     +RH+N++  +     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 254 GAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--- 306
             H      L+  Y + G+L  +L       + L     + I+L  A GL +LH  +   
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 307 --EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT----RVMGTFGYVAPE 360
             +P + HRD+KS NIL+ K     ++D GLA +     + +      RV GT  Y+APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPE 187
Query: 361 YASTGMLNE------RSDVYSFGILIMEV---ISGRNPVDYSRPPGEVCIP 402
                +  +      R D+++FG+++ EV   +     V+  +PP    +P
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLVRLL 248
           +GEG YG+VY         VA+K +   R  AE E        E+  +  + H N+V L+
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                     LV+E+++  +L++ L  +         +I +  +L   +G+ + H+    
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH--- 138
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE-YASTGM 366
           +++HRD+K  N+L++     KL+DFGLA+  G   RSY  T  + T  Y AP+    +  
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKK 196
Query: 367 LNERSDVYSFGILIMEVISGR 387
            +   D++S G +  E+I+G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
            VIG+G + +V   +  E     AVK        ++ G + ++ K E      ++H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNL--EQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYL 302
            LL   +      +V+E++D  +L  E     D G  +S       M  IL   + L Y 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYC 146
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           H+     ++HRD+K  N+LL  + N    KL DFG+A  LG E   V    +GT  ++AP
Sbjct: 147 HDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG-ESGLVAGGRVGTPHFMAP 202
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNP 389
           E        +  DV+  G+++  ++SG  P
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G+G YG V+ G  +   NVAVK + ++R +     + E+     +RH+N++  +     
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 254 GAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--- 306
             H      L+  Y + G+L  +L       + L     + I+L  A GL +LH  +   
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 307 --EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT----RVMGTFGYVAPE 360
             +P + HRD+KS NIL+ K     ++D GLA +     + +      RV GT  Y+APE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPE 216
Query: 361 YASTGMLNE------RSDVYSFGILIMEV---ISGRNPVDYSRPPGEVCIP 402
                +  +      R D+++FG+++ EV   +     V+  +PP    +P
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 267

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 109/240 (45%), Gaps = 43/240 (17%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNL----------------------- 218
           V  N +  ++ IG+G YG+V     E DNT  A+K L                       
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 219 ----LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYEYIDNGNLEQW 272
               +  RG  E+ ++ E+  + ++ H N+V+L+    +    H  +V+E ++ G + + 
Sbjct: 70  PGGCIQPRGPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME- 127
Query: 273 LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332
               V    PL+ +          KG+ YLH     K++HRDIK SN+L+ +  + K++D
Sbjct: 128 ----VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNP 389
           FG++       + ++  V GT  ++APE  S        +  DV++ G+ +   + G+ P
Sbjct: 181 FGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 258

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G+G YG V+ G  +   NVAVK + ++R +     + E+     +RH+N++  +     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 254 GAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--- 306
             H      L+  Y + G+L  +L       + L     + I+L  A GL +LH  +   
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 307 --EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT----RVMGTFGYVAPE 360
             +P + HRD+KS NIL+ K     ++D GLA +     + +      RV GT  Y+APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPE 187
Query: 361 YASTGMLNE------RSDVYSFGILIMEV---ISGRNPVDYSRPPGEVCIP 402
                +  +      R D+++FG+++ EV   +     V+  +PP    +P
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 85
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 144
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +       + T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 202 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 245

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 30  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 86
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 145
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +       + T  Y APE
Sbjct: 146 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 203 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 246

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  +  +RH N++ L          +L+ E +  G L  +L      
Sbjct: 53  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AE 108
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI-LLDKQW-NP--KLSDFGL 335
              LT +     +     G+ YLH     ++ H D+K  NI LLDK   NP  KL DFG+
Sbjct: 109 KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  + A   +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 166 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLVRLL 248
           +GEG YG+VY         VA+K +   R  AE E        E+  +  + H N+V L+
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                     LV+E+++  +L++ L  +         +I +  +L   +G+ + H+    
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH--- 138
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE-YASTGM 366
           +++HRD+K  N+L++     KL+DFGLA+  G   RSY  T  + T  Y AP+    +  
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKK 196
Query: 367 LNERSDVYSFGILIMEVISGR 387
            +   D++S G +  E+I+G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 184 STNGFAD----ENVIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEA 235
           ST  F+D    + V+G+G +G V      +      V V +    + + +KE  + EV+ 
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           + ++ H N+ +L  +  +  +  LV E    G L      ++      +      II   
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQV 135
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             G+TY H+    K+VHRD+K  N+LL+   K  N ++ DFGL+    A +       +G
Sbjct: 136 LSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--XKDKIG 190
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           T  Y+APE    G  +E+ DV+S G+++  ++SG  P
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  +  +RH N++ L          +L+ E +  G L  +L      
Sbjct: 46  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AE 101
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI-LLDKQW-NP--KLSDFGL 335
              LT +     +     G+ YLH     ++ H D+K  NI LLDK   NP  KL DFG+
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  + A   +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 159 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ +   RH+
Sbjct: 27  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHE 83
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 142
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 200 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 243

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +L     +         Y  NG L +++   +G             I+     L YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAST 364
               ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  + 
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
               + SD+++ G +I ++++G  P
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 114/237 (48%), Gaps = 36/237 (15%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ + R RH+
Sbjct: 45  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 101
Query: 243 NLVRL----LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           N++ +         E    + +  ++   +L + L      +  + +      +    +G
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY-----FLYQILRG 156
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGY 356
           L Y+H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y
Sbjct: 157 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 213
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
            APE     MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 214 RAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 261

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  +  +RH N++ L          +L+ E +  G L  +L      
Sbjct: 67  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AE 122
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI-LLDKQW-NP--KLSDFGL 335
              LT +     +     G+ YLH     ++ H D+K  NI LLDK   NP  KL DFG+
Sbjct: 123 KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 179
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  + A   +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 180 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 104/254 (40%), Gaps = 33/254 (12%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEV 233
           R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMNII 292
             + +  H ++V+L+G   E     ++ E    G L  +L   V   S  L   I     
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQ 119
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
           L TA  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++   
Sbjct: 120 LSTA--LAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD----------------YSRP 395
              ++APE  +       SDV+ FG+ + E++  G  P                     P
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 234
Query: 396 PGEVCIPQMNSLMT 409
           P   C P + SLMT
Sbjct: 235 PN--CPPTLYSLMT 246

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-----EFKVEVEAIGRVRHKNLV 245
           + +G G +G V  G  +     VAVK L  NR +        + K E++ +   RH +++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +L    +      +V EY+  G L  ++  HG V        E R  +       + Y H
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYCH 128
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
             +   VVHRD+K  N+LLD   N K++DFGL+ ++ ++  ++     G+  Y APE  S
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSC-GSPNYAAPEVIS 183
Query: 364 TGML-NERSDVYSFGILIMEVISGRNPVDYSRPP 396
             +      D++S G+++  ++ G  P D    P
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 30/250 (12%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR 240
           + ++ N F+   +IG GG+G VY     D   +     L+ +    K+   E  A+    
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERI 240
Query: 241 HKNLVR--------LLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRM- 289
             +LV          + Y      ++  + + ++ G+L    H  +  H   +  ++R  
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFY 296
Query: 290 --NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
              IILG    L ++H      VV+RD+K +NILLD+  + ++SD GLA     ++ + +
Sbjct: 297 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 349
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNS 406
              +GT GY+APE    G+  + S D +S G ++ +++ G +P    +   +  I +M  
Sbjct: 350 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406
Query: 407 LMTLSYCSSF 416
            M +    SF
Sbjct: 407 TMAVELPDSF 416

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +  +V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +L     +         Y  NG L +++   +G             I+     L YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAST 364
               ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  + 
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
               + SD+++ G +I ++++G  P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL 248
           IGEG +G V+ G+     N    VA+K   N    + +E F  E   + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMNIILGTAKGLTYLHEGLE 307
           G   E     ++ E    G L  +L   V  +S  L   I     L TA  L YL     
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTA--LAYLESK-- 127
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
            + VHRDI + N+L+      KL DFGL++ +     Y  ++      ++APE  +    
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 368 NERSDVYSFGILIMEVIS-GRNPVD----------------YSRPPGEVCIPQMNSLMT 409
              SDV+ FG+ + E++  G  P                     PP   C P + SLMT
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMT 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 28/233 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNL--LNNRGQAEKEFKVEVEAIGRVRHK 242
           + + + IGEG YG+V      DN N   VA+K +    ++   ++  + E++ +   RH+
Sbjct: 27  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHE 83
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   YI    +E  L+  +     L+ +     +    +GL Y+
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYI 142
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 361 YASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLM 408
                MLN +      D++S G ++ E++S R P+     PG+  + Q+N ++
Sbjct: 200 I----MLNSKGYTKSIDIWSVGCILAEMLSNR-PIF----PGKHYLDQLNHIL 243

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 30/250 (12%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR 240
           + ++ N F+   +IG GG+G VY     D   +     L+ +    K+   E  A+    
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERI 241
Query: 241 HKNLVR--------LLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRM- 289
             +LV          + Y      ++  + + ++ G+L    H  +  H   +  ++R  
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFY 297
Query: 290 --NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
              IILG    L ++H      VV+RD+K +NILLD+  + ++SD GLA     ++ + +
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNS 406
              +GT GY+APE    G+  + S D +S G ++ +++ G +P    +   +  I +M  
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 407 LMTLSYCSSF 416
            M +    SF
Sbjct: 408 TMAVELPDSF 417

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 30/250 (12%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR 240
           + ++ N F+   +IG GG+G VY     D   +     L+ +    K+   E  A+    
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERI 241
Query: 241 HKNLVR--------LLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRM- 289
             +LV          + Y      ++  + + ++ G+L    H  +  H   +  ++R  
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFY 297
Query: 290 --NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
              IILG    L ++H      VV+RD+K +NILLD+  + ++SD GLA     ++ + +
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNS 406
              +GT GY+APE    G+  + S D +S G ++ +++ G +P    +   +  I +M  
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 407 LMTLSYCSSF 416
            M +    SF
Sbjct: 408 TMAVELPDSF 417

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 30/250 (12%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR 240
           + ++ N F+   +IG GG+G VY     D   +     L+ +    K+   E  A+    
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERI 241
Query: 241 HKNLVR--------LLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRM- 289
             +LV          + Y      ++  + + ++ G+L    H  +  H   +  ++R  
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFY 297
Query: 290 --NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
              IILG    L ++H      VV+RD+K +NILLD+  + ++SD GLA     ++ + +
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNS 406
              +GT GY+APE    G+  + S D +S G ++ +++ G +P    +   +  I +M  
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 407 LMTLSYCSSF 416
            M +    SF
Sbjct: 408 TMAVELPDSF 417

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 21/234 (8%)
Query: 192 NVIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
            ++GEG +   V    L  +   A+K L   +    KE KV     E + + R+ H   V
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-E 304
           +L     +         Y  NG L +++   +G             I+     L YLH +
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS 363
           G    ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSSFF 417
                + SD+++ G +I ++++G  P    R   E  I Q    +   +   FF
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLEYDFPEKFF 256

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +  IG+G +G V+ G       VAVK + ++R +     + E+     +RH+N+   LG+
Sbjct: 9   QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 63
Query: 251 CAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPL---------TWEIRMNIILGTAKGLT 300
            A         +  DNG   Q WL  D   H  L         T E  + + L TA GL 
Sbjct: 64  IAA--------DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 115
Query: 301 YLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT---TRVMG 352
           +LH  +     +P + HRD+KS NIL+ K     ++D GLA    +    +       +G
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 175
Query: 353 TFGYVAPEYA--STGMLN----ERSDVYSFGILIMEV 383
           T  Y+APE    S  M +    +R+D+Y+ G++  E+
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 36/255 (14%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
           A GS   S D+   + +T  V+  G G     R  EVS   + D  VIG G +G+VY   
Sbjct: 16  AFGSMKVSRDKD-GSKVTTVVATPGQGPD---RPQEVS---YTDTKVIGNGSFGVVYQAK 68
Query: 207 LEDNTN-VAVKNLLNNRGQAEKEFK-VEVEAIGRVRHKNLVRLLGYCAEGAHRM------ 258
           L D+   VA+K +L      +K FK  E++ + ++ H N+VRL  +      +       
Sbjct: 69  LCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 123
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
           LV +Y+         H      +     +++  +    + L Y+H      + HRDIK  
Sbjct: 124 LVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQ 179
Query: 319 NILLDKQWNP-KLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPE--YASTGMLNERSD 372
           N+LLD      KL DFG AK L       SY+ +R      Y APE  + +T   +   D
Sbjct: 180 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-ID 233
Query: 373 VYSFGILIMEVISGR 387
           V+S G ++ E++ G+
Sbjct: 234 VWSAGCVLAELLLGQ 248

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +  IG+G +G V+ G       VAVK + ++R +     + E+     +RH+N+   LG+
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 62
Query: 251 CAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPL---------TWEIRMNIILGTAKGLT 300
            A            DNG   Q WL  D   H  L         T E  + + L TA GL 
Sbjct: 63  IAADNK--------DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 114
Query: 301 YLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT---TRVMG 352
           +LH  +     +P + HRD+KS NIL+ K     ++D GLA    +    +       +G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 353 TFGYVAPEYA--STGMLN----ERSDVYSFGILIMEV 383
           T  Y+APE    S  M +    +R+D+Y+ G++  E+
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 125 ASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVS 184
           +SGR R      +  +      A GS   S D+   + +T  V+  G G     R  EVS
Sbjct: 5   SSGRPRT-TSFAESCKPVQQPSAFGSMKVSRDKD-GSKVTTVVATPGQGPD---RPQEVS 59
Query: 185 TNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFK-VEVEAIGRVRHK 242
              + D  VIG G +G+VY   L D+   VA+K +L      +K FK  E++ + ++ H 
Sbjct: 60  ---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 111
Query: 243 NLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           N+VRL  +      +       LV +Y+         H      +     +++  +    
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF 170
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLL---GAERSYVTTRVMG 352
           + L Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ +R   
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 353 TFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
              Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 226 ---YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 258

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++    + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMEPEVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVIS------GRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYID 232

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 36/255 (14%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
           A GS   S D+   + +T  V+  G G     R  EVS   + D  VIG G +G+VY   
Sbjct: 22  AFGSMKVSRDKD-GSKVTTVVATPGQGPD---RPQEVS---YTDTKVIGNGSFGVVYQAK 74
Query: 207 LEDNTN-VAVKNLLNNRGQAEKEFK-VEVEAIGRVRHKNLVRLLGYCAEGAHRM------ 258
           L D+   VA+K +L      +K FK  E++ + ++ H N+VRL  +      +       
Sbjct: 75  LCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
           LV +Y+         H      +     +++  +    + L Y+H      + HRDIK  
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQ 185
Query: 319 NILLDKQWNP-KLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPE--YASTGMLNERSD 372
           N+LLD      KL DFG AK L       SY+ +R      Y APE  + +T   +   D
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-ID 239
Query: 373 VYSFGILIMEVISGR 387
           V+S G ++ E++ G+
Sbjct: 240 VWSAGCVLAELLLGQ 254

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +  IG+G +G V+ G       VAVK + ++R +     + E+     +RH+N+   LG+
Sbjct: 14  QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 68
Query: 251 CAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPL---------TWEIRMNIILGTAKGLT 300
            A         +  DNG   Q WL  D   H  L         T E  + + L TA GL 
Sbjct: 69  IAA--------DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 120
Query: 301 YLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT---TRVMG 352
           +LH  +     +P + HRD+KS NIL+ K     ++D GLA    +    +       +G
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 180
Query: 353 TFGYVAPEYA--STGMLN----ERSDVYSFGILIMEV 383
           T  Y+APE    S  M +    +R+D+Y+ G++  E+
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +  IG+G +G V+ G       VAVK + ++R +     + E+     +RH+N+   LG+
Sbjct: 11  QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 65
Query: 251 CAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPL---------TWEIRMNIILGTAKGLT 300
            A         +  DNG   Q WL  D   H  L         T E  + + L TA GL 
Sbjct: 66  IAA--------DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 117
Query: 301 YLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT---TRVMG 352
           +LH  +     +P + HRD+KS NIL+ K     ++D GLA    +    +       +G
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 177
Query: 353 TFGYVAPEYA--STGMLN----ERSDVYSFGILIMEV 383
           T  Y+APE    S  M +    +R+D+Y+ G++  E+
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +  IG+G +G V+ G       VAVK + ++R +     + E+     +RH+N+   LG+
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 101
Query: 251 CAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPL---------TWEIRMNIILGTAKGLT 300
            A            DNG   Q WL  D   H  L         T E  + + L TA GL 
Sbjct: 102 IAADNK--------DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153
Query: 301 YLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT---TRVMG 352
           +LH  +     +P + HRD+KS NIL+ K     ++D GLA    +    +       +G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 353 TFGYVAPEYA--STGMLN----ERSDVYSFGILIMEV 383
           T  Y+APE    S  M +    +R+D+Y+ G++  E+
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +  IG+G +G V+ G       VAVK + ++R +     + E+     +RH+N+   LG+
Sbjct: 34  QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 88
Query: 251 CAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPL---------TWEIRMNIILGTAKGLT 300
            A         +  DNG   Q WL  D   H  L         T E  + + L TA GL 
Sbjct: 89  IAA--------DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 140
Query: 301 YLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT---TRVMG 352
           +LH  +     +P + HRD+KS NIL+ K     ++D GLA    +    +       +G
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 200
Query: 353 TFGYVAPEYA--STGMLN----ERSDVYSFGILIMEV 383
           T  Y+APE    S  M +    +R+D+Y+ G++  E+
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 192 NVIGEGGYGIVY--HGVLEDNT------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
            V+G+G +G V+    V   ++       V  K  L  R +     K+E + +  V H  
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT--KMERDILADVNHPF 91
Query: 244 LVRL-LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           +V+L   +  EG    L+ +++  G+L   L  +V      T E     +   A GL +L
Sbjct: 92  VVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALGLDHL 146
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H      +++RD+K  NILLD++ + KL+DFGL+K    +         GT  Y+APE  
Sbjct: 147 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
           +    +  +D +S+G+L+ E+++G  P
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   +  VL    NVAVK L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     LV E +D  NL Q +H ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+   A  +++ T  + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
                     D++S G ++ E++ G
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 16/180 (8%)
Query: 213 VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQW 272
           +A K L    G  E E  V    + +++H N+V L      G H  L+ + +  G L   
Sbjct: 51  IAKKALEGKEGSMENEIAV----LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL--- 103
Query: 273 LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL---LDKQWNPK 329
               +      T      +I      + YLH+     +VHRD+K  N+L   LD+     
Sbjct: 104 -FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           +SDFGL+K+   +   V +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 160 ISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           IG+G YG V+ G       VAVK       +A    + E+     +RH+N++  +    +
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 254 GA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--- 306
           G        L+ +Y +NG+L  +L       + L  +  + +   +  GL +LH  +   
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 307 --EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV----TTRVMGTFGYVAPE 360
             +P + HRD+KS NIL+ K     ++D GLA    ++ + V     TRV GT  Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPE 216
Query: 361 YASTGMLNER------SDVYSFGILIMEV----ISGRNPVDYSRP 395
                +          +D+YSFG+++ EV    +SG    +Y  P
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 36/255 (14%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
           A GS   S D+   + +T  V+  G G     R  EVS   + D  VIG G +G+VY   
Sbjct: 67  AFGSMKVSRDKD-GSKVTTVVATPGQGPD---RPQEVS---YTDTKVIGNGSFGVVYQAK 119
Query: 207 LEDNTN-VAVKNLLNNRGQAEKEFK-VEVEAIGRVRHKNLVRLLGYCAEGAHRM------ 258
           L D+   VA+K +L      +K FK  E++ + ++ H N+VRL  +      +       
Sbjct: 120 LCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 174
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
           LV +Y+         H      +     +++  +    + L Y+H      + HRDIK  
Sbjct: 175 LVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQ 230
Query: 319 NILLDKQWNP-KLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPE--YASTGMLNERSD 372
           N+LLD      KL DFG AK L       SY+ +R      Y APE  + +T   +   D
Sbjct: 231 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-ID 284
Query: 373 VYSFGILIMEVISGR 387
           V+S G ++ E++ G+
Sbjct: 285 VWSAGCVLAELLLGQ 299

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLGY 250
           IG G +  VY G+  + T       L +R   + E   FK E E +  ++H N+VR    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 251 ---CAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                +G   + LV E   +G L+ +L            ++  +      KGL +LH   
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKR----FKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 307 EPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
            P ++HRD+K  NI +     + K+ D GLA L   +R+     V+GT  + APE     
Sbjct: 150 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXYEE- 204
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             +E  DVY+FG   +E  +   P
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 13/161 (8%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           E+  + +++H+N+V L        H  LV + +  G L   +  + G ++     + +  
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL-ERGVYTEKDASLVIQQ 114
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNIL-LDKQWNPKL--SDFGLAKLLGAERSYVTT 348
           +L   K   YLHE     +VHRD+K  N+L L  + N K+  +DFGL+K+   E++ + +
Sbjct: 115 VLSAVK---YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMS 165
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
              GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 29/160 (18%)
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           + L+G CAE               L++ + G      P+   I   + +   K L YL E
Sbjct: 103 MELMGTCAE--------------KLKKRMQG------PIPERILGKMTVAIVKALYYLKE 142
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY--- 361
             +  V+HRD+K SNILLD++   KL DFG++  L  +++    R  G   Y+APE    
Sbjct: 143 --KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDP 198
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
              +    + R+DV+S GI ++E+ +G+ P    +   EV
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N  +    +G G +G V     +G+++ +    VAVK L  +    E+E    E++
Sbjct: 35  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 94
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD-----VGPHSPLTWEIR 288
            +  +  H N+V LLG C  G   +++ EY   G+L  +L            SP   E  
Sbjct: 95  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 289 M---------NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
                     +     AKG+ +L        +HRD+ + NILL      K+ DFGLA+ +
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 340 GAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
             + +YV          ++APE     +    SDV+S+GI + E+ S G +P
Sbjct: 212 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 13/235 (5%)
Query: 158 TVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKN 217
           +V A+  P  + L   +W      +  ++ F  E+ +G G   IVY    +         
Sbjct: 25  SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84
Query: 218 LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
           +L  +   +K  + E+  + R+ H N+++L           LV E +  G L   +  + 
Sbjct: 85  VLK-KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-EK 142
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFG 334
           G +S       +  IL   + + YLHE     +VHRD+K  N+L          K++DFG
Sbjct: 143 GYYSERDAADAVKQIL---EAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           L+K++  E   +   V GT GY APE           D++S GI+   ++ G  P
Sbjct: 197 LSKIV--EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           IG G  GIV   Y  +LE   NVA+K L     N+  A++ ++ E+  +  V HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           L          E     +V E +D  NL Q +  ++  H  +++     ++     G+ +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
           LH      ++HRD+K SNI++      K+ DFGLA+  G   S++    + T  Y APE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMEPEVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVIS------GRNPVD 391
                  E  D++S G ++ E++       GR+ +D
Sbjct: 197 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 232

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N  +    +G G +G V     +G+++ +    VAVK L  +    E+E    E++
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD-----VGPHSPLTWEIR 288
            +  +  H N+V LLG C  G   +++ EY   G+L  +L            SP   E  
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 289 M---------NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
                     +     AKG+ +L        +HRD+ + NILL      K+ DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 340 GAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
             + +YV          ++APE     +    SDV+S+GI + E+ S G +P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 29  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 81
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 82  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 140
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLL---GAERSYVT 347
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ 
Sbjct: 141 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197
Query: 348 TRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           +R      Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 198 SRY-----YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 233

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 16  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 68
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 127
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLL---GAERSYVT 347
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ 
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 348 TRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           +R      Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 185 SRY-----YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 194 IGEGGYGIVYHGV--LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +GEG Y  VY G   L DN  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
                   LV+EY+D  +L+Q+L  D G  + +        +    +GL Y H     KV
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYL-DDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLN 368
           +HRD+K  N+L++++   KL+DFGLA+            V+ T  Y  P+    ST   +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDY-S 179
Query: 369 ERSDVYSFGILIMEVISGR 387
            + D++  G +  E+ +GR
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 194 IGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFK----VEVEAIGRVRHKNLVR 246
           +GEG +G   + YH        VA+K ++N +  A+ + +     E+  +  +RH ++++
Sbjct: 22  LGEGSFGKVKLAYHTT--TGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           L          ++V EY  N   +  +  D      ++ +            + Y H   
Sbjct: 79  LYDVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH- 132
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
             K+VHRD+K  N+LLD+  N K++DFGL+ ++  + +++ T   G+  Y APE  S  +
Sbjct: 133 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKL 188
Query: 367 L-NERSDVYSFGILIMEVISGRNPVDYSRPP 396
                 DV+S G+++  ++  R P D    P
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDESIP 219

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 194 IGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFK----VEVEAIGRVRHKNLVR 246
           +GEG +G   + YH        VA+K ++N +  A+ + +     E+  +  +RH ++++
Sbjct: 21  LGEGSFGKVKLAYHTT--TGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           L          ++V EY  N   +  +  D      ++ +            + Y H   
Sbjct: 78  LYDVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH- 131
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
             K+VHRD+K  N+LLD+  N K++DFGL+ ++  + +++ T   G+  Y APE  S  +
Sbjct: 132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKL 187
Query: 367 L-NERSDVYSFGILIMEVISGRNPVDYSRPP 396
                 DV+S G+++  ++  R P D    P
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRL 247
           +V+G G +  V   + ED      VA+K +     +  E   + E+  + +++H N+V L
Sbjct: 24  DVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                 G H  L+ + +  G L       +      T      +I      + YLH+   
Sbjct: 82  DDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD--- 134
Query: 308 PKVVHRDIKSSNIL---LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             +VHRD+K  N+L   LD+     +SDFGL+K+   +   V +   GT GYVAPE  + 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              ++  D +S G++   ++ G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 194 IGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFK----VEVEAIGRVRHKNLVR 246
           +GEG +G   + YH        VA+K ++N +  A+ + +     E+  +  +RH ++++
Sbjct: 12  LGEGSFGKVKLAYHTT--TGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           L          ++V EY  N   +  +  D      ++ +            + Y H   
Sbjct: 69  LYDVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH- 122
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
             K+VHRD+K  N+LLD+  N K++DFGL+ ++  + +++ T   G+  Y APE  S  +
Sbjct: 123 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKL 178
Query: 367 L-NERSDVYSFGILIMEVISGRNPVDYSRPP 396
                 DV+S G+++  ++  R P D    P
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESIP 209

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L  +    +E ++    + 
Sbjct: 16  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQI----MR 68
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 127
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLL---GAERSYVT 347
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ 
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 348 TRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           +R      Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 185 SRY-----YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N  +    +G G +G V     +G+++ +    VAVK L  +    E+E    E++
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD-----VGPHSPLTWEIR 288
            +  +  H N+V LLG C  G   +++ EY   G+L  +L            SP   E  
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 289 M---------NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
                     +     AKG+ +L        +HRD+ + NILL      K+ DFGLA+ +
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHI 218
Query: 340 GAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
             + +YV          ++APE     +    SDV+S+GI + E+ S G +P
Sbjct: 219 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N  +    +G G +G V     +G+++ +    VAVK L  +    E+E    E++
Sbjct: 37  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 96
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD-----VGPHSPLTWEIR 288
            +  +  H N+V LLG C  G   +++ EY   G+L  +L            SP   E  
Sbjct: 97  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 289 M---------NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
                     +     AKG+ +L        +HRD+ + NILL      K+ DFGLA+ +
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 213
Query: 340 GAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
             + +YV          ++APE     +    SDV+S+GI + E+ S G +P
Sbjct: 214 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L  +    +E ++    + 
Sbjct: 16  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQI----MR 68
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 127
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLL---GAERSYVT 347
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ 
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 348 TRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           +R      Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 185 SRY-----YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 21  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 73
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 74  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 132
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLL---GAERSYVT 347
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ 
Sbjct: 133 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189
Query: 348 TRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           +R      Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 190 SRY-----YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 225

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 194 IGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFK----VEVEAIGRVRHKNLVR 246
           +GEG +G   + YH        VA+K ++N +  A+ + +     E+  +  +RH ++++
Sbjct: 16  LGEGSFGKVKLAYHTT--TGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           L          ++V EY  N   +  +  D      ++ +            + Y H   
Sbjct: 73  LYDVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH- 126
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
             K+VHRD+K  N+LLD+  N K++DFGL+ ++  + +++ T   G+  Y APE  S  +
Sbjct: 127 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKL 182
Query: 367 L-NERSDVYSFGILIMEVISGRNPVDYSRPP 396
                 DV+S G+++  ++  R P D    P
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDESIP 213

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRL 247
           +V+G G +  V   + ED      VA+K +     +  E   + E+  + +++H N+V L
Sbjct: 24  DVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                 G H  L+ + +  G L       +      T      +I      + YLH+   
Sbjct: 82  DDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD--- 134
Query: 308 PKVVHRDIKSSNIL---LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             +VHRD+K  N+L   LD+     +SDFGL+K+   +   V +   GT GYVAPE  + 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              ++  D +S G++   ++ G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           VIG G Y  V    L+    +     VK  L N  +     + E     +  +   +  L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 249 GYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             C +   R+  V EY++ G+L    H  +     L  E         +  L YLHE   
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISLALNYLHER-- 172
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
             +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+APE       
Sbjct: 173 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
               D ++ G+L+ E+++GR+P D
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRL 247
           +V+G G +  V   + ED      VA+K +     +  E   + E+  + +++H N+V L
Sbjct: 24  DVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                 G H  L+ + +  G L       +      T      +I      + YLH+   
Sbjct: 82  DDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD--- 134
Query: 308 PKVVHRDIKSSNIL---LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             +VHRD+K  N+L   LD+     +SDFGL+K+   +   V +   GT GYVAPE  + 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              ++  D +S G++   ++ G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVE 234
           E   N  +    +G G +G V     +G+++ +    VAVK L  +    E+E    E++
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD-----VGPHSPLTWEIR 288
            +  +  H N+V LLG C  G   +++ EY   G+L  +L            SP   E  
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 289 M---------NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
                     +     AKG+ +L        +HRD+ + NILL      K+ DFGLA+ +
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 218
Query: 340 GAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
             + +YV          ++APE     +    SDV+S+GI + E+ S G +P
Sbjct: 219 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           VIG G Y  V    L+    +     VK  L N  +     + E     +  +   +  L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 249 GYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             C +   R+  V EY++ G+L    H  +     L  E         +  L YLHE   
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISLALNYLHER-- 125
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
             +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+APE       
Sbjct: 126 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
               D ++ G+L+ E+++GR+P D
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           VIG G Y  V    L+    +     VK  L N  +     + E     +  +   +  L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 249 GYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             C +   R+  V EY++ G+L    H  +     L  E         +  L YLHE   
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISLALNYLHER-- 140
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
             +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+APE       
Sbjct: 141 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
               D ++ G+L+ E+++GR+P D
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           VIG G Y  V    L+    +     VK  L N  +     + E     +  +   +  L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 249 GYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             C +   R+  V EY++ G+L    H  +     L  E         +  L YLHE   
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISLALNYLHER-- 129
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
             +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+APE       
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
               D ++ G+L+ E+++GR+P D
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 103/254 (40%), Gaps = 33/254 (12%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEV 233
           R+ E+          IGEG +G V+ G+     N    VA+K   N    + +E F  E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS-PLTWEIRMNII 292
             + +  H ++V+L+G   E     ++ E    G L  +L   V   S  L   I     
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQ 119
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
           L TA  L YL      + VHRDI + N+L+      KL DFGL++ +        ++   
Sbjct: 120 LSTA--LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL 174
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD----------------YSRP 395
              ++APE  +       SDV+ FG+ + E++  G  P                     P
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 234
Query: 396 PGEVCIPQMNSLMT 409
           P   C P + SLMT
Sbjct: 235 PN--CPPTLYSLMT 246

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 59/240 (24%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK----------VEVE 234
            + F +  V+G+G +G V          V  +N L++R  A K+ +           EV 
Sbjct: 5   ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVX 54
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLV---------------YEYIDNGNLEQWLHGD-VG 278
            +  + H+ +VR   Y A    R  V                EY +N  L   +H + + 
Sbjct: 55  LLASLNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLN 112
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK- 337
                 W +   I+    + L+Y+H      ++HR++K  NI +D+  N K+ DFGLAK 
Sbjct: 113 QQRDEYWRLFRQIL----EALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKN 165
Query: 338 ------LLGAERSYV------TTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI 384
                 +L  +   +       T  +GT  YVA E    TG  NE+ D YS GI+  E I
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  + +V H N++ L          +L+ E +  G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGL 335
              L+ E   + I     G+ YLH     K+ H D+K  NI+L  +  P    KL DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 110/237 (46%), Gaps = 42/237 (17%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G+G YG V+ G L    +VAVK + ++R +     + E+     +RH N+   LG+ A 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIAS 70
Query: 254 -------GAHRMLVYEYIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
                       L+  Y ++G+L  +L    + PH      + + + +  A GL +LH  
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPH------LALRLAVSAACGLAHLHVE 124
Query: 306 L-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV----TTRVMGTFGY 356
           +     +P + HRD KS N+L+       ++D GLA +      Y+      RV GT  Y
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRY 183
Query: 357 VAPEYASTGMLNE------RSDVYSFGILIMEVISGRNPV-----DYSRPPGEVCIP 402
           +APE     +  +       +D+++FG+++ E I+ R  V     DY RPP    +P
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWE-IARRTIVNGIVEDY-RPPFYDVVP 238

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  + +V H N++ L          +L+ E +  G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGL 335
              L+ E   + I     G+ YLH     K+ H D+K  NI+L  +  P    KL DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  + +V H N++ L          +L+ E +  G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGL 335
              L+ E   + I     G+ YLH     K+ H D+K  NI+L  +  P    KL DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  + +V H N++ L          +L+ E +  G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGL 335
              L+ E   + I     G+ YLH     K+ H D+K  NI+L  +  P    KL DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 113/252 (44%), Gaps = 30/252 (11%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
           A GS   S D+   + +T  V+  G G     R  EVS   + D  VIG G +G+VY   
Sbjct: 22  AFGSMKVSRDKD-GSKVTTVVATPGQGPD---RPQEVS---YTDTKVIGNGSFGVVYQAK 74
Query: 207 LEDNTN-VAVKNLLNNRGQAEKEFK-VEVEAIGRVRHKNLVRLLGYCAEGAHRM------ 258
           L D+   VA+K +L +     K FK  E++ + ++ H N+VRL  +      +       
Sbjct: 75  LCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
           LV +Y+         H      +     +++  +    + L Y+H      + HRDIK  
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQ 185
Query: 319 NILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLNERSDVYS 375
           N+LLD      KL DFG AK L   R       + +  Y APE  + +T   +   DV+S
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIFGATDYTSS-IDVWS 242
Query: 376 FGILIMEVISGR 387
            G ++ E++ G+
Sbjct: 243 AGCVLAELLLGQ 254

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + +E + EV  + +V H N++ L          +L+ E +  G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGL 335
              L+ E   + I     G+ YLH     K+ H D+K  NI+L  +  P    KL DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG   +E + EV  + +V H N++ L          +L+ E +  G L  +L      
Sbjct: 53  SRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGL 335
              L+ E   + I     G+ YLH     K+ H D+K  NI+L  +  P    KL DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E ++     Q L   +     L  E+  +      + + + H
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 33/231 (14%)
Query: 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
            + +  VIG G +G+V+   L ++  VA+K +L ++    +E ++    +  V+H N+V 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQI----MRIVKHPNVVD 96
Query: 247 LLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII----LGTA 296
           L  +      +       LV EY+         H     ++ L   + M +I        
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH-----YAKLKQTMPMLLIKLYMYQLL 151
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFG 355
           + L Y+H      + HRDIK  N+LLD      KL DFG AK+L A    V+   + +  
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRY 206
Query: 356 YVAPE--YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQM 404
           Y APE  + +T       D++S G ++ E++ G+        PGE  I Q+
Sbjct: 207 YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQPLF-----PGESGIDQL 251

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 16  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 68
Query: 238 RVRHKNLVRL-LGYCAEGAHRMLVY-----EYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL   + + G  + +VY     +Y+         H      +     +++  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 127
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSX 182
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 105/250 (42%), Gaps = 36/250 (14%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGY 250
           V+ EGG+  VY    +      A+K LL+N  +  +    EV  + ++  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 251 CA-------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
            +        G    L+   +  G L ++L   +    PL+ +  + I   T + + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---------GAERSYVTTRVM--G 352
              +P ++HRD+K  N+LL  Q   KL DFG A  +            R+ V   +    
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 353 TFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVD-----------YSRPPGE 398
           T  Y  PE     S   + E+ D+++ G ++  +   ++P +           YS PP +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHD 272
Query: 399 VCIPQMNSLM 408
                 +SL+
Sbjct: 273 TQYTVFHSLI 282

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--------VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
            V+G+G +G V+       ++        V  K  L  R +     K+E + +  V H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87
Query: 244 LVRL-LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           +V+L   +  EG    L+ +++  G+L   L  +V      T E     +   A  L +L
Sbjct: 88  IVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHL 142
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFGYVAPE 360
           H      +++RD+K  NILLD++ + KL+DFGL+K  +   +++Y      GT  Y+APE
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPE 196
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
             +     + +D +SFG+L+ E+++G  P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 26/227 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V     ++    +AVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 118 VFTPATS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 173
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 226
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLS 411
           M  N   D++S G ++ E+++GR        PG   I Q+  +M L+
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGRTLF-----PGTDHINQLQQIMRLT 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 86/163 (52%), Gaps = 14/163 (8%)
Query: 230 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVM----FTEEDV 129
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYV 346
              +   A  L +LH      +++RD+K  NILLD++ + KL+DFGL+K  +   +++Y 
Sbjct: 130 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 185
Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
                GT  Y+APE  +     + +D +SFG+L+ E+++G  P
Sbjct: 186 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL----EQWLHGDVGPHSPL 283
           +FK E++ I  ++++  +   G         ++YEY++N ++    E +   D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
             ++   II       +Y+H   E  + HRD+K SNIL+DK    KLSDFG ++ +  ++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDK 205
Query: 344 SYVTTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILI 380
               +R  GT+ ++ PE+ S  +     + D++S GI +
Sbjct: 206 KIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 16  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 68
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 127
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSX 182
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 86/163 (52%), Gaps = 14/163 (8%)
Query: 230 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVM----FTEEDV 128
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYV 346
              +   A  L +LH      +++RD+K  NILLD++ + KL+DFGL+K  +   +++Y 
Sbjct: 129 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 184
Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
                GT  Y+APE  +     + +D +SFG+L+ E+++G  P
Sbjct: 185 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 24  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 76
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 77  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 135
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 136 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSX 190
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 191 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 228

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNA 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 35  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 87
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 88  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 146
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 147 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSX 201
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 202 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 28  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 80
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 81  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 140 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSX 194
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 195 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 17  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 69
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 70  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 128
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 129 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSX 183
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 184 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 16  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 68
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 127
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSX 182
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 28  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 80
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 81  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 140 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSX 194
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 195 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 232

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEA--IGRVRHKNLVRLLGY 250
           +G+G + +V   V +         ++N +  + ++F K+E EA    +++H N+VRL   
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             E +   LV++ +  G L +    D+      +     + I    + + Y H      +
Sbjct: 73  IQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---GI 125
Query: 311 VHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           VHR++K  N+LL  +      KL+DFGLA  +    S       GT GY++PE       
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 368 NERSDVYSFGILIMEVISGRNPV-----------------DYSRPPGEVCIPQMNSLM 408
           ++  D+++ G+++  ++ G  P                  DY  P  +   P+  SL+
Sbjct: 184 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L ++    +E ++    + 
Sbjct: 20  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MR 72
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 73  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-Y 131
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 132 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSX 186
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 187 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 224

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLV 245
           V+G+G +G V   +L D        A+K L  +    + + +   VE   +  +     +
Sbjct: 26  VLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFL 82
Query: 246 RLLGYCAEGAHRM-LVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
             L  C +   R+  V EY++ G+L   +   G       + +   ++I      GL +L
Sbjct: 83  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GLFFL 136
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-VMGTFGYVAPEY 361
           H+     +++RD+K  N++LD + + K++DFG+ K    +   VTTR   GT  Y+APE 
Sbjct: 137 HKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG--VTTREFCGTPDYIAPEI 191
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVD 391
            +     +  D +++G+L+ E+++G+ P D
Sbjct: 192 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEA--IGRVRHKNLVRLLGY 250
           +G+G + +V   V +         ++N +  + ++F K+E EA    +++H N+VRL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             E +   LV++ +  G L +    D+      +     + I    + + Y H      +
Sbjct: 74  IQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---GI 126
Query: 311 VHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           VHR++K  N+LL  +      KL+DFGLA  +    S       GT GY++PE       
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 368 NERSDVYSFGILIMEVISGRNPV-----------------DYSRPPGEVCIPQMNSLM 408
           ++  D+++ G+++  ++ G  P                  DY  P  +   P+  SL+
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEA-IGRV-RHKNLVRLLGY 250
           +G+G + +V   V +  T      ++N +  + ++  K+E EA I R+ +H N+VRL   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E     LV++ +  G L +    D+      +     + I    + + ++H+     +
Sbjct: 99  ISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHCIHQILESVNHIHQH---DI 151
Query: 311 VHRDIKSSNILLDKQWN---PKLSDFGLA-KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           VHRD+K  N+LL  +      KL+DFGLA ++ G ++++      GT GY++PE      
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYLSPEVLRKDP 209
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
             +  D+++ G+++  ++ G  P
Sbjct: 210 YGKPVDIWACGVILYILLVGYPP 232

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEA--IGRVRHKNLVRLLGY 250
           +G+G + +V   V +         ++N +  + ++F K+E EA    +++H N+VRL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             E +   LV++ +  G L +    D+      +     + I    + + Y H      +
Sbjct: 74  IQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---GI 126
Query: 311 VHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           VHR++K  N+LL  +      KL+DFGLA  +    S       GT GY++PE       
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 368 NERSDVYSFGILIMEVISGRNPV-----------------DYSRPPGEVCIPQMNSLM 408
           ++  D+++ G+++  ++ G  P                  DY  P  +   P+  SL+
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 20/227 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVE 232
           ++E E   + +    ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 233 VEAIGRVR----HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
           +E +   +       ++RLL +       +L+ E        Q L   +     L  E+ 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELA 117
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVT 347
            +      + + + H      V+HRDIK  NIL+D  +   KL DFG   LL   +  V 
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
           T   GT  Y  PE+      + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 90  VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVE 232
           ++E E   + +    ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 233 VEAIGRVR----HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
           +E +   +       ++RLL +       +L+ E  +     Q L   +     L  E+ 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELA 117
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVT 347
            +      + + + H      V+HRDIK  NIL+D  +   KL DFG   LL   +  V 
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
           T   GT  Y  PE+      + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV-----KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     D   V       K+LL    Q EK   +E+     + H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L +          P        I+LG      YLH     
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 134
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGM 366
           +V+HRD+K  N+ L++    K+ DFGLA  +    ER  V   + GT  Y+APE  S   
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKG 191
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYS 393
            +   DV+S G ++  ++ G+ P + S
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 112/263 (42%), Gaps = 32/263 (12%)
Query: 169 HLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE 228
            +G G  + +      ++ +  +  +G+G + +V   V +         ++N +  + ++
Sbjct: 12  QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD 71
Query: 229 F-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW 285
           F K+E EA    +++H N+VRL     E +   LV++ +  G L +    D+      + 
Sbjct: 72  FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE----DIVAREFYSE 127
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAE 342
               + I    + + Y H      +VHR++K  N+LL  +      KL+DFGLA  +   
Sbjct: 128 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVN 182
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV------------ 390
            S       GT GY++PE       ++  D+++ G+++  ++ G  P             
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 391 -----DYSRPPGEVCIPQMNSLM 408
                DY  P  +   P+  SL+
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLI 265

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 90  VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 91  VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV-----KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     D   V       K+LL    Q EK   +E+     + H+++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 105
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L +          P        I+LG      YLH     
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 158
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGM 366
           +V+HRD+K  N+ L++    K+ DFGLA  +    ER  V   + GT  Y+APE  S   
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKG 215
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYS 393
            +   DV+S G ++  ++ G+ P + S
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 118 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 228
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVE 232
           ++E E   + +    ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V 
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 233 VEAIGRVR----HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
           +E +   +       ++RLL +       +L+ E  +     Q L   +     L  E+ 
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELA 139
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVT 347
            +      + + + H      V+HRDIK  NIL+D  +   KL DFG   LL   +  V 
Sbjct: 140 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 193
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
           T   GT  Y  PE+      + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 240

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVE 232
           ++E E   + +    ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 233 VEAIGRVR----HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
           +E +   +       ++RLL +       +L+ E  +     Q L   +     L  E+ 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 117
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVT 347
            +      + + + H      V+HRDIK  NIL+D  +   KL DFG   LL   +  V 
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
           T   GT  Y  PE+      + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 220
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV-----KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     D   V       K+LL    Q EK   +E+     + H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L +          P        I+LG      YLH     
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 160
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGM 366
           +V+HRD+K  N+ L++    K+ DFGLA  +    ER  V   + GT  Y+APE  S   
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKG 217
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYS 393
            +   DV+S G ++  ++ G+ P + S
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 91  VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 24/219 (10%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIG 237
           R  EVS   + D  VIG G +G+VY   L D+   VA+K +L  +    +E ++    + 
Sbjct: 16  RPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQI----MR 68
Query: 238 RVRHKNLVRLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++ H N+VRL  +      +       LV +Y+         H      +     +++  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-Y 127
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRV 350
           +    + L Y+H      + HRDIK  N+LLD      KL DFG AK L   R       
Sbjct: 128 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSX 182
Query: 351 MGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
           + +  Y APE  + +T   +   DV+S G ++ E++ G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 26  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+      + LT +    +I    +GL Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 192
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA 252
           +GEG + I    V + +       +++ R +A  +   E+ A+     H N+V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
           +  H  LV E ++ G L +     +      +      I+      ++++H+     VVH
Sbjct: 77  DQLHTFLVMELLNGGELFER----IKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVH 129
Query: 313 RDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           RD+K  N+L   + +    K+ DFG A+L   +   + T    T  Y APE  +    +E
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDE 188
Query: 370 RSDVYSFGILIMEVISGRNP 389
             D++S G+++  ++SG+ P
Sbjct: 189 SCDLWSLGVILYTMLSGQVP 208

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 118 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 228
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 123 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 179
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 180 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 233
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 265

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCA 252
           +G G +G+V+  V +    V V   +N     +K   K E+  + ++ H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
           +    +L+ E++  G L   +  +      ++    +N +    +GL ++HE     +VH
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVH 172
Query: 313 RDIKSSNILLD--KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
            DIK  NI+ +  K  + K+ DFGLA  L  +     T     F   APE      +   
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA--APEIVDREPVGFY 230
Query: 371 SDVYSFGILIMEVISGRNP 389
           +D+++ G+L   ++SG +P
Sbjct: 231 TDMWAIGVLGYVLLSGLSP 249

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +     Q L   +     L  E+  +      + + + H
Sbjct: 91  VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 96  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 245

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E        Q L   +     L  E+  +      + + + H
Sbjct: 75  VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           H +++ L+      +   LV++ +  G L  +L   V     L+ +   +I+    + ++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLEAVS 214
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           +LH      +VHRD+K  NILLD     +LSDFG +  L  E       + GT GY+APE
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPE 269
Query: 361 YASTGM------LNERSDVYSFGILIMEVISGRNPVDYSR 394
                M        +  D+++ G+++  +++G  P  + R
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 96  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 245

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V   + + +   VA+K L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 250 YCAEGAHRMLVYE-YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                +     Y+ Y+    ++  L   +G     + E    ++    KGL Y+H     
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA--- 163
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM- 366
            VVHRD+K  N+ +++    K+ DFGLA+   AE + YV TR      Y APE   + M 
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMH 218
Query: 367 LNERSDVYSFGILIMEVISGRN 388
            N+  D++S G ++ E+++G+ 
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKT 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 85  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 234

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 96  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 245

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E        Q L   +     L  E+  +      + + + H
Sbjct: 71  VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 94  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 243

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E        Q L   +     L  E+  +      + + + H
Sbjct: 71  VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 86  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 86  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 235

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV-----KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     D   V       K+LL    Q EK   +E+     + H+++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 87
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L +          P        I+LG      YLH     
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 140
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           +V+HRD+K  N+ L++    K+ DFGLA  +  +     T + GT  Y+APE  S    +
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 199
Query: 369 ERSDVYSFGILIMEVISGRNPVDYS 393
              DV+S G ++  ++ G+ P + S
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAI 236
           +V+ + F     IG+G +G V      D   +     +N +   E+      FK E++ +
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIM 69
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             + H  LV L     +     +V + +  G+L   L  +V        E     I    
Sbjct: 70  QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH----FKEETVKLFICELV 125
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
             L YL      +++HRD+K  NILLD+  +  ++DF +A +L  E    T  + GT  Y
Sbjct: 126 MALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPY 180
Query: 357 VAPEYAST---GMLNERSDVYSFGILIMEVISGRNP 389
           +APE  S+      +   D +S G+   E++ GR P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 94  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 243

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E        Q L   +     L  E+  +      + + + H
Sbjct: 71  VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 128 NX---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 87  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 142
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 143 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 195
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 236

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 20/220 (9%)
Query: 182 EVSTNGFADENVIGEGGYGIVY--HGVLEDNT------NVAVKNLLNNRGQAEKEFKVEV 233
           +V    F    V+G G YG V+    +   +T       V  K  +  + +  +  + E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
           + +  +R    +  L Y  +   ++ L+ +YI+ G L   L            E  + I 
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIY 164
Query: 293 LG-TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
           +G     L +LH+     +++RDIK  NILLD   +  L+DFGL+K   A+ +       
Sbjct: 165 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 352 GTFGYVAPEYASTGML--NERSDVYSFGILIMEVISGRNP 389
           GT  Y+AP+    G    ++  D +S G+L+ E+++G +P
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVR----HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R    G+     +V +E +   +       
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E        Q L   +     L  E+  +      + + + H
Sbjct: 74  VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 131 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 184
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
                + RS  V+S GIL+ +++ G  P ++ 
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV-----KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     D   V       K+LL    Q EK   +E+     + H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 83
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L +          P        I+LG      YLH     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 136
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           +V+HRD+K  N+ L++    K+ DFGLA  +  +     T + GT  Y+APE  S    +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 369 ERSDVYSFGILIMEVISGRNPVDYS 393
              DV+S G ++  ++ G+ P + S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 91  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 240

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 96  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 204
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 245

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 91  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 240

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 94  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 243

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 88  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 143
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 144 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 196
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 237

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V   + + +   VA+K L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 250 YCAEGAHRMLVYE-YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                +     Y+ Y+    ++  L   +G     + E    ++    KGL Y+H     
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSA--- 145
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM- 366
            VVHRD+K  N+ +++    K+ DFGLA+   AE + YV TR      Y APE   + M 
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMH 200
Query: 367 LNERSDVYSFGILIMEVISGRN 388
            N+  D++S G ++ E+++G+ 
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKT 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 91  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 240

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV-----KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     D   V       K+LL    Q EK   +E+     + H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 83
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L +          P        I+LG      YLH     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 136
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           +V+HRD+K  N+ L++    K+ DFGLA  +  +     T + GT  Y+APE  S    +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 369 ERSDVYSFGILIMEVISGRNPVDYS 393
              DV+S G ++  ++ G+ P + S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 95  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 244

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 26  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 192
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 234

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 94  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 243

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 95  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 244

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 36  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 93
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 202
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 244

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 101 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 250

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 101 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 250

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 101 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 250

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 196
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 100 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 156 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 249

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 108 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 216
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 257

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 232 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 118
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
            +L     L  L+      +VHRD+K  NILLD   N KL+DFG +  L          V
Sbjct: 119 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 170
Query: 351 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRNP 389
            GT  Y+APE     M        +  D++S G+++  +++G  P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 109 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 217
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 258

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 95/223 (42%), Gaps = 14/223 (6%)
Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGR-VRHKNLVRL 247
           VIG+G +G V     + +    AVK L      + + EK    E   + + V+H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                       V +YI+ G L   L  +     P        I    A  L YLH    
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHSL-- 158
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
             +V+RD+K  NILLD Q +  L+DFGL K    E +  T+   GT  Y+APE       
Sbjct: 159 -NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 368 NERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           +   D +  G ++ E++ G  P  YSR   E+    +N  + L
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQL 258

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGY 250
           +G G +G V H V E ++ +   +K +  +R Q   E  + E+E +  + H N++++   
Sbjct: 30  LGSGAFGDV-HLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             +  +  +V E  + G L + +         L+      ++      L Y H      V
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 311 VHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           VH+D+K  NIL  +  +P    K+ DFGLA+L  ++    +T   GT  Y+APE      
Sbjct: 146 VHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFKRD- 201
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
           +  + D++S G+++  +++G  P
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 40  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 97
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 98  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 154
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 155 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 206
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 248

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 232 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
            +L     L  L+      +VHRD+K  NILLD   N KL+DFG +  L       +  V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--V 183
Query: 351 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRNP 389
            GT  Y+APE     M        +  D++S G+++  +++G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 12/167 (7%)
Query: 226 EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW 285
           E   + E+  + +++H+N+V L        H  LV + +  G L       +      T 
Sbjct: 64  ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTE 119
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAE 342
           +    +I      + YLH      +VHRD+K  N+L    D++    +SDFGL+K+ G  
Sbjct: 120 KDASTLIRQVLDAVYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG-- 174
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           +  V +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 175 KGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 100 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 156 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 249

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 232 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
            +L     L  L+      +VHRD+K  NILLD   N KL+DFG +  L          V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 183
Query: 351 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRNP 389
            GT  Y+APE     M        +  D++S G+++  +++G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 91  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 112 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 220
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 261

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 50  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 216
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 258

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 49  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 106
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 107 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE    
Sbjct: 164 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 215
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 257

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 95  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y APE     
Sbjct: 151 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 244

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 112 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGLA+    E   YV TR      Y APE     
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNW 220
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 261

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVK-NLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGY 250
           ++G G +G V H   E  T + +   ++  RG  +KE  K E+  + ++ H NL++L   
Sbjct: 96  ILGGGRFGQV-HKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
                  +LV EY+D G L   +  +    + L   + M  I    +G+ ++H+     +
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI---CEGIRHMHQMY---I 208
Query: 311 VHRDIKSSNILL--DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           +H D+K  NIL         K+ DFGLA+              GT  ++APE  +   ++
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVS 266
Query: 369 ERSDVYSFGILIMEVISGRNP 389
             +D++S G++   ++SG +P
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSP 287

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +GEG +G V      +    VA+K +   L  +       + E+  +  +RH ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                   ++V EY   G L  +    +     +T +            + Y H     K
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDY----IVEKKRMTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-N 368
           +VHRD+K  N+LLD   N K++DFGL+ ++  + +++ T   G+  Y APE  +  +   
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVINGKLYAG 186
Query: 369 ERSDVYSFGILIMEVISGRNPVD 391
              DV+S GI++  ++ GR P D
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 29/239 (12%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLG 249
            ++GEG Y  V   V L++    AVK +    G +      EVE + + + +KN++ L+ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  +     LV+E +  G++       +             ++   A  L +LH      
Sbjct: 79  FFEDDTRFYLVFEKLQGGSI----LAHIQKQKHFNEREASRVVRDVAAALDFLHT---KG 131
Query: 310 VVHRDIKSSNILLD--KQWNP-KLSDFGLAKLLGAERSYVT------TRVMGTFGYVAPE 360
           + HRD+K  NIL +  ++ +P K+ DF L   +    S         T   G+  Y+APE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 361 YA-----STGMLNERSDVYSFGILIMEVISGRNP------VDYSRPPGEVCIPQMNSLM 408
                       ++R D++S G+++  ++SG  P       D     GEVC    N L 
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 250

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           EV  +  + H N+++L  +  +  +  LV E    G L      D   H     E+   +
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-----FDEIIHRMKFNEVDAAV 140
Query: 292 ILGTA-KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVT 347
           I+     G+TYLH+     +VHRD+K  N+LL+ +      K+ DFGL+ +   ++    
Sbjct: 141 IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--M 195
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
              +GT  Y+APE       +E+ DV+S G+++  +++G  P
Sbjct: 196 KERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPP 236

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLL 248
           V+G+G +G V    +++  ++ AVK L  +    + + +    E   +   R+   +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 249 GYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYLHEGL 306
             C +   R+  V E+++ G+L   +       S    E R           L +LH+  
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEIISALMFLHDK- 143
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
              +++RD+K  N+LLD + + KL+DFG+ K  G      T    GT  Y+APE     +
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 367 LNERSDVYSFGILIMEVISGRNPVD 391
                D ++ G+L+ E++ G  P +
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
            VIG+G + +V   +  E     AVK        ++ G + ++ K E      ++H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNL--EQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYL 302
            LL   +      +V+E++D  +L  E     D G  +S       M  IL   + L Y 
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYC 148
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           H+     ++HRD+K   +LL  + N    KL  FG+A  LG E   V    +GT  ++AP
Sbjct: 149 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAP 204
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNP 389
           E        +  DV+  G+++  ++SG  P
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 26  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + +V TR      Y APE    
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLN 192
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 234

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + +V TR      Y APE    
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLN 196
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ D+GLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DFGLA+    E + +V TR      Y APE    
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLN 196
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 15/174 (8%)
Query: 221 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVG 278
           N    +K F+ EV  +  + H N+V+L           LV EY   G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
                  E R          + Y H+     +VHRD+K+ N+LLD   N K++DFG +  
Sbjct: 112 EK-----EARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 339 LGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                   T    G+  Y APE +          DV+S G+++  ++SG  P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 15/174 (8%)
Query: 221 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVG 278
           N    +K F+ EV  +  + H N+V+L           LV EY   G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
                  E R          + Y H+     +VHRD+K+ N+LLD   N K++DFG +  
Sbjct: 112 EK-----EARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 339 LGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                   T    G+  Y APE +          DV+S G+++  ++SG  P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ DFGL +    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
              ++HRD+K SN+ +++    K+ DFGLA+    E     T  + T  Y APE     M
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGXVATRWYRAPEIMLNWM 198
Query: 367 -LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
             N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 15/174 (8%)
Query: 221 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVG 278
           N    +K F+ EV  +  + H N+V+L           LV EY   G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
                  E R          + Y H+     +VHRD+K+ N+LLD   N K++DFG +  
Sbjct: 112 EK-----EARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 339 LGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                   T    G+  Y APE +          DV+S G+++  ++SG  P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
            VIG+G + +V   +  E     AVK        ++ G + ++ K E      ++H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNL--EQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYL 302
            LL   +      +V+E++D  +L  E     D G  +S       M  IL   + L Y 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYC 146
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           H+     ++HRD+K   +LL  + N    KL  FG+A  LG E   V    +GT  ++AP
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAP 202
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNP 389
           E        +  DV+  G+++  ++SG  P
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 25/150 (16%)
Query: 251 CAEGAHRM-LVYEYIDNGNLEQWLHGDVG----PHSPL-TWEIRMNIILGTAKGLTYLHE 304
           C +   R+  V EY++ G+L   +   VG    PH+     EI + +    +KG+ Y   
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY--- 144
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-GTFGYVAPEY 361
                   RD+K  N++LD + + K++DFG+ K    E  +  VTT+   GT  Y+APE 
Sbjct: 145 --------RDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCGTPDYIAPEI 192
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVD 391
            +     +  D ++FG+L+ E+++G+ P +
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNL--LNNRGQAEKEFKVEVEAIGRVRH 241
           ++ F  ++++GEG YG+V     +     VA+K +   +    A +  + E++ +   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           +N++ +       +       YI    ++  LH  +     L+ +     I  T + +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTLRAVKV 127
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVT------TRVMG 352
           LH      V+HRD+K SN+L++   + K+ DFGLA+++    A+ S  T      T  + 
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 353 TFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 387
           T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     IG G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G++   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   K++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 51  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 106
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 164 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA-IGRV-RHKNLVRLLGY 250
           IG+G + +V   V L      A K +   +  A    K+E EA I R+ +H N+VRL   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E     LV++ +  G L +    D+      +     + I    + + + H+     V
Sbjct: 72  ISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 124
Query: 311 VHRDIKSSNILLDKQWN---PKLSDFGLA-KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           VHRD+K  N+LL  +      KL+DFGLA ++ G ++++      GT GY++PE      
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKEA 182
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
             +  D+++ G+++  ++ G  P
Sbjct: 183 YGKPVDIWACGVILYILLVGYPP 205

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 19/150 (12%)
Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVG----PHSPL-TWEIRMNIILGTAKGLTY 301
           L  C +   R+  V EY++ G+L   +   VG    PH+     EI + +    +KG+ Y
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
                      RD+K  N++LD + + K++DFG+ K         T    GT  Y+APE 
Sbjct: 466 -----------RDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEI 513
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVD 391
            +     +  D ++FG+L+ E+++G+ P +
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 51  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 106
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 164 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNL--LNNRGQAEKEFKVEVEAIGRVRH 241
           ++ F  ++++GEG YG+V     +     VA+K +   +    A +  + E++ +   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           +N++ +       +       YI    ++  LH  +     L+ +     I  T + +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTLRAVKV 127
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVT------TRVMG 352
           LH      V+HRD+K SN+L++   + K+ DFGLA+++    A+ S  T      T  + 
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 353 TFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 387
           T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           EN IG G +G V   V +  T +  A K +     +    FK E+E +  + H N++RL 
Sbjct: 14  ENTIGRGSWGEVKIAV-QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 249 GYCAEGAHRMLVYEYIDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
               +     LV E    G L E+ +H  V   S         I+      + Y H+   
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----RIMKDVLSAVAYCHKL-- 125
Query: 308 PKVVHRDIKSSNILL--DKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             V HRD+K  N L   D   +P KL DFGLA      +   T   +GT  YV+P+    
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE- 181
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
           G+     D +S G+++  ++ G  P
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     IG G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   K++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           EN IG G +G V   V +  T +  A K +     +    FK E+E +  + H N++RL 
Sbjct: 31  ENTIGRGSWGEVKIAV-QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 89
Query: 249 GYCAEGAHRMLVYEYIDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
               +     LV E    G L E+ +H  V   S         I+      + Y H+   
Sbjct: 90  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----RIMKDVLSAVAYCHKL-- 142
Query: 308 PKVVHRDIKSSNILL--DKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             V HRD+K  N L   D   +P KL DFGLA      +   T   +GT  YV+P+    
Sbjct: 143 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE- 198
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
           G+     D +S G+++  ++ G  P
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 13/172 (7%)
Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
           RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L        
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGLAK 337
            LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGLA 
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
            +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA-IGRV-RHKNLVRLLGY 250
           +G+G + +V   V +      A K +   +  A    K+E EA I R+ +H N+VRL   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E  H  L+++ +  G L +    D+      +     + I    + + + H+     V
Sbjct: 90  ISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 142
Query: 311 VHRDIKSSNILLDKQWN---PKLSDFGLA-KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           VHRD+K  N+LL  +      KL+DFGLA ++ G ++++      GT GY++PE      
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDP 200
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
             +  D+++ G+++  ++ G  P
Sbjct: 201 YGKPVDLWACGVILYILLVGYPP 223

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           EV  +  + H N+V+L           L+ EY   G +  +L      H  +  +   + 
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSK 116
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
                  + Y H+    ++VHRD+K+ N+LLD   N K++DFG +          T    
Sbjct: 117 FRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FC 171
Query: 352 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           G+  Y APE +          DV+S G+++  ++SG  P D
Sbjct: 172 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 8/107 (7%)
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
           P+T E  ++     A+G+ +L      K +HRD+ + NILL +    K+ DFGLA+ +  
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 342 ERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
              YV    TR+     ++APE     + + +SDV+S+G+L+ E+ S
Sbjct: 252 NPDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 23/231 (9%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYH------GVLEDNTNVAVKNLLNNRGQAEK 227
            W  L    V+ N F    V+G+GG+G V        G +     +  K +   +G+A  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA-- 229
Query: 228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLH--GDVG-PHSPL 283
              +  + I    +   V  L Y  E    + LV   ++ G+L+  ++  G  G P +  
Sbjct: 230 -MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
            +            GL  LH     ++V+RD+K  NILLD   + ++SD GLA  +  E 
Sbjct: 289 VF-----YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEG 339
Query: 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
             +  RV GT GY+APE           D ++ G L+ E+I+G++P    +
Sbjct: 340 QTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYH------GVLEDNTNVAVKNLLNNRGQAEK 227
            W  L    V+ N F    V+G+GG+G V        G +     +  K +   +G+A  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA-- 229
Query: 228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLH--GDVGPHSPLT 284
              +  + I    +   V  L Y  E    + LV   ++ G+L+  ++  G  G      
Sbjct: 230 -MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG------ 282
Query: 285 WEIRMNIILGTAKGLTYLHE---GLE----PKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
                      A+ + Y  E   GLE     ++V+RD+K  NILLD   + ++SD GLA 
Sbjct: 283 --------FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV 334
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            +  E   +  RV GT GY+APE           D ++ G L+ E+I+G++P    +
Sbjct: 335 HV-PEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           + D   +G GG G+V+  V  D +  VA+K ++    Q+ K    E++ I R+ H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 247 LLGYCAEGAHRM---------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
           +         ++         L   YI    +E  L  +V    PL  E     +    +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDL-ANVLEQGPLLEEHARLFMYQLLR 131
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           GL Y+H      V+HRD+K +N+ ++ +    K+ DFGLA+++    S+   +   + G 
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH---KGHLSEGL 185
Query: 357 VAPEYASTGML------NERSDVYSFGILIMEVISGRN 388
           V   Y S  +L       +  D+++ G +  E+++G+ 
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 15/174 (8%)
Query: 221 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVG 278
           N    +K F+ EV  +  + H N+V+L           LV EY   G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
                  E R          + Y H+     +VHRD+K+ N+LLD   N K++DFG +  
Sbjct: 112 EK-----EARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 339 LGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                        G+  Y APE +          DV+S G+++  ++SG  P D
Sbjct: 163 FTFGNK--LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 4   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 62
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 63  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 121 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 173
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 230 YEMAAGYPPFFADQP 244

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 24  AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 82
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 83  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 140
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 141 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 193
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 194 LIDQQGYIQVTDFGFAKRVKG----ATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 250 YEMAAGYPPFFADQP 264

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    KE +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY   G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           ++D+Q   K++DFGLAK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 MIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 11/172 (6%)
Query: 221 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH 280
           N    +K F+ EV  +  + H N+V+L           LV EY   G +  +L      H
Sbjct: 46  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA----H 100
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
             +  +            + Y H+     +VHRD+K+ N+LLD   N K++DFG +    
Sbjct: 101 GWMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 157
Query: 341 AERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                 T    G+  Y APE +          DV+S G+++  ++SG  P D
Sbjct: 158 FGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 220 NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP 279
           + RG + ++ + EV  +  ++H N++ L          +L+ E +  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL----AE 107
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK----LSDFGL 335
              LT E     +     G+ YLH     ++ H D+K  NI+L  +  PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           A  +     +    + GT  +VAPE  +   L   +D++S G++   ++SG +P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
           + D   +G G YG V   V       VA+K L     +   A++ ++ E+  +  +RH+N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHEN 85
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---HSPLTWEIRMNIILGTAKGLT 300
           ++ LL           + ++ D   +  ++  D+G    H  L  +    ++    KGL 
Sbjct: 86  VIGLLDVFTPDE---TLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
           Y+H      ++HRD+K  N+ +++    K+ DFGLA+   +E    V TR      Y AP
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAP 194
Query: 360 EYASTGM-LNERSDVYSFGILIMEVISGRN 388
           E     M   +  D++S G ++ E+I+G+ 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE--------KEFKVEVEAIGRVRHKNL 244
           +G G +G V+  V  E N  V VK +   +   +         +  +E+  + RV H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH--SPLTWEIRMNIILGTAKGLTYL 302
           +++L          LV E   +G L+ +   D  P    PL   I   ++  +A G   L
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLV--SAVGYLRL 148
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-Y 361
            +     ++HRDIK  NI++ + +  KL DFG A  L  ER  +     GT  Y APE  
Sbjct: 149 KD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEVL 201
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
                     +++S G+ +  ++   NP
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 24  AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 82
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 83  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 140
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 141 MEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 193
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 194 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 250 YEMAAGYPPFFADQP 264

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 10/161 (6%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           EV  +  + H N+V+L           LV EY   G +  +L      H  +  +     
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA----HGRMKEKEARAK 119
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
                  + Y H+     +VHRD+K+ N+LLD   N K++DFG +          T    
Sbjct: 120 FRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FC 174
Query: 352 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           G+  Y APE +          DV+S G+++  ++SG  P D
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 186 NGFADENVIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRV 239
           + F     IG G +G   +V H  +E   + A+K L   +    K+ +    E   +  V
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKH--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
               LV+L     + ++  +V EY+  G++   L        P        I+L      
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----F 154
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            YLH      +++RD+K  N+L+D+Q   K++DFG AK +       T  + GT  Y+AP
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           E   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNL--LNNRGQAEKEFKVEVEAIGRVRH 241
           ++ F  ++++GEG YG+V     +     VA+K +   +    A +  + E++ +   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           +N++ +       +       YI    ++  LH  +     L+ +     I  T + +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTLRAVKV 127
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYV- 357
           LH      V+HRD+K SN+L++   + K+ DFGLA+++    A+ S  T +  G   +V 
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 358 -----APEYASTGMLNERS-DVYSFGILIMEVISGR 387
                APE   T     R+ DV+S G ++ E+   R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 41/241 (17%)
Query: 186 NGFADENVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKN 243
           N    E ++G G  G +V+ G  +    VAVK +L +    A  E K+  E+     H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALMEIKLLTESDD---HPN 70
Query: 244 LVRLLGYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN---IILGTAKGL 299
           ++R   YC+E   R L +   + N NL+  +         L  +   N   ++   A G+
Sbjct: 71  VIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 300 TYLHEGLEPKVVHRDIKSSNILL--------DKQWNPK-----LSDFGLAKLLGAERSYV 346
            +LH     K++HRD+K  NIL+        D+Q   +     +SDFGL K L + +S  
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 347 TTRV---MGTFGYVAPEY--ASTGMLNERS-----DVYSFGILIMEVIS-GRNPV--DYS 393
            T +    GT G+ APE    S  +  +R      D++S G +   ++S G++P    YS
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 394 R 394
           R
Sbjct: 246 R 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYAST 364
               ++HRD+K SN+ +++    K+ DF LA+    E + YV TR      Y APE    
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRAPEIMLN 196
Query: 365 GM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
            M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           + E+E + ++ H  ++++  +  +     +V E ++ G L   + G+             
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYV 346
            ++L     + YLHE     ++HRD+K  N+LL  Q      K++DFG +K+LG E S +
Sbjct: 122 QMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 173
Query: 347 TTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            T + GT  Y+APE      T   N   D +S G+++   +SG  P    R
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           + E+E + ++ H  ++++  +  +     +V E ++ G L   + G+             
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYV 346
            ++L     + YLHE     ++HRD+K  N+LL  Q      K++DFG +K+LG E S +
Sbjct: 122 QMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 173
Query: 347 TTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            T + GT  Y+APE      T   N   D +S G+++   +SG  P    R
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           + E+E + ++ H  ++++  +  +     +V E ++ G L   + G+             
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYV 346
            ++L     + YLHE     ++HRD+K  N+LL  Q      K++DFG +K+LG E S +
Sbjct: 128 QMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 179
Query: 347 TTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            T + GT  Y+APE      T   N   D +S G+++   +SG  P    R
Sbjct: 180 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+  FGLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           + E+E + ++ H  ++++  +  +     +V E ++ G L   + G+             
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYV 346
            ++L     + YLHE     ++HRD+K  N+LL  Q      K++DFG +K+LG E S +
Sbjct: 261 QMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 312
Query: 347 TTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            T + GT  Y+APE      T   N   D +S G+++   +SG  P    R
Sbjct: 313 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 18/211 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNT------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           +++GEG YG V   VL+  T       +  K  L      E   K E++ + R+RHKN++
Sbjct: 11  DLLGEGSYGKVKE-VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 246 RLLG--YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +L+   Y  E     +V EY   G  E     D  P                  GL YLH
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-MGTFGYVAPEYA 362
                 +VH+DIK  N+LL      K+S  G+A+ L    +  T R   G+  +  PE A
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 363 S--TGMLNERSDVYSFGILIMEVISGRNPVD 391
           +        + D++S G+ +  + +G  P +
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           + E+E + ++ H  ++++  +  +     +V E ++ G L   + G+             
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYV 346
            ++L     + YLHE     ++HRD+K  N+LL  Q      K++DFG +K+LG E S +
Sbjct: 121 QMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 172
Query: 347 TTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            T + GT  Y+APE      T   N   D +S G+++   +SG  P    R
Sbjct: 173 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           + E+E + ++ H  ++++  +  +     +V E ++ G L   + G+             
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYV 346
            ++L     + YLHE     ++HRD+K  N+LL  Q      K++DFG +K+LG E S +
Sbjct: 122 QMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 173
Query: 347 TTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            T + GT  Y+APE      T   N   D +S G+++   +SG  P    R
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 47/245 (19%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLN---NRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
           +G+G YGIV+  +      V AVK + +   N   A++ F+ E+  +  +  H+N+V LL
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPH--SPLTWEIRMNIILGTAKGLTYLHE 304
                   R   LV++Y     +E  LH  +  +   P+    +  ++    K + YLH 
Sbjct: 76  NVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVH---KQYVVYQLIKVIKYLHS 127
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY------------------- 345
           G    ++HRD+K SNILL+ + + K++DFGL++     R                     
Sbjct: 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 346 -VTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQ 403
            + T  + T  Y APE    +    +  D++S G ++ E++ G+ P+     PG   + Q
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI----FPGSSTMNQ 239
Query: 404 MNSLM 408
           +  ++
Sbjct: 240 LERII 244

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
           + E+E + ++ H  ++++  +  +     +V E ++ G L   + G+             
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYV 346
            ++L     + YLHE     ++HRD+K  N+LL  Q      K++DFG +K+LG E S +
Sbjct: 247 QMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 298
Query: 347 TTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
            T + GT  Y+APE      T   N   D +S G+++   +SG  P    R
Sbjct: 299 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ D GLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 194 IGEGGYGIVYHGVLEDNT-----NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   Y     D        V  K++L    Q EK    E+     + + ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L + LH        +T       +  T +G+ YLH     
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKR---RKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
           +V+HRD+K  N+ L+   + K+ DFGLA  +  +     T + GT  Y+APE       +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVLCKKGHS 220
Query: 369 ERSDVYSFGILIMEVISGRNPVDYS 393
              D++S G ++  ++ G+ P + S
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAACKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 15/174 (8%)
Query: 221 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVG 278
           N    +K F+ EV  +  + H N+V+L           LV EY   G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
                  E R          + Y H+     +VHRD+K+ N+LLD   N K++DFG +  
Sbjct: 112 EK-----EARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 339 LGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                        G   Y APE +          DV+S G+++  ++SG  P D
Sbjct: 163 FTFGNK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 23/237 (9%)
Query: 167 VSHLGWGHWYT--LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ 224
           + +L W   +T  ++++ +    F    VIG G +G V    L++   V    +LN    
Sbjct: 53  LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112
Query: 225 AEKE----FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--DVG 278
            ++     F+ E + +     K +  L     +  +  LV +Y   G+L   L    D  
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 279 PHSPLTWEI-RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
           P     + +  M I + +   L Y         VHRDIK  NIL+D   + +L+DFG   
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNP 389
            L  + +  ++  +GT  Y++PE         G      D +S G+ + E++ G  P
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           ++D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 IIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ D GLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH   E  VV+RD+K  N++LDK  + K++DFGL K  G +         GT  Y+
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D +  G+++ E++ GR P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 14/163 (8%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           EV  +  + H N+V+L           L+ EY   G +  +L      H  +  +   + 
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSK 119
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTR 349
                  + Y H+    ++VHRD+K+ N+LLD   N K++DFG +    +G +       
Sbjct: 120 FRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-- 174
Query: 350 VMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
             G   Y APE +          DV+S G+++  ++SG  P D
Sbjct: 175 --GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 193 VIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEF------KVEVEAIGRVR----H 241
           ++G+GG+G V+ G  L D   VA+K +  NR              +EV  + +V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
             ++RLL +       MLV E        Q L   +    PL               + +
Sbjct: 98  PGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 302 LHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
            H      VVHRDIK  NIL+D ++   KL DFG   LL  E     T   GT  Y  PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPE 208
Query: 361 YASTGMLNE-RSDVYSFGILIMEVISGRNPVD 391
           + S    +   + V+S GIL+ +++ G  P +
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
           +R+L +    +    VIG G +G V     +    V    LL+     ++     F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AR 176
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             TA+ +  L        +HRD+K  N+LLDK  + KL+DFG    +  E        +G
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
           T  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
           +R+L +    +    VIG G +G V     +    V    LL+     ++     F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AR 171
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             TA+ +  L        +HRD+K  N+LLDK  + KL+DFG    +  E        +G
Sbjct: 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
           T  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH   E  VV+RD+K  N++LDK  + K++DFGL K  G +         GT  Y+
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 319
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D +  G+++ E++ GR P
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
           +R+L +    +    VIG G +G V     +    V    LL+     ++     F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AR 176
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             TA+ +  L        +HRD+K  N+LLDK  + KL+DFG    +  E        +G
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
           T  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH   E  VV+RD+K  N++LDK  + K++DFGL K  G +         GT  Y+
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 176
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D +  G+++ E++ GR P
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH   E  VV+RD+K  N++LDK  + K++DFGL K  G +         GT  Y+
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 178
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D +  G+++ E++ GR P
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH   E  VV+RD+K  N++LDK  + K++DFGL K  G +         GT  Y+
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 177
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           APE           D +  G+++ E++ GR P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAI 236
           +V+ N F    ++G+G +G V   V E  T    A+K L      A+ E      E   +
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 237 GRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
              RH  L   L Y  +   R+  V EY + G L  + H  +      T E         
Sbjct: 63  QNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEI 117
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
              L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  
Sbjct: 118 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 173
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE           D +  G+++ E++ GR P
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 5/120 (4%)
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           LT E  +      AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 343 RSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
             YV          ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 5/120 (4%)
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           LT E  +      AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 343 RSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
             YV          ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            ++ +G  P    +P
Sbjct: 229 YQMAAGYPPFFADQP 243

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAI 236
           +V+ N F    ++G+G +G V   V E  T    A+K L      A+ E      E   +
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 237 GRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
              RH  L   L Y  +   R+  V EY + G L  + H  +      T E         
Sbjct: 60  QNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEI 114
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
              L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE           D +  G+++ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 5/120 (4%)
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           LT E  +      AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 343 RSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
             YV          ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G G YG V   Y   L     VAVK L     +   A + ++ E+  +  ++H+N++ L
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           L             E      L      ++     L+ E    ++    +GL Y+H    
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-- 142
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM 366
             ++HRD+K SN+ +++    ++ DFGLA+    E + YV TR      Y APE     M
Sbjct: 143 -GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWM 196
Query: 367 -LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
             N+  D++S G ++ E++ G+        PG   I Q+  +M +
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALF-----PGSDYIDQLKRIMEV 236

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAI 236
           +V+ N F    ++G+G +G V   V E  T    A+K L      A+ E      E   +
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 237 GRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
              RH  L   L Y  +   R+  V EY + G L  + H  +      T E         
Sbjct: 60  QNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEI 114
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
              L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE           D +  G+++ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAI 236
           +V+ N F    ++G+G +G V   V E  T    A+K L      A+ E      E   +
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 237 GRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
              RH  L   L Y  +   R+  V EY + G L  + H  +      T E         
Sbjct: 60  QNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEI 114
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
              L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE           D +  G+++ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    KE +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY   G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           ++D+Q   +++DFGLAK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 MIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 5/120 (4%)
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           LT E  +      AKG+ +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 343 RSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVC 400
             YV          ++APE     +   +SDV+SFG+L+ E+ S G +P    +   E C
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 4   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 63  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 173
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 230 YEMAAGYPPFFADQP 244

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G G YG V   Y   L     VAVK L     +   A + ++ E+  +  ++H+N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           L             E      L      ++     L+ E    ++    +GL Y+H    
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA-- 150
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM 366
             ++HRD+K SN+ +++    ++ DFGLA+    E + YV TR      Y APE     M
Sbjct: 151 -GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWM 204
Query: 367 -LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
             N+  D++S G ++ E++ G+        PG   I Q+  +M +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF-----PGSDYIDQLKRIMEV 244

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 4   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 63  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 173
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 230 YEMAAGYPPFFADQP 244

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAI 236
           +V+ N F    ++G+G +G V   V E  T    A+K L      A+ E      E   +
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 237 GRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
              RH  L   L Y  +   R+  V EY + G L  + H  +      T E         
Sbjct: 60  QNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEI 114
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
              L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE           D +  G+++ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 4   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 63  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 121 MEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 173
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 230 YEMAAGYPPFFADQP 244

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAI 236
           +V+ N F    ++G+G +G V   V E  T    A+K L      A+ E      E   +
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 237 GRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
              RH  L   L Y  +   R+  V EY + G L  + H  +      T E         
Sbjct: 60  QNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEI 114
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
              L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV---DYSRPPGEVCIPQMNSLMTLS 411
           Y+APE           D +  G+++ E++ GR P    D+ R    + + ++    TLS
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS 229

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                     + E+ D   +   +  D+        LT +    +I    +GL Y+H   
Sbjct: 89  VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K SN+ +++    K+ D GLA+    E + YV TR      Y APE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 238

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G YG V     +  T   VAVK L     +   A++ ++ E+  +  ++H+N++ LL
Sbjct: 50  VGSGAYGSVC-AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG 305
                      + E+ D   +   +  D+        LT +    +I    +GL Y+H  
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               ++HRD+K SN+ +++    K+ DFGLA+    E        + T  Y APE     
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MXGXVATRWYRAPEIMLNW 217
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
           M  N+  D++S G ++ E+++GR        PG   I Q+  ++ L
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRL 258

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDNT-----NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   Y     D        V  K++L    Q EK    E+     + + ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L + LH        +T       +  T +G+ YLH     
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKR---RKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGM 366
           +V+HRD+K  N+ L+   + K+ DFGLA  +    ER      + GT  Y+APE      
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KXLCGTPNYIAPEVLCKKG 218
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYS 393
            +   D++S G ++  ++ G+ P + S
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAI 236
           +V+ N F    ++G+G +G V   V E  T    A+K L      A+ E      E   +
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 237 GRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
              RH  L   L Y  +   R+  V EY + G L  + H  +      T E         
Sbjct: 65  QNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEI 119
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
              L YLH      VV+RDIK  N++LDK  + K++DFGL K  G           GT  
Sbjct: 120 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 175
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           Y+APE           D +  G+++ E++ GR P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLL 248
           IG G +G+    ++ D      VAVK +   RG A  E  V+ E I    +RH N+VR  
Sbjct: 28  IGSGNFGVA--RLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFK 82
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                  H  ++ EY   G L + +  + G  S          +L    G++Y H     
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLS---GVSYCHSM--- 135
Query: 309 KVVHRDIKSSNILLDKQWNPKLS--DFGLAK---LLGAERSYVTTRVMGTFGYVAPEYAS 363
           ++ HRD+K  N LLD    P+L   DFG +K   L    +S V     GT  Y+APE   
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIAPEVLL 190
Query: 364 TGMLNER-SDVYSFGILIMEVISGRNPVDYSRPP 396
               + + +DV+S G+ +  ++ G  P +    P
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDNT-----NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   Y     D        V  K++L    Q EK    E+     + + ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L + LH        +T       +  T +G+ YLH     
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKR---RKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGM 366
           +V+HRD+K  N+ L+   + K+ DFGLA  +    ER      + GT  Y+APE      
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCKKG 218
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYS 393
            +   D++S G ++  ++ G+ P + S
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
             YLH      +++RD+K  N+L+D+Q   K++DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  G   ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGXEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  G   ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGXEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 120/278 (43%), Gaps = 50/278 (17%)
Query: 145 ERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG-IVY 203
           +R  GS  G   +    A  P           +L+ L VS      E ++G G  G +V+
Sbjct: 5   KRKRGSRGGKKGRKSRIANIPNFEQ-------SLKNLVVS------EKILGYGSSGTVVF 51
Query: 204 HGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML-VY 261
            G  +    VAVK +L +    A  E K+  E+     H N++R   YC+E   R L + 
Sbjct: 52  QGSFQGRP-VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIA 105
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMN---IILGTAKGLTYLHEGLEPKVVHRDIKSS 318
             + N NL+  +         L  +   N   ++   A G+ +LH     K++HRD+K  
Sbjct: 106 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQ 162
Query: 319 NILL--------DKQWNPK-----LSDFGLAKLLGAERSYVTTRV---MGTFGYVAPEY- 361
           NIL+        D+Q   +     +SDFGL K L + +      +    GT G+ APE  
Sbjct: 163 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL 222
Query: 362 --ASTGMLNERSDVYSFGILIMEVIS-GRNPV--DYSR 394
             ++   L    D++S G +   ++S G++P    YSR
Sbjct: 223 EESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G+    ++ D   N  VAVK +   RG+  ++  K E+     +RH N+VR   
Sbjct: 26  IGSGNFGVA--RLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKE 81
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                 H  +V EY   G L + +  + G  S          ++    G++Y H     +
Sbjct: 82  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---Q 134
Query: 310 VVHRDIKSSNILLDKQWNPKLS--DFGLAK---LLGAERSYVTTRVMGTFGYVAPEYAST 364
           V HRD+K  N LLD    P+L   DFG +K   L    +S V     GT  Y+APE    
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIAPEVLLK 189
Query: 365 GMLNER-SDVYSFGILIMEVISGRNPVDYSRPP 396
              + + +DV+S G+ +  ++ G  P +    P
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 222

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W +  +     + F     +G G +G   +V 
Sbjct: 4   AAAAKKGSEQESVKEFLAKAKEDF-LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 63  HK--ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 173
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 230 YEMAAGYPPFFADQP 244

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W +  +     + F     +G G +G   +V 
Sbjct: 24  AAAAKKGSEQESVKEFLAKAKEDF-LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVK 82
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 83  HK--ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 140
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 141 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 193
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 194 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 250 YEMAAGYPPFFADQP 264

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W +  +     + F     +G G +G   +V 
Sbjct: 4   AAAAKKGSEQESVKEFLAKAKEDF-LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 63  HK--ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 173
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 230 YEMAAGYPPFFADQP 244

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G G YG V   Y   L     VAVK L     +   A + ++ E+  +  ++H+N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           L             E      L      ++     L+ E    ++    +GL Y+H    
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-- 150
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM 366
             ++HRD+K SN+ +++    ++ DFGLA+    E + YV TR      Y APE     M
Sbjct: 151 -GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWM 204
Query: 367 -LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTL 410
             N+  D++S G ++ E++ G+        PG   I Q+  +M +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF-----PGSDYIDQLKRIMEV 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  G   ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGXEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 194 IGEGGYGIVYHGVLEDNT-----NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   Y     D        V  K++L    Q EK    E+     + + ++V   
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 92
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G+  +     +V E     +L + LH        +T       +  T +G+ YLH     
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLE-LHKR---RKAVTEPEARYFMRQTIQGVQYLHNN--- 145
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGM 366
           +V+HRD+K  N+ L+   + K+ DFGLA  +    ER      + GT  Y+APE      
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCKKG 202
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYS 393
            +   D++S G ++  ++ G+ P + S
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 120/278 (43%), Gaps = 50/278 (17%)
Query: 145 ERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG-IVY 203
           +R  GS  G   +    A  P           +L+ L VS      E ++G G  G +V+
Sbjct: 5   KRKRGSRGGKKGRKSRIANIPNFEQ-------SLKNLVVS------EKILGYGSSGTVVF 51
Query: 204 HGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML-VY 261
            G  +    VAVK +L +    A  E K+  E+     H N++R   YC+E   R L + 
Sbjct: 52  QGSFQGRP-VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIA 105
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMN---IILGTAKGLTYLHEGLEPKVVHRDIKSS 318
             + N NL+  +         L  +   N   ++   A G+ +LH     K++HRD+K  
Sbjct: 106 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQ 162
Query: 319 NILL--------DKQWNPK-----LSDFGLAKLLGAERSYVTTRV---MGTFGYVAPEY- 361
           NIL+        D+Q   +     +SDFGL K L + +      +    GT G+ APE  
Sbjct: 163 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL 222
Query: 362 --ASTGMLNERSDVYSFGILIMEVIS-GRNPV--DYSR 394
             ++   L    D++S G +   ++S G++P    YSR
Sbjct: 223 EESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 151
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 204
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 151
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 204
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 12/220 (5%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNN-RGQAEKEFKVEVEAI 236
           +  EV  +       +G G YG+V     +     +AVK +      Q +K   ++++  
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 237 GR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
            R V     V   G         +  E +D  +L+++    +     +  +I   I +  
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
            K L +LH  L   V+HRD+K SN+L++     K+ DFG++  L    S   T   G   
Sbjct: 163 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTIDAGCKP 218
Query: 356 YVAPEYASTGMLNE----RSDVYSFGILIMEVISGRNPVD 391
           Y+APE  +  +  +    +SD++S GI ++E+   R P D
Sbjct: 219 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
           +R L++    +    VIG G +G V     + +  V    LL+     ++     F  E 
Sbjct: 67  IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 127 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAK----- 177
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
             TA+ +  L       ++HRD+K  N+LLDK  + KL+DFG    +           +G
Sbjct: 178 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVG 237
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
           T  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 170 LGWGHWYT--LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK 227
           L W   +T  ++E+++    F    VIG G +G V    +++   +    +LN     ++
Sbjct: 56  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 115
Query: 228 E----FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--DVGPHS 281
                F+ E + +     + +  L     +  H  LV +Y   G+L   L    D  P  
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 175
Query: 282 PLTWEI-RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
              + I  M + + +   L Y         VHRDIK  N+LLD   + +L+DFG    + 
Sbjct: 176 MARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMN 226
Query: 341 AERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNP 389
            + +  ++  +GT  Y++PE         G      D +S G+ + E++ G  P
Sbjct: 227 DDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G+    ++ D   N  VAVK +   RG+  ++  K E+     +RH N+VR   
Sbjct: 27  IGAGNFGVAR--LMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKE 82
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                 H  +V EY   G L + +  + G  S          ++    G++Y H     +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLIS---GVSYAHAM---Q 135
Query: 310 VVHRDIKSSNILLDKQWNP--KLSDFGLAK---LLGAERSYVTTRVMGTFGYVAPEYAST 364
           V HRD+K  N LLD    P  K++DFG +K   L    +S V     GT  Y+APE    
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV-----GTPAYIAPEVLLK 190
Query: 365 GMLNER-SDVYSFGILIMEVISGRNPVDYSRPP 396
              + + +DV+S G+ +  ++ G  P +    P
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 223

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 19/227 (8%)
Query: 175 WYTLRELEVSTNGFADENVIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFK- 230
           W T  +     + F     +G G +G   +V H   E   + A+K L   +    K+ + 
Sbjct: 25  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQIEH 82
Query: 231 --VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
              E   +  V    LV+L     + ++  +V EY+  G +   L        P      
Sbjct: 83  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYA 142
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
             I+L       YLH      +++RD+K  N+L+D+Q   +++DFG AK +       T 
Sbjct: 143 AQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 191
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
            + GT  Y+APE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 192 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 170 LGWGHWYT--LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK 227
           L W   +T  ++E+++    F    VIG G +G V    +++   +    +LN     ++
Sbjct: 72  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 131
Query: 228 E----FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--DVGPHS 281
                F+ E + +     + +  L     +  H  LV +Y   G+L   L    D  P  
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 191
Query: 282 PLTWEI-RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
              + I  M + + +   L Y         VHRDIK  N+LLD   + +L+DFG    + 
Sbjct: 192 MARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMN 242
Query: 341 AERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNP 389
            + +  ++  +GT  Y++PE         G      D +S G+ + E++ G  P
Sbjct: 243 DDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           LV+L     + ++  +V EY+  G +   L        P        I+L       YLH
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 144
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT  Y+APE   
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIIL 197
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY   G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           ++D+Q   K++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 MIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 19/227 (8%)
Query: 175 WYTLRELEVSTNGFADENVIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFK- 230
           W T  +     + F     +G G +G   +V H   E   + A+K L   +    K+ + 
Sbjct: 17  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQIEH 74
Query: 231 --VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
              E   +  V    LV+L     + ++  +V EY+  G +   L        P      
Sbjct: 75  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 134
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
             I+L       YLH      +++RD+K  N+L+D+Q   +++DFG AK +       T 
Sbjct: 135 AQIVLT----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TW 183
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
            + GT  Y+APE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 184 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY   G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           ++D+Q   K++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 MIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  G   ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGXEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P     P
Sbjct: 229 YEMAAGYPPFFADEP 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT  Y+AP    +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLVRL 247
           +GEG YG VY  +    N  VA+K +   R + E+E        EV  +  ++H+N++ L
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                      L++EY +N +L++++  D  P   ++  +  + +     G+ + H    
Sbjct: 99  KSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPD--VSMRVIKSFLYQLINGVNFCHSR-- 151
Query: 308 PKVVHRDIKSSNILL---DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
            + +HRD+K  N+LL   D    P  K+ DFGLA+  G      T  ++ T  Y  PE
Sbjct: 152 -RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 31/241 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
           E+V+GEG +  V   + L  +   AVK +    G        EVE + + + H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEGLE 307
            +  E     LV+E +  G++   +H     +     E+  ++++   A  L +LH    
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN-----ELEASVVVQDVASALDFLHNK-- 130
Query: 308 PKVVHRDIKSSNILLD--KQWNP-KLSDFGLA---KLLGAERSYVTTRVM---GTFGYVA 358
             + HRD+K  NIL +   Q +P K+ DFGL    KL G      T  ++   G+  Y+A
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 359 PEYA-----STGMLNERSDVYSFGILIMEVISGRNPV------DYSRPPGEVCIPQMNSL 407
           PE          + ++R D++S G+++  ++SG  P       D     GE C    N L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 408 M 408
Sbjct: 250 F 250

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
             YLH      +++RD+K  N+++D+Q   K++DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
             YLH      +++RD+K  N+++D+Q   K++DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
             YLH      +++RD+K  N+++D+Q   K++DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
             YLH      +++RD+K  N+++D+Q   K++DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 71/174 (40%), Gaps = 15/174 (8%)
Query: 221 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVG 278
           N    +K F+ EV     + H N+V+L           LV EY   G +  +L  HG   
Sbjct: 53  NSSSLQKLFR-EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK 111
Query: 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
                  E R          + Y H+     +VHRD+K+ N+LLD   N K++DFG +  
Sbjct: 112 EK-----EARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNE 162
Query: 339 LGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
                        G   Y APE +          DV+S G+++  ++SG  P D
Sbjct: 163 FTFGNK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEA-IGRV-RHKNLVRLLGY 250
           +G+G + +V   V           ++N +  + ++  K+E EA I R+ +H N+VRL   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E  H  L+++ +  G L +    D+      +     + I    + + + H+     V
Sbjct: 79  ISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 131
Query: 311 VHRDIKSSNILLDKQWN---PKLSDFGLA-KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           VHR++K  N+LL  +      KL+DFGLA ++ G ++++      GT GY++PE      
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDP 189
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
             +  D+++ G+++  ++ G  P
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLL 248
           +++G+G    V+ G  +   ++    + NN       + + + E E + ++ HKN+V+L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 249 GYCAEGA--HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
               E    H++L+ E+   G+L   L      +     E  + ++     G+ +L E  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNHLREN- 131
Query: 307 EPKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
              +VHR+IK  NI+     D Q   KL+DFG A+ L  +  +V+  + GT  Y+ P+  
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMY 187
Query: 363 STGMLNERS--------DVYSFGILIMEVISGRNP 389
              +L +          D++S G+      +G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W T  +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H   E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  HK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+  G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           L+D+Q   +++DFG AK +       T  + GT   +APE   +   N+  D ++ G+LI
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G+    ++ D   N  VAVK +   RG+      K E+     +RH N+VR   
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYI--ERGEKIAANVKREIINHRSLRHPNIVRFKE 82
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                 H  +V EY   G L + +  + G  S          ++    G++Y H     +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---Q 135
Query: 310 VVHRDIKSSNILLDKQWNPKLS--DFGLAK---LLGAERSYVTTRVMGTFGYVAPEYAST 364
           V HRD+K  N LLD    P+L   DFG +K   L    +S V     GT  Y+APE    
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIAPEVLLK 190
Query: 365 GMLNER-SDVYSFGILIMEVISGRNPVDYSRPP 396
              + + +DV+S G+ +  ++ G  P +    P
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYG---IVY 203
           AA +  GS  ++V   +           W    +     + F     +G G +G   +V 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDF-LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260
           H  +E   + A+K L   +    K+ +    E   +  V    LV+L     + ++  +V
Sbjct: 62  H--METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY   G +   L        P        I+L       YLH      +++RD+K  N+
Sbjct: 120 MEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 321 LLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
           ++D+Q   +++DFG AK +       T  + GT  Y+APE   +   N+  D ++ G+LI
Sbjct: 173 MIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 381 MEVISGRNPVDYSRP 395
            E+ +G  P    +P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA-IGRV-RHKNLVRLLGY 250
           +G+G + +V   + +      A K +   +  A    K+E EA I R+ +H N+VRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E     LV++ +  G L +    D+      +     + I    + + + H      +
Sbjct: 72  ISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHCIQQILESVNHCHLN---GI 124
Query: 311 VHRDIKSSNILL---DKQWNPKLSDFGLA-KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           VHRD+K  N+LL    K    KL+DFGLA ++ G ++++      GT GY++PE      
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKDP 182
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
             +  D+++ G+++  ++ G  P
Sbjct: 183 YGKPVDMWACGVILYILLVGYPP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA-IGRV-RHKNLVRLLGY 250
           +G+G + +V   + +      A K +   +  A    K+E EA I R+ +H N+VRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E     LV++ +  G L +    D+      +     + I    + + + H      +
Sbjct: 72  ISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHCIQQILESVNHCHLN---GI 124
Query: 311 VHRDIKSSNILL---DKQWNPKLSDFGLA-KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           VHRD+K  N+LL    K    KL+DFGLA ++ G ++++      GT GY++PE      
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKDP 182
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
             +  D+++ G+++  ++ G  P
Sbjct: 183 YGKPVDMWACGVILYILLVGYPP 205

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLL 248
           +++G+G    V+ G  +   ++    + NN       + + + E E + ++ HKN+V+L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 249 GYCAEGA--HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
               E    H++L+ E+   G+L   L      +     E  + ++     G+ +L E  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNHLREN- 131
Query: 307 EPKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
              +VHR+IK  NI+     D Q   KL+DFG A+ L  +  +V   + GT  Y+ P+  
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMY 187
Query: 363 STGMLNERS--------DVYSFGILIMEVISGRNP 389
              +L +          D++S G+      +G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 41/241 (17%)
Query: 186 NGFADENVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKN 243
           N    E ++G G  G +V+ G  +    VAVK +L +    A  E K+  E+     H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALMEIKLLTESDD---HPN 70
Query: 244 LVRLLGYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN---IILGTAKGL 299
           ++R   YC+E   R L +   + N NL+  +         L  +   N   ++   A G+
Sbjct: 71  VIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 300 TYLHEGLEPKVVHRDIKSSNILL--------DKQWNPK-----LSDFGLAKLLGAERSYV 346
            +LH     K++HRD+K  NIL+        D+Q   +     +SDFGL K L + +   
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 347 TTRV---MGTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVIS-GRNPV--DYS 393
              +    GT G+ APE         +   L    D++S G +   ++S G++P    YS
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 394 R 394
           R
Sbjct: 246 R 246

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
           IG+G +G V+     +    VA+K +L    + EKE F +    E++ +  ++H+N+V L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 248 LGYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +  C   A           LV+++ ++ +L   L   +   +    +  M ++L    GL
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN---GL 138
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGY 356
            Y+H     K++HRD+K++N+L+ +    KL+DFGLA+     ++    R      T  Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
             PE     +L ER      D++  G ++ E+ + R+P+
Sbjct: 196 RPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 12/218 (5%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGR 238
           +EV  +       +G G YG+V     +     +AVK +      Q +K   ++++   R
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 239 -VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
            V     V   G         +  E +D  +L+++    +     +  +I   I +   K
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L +LH  L   V+HRD+K SN+L++     K+ DFG++  L  + +       G   Y+
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYM 176
Query: 358 APEYASTGMLNE----RSDVYSFGILIMEVISGRNPVD 391
           APE  +  +  +    +SD++S GI ++E+   R P D
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 31/241 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
           E+V+GEG +  V   + L  +   AVK +    G        EVE + + + H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEGLE 307
            +  E     LV+E +  G++   +H     +     E+  ++++   A  L +LH    
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN-----ELEASVVVQDVASALDFLHNK-- 130
Query: 308 PKVVHRDIKSSNILLD--KQWNP-KLSDFGLA---KLLGAERSYVTTRVM---GTFGYVA 358
             + HRD+K  NIL +   Q +P K+ DF L    KL G      T  ++   G+  Y+A
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 359 PEYA-----STGMLNERSDVYSFGILIMEVISGRNPV------DYSRPPGEVCIPQMNSL 407
           PE          + ++R D++S G+++  ++SG  P       D     GE C    N L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 408 M 408
Sbjct: 250 F 250

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 96/247 (38%), Gaps = 56/247 (22%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE------KEFKVEVEAIGRVRHKNLVRL 247
           IG+G YG+V   +      +    ++N     +      +  K EV  + ++ H N+ RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 248 LGYCAEGAHRMLVYEYIDNGNL-------------------------------EQWLHGD 276
                +  +  LV E    G+L                               E+ ++G 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 277 V-GPHSPLTWEIR----MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQWNPK 329
           + G    L +  R     NI+      L YLH      + HRDIK  N L   +K +  K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 330 LSDFGLAK---LLGAERSYVTTRVMGTFGYVAPEYASTGMLNE----RSDVYSFGILIME 382
           L DFGL+K    L     Y  T   GT  +VAPE  +T   NE    + D +S G+L+  
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT--NESYGPKCDAWSAGVLLHL 268
Query: 383 VISGRNP 389
           ++ G  P
Sbjct: 269 LLMGAVP 275

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
           IG+G +G V+     +    VA+K +L    + EKE F +    E++ +  ++H+N+V L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 248 LGYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +  C   A           LV+++ ++ +L   L   +   +    +  M ++L    GL
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN---GL 137
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGY 356
            Y+H     K++HRD+K++N+L+ +    KL+DFGLA+     ++    R      T  Y
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
             PE     +L ER      D++  G ++ E+ + R+P+
Sbjct: 195 RPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
           IG+G +G V+     +    VA+K +L    + EKE F +    E++ +  ++H+N+V L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 248 LGYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +  C   A           LV+++ ++ +L   L   +   +    +  M ++L    GL
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN---GL 138
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGY 356
            Y+H     K++HRD+K++N+L+ +    KL+DFGLA+     ++    R      T  Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
             PE     +L ER      D++  G ++ E+ + R+P+
Sbjct: 196 RPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
           IG+G +G V+     +    VA+K +L    + EKE F +    E++ +  ++H+N+V L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 248 LGYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +  C   A           LV+++ ++ +L   L   +   +    +  M ++L    GL
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN---GL 138
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGY 356
            Y+H     K++HRD+K++N+L+ +    KL+DFGLA+     ++    R      T  Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
             PE     +L ER      D++  G ++ E+ + R+P+
Sbjct: 196 RPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G+    ++ D   N  VAVK +   RG+  ++  K E+     +RH N+VR   
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKE 82
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                 H  +V EY   G L + +  + G  S          ++    G++Y H     +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---Q 135
Query: 310 VVHRDIKSSNILLDKQWNPKLS--DFGLAK---LLGAERSYVTTRVMGTFGYVAPEYAST 364
           V HRD+K  N LLD    P+L    FG +K   L    +S V     GT  Y+APE    
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV-----GTPAYIAPEVLLK 190
Query: 365 GMLNER-SDVYSFGILIMEVISGRNPVDYSRPP 396
              + + +DV+S G+ +  ++ G  P +    P
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 223

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 194 IGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           +G+G +  ++ GV  +         T V +K L        + F      + ++ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
              G C  G   +LV E++  G+L+ +L  +    + L W++ +   L  A     +H  
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-WKLEVAKQLAAA-----MHFL 129
Query: 306 LEPKVVHRDIKSSNILL-----DKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            E  ++H ++ + NILL      K  NP   KLSD G++ +    +  +  R+     +V
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERI----PWV 184
Query: 358 APE-YASTGMLNERSDVYSFGILIMEVISG 386
            PE   +   LN  +D +SFG  + E+ SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           EV  + ++ H N+++L  +  +  +  LV E    G L      ++      + E+   +
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFS-EVDAAV 125
Query: 292 ILGTA-KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVT 347
           I+     G TYLH+     +VHRD+K  N+LL+ +      K+ DFGL+     E     
Sbjct: 126 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKM 180
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
              +GT  Y+APE       +E+ DV+S G+++  ++ G  P
Sbjct: 181 KERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPP 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           EV  + ++ H N+++L  +  +  +  LV E    G L      ++      + E+   +
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFS-EVDAAV 108
Query: 292 ILGTA-KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVT 347
           I+     G TYLH+     +VHRD+K  N+LL+ +      K+ DFGL+     E     
Sbjct: 109 IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKM 163
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
              +GT  Y+APE       +E+ DV+S G+++  ++ G  P
Sbjct: 164 KERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPP 204

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 194 IGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +G G +G V+   +ED       AVK +     +AE     E+ A   +    +V L G 
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 153
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA-KGLTYLHEGLEPK 309
             EG    +  E ++ G+L Q +            E R    LG A +GL YLH     +
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVK-----EQGCLPEDRALYYLGQALEGLEYLHSR---R 205
Query: 310 VVHRDIKSSNILLDKQWN-PKLSDFGLAKLL---GAERSYVT-TRVMGTFGYVAPEYAST 364
           ++H D+K+ N+LL    +   L DFG A  L   G  +S +T   + GT  ++APE    
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              + + DV+S   +++ +++G +P
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLG 249
           IG G +G+    ++ D   N  VAVK +   RG+  ++  K E+     +RH N+VR   
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKE 82
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                 H  +V EY   G L + +  + G  S          ++    G++Y H     +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---Q 135
Query: 310 VVHRDIKSSNILLDKQWNPKLS--DFGLAK--LLGAERSYVTTRVMGTFGYVAPEYASTG 365
           V HRD+K  N LLD    P+L    FG +K  +L ++        +GT  Y+APE     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ----PKDTVGTPAYIAPEVLLKK 191
Query: 366 MLNER-SDVYSFGILIMEVISGRNPVDYSRPP 396
             + + +DV+S G+ +  ++ G  P +    P
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 223

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 194 IGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           +G+G +  ++ GV  +         T V +K L        + F      + ++ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY-LHE 304
              G C  G   +LV E++  G+L+ +L  +    + L W+      L  AK L + +H 
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-WK------LEVAKQLAWAMHF 128
Query: 305 GLEPKVVHRDIKSSNILL-----DKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
             E  ++H ++ + NILL      K  NP   KLSD G++ +    +  +  R+     +
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERI----PW 183
Query: 357 VAPE-YASTGMLNERSDVYSFGILIMEVISG 386
           V PE   +   LN  +D +SFG  + E+ SG
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 38/79 (48%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
            HRD+K  NIL+       L DFG+A     E+       +GT  Y APE  S      R
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 371 SDVYSFGILIMEVISGRNP 389
           +D+Y+   ++ E ++G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 186 NGFADENVIGEGGYGIVYHGVLEDNT--NVAVKNLLNNRGQAE----KEFKVEVEAIGRV 239
           + +  +++IG G YG VY    + NT  NVA+K +  NR   +    K    E+  + R+
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAY-DKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRL 82
Query: 240 RHKNLVRLLGYCAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           +   ++RL              + +   I + +L++     +     LT E    I+   
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF----LTEEHIKTILYNL 138
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
             G  ++HE     ++HRD+K +N LL++  + K+ DFGLA+ + +E+ 
Sbjct: 139 LLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 30/227 (13%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE-----------KE 228
           EL    + +  +  I  G YG V  GV  +   VA+K + N                 K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 229 FKVEVEAIGRVRHKNLVRL----LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
              E+  +    H N++ L    + +     H++ +   +   +L Q +H      SP  
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
            +  M  IL    GL  LHE     VVHRD+   NILL    +  + DF LA+   A+ +
Sbjct: 136 IQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 345 ---YVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
              YVT R      Y APE         +  D++S G ++ E+ + +
Sbjct: 190 KTHYVTHR-----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAE----KEFKVEVEAIGRVR 240
           + +  +++IG G YG VY    ++ N NVA+K +  NR   +    K    E+  + R++
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLK 85
Query: 241 HKNLVRLLGYCAE----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
              ++RL              + +   I + +L++     +         I  N++LG  
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEK 145
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
               ++HE     ++HRD+K +N LL++  + K+ DFGLA+ + +++ 
Sbjct: 146 ----FIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL--EDNT--NVAVKNLLNNRGQAE--KEFKV 231
           L ++ +    F    ++G+G +G V    L  ED +   VAVK L  +   +   +EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHR------MLVYEYIDNGNLEQWLHGDVGPHSP--L 283
           E   +    H ++ +L+G       +      M++  ++ +G+L  +L       +P  L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
             +  +  ++  A G+ YL        +HRD+ + N +L +     ++DFGL++ + +  
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 344 SY---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            Y     +++     ++A E  +  +    SDV++FG+ + E+++ G+ P
Sbjct: 192 YYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
           +G G +GIV+  V   +    +   +  +G  +   K E+  +   RH+N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
               ++++E+I   ++ + ++        L     ++ +    + L +LH      + H 
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 314 DIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTF-GYVAPEYASTGMLNER 370
           DI+  NI+   + +   K+ +FG A+ L    ++   R++ T   Y APE     +++  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTA 183
Query: 371 SDVYSFGILIMEVISGRNP 389
           +D++S G L+  ++SG NP
Sbjct: 184 TDMWSLGTLVYVLLSGINP 202

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 30/227 (13%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE-----------KE 228
           EL    + +  +  I  G YG V  GV  +   VA+K + N                 K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 229 FKVEVEAIGRVRHKNLVRL----LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
              E+  +    H N++ L    + +     H++ +   +   +L Q +H      SP  
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
            +  M  IL    GL  LHE     VVHRD+   NILL    +  + DF LA+   A+ +
Sbjct: 136 IQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 345 ---YVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
              YVT R      Y APE         +  D++S G ++ E+ + +
Sbjct: 190 KTHYVTHR-----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAKLLGAERSY 345
           + +I    +G+ YLH+     +VH D+K  NILL   +   + K+ DFG+++ +G   + 
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HAC 188
Query: 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
               +MGT  Y+APE  +   +   +D+++ GI+   +++  +P
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 194 IGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +G G +G V+   +ED       AVK +     +AE     E+ A   +    +V L G 
Sbjct: 82  LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 134
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA-KGLTYLHEGLEPK 309
             EG    +  E ++ G+L Q +            E R    LG A +GL YLH     +
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVK-----EQGCLPEDRALYYLGQALEGLEYLHSR---R 186
Query: 310 VVHRDIKSSNILLDKQWN-PKLSDFGLAKLL---GAERSYVT-TRVMGTFGYVAPEYAST 364
           ++H D+K+ N+LL    +   L DFG A  L   G  +  +T   + GT  ++APE    
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              + + DV+S   +++ +++G +P
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +G G +G V H + +  T    AVK +     + E     E+ A   +    +V L G  
Sbjct: 66  VGRGSFGEV-HRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 119
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA-KGLTYLHEGLEPKV 310
            EG    +  E ++ G+L Q +            E R    LG A +GL YLH     ++
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHT---RRI 171
Query: 311 VHRDIKSSNILLDKQWN-PKLSDFGLAKLL---GAERSYVT-TRVMGTFGYVAPEYASTG 365
           +H D+K+ N+LL    +   L DFG A  L   G  +S +T   + GT  ++APE     
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 366 MLNERSDVYSFGILIMEVISGRNP-VDYSRPP 396
             + + D++S   +++ +++G +P   Y R P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 16/176 (9%)
Query: 229 FKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
           F+VE + A   +    +V L G   EG    +  E ++ G+L Q +            E 
Sbjct: 110 FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-----QMGCLPED 164
Query: 288 RMNIILGTA-KGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLL---GAE 342
           R    LG A +GL YLH     +++H D+K+ N+LL    +   L DFG A  L   G  
Sbjct: 165 RALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 343 RSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP-VDYSRPP 396
           +S +T   + GT  ++APE       + + D++S   +++ +++G +P   Y R P
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 277

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 194 IGEGGYGIVYHGVLEDNT--NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           +G G +G V H + +  T    AVK +     + E     E+ A   +    +V L G  
Sbjct: 82  VGRGSFGEV-HRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 135
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA-KGLTYLHEGLEPKV 310
            EG    +  E ++ G+L Q +            E R    LG A +GL YLH     ++
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHT---RRI 187
Query: 311 VHRDIKSSNILLDKQWN-PKLSDFGLAKLL---GAERSYVT-TRVMGTFGYVAPEYASTG 365
           +H D+K+ N+LL    +   L DFG A  L   G  +S +T   + GT  ++APE     
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 366 MLNERSDVYSFGILIMEVISGRNP-VDYSRPP 396
             + + D++S   +++ +++G +P   Y R P
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 279

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 188 FADENVIGEGGYGIVYH-GVLEDNTNVAVKNLLNN-RGQAEKEFKV-EVEAIGRV-RHKN 243
           F   + +G G YG V+     ED    AVK  ++  RG  ++  K+ EV +  +V +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 244 LVRLLGYCAEGAHRMLVYEYID---NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
            VRL     EG    L  E        + E W  G   P + +   +R  ++      L 
Sbjct: 119 CVRLEQAWEEGGILYLQTELCGPSLQQHCEAW--GASLPEAQVWGYLRDTLL-----ALA 171
Query: 301 YLH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           +LH +GL    VH D+K +NI L  +   KL DFGL   LG   +       G   Y+AP
Sbjct: 172 HLHSQGL----VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAP 225
Query: 360 EYASTGMLNERSDVYSFGILIMEV 383
           E    G     +DV+S G+ I+EV
Sbjct: 226 ELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 50/241 (20%)
Query: 185 TNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR 240
           +N F  E+ IGEG +  VY    +        +A+K+L+            E++ +    
Sbjct: 20  SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR--IAAELQCLTVAG 77
Query: 241 HKNLVRLLGYC-AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
            ++ V  + YC  +  H ++   Y+++ +    L+        L+++     +L   K L
Sbjct: 78  GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKAL 130
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLA-----------KLLGAE----- 342
             +H+     +VHRD+K SN L +++     L DFGLA           K + +E     
Sbjct: 131 KRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQER 187
Query: 343 ------------RSYVTTRVMGTFGYVAPEYASTGMLNERS--DVYSFGILIMEVISGRN 388
                       R  V  R  GT G+ APE   T   N+ +  D++S G++ + ++SGR 
Sbjct: 188 CSQNKCSICLSRRQQVAPRA-GTPGFRAPEVL-TKCPNQTTAIDMWSAGVIFLSLLSGRY 245
Query: 389 P 389
           P
Sbjct: 246 P 246
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	424
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-153
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-144
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-121
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-80
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-63
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-48
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-38
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  436 bits (1123), Expect = e-153
 Identities = 107/241 (44%), Positives = 161/241 (66%), Gaps = 2/241 (0%)

Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL 218
           V A   PEV HLG    ++LREL+V+++ F+++N++G GG+G VY G L D T VAVK L
Sbjct: 4   VPAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62

Query: 219 LNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
              R Q  E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L    
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122

Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
               PL W  R  I LG+A+GL YLH+  +PK++HRD+K++NILLD+++   + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
           L+  + ++VTT V GT G++APEY STG  +E++DV+ +G++++E+I+G+   D +R   
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 398 E 398
           +
Sbjct: 243 D 243

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  413 bits (1065), Expect = e-144
 Identities = 97/254 (38%), Positives = 153/254 (60%), Gaps = 4/254 (1%)

Query: 149 GSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE 208
           GS +     ++  A++         +   L +LE +TN F  + +IG G +G VY GVL 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 209 DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268
           D   VA+K       Q  +EF+ E+E +   RH +LV L+G+C E    +L+Y+Y++NGN
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
           L++ L+G   P   ++WE R+ I +G A+GL YLH      ++HRD+KS NILLD+ + P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178

Query: 329 KLSDFGLAKL-LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
           K++DFG++K     ++++++T V GT GY+ PEY   G L E+SDVYSFG+++ EV+  R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 388 NPVDYSRPPGEVCI 401
           + +  S P   V +
Sbjct: 239 SAIVQSLPREMVNL 252

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  352 bits (906), Expect = e-121
 Identities = 92/234 (39%), Positives = 142/234 (60%), Gaps = 17/234 (7%)

Query: 174 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----G 223
           H ++  EL+  TN F +       N +GEGG+G+VY G + +NT VAVK L         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
           + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+ NG+L   L    G   PL
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130

Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE- 342
           +W +R  I  G A G+ +LH   E   +HRDIKS+NILLD+ +  K+SDFGLA+      
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
           ++ +T+R++GT  Y+APE    G +  +SD+YSFG++++E+I+G   VD  R P
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  250 bits (641), Expect = 1e-80
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 24/240 (10%)

Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
               L   +       V   G +G V+   L  N  VAVK +   + +   + + EV ++
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSL 72

Query: 237 GRVRHKNLVRLLGYCAEGAH----RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
             ++H+N+++ +G    G        L+  + + G+L  +L       + ++W    +I 
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127

Query: 293 LGTAKGLTYLHE-------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
              A+GL YLHE       G +P + HRDIKS N+LL       ++DFGLA    A +S 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 346 V-TTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
             T   +GT  Y+APE     +  +     R D+Y+ G+++ E+ S     D       +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (521), Expect = 6e-63
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 22/276 (7%)

Query: 151 HHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN 210
           HH      ++    P   +L +       ++++       +  IG G +G V+       
Sbjct: 3   HHHH-HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60

Query: 211 TNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268
           ++VAVK L+      +   EF  EV  + R+RH N+V  +G   +  +  +V EY+  G+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
           L + LH   G    L    R+++    AKG+ YLH    P +VHR++KS N+L+DK++  
Sbjct: 121 LYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178

Query: 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
           K+ DFGL++L  A     +    GT  ++APE       NE+SDVYSFG+++ E+ + + 
Sbjct: 179 KVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237

Query: 389 P--------------VDYSRPP-GEVCIPQMNSLMT 409
           P                  R        PQ+ +++ 
Sbjct: 238 PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  196 bits (501), Expect = 1e-59
 Identities = 59/250 (23%), Positives = 92/250 (36%), Gaps = 36/250 (14%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIG 237
           E  +  +      +IG G YG VY G L D   VAVK          + F  E     + 
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62

Query: 238 RVRHKNLVRLLGYCAEG-----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
            + H N+ R +              +LV EY  NG+L ++L           W     + 
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLA 117

Query: 293 LGTAKGLTYLHE------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG------ 340
               +GL YLH         +P + HRD+ S N+L+       +SDFGL+  L       
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 341 -AERSYVTTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISGRNPVDY 392
             E        +GT  Y+APE     +         ++ D+Y+ G++  E+      +  
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 393 SRPPGEVCIP 402
                E  + 
Sbjct: 238 GESVPEYQMA 247

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (490), Expect = 2e-58
 Identities = 71/245 (28%), Positives = 108/245 (44%), Gaps = 27/245 (11%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
            +       E V+G G +G+V         +VA+K + +      K F VE+  + RV H
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNH 60

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
            N+V+L G C       LV EY + G+L   LHG   P    T    M+  L  ++G+ Y
Sbjct: 61  PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           LH      ++HRD+K  N+LL       K+ DFG A     +     T   G+  ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE 173

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP-VDYSRPPGEV---------------CIPQM 404
                  +E+ DV+S+GI++ EVI+ R P  +   P   +                   +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233

Query: 405 NSLMT 409
            SLMT
Sbjct: 234 ESLMT 238

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (485), Expect = 6e-58
 Identities = 68/265 (25%), Positives = 127/265 (47%), Gaps = 46/265 (17%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE-------KEFK 230
           R   ++ N    E  IG+GG+G+V+ G  ++D + VA+K+L+    + E       +EF+
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
            EV  +  + H N+V+L G         +V E++  G+L   L        P+ W +++ 
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGLAKLLGAERSY 345
           ++L  A G+ Y+     P +VHRD++S NI L           K++DFGL++    +  +
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVH 181

Query: 346 VTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGRNPVDYS---------- 393
             + ++G F ++APE   A      E++D YSF +++  +++G  P  +           
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFI 239

Query: 394 --------RPP-GEVCIPQMNSLMT 409
                   RP   E C P++ +++ 
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIE 264

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (483), Expect = 7e-58
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 40/258 (15%)

Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLL----NNRGQAEKEFKVEVEAI 236
           LE+       E +IG GG+G VY         VAVK        +  Q  +  + E +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             ++H N++ L G C +  +  LV E+   G L + L G       +  +I +N  +  A
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIA 115

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDK--------QWNPKLSDFGLAKLLGAERSYVTT 348
           +G+ YLH+     ++HRD+KSSNIL+ +            K++DFGLA+     R+   +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS 173

Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS--------------- 393
              G + ++APE     M ++ SDV+S+G+L+ E+++G  P  +                
Sbjct: 174 AA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGVAMNK 230

Query: 394 -RPP-GEVCIPQMNSLMT 409
              P    C      LM 
Sbjct: 231 LALPIPSTCPEPFAKLME 248

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  188 bits (480), Expect = 2e-57
 Identities = 50/253 (19%), Positives = 97/253 (38%), Gaps = 32/253 (12%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAI 236
           +   +          + E   G ++ G      ++ VK L       +  ++F  E   +
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61

Query: 237 GRVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               H N++ +LG C      H  L+  ++  G+L   LH   G +  +     +   L 
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALD 119

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
            A+G+ +LH  LEP +    + S ++++D+    ++S   +        S+ +   M   
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAP 172

Query: 355 GYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNP-VDYS-------------RPP- 396
            +VAPE             +D++SF +L+ E+++   P  D S             RP  
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232

Query: 397 GEVCIPQMNSLMT 409
                P ++ LM 
Sbjct: 233 PPGISPHVSKLMK 245

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (481), Expect = 5e-57
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 20/219 (9%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
             V+G+G +G        +    + +K L+    + ++ F  EV+ +  + H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              +      + EYI  G L   +       S   W  R++     A G+ YLH      
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMN 128

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLL-------------GAERSYVTTRVMGTFGY 356
           ++HRD+ S N L+ +  N  ++DFGLA+L+                       V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           +APE  +    +E+ DV+SFGI++ E+I   N      P
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (457), Expect = 9e-54
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 15/219 (6%)

Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 234
              + E+          IG G +G VY G    + +VAVK L       Q  + FK EV 
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72

Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
            + + RH N++  +GY        +V ++ +  +L   LH      +    +  ++I   
Sbjct: 73  VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQ 128

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT 353
           TA+G+ YLH      ++HRD+KS+NI L +    K+ DFGLA        S+   ++ G+
Sbjct: 129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

Query: 354 FGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNP 389
             ++APE      +   + +SDVY+FGI++ E+++G+ P
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  179 bits (456), Expect = 3e-53
 Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 24/228 (10%)

Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 234
            L+E ++         +IG+G +G VYHG    +  VA++ +   R      K FK EV 
Sbjct: 24  FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81

Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
           A  + RH+N+V  +G C    H  ++        L   +         L       I   
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM--- 351
             KG+ YLH      ++H+D+KS N+  D      ++DFGL  + G  ++      +   
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 352 -GTFGYVAPEYASTGML---------NERSDVYSFGILIMEVISGRNP 389
            G   ++APE                ++ SDV++ G +  E+ +   P
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  176 bits (449), Expect = 2e-52
 Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 32/241 (13%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIGRVRHKNLVRLL 248
              +G+G YG V+ G      NVAVK       + EK +  E E      +RH+N++  +
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 249 GYCAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
                  H      L+  Y + G+L  +L       + L     + I+L  A GL +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 305 GLE-----PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGY 356
            +      P + HRD+KS NIL+ K     ++D GLA +      +        +GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 357 VAPE------YASTGMLNERSDVYSFGILIMEVISGRNP---VDYSRPPGEVCIPQMNSL 407
           +APE              +R D+++FG+++ EV         V+  +PP    +P   S 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 408 M 408
            
Sbjct: 244 E 244

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  173 bits (440), Expect = 1e-50
 Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 28/238 (11%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
              IG+G YG V+ G       VAVK +     +A    + E+     +RH+N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 251 CAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 304
             +G        L+ +Y +NG+L  +L       + L  +  + +   +  GL +LH   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 305 ---GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYVA 358
                +P + HRD+KS NIL+ K     ++D GLA    ++ +         +GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 359 PE------YASTGMLNERSDVYSFGILIMEVISGRNP---VDYSRPPGEVCIPQMNSL 407
           PE        +       +D+YSFG+++ EV         V+  + P    +P   S 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (423), Expect = 3e-48
 Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 36/242 (14%)

Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEV 233
                R + +       +  IG+G +G V+ G       VAVK       + E+ +  E 
Sbjct: 37  QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREA 85

Query: 234 E--AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
           E      +RH+N++  +              LV +Y ++G+L  +L+        +T E 
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEG 140

Query: 288 RMNIILGTAKGLTYLHEGLE-----PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
            + + L TA GL +LH  +      P + HRD+KS NIL+ K     ++D GLA    + 
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200

Query: 343 RS---YVTTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
                      +GT  Y+APE              +R+D+Y+ G++  E+    +     
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

Query: 394 RP 395
             
Sbjct: 261 ED 262

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  139 bits (353), Expect = 2e-38
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 15/202 (7%)

Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G GG   VY    ED   N  VA+K +      + +  K F+ EV    ++ H+N+V +
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
           +    E     LV EYI+   L +++      H PL+ +  +N       G+ + H+   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM-- 130

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
            ++VHRDIK  NIL+D     K+ DFG+AK L       T  V+GT  Y +PE A     
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 368 NERSDVYSFGILIMEVISGRNP 389
           +E +D+YS GI++ E++ G  P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  141 bits (357), Expect = 3e-38
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 12/204 (5%)

Query: 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
              IG G +G V+ G L  DNT VAVK+         + +F  E   + +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           G C +     +V E +  G+   +L  +      L  +  + ++   A G+ YL      
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE---SK 232

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGM 366
             +HRD+ + N L+ ++   K+SDFG+++   A+  Y  +  +        APE  + G 
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGR 291

Query: 367 LNERSDVYSFGILIMEVIS-GRNP 389
            +  SDV+SFGIL+ E  S G +P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (347), Expect = 1e-37
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 18/229 (7%)

Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG 223
            P  + LG+G W      E+          +G G +G+V +G      +VA+K +     
Sbjct: 8   APSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGS 60

Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
            +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L          
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RF 117

Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
             +  + +     + + YL      + +HRD+ + N L++ Q   K+SDFGL++ +    
Sbjct: 118 QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LD 172

Query: 344 SYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              T+ V   F      PE       + +SD+++FG+L+ E+ S G+ P
Sbjct: 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  135 bits (342), Expect = 3e-37
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 12/202 (5%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
              IG G +G+V+ G   +   VA+K +      +E++F  E E + ++ H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
           C E A   LV E++++G L  +L    G       E  + + L   +G+ YL    E  V
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 125

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLN 368
           +HRD+ + N L+ +    K+SDFG+ + +       T+     F     +PE  S    +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 369 ERSDVYSFGILIMEVIS-GRNP 389
            +SDV+SFG+L+ EV S G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  134 bits (339), Expect = 1e-36
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 18/220 (8%)

Query: 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVE 232
           GH       E+          +G G +G+V  G  +   +VAVK +      +E EF  E
Sbjct: 1   GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQE 53

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
            + + ++ H  LV+  G C++     +V EYI NG L  +L    G     +  + M   
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEM--C 110

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
               +G+ +L      + +HRD+ + N L+D+    K+SDFG+ + +        + V  
Sbjct: 111 YDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGT 165

Query: 353 TFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            F     APE       + +SDV++FGIL+ EV S G+ P
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  134 bits (339), Expect = 1e-36
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 16/207 (7%)

Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLV 245
           +  +G G +G V  G     +    VAVK L N       + E   E   + ++ +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           R++G C   +  MLV E  + G L ++L      +  +  +  + ++   + G+ YL E 
Sbjct: 82  RMIGICEAESW-MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL-E- 134

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAS 363
            E   VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +  G +   + APE  +
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNP 389
               + +SDV+SFG+L+ E  S G+ P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (339), Expect = 2e-36
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +  +G G +G V  GV    +   +VA+K L         +E   E + + ++ +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           L+G C   A  MLV E    G L ++L G       +       ++   + G+ YL E  
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE-- 128

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 364
               VHRD+ + N+LL  +   K+SDFGL+K LGA+ SY T R  G +   + APE  + 
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 365 GMLNERSDVYSFGILIMEVIS-GRNP 389
              + RSDV+S+G+ + E +S G+ P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (346), Expect = 3e-36
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 8/200 (4%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           E  +G+G +G V+ G     T VA+K L      + + F  E + + ++RH+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E     +V EY+  G+L  +L G+ G +  L     +++    A G+ Y+        
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER---MNY 301

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           VHRD++++NIL+ +    K++DFGLA+L+                + APE A  G    +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 371 SDVYSFGILIMEVIS-GRNP 389
           SDV+SFGIL+ E+ + GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (350), Expect = 4e-36
 Identities = 71/320 (22%), Positives = 124/320 (38%), Gaps = 14/320 (4%)

Query: 77  PTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIG 136
                + + ++ +++  D       +     +           +   P++  +       
Sbjct: 227 TKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDT 286

Query: 137 KDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGE 196
            +     PE A  +               E            +      N    +  +G 
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGC 346

Query: 197 GGYGIVYHGVLE---DNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
           G +G V  GV        +VA+K L         +E   E + + ++ +  +VRL+G C 
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406

Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
             A  MLV E    G L ++L G       +       ++   + G+ YL E      VH
Sbjct: 407 AEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE---KNFVH 459

Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNER 370
           R++ + N+LL  +   K+SDFGL+K LGA+ SY T R  G +     APE  +    + R
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519

Query: 371 SDVYSFGILIMEVIS-GRNP 389
           SDV+S+G+ + E +S G+ P
Sbjct: 520 SDVWSYGVTMWEALSYGQKP 539

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (338), Expect = 5e-36
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 14/207 (6%)

Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
           E +IG G  G V +G L    + +  VA+K L     + ++ +F  E   +G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           RL G    G   M+V EY++NG+L+ +L    G     T    + ++ G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLS-- 168

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYAS 363
            +   VHRD+ + N+L+D     K+SDFGL+++L  +     T   G       APE  +
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNP 389
               +  SDV+SFG+++ EV++ G  P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  136 bits (344), Expect = 9e-36
 Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 18/230 (7%)

Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR 222
           T       +  W      E+       ++ +G G YG VY GV +  +  VAVK L    
Sbjct: 204 TIYGVSPNYDKW------EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED 256

Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
               +EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +L         
Sbjct: 257 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QE 314

Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
           ++  + + +    +  + YL    +   +HR++ + N L+ +    K++DFGL++L+   
Sbjct: 315 VSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--T 369

Query: 343 RSYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               T      F     APE  +    + +SDV++FG+L+ E+ + G +P
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (336), Expect = 1e-35
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)

Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
             V+G G +G VY G+           VA+K L      +A KE   E   +  V + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
            RLLG C   +   L+ + +  G L  ++         +  +  +N  +  AKG+ YL +
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYV 357
               ++VHRD+ + N+L+    + K++DFGLAKLLGAE               M      
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------ 186

Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           A E     +   +SDV+S+G+ + E+++ G  P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  132 bits (334), Expect = 2e-35
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
             V+G G +G V+ GV           V +K + +  G Q+ +     + AIG + H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           VRLLG C  G+   LV +Y+  G+L   +    G   P      +N  +  AKG+ YL E
Sbjct: 78  VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
                +VHR++ + N+LL      +++DFG+A LL  +   +            ++A E 
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188

Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              G    +SDV+S+G+ + E+++ G  P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (341), Expect = 2e-35
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 12/213 (5%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
             E+       E  +G G +G V+      +T VAVK +      + + F  E   +  +
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTL 240

Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H  LV+L     +     ++ E++  G+L  +L  D G  S       ++     A+G+
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGM 297

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--V 357
            ++ +      +HRD++++NIL+      K++DFGLA+++  E +  T R    F     
Sbjct: 298 AFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT 352

Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           APE  + G    +SDV+SFGIL+ME+++ GR P
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  133 bits (337), Expect = 2e-35
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 14/207 (6%)

Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
           + V+G G +G V  G L    +   +VA+K L     + ++ +F  E   +G+  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           RL G   +    M+V EY++NG+L+ +L          T    + ++ G A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLS-- 164

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYAS 363
            +   VHRD+ + NIL++     K+SDFGL ++L  +     T   G       +PE  +
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNP 389
                  SDV+S+GI++ EV+S G  P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  131 bits (331), Expect = 2e-35
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 17/205 (8%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
            IG G +  VY G+  E    VA              + FK E E +  ++H N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 250 YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
                        LV E + +G L+ +L         +  ++  +      KGL +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 306 LEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             P ++HRD+K  NI +     + K+ D GLA L  A  +     V+GT  ++APE    
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204

Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              +E  DVY+FG+ ++E+ +   P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP 228

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  135 bits (341), Expect = 2e-35
 Identities = 67/251 (26%), Positives = 99/251 (39%), Gaps = 24/251 (9%)

Query: 143 YPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIV 202
           Y   A G         V               W       ++         IG+G +G V
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDV 209

Query: 203 YHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLVY 261
             G       VAVK +        + F  E   + ++RH NLV+LLG   E      +V 
Sbjct: 210 MLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266

Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
           EY+  G+L  +L       S L  +  +   L   + + YL        VHRD+ + N+L
Sbjct: 267 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 321

Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGIL 379
           + +    K+SDFGL       +   +T+  G       APE       + +SDV+SFGIL
Sbjct: 322 VSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375

Query: 380 IMEVIS-GRNP 389
           + E+ S GR P
Sbjct: 376 LWEIYSFGRVP 386

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (330), Expect = 2e-35
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 18/203 (8%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
              IG+G +G V  G       VAVK +        + F  E   + ++RH NLV+LLG 
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 251 CAEGAHR-MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
             E      +V EY+  G+L  +L       S L  +  +   L   + + YL       
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NN 137

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGML 367
            VHRD+ + N+L+ +    K+SDFGL       +   +T+  G       APE       
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKF 191

Query: 368 NERSDVYSFGILIMEVIS-GRNP 389
           + +SDV+SFGIL+ E+ S GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (332), Expect = 3e-35
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 19/207 (9%)

Query: 191 ENVIGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
             ++G GG G VY    ED      VA+K L++    ++       + E    GR++  +
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +V +  +        +    I+  +L   L        PL     + I+      L   H
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH 151

Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
             G      HRD+K  NIL+       L DFG+A     E+       +GT  Y+APE  
Sbjct: 152 AAGA----THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
           S      R+D+Y+   ++ E ++G  P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  135 bits (341), Expect = 4e-35
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 8/200 (4%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           E  +G+G +G V+ G     T VA+K L      + + F  E + + ++RH+ LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
            +E     +V EY+  G+L  +L G+ G +  L     +++    A G+ Y+        
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 384

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           VHRD++++NIL+ +    K++DFGLA+L+                + APE A  G    +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 371 SDVYSFGILIMEVIS-GRNP 389
           SDV+SFGIL+ E+ + GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (329), Expect = 4e-35
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 17/209 (8%)

Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
              +G+G +G+V  G          +VAVK L   + ++ +A  +F  EV A+  + H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           L+RL G         +V E    G+L   L    G              +  A+G+ YL 
Sbjct: 83  LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE 138

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEY 361
                + +HRD+ + N+LL  +   K+ DFGL + L     +   +      +   APE 
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
             T   +  SD + FG+ + E+ + G+ P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (328), Expect = 5e-35
 Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 12/202 (5%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
              +G G +G V+ G    +T VAVK+L      +   F  E   + +++H+ LVRL   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             +     ++ EY++NG+L  +L    G    LT    +++    A+G+ ++ E      
Sbjct: 77  VTQE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NY 130

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLN 368
           +HRD++++NIL+    + K++DFGLA+L+  +  Y T R    F     APE  + G   
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFT 188

Query: 369 ERSDVYSFGILIMEVIS-GRNP 389
            +SDV+SFGIL+ E+++ GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  130 bits (329), Expect = 6e-35
 Identities = 54/223 (24%), Positives = 102/223 (45%), Gaps = 17/223 (7%)

Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNL 244
              +GEG +G V     +         VAVK+L    G     + K E+E +  + H+N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           V+  G C E       L+ E++ +G+L+++L  +      +  + ++   +   KG+ YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPE 360
                 + VHRD+ + N+L++ +   K+ DFGL K +  ++ Y T +        + APE
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 361 YASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVCIP 402
                     SDV+SFG+ + E+++   +         ++  P
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (329), Expect = 7e-35
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 194 IGEGGYGIVYHGVLEDNT---NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           +G GG   V+     D     +VAVK L   L         F+ E +    + H  +V +
Sbjct: 20  LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 248 LGY-CAEGAHRMLVY---EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
                AE     L Y   EY+D   L   +H       P+T +  + +I    + L + H
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH 133

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEY 361
           +     ++HRD+K +NI++      K+ DFG+A+ +    + VT    V+GT  Y++PE 
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
           A    ++ RSDVYS G ++ EV++G  P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  129 bits (326), Expect = 1e-34
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 12/203 (5%)

Query: 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++ +G G YG VY GV +  +  VAVK L        +EF  E   +  ++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
            C       ++ E++  GNL  +L         ++  + + +    +  + YL    +  
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE---KKN 131

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGML 367
            +HRD+ + N L+ +    K++DFGL++L+       T      F     APE  +    
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 368 NERSDVYSFGILIMEVIS-GRNP 389
           + +SDV++FG+L+ E+ + G +P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  130 bits (329), Expect = 1e-34
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 191 ENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
            + +G+G +G V               VAVK L ++    +++F+ E++ +  +    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +  G       +   LV EY+ +G L  +L         L     +       KG+ YL 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG 144

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
                + VHRD+ + NIL++ + + K++DFGLAKLL  ++ Y   R  G     + APE 
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            S  + + +SDV+SFG+++ E+ +     
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (326), Expect = 2e-34
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 21/237 (8%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG 237
             + +    +     +GEGG+  V     L D    A+K +L +  Q  +E + E +   
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 238 RVRHKNLVRLLGYCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNII 292
              H N++RL+ YC           L+  +   G L   +       + LT  +I + ++
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LWLL 140

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM- 351
           LG  +GL  +H        HRD+K +NILL  +  P L D G               +  
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 352 -------GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
                   T  Y APE     S  +++ER+DV+S G ++  ++ G  P D     G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  128 bits (324), Expect = 2e-34
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)

Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
              +G+G +G V     +         VAVK L ++  +  ++F+ E+E +  ++H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +  G C     R   L+ EY+  G+L  +L         +     +       KG+ YL 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
                + +HRD+ + NIL++ +   K+ DFGL K+L  ++ +   +  G     + APE 
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
            +    +  SDV+SFG+++ E+ +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  128 bits (325), Expect = 3e-34
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 191 ENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNL 244
           + VIG G +G VY G+L     +    VA+K L     + ++ +F  E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           +RL G  ++    M++ EY++NG L+++L    G     +    + ++ G A G+ YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLA- 164

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYA 362
                 VHRD+ + NIL++     K+SDFGL+++L  +     T   G       APE  
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNP 389
           S       SDV+SFGI++ EV++ G  P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  127 bits (321), Expect = 1e-33
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
             V+G G +G VY G+           VA+K L      +A KE   E   +  V + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
            RLLG C   +   L+ + +  G L  ++         +  +  +N  +  AKG+ YL +
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
               ++VHRD+ + N+L+    + K++DFGLAKLLGAE         G      ++A E 
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190

Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               +   +SDV+S+G+ + E+++ G  P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (321), Expect = 1e-33
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)

Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
              +G+G +G V     +         VAVK L ++  +  ++F+ E+E +  ++H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           +  G C     R   L+ EY+  G+L  +L         +     +       KG+ YL 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
                + +HRD+ + NIL++ +   K+ DFGL K+L  ++ Y   +  G     + APE 
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 362 ASTGMLNERSDVYSFGILIMEVIS 385
            +    +  SDV+SFG+++ E+ +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (332), Expect = 2e-33
 Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 28/207 (13%)

Query: 193 VIGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL 248
            I  GG G +Y      +     V +K L+++     +     E + +  V H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 249 GYCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
            +             +V EY+   +L++           L     +  +L     L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199

Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
             GL    V+ D+K  NI+L ++   KL D G    + +        + GT G+ APE  
Sbjct: 200 SIGL----VYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIV 249

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
            TG     +D+Y+ G  +  +      
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPT 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  126 bits (318), Expect = 2e-33
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 22/229 (9%)

Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
              +GEG +G V     +         VAVK L  + G Q    +K E++ +  + H+++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           ++  G C +       LV EY+  G+L  +L       + L     +       +G+ YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPE 360
           H       +HRD+ + N+LLD     K+ DFGLAK +     Y   R  G     + APE
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207

Query: 361 YASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVCI---PQMN 405
                     SDV+SFG+ + E+++   +         E+      QM 
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  126 bits (319), Expect = 3e-33
 Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 28/248 (11%)

Query: 161 AAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVA 214
           A++ PE         Y   E EV+         +G+G +G+VY GV       E  T VA
Sbjct: 2   ASVNPEYFSAA--DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59

Query: 215 VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL 273
           +K +       E+ EF  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L
Sbjct: 60  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119

Query: 274 ------HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327
                   +    +P +    + +    A G+ YL+     K VHRD+ + N ++ + + 
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176

Query: 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIME 382
            K+ DFG+ + +     Y      G  G +     +PE    G+    SDV+SFG+++ E
Sbjct: 177 VKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232

Query: 383 VIS-GRNP 389
           + +    P
Sbjct: 233 IATLAEQP 240

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  124 bits (314), Expect = 6e-33
 Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 29/217 (13%)

Query: 191 ENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
              +G+G +  ++ GV            T V +K L        + F      + ++ HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           +LV   G C  G   +LV E++  G+L+ +L  +      + W++ +      A  + +L
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEV--AKQLAAAMHFL 129

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNP--------KLSDFGLAKLLGAERSYVTTRVMGTF 354
               E  ++H ++ + NILL ++ +         KLSD G++  +   +  +  R+    
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184

Query: 355 GYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRNP 389
               PE       LN  +D +SFG  + E+ S G  P
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (317), Expect = 7e-33
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 9/200 (4%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLG 249
            IGEG +G        ED     +K + ++     E+E  + EV  +  ++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              E     +V +Y + G+L + ++   G       +  ++  +     L ++H+    K
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RK 145

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           ++HRDIKS NI L K    +L DFG+A++L +        + GT  Y++PE       N 
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN 204

Query: 370 RSDVYSFGILIMEVISGRNP 389
           +SD+++ G ++ E+ + ++ 
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  124 bits (314), Expect = 1e-32
 Identities = 63/261 (24%), Positives = 111/261 (42%), Gaps = 36/261 (13%)

Query: 150 SHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED 209
           SHH       ++ + P  S         L ++ +  N      ++GEG +G V  G L+ 
Sbjct: 4   SHHHHHH---SSGLVPRGSEE---LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57

Query: 210 ----NTNVAVKNL-LNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM 258
               +  VAVK + L+N  Q E  EF  E   +    H N++RLLG C E         M
Sbjct: 58  EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117

Query: 259 LVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
           ++  ++  G+L  +L           +  +  +  ++  A G+ YL        +HRD+ 
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLA 174

Query: 317 SSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYASTGMLNE 369
           + N +L       ++DFGL+K + +   Y   R+       +      A E  +  +   
Sbjct: 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTS 228

Query: 370 RSDVYSFGILIMEVIS-GRNP 389
           +SDV++FG+ + E+ + G  P
Sbjct: 229 KSDVWAFGVTMWEIATRGMTP 249

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (311), Expect = 1e-32
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 8/204 (3%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLG 249
            IG G YG         D   +  K L   +  +AEK+  V EV  +  ++H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 250 YCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--G 305
              +  +  L  V EY + G+L   +         L  E  + ++      L   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               V+HRD+K +N+ LD + N KL DFGLA++L  + S+  T V GT  Y++PE  +  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             NE+SD++S G L+ E+ +   P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  124 bits (314), Expect = 1e-32
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 30/222 (13%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           +  +GEG +G V+          +D   VAVK L      A ++F+ E E +  ++H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----------HGDVGPHSPLTWEIRMNIIL 293
           VR  G C EG   ++V+EY+ +G+L ++L            G+     PL     + +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
             A G+ YL        VHRD+ + N L+ +    K+ DFG+++ + +   Y     +G 
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGG 218

Query: 354 FGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              +      PE          SDV+SFG+++ E+ + G+ P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (312), Expect = 1e-32
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLL 248
            IG G +  VY    L D   VA+K   + +      +   + E++ + ++ H N+++  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
               E     +V E  D G+L + +         +         +     L ++H     
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YA 362
           +V+HRDIK +N+ +      KL D GL +   ++ +   + V GT  Y++PE      Y 
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY- 213

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                N +SD++S G L+ E+ + ++P
Sbjct: 214 -----NFKSDIWSLGCLLYEMAALQSP 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  124 bits (313), Expect = 2e-32
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
              +G G +G VY G +           VAVK L     + ++ +F +E   I +  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 300
           +VR +G   +   R ++ E +  G+L+ +L          S L     +++    A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG-- 355
           YL E      +HRDI + N LL         K+ DFG+A+ +    SY            
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 210

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           ++ PE    G+   ++D +SFG+L+ E+ S G  P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  123 bits (311), Expect = 2e-32
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 20/211 (9%)

Query: 191 ENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
           + VIG+G +G+VYHG   D        A+K+L       +   F  E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 246 RLLGYCAEGA-HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
            L+G          ++  Y+ +G+L Q++     P    T +  ++  L  A+G+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----AP 359
               K VHRD+ + N +LD+ +  K++DFGLA+ +  +R Y + +       +     A 
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ-QHRHARLPVKWTAL 197

Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E   T     +SDV+SFG+L+ E+++ G  P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (309), Expect = 2e-32
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 13/205 (6%)

Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
             ++GEG +G VY GV      +  NVAVK    +     +++F  E   +  + H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +L+G   E     ++ E    G L  +L  +      L     +   L   K + YL   
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLES- 131

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
                VHRDI   NIL+      KL DFGL++ +  E  Y  +       +++PE  +  
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 366 MLNERSDVYSFGILIMEVIS-GRNP 389
                SDV+ F + + E++S G+ P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  122 bits (308), Expect = 5e-32
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 41/221 (18%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           V+G+G +G V       D+   A+K  + +  +       EV  +  + H+ +VR     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 252 AEGAHRM-------------LVYEYIDNGNLEQWLHGDVGPHSP--LTWEIRMNIILGTA 296
            E  + +             +  EY +NG L   +H     +      W +   I+    
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEA-- 128

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---------- 346
             L+Y+H      ++HRD+K  NI +D+  N K+ DFGLAK +      +          
Sbjct: 129 --LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 347 ----TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIME 382
               T+ + GT  YVA E    TG  NE+ D+YS GI+  E
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  122 bits (308), Expect = 6e-32
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 35/225 (15%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           +  +GEG +G V+          +D   VAVK L +    A K+F+ E E +  ++H+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNII 292
           V+  G C +G   ++V+EY+ +G+L ++L                     L     ++I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---- 348
              A G+ YL        VHRD+ + N L+      K+ DFG+++ + +   Y       
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 349 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              R M       PE          SDV+SFG+++ E+ + G+ P
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  121 bits (307), Expect = 6e-32
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 36/226 (15%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKN 243
              +GE  +G VY G L      E    VA+K L +   G   +EF+ E     R++H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNI 291
           +V LLG   +     +++ Y  +G+L ++L              D    S L     +++
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--- 348
           +   A G+ YL       VVH+D+ + N+L+  + N K+SD GL + + A   Y      
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 349 ----RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               R M      APE    G  +  SD++S+G+++ EV S G  P
Sbjct: 191 LLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  121 bits (306), Expect = 7e-32
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 28/219 (12%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           F +  +IG GG+G V+      D     +K +  N  +AE+E    V+A+ ++ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68

Query: 247 LLGYCAEGAHRM----------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
             G      +                  +  E+ D G LEQW+    G    L   + + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALE 126

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
           +     KG+ Y+H     K+++RD+K SNI L      K+ DFGL   L  +     TR 
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRS 181

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
            GT  Y++PE  S+    +  D+Y+ G+++ E++   + 
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  121 bits (306), Expect = 8e-32
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 29/215 (13%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
            +G GG+G+V+      D+ N A+K + L NR  A ++   EV+A+ ++ H  +VR    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 251 CAEGAHRM------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
             E                 +  +     NL+ W++G           + ++I L  A+ 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFLQIAEA 130

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM------- 351
           + +LH      ++HRD+K SNI        K+ DFGL   +  +    T           
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 352 ----GTFGYVAPEYASTGMLNERSDVYSFGILIME 382
               GT  Y++PE       + + D++S G+++ E
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (305), Expect = 8e-32
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 13/220 (5%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFK 230
            + R+ E+          IGEG +G V+ G+          VA+K           ++F 
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
            E   + +  H ++V+L+G         ++ E    G L  +L         L     + 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
                +  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++ 
Sbjct: 121 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177

Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                ++APE  +       SDV+ FG+ + E++  G  P
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  121 bits (305), Expect = 1e-31
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
             VIG G +G VYHG L DN     + AVK+L       E  +F  E   +    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 246 RLLGYCAEGAH-RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ YL  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS 146

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG------YVA 358
               K VHRD+ + N +LD+++  K++DFGLA+ +  +  Y    V    G      ++A
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200

Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
            E   T     +SDV+SFG+L+ E+++ G  P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  122 bits (309), Expect = 1e-31
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
              +G G +G VY G +           VAVK L     + ++ +F +E   I +  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 300
           +VR +G   +   R ++ E +  G+L+ +L          S L     +++    A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG-- 355
           YL E      +HRDI + N LL         K+ DFG+A+ +     Y            
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVK 251

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           ++ PE    G+   ++D +SFG+L+ E+ S G  P
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  121 bits (306), Expect = 2e-31
 Identities = 47/231 (20%), Positives = 97/231 (41%), Gaps = 21/231 (9%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNL-LNNRGQAEKE-F 229
             L ++ +    F    ++G+G +G V    L+        VAVK L  +    ++ E F
Sbjct: 13  EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF 72

Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEG------AHRMLVYEYIDNGNLEQWL--HGDVGPHS 281
             E   +    H ++ +L+G              M++  ++ +G+L  +L          
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
            L  +  +  ++  A G+ YL        +HRD+ + N +L +     ++DFGL++ +  
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI-Y 188

Query: 342 ERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              Y            ++A E  +  +    SDV++FG+ + E+++ G+ P
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  125 bits (315), Expect = 3e-31
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 13/205 (6%)

Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
              IGEG +G V+ G+          VA+K           ++F  E   + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +L+G   E     ++ E    G L  +L         L     +      +  L YL   
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES- 509

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              + VHRDI + N+L+      KL DFGL++ +     Y  ++      ++APE  +  
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 366 MLNERSDVYSFGILIMEVIS-GRNP 389
                SDV+ FG+ + E++  G  P
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP 592

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  121 bits (305), Expect = 5e-31
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 20/211 (9%)

Query: 191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
             VIG G +G VYHG L DN     + AVK+L       E  +F  E   +    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 246 RLLGYCAEGAH-RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ +L  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----AP 359
               K VHRD+ + N +LD+++  K++DFGLA+ +  ++ + +     T   +     A 
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMAL 265

Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           E   T     +SDV+SFG+L+ E+++ G  P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  118 bits (299), Expect = 8e-31
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 9/201 (4%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
           V+G+G YGIVY G  L +   +A+K +     +  +    E+     ++HKN+V+ LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
           +E     +  E +  G+L   L    GP      +          +GL YLH+    ++V
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDN---QIV 144

Query: 312 HRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLN 368
           HRDIK  N+L++      K+SDFG +K L        T   GT  Y+APE          
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203

Query: 369 ERSDVYSFGILIMEVISGRNP 389
           + +D++S G  I+E+ +G+ P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  119 bits (301), Expect = 1e-30
 Identities = 63/267 (23%), Positives = 115/267 (43%), Gaps = 39/267 (14%)

Query: 153 GSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL----- 207
           GS       +  P ++ +         + E   +       +GEG +G V          
Sbjct: 2   GSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDK 61

Query: 208 ---EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE 262
              ++   VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ E
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121

Query: 263 YIDNGNLEQWL------------HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
           Y   GNL ++L              +  P   +T++  ++     A+G+ YL      K 
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKC 178

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYAS 363
           +HRD+ + N+L+ +    K++DFGLA+ +     Y  T         M      APE   
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALF 232

Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNP 389
             +   +SDV+SFG+L+ E+ + G +P
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (300), Expect = 1e-30
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 27/219 (12%)

Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLV 245
           ++VIGEG +G V    +       + A+K +     + +  +F  E+E + ++  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNIIL 293
            LLG C    +  L  EY  +GNL  +L                   S L+ +  ++   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
             A+G+ YL    + + +HRD+ + NIL+ + +  K++DFGL++     +     + MG 
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202

Query: 354 F--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
               ++A E  +  +    SDV+S+G+L+ E++S G  P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (293), Expect = 4e-30
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
             +G+G +G VY     +    +A+K L    L   G   +  + EVE    +RH N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           L GY  +     L+ EY   G + + L       S    +     I   A  L+Y H   
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS-- 127

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
             +V+HRDIK  N+LL      K++DFG +    + R        GT  Y+ PE     M
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLPPEMIEGRM 183

Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            +E+ D++S G+L  E + G+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  116 bits (294), Expect = 6e-30
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 44/234 (18%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
              +GEG +G V              T VAVK L  N   +E  +   E   + +V H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--------------------HGDVGPHSPL 283
           +++L G C++    +L+ EY   G+L  +L                      D      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           T    ++     ++G+ YL    E K+VHRD+ + NIL+ +    K+SDFGL++ +  E 
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 344 SYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           SYV         + M      A E     +   +SDV+SFG+L+ E+++ G NP
Sbjct: 205 SYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (294), Expect = 7e-30
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 12/204 (5%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
                 IGEG  GIV           VAVK +   + Q  +    EV  +   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
           +      G    ++ E++  G L      D+     L  E ++  +     + L YLH  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLN-EEQIATVCEAVLQALAYLHA- 159

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               V+HRDIKS +ILL      KLSDFG    +  +     + V GT  ++APE  S  
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
           +     D++S GI+++E++ G  P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  117 bits (296), Expect = 9e-30
 Identities = 62/256 (24%), Positives = 111/256 (43%), Gaps = 39/256 (15%)

Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL--------EDNTNVAV 215
           TP ++ +         + E   +       +GEG +G V             ++   VAV
Sbjct: 59  TPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAV 118

Query: 216 KNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNL---- 269
           K L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY   GNL    
Sbjct: 119 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178

Query: 270 --------EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
                   E     +  P   +T++  ++     A+G+ YL      K +HRD+ + N+L
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235

Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYASTGMLNERSDVY 374
           + +    K++DFGLA+ +     Y  T         M      APE     +   +SDV+
Sbjct: 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVW 289

Query: 375 SFGILIMEVIS-GRNP 389
           SFG+L+ E+ + G +P
Sbjct: 290 SFGVLMWEIFTLGGSP 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (293), Expect = 1e-29
 Identities = 65/243 (26%), Positives = 100/243 (41%), Gaps = 38/243 (15%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
           Y   + E   +       +G G +G V                VAVK L      +E   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76

Query: 229 FKVEVEAIGRV-RHKNLVRLLGYC-AEGAHRMLVYEYIDNGNLEQWL------------H 274
              E++ +  +  H N+V LLG C   G   M++ E+   GNL  +L             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 275 GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
            +      LT E  +      AKG+ +L      K +HRD+ + NILL ++   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 193

Query: 335 LAKLLGAERSYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 386
           LA+ +  +  YV         + M      APE     +   +SDV+SFG+L+ E+ S G
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLG 247

Query: 387 RNP 389
            +P
Sbjct: 248 ASP 250

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 1e-29
 Identities = 29/240 (12%), Positives = 53/240 (22%), Gaps = 41/240 (17%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
            +  G   +V+    +E   + A+K       N     +       A  R+  ++     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 249 GYCAEGA--------------------------HRMLVYEYI--DNGNLEQWLHGDVGPH 280
                                            + +L+      D   L   L       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
                     +     +    L       +VH      N+ +       L D      +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 341 AERSYVTTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
                          Y   E+  AST       + +  G+ I  V     P     P  +
Sbjct: 246 T----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (290), Expect = 1e-29
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +     IG+G  G VY  + +     VA++ +   +   ++    E+  +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
            L     G    +V EY+  G+L      DV   + +  E ++  +     + L +LH  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMD-EGQIAAVCRECLQALEFLHSN 135

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              +V+HRDIKS NILL    + KL+DFG    +  E+S  +T V GT  ++APE  +  
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
               + D++S GI+ +E+I G  P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (289), Expect = 3e-29
 Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 39/229 (17%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
              +G G +G V           +    VAVK L  +    E+     E++ +  +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--------------HGDVGPHSPLTWEIR 288
           N+V LLG C  G   +++ EY   G+L  +L                       L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
           ++     AKG+ +L        +HRD+ + NILL      K+ DFGLA+ +  + +YV  
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 349 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                  + M      APE     +    SDV+S+GI + E+ S G +P
Sbjct: 205 GNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  116 bits (291), Expect = 5e-29
 Identities = 36/236 (15%), Positives = 65/236 (27%), Gaps = 43/236 (18%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVR-------- 240
           V+G+            E   +  V            A K+ K EV  +  +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 241 -----------------HKNLVRLLGYCAEGAHRMLV----YEYIDNGNLEQWLHGDVGP 279
                             K ++R+     +               +     + L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 280 HSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
           H  L    R+ + L   + L  LH  G    +VH  ++  +I+LD++    L+ F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 339 LGAERSYVTTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNP 389
            GA       R        A            ++    D ++ G+ I  +     P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  114 bits (288), Expect = 6e-29
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 35/225 (15%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
              +G G +G V           +    VAVK L +     EK     E++ +  + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------HGDVGPHSPLTWEIRMNII 292
           N+V LLG C  G   +++ EY   G+L  +L                +S  +    ++  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---- 348
              A+G+ +L        +HRD+ + N+LL      K+ DFGLA+ +  + +Y+      
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 349 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
              + M      APE     +   +SDV+S+GIL+ E+ S G NP
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  114 bits (287), Expect = 9e-29
 Identities = 64/245 (26%), Positives = 101/245 (41%), Gaps = 40/245 (16%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFK 230
           L  LE   N       IGEG +G V+          E  T VAVK L        + +F+
Sbjct: 39  LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------------- 273
            E   +    + N+V+LLG CA G    L++EY+  G+L ++L                 
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 274 ---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330
                      PL+   ++ I    A G+ YL E    K VHRD+ + N L+ +    K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215

Query: 331 SDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS 385
           +DFGL++ + +   Y           +      PE          SDV+++G+++ E+ S
Sbjct: 216 ADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

Query: 386 -GRNP 389
            G  P
Sbjct: 272 YGLQP 276

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (286), Expect = 1e-28
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 44/234 (18%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
             V+G G +G V +           +  VAVK L      +E+     E++ + ++  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-------------------HGDVGPHSPL 283
           N+V LLG C       L++EY   G+L  +L                     +    + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           T+E  +      AKG+ +L        VHRD+ + N+L+      K+ DFGLA+ + ++ 
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 344 SYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           +YV         + M      APE    G+   +SDV+S+GIL+ E+ S G NP
Sbjct: 227 NYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  114 bits (287), Expect = 2e-28
 Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 39/229 (17%)

Query: 191 ENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-R 240
              +GEG +G V                T VAVK L ++  + +  +   E+E +  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIR 288
           HKN++ LLG C +     ++ EY   GNL ++L            +    P   L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
           ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 349 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
                  + M      APE     +   +SDV+SFG+L+ E+ + G +P
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (282), Expect = 2e-28
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 12/226 (5%)

Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 238
           +EV  +       +G G YG+V     +     +AVK +      Q +K   ++++   R
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 239 -VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
            V     V   G         +  E +D  +L+++    +     +  +I   I +   K
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L +LH   +  V+HRD+K SN+L++     K+ DFG++  L            G   Y+
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYM 176

Query: 358 APE----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           APE      +    + +SD++S GI ++E+   R P D    P + 
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  113 bits (285), Expect = 2e-28
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 11/213 (5%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           +  E+  + F   + +G G  G+V+          +A K + L  +     +   E++ +
Sbjct: 26  KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85

Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
                  +V   G         +  E++D G+L+Q L         +  +I   + +   
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 141

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           KGLTYL E  + K++HRD+K SNIL++ +   KL DFG++  L    S   + V GT  Y
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSY 196

Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           ++PE       + +SD++S G+ ++E+  GR P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 2e-28
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
           F     IG+G +G V+ G+       VA+K +     + E E  + E+  + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +  G   +     ++ EY+  G+       D+    PL       I+    KGL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              K +HRDIK++N+LL +    KL+DFG+A  L   +    T  +GT  ++APE     
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 194

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             + ++D++S GI  +E+  G  P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (283), Expect = 3e-28
 Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 30/222 (13%)

Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVE 232
           HW T +              +G G +G V+     +     AVK +     + E     E
Sbjct: 58  HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
           + A   +    +V L G   EG    +  E ++ G+L Q +         L  +  +  +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYL 156

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTR-- 349
               +GL YLH     +++H D+K+ N+LL    +   L DFG A  L  +    +    
Sbjct: 157 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 350 --VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
             + GT  ++APE       + + D++S   +++ +++G +P
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  111 bits (280), Expect = 5e-28
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 25/214 (11%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
             IG GG   V+  + E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             Y     +  +V E   N +L  WL         +    R +      + +  +H+   
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
             +VH D+K +N L+      KL DFG+A  +     S V    +GT  Y+ PE      
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
                  S   ++ +SDV+S G ++  +  G+ P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  112 bits (281), Expect = 6e-28
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 25/214 (11%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
             IG GG   V+  + E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             Y     +  +V E   N +L  WL         +    R +      + +  +H+   
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 127

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
             +VH D+K +N L+      KL DFG+A  +     S V    +GT  Y+ PE      
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
                  S   ++ +SDV+S G ++  +  G+ P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  111 bits (280), Expect = 6e-28
 Identities = 71/259 (27%), Positives = 111/259 (42%), Gaps = 20/259 (7%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           +  + +     D   IG G YG V   V       +AVK +      + +K+  ++++ +
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 237 GR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
            R      +V+  G         +  E +     + + +        +  EI   I L T
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
            K L +L E    K++HRDIK SNILLD+  N KL DFG++  L    S   TR  G   
Sbjct: 135 VKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRP 190

Query: 356 YVAPE----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--CI-----PQM 404
           Y+APE     AS    + RSDV+S GI + E+ +GR P        +    +     PQ+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250

Query: 405 NSLMTLSYCSSF--FLICC 421
           ++     +  SF  F+  C
Sbjct: 251 SNSEEREFSPSFINFVNLC 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  110 bits (278), Expect = 7e-28
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 16/204 (7%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     +     A K    +LL    Q EK   +E+     + H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
           G+  +     +V E     +L +           LT  E R   +     G  YLH    
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHRN-- 134

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
            +V+HRD+K  N+ L++    K+ DFGLA  +  +       + GT  Y+APE  S    
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192

Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
           +   DV+S G ++  ++ G+ P +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFE 216

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  111 bits (279), Expect = 7e-28
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 10/203 (4%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           F     +GEG YG VY  +  E    VA+K +        +E   E+  + +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
             G   +     +V EY   G++   +      +  LT +    I+  T KGL YLH   
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM- 144

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
             + +HRDIK+ NILL+ + + KL+DFG+A  L    +   T + GT  ++APE      
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201

Query: 367 LNERSDVYSFGILIMEVISGRNP 389
            N  +D++S GI  +E+  G+ P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPP 224

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (275), Expect = 1e-27
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+G +  VY    +     VA+K      +   G  ++  + EV+   +++H +++ L 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
            Y  +  +  LV E   NG + ++L   V P    +  E R + +     G+ YLH    
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEAR-HFMHQIITGMLYLHS--- 130

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
             ++HRD+  SN+LL +  N K++DFGLA  L        T + GT  Y++PE A+    
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189

Query: 368 NERSDVYSFGILIMEVISGRNP 389
              SDV+S G +   ++ GR P
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP 211

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  109 bits (275), Expect = 2e-27
 Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 42/226 (18%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLL 248
            IG G +G V+  V   D    A+K       G  +++  + EV A   + +H ++VR  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
              AE  H ++  EY + G+L   +  +    S        +++L   +GL Y+H     
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 309 KVVHRDIKSSNILLDKQWNP-------------------KLSDFGLAKLLGAERSYVTTR 349
            +VH DIK SNI + +   P                   K+ D G    + + +      
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191

Query: 350 VMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRNP 389
             G   ++A E     +L E       +D+++  + ++        
Sbjct: 192 --GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  110 bits (276), Expect = 3e-27
 Identities = 57/252 (22%), Positives = 100/252 (39%), Gaps = 38/252 (15%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
             V+ EGG+  VY    +      A+K LL+N  +  +    EV  + ++  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 249 GYCAEGAHRM-------LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLT 300
              + G           L+   +  G L ++L   +    PL+   +   I   T + + 
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL-KIFYQTCRAVQ 150

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM--------- 351
           ++H   +P ++HRD+K  N+LL  Q   KL DFG A  +     Y  +            
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 352 --GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNP-----------VDYSRP 395
              T  Y  PE     S   + E+ D+++ G ++  +   ++P             YS P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIP 269

Query: 396 PGEVCIPQMNSL 407
           P +      +SL
Sbjct: 270 PHDTQYTVFHSL 281

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 3e-27
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 16/202 (7%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
            +G+G +G VY     ++   +A+K L    L   G  E + + E+E    +RH N++R+
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             Y  +     L+ E+   G L + L      H     +     +   A  L Y HE   
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHE--- 132

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
            KV+HRDIK  N+L+  +   K++DFG +    + R      + GT  Y+ PE       
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTH 189

Query: 368 NERSDVYSFGILIMEVISGRNP 389
           +E+ D++  G+L  E + G  P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (282), Expect = 4e-27
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 23/218 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL-- 248
            +G GG+G V   +  +    VA+K          +E + +E++ + ++ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTY 301
                  A     +L  EY + G+L ++L+        L    IR  ++ I      L Y
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDIS---SALRY 136

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           LHE    +++HRD+K  NI+L         K+ D G AK L  +    T  V GT  Y+A
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLA 191

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
           PE           D +SFG L  E I+G  P   +  P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  109 bits (275), Expect = 4e-27
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 16/202 (7%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G+GG+   +     +     A K    +LL    Q EK   +E+     + H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
           G+  +     +V E     +L +           LT  E R   +     G  YLH    
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHR--- 159

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
            +V+HRD+K  N+ L++    K+ DFGLA  +  +       + GT  Y+APE  S    
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218

Query: 368 NERSDVYSFGILIMEVISGRNP 389
           +   DV+S G ++  ++ G+ P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (272), Expect = 6e-27
 Identities = 45/209 (21%), Positives = 96/209 (45%), Gaps = 15/209 (7%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           +     +G+G +G VY     E     A K +     +  +++ VE+E +    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
           LLG         ++ E+   G ++  +         LT E ++ ++     + L +LH  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LT-EPQIQVVCRQMLEALNFLHSK 136

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
              +++HRD+K+ N+L+  + + +L+DFG++           +  +GT  ++APE     
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192

Query: 366 ML-----NERSDVYSFGILIMEVISGRNP 389
            +     + ++D++S GI ++E+     P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  108 bits (272), Expect = 7e-27
 Identities = 59/206 (28%), Positives = 82/206 (39%), Gaps = 24/206 (11%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLL 248
            +G G YG V+     ED    AVK      RG  ++  K+ EV +  +V +H   VRL 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
               EG    L  E     +L+Q         + L        +  T   L +LH     
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS---Q 176

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YAS 363
            +VH D+K +NI L  +   KL DFGL   LG        +  G   Y+APE     Y  
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPELLQGSY-- 232

Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
                  +DV+S G+ I+EV      
Sbjct: 233 ----GTAADVFSLGLTILEVACNMEL 254

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (273), Expect = 1e-26
 Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 25/214 (11%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
             IG GG   V+  + E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             Y     +  +V E   N +L  WL         +    R +      + +  +H+   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-- 174

Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
             +VH D+K +N L+      KL DFG+A  +     S V    +G   Y+ PE      
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
                  S   ++ +SDV+S G ++  +  G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (268), Expect = 2e-26
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 24/214 (11%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++G+G    V+ G   +     A+K  N ++     + + + E E + ++ HKN+V+L  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74

Query: 250 Y--CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                   H++L+ E+   G+L   L  +      L     + ++     G+ +L E   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131

Query: 308 PKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
             +VHR+IK  NI+     D Q   KL+DFG A+ L  +     +   GT  Y+ P+   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYE 188

Query: 364 TGML--------NERSDVYSFGILIMEVISGRNP 389
             +L            D++S G+      +G  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (268), Expect = 2e-26
 Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 16/230 (6%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
           +  +   N   +   +G G  G V+     +    +AVK +  +   +  K   ++++ +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 237 GR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
            +      +V+  G         +  E +     +           P+   I   + +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAI 133

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
            K L YL E  +  V+HRD+K SNILLD++   KL DFG++  L         R  G   
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAA 189

Query: 356 YVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVC 400
           Y+APE       +    + R+DV+S GI ++E+ +G+ P    +   EV 
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (270), Expect = 3e-26
 Identities = 37/241 (15%), Positives = 71/241 (29%), Gaps = 52/241 (21%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVR-------- 240
           V+G+            E   +  V            A K+ K EV  +  +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 241 -----------------HKNLVRLLGYCAEGAHRMLVYEY----IDNGNLEQWLHGDVGP 279
                             K ++R+     +       + Y     +     + L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
           H  L    R+ + L   + L  LH      +VH  ++  +I+LD++    L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 340 GAERSYVTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRN 388
           GA           + G+  PE  +             ++    D ++ G++I  +     
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 389 P 389
           P
Sbjct: 312 P 312

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (269), Expect = 3e-26
 Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 29/220 (13%)

Query: 193 VIGEGGYGIVYHGVLEDNTNVAVK-----------------NLLNNRGQAEKEFKVEVEA 235
            + +G +  +     +DN   A+K                 N   +      +FK E++ 
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRMNI 291
           I  ++++  +   G         ++YEY++N ++ ++       D      +  ++   I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
           I       +Y+H      + HRD+K SNIL+DK    KLSDFG ++        +     
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKG-SR 211

Query: 352 GTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNP 389
           GT+ ++ PE+ S        + D++S GI +  +     P
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  108 bits (271), Expect = 4e-26
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 21/213 (9%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           F  ++V+G G  G + +  + DN +VAVK +L      A++E ++  E+     H N++R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIR 82

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
                 +   + +  E      L++++               + ++  T  GL +LH   
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 307 EPKVVHRDIKSSNILL-----DKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAP 359
              +VHRD+K  NIL+       +    +SDFGL K L   R   + R  V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 360 EY---ASTGMLNERSDVYSFGILIMEVISGRNP 389
           E              D++S G +   VIS  + 
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (267), Expect = 6e-26
 Identities = 34/238 (14%), Positives = 75/238 (31%), Gaps = 38/238 (15%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKEFKVE 232
            E ++ +      +++GEG +  VY     D  +        +K     +     EF + 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114

Query: 233 VEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-HGDVGPHSPLTWEIR 288
            + + R++       ++           +LV E    G L   +      P   +   + 
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-----------KLSDFGLAK 337
           ++  +     +  +H+    +++H DIK  N +L   +              L D G + 
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 338 LLGAERSYVTTRVM-GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
            +              T G+   E     ML+ +      D +     +  ++ G   
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  107 bits (269), Expect = 6e-26
 Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 24/214 (11%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++G+G    V+ G   +     A+K  N ++     + + + E E + ++ HKN+V+L  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74

Query: 250 YCAEGAHRM--LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
              E   R   L+ E+   G+L   L  +      L     + ++     G+ +L E   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131

Query: 308 PKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
             +VHR+IK  NI+     D Q   KL+DFG A+ L  +     +   GT  Y+ P+   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYE 188

Query: 364 TGML--------NERSDVYSFGILIMEVISGRNP 389
             +L            D++S G+      +G  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 7e-26
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 20/215 (9%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLV 245
           F    ++G G YG VY G  ++     A+K +++  G  E+E K E+  + +   H+N+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 84

Query: 246 RLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
              G +  +    M     LV E+   G++   +    G  + L  E    I     +GL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGL 142

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           ++LH+    KV+HRDIK  N+LL +    KL DFG++  L        T  +GT  ++AP
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 198

Query: 360 E-----YASTGMLNERSDVYSFGILIMEVISGRNP 389
           E            + +SD++S GI  +E+  G  P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (261), Expect = 2e-25
 Identities = 54/268 (20%), Positives = 91/268 (33%), Gaps = 80/268 (29%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           F     +G GG+G+V+      D+ N A+K + L NR  A ++   EV+A+ ++ H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 246 RLLGYCAEGAHRMLVYE------------------------------------------- 262
           R      E        E                                           
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 263 ---------YI-----DNGNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEG 305
                    YI        NL+ W++           +   I + I       + +LH  
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFLH-- 181

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-----------TRVMGTF 354
               ++HRD+K SNI        K+ DFGL   +  +    T           T  +GT 
Sbjct: 182 -SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 355 GYVAPEYASTGMLNERSDVYSFGILIME 382
            Y++PE       + + D++S G+++ E
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (259), Expect = 2e-24
 Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 34/223 (15%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG 249
           E ++G G  G V          VAVK +L +         +E++ +     H N++R   
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYC 76

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM-NIILGTAKGLTYLHEGL 306
                    +  E   N NL+  +        +  L  E    +++   A G+ +LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133

Query: 307 EPKVVHRDIKSSNILLDKQWNP-------------KLSDFGLAKLLGAERSYVTTRVM-- 351
             K++HRD+K  NIL+                    +SDFGL K L + +S   T +   
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 352 -GTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISG 386
            GT G+ APE         +   L    D++S G +   ++S 
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (257), Expect = 2e-24
 Identities = 42/225 (18%), Positives = 72/225 (32%), Gaps = 18/225 (8%)

Query: 178 LRELEVSTNGFADENVIGEG--GYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVE 232
           +         +    VIG+G      V           V V+  NL     +     + E
Sbjct: 17  MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
           +       H N+V             +V  ++  G+ +  +         +       I+
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYIL 134

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
            G  K L Y+H       VHR +K+S+IL+       LS       + +           
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 353 TFGYV------APEYASTGML--NERSDVYSFGILIMEVISGRNP 389
               V      +PE     +   + +SD+YS GI   E+ +G  P
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  102 bits (256), Expect = 3e-24
 Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 51/279 (18%)

Query: 149 GSHHGSGDQTVAAAITPEVSHLGWG-----HWYTLRELEVSTNGFADENVIGEGGYGIVY 203
           GS   S        + P                T  + E++   + +  VIG G +G+V+
Sbjct: 1   GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA---YTNCKVIGNGSFGVVF 57

Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRM---- 258
              L ++  VA+K +L      +K FK  E++ +  V+H N+V L  +      +     
Sbjct: 58  QAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112

Query: 259 --LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
             LV EY+    + +           +   +    +    + L Y+H      + HRDIK
Sbjct: 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIK 168

Query: 317 SSNILLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNERS- 371
             N+LLD      KL DFG AK+L A     SY+ +R      Y APE     +    + 
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPEL----IFGATNY 219

Query: 372 ----DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQM 404
               D++S G ++ E++ G       +P  PGE  I Q+
Sbjct: 220 TTNIDIWSTGCVMAELMQG-------QPLFPGESGIDQL 251

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (251), Expect = 4e-24
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 28/220 (12%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
           +  + VIG G   +V           VA+K +   + Q   +    E++A+ +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNL----EQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLT 300
                        LV + +  G++    +  +         L  E  +  IL    +GL 
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLE 135

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF-G---Y 356
           YLH+      +HRD+K+ NILL +  + +++DFG++  L         +V  TF G   +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 357 VAPE-------YASTGMLNERSDVYSFGILIMEVISGRNP 389
           +APE       Y      + ++D++SFGI  +E+ +G  P
Sbjct: 193 MAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (250), Expect = 1e-23
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKN 243
           F+D   IG G +G VY    + ++  VA+K +  +  Q+    ++   EV  + ++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
            ++  G         LV EY   G+    L     P      E+ +  +  G  +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAVTHGALQGLAYL 170

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-- 360
           H      ++HRD+K+ NILL +    KL DFG A ++    S+V     GT  ++APE  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 222

Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNP 389
                G  + + DV+S GI  +E+   + P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (252), Expect = 1e-23
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 44/237 (18%)

Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLV 245
           + D  VIG G +G+VY   L +    VA+K +L      +K FK  E++ + ++ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110

Query: 246 RLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           RL  +      +       LV +Y+    + +           L        +    + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFG 355
            Y+H      + HRDIK  N+LLD      KL DFG AK L       SY+ +R      
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 221

Query: 356 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMN 405
           Y APE     +          DV+S G ++ E++ G       +P  PG+  + Q+ 
Sbjct: 222 YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLG-------QPIFPGDSGVDQLV 267

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 98.0 bits (245), Expect = 3e-23
 Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 44/216 (20%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
             IGEG YG+V+            +N    +  A K+F    +                +
Sbjct: 9   GKIGEGSYGVVFKC----------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ 58

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           ++H NLV LL          LV+EY D+  +   L  D          ++ +I   T + 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-SITWQTLQA 114

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           + + H+      +HRD+K  NIL+ K    KL DFG A+LL     Y    V  T  Y +
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170

Query: 359 PE-------YASTGMLNERSDVYSFGILIMEVISGR 387
           PE       Y    +     DV++ G +  E++SG 
Sbjct: 171 PELLVGDTQY-GPPV-----DVWAIGCVFAELLSGV 200

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 38/240 (15%)

Query: 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
            + F  E + G+G +G V  G       +VA+K ++ +     +E +  ++ +  + H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 244 LVRLLGY-CAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
           +V+L  Y    G          +V EY+ +  L +               +    +    
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAER---SYVTTRVMG 352
           + +  LH      V HRDIK  N+L+++     KL DFG AK L       +Y+ +R   
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196

Query: 353 TFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMN 405
              Y APE     +   +      D++S G +  E++ G        P   G+    Q++
Sbjct: 197 ---YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLG-------EPIFRGDNSAGQLH 242

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.9 bits (237), Expect = 3e-22
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 32/212 (15%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 245
             IGEG YG V+     E +  VA+K +   R   + E        E+  +  ++HKN+V
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           RL           LV+E+ D  +L+++     G   P   +  +  +L   KGL + H  
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR 120

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE---- 360
               V+HRD+K  N+L+++    KL++FGLA+  G   R Y +  V+ T  Y  P+    
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFG 175

Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGRNP 389
              Y ST +     D++S G +  E+ +   P
Sbjct: 176 AKLY-STSI-----DMWSAGCIFAELANAGRP 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 46/219 (21%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 238
             +G G Y  VY G           N       A KE K++ E      AI R       
Sbjct: 11  EKLGNGTYATVYKG----------LNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKE 59

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTA 296
           ++H+N+VRL           LV+E++DN +L++++           L   +         
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFG 355
           +GL + HE    K++HRD+K  N+L++K+   KL DFGLA+  G    ++ ++ V+ T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLW 173

Query: 356 YVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
           Y AP+       Y ST +     D++S G ++ E+I+G+
Sbjct: 174 YRAPDVLMGSRTY-STSI-----DIWSCGCILAEMITGK 206

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 44/216 (20%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
            ++GEG YG+V             +N    R  A K+F    +                +
Sbjct: 31  GLVGEGSYGMVMKC----------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           +RH+NLV LL  C +     LV+E++D+  +   L  ++ P+  L +++    +     G
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPN-GLDYQVVQKYLFQIING 136

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           + + H      ++HRDIK  NIL+ +    KL DFG A+ L A        V  T  Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192

Query: 359 PE-------YASTGMLNERSDVYSFGILIMEVISGR 387
           PE       Y    +     DV++ G L+ E+  G 
Sbjct: 193 PELLVGDVKY-GKAV-----DVWAIGCLVTEMFMGE 222

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 40/218 (18%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAI---------GRVR 240
             IGEG YG V+      N    VA+K +   R Q  +E  + +  I             
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFE 72

Query: 241 HKNLVRLL----GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           H N+VRL         +   ++ LV+E++D  +L  +L  D  P   +  E   +++   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQL 129

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
            +GL +LH     +VVHRD+K  NIL+      KL+DFGLA++   + +  T+ V+ T  
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLW 184

Query: 356 YVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           Y APE      Y +T +     D++S G +  E+   +
Sbjct: 185 YRAPEVLLQSSY-ATPV-----DLWSVGCIFAEMFRRK 216

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 94.2 bits (235), Expect = 7e-22
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 35/211 (16%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
             +GEG YG+VY    +D+    VA+K +   R  AE E        E+  +  + H N+
Sbjct: 27  EKVGEGTYGVVYKA--KDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNI 81

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           V L+          LV+E+++  +L++ L  +         +I +  +L   +G+ + H+
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ 137

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE--- 360
               +++HRD+K  N+L++     KL+DFGLA+  G   RSY T  V+ T  Y AP+   
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPDVLM 192

Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGR 387
               Y ST +     D++S G +  E+I+G+
Sbjct: 193 GSKKY-STSV-----DIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 93.7 bits (234), Expect = 7e-22
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 35/211 (16%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
             IGEG YG+VY    ++N     A+K +   R + E E        E+  +  ++H N+
Sbjct: 8   EKIGEGTYGVVYKA--QNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           V+L          +LV+E++D  +L++ L    G    +T +  +  +L    G+ Y H+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHD 118

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE--- 360
               +V+HRD+K  N+L++++   K++DFGLA+  G   R Y T  ++ T  Y AP+   
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLM 173

Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGR 387
               Y ST +     D++S G +  E+++G 
Sbjct: 174 GSKKY-STTI-----DIWSVGCIFAEMVNGT 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 40/219 (18%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV-----------EAIGRV 239
             IG G YG VY          VA+K++   R          +             +   
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAF 71

Query: 240 RHKNLVRLLGYCAEGAHR-----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
            H N+VRL+  CA           LV+E++D  +L  +L  D  P   L  E   +++  
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQ 128

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
             +GL +LH      +VHRD+K  NIL+      KL+DFGLA++   + +  T  V+ T 
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TL 183

Query: 355 GYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
            Y APE      Y +T +     D++S G +  E+   +
Sbjct: 184 WYRAPEVLLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 26/214 (12%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
           ++GEG YG V   +  E     AVK      L      E   K E++ + R+RHKN+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 248 LG--YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIR---MNIILGTAKGLTY 301
           +   Y  E     +V EY   G  E     D  P       +       +I     GL Y
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLID----GLEY 124

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER--SYVTTRVMGTFGYVAP 359
           LH      +VH+DIK  N+LL      K+S  G+A+ L          T   G+  +  P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180

Query: 360 EYASTGMLNE--RSDVYSFGILIMEVISGRNPVD 391
           E A+        + D++S G+ +  + +G  P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 16/205 (7%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
              +G G YG V        +   A+K     +    +  +   EV  +  + H N+++L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
             +  +  +  LV E    G L   +                 II     G+TYLH+   
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-- 155

Query: 308 PKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
             +VHRD+K  N+LL   +K    K+ DFGL+ +   E        +GT  Y+APE    
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE-VLR 211

Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              +E+ DV+S G+++  +++G  P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 29/210 (13%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV----EVEAIGRVRHKNLV 245
           + +GEG +  VY       N  VA+K + L +R +A+         E++ +  + H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            LL      ++  LV+++++  +LE  +         LT       +L T +GL YLH+ 
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH 131

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE---- 360
               ++HRD+K +N+LLD+    KL+DFGLAK  G+  R+Y T +V+ T  Y APE    
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV-TRWYRAPELLFG 186

Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGR 387
              Y   G+     D+++ G ++ E++   
Sbjct: 187 ARMY-GVGV-----DMWAVGCILAELLLRV 210

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 93.2 bits (232), Expect = 8e-21
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           + V+G+G +G V            AVK      +  +   E     EV+ + ++ H N++
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIM 89

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
           +L  +  +  +  LV E    G L   +          +      II     G+TY+H+ 
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 306 LEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
              K+VHRD+K  N+LL    K  N ++ DFGL+    A +       +GT  Y+APE  
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPE-V 199

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
             G  +E+ DV+S G+++  ++SG  P
Sbjct: 200 LHGTYDEKCDVWSTGVILYILLSGCPP 226

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 27/216 (12%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK-------------NLLNNRGQAEKEFKVEVEAI 236
              +G G YG V        ++  A+K             +   N  +  +E   E+  +
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
             + H N+++L     +  +  LV E+ + G L + +                NI+    
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQIL 156

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
            G+ YLH+     +VHRDIK  NILL   +   N K+ DFGL+      + Y     +GT
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGT 211

Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
             Y+APE       NE+ DV+S G+++  ++ G  P
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 26/285 (9%)

Query: 110 DPLPEPEPILV-EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVS 168
            P     P+L+  D     R     E GK  R      +   ++             E+ 
Sbjct: 92  KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151

Query: 169 HLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAE 226
           H      Y + E             +G G +G+V+    E  T    A K ++      +
Sbjct: 152 HDHVLDHYDIHE------------ELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDK 198

Query: 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
           +  + E++ +  +RH  LV L     +    +++YE++  G L + +      H+ ++ +
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSED 255

Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERS 344
             +  +    KGL ++HE      VH D+K  NI+   + +   KL DFGL   L  ++S
Sbjct: 256 EAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312

Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
                  GT  + APE A    +   +D++S G+L   ++SG +P
Sbjct: 313 VKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 52/222 (23%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
             +GEG YG VY             + + N   A K  ++E E  G              
Sbjct: 40  TKLGEGTYGEVYKA----------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           ++H+N++ L           L++EY +N +L++++      +  ++  +  + +     G
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLING 144

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP-----KLSDFGLAKLLGAE-RSYVTTRVMG 352
           + + H     + +HRD+K  N+LL           K+ DFGLA+  G   R + T  ++ 
Sbjct: 145 VNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII- 199

Query: 353 TFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
           T  Y  PE       Y ST +     D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHY-STSV-----DIWSIACIWAEMLMKT 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)

Query: 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEF--- 229
           W  L    +  + F D  V+G GG+G V+       T    A K L   R +  K +   
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGA 232

Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
            VE + + +V  + +V L  Y  E    + LV   ++ G++   ++     +     E R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPR 290

Query: 289 MN-----IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
                  I+ G    L +LH+     +++RD+K  N+LLD   N ++SD GLA  L A +
Sbjct: 291 AIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

Query: 344 SYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           +       GT G++APE     +L         D ++ G+ + E+I+ R P
Sbjct: 344 TKTKGYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 28/204 (13%), Positives = 54/204 (26%), Gaps = 47/204 (23%)

Query: 193 VIGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 246
             G       +  +  D      VA+  +       +   +E       + R+    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G 305
           +L      A  ++V E+I  G+L++       P         +  +   A      H  G
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------AIRAMQSLAAAADAAHRAG 149

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               V       S +         +S  G   L                  +        
Sbjct: 150 ----VALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA----- 179

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
             N + D+   G  +  ++  R P
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWP 201

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 20/256 (7%)

Query: 146 RAAGSHHGSGDQTVAAAITPEVSHLGWGHW-----YTLRELEVSTNGFAD----ENVIGE 196
           R +  HH  G +       P+++     +      Y  + +EV      D       +G 
Sbjct: 2   RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61

Query: 197 GGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255
           G +G+V+  V          K +       +   K E+  + ++ H  L+ L     +  
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315
             +L+ E++  G L   +  +    S       M        GL ++HE     +VH DI
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH---SIVHLDI 175

Query: 316 KSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
           K  NI+ + +     K+ DFGLA  L  +          T  + APE      +   +D+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDM 233

Query: 374 YSFGILIMEVISGRNP 389
           ++ G+L   ++SG +P
Sbjct: 234 WAIGVLGYVLLSGLSP 249

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 49/221 (22%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
           +GEG YG V   V       VAVK +++ +   +    +  E+     + H+N+V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
             EG  + L  EY   G L   +                 M           ++ G    
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMAGVV-- 119

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGY 356
             YLH      + HRDIK  N+LLD++ N K+SDFGLA +         +     GT  Y
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173

Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
           VAPE     +L  R       DV+S GI++  +++G  P D
Sbjct: 174 VAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 13/196 (6%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           VIG+G + +V   +  E     AVK        ++ G + ++ K E      ++H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           LL   +      +V+E++D  +L   +          +  +  + +    + L Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149

Query: 307 EPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
              ++HRD+K   +LL  + N    KL  FG+A  LG        RV GT  ++APE   
Sbjct: 150 --NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206

Query: 364 TGMLNERSDVYSFGIL 379
                +  DV+  G++
Sbjct: 207 REPYGKPVDVWGCGVI 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 76/276 (27%)

Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGR 238
           LE S+  ++    +G G +GIV     +E     A+K +L      +  +K  E++ +  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56

Query: 239 VRHKNLVRLLGYCAEGAHRM--------------------------------------LV 260
           + H N+++L+ Y                                              ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
            EY+ +  L + L   +     +   +    I    + + ++H      + HRDIK  N+
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172

Query: 321 LLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNERS----- 371
           L++ + N  KL DFG AK L       +Y+ +R      Y APE     ML         
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSI 223

Query: 372 DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMN 405
           D++S G +  E+I G       +P   GE  I Q+ 
Sbjct: 224 DLWSIGCVFGELILG-------KPLFSGETSIDQLV 252

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 57/274 (20%)

Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
               HH SG     + + P  + L        +E E   + +    ++G GG+G VY G+
Sbjct: 5   HHHHHHSSGLVPRGSHMAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63

Query: 207 -LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVRHK--NLVRLLGYCAEGAHR 257
            + DN  VA+K    + +++ G+     +V  EV  + +V      ++RLL +       
Sbjct: 64  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123

Query: 258 MLVYEYIDN-GNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKGLTYLHE 304
           +L+ E  +   +L  ++   G             +           ++    + + + H 
Sbjct: 124 VLILERPEPVQDLFDFITERG------------ALQEELARSFFWQVL----EAVRHCHN 167

Query: 305 GLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                V+HRDIK  NIL+D  +   KL DFG   LL  + +  T    GT  Y  PE   
Sbjct: 168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPE--- 218

Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
              +         + V+S GIL+ +++ G  P +
Sbjct: 219 --WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 47/217 (21%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 238
           + +GEG Y  VY G          K+ L +   A KE ++E E      AI R       
Sbjct: 8   DKLGEGTYATVYKG----------KSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 56

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           ++H N+V L           LV+EY+D  +L+Q+L       + +        +    +G
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRG 112

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYV 357
           L Y H     KV+HRD+K  N+L++++   KL+DFGLA+      ++Y    V+ T  Y 
Sbjct: 113 LAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYR 167

Query: 358 APE-------YASTGMLNERSDVYSFGILIMEVISGR 387
            P+       Y ST +     D++  G +  E+ +GR
Sbjct: 168 PPDILLGSTDY-STQI-----DMWGVGCIFYEMATGR 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 59/224 (26%), Positives = 86/224 (38%), Gaps = 46/224 (20%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVR----H 241
           ++G+GG+G V+ G  L D   VA+K    N +              EV  + +V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD----VGPHSPLT--------WEIRM 289
             ++RLL +       MLV E             D    +    PL          ++  
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA-------QDLFDYITEKGPLGEGPSRCFFGQV-- 148

Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTT 348
                    + + H      VVHRDIK  NIL+D +    KL DFG   LL       T 
Sbjct: 149 ------VAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTD 197

Query: 349 RVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVD 391
              GT  Y  PE+ S        + V+S GIL+ +++ G  P +
Sbjct: 198 FD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 51/222 (22%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK-EFKV--EVEAIGRVRHKNLVRLLG 249
           +GEG YG V   V       VAVK +  +  +A      +  E+     + H+N+V+  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAK 297
           +  EG  + L  EY   G L   +                 M           ++ G   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMAG--- 117

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFG 355
            + YLH      + HRDIK  N+LLD++ N K+SDFGLA +         +     GT  
Sbjct: 118 -VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172

Query: 356 YVAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
           YVAPE     +L  R       DV+S GI++  +++G  P D
Sbjct: 173 YVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 31/188 (16%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 245
             IG+G +G V+     +    VA+K +     + EKE F +    E++ +  ++H+N+V
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79

Query: 246 RLLGYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
            L+  C   A           LV+++ ++ +L   L          T      ++     
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLN 135

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----AERSYVTTRVMG 352
           GL Y+H     K++HRD+K++N+L+ +    KL+DFGLA+            Y T RV+ 
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNRVV- 190

Query: 353 TFGYVAPE 360
           T  Y  PE
Sbjct: 191 TLWYRPPE 198

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 26/210 (12%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
             ++G+G +G V            AVK  N  + + +       EVE + ++ H N+++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
                + +   +V E    G L   +          +      II     G+TY+H+   
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH-- 140

Query: 308 PKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---- 360
             +VHRD+K  NILL   +K  + K+ DFGL+     +++      +GT  Y+APE    
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG 197

Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNP 389
            Y      +E+ DV+S G+++  ++SG  P
Sbjct: 198 TY------DEKCDVWSAGVILYILLSGTPP 221

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 26/194 (13%)

Query: 179 RELEVSTNGFADE----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV 233
           ++L  ++  F D       IG G Y +    +    N   AVK +  ++    ++   E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEI 66

Query: 234 EAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM--N 290
           E + R  +H N++ L     +G +  +V E +  G L   +       S    E R    
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFS----E-REASA 120

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP---KLSDFGLAKLLGAERSYV 346
           ++    K + YLH      VVHRD+K SNIL  D+  NP   ++ DFG AK L AE   +
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177

Query: 347 TTRVMGTFGYVAPE 360
            T    T  +VAPE
Sbjct: 178 MTPC-YTANFVAPE 190

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 32/201 (15%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
             V+G G +  V+           A+K +  +    +   + E+  + +++H+N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM---------NIILGTAKGLT 300
                 H  LV + +  G L   +             +            +I      + 
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI-------------LERGVYTEKDASLVIQQVLSAVK 120

Query: 301 YLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           YLHE     +VHRD+K  N+L    ++     ++DFGL+K+   +   ++T   GT GYV
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYV 174

Query: 358 APEYASTGMLNERSDVYSFGI 378
           APE  +    ++  D +S G+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGV 195

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 36/190 (18%)

Query: 194 IGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNL 244
           +G G YG VY    +D  +    A+K +        +   + + A   +      +H N+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80

Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLH-----GDVGPHSPLTWEIRMNIILGTAK 297
           + L       A R   L+++Y ++ +L   +              L   +  +++     
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAE-RSY--VTTRV 350
           G+ YLH      V+HRD+K +NIL+  +       K++D G A+L  +  +    +   V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 351 MGTFGYVAPE 360
           + TF Y APE
Sbjct: 197 V-TFWYRAPE 205

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 55/249 (22%), Positives = 91/249 (36%), Gaps = 49/249 (19%)

Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE--FKVEVEA---------I 236
           +  +  I  G YG V  GV  +   VA+K + N                          +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 237 GRVRHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
               H N++ L   +       M    LV E +   +L Q +H        ++ +     
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD---QRIVISPQHIQYF 139

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTT 348
           +     GL  LHE     VVHRD+   NILL    +  + DF LA+   A+ +   YVT 
Sbjct: 140 MYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196

Query: 349 RVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEVCI 401
           R      Y APE     ++  +      D++S G ++ E+ +        +    G    
Sbjct: 197 RW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNR-------KALFRGSTFY 240

Query: 402 PQMNSLMTL 410
            Q+N ++ +
Sbjct: 241 NQLNKIVEV 249

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 11/191 (5%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGY 250
            +G G +G V+            +K +  +R Q   E  + E+E +  + H N++++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
             +  +  +V E  + G L + +         L+      ++      L Y H      V
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145

Query: 311 VHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
           VH+D+K  NIL          K+ DFGLA+L  ++    T    GT  Y+APE      +
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAA-GTALYMAPEVFK-RDV 202

Query: 368 NERSDVYSFGI 378
             + D++S G+
Sbjct: 203 TFKCDIWSAGV 213

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 63/241 (26%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK------------------------NLLNNRGQAEKE 228
           IG+G YG+V       DNT  A+K                                    
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 229 FKVEVE-AIGR-VRHKNLVRLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
            +V  E AI + + H N+V+L            H  +V+E ++ G +      +V    P
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM-----EVPTLKP 133

Query: 283 LT----WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
           L+         ++I G    + YLH     K++HRDIK SN+L+ +  + K++DFG++  
Sbjct: 134 LSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNER--------SDVYSFGILIMEVISGRNPV 390
                + ++  V GT  ++APE      L+E          DV++ G+ +   + G+ P 
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 391 D 391
            
Sbjct: 241 M 241

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.1 bits (214), Expect = 7e-19
 Identities = 41/202 (20%), Positives = 88/202 (43%), Gaps = 16/202 (7%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
            +G G +GIV+  V          K  +  +G  +   K E+  +   RH+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                 ++++E+I   ++ + ++      +       ++ +    + L +LH      + 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFLHSH---NIG 124

Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           H DI+  NI+   + +   K+ +FG A+ L    ++    +     Y APE     +++ 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVST 182

Query: 370 RSDVYSFGIL--IMEVISGRNP 389
            +D++S G L  ++  +SG NP
Sbjct: 183 ATDMWSLGTLVYVL--LSGINP 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 24/181 (13%)

Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHK 242
            +G G  G V     E  T   VA++             E +     + E+E + ++ H 
Sbjct: 142 TLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
            ++++  +     +  +V E ++ G L       V  +  L               + YL
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYL 255

Query: 303 HEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           HE     ++HRD+K  N+LL   ++    K++DFG +K+LG E S + T   GT  Y+AP
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAP 310

Query: 360 E 360
           E
Sbjct: 311 E 311

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 30/225 (13%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVE-- 232
             + ++ N F+   +IG GG+G VY     D   + A+K L   R + ++       E  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 233 -VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
            +  +       +V +  Y      ++  + + ++ G+L   L         +  E  M 
Sbjct: 242 MLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMR 295

Query: 291 -----IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
                IILG    L ++H      VV+RD+K +NILLD+  + ++SD GLA     ++ +
Sbjct: 296 FYAAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348

Query: 346 VTTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNP 389
               V GT GY+APE    G+  + S D +S G ++ +++ G +P
Sbjct: 349 --ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 33/230 (14%)

Query: 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---K 230
           W  L    V+ N F    V+G+GG+G V    +     + A K L   R +  K      
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
            E + + +V  + +V L  Y  E    + LV   ++ G+L+  ++       P   E R 
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARA 288

Query: 290 -----NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
                 I  G    L  LH     ++V+RD+K  NILLD   + ++SD GLA  +  E  
Sbjct: 289 VFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQ 340

Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
            +  RV GT GY+APE     ++         D ++ G L+ E+I+G++P
Sbjct: 341 TIKGRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 62/317 (19%), Positives = 101/317 (31%), Gaps = 75/317 (23%)

Query: 68  SNYNSSSGNPTIP-NISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPAS 126
            +++SS  +        +  +EIR  P+ N         +   DP      +        
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 127 GRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTN 186
            + +              E       G  D+    A   E         Y  ++      
Sbjct: 64  AQPKG------------TENLYFQSMGPEDELPDWAAAKEFYQK-----YDPKD------ 100

Query: 187 GFADENVIGEGGYGIVYHGV-LEDNTNVAVK--------NLLNNRGQAEKEFKVEVEAIG 237
                 VIG G   +V   V        AVK               +  +  + E   + 
Sbjct: 101 ------VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 238 RVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTW 285
           +V  H +++ L+      +   LV++ +  G L           E+              
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK-------------- 200

Query: 286 EIR--MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
           E R  M  +L   + +++LH      +VHRD+K  NILLD     +LSDFG +  L    
Sbjct: 201 ETRSIMRSLL---EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254

Query: 344 SYVTTRVMGTFGYVAPE 360
                   GT GY+APE
Sbjct: 255 KL-RELC-GTPGYLAPE 269

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 20/198 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
            +G G + IV            A K         +R    +E  + EV  + +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            L          +L+ E +  G L  +L       S       +  IL    G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134

Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
              K+ H D+K  NI+L  +  P    KL DFGLA  +     +    + GT  +VAPE 
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189

Query: 362 ASTGMLNERSDVYSFGIL 379
            +   L   +D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVI 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 47/219 (21%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
           IG+G +  V     +     VA+K +   +       K+  EV  +  + H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
                   L+ EY   G +  +L  HG            RM           I+      
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVSA---- 126

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           + Y H+    ++VHRD+K+ N+LLD   N K++DFG +         +     G   Y A
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPYAA 181

Query: 359 PEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
           PE     +   +       DV+S G+++  ++SG  P D
Sbjct: 182 PE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.0 bits (206), Expect = 4e-18
 Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 20/199 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
            +G G + IV            A K      L ++R    +E  + EV  +  +RH N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            L          +L+ E +  G L  +L       +       +  IL    G+ YLH  
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD---GVHYLHSK 127

Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
              ++ H D+K  NI+L  +  P    KL DFG+A  + A   +    + GT  +VAPE 
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEI 182

Query: 362 ASTGMLNERSDVYSFGILI 380
            +   L   +D++S G++ 
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 49/195 (25%), Positives = 70/195 (35%), Gaps = 24/195 (12%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
            IG G +G V   V        A K +     +    FK E+E +  + H N++RL    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +     LV E    G L + +                 I+      + Y H+     V 
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVA 128

Query: 312 HRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YAS 363
           HRD+K  N L          KL DFGLA      +    T+V GT  YV+P+     Y  
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-GTPYYVSPQVLEGLY-- 184

Query: 364 TGMLNERSDVYSFGI 378
                   D +S G+
Sbjct: 185 ----GPECDEWSAGV 195

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 52/217 (23%), Positives = 81/217 (37%), Gaps = 36/217 (16%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--------NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           +G G +G V+  V  E N  V VK                   +  +E+  + RV H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV----GPHSPLTWEIRMNIILGTAKGLT 300
           +++L          LV E   +G        D+      H  L   +   I       + 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-------LDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           YL       ++HRDIK  NI++ + +  KL DFG A  L        T   GT  Y APE
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPE 199

Query: 361 YASTGMLNERS------DVYSFGILIMEVISGRNPVD 391
                +L          +++S G+ +  ++   NP  
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 50/193 (25%), Positives = 78/193 (40%), Gaps = 26/193 (13%)

Query: 184 STNGFADE----NVIGEGGYGIVYHGVLEDNTN--VAVK-------NLLNNRGQAEKEFK 230
           ST+GF +      ++G G   +V   +    T    AVK          +     E    
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 231 V--EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
              EV+ + +V  H N+++L           LV++ +  G L  +L         L+ + 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKE 125

Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
              I+    + +  LH+     +VHRD+K  NILLD   N KL+DFG +  L        
Sbjct: 126 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-R 181

Query: 348 TRVMGTFGYVAPE 360
               GT  Y+APE
Sbjct: 182 EVC-GTPSYLAPE 193

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 54/247 (21%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
            IG+G YG+V   +  +     A+K      +     +  +  K EV  + ++ H N+ R
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 247 LLGYCAEGAHRMLVYEYIDNGNL--------------------EQWLHGDVGPHSPLTWE 286
           L     +  +  LV E    G+L                    +  +      +      
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 287 IRMNIILGTAKGLT----------------YLHEGLEPKVVHRDIKSSNILL--DKQWNP 328
                                         YLH      + HRDIK  N L   +K +  
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209

Query: 329 KLSDFGLAKLLG----AERSYVTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIME 382
           KL DFGL+K        E   +TT+  GT  +VAPE    +      + D +S G+L+  
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 383 VISGRNP 389
           ++ G  P
Sbjct: 269 LLMGAVP 275

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 20/198 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
            +G G + IV            A K         +R    +E  + EV  + +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            L          +L+ E +  G L  +L       S       +  IL    G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134

Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
              K+ H D+K  NI+L  +  P    KL DFGLA  +     +    + GT  +VAPE 
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189

Query: 362 ASTGMLNERSDVYSFGIL 379
            +   L   +D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVI 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 61/290 (21%), Positives = 108/290 (37%), Gaps = 34/290 (11%)

Query: 97  SNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGD 156
              N    S  N                 S  +       K  R +       +     D
Sbjct: 15  GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74

Query: 157 QTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAV 215
             +  A    V+       YT+ + E+          +G G +G V+          +A 
Sbjct: 75  HRIVTAKQGAVNSF-----YTVSKTEI----------LGGGRFGQVHKCEETATGLKLAA 119

Query: 216 KNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH 274
           K ++  RG  +KE  K E+  + ++ H NL++L          +LV EY+D G L   + 
Sbjct: 120 K-IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI- 177

Query: 275 GDVGPHSPLT-WEIR--MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP-K 329
             +     LT  +    M  I     G+ ++H+     ++H D+K  NIL  ++     K
Sbjct: 178 --IDESYNLTELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIK 229

Query: 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379
           + DFGLA+              GT  ++APE  +   ++  +D++S G++
Sbjct: 230 IIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 24/181 (13%)

Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHK 242
            +G G  G V     E  T   VA+K             E +     + E+E + ++ H 
Sbjct: 17  TLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
            ++++  +     +  +V E ++ G L   + G    +  L               + YL
Sbjct: 76  CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL 130

Query: 303 HEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           HE     ++HRD+K  N+LL   ++    K++DFG +K+LG E S + T   GT  Y+AP
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAP 185

Query: 360 E 360
           E
Sbjct: 186 E 186

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 41/212 (19%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYC 251
           +G G Y  V+  + + +N  V VK L   +   +K+ K E++ +  +R   N++ L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 252 AEGAHRMLVY--EYIDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTYLHEGL 306
            +   R      E+++N + +Q           LT ++IR  M  IL   K L Y H   
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHSM- 149

Query: 307 EPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYA 362
              ++HRD+K  N+++D +    +L D+GLA+     + Y   V +R      +  PE  
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPEL- 201

Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
              +++ +      D++S G ++  +I  + P
Sbjct: 202 ---LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 42/217 (19%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
           +  +GEG + I    V  + N   AVK +       E   + E+ A+     H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72

Query: 249 GYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 297
               +  H  LV E ++ G L           E               E    I+     
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET--------------EAS-YIMRKLVS 117

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTF 354
            ++++H+     VVHRD+K  N+L  D+  N   K+ DFG A+L   +   + T    T 
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173

Query: 355 GYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRNP 389
            Y APE  +    +E  D++S G++   M  +SG+ P
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVP 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 28/204 (13%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKN 243
              +G G + +V            A K        ++R    +E  + EV  +  ++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGL 299
           ++ L          +L+ E +  G  E  L   +     LT E      +  IL    G+
Sbjct: 76  VITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLT-EEEATEFLKQILN---GV 127

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFG 355
            YLH     ++ H D+K  NI+L  +  P    K+ DFGLA  +     +    + GT  
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPE 182

Query: 356 YVAPEYASTGMLNERSDVYSFGIL 379
           +VAPE  +   L   +D++S G++
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVI 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 38/215 (17%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
           ++GEG +  V        +   A+K L       E +      E + + R+ H   V+L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-------------IILGT 295
               +         Y  NG L +++              ++              I+   
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVSA- 142

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTF 354
              L YLH      ++HRD+K  NILL++  + +++DFG AK+L  E          GT 
Sbjct: 143 ---LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
            YV+PE  +     + SD+++ G +I ++++G  P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 57/247 (23%), Positives = 110/247 (44%), Gaps = 46/247 (18%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIG 237
           E+    +     +G G YG V   +       VA+K L     +   A++ ++ E+  + 
Sbjct: 21  ELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLK 78

Query: 238 RVRHKNLVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
            ++H+N++ LL  +    + R      LV  ++   +L++ +          + E    +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYL 131

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRV 350
           +    KGL Y+H      VVHRD+K  N+ +++    K+ DFGLA+   AE + YV TR 
Sbjct: 132 VYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188

Query: 351 MGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQ 403
                Y APE     +L+        D++S G ++ E+++G       +    G+  + Q
Sbjct: 189 -----YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTG-------KTLFKGKDYLDQ 232

Query: 404 MNSLMTL 410
           +  ++ +
Sbjct: 233 LTQILKV 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 65/238 (27%), Positives = 101/238 (42%), Gaps = 38/238 (15%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
           + +   IG G  GIV          NVA+K L     N+  A++ ++ E+  +  V HKN
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85

Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
           ++ LL  +  + +        +V E +D  NL Q +         L  E    ++     
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 138

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTF 354
           G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G       YV TR     
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 191

Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMNSLMTL 410
            Y APE        E  D++S G ++ E+I G           PG   I Q N ++  
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG-------GVLFPGTDHIDQWNKVIEQ 241

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 26/197 (13%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLG 249
           ++G+G +G V            AVK +       +       EVE + ++ H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              + +   +V E    G L   +       S       +  +     G+TY+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFS---GITYMHKH---N 141

Query: 310 VVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----Y 361
           +VHRD+K  NILL   +K  + K+ DFGL+            R+ GT  Y+APE     Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI-GTAYYIAPEVLRGTY 199

Query: 362 ASTGMLNERSDVYSFGI 378
                 +E+ DV+S G+
Sbjct: 200 ------DEKCDVWSAGV 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 22/178 (12%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
            +G+G + +V   V +      A   +       +  ++ + E      ++H N+VRL  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGLTYLHEG 305
             +E  H  L+++ +  G L + +      +S    E      +  IL     + + H+ 
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIV-AREYYS----EADASHCIQQILE---AVLHCHQM 129

Query: 306 LEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
               VVHR++K  N+LL    K    KL+DFGLA  +  E+        GT GY++PE
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 47/220 (21%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
           E+V+GEG +  V   + L  +   AVK +    G        EVE + + + H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 249 GYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 297
            +  E     LV+E +  G++           E               E    ++   A 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL--------------EAS-VVVQDVAS 122

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL--GAERSYVTTRVM- 351
            L +LH      + HRD+K  NIL    ++    K+ DF L   +    + S ++T  + 
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 352 ---GTFGYVAPE-----YASTGMLNERSDVYSFG-IL-IM 381
              G+  Y+APE          + ++R D++S G IL I+
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 50/221 (22%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G +G V  G        VAVK      + +     K  K E++ +   RH ++++L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKLY 77

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTA 296
              +      +V EY+  G L  ++  HG            R+           I+    
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL---- 121

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
             + Y H      VVHRD+K  N+LLD   N K++DFGL+ ++       T+   G+  Y
Sbjct: 122 SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNY 176

Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
            APE     +++ R       D++S G+++  ++ G  P D
Sbjct: 177 AAPE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 46/242 (19%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
           + +   IG G  GIV        + NVA+K L     N+  A++ ++ E+  +  V HKN
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122

Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
           ++ LL  +  +          LV E +D  NL Q +         L  E    ++     
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 175

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTF 354
           G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G       YV TR     
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228

Query: 355 GYVAPEYASTGMLNER----SDVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMNSLM 408
            Y APE     +L        D++S G ++ E++         +   PG   I Q N ++
Sbjct: 229 -YRAPEV----ILGMGYKENVDIWSVGCIMGEMVRH-------KILFPGRDYIDQWNKVI 276

Query: 409 TL 410
             
Sbjct: 277 EQ 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 19/192 (9%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
            +G G   IVY           A+K L   +   +K  + E+  + R+ H N+++L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM--NIILGTAKGLTYLHEGLEPK 309
                  LV E +  G L   +  + G +S    E R   + +    + + YLHE     
Sbjct: 118 ETPTEISLVLELVTGGELFDRIV-EKGYYS----E-RDAADAVKQILEAVAYLHEN---G 168

Query: 310 VVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
           +VHRD+K  N+L      +   K++DFGL+K++  +    T  V GT GY APE      
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCA 226

Query: 367 LNERSDVYSFGI 378
                D++S GI
Sbjct: 227 YGPEVDMWSVGI 238

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 18/195 (9%)

Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLL 248
            +G+G + +V   V    T    A K +   +  A    K+  E     +++H N+VRL 
Sbjct: 13  ELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
               E +   LV++ +  G L + +      +S       +  IL   + + Y H     
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQIL---ESIAYCHSN--- 124

Query: 309 KVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
            +VHR++K  N+LL  +      KL+DFGLA  +    ++      GT GY++PE     
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPEVLKKD 182

Query: 366 MLNERSDVYSFG-IL 379
             ++  D+++ G IL
Sbjct: 183 PYSKPVDIWACGVIL 197

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 52/221 (23%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
           IG G +G+            VAVK +   RG A  E  V  E+     +RH N+VR    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEV 84

Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
                H  ++ EY   G L + +   G            R +          ++     G
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS----G 128

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
           ++Y H     ++ HRD+K  N LLD    P  K+ DFG +K      S   + V GT  Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAY 183

Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
           +APE     +L  +      +DV+S G+ +  ++ G  P +
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 15/174 (8%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLG 249
            +G+G + +V   V        A K +   +   +  ++ + E     +++H N+VRL  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
              E +   LV++ +  G L +    D+      +     + I    + + Y H      
Sbjct: 96  SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 148

Query: 310 VVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           +VHR++K  N+LL  +      KL+DFGLA  +    ++      GT GY++PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPE 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 44/241 (18%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
           + D   +G G YG V   V       VA+K L     +   A++ ++ E+  +  +RH+N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHEN 85

Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
           ++ LL  +  +          LV  ++   +L + +  +      L  +    ++    K
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE-----KLGEDRIQFLVYQMLK 139

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGY 356
           GL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   +E + YV TR      Y
Sbjct: 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMNSLMT 409
            APE     +LN        D++S G ++ E+I+G       +    G   + Q+  +M 
Sbjct: 192 RAPEV----ILNWMRYTQTVDIWSVGCIMAEMITG-------KTLFKGSDHLDQLKEIMK 240

Query: 410 L 410
           +
Sbjct: 241 V 241

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 39/241 (16%)

Query: 169 HLGWGHWYTLRELEVSTNGFAD-----ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR 222
           H   G     +  E       D     + V+G G  G V            A+K LL + 
Sbjct: 7   HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDS 65

Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM----LVYEYIDNGNL-----EQWL 273
            +A +E     +A G     ++V +L       H      ++ E ++ G L     E+  
Sbjct: 66  PKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-- 120

Query: 274 HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKL 330
                     T      I+      + +LH      + HRD+K  N+L    +K    KL
Sbjct: 121 -----GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172

Query: 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRN 388
           +DFG AK        + T    T  YVAPE       ++  D++S G++  I+  + G  
Sbjct: 173 TDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGFP 227

Query: 389 P 389
           P
Sbjct: 228 P 228

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 53/254 (20%), Positives = 106/254 (41%), Gaps = 57/254 (22%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           + D   +G GG G+V+  V  + +  VA+K + L +    +   + E++ I R+ H N+V
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71

Query: 246 RLL----------GYCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           ++                    +    +V EY++  +L   L        PL  E     
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLLEEHARLF 125

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAERS------ 344
           +    +GL Y+H      V+HRD+K +N+ ++ +    K+ DFGLA+++    S      
Sbjct: 126 MYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 345 -YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--P 396
             + T+      Y +P      +L+  +     D+++ G +  E+++G       +    
Sbjct: 183 EGLVTK-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTG-------KTLFA 226

Query: 397 GEVCIPQMNSLMTL 410
           G   + QM  ++  
Sbjct: 227 GAHELEQMQLILES 240

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 36/214 (16%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +G G +G V  G        VAVK      + +     K  + E++ +   RH ++++L 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKLY 82

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 303
              +  +   +V EY+  G L  ++  +G +        E R     I+     G+ Y H
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQIL----SGVDYCH 133

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 VVHRD+K  N+LLD   N K++DFGL+ ++       T+   G+  Y APE   
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE--- 185

Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
             +++ R       D++S G+++  ++ G  P D
Sbjct: 186 --VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 41/194 (21%), Positives = 82/194 (42%), Gaps = 14/194 (7%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRH-KNLVRLL 248
            +G G + +V   +        A K L   R   +   ++  E+  +   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                 +  +L+ EY   G +      ++     ++    + +I    +G+ YLH+    
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVYYLHQN--- 150

Query: 309 KVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
            +VH D+K  NILL         K+ DFG+++ +G         +MGT  Y+APE  +  
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNYD 208

Query: 366 MLNERSDVYSFGIL 379
            +   +D+++ GI+
Sbjct: 209 PITTATDMWNIGII 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 63/251 (25%), Positives = 117/251 (46%), Gaps = 49/251 (19%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGR 238
           +V    + + + IGEG YG+V       +   VA+K +    ++   ++  + E++ + R
Sbjct: 24  DVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLR 81

Query: 239 VRHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
            RH+N++ +     A    +M    +V + ++  +L + L         L+ +     + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLY 135

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------YV 346
              +GL Y+H      V+HRD+K SN+LL+   + K+ DFGLA++   +         YV
Sbjct: 136 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 347 TTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEV 399
            TR      Y APE     MLN +      D++S G ++ E++S        RP  PG+ 
Sbjct: 193 ATR-----WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSN-------RPIFPGKH 236

Query: 400 CIPQMNSLMTL 410
            + Q+N ++ +
Sbjct: 237 YLDQLNHILGI 247

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 44/241 (18%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
           + + + +G G YG V      +    VAVK L     +   A++ ++ E+  +  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89

Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
           ++ LL  +    +        LV   +   +L   +         LT +    +I    +
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLTDDHVQFLIYQILR 143

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGY 356
           GL Y+H      ++HRD+K SN+ +++    K+ DFGLA+    E + YV TR      Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195

Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGEVCIPQMNSLMT 409
            APE     MLN        D++S G ++ E+++G       R   PG   I Q+  ++ 
Sbjct: 196 RAPEI----MLNWMHYNQTVDIWSVGCIMAELLTG-------RTLFPGTDHIDQLKLILR 244

Query: 410 L 410
           L
Sbjct: 245 L 245

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 54/252 (21%), Positives = 101/252 (40%), Gaps = 55/252 (21%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           F  ++++GEG YG+V           VA+K     +    A +  + E++ +   +H+N+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71

Query: 245 VRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           + +      +         ++ E +   +L + +         L+ +     I  T + +
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAV 125

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS--------------Y 345
             LH      V+HRD+K SN+L++   + K+ DFGLA+++    +              +
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 346 VTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVDYSRP--PGE 398
           V TR      Y APE     ML         DV+S G ++ E+          RP  PG 
Sbjct: 183 VATR-----WYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLR-------RPIFPGR 226

Query: 399 VCIPQMNSLMTL 410
               Q+  +  +
Sbjct: 227 DYRHQLLLIFGI 238

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 37/214 (17%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           +GEG +G V      +    VA+K     LL       +  + E+  +  +RH ++++L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 303
                    ++V EY   G L  ++     +        E R     II      + Y H
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQII----CAIEYCH 125

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                K+VHRD+K  N+LLD   N K++DFGL+ ++       T+   G+  Y APE   
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE--- 177

Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
             ++N +       DV+S GI++  ++ GR P D
Sbjct: 178 --VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 33/231 (14%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNL----LNNRGQAEKEFKVE 232
           L+E+ +  + F    VIG G +  V    ++    V A+K +    +  RG+    F+ E
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREE 111

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTW------ 285
            + +     + + +L  +  +  + + LV EY   G+L   L    G   P         
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA 169

Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
           EI M         +  +H       VHRDIK  NILLD+  + +L+DFG    L A+ + 
Sbjct: 170 EIVM--------AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 346 VTTRVMGTFGYVAPEYASTGMLNERSDVY-------SFGILIMEVISGRNP 389
            +   +GT  Y++PE          +  Y       + G+   E+  G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 57/263 (21%), Positives = 106/263 (40%), Gaps = 64/263 (24%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
           +  +++IG G YG VY         NVA+K +     +    ++  + E+  + R++   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDY 86

Query: 244 LVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           ++RL      +   +     +V E  D+ +L++     +     LT E    I+     G
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLG 141

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------------- 344
             ++HE     ++HRD+K +N LL++  + K+ DFGLA+ + +E+               
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 345 ------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
                       +V TR      Y APE     +L + +     D++S G +  E+++  
Sbjct: 199 PHNKNLKKQLTSHVVTR-----WYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 388 NPVDYS----RP--PGEVCIPQM 404
                      P  PG  C P  
Sbjct: 250 QSHINDPTNRFPLFPGSSCFPLS 272

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 18/100 (18%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YL      +++HRD+K  NILLD+  +  ++DF +A +L  E     T + GT  Y+
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYM 181

Query: 358 APEYASTGMLNERS--------DVYSFGILIMEVISGRNP 389
           APE     M + R         D +S G+   E++ GR P
Sbjct: 182 APE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 52/270 (19%), Positives = 98/270 (36%), Gaps = 69/270 (25%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
           +   ++IG G YG V       +   VA+K +L    +    ++  + E+  + R+ H +
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113

Query: 244 LVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           +V++L     +   +     +V E       +            LT      ++     G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------------- 344
           + Y+H      ++HRD+K +N L+++  + K+ DFGLA+ +    +              
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 345 -----------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 382
                            +V TR      Y APE     +L + +     DV+S G +  E
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTR-----WYRAPEL----ILLQENYTEAIDVWSIGCIFAE 276

Query: 383 VISGRNPVDYS----RP--PGEVCIPQMNS 406
           +++             P  PG  C P    
Sbjct: 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPD 306

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 36/221 (16%)

Query: 181 LEVSTNGFADE-----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
           L++  N   D+      V+G G  G V            A+K +L +  +A +E ++   
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 110

Query: 235 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNL-----EQWLHGDVGPHSPLTW 285
           A       ++VR++       A     ++V E +D G L     ++            T 
Sbjct: 111 ASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAFTE 160

Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAE 342
                I+    + + YLH      + HRD+K  N+L   K+ N   KL+DFG AK   + 
Sbjct: 161 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217

Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFG-IL-IM 381
            S  T     T  YVAPE       ++  D++S G I+ I+
Sbjct: 218 NSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 36/230 (15%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNL----LNNRGQAEKEFKVE 232
           +R+L +    +    VIG G +G V     +    V A+K L    +  R  +   F  E
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEE 119

Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
            + +       +V+L  Y  +    + +V EY+  G+L   +                ++
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDV 165

Query: 292 ILGTAK--------GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
               A+         L  +H       +HRD+K  N+LLDK  + KL+DFG    +  E 
Sbjct: 166 PEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

Query: 344 SYVTTRVMGTFGYVAPE----YASTGMLNERSDVYSFGILIMEVISGRNP 389
                  +GT  Y++PE        G      D +S G+ + E++ G  P
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 29/228 (12%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKE---FKVEV 233
           ++++ +    F    VIG G +G V    L++   V A+K L         E   F+ E 
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125

Query: 234 EAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--- 288
           + +     K +  L  + A  +  +  LV +Y   G+L   L            E     
Sbjct: 126 DVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP----EEMARF 179

Query: 289 --MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
               +++     +  +H+      VHRDIK  NIL+D   + +L+DFG    L  + +  
Sbjct: 180 YLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 347 TTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNP 389
           ++  +GT  Y++PE         G      D +S G+ + E++ G  P
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 33/212 (15%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
           ++G+G +G V     +      A+K L      A+ E      E   +   RH  L  L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-----IILGTAKGLTYL 302
            Y  +   R+  V EY + G L   L         +  E R       I+      L YL
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSA----LDYL 264

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H      VV+RD+K  N++LDK  + K++DFGL K  G +         GT  Y+APE  
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-- 319

Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
              +L +       D +  G+++ E++ GR P
Sbjct: 320 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 77/268 (28%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR------ 240
           +     +G+G YGIV+  +       VAVK + +        F+   +A    R      
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIMILT 63

Query: 241 ----HKNLVRLLG-YCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
               H+N+V LL    A+    + LV++Y++  +L   +  +      L    +  ++  
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQ 117

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---------- 344
             K + YLH G    ++HRD+K SNILL+ + + K++DFGL++     R           
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 345 ---------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVI 384
                          YV TR      Y APE     +L         D++S G ++ E++
Sbjct: 175 ENTENFDDDQPILTDYVATR-----WYRAPEI----LLGSTKYTKGIDMWSLGCILGEIL 225

Query: 385 SGRNPVDYSRP--PGEVCIPQMNSLMTL 410
            G       +P  PG   + Q+  ++ +
Sbjct: 226 CG-------KPIFPGSSTMNQLERIIGV 246

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 34/212 (16%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
           ++G+G +G V     +      A+K L      A+ E      E   +   RH  L  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-----IILGTAKGLTYL 302
            Y  +   R+  V EY + G L   L         +  E R       I+      L YL
Sbjct: 72  -YAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSA----LEYL 121

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H      VV+RDIK  N++LDK  + K++DFGL K  G           GT  Y+APE  
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-- 175

Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
              +L +       D +  G+++ E++ GR P
Sbjct: 176 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L +LH      +++RD+K  NILLD++ + KL+DFGL+K    +         GT  Y+
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     ++N R      D +SFG+L+ E+++G  P
Sbjct: 194 APE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L +LH+     +++RD+K  NI+L+ Q + KL+DFGL K        VT    GT  Y+
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYM 188

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     +L         D +S G L+ ++++G  P
Sbjct: 189 APE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLH      +V+RD+K  NILLD Q +  L+DFGL K    E +  T+   GT  Y+
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYL 206

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     +L+++      D +  G ++ E++ G  P
Sbjct: 207 APE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L +LH+     +++RD+K  N+LLD + + KL+DFG+ K  G      T    GT  Y+
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     +L E       D ++ G+L+ E++ G  P
Sbjct: 192 APE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 15/99 (15%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L +LH+     +++RDIK  NILLD   +  L+DFGL+K   A+ +       GT  Y+
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 358 APEYASTGMLNERS-------DVYSFGILIMEVISGRNP 389
           AP+     ++           D +S G+L+ E+++G +P
Sbjct: 228 APD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 59/272 (21%), Positives = 91/272 (33%), Gaps = 76/272 (27%)

Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAE-KEFKVE----------- 232
              +G G +G V                VAVK L      +E +    E           
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 233 --VEAIGRV--------------RHKNLVRLL--------GYCAEGAHRMLVYEYIDNGN 268
             V  +G                +  NL   L         Y  +GA      +Y+    
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 269 LEQWLHGDVGPHS-----------------------------PLTWEIRMNIILGTAKGL 299
           ++     D    S                              LT E  +      AKG+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVA 358
            +L      K +HRD+ + NILL ++   K+ DFGLA+ +  +  YV          ++A
Sbjct: 207 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263

Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
           PE     +   +SDV+SFG+L+ E+ S G +P
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 35/211 (16%)

Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
            +G G +G V     +++ N  A+K L   +    K+      E   +  V    LV+L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN----------IILGTAKG 298
               + ++  +V EY+  G  E + H        L    R +          I+L     
Sbjct: 108 FSFKDNSNLYMVMEYVAGG--EMFSH--------LRRIGRFSEPHARFYAAQIVLT---- 153

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
             YLH      +++RD+K  N+L+D+Q   +++DFG AK +       T  + GT   +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALA 206

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           PE   +   N+  D ++ G+LI E+ +G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.7 bits (161), Expect = 5e-12
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLHE     +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 177

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     +L         D ++ G+L+ E+++GR+P
Sbjct: 178 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL +LH      +V+RD+K  NILLDK  + K++DFG+ K         T    GT  Y+
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYI 185

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     +L  +      D +SFG+L+ E++ G++P
Sbjct: 186 APE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
            L YLHE     +++RD+K  N+LLD + + KL+D+G+ K  G      T+   GT  Y+
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     +L         D ++ G+L+ E+++GR+P
Sbjct: 221 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL +L       +++RD+K  N++LD + + K++DFG+ K         T    GT  Y+
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 188

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     ++  +      D ++FG+L+ E+++G+ P
Sbjct: 189 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 14/97 (14%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
           GL +L       +++RD+K  N++LD + + K++DFG+ K         T    GT  Y+
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 509

Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           APE     ++  +      D ++FG+L+ E+++G+ P
Sbjct: 510 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 63.3 bits (155), Expect = 2e-11
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 19/98 (19%)

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGY 356
            L YLH      +++RD+K  NILLDK  + K++DFG AK +        T  + GT  Y
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDY 169

Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
           +APE     +++ +      D +SFGILI E+++G  P
Sbjct: 170 IAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.6 bits (151), Expect = 5e-11
 Identities = 36/203 (17%), Positives = 61/203 (30%), Gaps = 57/203 (28%)

Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVK--------NLLNNRGQAEKEFKVEVE 234
           + T        IGEG +G V+  +  D+T VA+K         +  +  +  +E   E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 235 ---------AIGRVRHKNLVRLLG-YCAEGAH---------------------------- 256
                         R +  + L   +C +G++                            
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 257 -RMLVYEYIDNGN-LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314
              +V E+   G  LEQ            +     +I+      L         +  HRD
Sbjct: 136 QLFIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187

Query: 315 IKSSNILLDKQWNPKLSDFGLAK 337
           +   N+LL K    KL      K
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGK 210

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 48/225 (21%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKEFKV-------EVEAIGRVRH 241
            +G G +  V+    + +NT+VA+K +  +      AE E K+       +      +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 242 KNLVRLLGY----CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGT 295
            ++++LL +       G H ++V+E +   NL   +  +   G       +I   ++LG 
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG- 143

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP------KLSDFGLAKLLGAERS-YVTT 348
              L Y+H      ++H DIK  N+L++   +P      K++D G A       +  + T
Sbjct: 144 ---LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198

Query: 349 RVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
           R      Y +PE      +         +D++S   LI E+I+G 
Sbjct: 199 RE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 35/232 (15%)

Query: 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKE 228
              Y ++  E   + +  +++IG+G +G V       +   VA+K + N      QA+ E
Sbjct: 42  YD-YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE 100

Query: 229 FKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLT 284
            ++   +          +V L  +     H  LV+E +   NL   L      G    LT
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLT 159

Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAE 342
            +    +       L +L    E  ++H D+K  NILL        K+ DFG +  LG  
Sbjct: 160 RKFAQQMCTA----LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

Query: 343 R-SYVTTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
              Y+ +R    F Y +PE      Y      +   D++S G +++E+ +G 
Sbjct: 215 IYQYIQSR----F-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 43/176 (24%), Positives = 69/176 (39%), Gaps = 34/176 (19%)

Query: 181 LEVSTNGFADE-----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
           L++  N   D+      V+G G  G V            A+K L +       + + EVE
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVE 62

Query: 235 AIGRV-RHKNLVRLLGYC----AEGAHRMLVYEYIDNGNL-----EQWLHGDVGPHSPLT 284
              R  +  ++VR++       A     ++V E +D G L     ++            T
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAFT 115

Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP--KLSDFGLAK 337
                 I+    + + YLH      + HRD+K  N+L   K+ N   KL+DFG AK
Sbjct: 116 EREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 24/155 (15%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           IG G +G +  G  L  N  VA+K   + +   Q   E++   +         + ++  +
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQVYYF 73

Query: 251 CAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTYLHEGLE 307
              G +  +V E +  G +LE     D+      T+ ++  +++       + Y+H    
Sbjct: 74  GPCGKYNAMVLELL--GPSLE-----DLFDLCDRTFSLKTVLMIAIQLISRMEYVHS--- 123

Query: 308 PKVVHRDIKSSNILLDKQWNPK-----LSDFGLAK 337
             +++RD+K  N L+ +  N       + DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 26/156 (16%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKN--LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           IGEG +G+++ G  L +N  VA+K     ++  Q   E++      G      +  +  +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNVYYF 74

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYLHEGL 306
             EG H +LV + +   +LE  L       S  T       +   AK     +  +HE  
Sbjct: 75  GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT-------VAMAAKQMLARVQSIHE-- 124

Query: 307 EPKVVHRDIKSSNILLDKQWNPK-----LSDFGLAK 337
              +V+RDIK  N L+ +  +       + DFG+ K
Sbjct: 125 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKEFKV--EVEAIGRVRHKNLVR 246
           VIG+G +G V      + + +VA+K + N      QA +E ++   +    +    N++ 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           +L       H  + +E +   NL + +  +   G   PL  +   +I+    + L  LH+
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL----QCLDALHK 218

Query: 305 GLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPE- 360
               +++H D+K  NILL +Q     K+ DFG +         Y+ +R    F Y APE 
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRAPEV 270

Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGR 387
                Y          D++S G ++ E+++G 
Sbjct: 271 ILGARY------GMPIDMWSLGCILAELLTGY 296

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 36/170 (21%)

Query: 194 IGEGGYGIVYHGVLEDNTNV------AVKNLLNNRGQAEKEFKV-----EVEAIGRVRHK 242
           IG+GG+G +Y   +  + +V       VK   ++ G    E K      + E I +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 243 NLVRLLG----------YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL--TWEIRMN 290
             ++ LG               ++R ++ +   + +L++ ++             ++ + 
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFSRKTVLQLSLR 160

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK---LSDFGLAK 337
           I+      L Y+HE    + VH DIK+SN+LL+ + NP    L D+GLA 
Sbjct: 161 IL----DILEYIHE---HEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAY 202

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 46/257 (17%), Positives = 89/257 (34%), Gaps = 74/257 (28%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVR-----HKNL 244
           +G G +  V+    ++    VA+K   +  +    A  E ++  +++          + +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL-KSVRNSDPNDPNREMV 103

Query: 245 VRLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           V+LL         G H  +V+E + + +L +W+      +  L       II    +GL 
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWII--KSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 301 YLHEGLEPKVVHRDIKSSNILL-------------------------------------- 322
           YLH   + +++H DIK  NILL                                      
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 323 -----------DKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNER 370
                       ++   K++D G A  +    +  + TR      Y + E       N  
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273

Query: 371 SDVYSFGILIMEVISGR 387
           +D++S   +  E+ +G 
Sbjct: 274 ADIWSTACMAFELATGD 290

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 33/167 (19%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVA---VKNLLNNRGQAEKEFKVE-----VEAIGRVRHKNL 244
           IG GG+G++Y           A   VK      G    E K        + I +   +  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 245 VRLLG-----YC-----AEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLT-WEIRMNII 292
           +  LG               ++R +V E +  G +L++ + G  G     T  ++ + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRML 161

Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
                 L Y+HE    + VH DIK++N+LL  +   +  L+D+GL+ 
Sbjct: 162 ----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 27/169 (15%), Positives = 59/169 (34%), Gaps = 34/169 (20%)

Query: 194 IGEGGYGIVYHGV---------LEDNTNVAVK-NLLNNRGQAEKEF------KVEVEAIG 237
                 GI+Y                   ++K +  + R   E+ F       ++V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 238 RVRHKNLV---RLLGY-CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS---PLTWEIRMN 290
           ++    L+     +G+   +  +R LV   +   +L+         H        ++   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQS-ALDVSPKHVLSERSVLQVACR 167

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
           ++      L +LHE    + VH ++ + NI +D +   +  L+ +G A 
Sbjct: 168 LL----DALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 37/159 (23%), Positives = 63/159 (39%), Gaps = 34/159 (21%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL------ 244
           IG G +G +Y G  +     VA+K   +     Q   E K+         +K +      
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---------YKMMQGGVGI 67

Query: 245 VRLLGYCAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTY 301
             +    AEG + ++V E +  G +LE     D+       + ++  ++L       + Y
Sbjct: 68  PTIRWCGAEGDYNVMVMELL--GPSLE-----DLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPK---LSDFGLAK 337
           +H       +HRD+K  N L+          + DFGLAK
Sbjct: 121 IHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 20/152 (13%)

Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           IG G +G +Y G  ++ N  VA+K  N+     Q   E K+     G      +  +  +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG---GTGIPNVRWF 71

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTYLHEGLEP 308
             EG + +LV + +   +LE   +      S     ++  ++L       + ++H     
Sbjct: 72  GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLS-----LKTVLMLADQMINRVEFVHS---K 122

Query: 309 KVVHRDIKSSNILLDKQWNPK---LSDFGLAK 337
             +HRDIK  N L+          + DFGLAK
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 1e-04
 Identities = 49/388 (12%), Positives = 93/388 (23%), Gaps = 134/388 (34%)

Query: 35  VLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYN----SSSGNPTIPNISKEIQEIR 90
            L LF    W    +     ++ +       L  NY             P++   +   +
Sbjct: 64  TLRLF----WTLLSKQEEMVQKFVE----EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115

Query: 91  IDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAYPERAAGS 150
            D   N N     ++     P  +    L+E  PA       + I               
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN-----VLI--------------- 155

Query: 151 HHG---SGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL 207
             G   SG   VA                                V  +  + I +  + 
Sbjct: 156 -DGVLGSGKTWVALD--------------VCL----------SYKVQCKMDFKIFWLNLK 190

Query: 208 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267
             N+   V  +L                                        +   ID  
Sbjct: 191 NCNSPETVLEMLQK--------------------------------------LLYQIDPN 212

Query: 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327
              +  H         + +  +  +L                   +  ++  ++L    N
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLL-----------------KSKPYENCLLVLLNVQN 255

Query: 328 PK-LSDFGL-AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVY----SFGILIM 381
            K  + F L  K+L      +TTR      +++    +   L+  S          +L+ 
Sbjct: 256 AKAWNAFNLSCKIL------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL- 308

Query: 382 EVISGRNPVDYSRPPGEVC--IPQMNSL 407
           + +           P EV    P+  S+
Sbjct: 309 KYLD----CRPQDLPREVLTTNPRRLSI 332

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	424
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.84
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.65
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.46
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.39
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.15
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.15
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.91
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.76
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.75
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.58
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.55
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.48
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.4
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.39
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.23
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.09
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	97.09
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.0
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	96.81
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.76
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.66
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.15
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	95.8
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.43
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	95.27
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	94.23
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	93.78
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.58
2k1a_A	42	Integrin alpha-IIB; single-PASS transmembrane segm	92.67
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	92.35
1q55_A	880	EP-cadherin, C-cadherin; trans interaction, desmos	88.76
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	87.74
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.51
2knc_B	79	Integrin beta-3; transmembrane signaling, protein	85.74
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	83.45
2k9j_B	43	Integrin beta-3; transmembrane complex, cell adhes	83.34
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.01
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.21
2kv5_A	33	FST, putative uncharacterized protein RNAI; toxin-	81.68

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.2e-53  Score=402.81  Aligned_cols=229  Identities=27%  Similarity=0.485  Sum_probs=197.8

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ++..++|.+.+.||+|+||+||+|++.      ++..||||++........++|.+|+++|++++|||||+++|+|.+++
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            356678999999999999999999864      36779999998777777788999999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW  326 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~  326 (424)
                      ..+||||||++|+|.++|+...         .....+++..++.++.|+++||+|||++   +|+||||||+||||+.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence            9999999999999999997642         2345799999999999999999999999   999999999999999999


Q ss_pred             ceEEEecCCccccCCCccee-eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC-----------
Q 014466          327 NPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS-----------  393 (424)
Q Consensus       327 ~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~-----------  393 (424)
                      ++||+|||+|+......... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||...           
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999998765443332 234579999999999999999999999999999999999 99999742           


Q ss_pred             ---CCCCCccHHHHHHHHHhhhc
Q 014466          394 ---RPPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       394 ---~~~~~~~~~~~~~~~~~~~~  413 (424)
                         .+.+..+..++.++|..||.
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~  268 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQ  268 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCCCccchHHHHHHHHHHcC
Confidence               23455677888889988886

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-52  Score=402.10  Aligned_cols=229  Identities=27%  Similarity=0.480  Sum_probs=191.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ++..++|.+.++||+|+||+||+|++.      +++.||||++........++|.+|+++|++++|||||+++|+|.++.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            455678889999999999999999864      46789999998777777788999999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK  324 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~  324 (424)
                      ..+||||||++|+|.++++....           ...++++..++.|+.|+++||+|||++   +||||||||+||||++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence            99999999999999999976532           235699999999999999999999998   9999999999999999


Q ss_pred             CCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC---------
Q 014466          325 QWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS---------  393 (424)
Q Consensus       325 ~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~---------  393 (424)
                      ++++||+|||+++.+..... ...+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||...         
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999987644332 23345789999999999999999999999999999999999 99999742         


Q ss_pred             -----CCCCCccHHHHHHHHHhhhc
Q 014466          394 -----RPPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       394 -----~~~~~~~~~~~~~~~~~~~~  413 (424)
                           .+.+..+..++..+|..||.
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~  298 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQ  298 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCC
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcC
Confidence                 23455677888888888886

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-52  Score=403.46  Aligned_cols=202  Identities=24%  Similarity=0.419  Sum_probs=175.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++++.||+|+||+||+|++. +|+.||||++....  ....+.+.+|+++|++++|||||++++++++++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999975 68899999996543  3445679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ||+||+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+||||+.+|++||+|||+|+.+...
T Consensus       104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999997652  35678999999999999999999999   9999999999999999999999999999876432


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ....+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence             22234578999999999999999999999999999999999999999753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-52  Score=398.25  Aligned_cols=201  Identities=24%  Similarity=0.387  Sum_probs=182.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||+||+|++. +++.||||++.+.   .....+.+.+|+++|++++|||||++++++++++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            47999999999999999999975 6889999999654   2334567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |||+||+|.+++.+.    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999865    5799999999999999999999999   999999999999999999999999999997754


Q ss_pred             Cc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. .......+||+.|||||++.+..|+.++|||||||+||||+||+.||...
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            32 23445679999999999999999999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.8e-52  Score=402.79  Aligned_cols=199  Identities=29%  Similarity=0.397  Sum_probs=181.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ..|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999976 68899999997665555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      +||+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+||||+.+|++||+|||+|+.+.... 
T Consensus       154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            999999999753     689999999999999999999999   99999999999999999999999999998765432 


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  273 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  273 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            2345678999999999999999999999999999999999999999753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.4e-52  Score=397.46  Aligned_cols=230  Identities=28%  Similarity=0.428  Sum_probs=196.7

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ++...++++.+.||+|+||+||+|++.      +++.||||++.... ....++|.+|++++++++|||||+++|+|.++
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            345567888999999999999999863      46789999996543 34457899999999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      +..+||||||++|+|.++|.....            ....+++..++.++.|+|+||+|||++   +||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            999999999999999999965421            124689999999999999999999999   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC--------
Q 014466          323 DKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY--------  392 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~--------  392 (424)
                      ++++++||+|||+++.+..... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||..        
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987644322 23445789999999999999999999999999999999999 8999974        


Q ss_pred             ------CCCCCCccHHHHHHHHHhhhcc
Q 014466          393 ------SRPPGEVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       393 ------~~~~~~~~~~~~~~~~~~~~~~  414 (424)
                            ..|.+..+..++.++|..||..
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~  286 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNE  286 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCC
Confidence                  2345667788899999999863

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-51  Score=392.38  Aligned_cols=224  Identities=29%  Similarity=0.456  Sum_probs=186.1

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +++..+++++.+.||+|+||+||+|+++  ..||||++...  .....+.|.+|++++++++|||||++++++.+ +..+
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            4788899999999999999999999875  35999988543  34456789999999999999999999999865 5689


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ||||||++|+|.++|+..   ...+++..++.|+.|+++||+|||++   +||||||||+||||++++++||+|||+|+.
T Consensus       108 iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             EEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             EEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            999999999999999765   35799999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCc-ceeeecccccccccccccccC---CCCCCccchHHHHHHHHHHHcCCCCCCCCCC-------------------
Q 014466          339 LGAER-SYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRP-------------------  395 (424)
Q Consensus       339 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~-------------------  395 (424)
                      ..... .......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||....+                   
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  261 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK  261 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence            64322 233456789999999999864   4699999999999999999999999974321                   


Q ss_pred             CCCccHHHHHHHHHhhhc
Q 014466          396 PGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~  413 (424)
                      ....+..++..++..||.
T Consensus       262 ~~~~~~~~l~~li~~cl~  279 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVK  279 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTC
T ss_pred             ccccchHHHHHHHHHHcC
Confidence            123355677788888876

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=405.21  Aligned_cols=200  Identities=29%  Similarity=0.395  Sum_probs=182.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .+.|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            457999999999999999999976 5889999999766655566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      |+||+|.++++..     .+++..+..++.||+.||+|||++   +||||||||+||||+.+|++||+|||+|+.+....
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999999753     689999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  350 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  350 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence             2345678999999999999999999999999999999999999999753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-51  Score=390.38  Aligned_cols=201  Identities=27%  Similarity=0.343  Sum_probs=172.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      .++|++++.||+|+||+||+|+..    +++.||+|++.+..  ......+.+|+++|++++|||||++++++++++..|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            357999999999999999999863    46789999986542  222346788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ||||||+||+|.+++.+.    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+.
T Consensus       103 ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            999999999999999875    5799999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .... .......+||+.|||||++.+..|+.++|||||||+||||+||+.||...
T Consensus       176 ~~~~-~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~  229 (304)
T 3ubd_A          176 SIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK  229 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCC-CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence            5332 22344578999999999999999999999999999999999999999753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-50  Score=390.52  Aligned_cols=199  Identities=23%  Similarity=0.293  Sum_probs=174.3

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ..+.|++.+.||+|+||+||+|++. +|+.||||++.....     ..+|+++++.++|||||++++++.+++.+|||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3456888999999999999999976 588999999965432     2359999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCccccCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGA  341 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~~~~~  341 (424)
                      ||+||+|.+++++.    ..+++..+..++.|++.||+|||++   +||||||||+||||+.+| ++||+|||+|+.+..
T Consensus       131 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            99999999999865    5799999999999999999999999   999999999999999987 699999999987654


Q ss_pred             Ccce----eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSY----VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ....    .....+||+.|||||++.+..|+.++|||||||+||||+||+.||....
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  260 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF  260 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            3211    2234689999999999999999999999999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-50  Score=380.62  Aligned_cols=195  Identities=28%  Similarity=0.455  Sum_probs=170.4

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee----CCeeeEE
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV  260 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lv  260 (424)
                      |++.++||+|+||+||+|.+. ++..||+|++...  .....+.|.+|++++++++|||||+++++|.+    +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            366788999999999999976 5788999999654  33445679999999999999999999999875    3467899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEcC-CCceEEEecCCcc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDK-QWNPKLSDFGLAK  337 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~~-~~~~kL~DfG~a~  337 (424)
                      ||||++|+|.+++++.    ..+++..+..++.|++.||+|||++   +  |+||||||+||||+. ++.+||+|||+|+
T Consensus       108 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999999875    5789999999999999999999998   6  999999999999984 7999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....   ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||...
T Consensus       181 ~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~  232 (290)
T 3fpq_A          181 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            6432   23455789999999998875 6999999999999999999999999643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-50  Score=378.46  Aligned_cols=198  Identities=24%  Similarity=0.419  Sum_probs=163.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999965 68999999996542   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||| +|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 67999999765    5799999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .  ......+||+.|+|||++.+..| +.++||||+||++|||+||+.||+..
T Consensus       165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence            2  23345789999999999998876 57999999999999999999999753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5e-50  Score=389.86  Aligned_cols=233  Identities=27%  Similarity=0.407  Sum_probs=197.2

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCC-CceeeEee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRH-KNLVRLLG  249 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h-pnIv~l~~  249 (424)
                      ..+++++.++|++.+.||+|+||+||+|.+..      ++.||||++..... ...+.|.+|+++|++++| ||||+++|
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            34568899999999999999999999999653      24699999976543 345679999999999965 99999999


Q ss_pred             EeeeC-CeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCC
Q 014466          250 YCAEG-AHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK  316 (424)
Q Consensus       250 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlk  316 (424)
                      +|.+. ..++||||||++|+|.++|+....            ....+++..++.++.|+|+||+|||++   +|||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence            98764 568999999999999999975421            134589999999999999999999999   99999999


Q ss_pred             CCCEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          317 SSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       317 p~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      |+|||+++++.+||+|||+|+.+...... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999976544333 3445779999999999999999999999999999999998 999997432


Q ss_pred             ---------------CCCCccHHHHHHHHHhhhc
Q 014466          395 ---------------PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       395 ---------------~~~~~~~~~~~~~~~~~~~  413 (424)
                                     +.+..+..++.++|..||.
T Consensus       293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~  326 (353)
T 4ase_A          293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  326 (353)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence                           2344566788888888886

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-48  Score=370.09  Aligned_cols=198  Identities=25%  Similarity=0.475  Sum_probs=161.8

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC---------
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA---------  255 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---------  255 (424)
                      +|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5889999999999999999976 68899999986543 344567899999999999999999999987544         


Q ss_pred             ---eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          256 ---HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       256 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                         ..|+|||||++|+|.+++..... ....++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence               36899999999999999986532 23456677889999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCcce-----------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          333 FGLAKLLGAERSY-----------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       333 fG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ||+|+.+......           ..+..+||+.|||||++.+..|+.++|||||||+||||++   ||.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            9999876543211           1234689999999999999999999999999999999996   775

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.2e-48  Score=370.03  Aligned_cols=198  Identities=27%  Similarity=0.409  Sum_probs=163.8

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC----eeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~lv~e  262 (424)
                      +|.+.+.||+|+||+||+|+++ |+.||||++.... .....+..|+..+.+++|||||++++++.+++    .++||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            5778899999999999999985 8899999985432 22233445677778899999999999998654    5789999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ||++|+|.++|+..     .+++..+..++.|+++||+|||+++     .++|+||||||+||||+.++++||+|||+++
T Consensus        82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999764     6899999999999999999999752     4589999999999999999999999999998


Q ss_pred             ccCCCccee---eecccccccccccccccCC------CCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          338 LLGAERSYV---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       338 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      .........   ....+||+.|||||++.+.      .|+.++|||||||+||||+||+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            765443322   2346899999999998764      46789999999999999999987664

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=371.53  Aligned_cols=200  Identities=26%  Similarity=0.422  Sum_probs=173.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeee------CCe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH  256 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~  256 (424)
                      ++|++++.||+|+||+||+|++. +|+.||||++.+..  ....+.+.+|+++|+.++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999975 68899999996542  3345678899999999999999999998764      357


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .|||||||+ |+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 5899999765    5799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCC---cceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAE---RSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +.+...   ........+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~  266 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK  266 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence            876432   12234567899999999998765 5799999999999999999999999653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-46  Score=385.39  Aligned_cols=203  Identities=24%  Similarity=0.358  Sum_probs=177.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhH---HHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAE---KEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~---~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      .+..++|++.++||+|+||+||+|+.. +|+.||||++.+..   ....   .....++++++.++|||||+++++|++.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            445678999999999999999999976 58899999996532   1112   2233457788889999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      +.+|||||||+||+|.++|.+.    ..+++..+..++.||+.||+|||++   +||||||||+||||+.+|++||+|||
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccc
Confidence            9999999999999999999875    5799999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +|+.+...   .....+||+.|||||++. +..|+.++|||||||+||||++|+.||....
T Consensus       338 lA~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          338 LACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             TCEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             eeeecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99876433   234578999999999996 4679999999999999999999999997544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.6e-46  Score=361.61  Aligned_cols=196  Identities=25%  Similarity=0.402  Sum_probs=169.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .++|++.+.||+|+||+||+|+.+    .++.||+|++.+..  ....+.+|+++|+.+ +|||||++++++.++++.||
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            467999999999999999999864    35779999986543  335678899999998 69999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEEEecCCccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKL  338 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DfG~a~~  338 (424)
                      ||||+++|+|.++++       .+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +++||+|||+|+.
T Consensus        98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999983       478999999999999999999999   99999999999999876 7999999999986


Q ss_pred             cCCCcc---------------------------eeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCC
Q 014466          339 LGAERS---------------------------YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       339 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                      ......                           ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            533211                           122346799999999998765 5899999999999999999999999


Q ss_pred             CC
Q 014466          391 DY  392 (424)
Q Consensus       391 ~~  392 (424)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            64

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-45  Score=379.12  Aligned_cols=201  Identities=24%  Similarity=0.426  Sum_probs=182.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|.+........+.+.+|+++|+.++|||||+++++|.++..+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            358999999999999999999976 6889999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC--CceEEEecCCccccCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ--WNPKLSDFGLAKLLGA  341 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DfG~a~~~~~  341 (424)
                      |+||+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+..
T Consensus       236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            9999999999654   35789999999999999999999999   99999999999999854  8999999999998754


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...
T Consensus       310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~  359 (573)
T 3uto_A          310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  359 (573)
T ss_dssp             TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            33  334568999999999999999999999999999999999999999743

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.9e-43  Score=337.52  Aligned_cols=223  Identities=42%  Similarity=0.758  Sum_probs=195.5

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      +++.+++...++|++.+.||+|+||.||+|++.+++.||+|++........+.+.+|+++++.++||||+++++++.+++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34556677889999999999999999999998889999999987776667788999999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++|+|.+++.........+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999977654445799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCccH
Q 014466          336 AKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCI  401 (424)
Q Consensus       336 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~~~~~  401 (424)
                      ++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+......
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~  252 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL  252 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH
Confidence            98654322 2223445689999999999989999999999999999999999999987665444333

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=328.09  Aligned_cols=207  Identities=27%  Similarity=0.473  Sum_probs=183.7

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      +..++|.+.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.++...++||
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            45678999999999999999999976 58889999987777777788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        87 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           87 EYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             ECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999999999875   35789999999999999999999999   999999999999999999999999999987643


Q ss_pred             Cccee-------------eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          342 ERSYV-------------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       342 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      .....             .....||+.|+|||++.+..++.++||||||+++|||++|..||....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~  227 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP  227 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence            32211             1146799999999999999999999999999999999999999986554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.8e-43  Score=338.08  Aligned_cols=219  Identities=44%  Similarity=0.831  Sum_probs=195.0

Q ss_pred             CcceeeeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEe
Q 014466          173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYC  251 (424)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  251 (424)
                      ...+++.++++..++|++.+.||+|+||.||+|+..+++.||+|++..... .....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            344667888899999999999999999999999988899999999865432 2233688999999999999999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS  331 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~  331 (424)
                      .++...++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998876556679999999999999999999999766789999999999999999999999


Q ss_pred             ecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      |||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            999999876555555566779999999999998899999999999999999999999996

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6e-43  Score=350.50  Aligned_cols=210  Identities=24%  Similarity=0.331  Sum_probs=184.7

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      ++++++..++|++.++||+|+||+||+|++.. ++.||+|++.+...   .....+.+|++++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            45556778899999999999999999999874 67899999865321   122348889999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      +...++||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999864   25789999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++.............+||+.|+|||++.     ...|+.++|||||||++|||++|+.||...
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            999876555555555678999999999986     567999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.8e-42  Score=327.30  Aligned_cols=201  Identities=26%  Similarity=0.416  Sum_probs=181.5

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            345899999999999999999996 4688999999976665666788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999764     588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            32 334567999999999999999999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.4e-42  Score=333.42  Aligned_cols=202  Identities=27%  Similarity=0.319  Sum_probs=179.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ..++|++.+.||+|+||+||+|+.. +++.||+|++.+.   .......+.+|+++++.++||||+++++++.+.+..++
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            3468999999999999999999976 5888999998654   22345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++..
T Consensus        83 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            99999999999999765    5789999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... .......+||+.|+|||++.+..|+.++|+|||||++|||++|+.||...
T Consensus       156 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          156 ISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             CCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence            322 22345578999999999999999999999999999999999999999753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.8e-42  Score=330.52  Aligned_cols=201  Identities=23%  Similarity=0.375  Sum_probs=179.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ..++|++.+.||+|+||.||+|++ .+|+.||+|++...  .....+.+.+|+++++.++||||+++++++.++...++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            345899999999999999999997 47899999998654  334556788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999999999765    5689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCcceeeecccccccccccccccCCCCC-CccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...  .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||+..
T Consensus       166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  217 (328)
T 3fe3_A          166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ  217 (328)
T ss_dssp             SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence            332  33556899999999999888875 7899999999999999999999754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.3e-43  Score=346.80  Aligned_cols=208  Identities=23%  Similarity=0.319  Sum_probs=183.0

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      ++++++..++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4455677889999999999999999999976 47889999986532   1122357789999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      +...|+||||+++|+|.++++..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999753     588999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCC----CCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++.............+||+.|+|||++.+..    |+.++|||||||++|||++|+.||...
T Consensus       213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  276 (410)
T 3v8s_A          213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  276 (410)
T ss_dssp             TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence            999877655444455678999999999997665    889999999999999999999999753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.5e-42  Score=325.88  Aligned_cols=205  Identities=30%  Similarity=0.504  Sum_probs=176.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +..++|++.+.||+|+||.||+|++. +++.||+|.+...   .....+.+.+|++++++++||||+++++++.+++..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            34568999999999999999999975 5888999998543   2344567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++++|.+++...    .++++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++.
T Consensus        88 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             EEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            999999999999999765    4789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||+...
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            65444344455679999999999999999999999999999999999999997543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=345.46  Aligned_cols=210  Identities=24%  Similarity=0.306  Sum_probs=184.5

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      +++.++..++|++.+.||+|+||+||+|+.+ +++.||+|++.+...   ...+.+.+|++++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4556677889999999999999999999986 688999999865321   223457889999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ++..|+||||+++|+|.+++.+.   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999999999764   24689999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeeccccccccccccccc-------CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS-------TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++.............+||+.|+|||++.       ...|+.++|||||||++|||++|+.||...
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            999877554444445578999999999987       467899999999999999999999999654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=336.28  Aligned_cols=204  Identities=23%  Similarity=0.357  Sum_probs=174.0

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  256 (424)
                      .+..++|++.+.||+|+||+||+|+.. +++.||+|++.+.   .....+.+..|.++++.+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            345678999999999999999999976 5788999998754   223445678899999988 79999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+|||++
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccce
Confidence            99999999999999999765    5689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +.... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       172 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          172 KEGIC-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeccc-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence            85322 223345578999999999999999999999999999999999999999754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-41  Score=333.03  Aligned_cols=229  Identities=27%  Similarity=0.447  Sum_probs=190.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC  251 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  251 (424)
                      ++..++|++.+.||+|+||.||+|++.        ++..||+|++.... ....+.+.+|+++++.+ +||||+++++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            456678999999999999999999863        34569999987653 34456799999999999 899999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      .+++..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            999999999999999999999986532            124588999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC---
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR---  394 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~---  394 (424)
                      ||++.++.+||+|||+++....... .......+|+.|+|||++.+..|+.++|||||||++|||++ |+.||....   
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999987644322 22334567889999999999999999999999999999999 999997532   


Q ss_pred             -----------CCCCccHHHHHHHHHhhhc
Q 014466          395 -----------PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       395 -----------~~~~~~~~~~~~~~~~~~~  413 (424)
                                 +.+..+..++..++..||.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  343 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWH  343 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence                       1223344566666666664

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-41  Score=325.39  Aligned_cols=210  Identities=31%  Similarity=0.529  Sum_probs=173.3

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ...+++..++|++.+.||+|+||+||+|++. ++.||+|++....  ....+.+.+|++++++++||||+++++++.+..
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            4556778889999999999999999999874 7889999986553  344567899999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEcCCCceEEEec
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence            99999999999999999976521 12388999999999999999999998   8  999999999999999999999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~  242 (309)
T 3p86_A          184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL  242 (309)
T ss_dssp             C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999864332 22234567999999999999999999999999999999999999999753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-41  Score=336.88  Aligned_cols=203  Identities=26%  Similarity=0.363  Sum_probs=177.8

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +..++|++.++||+|+||+||+|+.. +++.||+|++.+..   ....+.+..|..++.++ +||||+++++++.++...
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            34568999999999999999999976 46789999987642   22234577899999887 899999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++|+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++
T Consensus       129 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence            9999999999999999865    5789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||+..
T Consensus       202 ~~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          202 EGLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             CCCC-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             eccc-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            5322 223345678999999999999999999999999999999999999999753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=326.24  Aligned_cols=198  Identities=29%  Similarity=0.410  Sum_probs=178.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            457999999999999999999976 68889999986542   23456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            9999999999999865    4689999999999999999999998   99999999999999999999999999998653


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..    ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            32    33567999999999999999999999999999999999999999653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-41  Score=317.73  Aligned_cols=205  Identities=29%  Similarity=0.508  Sum_probs=183.0

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .+..++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.++...++||
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            566778999999999999999999998888999999875543 3467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             ECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999999999765   35689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~  211 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  211 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            43333444567889999999999999999999999999999999 99999753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-41  Score=330.25  Aligned_cols=204  Identities=26%  Similarity=0.391  Sum_probs=178.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  256 (424)
                      .+..++|++.+.||+|+||.||+|+.+ +++.||+|++.+..   ....+.+..|.+++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            456679999999999999999999986 57889999986542   23345677899999877 99999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            99999999999999999765    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +..... .......+||+.|+|||++.+..|+.++|+|||||++|||++|+.||...
T Consensus       166 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          166 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             BCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence            854322 22345678999999999999999999999999999999999999999754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-41  Score=319.54  Aligned_cols=204  Identities=25%  Similarity=0.442  Sum_probs=179.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+++.+|+++++.++||||+++++++.++...++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            667789999999999999999999998888899999875543 3467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999999764   24689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~  224 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER  224 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            43333344557889999999998999999999999999999998 9999974

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=324.73  Aligned_cols=226  Identities=31%  Similarity=0.514  Sum_probs=188.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ++..++|++.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|+++++.++||||+++++++.++..
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            455678999999999999999999975    3445999999765 34455679999999999999999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             cEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcc
Confidence            99999999999999999765   35789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcc--eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCCc
Q 014466          337 KLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGEV  399 (424)
Q Consensus       337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~~  399 (424)
                      +.......  .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...              .+.+..
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  278 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG  278 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence            87654322  22333456888999999999999999999999999999999 99999642              233344


Q ss_pred             cHHHHHHHHHhhhc
Q 014466          400 CIPQMNSLMTLSYC  413 (424)
Q Consensus       400 ~~~~~~~~~~~~~~  413 (424)
                      +...+..++..||.
T Consensus       279 ~~~~l~~li~~~l~  292 (325)
T 3kul_A          279 CPHALHQLMLDCWH  292 (325)
T ss_dssp             CCHHHHHHHHHHTC
T ss_pred             cCHHHHHHHHHHcc
Confidence            55666677777665

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=332.62  Aligned_cols=209  Identities=16%  Similarity=0.217  Sum_probs=180.1

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEE------EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC---CCceeeEe
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLL  248 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~  248 (424)
                      ..++++..++|.+.+.||+|+||+||+|+      ..+++.||+|++....   ..++..|+++++.++   |+||++++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            45667888999999999999999999994      4468889999986543   345677778777776   99999999


Q ss_pred             eEeeeCCeeeEEEEecCCCCHHHHHccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---
Q 014466          249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---  324 (424)
Q Consensus       249 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---  324 (424)
                      +++..++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++   +|+||||||+|||++.   
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence            999999999999999999999999975321 235799999999999999999999998   9999999999999988   


Q ss_pred             --------CCceEEEecCCccccCC-CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          325 --------QWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       325 --------~~~~kL~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                              ++.+||+|||+++.+.. .........+||+.|+|||++.+..|+.++|||||||++|||+||+.||..
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                    89999999999976532 223344567899999999999999999999999999999999999999863

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=332.62  Aligned_cols=204  Identities=25%  Similarity=0.373  Sum_probs=180.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ++..++|++.+.||+|+||.||+|... +++.||+|.+.+..   ....+.+.+|+++++.++|||||++++++.+....
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            455678999999999999999999976 47789999986542   23456788899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+.+|+|.+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999999999865    5789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccC---CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .+...  ......+||+.|+|||++..   ..|+.++|||||||++|||++|+.||....
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  221 (384)
T 4fr4_A          164 MLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS  221 (384)
T ss_dssp             ECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred             eccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence            76432  23455789999999999864   458999999999999999999999997543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.6e-41  Score=328.59  Aligned_cols=200  Identities=26%  Similarity=0.388  Sum_probs=178.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch------hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .+.|++.+.||+|+||.||+|+.. +|+.||+|.+.+....      ..+.+.+|+++++.++||||+++++++.++...
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457999999999999999999976 5888999999764322      356789999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC----ceEEEec
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDF  333 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kL~Df  333 (424)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999764    5789999999999999999999999   999999999999998877    7999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |++.......  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...
T Consensus       164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~  221 (361)
T 2yab_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  221 (361)
T ss_dssp             SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            9998764332  234567999999999999999999999999999999999999999653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-41  Score=328.85  Aligned_cols=201  Identities=27%  Similarity=0.370  Sum_probs=178.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  258 (424)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.+.   .....+.+.+|+++++++ +||||+++++++.++...+
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            3457999999999999999999976 5788999999754   233456688899999988 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++.
T Consensus        87 lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccc
Confidence            999999999999999765    4689999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .... .......+||+.|+|||++.+..|+.++|+|||||++|||++|+.||+.
T Consensus       160 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          160 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             SCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            4222 2234557899999999999999999999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.4e-41  Score=315.17  Aligned_cols=204  Identities=28%  Similarity=0.467  Sum_probs=182.8

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++++++||||+++++++.++...++||
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            566779999999999999999999998888899999865443 3467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999999999999765   24589999999999999999999999   999999999999999999999999999987655


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL  208 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence            54444445567788999999999899999999999999999999 9999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-41  Score=328.49  Aligned_cols=204  Identities=24%  Similarity=0.330  Sum_probs=178.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  256 (424)
                      .+..++|++.+.||+|+||.||+|+... ++.||+|++.+..   ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            3456789999999999999999999874 6789999986542   23446678899999988 89999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .|+||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+|||++
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            99999999999999999865    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +..... .......+||+.|+|||++.+..|+.++|+|||||++|||++|+.||...
T Consensus       169 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          169 KENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             BCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence            854222 22345578999999999999999999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.3e-41  Score=325.18  Aligned_cols=203  Identities=28%  Similarity=0.397  Sum_probs=170.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEE----cCCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      +..++|++.+.||+|+||.||+|+.    .+++.||+|++.+..    ......+.+|+++++.++||||+++++++.++
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            4456899999999999999999997    468899999986542    23345678899999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence            9999999999999999999765    4688999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +++..... .......+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       167 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  224 (327)
T 3a62_A          167 LCKESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE  224 (327)
T ss_dssp             CC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence            99754322 22334567999999999999999999999999999999999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.9e-41  Score=327.74  Aligned_cols=199  Identities=24%  Similarity=0.293  Sum_probs=179.0

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.++...++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            4468999999999999999999976 58899999986542   2345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       119 v~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence            99999999999999865    4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  241 (350)
T 1rdq_E          192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence            432    23467999999999999999999999999999999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-41  Score=341.90  Aligned_cols=228  Identities=25%  Similarity=0.454  Sum_probs=195.1

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ..+++..++|++.+.||+|+||.||+|.++++..||||++.... ...+.|.+|+++++.++||||+++++++. +...+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34578888999999999999999999999888899999987544 34678999999999999999999999987 56789


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.++++...  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            9999999999999997542  13578889999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCCccHHH
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGEVCIPQ  403 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~~~~~~  403 (424)
                      .............+|..|+|||++....++.++|||||||+||||+| |+.||...              .+.+..+..+
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  413 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE  413 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            64432222334456789999999999999999999999999999999 99999742              3344556677


Q ss_pred             HHHHHHhhhc
Q 014466          404 MNSLMTLSYC  413 (424)
Q Consensus       404 ~~~~~~~~~~  413 (424)
                      +..+|..||.
T Consensus       414 l~~li~~cl~  423 (454)
T 1qcf_A          414 LYNIMMRCWK  423 (454)
T ss_dssp             HHHHHHHHTC
T ss_pred             HHHHHHHHcc
Confidence            7888888876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.4e-41  Score=329.11  Aligned_cols=205  Identities=23%  Similarity=0.364  Sum_probs=178.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..++|++.+.||+|+||+||+|... +++.||+|++....     ....+.+.+|+++++.++||||+++++++.+++..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3457999999999999999999975 58899999985432     22457789999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc---eEEEecC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFG  334 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DfG  334 (424)
                      ++||||+++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999988865432334689999999999999999999999   9999999999999987655   9999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ++....... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus       179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            998765432 223456799999999999999999999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.6e-41  Score=331.55  Aligned_cols=197  Identities=24%  Similarity=0.334  Sum_probs=162.5

Q ss_pred             CCcccc-eeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHh-cCCCCceeeEeeEeee----CCeee
Q 014466          186 NGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIG-RVRHKNLVRLLGYCAE----GAHRM  258 (424)
Q Consensus       186 ~~~~~~-~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~----~~~~~  258 (424)
                      ++|.+. ++||+|+||+||+|.+. +++.||||++...     ..+.+|++++. ..+||||+++++++..    +...+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            356665 78999999999999976 5788999998532     34667888874 4589999999999875    56789


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL  335 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~  335 (424)
                      +||||+++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus       136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999998652  24689999999999999999999998   9999999999999987   78899999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.....  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            9865432  22345679999999999999999999999999999999999999997654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-40  Score=318.83  Aligned_cols=205  Identities=23%  Similarity=0.370  Sum_probs=177.0

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      +...++|++.+.||+|+||+||+|++.+++.||+|++....  ....+.+.+|++++++++||||+++++++.++...++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            45567899999999999999999999889999999986442  2334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++ +|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        97 v~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEcCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            9999985 888888765   35689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       170 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  224 (311)
T 3niz_A          170 GIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT  224 (311)
T ss_dssp             TSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence            4332 22344578999999998876 568999999999999999999999997654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.5e-41  Score=331.40  Aligned_cols=202  Identities=29%  Similarity=0.341  Sum_probs=170.1

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHH-HhcCCCCceeeEeeEeeeCCeee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|++.+...   .....+..|..+ ++.++||||+++++++.+.+..|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            4468999999999999999999976 477899999966532   233456667766 57789999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++.+.    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++.
T Consensus       116 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            999999999999999865    4688999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .... .......+||+.|+|||++.+..|+.++|+|||||++|||++|+.||...
T Consensus       189 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  242 (373)
T 2r5t_A          189 NIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  242 (373)
T ss_dssp             GBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            4222 22345678999999999999999999999999999999999999999643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9e-41  Score=327.45  Aligned_cols=201  Identities=22%  Similarity=0.371  Sum_probs=177.8

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|+++++.++||||+++++++.++...++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457999999999999999999976 58899999996543  33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC---ceEEEecCCcc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAK  337 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DfG~a~  337 (424)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++   .+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999999765    5689999999999999999999999   999999999999998654   59999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  233 (362)
T 2bdw_A          180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  233 (362)
T ss_dssp             CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            764332  234567999999999999999999999999999999999999999643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.9e-41  Score=332.76  Aligned_cols=227  Identities=28%  Similarity=0.442  Sum_probs=192.5

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +++..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.|.+|+++++.++||||+++++++.+++..+
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            3567789999999999999999999986 68889999986543 234457889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       189 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            999999999999999764   24588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCcceee-ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCCccHH
Q 014466          339 LGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGEVCIP  402 (424)
Q Consensus       339 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~~~~~  402 (424)
                      ......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||...              .+.+..+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD  342 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            533221111 12235778999999998999999999999999999998 99999742              234455667


Q ss_pred             HHHHHHHhhhc
Q 014466          403 QMNSLMTLSYC  413 (424)
Q Consensus       403 ~~~~~~~~~~~  413 (424)
                      ++..+|..||.
T Consensus       343 ~l~~li~~cl~  353 (377)
T 3cbl_A          343 AVFRLMEQCWA  353 (377)
T ss_dssp             HHHHHHHHHTC
T ss_pred             HHHHHHHHHcC
Confidence            78888888876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.8e-41  Score=318.47  Aligned_cols=205  Identities=25%  Similarity=0.431  Sum_probs=174.8

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-----CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--  254 (424)
                      ++..++|++.+.||+|+||.||+|++.     +++.||+|++........+.+.+|++++++++||||+++++++...  
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345678999999999999999999852     5788999999877767778899999999999999999999998653  


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence            45889999999999999997752   4589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcc--eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          335 LAKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +++.......  .......+|..|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            9987644322  122334578889999999999999999999999999999999999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-40  Score=319.03  Aligned_cols=198  Identities=28%  Similarity=0.394  Sum_probs=178.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            3566789999999999999986 689999999977666667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~  345 (424)
                      +++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus       126 ~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  196 (321)
T 2c30_A          126 GGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-  196 (321)
T ss_dssp             SCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-
Confidence            9999999864     3689999999999999999999999   999999999999999999999999999987644322 


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            234567999999999999999999999999999999999999999754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.2e-41  Score=323.05  Aligned_cols=203  Identities=31%  Similarity=0.455  Sum_probs=175.9

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 688899999865432 334668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999998755    5689999999999999999999999   9999999999999999999999999999865322


Q ss_pred             c-ceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 R-SYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||+...
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  212 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            2 222345689999999999987775 778999999999999999999997644

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.1e-41  Score=328.71  Aligned_cols=226  Identities=30%  Similarity=0.504  Sum_probs=178.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ++..++|++.+.||+|+||.||+|++.    ++..||||++... .....+.|.+|++++++++||||+++++++.++..
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            445668999999999999999999865    4667999998654 33455679999999999999999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.++++..   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            99999999999999999765   35689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcce--eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCc
Q 014466          337 KLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEV  399 (424)
Q Consensus       337 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~  399 (424)
                      +........  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....              +....
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  274 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD  274 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            876443221  1222345778999999999999999999999999999998 999996432              23334


Q ss_pred             cHHHHHHHHHhhhc
Q 014466          400 CIPQMNSLMTLSYC  413 (424)
Q Consensus       400 ~~~~~~~~~~~~~~  413 (424)
                      +..++..++..||.
T Consensus       275 ~~~~l~~li~~cl~  288 (373)
T 2qol_A          275 CPAALYQLMLDCWQ  288 (373)
T ss_dssp             CBHHHHHHHHHHTC
T ss_pred             ccHHHHHHHHHHhC
Confidence            45566677777665

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=319.31  Aligned_cols=200  Identities=24%  Similarity=0.381  Sum_probs=178.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .+.|++.+.||+|+||.||+|... +++.||+|.+.....      ...+.+.+|+++++.++||||+++++++.++...
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            347899999999999999999976 588899999865432      1357799999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC----ceEEEec
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDF  333 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kL~Df  333 (424)
                      ++||||+++|+|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999999764    5789999999999999999999999   999999999999999887    7999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  220 (326)
T 2y0a_A          163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  220 (326)
T ss_dssp             TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            9998764332  234467999999999999999999999999999999999999999653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=331.76  Aligned_cols=200  Identities=23%  Similarity=0.329  Sum_probs=176.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .++|++.+.||+|+||.||+|... +++.+|+|++.....  ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            357899999999999999999975 688899999876542  34467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc---CCCceEEEecCCccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKL  338 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DfG~a~~  338 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999765    5689999999999999999999999   999999999999998   567899999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||..
T Consensus       163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~  215 (444)
T 3soa_A          163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD  215 (444)
T ss_dssp             CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            64432 223456799999999999999999999999999999999999999964

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-40  Score=325.84  Aligned_cols=201  Identities=22%  Similarity=0.350  Sum_probs=179.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+++++.++||||+++++++.++...++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999976 5788999998776666667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC--CCceEEEecCCccccCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kL~DfG~a~~~~~  341 (424)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.  ++.+||+|||+++....
T Consensus       130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999764   24689999999999999999999999   9999999999999974  57799999999987654


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  253 (387)
T 1kob_A          204 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE  253 (387)
T ss_dssp             TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             Cc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence            32  233457999999999999999999999999999999999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-40  Score=317.78  Aligned_cols=200  Identities=21%  Similarity=0.331  Sum_probs=178.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++.+.||+|+||.||+|.+. +++.+|+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 4778999988644 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC--CCceEEEecCCccccCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kL~DfG~a~~~~~  341 (424)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.  ++.+||+|||+++....
T Consensus        83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999765   24689999999999999999999999   9999999999999987  78999999999987644


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  206 (321)
T 1tki_A          157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence            32  234467899999999999988999999999999999999999999754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-40  Score=339.01  Aligned_cols=209  Identities=25%  Similarity=0.361  Sum_probs=184.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .+..++|++.+.||+|+||.||+|+.. +|+.||+|++.+..   ......+..|++++++++||||+++++++.+....
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            345678999999999999999999986 58899999996542   23346788899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |+||||++||+|.+++.........+++..++.++.|++.||+|||++   +|+||||||+|||++.+|++||+|||+++
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceee
Confidence            999999999999999987644446799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       338 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             ECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             eccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            7643322 2344689999999999999999999999999999999999999997653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9e-41  Score=340.65  Aligned_cols=229  Identities=25%  Similarity=0.452  Sum_probs=196.5

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..+++..++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+++|++++||||+++++++.++...
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            4457788899999999999999999999875 7889999986543 3457799999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence            99999999999999998652  35688999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHH
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIP  402 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~  402 (424)
                      ..............++..|+|||++.+..++.++|||||||+||||+| |+.||....              +.+..+..
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  446 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            765443333334556789999999999999999999999999999999 999997532              23344556


Q ss_pred             HHHHHHHhhhc
Q 014466          403 QMNSLMTLSYC  413 (424)
Q Consensus       403 ~~~~~~~~~~~  413 (424)
                      ++..+|..||.
T Consensus       447 ~l~~li~~cl~  457 (495)
T 1opk_A          447 KVYELMRACWQ  457 (495)
T ss_dssp             HHHHHHHHHTC
T ss_pred             HHHHHHHHHcC
Confidence            77777777775

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=314.19  Aligned_cols=201  Identities=27%  Similarity=0.435  Sum_probs=169.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--------------------------hhHHHHHHHHHHH
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------------------------QAEKEFKVEVEAI  236 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l  236 (424)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.....                          ...+.+.+|++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3468999999999999999999975 578899999865431                          1134688899999


Q ss_pred             hcCCCCceeeEeeEeee--CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCC
Q 014466          237 GRVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD  314 (424)
Q Consensus       237 ~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrD  314 (424)
                      ++++||||+++++++.+  +...++||||+++++|.+++..     ..+++..++.++.|++.||+|||++   +|+|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  162 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD  162 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            99999999999999986  5688999999999999876532     4789999999999999999999999   999999


Q ss_pred             CCCCCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccCCC---CCCccchHHHHHHHHHHHcCCCCCC
Q 014466          315 IKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       315 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      |||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||.
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999987654322 234567999999999987665   4778999999999999999999997


Q ss_pred             CC
Q 014466          392 YS  393 (424)
Q Consensus       392 ~~  393 (424)
                      ..
T Consensus       242 ~~  243 (298)
T 2zv2_A          242 DE  243 (298)
T ss_dssp             CS
T ss_pred             Cc
Confidence            53

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-40  Score=310.08  Aligned_cols=205  Identities=29%  Similarity=0.497  Sum_probs=181.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .+..++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            456678999999999999999999998888999999876543 3467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999999765   25688999999999999999999999   999999999999999999999999999987644


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  209 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence            33333334567889999999998999999999999999999999 99999753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-40  Score=321.02  Aligned_cols=208  Identities=29%  Similarity=0.451  Sum_probs=175.7

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC----
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----  255 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----  255 (424)
                      ++.+..++|++.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.+..    
T Consensus        18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             CEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            34567789999999999999999999986 7889999986543 33345666999999999999999999998744    


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeeeCCCCCCCEEEcCCCce
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------EPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-------~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      ..++||||+++|+|.++++..     .+++..++.++.|++.||+|||+.+       +++|+||||||+|||++.++.+
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             eEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            468999999999999999764     5899999999999999999999751       2379999999999999999999


Q ss_pred             EEEecCCccccCCCcce-eeecccccccccccccccC-----CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ||+|||+++........ ......||+.|+|||++.+     ..++.++|||||||++|||+||+.||....
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            99999999876543322 2334679999999999876     346678899999999999999999997643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-40  Score=313.33  Aligned_cols=207  Identities=25%  Similarity=0.401  Sum_probs=167.4

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ++++..++|++.+.||+|+||.||+|.+..    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. +
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            446777899999999999999999999753    3458999886543 344567899999999999999999999985 4


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      +..++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccc
Confidence            5688999999999999999765   24689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            998765443333444567889999999999999999999999999999997 99999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=324.01  Aligned_cols=202  Identities=26%  Similarity=0.388  Sum_probs=163.6

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+...++|++.+.||+|+||.||+|++. +++.||+|++....  ..+.+.+|++++++++||||+++++++.++...++
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            3455678999999999999999999987 47789999986543  34568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCCc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLA  336 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~a  336 (424)
                      ||||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||++
T Consensus       126 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            99999999999999765    5689999999999999999999999   9999999999999975   889999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       199 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  253 (349)
T 2w4o_A          199 KIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE  253 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred             cccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            865332  2234567999999999999999999999999999999999999999654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.3e-41  Score=321.46  Aligned_cols=205  Identities=27%  Similarity=0.445  Sum_probs=170.8

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe--
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--  256 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--  256 (424)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|++++++++||||+++++++.....  
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            34568999999999999999999974 68889999996542   3344678899999999999999999999876543  


Q ss_pred             --eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          257 --RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       257 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                        .++||||+++++|.++++..    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             cccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence              38999999999999999765    4789999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcc--eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +++.+.....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  223 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  223 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9987644322  22334679999999999999999999999999999999999999997543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.5e-40  Score=322.35  Aligned_cols=199  Identities=25%  Similarity=0.429  Sum_probs=175.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+++++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            358999999999999999999974 68899999986532   22235788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+ +|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 67999988765    4689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCcceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...  .....+||+.|+|||++.+..+ ++++|||||||++|||++|+.||+..
T Consensus       160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            332  2345679999999999988776 68999999999999999999999854

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=324.65  Aligned_cols=209  Identities=29%  Similarity=0.460  Sum_probs=181.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC  251 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  251 (424)
                      ++..++|++.+.||+|+||.||+|++.        .+..||+|++.... ....+.+.+|+++++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            567789999999999999999999963        23469999986653 34456788999999999 999999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      .+++..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999987532            124689999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999987644322 22344567899999999999999999999999999999999 99999753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=321.37  Aligned_cols=230  Identities=29%  Similarity=0.460  Sum_probs=191.1

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      +++..++|++.+.||+|+||.||+|++.+      ++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            46677899999999999999999999753      3779999987653 3445679999999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeC
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGP--------------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR  313 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHr  313 (424)
                      +...++||||+++|+|.+++......                    ...+++..++.++.|+++||+|||++   +|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            99999999999999999999764311                    15789999999999999999999999   99999


Q ss_pred             CCCCCCEEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC
Q 014466          314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD  391 (424)
Q Consensus       314 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~  391 (424)
                      ||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999986643322 22334568999999999999999999999999999999999 999997


Q ss_pred             CCC--------------CCCCccHHHHHHHHHhhhc
Q 014466          392 YSR--------------PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       392 ~~~--------------~~~~~~~~~~~~~~~~~~~  413 (424)
                      ...              +.+..+..++..++..||.
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  314 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWS  314 (343)
T ss_dssp             TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcc
Confidence            432              1223344566666666664

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-40  Score=313.33  Aligned_cols=200  Identities=25%  Similarity=0.413  Sum_probs=172.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||+|+..+++.||+|++.....  ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            47899999999999999999998899999999865432  2246788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            986 999998765   25688999999999999999999999   99999999999999999999999999998764322


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             22334578999999999875 45899999999999999999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-40  Score=336.44  Aligned_cols=227  Identities=29%  Similarity=0.480  Sum_probs=187.9

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|++++++++||||+++++++.+ ...++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            3467888999999999999999999999888889999987544 335678999999999999999999999876 66899


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       256 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            999999999999997532  24588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCCccHHHH
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGEVCIPQM  404 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~~~~~~~  404 (424)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.||...              .+.+..+...+
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  410 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            4433223334557889999999999999999999999999999999 99999743              23344566677


Q ss_pred             HHHHHhhhc
Q 014466          405 NSLMTLSYC  413 (424)
Q Consensus       405 ~~~~~~~~~  413 (424)
                      ..+|..||.
T Consensus       411 ~~li~~cl~  419 (452)
T 1fmk_A          411 HDLMCQCWR  419 (452)
T ss_dssp             HHHHHHHTC
T ss_pred             HHHHHHHcc
Confidence            788888776

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.9e-41  Score=336.50  Aligned_cols=204  Identities=25%  Similarity=0.311  Sum_probs=170.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .+..++|++.+.||+|+||.||+|... +++.||+|++...   .......+.+|+++++.++||||+++++++.+.+..
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            345678999999999999999999975 5888999998653   233345677899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||++
T Consensus       224 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             EEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCc
Confidence            9999999999999999765    578999999999999999999998 7   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +..... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       297 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          297 KEGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             CTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            864322 22344578999999999999999999999999999999999999999653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-40  Score=325.85  Aligned_cols=214  Identities=28%  Similarity=0.418  Sum_probs=181.5

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLG  249 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~  249 (424)
                      ...+++..++|++.+.||+|+||.||+|++.      +++.||||++.... ....+.+.+|+++++++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            3455788899999999999999999999843      35679999997643 34456799999999999 7999999999


Q ss_pred             EeeeCC-eeeEEEEecCCCCHHHHHccCCCC-------------------------------------------------
Q 014466          250 YCAEGA-HRMLVYEYIDNGNLEQWLHGDVGP-------------------------------------------------  279 (424)
Q Consensus       250 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------  279 (424)
                      ++.+.+ ..++||||+++|+|.+++......                                                 
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998755 488999999999999999765321                                                 


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc-e
Q 014466          280 -------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-Y  345 (424)
Q Consensus       280 -------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~  345 (424)
                                   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....... .
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                         12288999999999999999999999   999999999999999999999999999986643322 2


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      ......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  300 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  300 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence            3345678999999999999999999999999999999998 999997643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-40  Score=340.34  Aligned_cols=207  Identities=26%  Similarity=0.366  Sum_probs=183.2

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ..+..++|++.+.||+|+||.||+|+.. +|+.||+|++.+..   ......+.+|+++++.++||||+++++++.++..
T Consensus       179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            3466778999999999999999999976 68899999986542   2334568889999999999999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||++
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccc
Confidence            999999999999999997652  24589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +.+....  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       334 ~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          334 VHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             EECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             eecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            8764332  2344689999999999999999999999999999999999999998654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.8e-40  Score=307.41  Aligned_cols=220  Identities=30%  Similarity=0.538  Sum_probs=176.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc----hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG----QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ++..++|++.+.||+|+||.||+|.+. ++.+|+|++.....    ...+.+.+|+++++.++||||+++++++.++...
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            556789999999999999999999986 78899999865422    2346788999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC---eeeCCCCCCCEEEcC--------CC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK---VVHRDIKSSNILLDK--------QW  326 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~---ivHrDlkp~NILl~~--------~~  326 (424)
                      ++||||+++++|.+++..     ..+++..++.++.|++.||+|||++   +   |+||||||+|||++.        ++
T Consensus        82 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             EEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCc
Confidence            999999999999999964     3689999999999999999999998   7   999999999999986        67


Q ss_pred             ceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC------------
Q 014466          327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR------------  394 (424)
Q Consensus       327 ~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~------------  394 (424)
                      .+||+|||++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....            
T Consensus       154 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             ceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            89999999998654322   234568999999999999999999999999999999999999997532            


Q ss_pred             ---CCCCccHHHHHHHHHhhhc
Q 014466          395 ---PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       395 ---~~~~~~~~~~~~~~~~~~~  413 (424)
                         +.+..+..++.+++..||.
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~  252 (271)
T 3dtc_A          231 LALPIPSTCPEPFAKLMEDCWN  252 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCCcccCHHHHHHHHHHhc
Confidence               2233344566666666664

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.9e-40  Score=330.36  Aligned_cols=222  Identities=29%  Similarity=0.456  Sum_probs=189.0

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC-eee
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRM  258 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~  258 (424)
                      .+++..++|++.+.||+|+||.||+|.+. ++.||||.+....  ..+.|.+|++++++++||||+++++++.+.. ..+
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            34677789999999999999999999986 7789999986543  4567899999999999999999999987655 789


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            9999999999999998652  23478999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHHH
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIPQ  403 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~~  403 (424)
                      ....    .....++..|+|||++.+..++.++|||||||++|||++ |+.||....              +.+..+..+
T Consensus       339 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~  414 (450)
T 1k9a_A          339 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA  414 (450)
T ss_dssp             CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            4322    223357889999999999999999999999999999998 999997532              233445677


Q ss_pred             HHHHHHhhhc
Q 014466          404 MNSLMTLSYC  413 (424)
Q Consensus       404 ~~~~~~~~~~  413 (424)
                      +..+|..||.
T Consensus       415 l~~li~~cl~  424 (450)
T 1k9a_A          415 VYDVMKNCWH  424 (450)
T ss_dssp             HHHHHHHHTC
T ss_pred             HHHHHHHHcC
Confidence            8888888876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=326.19  Aligned_cols=229  Identities=28%  Similarity=0.436  Sum_probs=188.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ++..++|++.+.||+|+||+||+|.+.      ++..||||++... .......+.+|+.++++++||||+++++++.++
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            456678999999999999999999953      3567999998654 344556788999999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC---ce
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NP  328 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~---~~  328 (424)
                      ...++||||+++|+|.+++.....   ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++   .+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence            999999999999999999976532   234689999999999999999999999   999999999999999555   49


Q ss_pred             EEEecCCccccCCCc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC------------
Q 014466          329 KLSDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR------------  394 (424)
Q Consensus       329 kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~------------  394 (424)
                      ||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....            
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999998543221 122334568999999999999999999999999999999998 999997532            


Q ss_pred             --CCCCccHHHHHHHHHhhhc
Q 014466          395 --PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       395 --~~~~~~~~~~~~~~~~~~~  413 (424)
                        +....+..++..++..||.
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~  324 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQ  324 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCccCCHHHHHHHHHHcC
Confidence              1233344556666666664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.2e-40  Score=316.78  Aligned_cols=202  Identities=23%  Similarity=0.434  Sum_probs=172.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC--------
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--------  255 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--------  255 (424)
                      ++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            47889999999999999999986 78899999996543 345678999999999999999999999986543        


Q ss_pred             -------------------------------------------------eeeEEEEecCCCCHHHHHccCCCCCCCCCHH
Q 014466          256 -------------------------------------------------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE  286 (424)
Q Consensus       256 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~  286 (424)
                                                                       ..++||||+++|+|.+++..... ....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence                                                             27899999999999999987642 3446677


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc-----------eeeeccccccc
Q 014466          287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-----------YVTTRVMGTFG  355 (424)
Q Consensus       287 ~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-----------~~~~~~~gt~~  355 (424)
                      .++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7899999999999999999   999999999999999999999999999987654321           12234579999


Q ss_pred             ccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       356 y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      |+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            999999999999999999999999999999988763

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-40  Score=318.72  Aligned_cols=203  Identities=23%  Similarity=0.389  Sum_probs=171.8

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCC--CceeeEeeEeeeCCe
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAH  256 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~  256 (424)
                      +++..++|++.+.||+|+||.||+|...+++.||+|++...  .....+.+.+|+++++.++|  |||+++++++.++..
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            45667789999999999999999999888999999998654  33445778999999999987  999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||| +.+++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||++
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             EEEEEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccc
Confidence            999999 5577999999875    5789999999999999999999999   999999999999997 578999999999


Q ss_pred             cccCCCcce-eeecccccccccccccccC-----------CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          337 KLLGAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       337 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +........ ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            876443222 2345679999999999864           6789999999999999999999999974

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.6e-40  Score=320.74  Aligned_cols=202  Identities=23%  Similarity=0.346  Sum_probs=167.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ...++|++.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.++...++||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            34568999999999999999999976 688899999865432 2356888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc--eEEEecCCcccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDFGLAKLL  339 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DfG~a~~~  339 (424)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.  +||+|||+++..
T Consensus        96 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           96 EYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999765    4689999999999999999999999   9999999999999987765  999999999743


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCc-cchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..  ........||+.|+|||++.+..++.+ +|||||||++|||++|+.||....
T Consensus       169 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          169 VL--HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             cc--cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence            22  222344579999999999988887765 899999999999999999997643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=324.65  Aligned_cols=204  Identities=26%  Similarity=0.359  Sum_probs=176.4

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEE----cCCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCceeeEeeEeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE  253 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  253 (424)
                      +..++|++.+.||+|+||.||+|+.    .+++.||||++....    ....+.+.+|+++++++ +||||+++++++.+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            3456899999999999999999997    368899999985432    22345577799999999 69999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      +...++||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             CceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeC
Confidence            99999999999999999999765    4689999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++.+...........+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       204 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             CCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            9998765444444455789999999999975  45789999999999999999999999754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7e-40  Score=308.81  Aligned_cols=207  Identities=29%  Similarity=0.508  Sum_probs=181.0

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ++++..++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|+++++.++||||+++++++.+ +..++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            4577788999999999999999999999888889999986543 335678999999999999999999999875 45889


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            999999999999997541  12688999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ............+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence            5544333344567889999999998899999999999999999999 99999753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7e-40  Score=313.79  Aligned_cols=210  Identities=29%  Similarity=0.454  Sum_probs=181.4

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      +++..++|.+.+.||+|+||.||+|.+.      +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3567789999999999999999999862      34679999986543 3445778999999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeC
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR  313 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHr  313 (424)
                      ++..++||||+++|+|.+++.....                    ....+++..++.++.|++.||+|||++   +|+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence            9999999999999999999986532                    123488999999999999999999999   99999


Q ss_pred             CCCCCCEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC
Q 014466          314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD  391 (424)
Q Consensus       314 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~  391 (424)
                      ||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876443322 2234567889999999999999999999999999999999 999997


Q ss_pred             CC
Q 014466          392 YS  393 (424)
Q Consensus       392 ~~  393 (424)
                      ..
T Consensus       255 ~~  256 (314)
T 2ivs_A          255 GI  256 (314)
T ss_dssp             TC
T ss_pred             CC
Confidence            54

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-40  Score=313.97  Aligned_cols=200  Identities=28%  Similarity=0.304  Sum_probs=167.2

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      ++..++|++.+.||+|+||+||+|++. +++.||||++....  ......+..|+..+..+ +||||+++++++.++...
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            444568999999999999999999987 68899999986542  22333444555555555 999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++.
T Consensus       133 ~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence            9999999 66999988765   25689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      .....  .......||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus       206 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          206 ELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             ecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            76432  22344569999999998876 78999999999999999999977664

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=312.93  Aligned_cols=206  Identities=25%  Similarity=0.350  Sum_probs=177.4

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC--eee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~  258 (424)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++....  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            34568999999999999999999976 48889999986543 334567889999999999999999999998765  778


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE----cCCCceEEEecC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFG  334 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DfG  334 (424)
                      +||||+++++|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||
T Consensus        86 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            99999999999999986532 23489999999999999999999999   99999999999999    778889999999


Q ss_pred             CccccCCCcceeeeccccccccccccccc--------CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAS--------TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +++......  ......||+.|+|||++.        +..++.++|||||||++|||++|+.||....
T Consensus       162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             CceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            998764432  233467999999999886        5789999999999999999999999997543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-39  Score=308.90  Aligned_cols=198  Identities=26%  Similarity=0.416  Sum_probs=172.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999976 57889999986543  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++ +|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..+..
T Consensus        82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9986 666666543   25789999999999999999999999   9999999999999999999999999999876433


Q ss_pred             cceeeecccccccccccccccCCC-CCCccchHHHHHHHHHHHcCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      . .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus       155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence            2 2234467899999999987765 8999999999999999999988864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.4e-40  Score=315.33  Aligned_cols=213  Identities=22%  Similarity=0.403  Sum_probs=165.0

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcCCC----EEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEe
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNT----NVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC  251 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  251 (424)
                      ++++.+..++|++.+.||+|+||.||+|.+....    .||+|.+...  .....+.+.+|++++++++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            3455677889999999999999999999965332    7999998654  344567899999999999999999999999


Q ss_pred             eeCCee------eEEEEecCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc
Q 014466          252 AEGAHR------MLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD  323 (424)
Q Consensus       252 ~~~~~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~  323 (424)
                      ......      ++||||+++|+|.+++....  .....+++..++.++.|++.||+|||++   +|+||||||+|||++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLA  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEc
Confidence            877655      89999999999999986542  1223689999999999999999999999   999999999999999


Q ss_pred             CCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          324 KQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       324 ~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  243 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI  243 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence            999999999999987643322 22234457889999999999999999999999999999999 99999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8e-40  Score=321.94  Aligned_cols=196  Identities=24%  Similarity=0.364  Sum_probs=170.0

Q ss_pred             cceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCCCC
Q 014466          190 DENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      ..+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3678999999999999975 588999999987766667789999999999999999999999999999999999999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE--cCCCceEEEecCCccccCCCccee
Q 014466          269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl--~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++.+....  .
T Consensus       173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~  244 (373)
T 2x4f_A          173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K  244 (373)
T ss_dssp             EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence            99988754   24688999999999999999999999   99999999999999  567889999999998764432  2


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            33457999999999999999999999999999999999999999653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-40  Score=318.41  Aligned_cols=211  Identities=29%  Similarity=0.465  Sum_probs=178.9

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  252 (424)
                      +++..++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ....+.+.+|+++++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4677789999999999999999999962      34579999986542 33446788999999999 8999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeC
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVGP-------------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR  313 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHr  313 (424)
                      +++..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||+.   +|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            999999999999999999999865321                   13478999999999999999999999   99999


Q ss_pred             CCCCCCEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC
Q 014466          314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD  391 (424)
Q Consensus       314 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~  391 (424)
                      ||||+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999866443322 2334567889999999999999999999999999999998 999997


Q ss_pred             CCC
Q 014466          392 YSR  394 (424)
Q Consensus       392 ~~~  394 (424)
                      ...
T Consensus       277 ~~~  279 (344)
T 1rjb_A          277 GIP  279 (344)
T ss_dssp             TCC
T ss_pred             cCC
Confidence            643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-39  Score=321.28  Aligned_cols=206  Identities=19%  Similarity=0.231  Sum_probs=179.0

Q ss_pred             cCCCcccceeEccc--CcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          184 STNGFADENVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       184 ~~~~~~~~~~LG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ..++|++.+.||+|  +||.||+|++. +++.||||++....  ....+.+.+|+++++.++|||||++++++.+++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34589999999999  99999999987 68899999996543  344567888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+..
T Consensus       103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999997653  35689999999999999999999999   999999999999999999999999998865


Q ss_pred             cCCCcc------eeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          339 LGAERS------YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       339 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ......      .......||+.|+|||++.+  ..|+.++|||||||++|||++|+.||....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            422111      11223478999999999987  679999999999999999999999997644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.7e-40  Score=316.94  Aligned_cols=202  Identities=19%  Similarity=0.253  Sum_probs=177.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..++|++.+.||+|+||.||+|... +++.||||.+.....  .+.+.+|+++++.+ +||||+++++++.++...++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            4568999999999999999999974 688899998865432  23578899999999 9999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc-----eEEEecCCc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-----PKLSDFGLA  336 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kL~DfG~a  336 (424)
                      ||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||++
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            999 89999999865   35789999999999999999999999   9999999999999999887     999999999


Q ss_pred             cccCCCcce------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            876433221      1245679999999999999999999999999999999999999998754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9e-40  Score=313.76  Aligned_cols=211  Identities=26%  Similarity=0.370  Sum_probs=178.7

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee----
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----  253 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----  253 (424)
                      ..+.+..++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+++++.++||||+++++++..    
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            44567778999999999999999999997 4688999999977666777889999999999999999999999873    


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ....++||||+++|+|.+++.........+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEec
Confidence            3477899999999999999986433346799999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcce--------eeecccccccccccccccCCC---CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          334 GLAKLLGAERSY--------VTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       334 G~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      |++.........        ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||+.
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            998764321110        012345799999999987654   78999999999999999999999953

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.7e-40  Score=316.24  Aligned_cols=224  Identities=29%  Similarity=0.511  Sum_probs=179.6

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCE----EEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      +..++|++.+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|++++++++||||+++++++.++. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            34568999999999999999999965 3443    577877543 2345578999999999999999999999998765 


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++|+||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+|||++
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence            77999999999999999875   35789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCcc
Q 014466          337 KLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVC  400 (424)
Q Consensus       337 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~  400 (424)
                      +....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||+...              +....+
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccC
Confidence            87654332 22334567889999999999999999999999999999999 999997532              223334


Q ss_pred             HHHHHHHHHhhhc
Q 014466          401 IPQMNSLMTLSYC  413 (424)
Q Consensus       401 ~~~~~~~~~~~~~  413 (424)
                      ..++..++..||.
T Consensus       245 ~~~~~~li~~~l~  257 (327)
T 3poz_A          245 TIDVYMIMVKCWM  257 (327)
T ss_dssp             CHHHHHHHHHHTC
T ss_pred             CHHHHHHHHHHcC
Confidence            4556666666665

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-39  Score=321.69  Aligned_cols=200  Identities=26%  Similarity=0.425  Sum_probs=163.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCC--eee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA--HRM  258 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~--~~~  258 (424)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+++.+. ||||+++++++..++  ..|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            458999999999999999999975 6889999998653  3344567788999999997 999999999997544  689


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||++ ++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        88 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            9999998 5999999753     688999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCC--------------------cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAE--------------------RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +...                    .....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            5321                    1122344689999999999876 67999999999999999999999999654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-40  Score=341.16  Aligned_cols=227  Identities=29%  Similarity=0.480  Sum_probs=193.0

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ ...++
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            4567778899999999999999999999888889999987644 335679999999999999999999999876 67899


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++|+|.++++...  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+
T Consensus       339 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             eeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            999999999999997532  24588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCCccHHHH
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGEVCIPQM  404 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~~~~~~~  404 (424)
                      ............++..|+|||++.+..++.++|||||||+||||++ |+.||...              .+....+..++
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  493 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            4332222233456789999999999999999999999999999999 99999743              23344556677


Q ss_pred             HHHHHhhhc
Q 014466          405 NSLMTLSYC  413 (424)
Q Consensus       405 ~~~~~~~~~  413 (424)
                      ..+|..||.
T Consensus       494 ~~li~~cl~  502 (535)
T 2h8h_A          494 HDLMCQCWR  502 (535)
T ss_dssp             HHHHHHHTC
T ss_pred             HHHHHHHcC
Confidence            788888776

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.4e-39  Score=316.53  Aligned_cols=207  Identities=24%  Similarity=0.314  Sum_probs=181.0

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----CCceeeEee
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----HKNLVRLLG  249 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~~  249 (424)
                      +.++...+..++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+..|+++++.++     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            345556777889999999999999999999975 5788999998643 344556778999999986     999999999


Q ss_pred             EeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-----
Q 014466          250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-----  324 (424)
Q Consensus       250 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-----  324 (424)
                      ++...+..++||||+ +++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.     
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence            999999999999999 889999998763  24689999999999999999999999   9999999999999975     


Q ss_pred             --------------------CCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHH
Q 014466          325 --------------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  384 (424)
Q Consensus       325 --------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ell  384 (424)
                                          ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                                788999999999864332    23467899999999999999999999999999999999


Q ss_pred             cCCCCCCCC
Q 014466          385 SGRNPVDYS  393 (424)
Q Consensus       385 tg~~Pf~~~  393 (424)
                      +|+.||...
T Consensus       254 ~g~~pf~~~  262 (360)
T 3llt_A          254 TGSLLFRTH  262 (360)
T ss_dssp             HSSCSCCCS
T ss_pred             HCCCCCCCC
Confidence            999999754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.9e-40  Score=314.12  Aligned_cols=204  Identities=25%  Similarity=0.447  Sum_probs=162.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357899999999999999999965 58889999986543 2334678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          263 YIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |++ |+|.+++....  .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999986542  1234689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            332 22334578999999999876 46899999999999999999999999754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3e-39  Score=312.88  Aligned_cols=209  Identities=29%  Similarity=0.491  Sum_probs=180.0

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC  251 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  251 (424)
                      ++..++|++.+.||+|+||.||+|.+.        ++..||+|++.... ....+.+.+|+++++.+ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            567789999999999999999999863        46679999987553 34456788999999999 899999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      .+++..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            9999999999999999999999865321            23488999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            99999999999999999876543322 2334567889999999998899999999999999999999 99999753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-39  Score=309.69  Aligned_cols=200  Identities=29%  Similarity=0.437  Sum_probs=167.5

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhc--CCCCceeeEeeEeee----CCe
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAE----GAH  256 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~----~~~  256 (424)
                      ...++|++.+.||+|+||.||+|++ +++.||||++...   ..+.+..|.+++..  ++||||+++++++.+    ...
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            3456899999999999999999998 5888999998543   33455556666665  799999999998654    345


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      .++||||+++|+|.++++.     ..+++..++.++.|++.||+|||        +.   +|+||||||+|||++.++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            7899999999999999954     36899999999999999999999        77   99999999999999999999


Q ss_pred             EEEecCCccccCCCccee---eecccccccccccccccCC------CCCCccchHHHHHHHHHHHcC----------CCC
Q 014466          329 KLSDFGLAKLLGAERSYV---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISG----------RNP  389 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGv~l~elltg----------~~P  389 (424)
                      ||+|||+++.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999998654433222   2335799999999999876      455789999999999999999          888


Q ss_pred             CCCCC
Q 014466          390 VDYSR  394 (424)
Q Consensus       390 f~~~~  394 (424)
                      |....
T Consensus       233 f~~~~  237 (301)
T 3q4u_A          233 FYDVV  237 (301)
T ss_dssp             TTTTS
T ss_pred             ccccC
Confidence            86543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.8e-39  Score=311.74  Aligned_cols=202  Identities=23%  Similarity=0.375  Sum_probs=179.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ..++|.+.+.||+|+||.||++.+. +++.+|+|.+...   .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3457999999999999999999976 4678899988654   23455678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       119 v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99999999999998765    4789999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          192 EYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             CSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence            4322 2234467999999999999999999999999999999999999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-39  Score=306.02  Aligned_cols=202  Identities=29%  Similarity=0.485  Sum_probs=175.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      +...++|++.+.||+|+||.||+|.+. ++..||+|++....   ....+.+.+|++++++++||||+++++++.+....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            345678999999999999999999976 46689999986542   22346788999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccc
Confidence            9999999999999999765    4689999999999999999999998   99999999999999999999999999986


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  210 (279)
T 3fdn_A          158 HAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN  210 (279)
T ss_dssp             CC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence            54322   234457899999999999999999999999999999999999999753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.6e-40  Score=320.26  Aligned_cols=204  Identities=20%  Similarity=0.295  Sum_probs=171.0

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCCchhHH-----------HHHHHHHHHhcCCCCcee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-----------EFKVEVEAIGRVRHKNLV  245 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~Ei~~l~~l~hpnIv  245 (424)
                      ...++|++.+.||+|+||.||+|.+..      ++.||+|.+.........           .+..|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            456789999999999999999999764      367999998765432211           233466677888999999


Q ss_pred             eEeeEeeeC----CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEE
Q 014466          246 RLLGYCAEG----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL  321 (424)
Q Consensus       246 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NIL  321 (424)
                      ++++++...    ...+|||||+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil  184 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL  184 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence            999998764    4578999999 99999999865   35799999999999999999999999   9999999999999


Q ss_pred             Ec--CCCceEEEecCCccccCCCcce------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          322 LD--KQWNPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       322 l~--~~~~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++  .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  8899999999999876433221      113356999999999999999999999999999999999999999854

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-39  Score=329.85  Aligned_cols=202  Identities=26%  Similarity=0.457  Sum_probs=179.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +..++|.+.+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+++++.++||||+++++++.+....+
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34468999999999999999999976 688999999865422   23467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||++..
T Consensus        93 lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            999999999999999764    5789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....  ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||+..
T Consensus       166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  219 (476)
T 2y94_A          166 MSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD  219 (476)
T ss_dssp             CCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence            6432  22345679999999999988776 68999999999999999999999754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-39  Score=311.02  Aligned_cols=211  Identities=28%  Similarity=0.452  Sum_probs=182.7

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEE------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  252 (424)
                      +++..++|++.+.||+|+||.||+|++      .+++.||+|.+..... ...+.+.+|+++++++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            467778999999999999999999985      2456799999875543 3456789999999999 9999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCC
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVGP--------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~  318 (424)
                      +++..++||||+++|+|.+++......              ...+++..++.++.|++.||+|||++   +|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence            999999999999999999999865321              23589999999999999999999999   9999999999


Q ss_pred             CEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      |||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999999999999999999876544332 2334567889999999999999999999999999999999 999997543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.4e-39  Score=304.79  Aligned_cols=198  Identities=25%  Similarity=0.357  Sum_probs=177.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ++|++.+.||+|+||.||+|.+.. +..+|+|++........+.+.+|++++++++||||+++++++.++...++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            478999999999999999999764 6689999997766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceEEEecCCccccCC
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DfG~a~~~~~  341 (424)
                      ++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||++.....
T Consensus        89 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           89 TGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998765    4689999999999999999999999   99999999999999   7889999999999987643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..  ......||+.|+|||++.+. ++.++||||||+++|||++|+.||...
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (277)
T 3f3z_A          162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP  210 (277)
T ss_dssp             TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence            32  23445799999999988664 899999999999999999999999753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-39  Score=328.09  Aligned_cols=198  Identities=28%  Similarity=0.359  Sum_probs=167.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------  254 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------  254 (424)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++...  .....+.+.+|+++++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999976 5788999999754  334556788999999999999999999999654      


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...|+||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            357999999986 57776642      478999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +++.....  ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99875432  2345578999999999999999999999999999999999999999653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-39  Score=306.52  Aligned_cols=204  Identities=27%  Similarity=0.449  Sum_probs=173.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCC----CEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      .+..++|++.+.||+|+||.||+|++.+.    ..||+|.+... .....+.+.+|+++++.++||||+++++++.++ .
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   86 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P   86 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence            45667899999999999999999986532    34899998765 334567799999999999999999999998754 5


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence            68999999999999999765   24689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence            8765444333445567889999999999999999999999999999998 9999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=304.01  Aligned_cols=202  Identities=27%  Similarity=0.467  Sum_probs=157.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            47899999999999999999974 68899999986542   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999865   35789999999999999999999999   999999999999999999999999999987643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence            222 2234578999999999999999999999999999999999999998543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-39  Score=343.18  Aligned_cols=204  Identities=24%  Similarity=0.336  Sum_probs=178.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  256 (424)
                      .+..++|++.+.||+|+||.||+|++. +++.||||++.+.   .....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            345678999999999999999999976 4778999998653   223345677899999988 79999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      +||||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++++||+|||++
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence            99999999999999999875    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +..... .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus       490 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          490 KENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             EECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            864322 22345678999999999999999999999999999999999999999754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-39  Score=308.38  Aligned_cols=209  Identities=26%  Similarity=0.474  Sum_probs=186.0

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      +.+++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|++++++++||||+++++++.++...
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            4457788899999999999999999999874 7789999986543 4456788999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++++|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence            99999999999999997652  35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            776555444555667889999999999999999999999999999999 99999753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-39  Score=310.32  Aligned_cols=202  Identities=23%  Similarity=0.337  Sum_probs=167.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            458999999999999999999976 57889999986542   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999865    4689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence            44333344567999999999999999999999999999999999999999753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-39  Score=313.89  Aligned_cols=193  Identities=26%  Similarity=0.417  Sum_probs=152.3

Q ss_pred             ceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEecCCCC
Q 014466          191 ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      .+.||+|+||.||+|.+. +++.||+|++.+.   ....+.+|+++++.+. ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999976 5888999998643   3456778999999997 9999999999999999999999999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC---ceEEEecCCccccCCCcce
Q 014466          269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAKLLGAERSY  345 (424)
Q Consensus       269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DfG~a~~~~~~~~~  345 (424)
                      |.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++   .+||+|||+++...... .
T Consensus        93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~  164 (325)
T 3kn6_A           93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q  164 (325)
T ss_dssp             HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence            99999875    5789999999999999999999999   999999999999998766   79999999998654332 2


Q ss_pred             eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            3345678999999999999999999999999999999999999998644

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.3e-39  Score=301.73  Aligned_cols=199  Identities=22%  Similarity=0.381  Sum_probs=176.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            568999999999999999999976 58889999986543  344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc---eEEEecCCccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKL  338 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DfG~a~~  338 (424)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999988765    4689999999999999999999999   9999999999999986655   99999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence            64332  23346799999999999999999999999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-39  Score=319.40  Aligned_cols=203  Identities=23%  Similarity=0.377  Sum_probs=171.7

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCC--CCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~  257 (424)
                      .+...+|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++++++  ||||+++++++..+...
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            3445579999999999999999999888899999998654  3345577999999999996  59999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||| +.+++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++
T Consensus       132 ~lv~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             EEEEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            99999 5678999999875    4788889999999999999999998   999999999999995 5799999999998


Q ss_pred             ccCCCcc-eeeecccccccccccccccC-----------CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERS-YVTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .+..... ......+||+.|+|||++.+           ..|+.++|||||||+||||++|+.||...
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence            7643322 22345679999999999865           46899999999999999999999999753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-39  Score=303.85  Aligned_cols=200  Identities=31%  Similarity=0.609  Sum_probs=172.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchh-------HHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA-------EKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      .+..++|++.+.||+|+||.||+|++. +++.||+|++.......       .+.+.+|++++++++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            345678999999999999999999975 68889999986543211       1678899999999999999999999977


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEcCCCc----
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWN----  327 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~~~~~----  327 (424)
                      ..  ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +  |+||||||+|||++.++.    
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             CC--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCce
Confidence            65  6999999999999988765   35789999999999999999999998   8  999999999999988776    


Q ss_pred             -eEEEecCCccccCCCcceeeecccccccccccccc--cCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          328 -PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       328 -~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       +||+|||+++....    ......||+.|+|||++  ....++.++||||||+++|||++|+.||+..
T Consensus       167 ~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          167 CAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             CEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence             99999999985432    23446799999999998  4556889999999999999999999999754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=316.56  Aligned_cols=219  Identities=23%  Similarity=0.376  Sum_probs=183.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.....        ...+.+.+|++++++++||||+++++++.+...
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            47899999999999999999965 578899999875431        123457779999999999999999999999999


Q ss_pred             eeEEEEecCCC-CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          257 RMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       257 ~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      .++||||+.+| +|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            99999999777 999999865    4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCCC-------CCCCccHHHHHHH
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSR-------PPGEVCIPQMNSL  407 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~~-------~~~~~~~~~~~~~  407 (424)
                      +.......  ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....       ..+.....++..+
T Consensus       177 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          177 AAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL  254 (335)
T ss_dssp             CEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHH
T ss_pred             ceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHH
Confidence            98764432  2334679999999999988877 789999999999999999999996422       1222234556666


Q ss_pred             HHhhhc
Q 014466          408 MTLSYC  413 (424)
Q Consensus       408 ~~~~~~  413 (424)
                      +..++.
T Consensus       255 i~~~L~  260 (335)
T 3dls_A          255 VSGLLQ  260 (335)
T ss_dssp             HHHHTC
T ss_pred             HHHHcc
Confidence            655554

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.7e-39  Score=311.15  Aligned_cols=215  Identities=26%  Similarity=0.486  Sum_probs=183.5

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEe
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLL  248 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~  248 (424)
                      +...++++..++|++.+.||+|+||.||+|++.      +++.||+|.+..... .....+.+|+++++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            445566788889999999999999999999864      367799999865433 3455788999999999999999999


Q ss_pred             eEeeeCCeeeEEEEecCCCCHHHHHccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDV------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       249 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      +++.++...++||||+++|+|.+++....      .....+++..++.++.|++.||+|||++   +|+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            99999999999999999999999987531      1124678999999999999999999999   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          323 DKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            99999999999999865433222 2233457889999999999999999999999999999999 89999753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-38  Score=303.26  Aligned_cols=201  Identities=22%  Similarity=0.373  Sum_probs=178.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|.+.+.||+|+||.||+|.+. +++.+|+|.+...   .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357899999999999999999987 4778899988654   234456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999998765    4789999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... .......||+.|+|||++.+..++.++|+||||+++|||++|+.||+..
T Consensus       167 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          167 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             STT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            322 2234467899999999999999999999999999999999999999753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-39  Score=328.66  Aligned_cols=193  Identities=25%  Similarity=0.373  Sum_probs=155.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee-----CCe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH  256 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~~  256 (424)
                      .++|++.+.||+|+||+||+|++. +++.||||++...  .....+.+.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999966 6888999998654  33445678899999999999999999999943     356


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .|+||||+. ++|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++++||+|||++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            899999985 5999999765    5789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcc--------------------------eeeecccccccccccccc-cCCCCCCccchHHHHHHHHHHHc
Q 014466          337 KLLGAERS--------------------------YVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVIS  385 (424)
Q Consensus       337 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~ellt  385 (424)
                      +.......                          ...+..+||+.|+|||++ ....|+.++|||||||+||||++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            87643211                          123456789999999976 56779999999999999999999

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.6e-39  Score=310.60  Aligned_cols=200  Identities=26%  Similarity=0.384  Sum_probs=178.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+.....      ...+.+.+|+++++.++||||+++++++.++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            357899999999999999999976 588899999865432      1357799999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC----ceEEEec
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDF  333 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kL~Df  333 (424)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999764    5789999999999999999999999   999999999999999888    7999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  221 (321)
T 2a2a_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  221 (321)
T ss_dssp             TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence            9998764332  234457999999999999999999999999999999999999999653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-39  Score=304.56  Aligned_cols=206  Identities=30%  Similarity=0.514  Sum_probs=177.5

Q ss_pred             eeecCCCcccce-eEcccCcEEEEEEEEc---CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          181 LEVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       181 ~~~~~~~~~~~~-~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      +.+..++|.+.+ .||+|+||.||+|.+.   ++..||+|.+.... ....+.+.+|+++++.++||||+++++++ ..+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            345666777777 9999999999999864   56779999987643 34567799999999999999999999999 456


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence            689999999999999999754   35689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccee--eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          336 AKLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +..........  .....||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  217 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  217 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            98775433322  223456899999999998899999999999999999999 99999753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.7e-39  Score=312.45  Aligned_cols=196  Identities=30%  Similarity=0.456  Sum_probs=172.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .+.|+..+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.++...++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            346888999999999999999974 68889999986543   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+. |+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       133 ~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            99997 5888888654   25789999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCcceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ..     ....||+.|+|||++.   ...++.++|||||||++|||++|+.||..
T Consensus       206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            32     3457999999999884   57799999999999999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=307.87  Aligned_cols=201  Identities=27%  Similarity=0.382  Sum_probs=171.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999986 488899999865433  335678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999988755    5689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            22 2344578999999998876 678999999999999999999999997543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-39  Score=311.10  Aligned_cols=226  Identities=31%  Similarity=0.514  Sum_probs=182.2

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCC-----CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ++..++|++.+.||+|+||.||+|.+...     ..||+|.+.... ......+.+|+++++.++||||+++++++.+..
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            55677899999999999999999986532     349999986543 344567889999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             CcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence            999999999999999999765   35789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcc--eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCC
Q 014466          336 AKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGE  398 (424)
Q Consensus       336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~  398 (424)
                      ++.......  .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...              .+...
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~  273 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  273 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc
Confidence            987643322  12223456889999999999999999999999999999999 99999632              22233


Q ss_pred             ccHHHHHHHHHhhhc
Q 014466          399 VCIPQMNSLMTLSYC  413 (424)
Q Consensus       399 ~~~~~~~~~~~~~~~  413 (424)
                      .+..++..++..||.
T Consensus       274 ~~~~~l~~li~~~l~  288 (333)
T 1mqb_A          274 DCPSAIYQLMMQCWQ  288 (333)
T ss_dssp             TCBHHHHHHHHHHTC
T ss_pred             cCCHHHHHHHHHHcC
Confidence            344566666666664

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.7e-39  Score=310.28  Aligned_cols=204  Identities=24%  Similarity=0.369  Sum_probs=172.0

Q ss_pred             CCCcccc-eeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEE
Q 014466          185 TNGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       185 ~~~~~~~-~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .+.|++. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999999964 6889999999776666677889999999885 7999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc---eEEEecCCccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKL  338 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DfG~a~~  338 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.   +||+|||++..
T Consensus        91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999865    4689999999999999999999999   9999999999999988776   99999999886


Q ss_pred             cCCCcc------eeeecccccccccccccccC-----CCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          339 LGAERS------YVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       339 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ......      ......+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  231 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG  231 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence            532211      11234569999999999875     5688999999999999999999999986543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.9e-40  Score=316.25  Aligned_cols=205  Identities=28%  Similarity=0.471  Sum_probs=171.7

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCE----EEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      +..++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~   88 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS   88 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence            45678999999999999999999975 3443    7777764432 2333467789999999999999999999874 56


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             cEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence            88999999999999999765   24688889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          337 KLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      +.+..... .......||..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence            87654332 22344668889999999999999999999999999999999 999998643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.6e-39  Score=305.21  Aligned_cols=204  Identities=21%  Similarity=0.286  Sum_probs=178.2

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+..++|++.+.||+|+||.||+|.. .+++.||+|.+....  ..+.+.+|++.++.+ +|+|++++++++.++...++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            45567899999999999999999996 468889999885442  234577899999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc-----eEEEecC
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-----PKLSDFG  334 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kL~DfG  334 (424)
                      ||||+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.     +||+|||
T Consensus        84 v~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            99999 88999999865   24689999999999999999999998   9999999999999987776     9999999


Q ss_pred             CccccCCCcc------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +++.......      .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            9987654322      12345679999999999999999999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.2e-39  Score=301.50  Aligned_cols=199  Identities=19%  Similarity=0.340  Sum_probs=173.8

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Cee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  257 (424)
                      .+..++|++.+.||+|+||.||+|++. ++.||+|++....  ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            455678999999999999999999986 7889999986543  34456799999999999999999999999877  778


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.++|+|||+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~  159 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADV  159 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred             EeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccc
Confidence            99999999999999998752  23689999999999999999999998   7  99999999999999999999999998


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCC---ccchHHHHHHHHHHHcCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +....      .....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||..
T Consensus       160 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  213 (271)
T 3kmu_A          160 KFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD  213 (271)
T ss_dssp             CCTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred             eeeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            76432      22346899999999998766555   79999999999999999999974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=315.92  Aligned_cols=202  Identities=21%  Similarity=0.299  Sum_probs=168.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCCchh-----------HHHHHHHHHHHhcCCCCceeeE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQA-----------EKEFKVEVEAIGRVRHKNLVRL  247 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~hpnIv~l  247 (424)
                      +..++|++.+.||+|+||.||+|.+.    ++..+|+|++.......           ...+.+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            45578999999999999999999975    46779999987654321           1235678899999999999999


Q ss_pred             eeEeee----CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc
Q 014466          248 LGYCAE----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD  323 (424)
Q Consensus       248 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~  323 (424)
                      ++++.+    +...++||||+ +++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG  185 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence            999987    67889999999 89999999865    3789999999999999999999999   999999999999999


Q ss_pred             CCC--ceEEEecCCccccCCCcce------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          324 KQW--NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       324 ~~~--~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            887  9999999999876432211      11345799999999999999999999999999999999999999964

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.6e-39  Score=308.02  Aligned_cols=205  Identities=23%  Similarity=0.364  Sum_probs=166.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|++.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            357899999999999999999974 6889999998653   334456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999975332346789999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            332 2233457899999999999999999999999999999999999999643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-39  Score=308.07  Aligned_cols=198  Identities=24%  Similarity=0.418  Sum_probs=173.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-C-------CEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-N-------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      ++..++|++.+.||+|+||.||+|++.. +       ..||+|.+........+.+.+|+++++.++||||+++++++.+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            3556789999999999999999998653 3       4699999877666777889999999999999999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc------
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN------  327 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~------  327 (424)
                      ++..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.      
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence            99999999999999999999875   23489999999999999999999999   9999999999999998887      


Q ss_pred             --eEEEecCCccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          328 --PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       328 --~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                        +||+|||++......     ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+
T Consensus       158 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             CEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence              999999999754322     23457899999999987 77999999999999999999955444

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.8e-39  Score=305.01  Aligned_cols=204  Identities=31%  Similarity=0.514  Sum_probs=165.2

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      .++..++|++.+.||+|+||.||+|++.  ..+|+|++...  .....+.+.+|+++++.++||||++++++. .....+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            3778889999999999999999999864  45999998654  334457799999999999999999999965 445688


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        96 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             EEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccc
Confidence            999999999999999755   35789999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCC-cceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAE-RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .... .........||+.|+|||++.   +..++.++||||||+++|||++|+.||...
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  228 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI  228 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence            5432 222234467999999999886   677889999999999999999999999753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-39  Score=316.49  Aligned_cols=206  Identities=28%  Similarity=0.365  Sum_probs=170.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-----CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++...     .....+.+.+|++++++++||||+++++++.++...+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            458999999999999999999975 5778999998654     2345577899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCC------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 014466          259 LVYEYIDNGNLEQWLHGDVGP------------------------------------HSPLTWEIRMNIILGTAKGLTYL  302 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~al~~L  302 (424)
                      +||||+++|+|.+++......                                    ...+++..++.++.|++.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998632110                                    11235677888999999999999


Q ss_pred             HcCCCCCeeeCCCCCCCEEEcCCC--ceEEEecCCccccCCC---cceeeecccccccccccccccC--CCCCCccchHH
Q 014466          303 HEGLEPKVVHRDIKSSNILLDKQW--NPKLSDFGLAKLLGAE---RSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYS  375 (424)
Q Consensus       303 H~~~~~~ivHrDlkp~NILl~~~~--~~kL~DfG~a~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwS  375 (424)
                      |+.   +|+||||||+|||++.++  .+||+|||+++.+...   .........||+.|+|||++.+  ..++.++||||
T Consensus       185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999   999999999999998776  8999999999865332   2222345679999999999865  67899999999


Q ss_pred             HHHHHHHHHcCCCCCCCC
Q 014466          376 FGILIMEVISGRNPVDYS  393 (424)
Q Consensus       376 lGv~l~elltg~~Pf~~~  393 (424)
                      ||+++|||++|+.||...
T Consensus       262 lG~il~el~~g~~pf~~~  279 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGV  279 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCS
T ss_pred             HHHHHHHHHHCCCCCCCC
Confidence            999999999999999643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.5e-39  Score=307.39  Aligned_cols=203  Identities=26%  Similarity=0.449  Sum_probs=174.4

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEE-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--  254 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--  254 (424)
                      +..+.|++.+.||+|+||.||+|++     .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.  
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            3455789999999999999999984     357889999986543 34457789999999999999999999999876  


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence            5688999999999999999665   25689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcc--eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          335 LAKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       335 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ++........  .......||..|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            9987654433  22334568889999999999999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.4e-39  Score=321.64  Aligned_cols=199  Identities=26%  Similarity=0.378  Sum_probs=168.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----Ce
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH  256 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  256 (424)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            458999999999999999999976 5778999999654  334456788999999999999999999999776     56


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .|+||||+++ +|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~-~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCCc-CHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            8999999974 999999765    5689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcc---------------------eeeecccccccccccccc-cCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          337 KLLGAERS---------------------YVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       337 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      +.......                     ...+..+||+.|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            87643321                     123567899999999986 56779999999999999999998666654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=335.94  Aligned_cols=225  Identities=29%  Similarity=0.498  Sum_probs=184.8

Q ss_pred             eecCCCcccce-eEcccCcEEEEEEEEc---CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~-~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      .+..+++.+.+ .||+|+||.||+|.+.   ++..||||++.... ....+.+.+|+++|+.++|||||++++++.+ +.
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            45556666666 8999999999999875   45569999987643 3456789999999999999999999999976 56


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             eEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence            89999999999999999765   35789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceee--ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCc
Q 014466          337 KLLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEV  399 (424)
Q Consensus       337 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~  399 (424)
                      +.+........  ....+|+.|+|||++.+..++.++|||||||+||||++ |+.||....              +.+..
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~  563 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE  563 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTT
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            87644332222  22345689999999999999999999999999999998 999997533              23344


Q ss_pred             cHHHHHHHHHhhhc
Q 014466          400 CIPQMNSLMTLSYC  413 (424)
Q Consensus       400 ~~~~~~~~~~~~~~  413 (424)
                      +..++..+|..||.
T Consensus       564 ~~~~l~~li~~cl~  577 (613)
T 2ozo_A          564 CPPELYALMSDCWI  577 (613)
T ss_dssp             CCHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHHcC
Confidence            56778888888876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-39  Score=311.62  Aligned_cols=203  Identities=27%  Similarity=0.419  Sum_probs=178.9

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEE-----cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEee--eCC
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGA  255 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~  255 (424)
                      +..++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  +..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            4456899999999999999999985     357789999998777677778999999999999999999999886  455


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             eEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            6889999999999999997642   4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcce--eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          336 AKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  231 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC  231 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            9876543322  2234568889999999999999999999999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=307.60  Aligned_cols=203  Identities=30%  Similarity=0.427  Sum_probs=170.0

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcC---CCCceeeEeeEeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRV---RHKNLVRLLGYCAE  253 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~  253 (424)
                      +..++|++.+.||+|+||+||+|++. +++.||+|++....     ......+.+|+++++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            45678999999999999999999964 68889999986432     11234566677777766   49999999999987


Q ss_pred             CC-----eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          254 GA-----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       254 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      ..     ..++||||++ ++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            55     5789999997 59999998763  23489999999999999999999999   99999999999999999999


Q ss_pred             EEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ||+|||+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999865432  2334567999999999999999999999999999999999999999653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2e-39  Score=315.45  Aligned_cols=197  Identities=27%  Similarity=0.423  Sum_probs=171.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+.+....    ..+|++++.++ +||||+++++++.++...++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457899999999999999999976 5788999999765432    34578888887 79999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC----CceEEEecCCccc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL  338 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kL~DfG~a~~  338 (424)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||+..+    +.+||+|||+++.
T Consensus        97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999765    5689999999999999999999999   99999999999998543    3599999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence            644322 334567999999999998888999999999999999999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.1e-40  Score=323.80  Aligned_cols=222  Identities=17%  Similarity=0.238  Sum_probs=174.5

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecC---CchhHHHHHHHH---HHHhcCCCCceeeEe-------
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEV---EAIGRVRHKNLVRLL-------  248 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~hpnIv~l~-------  248 (424)
                      ...++|++.+.||+|+||.||+|++ .+++.||||++...   .....+.+.+|+   +.++.++|||||+++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3456899999999999999999995 46899999999643   344567889999   555666899999998       


Q ss_pred             eEeeeCC-----------------eeeEEEEecCCCCHHHHHccCCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 014466          249 GYCAEGA-----------------HRMLVYEYIDNGNLEQWLHGDVGP---HSPLTWEIRMNIILGTAKGLTYLHEGLEP  308 (424)
Q Consensus       249 ~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~al~~LH~~~~~  308 (424)
                      +++.+.+                 ..++||||+ +|+|.+++......   ...+++..++.++.|++.||+|||++   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---  225 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---  225 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence            6665543                 278999999 57999999764210   12344588888999999999999999   


Q ss_pred             CeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccCC-----------CCCCccchHHHH
Q 014466          309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----------MLNERSDVYSFG  377 (424)
Q Consensus       309 ~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDiwSlG  377 (424)
                      +|+||||||+|||++.++.+||+|||+++..+.    ......| +.|+|||++.+.           .|+.++||||||
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            999999999999999999999999999986322    3345667 999999999887           899999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCC---------CccHHHHHHHHHhhhc
Q 014466          378 ILIMEVISGRNPVDYSRPPG---------EVCIPQMNSLMTLSYC  413 (424)
Q Consensus       378 v~l~elltg~~Pf~~~~~~~---------~~~~~~~~~~~~~~~~  413 (424)
                      |++|||++|+.||.......         .....++..++..||.
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  345 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLR  345 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTC
T ss_pred             HHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcC
Confidence            99999999999997644321         1233456666666664

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-38  Score=306.99  Aligned_cols=198  Identities=27%  Similarity=0.438  Sum_probs=172.6

Q ss_pred             CcccceeEcccCcEEEEEEEEc-----CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC--Ceee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  258 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~  258 (424)
                      .|++.+.||+|+||.||++.+.     +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.  ...+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3489999999999999998753     57889999997653 34456789999999999999999999999874  5788


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++...     .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence            999999999999999765     488999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCcce--eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            7543322  23345688899999999999999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=309.30  Aligned_cols=224  Identities=29%  Similarity=0.511  Sum_probs=178.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCE----EEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      +..++|++.+.||+|+||.||+|.+. +++.    ||+|.+... .....+.+.+|+++++.++||||+++++++.++. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            45678999999999999999999965 3444    467766433 3445678999999999999999999999998765 


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++|+||+.+|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            78999999999999999875   35689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCcc
Q 014466          337 KLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVC  400 (424)
Q Consensus       337 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~  400 (424)
                      +....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||+...              +.+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            87643322 22334557889999999999999999999999999999999 999998532              223334


Q ss_pred             HHHHHHHHHhhhc
Q 014466          401 IPQMNSLMTLSYC  413 (424)
Q Consensus       401 ~~~~~~~~~~~~~  413 (424)
                      ..++..++..||.
T Consensus       245 ~~~l~~li~~~l~  257 (327)
T 3lzb_A          245 TIDVYMIMRKCWM  257 (327)
T ss_dssp             CHHHHHHHHHHTC
T ss_pred             CHHHHHHHHHHcC
Confidence            4556666666654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3e-39  Score=305.90  Aligned_cols=202  Identities=23%  Similarity=0.370  Sum_probs=171.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|.+.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            47899999999999999999975 57889999986653 33467889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceEEEecCCccccC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DfG~a~~~~  340 (424)
                      +++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999865432235789999999999999999999999   99999999999999   456789999999998654


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..  .......||+.|+|||++. ..++.++||||||+++|||++|+.||...
T Consensus       179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~  228 (285)
T 3is5_A          179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT  228 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence            32  2234567999999999886 56889999999999999999999999743

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.6e-39  Score=304.70  Aligned_cols=205  Identities=27%  Similarity=0.401  Sum_probs=174.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeee--CCeeeE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRML  259 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l  259 (424)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+  +...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357899999999999999999976 68889999986543  3445678999999999999999999998854  567899


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eeeCCCCCCCEEEcCCCceEEEecC
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-----VVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-----ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+.   +     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999976533345689999999999999999999998   7     9999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence            9987543321 123456899999999999999999999999999999999999999754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-39  Score=313.66  Aligned_cols=196  Identities=27%  Similarity=0.413  Sum_probs=166.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999975 6889999998553  3334567889999999999999999999997653      


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+ +++|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            459999999 77999999753     688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.....    .+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9875432    345678999999998877 78999999999999999999999999654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-39  Score=313.24  Aligned_cols=210  Identities=28%  Similarity=0.460  Sum_probs=180.3

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcC-C-----CEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLED-N-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  252 (424)
                      +++..++|++.+.||+|+||.||+|.+.. +     ..||+|.+.... ....+.+.+|+++++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            46778899999999999999999999753 2     369999986553 34456789999999999 8999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVG----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      +++..++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||++   +|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence            99999999999999999999875321          124688999999999999999999999   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          323 DKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999999999865433222 2334567889999999999999999999999999999999 99999754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-38  Score=304.46  Aligned_cols=200  Identities=42%  Similarity=0.766  Sum_probs=173.2

Q ss_pred             cceeEcccCcEEEEEEEEcCCCEEEEEEeecC----CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecC
Q 014466          190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      ..+.||+|+||.||+|.. +++.||+|++...    .....+.+.+|+++++.++||||+++++++.++...++||||++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  113 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP  113 (307)
T ss_dssp             TCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             cCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence            348999999999999987 4788999998653    23445779999999999999999999999999999999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc-
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-  344 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-  344 (424)
                      +++|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       114 ~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          114 NGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             TCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             CCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            9999999975422 35689999999999999999999999   999999999999999999999999999987644322 


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||+....
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            22344679999999998865 488999999999999999999999986543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.5e-39  Score=305.06  Aligned_cols=198  Identities=24%  Similarity=0.399  Sum_probs=173.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++||||+++++++.++...++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            47889999999999999999976 68899999997665555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceEEEecCCccccCC
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DfG~a~~~~~  341 (424)
                      ++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++.....
T Consensus        89 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           89 SGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999998765    4689999999999999999999999   99999999999999   7889999999999975432


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  210 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE  210 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            2   223456899999999999999999999999999999999999999643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=309.36  Aligned_cols=209  Identities=25%  Similarity=0.408  Sum_probs=164.4

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEee----
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA----  252 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~----  252 (424)
                      ..+++...+|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++++. ||||+++++++.    
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            345677779999999999999999999975 68899999997777677778999999999996 999999999983    


Q ss_pred             ----eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEcCCC
Q 014466          253 ----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQW  326 (424)
Q Consensus       253 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~~~~  326 (424)
                          .....++||||+. |+|.+++..... ...+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence                3445789999996 699998865321 35689999999999999999999998   8  99999999999999999


Q ss_pred             ceEEEecCCccccCCCcce-----------eeecccccccccccccc---cCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          327 NPKLSDFGLAKLLGAERSY-----------VTTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       327 ~~kL~DfG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .+||+|||+++........           ......||+.|+|||++   .+..++.++||||||+++|||++|+.||+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999876443221           11235689999999998   567789999999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=312.08  Aligned_cols=201  Identities=26%  Similarity=0.405  Sum_probs=166.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchh-HHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....... ...+.+|+++++.++||||+++++++.++...++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999976 68889999986443221 12455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  153 (324)
T 3mtl_A           82 LDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-  153 (324)
T ss_dssp             CSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             ccc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence            985 999998765   24689999999999999999999999   9999999999999999999999999999865332 


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST  205 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            222334578999999998876 678999999999999999999999997543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-38  Score=300.38  Aligned_cols=199  Identities=26%  Similarity=0.409  Sum_probs=174.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....      ...+.+.+|++++++++||||+++++++.++...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999987 588999999865422      23578999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC----ceEEEecC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG  334 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DfG  334 (424)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999764    4689999999999999999999999   999999999999998877    79999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  214 (283)
T 3bhy_A          158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE  214 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence            998764322  223456899999999999999999999999999999999999999754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.4e-39  Score=314.81  Aligned_cols=203  Identities=26%  Similarity=0.418  Sum_probs=178.1

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ++..++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            455678999999999999999999976 6788999998765 34445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++++|.+++...    ..+++..+..++.+++.||+|||+..  +|+||||||+|||++.++.+||+|||++...
T Consensus       109 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999765    46889999999999999999999731  7999999999999999999999999999754


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       183 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          183 ID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             HH---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             cc---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            22   1233457999999999999999999999999999999999999999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.1e-38  Score=300.39  Aligned_cols=201  Identities=26%  Similarity=0.444  Sum_probs=178.9

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..+.|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            3457899999999999999999975 58889999986543 345678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99999999999964     3689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       172 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          172 TQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             TB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence            32 2234567899999999999999999999999999999999999999753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=305.33  Aligned_cols=201  Identities=33%  Similarity=0.545  Sum_probs=166.4

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      +..++|++.+.||+|+||.||+|.+. ++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++|||
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            34568899999999999999999986 788999998543  345678999999999999999999999874  4789999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc-eEEEecCCccccCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGA  341 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kL~DfG~a~~~~~  341 (424)
                      |+++|+|.+++.... ....+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.....
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           80 YAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             CCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             cCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            999999999998652 1235788999999999999999999921128999999999999998887 79999999976532


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .    .....||+.|+|||++.+..++.++||||||+++|||++|+.||+..
T Consensus       159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            2    23346899999999999999999999999999999999999999753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1e-38  Score=301.74  Aligned_cols=201  Identities=26%  Similarity=0.449  Sum_probs=178.1

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +..++|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++.++...+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            34568999999999999999999976 46789999986542   223467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             EEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            999999999999999765    4689999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ....   ......||+.|+|||++.+..++.++|+||||+++|||++|+.||+..
T Consensus       164 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  215 (284)
T 2vgo_A          164 APSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP  215 (284)
T ss_dssp             CSSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Cccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence            5332   223457899999999999999999999999999999999999999753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-38  Score=299.95  Aligned_cols=202  Identities=31%  Similarity=0.451  Sum_probs=177.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            47889999999999999999976 68889999986543 34457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.......
T Consensus        87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999998754    5689999999999999999999999   99999999999999999999999999998653322


Q ss_pred             -ceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          344 -SYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       344 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                       ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||+...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  212 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence             122345678999999999987765 778999999999999999999997644

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.2e-39  Score=308.62  Aligned_cols=213  Identities=28%  Similarity=0.422  Sum_probs=180.9

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCceeeEeeE
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGY  250 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  250 (424)
                      ..+++..++|++.+.||+|+||.||+|.+.      +++.||+|.+..... ...+.+.+|+++++++ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            344677789999999999999999999852      457799999876533 3456788999999999 79999999999


Q ss_pred             eeeCC-eeeEEEEecCCCCHHHHHccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCC
Q 014466          251 CAEGA-HRMLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS  317 (424)
Q Consensus       251 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp  317 (424)
                      +...+ ..++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.   +|+||||||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp  176 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  176 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence            87754 588999999999999999876321            12388999999999999999999999   999999999


Q ss_pred             CCEEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 014466          318 SNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR  394 (424)
Q Consensus       318 ~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~  394 (424)
                      +|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999999987644332 23344568899999999999999999999999999999998 999997543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.8e-38  Score=298.73  Aligned_cols=197  Identities=28%  Similarity=0.445  Sum_probs=171.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee----CCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~  257 (424)
                      ...|.+.+.||+|+||.||+|.+. ++..||+|.+...  .....+.+.+|+++++.++||||+++++++..    +...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345888899999999999999975 5778999998654  33455678999999999999999999999865    3567


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEc-CCCceEEEecC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLD-KQWNPKLSDFG  334 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kL~DfG  334 (424)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +  |+||||||+|||++ .++.+||+|||
T Consensus       105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            8999999999999999765    4688999999999999999999998   7  99999999999997 78999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ++......   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||..
T Consensus       178 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          178 LATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             GGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             Cccccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            99764332   2334579999999998874 589999999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-38  Score=301.97  Aligned_cols=206  Identities=31%  Similarity=0.498  Sum_probs=174.8

Q ss_pred             eeeecCCCcccce-eEcccCcEEEEEEEEc---CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeee
Q 014466          180 ELEVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE  253 (424)
Q Consensus       180 ~~~~~~~~~~~~~-~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  253 (424)
                      +..+..++|++.+ .||+|+||.||+|.+.   +++.||+|.+....  ....+.+.+|+++++.++||||+++++++ +
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            4456667889888 9999999999999753   35779999986543  33456799999999999999999999999 5


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      .+..++||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence            56788999999999999999875    4689999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceee--ecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          334 GLAKLLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      |++...........  ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  224 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  224 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99987654433222  23446789999999998889999999999999999999 99999753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.1e-39  Score=310.79  Aligned_cols=201  Identities=23%  Similarity=0.390  Sum_probs=165.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ..++|++.+.||+|+||+||+|++. +++.||+|++.....  ...+.+.+|++++++++||||+++++++.++...++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3458999999999999999999965 678899999865432  2345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc-----CCCceEEEecCC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-----KQWNPKLSDFGL  335 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~-----~~~~~kL~DfG~  335 (424)
                      |||+++ +|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++     .++.+||+|||+
T Consensus       112 ~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999985 999999875    4689999999999999999999999   999999999999994     455699999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       184 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          184 ARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            98764332 223445789999999998764 5899999999999999999999999654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=309.23  Aligned_cols=203  Identities=25%  Similarity=0.447  Sum_probs=177.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEE-----cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC--
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--  255 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  255 (424)
                      +..++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...+  
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            4456789999999999999999985     357889999998776677788999999999999999999999987654  


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence            678999999999999999875   24689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccee--eecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          336 AKLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       336 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      +..........  .....++..|+|||.+.+..++.++||||||+++|||+||..||.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            98765443322  233457888999999998889999999999999999999999886

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=299.10  Aligned_cols=208  Identities=29%  Similarity=0.469  Sum_probs=176.3

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +.....+.|....+||+|+||.||+|.+. +++.||+|.+........+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            34555667777889999999999999975 57889999997766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEecCCcc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAK  337 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DfG~a~  337 (424)
                      +||||+++++|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++. ++.+||+|||++.
T Consensus        96 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            99999999999999976532 24567888999999999999999999   9999999999999987 8999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCC--CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ...... .......||+.|+|||++.+..  ++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          172 RLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             ESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             ccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence            764322 2234467899999999987643  88999999999999999999999963

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-38  Score=314.62  Aligned_cols=203  Identities=24%  Similarity=0.350  Sum_probs=167.8

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----  254 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----  254 (424)
                      ++...++|++.+.||+|+||+||+|.+. +++.||+|++......    ..+|+++++.++||||+++++++...     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            3556789999999999999999999974 6889999998654322    23699999999999999999998443     


Q ss_pred             ---------------------------------CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 014466          255 ---------------------------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY  301 (424)
Q Consensus       255 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~  301 (424)
                                                       ...++||||+++ +|.+.+.........+++..+..++.|+++||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             347899999985 8887776533334679999999999999999999


Q ss_pred             HHcCCCCCeeeCCCCCCCEEEc-CCCceEEEecCCccccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHH
Q 014466          302 LHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGIL  379 (424)
Q Consensus       302 LH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~  379 (424)
                      ||+.   +|+||||||+|||++ .++.+||+|||+++......  ......||+.|+|||++.+. .++.++|||||||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9998   999999999999998 68899999999998764332  23445789999999988765 49999999999999


Q ss_pred             HHHHHcCCCCCCCC
Q 014466          380 IMEVISGRNPVDYS  393 (424)
Q Consensus       380 l~elltg~~Pf~~~  393 (424)
                      +|||++|+.||...
T Consensus       232 l~ell~g~~pf~~~  245 (383)
T 3eb0_A          232 FGELILGKPLFSGE  245 (383)
T ss_dssp             HHHHHHSSCSSCCS
T ss_pred             HHHHHhCCCCCCCC
Confidence            99999999999754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-38  Score=305.60  Aligned_cols=212  Identities=24%  Similarity=0.424  Sum_probs=168.8

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEcC----CCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEee
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA  252 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  252 (424)
                      .++.+..++|.+.+.||+|+||.||+|.+..    +..||+|.+...  .....+.+.+|++++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            4456777899999999999999999998652    347999998654  3344567899999999999999999999998


Q ss_pred             eCCe-----eeEEEEecCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          253 EGAH-----RMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       253 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      +...     .++||||+++|+|.+++....  .....+++..++.++.|++.||.|||++   +|+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            7553     489999999999999985432  2245799999999999999999999998   99999999999999999


Q ss_pred             CceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          326 WNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            9999999999986643322 12233457889999999999999999999999999999999 99999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-38  Score=299.41  Aligned_cols=199  Identities=23%  Similarity=0.338  Sum_probs=171.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357899999999999999999986 6889999998754  334456788899999999 999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC---------------
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---------------  325 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~---------------  325 (424)
                      |||+++++|.+++.........+++..++.++.|++.||+|||++   +|+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999976532235689999999999999999999999   99999999999999844               


Q ss_pred             ----CceEEEecCCccccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          326 ----WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       326 ----~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                          ..+||+|||.+.......     ...||+.|+|||++.+. .++.++||||||+++|||++|..|+.
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                479999999998764322     23589999999998766 66789999999999999999998764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-38  Score=324.93  Aligned_cols=199  Identities=25%  Similarity=0.412  Sum_probs=170.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .++|++.+.||+|+||+||+|+.. ++..||+|++....  ......+.+|+++++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            447999999999999999999976 67889999986543  233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC---CceEEEecCCccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKL  338 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DfG~a~~  338 (424)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++..   +.+||+|||++..
T Consensus       116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999988765    5689999999999999999999999   99999999999999764   4599999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....  .....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||...
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  240 (494)
T 3lij_A          189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ  240 (494)
T ss_dssp             CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            64332  334567999999999886 46999999999999999999999999754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-39  Score=314.27  Aligned_cols=221  Identities=29%  Similarity=0.451  Sum_probs=173.3

Q ss_pred             CcccceeEcccCcEEEEEEEEcC--C--CEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEee-eCCeeeEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLED--N--TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lv  260 (424)
                      .|++.+.||+|+||.||+|++.+  +  ..||+|.+... .....+.+.+|++++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            47788999999999999998642  2  35789988654 3345678999999999999999999999865 45678899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++...   ...+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999765   34678899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCcce---eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCCC--------------CCCccHH
Q 014466          341 AERSY---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP--------------PGEVCIP  402 (424)
Q Consensus       341 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~~--------------~~~~~~~  402 (424)
                      .....   ......+|+.|+|||++.+..++.++|||||||++|||+| |..||.....              .+..+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~  323 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  323 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            33211   2233557889999999999999999999999999999999 7888875332              2333556


Q ss_pred             HHHHHHHhhhc
Q 014466          403 QMNSLMTLSYC  413 (424)
Q Consensus       403 ~~~~~~~~~~~  413 (424)
                      ++..++..||.
T Consensus       324 ~l~~li~~cl~  334 (373)
T 3c1x_A          324 PLYEVMLKCWH  334 (373)
T ss_dssp             HHHHHHHHHTC
T ss_pred             HHHHHHHHHcC
Confidence            67777777775

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-38  Score=307.95  Aligned_cols=203  Identities=28%  Similarity=0.449  Sum_probs=172.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.....  ...+.+.+|+++++.++||||+++++++.++...++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3458999999999999999999976 488899999865433  3345688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       103 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          103 FEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            9999999998887654    4689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       176 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          176 APG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            332 223445789999999998775 78999999999999999999999997543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.9e-39  Score=319.72  Aligned_cols=200  Identities=25%  Similarity=0.419  Sum_probs=164.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.....        .....+.+|++++++++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            468999999999999999999976 578899999865421        122347889999999999999999999865 5


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC---ceEEEe
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSD  332 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kL~D  332 (424)
                      ..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++   .+||+|
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             ceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence            578999999999999988765    5789999999999999999999999   999999999999997544   599999


Q ss_pred             cCCccccCCCcceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ||+++.....  ......+||+.|+|||++.   ...|+.++|||||||++|||++|+.||....
T Consensus       286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            9999876432  2334567999999999885   3678889999999999999999999997643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-38  Score=298.21  Aligned_cols=203  Identities=25%  Similarity=0.437  Sum_probs=170.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .+..++|++.+.||+|+||.||+|.+. +++.||+|.+....   ....+.+.+|+++++.++||||+++++++.+....
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            345578999999999999999999986 68899999986542   23346788999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        87 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             EEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence            9999999999999999765    4688999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......  ......||+.|+|||.+.+..+ +.++|+||||+++|||++|+.||+..
T Consensus       160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  214 (276)
T 2h6d_A          160 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE  214 (276)
T ss_dssp             CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            754322  2334568999999999988765 68999999999999999999999753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.7e-38  Score=322.20  Aligned_cols=203  Identities=27%  Similarity=0.429  Sum_probs=174.8

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-------------hhHHHHHHHHHHHhcCCCCceeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-------------QAEKEFKVEVEAIGRVRHKNLVRL  247 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~hpnIv~l  247 (424)
                      ....++|++.+.||+|+||+||+|+.. +++.||+|++.....             ...+.+.+|++++++++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            344578999999999999999999976 578899999865421             234678899999999999999999


Q ss_pred             eeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-
Q 014466          248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-  326 (424)
Q Consensus       248 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-  326 (424)
                      ++++.++...++||||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++ 
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCC
Confidence            99999999999999999999999998765    5689999999999999999999999   999999999999998776 


Q ss_pred             --ceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          327 --NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       327 --~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                        .+||+|||++......  .......||+.|+|||++. ..|+.++|||||||++|+|++|+.||....
T Consensus       185 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             CSSEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CccEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              6999999999876433  2334567999999999987 469999999999999999999999997543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.3e-39  Score=326.27  Aligned_cols=201  Identities=27%  Similarity=0.441  Sum_probs=177.8

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+....+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34568999999999999999999976 68899999986542   345677899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceEEEecCC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGL  335 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DfG~  335 (424)
                      +||||+.+|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            999999999999999765    5689999999999999999999999   99999999999999   5678999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +..+....  ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...
T Consensus       176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  230 (484)
T 3nyv_A          176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA  230 (484)
T ss_dssp             HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence            98764332  2344679999999999876 6999999999999999999999999754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=317.90  Aligned_cols=206  Identities=25%  Similarity=0.350  Sum_probs=176.6

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC--eee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~  258 (424)
                      ...++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            44568999999999999999999976 48899999986543 234567888999999999999999999998765  679


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE----cCCCceEEEecC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFG  334 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DfG  334 (424)
                      +||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            99999999999999976532 23489999999999999999999999   99999999999999    777889999999


Q ss_pred             CccccCCCcceeeecccccccccccccccC--------CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +++......  ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||....
T Consensus       162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~  227 (396)
T 4eut_A          162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (396)
T ss_dssp             GCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             CceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            998764432  2334679999999998865        567889999999999999999999997544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.4e-39  Score=305.11  Aligned_cols=204  Identities=21%  Similarity=0.340  Sum_probs=172.7

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|+++++.++||||+++++++.+++..++||
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            35568999999999999999999986 47889999987666666778999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999998764   24689999999999999999999999   999999999999999999999999998764321


Q ss_pred             Ccceeeecccccccccccccc-----cCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      . ........||+.|+|||++     ....++.++||||||+++|||++|+.||...
T Consensus       170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  225 (302)
T 2j7t_A          170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  225 (302)
T ss_dssp             H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            1 1122345689999999988     4677899999999999999999999999754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-38  Score=309.19  Aligned_cols=201  Identities=23%  Similarity=0.371  Sum_probs=171.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeee--------C
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G  254 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------~  254 (424)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.....  .....+.+|+++++.++||||+++++++.+        +
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            58999999999999999999974 688999999855432  234567789999999999999999999987        3


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      +..++||||+++ +|.+.+...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            468899999986 787777655   25689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCC---cceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAE---RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +++.+...   .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99876422   1222345678999999998876 56899999999999999999999999754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.6e-38  Score=299.98  Aligned_cols=202  Identities=31%  Similarity=0.474  Sum_probs=168.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCC----CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEee-eCCeeeE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRML  259 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~l  259 (424)
                      .+|++.+.||+|+||.||+|++.++    ..+|+|.+.... ....+.+.+|++++++++||||+++++++. .+...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            3688899999999999999986432    247899886543 344567899999999999999999999864 5567889


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999764   35688999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcc---eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          340 GAERS---YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       340 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      .....   .......||+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence            44322   22334567889999999999999999999999999999999 66666543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=301.46  Aligned_cols=202  Identities=29%  Similarity=0.419  Sum_probs=172.8

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|.+....  ..+.+.+|+++++.++||||+++++++.++...++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34568999999999999999999976 48889999986543  3456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||++.....
T Consensus       104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999999743   25789999999999999999999999   999999999999999999999999999987643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       178 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  228 (314)
T 3com_A          178 TM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI  228 (314)
T ss_dssp             TB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             hc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            32 2233457899999999999999999999999999999999999999753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-38  Score=305.81  Aligned_cols=206  Identities=28%  Similarity=0.476  Sum_probs=172.6

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCE--EEEEEeecC-CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTN--VAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +..++|++.+.||+|+||.||+|++. ++..  +|+|.+... .....+.+.+|+++++++ +||||+++++++.+++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            34568999999999999999999965 4554  489988653 233456788999999999 999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          258 MLVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      ++||||+++|+|.+++....            .....+++..++.++.|++.||+|||++   +|+||||||+|||++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999997653            2235789999999999999999999999   99999999999999999


Q ss_pred             CceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      +.+||+|||+++....  ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       179 ~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  245 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  245 (327)
T ss_dssp             GCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CeEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999974321  112233457889999999999899999999999999999998 99999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.5e-38  Score=309.41  Aligned_cols=200  Identities=25%  Similarity=0.430  Sum_probs=175.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG  254 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  254 (424)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....        ...+.+.+|+++++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            357899999999999999999986 689999999865431        1235678899999999 799999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence            9999999999999999999764    4689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccC------CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++..+....  ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||...
T Consensus       246 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          246 FSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            998764332  2345679999999998853      36889999999999999999999999653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-38  Score=301.09  Aligned_cols=206  Identities=24%  Similarity=0.334  Sum_probs=162.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      ++..++|++.+.||+|+||.||+|++. +++.||+|++.....  ...+.+.++...++.++||||+++++++.+++..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            566779999999999999999999975 688899999865432  22334555666688899999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++ +|.+++.........+++..++.++.|++.||+|||++.  +|+||||||+|||++.++.+||+|||++..
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99999985 888887653333467999999999999999999999842  899999999999999999999999999986


Q ss_pred             cCCCcceeeecccccccccccccc----cCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .....  ......||+.|+|||++    .+..++.++||||||+++|||++|+.||+.
T Consensus       160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          160 LVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            54322  22334689999999996    566789999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-38  Score=323.66  Aligned_cols=198  Identities=26%  Similarity=0.412  Sum_probs=173.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++...  .......+.+|++++++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            47899999999999999999976 6889999998643  22345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc---CCCceEEEecCCcccc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLL  339 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DfG~a~~~  339 (424)
                      |+++|+|.+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+|||+++..
T Consensus       102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999988765    4689999999999999999999999   999999999999995   4567999999999865


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...  ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...
T Consensus       175 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  225 (486)
T 3mwu_A          175 QQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK  225 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            433  22345679999999999876 5899999999999999999999999653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-38  Score=309.05  Aligned_cols=197  Identities=29%  Similarity=0.370  Sum_probs=163.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999976 5788999998654  3344567889999999999999999999997654      


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++ +|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            78999999975 78888852      478899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9865432  2234567999999999999999999999999999999999999999754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-38  Score=303.00  Aligned_cols=201  Identities=29%  Similarity=0.476  Sum_probs=165.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC--CCCceeeEeeEeeeC----Cee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV--RHKNLVRLLGYCAEG----AHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~l~~~~~~~----~~~  257 (424)
                      ..++|++.+.||+|+||.||+|++. ++.||+|++....   ...+..|.+++..+  +||||+++++++.+.    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3458999999999999999999986 8899999985432   23344455555554  999999999999877    678


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                      ++||||+++|+|.++++..     .+++..++.++.|++.||+|||+..     .++|+||||||+|||++.++.+||+|
T Consensus       111 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            9999999999999999754     6889999999999999999999651     33899999999999999999999999


Q ss_pred             cCCccccCCCccee---eecccccccccccccccCCCCCCc------cchHHHHHHHHHHHcC----------CCCCCCC
Q 014466          333 FGLAKLLGAERSYV---TTRVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISG----------RNPVDYS  393 (424)
Q Consensus       333 fG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDiwSlGv~l~elltg----------~~Pf~~~  393 (424)
                      ||+++.+.......   .....||+.|+|||++.+..++..      +|||||||++|||+||          +.||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            99998664332221   234579999999999988777665      9999999999999999          7777654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-38  Score=331.55  Aligned_cols=214  Identities=31%  Similarity=0.503  Sum_probs=177.3

Q ss_pred             eeEcccCcEEEEEEEEc---CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      +.||+|+||.||+|.+.   .++.||||++....  ....+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            48999999999999764   35679999986543  3446789999999999999999999999975 457899999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcce-
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-  345 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-  345 (424)
                      |+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus       454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999999765    5789999999999999999999999   9999999999999999999999999999876543322 


Q ss_pred             -eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHHHHHHHHH
Q 014466          346 -VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIPQMNSLMT  409 (424)
Q Consensus       346 -~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~~~~~~~~  409 (424)
                       ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....              +.+..+..++..+|.
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             2233457889999999999999999999999999999998 999997532              233445667777887


Q ss_pred             hhhc
Q 014466          410 LSYC  413 (424)
Q Consensus       410 ~~~~  413 (424)
                      .||.
T Consensus       607 ~cl~  610 (635)
T 4fl3_A          607 LCWT  610 (635)
T ss_dssp             HHTC
T ss_pred             HHcC
Confidence            7775

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-38  Score=297.64  Aligned_cols=198  Identities=29%  Similarity=0.430  Sum_probs=169.0

Q ss_pred             CcccceeEcccCcEEEEEEEEcC-CC---EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee-eEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLED-NT---NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLV  260 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-~lv  260 (424)
                      .|...+.||+|+||.||+|.+.+ +.   .+|+|.+.... ....+.+.+|+++++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667999999999999998643 22   68999986543 34557789999999999999999999999876655 899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+.+|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999764   35688999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCcc---eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCC
Q 014466          341 AERS---YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       341 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                      ....   .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence            3321   2223456889999999999999999999999999999999965554

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.1e-38  Score=296.57  Aligned_cols=202  Identities=22%  Similarity=0.311  Sum_probs=172.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEe-eeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++......  +.+.+|+++++.++|++++..+.++ .++...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999997 46888999988654322  3578899999999988866666555 56778899999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceEEEecCCcccc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DfG~a~~~  339 (424)
                      |+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||++...
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 88999999754   25789999999999999999999999   99999999999999   48889999999999876


Q ss_pred             CCCcce------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          340 GAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  220 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  220 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence            543321      12456799999999999999999999999999999999999999987543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.3e-38  Score=316.37  Aligned_cols=197  Identities=27%  Similarity=0.364  Sum_probs=164.2

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------CeeeE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AHRML  259 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~~~l  259 (424)
                      +|++.+.||+|+||.||+|++. +++.||||++.....    .+.+|+++++.++||||+++++++...      ...++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            6888999999999999999986 588999999865432    234699999999999999999998542      23569


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-CceEEEecCCccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKL  338 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DfG~a~~  338 (424)
                      ||||+++ +|.+.+.........+++..++.++.|+++||+|||++   +|+||||||+|||++.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999986 67666653222246789999999999999999999998   99999999999999965 5789999999987


Q ss_pred             cCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +....  ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||...
T Consensus       207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            64332  23346789999999998764 7999999999999999999999999653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-38  Score=313.33  Aligned_cols=195  Identities=12%  Similarity=0.059  Sum_probs=152.0

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHH---HHHhcCCCCceeeEe-------eEee
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEV---EAIGRVRHKNLVRLL-------GYCA  252 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~hpnIv~l~-------~~~~  252 (424)
                      .|++.+.||+|+||.||+|++. +++.||+|++.....   ...+.+.+|+   +.++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            5888999999999999999976 688899999977543   3345677785   45555 799988755       4443


Q ss_pred             eC-----------------CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCC
Q 014466          253 EG-----------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR------MNIILGTAKGLTYLHEGLEPK  309 (424)
Q Consensus       253 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~al~~LH~~~~~~  309 (424)
                      ..                 ...++||||++ |+|.+++....   ..+.+..+      ..++.|+++||+|||++   +
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            32                 34799999999 79999998642   23344444      67779999999999999   9


Q ss_pred             eeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCC
Q 014466          310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGR  387 (424)
Q Consensus       310 ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~  387 (424)
                      |+||||||+|||++.++.+||+|||+++..+..    .....+|+.|+|||++.+  ..|+.++|||||||++|||++|+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999865322    224557799999999987  77999999999999999999999


Q ss_pred             CCCCCC
Q 014466          388 NPVDYS  393 (424)
Q Consensus       388 ~Pf~~~  393 (424)
                      .||...
T Consensus       291 ~Pf~~~  296 (371)
T 3q60_A          291 LPFGLV  296 (371)
T ss_dssp             CSTTBC
T ss_pred             CCCCCc
Confidence            999876

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=301.50  Aligned_cols=209  Identities=28%  Similarity=0.416  Sum_probs=172.4

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeee--
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE--  253 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--  253 (424)
                      +..+....++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+++++++ +||||+++++++..  
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            4455667789999999999999999999975 68889999986543 3346788899999999 89999999999976  


Q ss_pred             ----CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          254 ----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       254 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                          ....++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence                467899999999999999997652  24688999999999999999999999   999999999999999999999


Q ss_pred             EEecCCccccCCCcceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+|||++....... .......||+.|+|||++.     +..++.++|||||||++|||++|+.||...
T Consensus       170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            99999998654322 1233457899999999986     567899999999999999999999999653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.4e-38  Score=310.97  Aligned_cols=212  Identities=22%  Similarity=0.275  Sum_probs=176.8

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC--------CCceee
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR--------HKNLVR  246 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~  246 (424)
                      +.++..++..++|++.+.||+|+||+||+|++. +++.||+|++... ....+.+.+|+++++.++        |+||++
T Consensus        27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            334444556789999999999999999999975 5778999998643 344567888999999885        788999


Q ss_pred             EeeEee----eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          247 LLGYCA----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       247 l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      +++++.    ++...++||||+ +++|.+++....  ...+++..++.++.|++.||+|||+++  +|+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll  180 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL  180 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence            999987    556789999999 557766665442  356899999999999999999999853  79999999999999


Q ss_pred             cCCC-------------------------------------------------ceEEEecCCccccCCCcceeeeccccc
Q 014466          323 DKQW-------------------------------------------------NPKLSDFGLAKLLGAERSYVTTRVMGT  353 (424)
Q Consensus       323 ~~~~-------------------------------------------------~~kL~DfG~a~~~~~~~~~~~~~~~gt  353 (424)
                      +.++                                                 .+||+|||++......    .....||
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt  256 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT  256 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSC
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCC
Confidence            9775                                                 7999999999875432    3345789


Q ss_pred             ccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q 014466          354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG  397 (424)
Q Consensus       354 ~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~~  397 (424)
                      +.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  300 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE  300 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence            99999999999999999999999999999999999998765433

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-38  Score=304.38  Aligned_cols=207  Identities=22%  Similarity=0.361  Sum_probs=175.4

Q ss_pred             eeeecCCCcccc-eeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeC
Q 014466          180 ELEVSTNGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG  254 (424)
Q Consensus       180 ~~~~~~~~~~~~-~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  254 (424)
                      ..+...+.|.+. +.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.+ .||||+++++++.+.
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            334455667777 89999999999999976 58899999986542  33457788999999999 569999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEE
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLS  331 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~  331 (424)
                      ...++||||+++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.   ++.+||+
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence            99999999999999999986542  35789999999999999999999999   9999999999999988   7899999


Q ss_pred             ecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999998764322  234467999999999999999999999999999999999999999643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=315.16  Aligned_cols=199  Identities=17%  Similarity=0.225  Sum_probs=171.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcC---------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceee---------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLED---------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR---------  246 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~---------  246 (424)
                      .++|++.+.||+|+||.||+|++..         ++.||+|.+...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999999764         788999998654     35778999999999999987         


Q ss_pred             ------EeeEeee-CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          247 ------LLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       247 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                            +++++.. +...++||||+ +++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  6677766 67889999999 899999998652  25789999999999999999999999   99999999999


Q ss_pred             EEEcCCC--ceEEEecCCccccCCCcce------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          320 ILLDKQW--NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       320 ILl~~~~--~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ||++.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876433221      1234579999999999999999999999999999999999999998


Q ss_pred             CCC
Q 014466          392 YSR  394 (424)
Q Consensus       392 ~~~  394 (424)
                      ...
T Consensus       270 ~~~  272 (352)
T 2jii_A          270 NCL  272 (352)
T ss_dssp             GGT
T ss_pred             cCC
Confidence            654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.5e-38  Score=296.96  Aligned_cols=203  Identities=22%  Similarity=0.309  Sum_probs=169.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEe-eeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||.||+|++ .+++.||+|.+.....  .+.+.+|+++++.++|++++..+.++ .++...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            46899999999999999999997 4688899998654322  23477899999999988877666655 66778899999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceEEEecCCcccc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DfG~a~~~  339 (424)
                      |+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99 88999999754   24689999999999999999999999   99999999999999   78899999999999876


Q ss_pred             CCCcc------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q 014466          340 GAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP  396 (424)
Q Consensus       340 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~~  396 (424)
                      .....      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  221 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence            54322      1223567999999999999999999999999999999999999999875543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-38  Score=311.03  Aligned_cols=206  Identities=26%  Similarity=0.328  Sum_probs=169.3

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc-----------hhHHHHHHHHHHHhcCCCCceeeE
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-----------QAEKEFKVEVEAIGRVRHKNLVRL  247 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~Ei~~l~~l~hpnIv~l  247 (424)
                      .++....++|++.+.||+|+||.||+|.+.+++.||||++.....           ...+.+.+|++++++++||||+++
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            445667789999999999999999999988899999999854321           223678999999999999999999


Q ss_pred             eeEeee-----CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE
Q 014466          248 LGYCAE-----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL  322 (424)
Q Consensus       248 ~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl  322 (424)
                      ++++..     ....++||||++ |+|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL  167 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence            999853     336789999998 5888888754   35789999999999999999999999   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          323 DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       323 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +.++.+||+|||+++.....  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            99999999999999854322  22344678999999998876 77999999999999999999999999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-38  Score=313.39  Aligned_cols=199  Identities=26%  Similarity=0.373  Sum_probs=165.2

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------eee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRM  258 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~~~  258 (424)
                      ..+|++.+.||+|+||+||+|++..+..+|+|++......    ..+|+++++.++||||+++++++....      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3479999999999999999999987778999998754322    235999999999999999999986443      378


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc-CCCceEEEecCCcc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAK  337 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DfG~a~  337 (424)
                      +||||++++ +...+.........+++..++.++.|++.||+|||++   +|+||||||+|||++ .++.+||+|||+++
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            999999874 4443332211235789999999999999999999999   999999999999999 79999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ......  ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||...
T Consensus       191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            764332  23346789999999988664 5999999999999999999999999654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.7e-38  Score=310.42  Aligned_cols=196  Identities=27%  Similarity=0.404  Sum_probs=154.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------C
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~  255 (424)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            368999999999999999999965 5788999998653  334456788999999999999999999998654      5


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++|+||+ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            678999999 6799988864     3689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9865322    344679999999999876 77999999999999999999999999654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=308.87  Aligned_cols=202  Identities=27%  Similarity=0.397  Sum_probs=168.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch-----hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++......     ..+.+.+|+++++.++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3468999999999999999999975 5889999998643221     124677899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++ +|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999986 899988765   24678888999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus       161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            764332 23345678999999999865 45899999999999999999999999654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.8e-38  Score=304.16  Aligned_cols=209  Identities=29%  Similarity=0.447  Sum_probs=174.2

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEE------cCCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ++..++|++.+.||+|+||.||+|++      .++..||+|.+... .......+.+|+.++++++||||+++++++.++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            45667899999999999999999983      24678999998654 344556788999999999999999999999999


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCce
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNP  328 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~  328 (424)
                      ...++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence            999999999999999999987532   124588999999999999999999999   9999999999999984   4469


Q ss_pred             EEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  249 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  249 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence            9999999975533221 22234567899999999999999999999999999999998 99999743

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.4e-38  Score=307.26  Aligned_cols=201  Identities=25%  Similarity=0.401  Sum_probs=173.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----Cee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~  257 (424)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            358999999999999999999976 57789999986543 33446788999999999999999999999755     367


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++||||+++ +|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            899999975 999999753     589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccee--eeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          338 LLGAERSYV--TTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .........  .....||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence            764332221  24467999999999865 4558999999999999999999999997654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.9e-38  Score=301.55  Aligned_cols=193  Identities=23%  Similarity=0.370  Sum_probs=169.9

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeee--CCeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~~~~~lv  260 (424)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...   ..+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            468999999999999999999964 6888999998643   2467889999999997 9999999999987  5678999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCcccc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLL  339 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~~~  339 (424)
                      |||+++++|.+++.       .+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+++..
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999884       368889999999999999999999   999999999999999776 8999999999876


Q ss_pred             CCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       182 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          182 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            4332  2344578999999999876 7799999999999999999999999954

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.7e-38  Score=297.98  Aligned_cols=201  Identities=31%  Similarity=0.473  Sum_probs=167.7

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-CeeeE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-AHRML  259 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~l  259 (424)
                      +.+..++|++.+.||+|+||.||+|.+. ++.||+|.+....  ..+.+.+|++++++++||||+++++++.+. ...++
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            3566778999999999999999999885 7889999986543  456788999999999999999999997554 47899


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            999999999999997641  12378899999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ...    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          168 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             ccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            332    223457889999999999999999999999999999998 99999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-37  Score=295.99  Aligned_cols=201  Identities=25%  Similarity=0.385  Sum_probs=176.0

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---------chhHHHHHHHHHHHhcCC-CCceeeEeeEee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---------GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA  252 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~  252 (424)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+....         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3568999999999999999999986 57889999986543         122456788999999995 999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                      ++...++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999999765    5789999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCcceeeeccccccccccccccc------CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ||++.......  ......||+.|+|||++.      ...++.++||||||+++|||++|+.||...
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  232 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  232 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence            99998764332  234467899999999884      567899999999999999999999999643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=306.54  Aligned_cols=202  Identities=29%  Similarity=0.475  Sum_probs=162.5

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHH--HHHHhcCCCCceeeEeeEee-----eC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVE--VEAIGRVRHKNLVRLLGYCA-----EG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E--i~~l~~l~hpnIv~l~~~~~-----~~  254 (424)
                      .+..++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|  +..+..++||||+++++++.     ..
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            35567899999999999999999987 47899999986433   2333334  44455689999999998553     23


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeeeCCCCCCCEEEcCCCce
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------EPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------~~~ivHrDlkp~NILl~~~~~~  328 (424)
                      ...++||||+++|+|.+++...     ..++..+..++.|+++||+|||+..      .++|+||||||+|||++.++.+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             ceEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            3678999999999999999765     4488889999999999999999762      2389999999999999999999


Q ss_pred             EEEecCCccccCCCc-------ceeeecccccccccccccccC-------CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          329 KLSDFGLAKLLGAER-------SYVTTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       329 kL~DfG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ||+|||+++.+....       ........||+.|+|||++.+       ..++.++|||||||++|||++|..||..
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999998764322       122234579999999999876       4567789999999999999999777643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-38  Score=307.92  Aligned_cols=204  Identities=23%  Similarity=0.387  Sum_probs=178.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCch-----------------hHHHHHHHHHHHhcCCCCce
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-----------------AEKEFKVEVEAIGRVRHKNL  244 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~hpnI  244 (424)
                      ....++|++.+.||+|+||.||+|.+ +++.||+|.+......                 ..+.+.+|++++++++||||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            44567999999999999999999999 7999999998643211                 11778999999999999999


Q ss_pred             eeEeeEeeeCCeeeEEEEecCCCCHHHH------HccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCC
Q 014466          245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW------LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKS  317 (424)
Q Consensus       245 v~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp  317 (424)
                      +++++++.+++..++||||+++|+|.++      +...  ....+++..++.++.|++.||+|||+ .   +|+||||||
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p  180 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKP  180 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCG
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCCh
Confidence            9999999999999999999999999998      5442  13679999999999999999999998 8   999999999


Q ss_pred             CCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccCC-CCCC-ccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          318 SNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNE-RSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       318 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +|||++.++.+||+|||++......   ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999875433   34456799999999999877 6766 9999999999999999999997543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=295.81  Aligned_cols=202  Identities=26%  Similarity=0.368  Sum_probs=170.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCCCceeeEeeEee--eCCeee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRM  258 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~  258 (424)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+....    ....+.+.+|+++++.++||||+++++++.  +....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            58999999999999999999975 57889999986542    234567899999999999999999999984  455789


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||++++ |.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus        85 lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            999999886 777776542  35789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCC-cceeeecccccccccccccccCCC--CCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAE-RSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .... .........||+.|+|||++.+..  ++.++||||||+++|||++|+.||+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD  216 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            6432 222334567999999999987644  477999999999999999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.4e-38  Score=299.75  Aligned_cols=202  Identities=26%  Similarity=0.432  Sum_probs=167.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEee----------
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----------  252 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----------  252 (424)
                      ..++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            35689999999999999999999874 8889999998776677788999999999999999999999873          


Q ss_pred             ----eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc-CCCc
Q 014466          253 ----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWN  327 (424)
Q Consensus       253 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~-~~~~  327 (424)
                          +....++||||++ |+|.+++..     ..+++..++.++.|++.||+|||++   +|+||||||+|||++ .++.
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence                4467899999998 599999964     4688999999999999999999999   999999999999997 5679


Q ss_pred             eEEEecCCccccCCCcc--eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          328 PKLSDFGLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       328 ~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +||+|||+++.......  .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999987643211  12234567999999998765 779999999999999999999999997543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-37  Score=298.84  Aligned_cols=209  Identities=22%  Similarity=0.375  Sum_probs=174.4

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCC--CCceeeEeeEe
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR--HKNLVRLLGYC  251 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~  251 (424)
                      +.+..+.+..++|++.+.||+|+||.||+|.+.+++.||+|++...  .....+.+.+|++++++++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            4466778888899999999999999999999888999999998654  3345577899999999997  59999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS  331 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~  331 (424)
                      .++...++||| +.+++|.+++...    ..+++..++.++.|++.||.|||++   +|+||||||+|||+++ +.+||+
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence            99999999999 5678999999865    4788999999999999999999999   9999999999999975 899999


Q ss_pred             ecCCccccCCCcce-eeecccccccccccccccC-----------CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          332 DFGLAKLLGAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       332 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |||++......... ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||...
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            99999876433221 2234578999999999865           47888999999999999999999999753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.5e-38  Score=302.94  Aligned_cols=199  Identities=25%  Similarity=0.429  Sum_probs=168.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ++|++.+.||+|+||.||+|.+. +++.||||.+.....        .....+.+|+++++.++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            47899999999999999999976 478899999865321        12345788999999999999999999997655 


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc---eEEEec
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDF  333 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kL~Df  333 (424)
                      .++||||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.   +||+||
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            89999999999999999764    5789999999999999999999999   9999999999999987665   999999


Q ss_pred             CCccccCCCcceeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |+++......  ......||+.|+|||++.   ...++.++|||||||++|||++|+.||....
T Consensus       162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            9998764322  223456899999999873   5678999999999999999999999997654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.2e-38  Score=296.93  Aligned_cols=195  Identities=28%  Similarity=0.508  Sum_probs=171.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee-----------
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-----------  253 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----------  253 (424)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....    +.+.+|+++++.++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            47889999999999999999986 68899999987554    346679999999999999999998864           


Q ss_pred             -----CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCce
Q 014466          254 -----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP  328 (424)
Q Consensus       254 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~  328 (424)
                           ....++||||+++++|.+++....  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence                 445789999999999999997642  24689999999999999999999999   99999999999999999999


Q ss_pred             EEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ||+|||++.......  ......||+.|+|||++.+..++.++||||||+++|||++|..||.
T Consensus       162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            999999998764432  2334568999999999999999999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-38  Score=302.33  Aligned_cols=209  Identities=24%  Similarity=0.393  Sum_probs=159.7

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            566789999999999999999999854 68889999885443 3345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          260 VYEYIDNGNLEQWLHGD----VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ||||+++++|.+++...    ......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999998641    11235689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcc----eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERS----YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +........    .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  230 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY  230 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence            876543221    12234578999999998865 56899999999999999999999999753

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.3e-38  Score=328.97  Aligned_cols=227  Identities=26%  Similarity=0.426  Sum_probs=185.1

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      ..++..++|++.+.||+|+||.||+|.+..    +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            345667889999999999999999999753    3468999886543 3445679999999999999999999999854 


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      +..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence            5689999999999999999865   24689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCc
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEV  399 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~  399 (424)
                      +++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||....              +.+..
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  616 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN  616 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            998765544444445567889999999999999999999999999999997 999997432              23333


Q ss_pred             cHHHHHHHHHhhhc
Q 014466          400 CIPQMNSLMTLSYC  413 (424)
Q Consensus       400 ~~~~~~~~~~~~~~  413 (424)
                      +..++..++..||.
T Consensus       617 ~~~~l~~li~~~l~  630 (656)
T 2j0j_A          617 CPPTLYSLMTKCWA  630 (656)
T ss_dssp             CCHHHHHHHHHHTC
T ss_pred             ccHHHHHHHHHHcC
Confidence            44566667766665

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.3e-38  Score=297.44  Aligned_cols=204  Identities=26%  Similarity=0.425  Sum_probs=166.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc--CCC--EEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE--DNT--NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG  254 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  254 (424)
                      .+..++|++.+.||+|+||.||+|++.  +++  .||+|.+...   .....+.+.+|++++++++||||+++++++.++
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            345668999999999999999999864  233  5899988654   334567889999999999999999999999876


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      . .++||||+++++|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence            5 78999999999999999764   24688999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcce--eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          335 LAKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      ++.........  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  227 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG  227 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            99876543322  2233567889999999998889999999999999999999 9999964

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.4e-38  Score=302.39  Aligned_cols=228  Identities=26%  Similarity=0.387  Sum_probs=184.2

Q ss_pred             eeeeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch------hHHHHHHHHHHHhcCC--CCceee
Q 014466          176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVR--HKNLVR  246 (424)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--hpnIv~  246 (424)
                      .+....+...++|++.+.||+|+||.||+|++. +++.||+|.+......      ..+.+.+|++++++++  ||||++
T Consensus        33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence            344556677889999999999999999999965 5788999998654321      2245667999999996  599999


Q ss_pred             EeeEeeeCCeeeEEEEecCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc-C
Q 014466          247 LLGYCAEGAHRMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-K  324 (424)
Q Consensus       247 l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~-~  324 (424)
                      +++++.+++..++|||++.+ ++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++ +
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  185 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence            99999999999999999986 8999999765    5789999999999999999999999   999999999999999 7


Q ss_pred             CCceEEEecCCccccCCCcceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCCC-------CC
Q 014466          325 QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSR-------PP  396 (424)
Q Consensus       325 ~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~~-------~~  396 (424)
                      ++.+||+|||+++.....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||+...       ..
T Consensus       186 ~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  262 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF  262 (320)
T ss_dssp             TTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCC
T ss_pred             CCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccc
Confidence            899999999999876432   2334579999999999877665 678999999999999999999997421       12


Q ss_pred             CCccHHHHHHHHHhhhc
Q 014466          397 GEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       397 ~~~~~~~~~~~~~~~~~  413 (424)
                      ......++..++..||.
T Consensus       263 ~~~~~~~~~~li~~~l~  279 (320)
T 3a99_A          263 RQRVSSECQHLIRWCLA  279 (320)
T ss_dssp             SSCCCHHHHHHHHHHTC
T ss_pred             cccCCHHHHHHHHHHcc
Confidence            22334566666666664

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-37  Score=303.41  Aligned_cols=195  Identities=26%  Similarity=0.415  Sum_probs=168.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee----
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~----  257 (424)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++...  .....+.+.+|+++++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999976 5888999998654  233456788999999999999999999999877654    


Q ss_pred             --eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          258 --MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       258 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                        ++||||+. ++|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 58988874      3488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9865322    344678999999999877 78999999999999999999999999754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.7e-37  Score=311.33  Aligned_cols=203  Identities=22%  Similarity=0.288  Sum_probs=173.4

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC-CceeeEeeEeeeCCeeeEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..++|++.+.||+|+||.||+|++. +++.||||++......  ..+..|+++++.++| ++|..+..++.+....+|||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            3568999999999999999999974 6889999987544322  347789999999987 56666667777888899999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE---cCCCceEEEecCCccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKL  338 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DfG~a~~  338 (424)
                      ||+ +++|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+||||   +.++.+||+|||+++.
T Consensus        83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999 88999999754   25789999999999999999999999   99999999999999   6889999999999987


Q ss_pred             cCCCcce------eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          339 LGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       339 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      +......      ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            6543221      12356799999999999999999999999999999999999999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.2e-37  Score=297.94  Aligned_cols=202  Identities=22%  Similarity=0.343  Sum_probs=175.2

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEE-c-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc------eeeEeeEeee
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVL-E-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLLGYCAE  253 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~~~~  253 (424)
                      ++..++|++.+.||+|+||.||+|.+ . +++.||+|++... ....+.+.+|+++++.++|+|      |+++++++.+
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            45667999999999999999999997 3 5778999988643 344567888999999887654      9999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---------
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---------  324 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---------  324 (424)
                      ++..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.         
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            99999999999 789999997653  24688999999999999999999999   9999999999999987         


Q ss_pred             ----------CCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          325 ----------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       325 ----------~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                                ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                      668999999999864322    234578999999999999999999999999999999999999997543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-37  Score=300.53  Aligned_cols=199  Identities=28%  Similarity=0.428  Sum_probs=170.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhc--CCCCceeeEeeEeeeCC----ee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAEGA----HR  257 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~----~~  257 (424)
                      ..++|++.+.||+|+||.||+|++. ++.||+|.+...   ....+.+|.+++..  ++||||+++++++....    ..
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            3458999999999999999999985 889999998543   34567778888887  79999999999998776    78


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                      ++||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.   +|+||||||+|||++.++++|
T Consensus       116 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence            9999999999999999754     5889999999999999999999        77   999999999999999999999


Q ss_pred             EEecCCccccCCCcce---eeecccccccccccccccCCC------CCCccchHHHHHHHHHHHcC----------CCCC
Q 014466          330 LSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISG----------RNPV  390 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlGv~l~elltg----------~~Pf  390 (424)
                      |+|||++.........   ......||+.|+|||++.+..      ++.++||||||+++|||+||          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            9999999876543322   234457999999999987652      34689999999999999999          7888


Q ss_pred             CCCC
Q 014466          391 DYSR  394 (424)
Q Consensus       391 ~~~~  394 (424)
                      ....
T Consensus       268 ~~~~  271 (342)
T 1b6c_B          268 YDLV  271 (342)
T ss_dssp             TTTS
T ss_pred             cccC
Confidence            7543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.1e-37  Score=300.57  Aligned_cols=201  Identities=23%  Similarity=0.358  Sum_probs=171.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----Ce
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH  256 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  256 (424)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++..+     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3468999999999999999999976 57889999986543 34456788999999999999999999988754     67


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+. ++|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            899999997 5999998753     689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcce---------eeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSY---------VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +........         ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            876432211         1223578999999998754 77999999999999999999999999754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-37  Score=298.52  Aligned_cols=202  Identities=29%  Similarity=0.423  Sum_probs=170.8

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc--CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCceeeEeeEee----
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCA----  252 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~----  252 (424)
                      ..++|++.+.||+|+||.||+|++.  +++.||+|++.....  .....+.+|+++++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4568999999999999999999983  577899998864322  1123455677776665   8999999999987    


Q ss_pred             -eCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE
Q 014466          253 -EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS  331 (424)
Q Consensus       253 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~  331 (424)
                       .....++||||++ |+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567889999998 59999998753  24589999999999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            999998654322  234467899999999999999999999999999999999999999754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=311.81  Aligned_cols=202  Identities=22%  Similarity=0.361  Sum_probs=155.2

Q ss_pred             Cccc-ceeEcccCcEEEEEEEEc---CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee--CCeeeEE
Q 014466          187 GFAD-ENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV  260 (424)
Q Consensus       187 ~~~~-~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv  260 (424)
                      .|++ .++||+|+||.||+|++.   +++.||+|++.....  ...+.+|+++++.++||||+++++++..  +...++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4555 568999999999999976   477899999865432  2467789999999999999999999954  6788999


Q ss_pred             EEecCCCCHHHHHccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE----cCCCceEEE
Q 014466          261 YEYIDNGNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLS  331 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kL~  331 (424)
                      |||+++ +|.+++....     .....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 8888775321     1123589999999999999999999999   99999999999999    678899999


Q ss_pred             ecCCccccCCCcc--eeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          332 DFGLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       332 DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      |||+++.......  ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999987643221  22345679999999999877 459999999999999999999999997554

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-37  Score=303.18  Aligned_cols=204  Identities=23%  Similarity=0.314  Sum_probs=158.3

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe-----
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  256 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-----  256 (424)
                      ...++|++.+.||+|+||.||+|++. +++.||||++...... ...+.+|++.++.++||||+++++++.....     
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            34568999999999999999999975 5888999998654322 2345668888899999999999999965433     


Q ss_pred             --eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeeeCCCCCCCEEEcC-CCceEEE
Q 014466          257 --RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--EGLEPKVVHRDIKSSNILLDK-QWNPKLS  331 (424)
Q Consensus       257 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--~~~~~~ivHrDlkp~NILl~~-~~~~kL~  331 (424)
                        .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEe
Confidence              7899999987 555554432223467889999999999999999999  77   9999999999999997 8999999


Q ss_pred             ecCCccccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       332 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       175 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          175 DFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             CCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            999998764332  23446789999999988654 4899999999999999999999999764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.7e-37  Score=303.09  Aligned_cols=207  Identities=23%  Similarity=0.308  Sum_probs=175.2

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CC-----ceeeEeeE
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HK-----NLVRLLGY  250 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~l~~~  250 (424)
                      +...+...++|++.+.||+|+||+||+|++. +++.||||++... ......+..|+++++.++ |+     +|++++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            3444566789999999999999999999976 5778999998643 334566778888888875 44     49999999


Q ss_pred             eeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc--CCCce
Q 014466          251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNP  328 (424)
Q Consensus       251 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~--~~~~~  328 (424)
                      +......++||||+++ +|.+++....  ...+++..+..++.|++.||.|||.+ +.+|+||||||+|||++  .++.+
T Consensus       125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLSY-NLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEETTEEEEEEECCCC-BHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eccCCceEEEEecCCC-CHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            9999999999999965 9999997653  24689999999999999999999942 22899999999999994  47889


Q ss_pred             EEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ||+|||+++..+..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876432    33467899999999999999999999999999999999999999754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.9e-37  Score=305.38  Aligned_cols=200  Identities=21%  Similarity=0.287  Sum_probs=173.4

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC------CCCceeeEeeEeeeCC
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNLVRLLGYCAEGA  255 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~l~~~~~~~~  255 (424)
                      ....+|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+++++.+      +|+||+++++++....
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            44568999999999999999999976 4788999998653 33345677788888776      5779999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc--eEEEec
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDF  333 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kL~Df  333 (424)
                      ..++||||+. ++|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.  +||+||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            9999999996 59999997763  24589999999999999999999999   9999999999999999887  999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |++.....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       247 G~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          247 GSSCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TTCEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99976432    233467899999999999999999999999999999999999999654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.7e-38  Score=301.34  Aligned_cols=207  Identities=27%  Similarity=0.410  Sum_probs=172.6

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      +.++++..++|++.+.||+|+||.||+|.+.+  .+|+|.+....  ....+.+.+|++++++++||||+++++++.+..
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            45567888899999999999999999999853  49999886432  233356778999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999999765   24688899999999999999999999   999999999999998 67999999999


Q ss_pred             ccccCCCc----ceeeecccccccccccccccC---------CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAER----SYVTTRVMGTFGYVAPEYAST---------GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +.......    ........||+.|+|||++..         ..++.++||||||+++|||++|+.||...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            87543211    122233568999999998864         45788999999999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.1e-37  Score=291.81  Aligned_cols=193  Identities=29%  Similarity=0.457  Sum_probs=161.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee-----------
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-----------  253 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----------  253 (424)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+++++.++||||+++++++.+           
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            47889999999999999999975 6889999998543 3445678899999999999999999998865           


Q ss_pred             --CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEE
Q 014466          254 --GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS  331 (424)
Q Consensus       254 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~  331 (424)
                        ....++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence              45678999999999999999864   24678888999999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCc-------------ceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHc
Q 014466          332 DFGLAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVIS  385 (424)
Q Consensus       332 DfG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~ellt  385 (424)
                      |||++.......             ........||+.|+|||++.+. .++.++||||||+++|||++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            999998654221             1223345789999999998764 78999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-36  Score=293.09  Aligned_cols=209  Identities=30%  Similarity=0.425  Sum_probs=156.2

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHH-HHhcCCCCceeeEeeEeeeCC
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ..+++..++|++.+.||+|+||.||+|... +++.||+|++..... .....+..|+. +++.++||||+++++++.+++
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            345677789999999999999999999985 688899999976532 33445555665 778889999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ..++||||+++ +|.+++.... .....+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence            99999999986 8888775311 11357899999999999999999999842  79999999999999999999999999


Q ss_pred             CccccCCCcceeeecccccccccccccc----cCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +++......  ......||+.|+|||++    .+..++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          172 ISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             SSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             Cceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            998654322  22334689999999998    566789999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.8e-37  Score=297.28  Aligned_cols=199  Identities=21%  Similarity=0.298  Sum_probs=147.3

Q ss_pred             cCCCcccc-eeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee----CCee
Q 014466          184 STNGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHR  257 (424)
Q Consensus       184 ~~~~~~~~-~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~  257 (424)
                      ..++|.+. ++||+|+||.||+|.+. +++.||+|++.... .   ...+....++.++||||+++++++..    +...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            34578885 46999999999999987 68899999986532 1   22223344667799999999999976    4457


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecC
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFG  334 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG  334 (424)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            89999999999999998653  24789999999999999999999999   9999999999999976   4559999999


Q ss_pred             CccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      +++.....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (336)
T 3fhr_A          177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT  233 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            99865322   2334578999999999999999999999999999999999999996543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7e-37  Score=289.70  Aligned_cols=199  Identities=26%  Similarity=0.404  Sum_probs=173.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            357899999999999999999986 68889999986542  334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC---CceEEEecCCccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKL  338 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DfG~a~~  338 (424)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||++   +++||||||+|||++.+   +.+||+|||++..
T Consensus       101 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999988765    4689999999999999999999999   99999999999999754   4699999999986


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....  ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||...
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (287)
T 2wei_A          174 FQQNT--KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGK  225 (287)
T ss_dssp             BCCCS--SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCC--ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence            54322  22334689999999988764 899999999999999999999999753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=295.84  Aligned_cols=222  Identities=28%  Similarity=0.398  Sum_probs=173.7

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch------hHHHHHHHHHHHhcC----CCCceeeEeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRV----RHKNLVRLLGY  250 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~hpnIv~l~~~  250 (424)
                      +...++|++.+.||+|+||.||+|++. +++.||+|++......      ....+.+|+++++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            445678999999999999999999864 6788999998654321      223455689999888    89999999999


Q ss_pred             eeeCCeeeEEEEe-cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc-CCCce
Q 014466          251 CAEGAHRMLVYEY-IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNP  328 (424)
Q Consensus       251 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~-~~~~~  328 (424)
                      +.+.+..++|||| +.+++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++ .++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            9999999999999 7899999999865    4689999999999999999999999   999999999999999 88999


Q ss_pred             EEEecCCccccCCCcceeeecccccccccccccccCCCCC-CccchHHHHHHHHHHHcCCCCCCCCC-------CCCCcc
Q 014466          329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSR-------PPGEVC  400 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGv~l~elltg~~Pf~~~~-------~~~~~~  400 (424)
                      ||+|||++.......   .....||+.|+|||++.+..+. .++||||||+++|||++|+.||+...       ......
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  256 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV  256 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTS
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccC
Confidence            999999998764332   3345689999999998776664 58999999999999999999997421       112223


Q ss_pred             HHHHHHHHHhhhc
Q 014466          401 IPQMNSLMTLSYC  413 (424)
Q Consensus       401 ~~~~~~~~~~~~~  413 (424)
                      ..++..++..|+.
T Consensus       257 ~~~~~~li~~~l~  269 (312)
T 2iwi_A          257 SPDCCALIRRCLA  269 (312)
T ss_dssp             CHHHHHHHHHHTC
T ss_pred             CHHHHHHHHHHcc
Confidence            3455556665554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=298.49  Aligned_cols=196  Identities=26%  Similarity=0.404  Sum_probs=167.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe-----
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  256 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-----  256 (424)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            358999999999999999999975 58889999986542  3345678899999999999999999999987654     


Q ss_pred             -eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          257 -RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       257 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                       .++||||++ ++|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             489999997 48887763      3488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865322    334578999999998876 778999999999999999999999997543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=290.40  Aligned_cols=204  Identities=25%  Similarity=0.381  Sum_probs=156.6

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch-h-HHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-A-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      .+....++|++.+.||+|+||.||+|.+. +++.||+|++...... . .+.+.++..+++.++||||+++++++.+++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            44666789999999999999999999986 6889999999765332 2 2345555667888899999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      .++||||+ ++.+..+....   ...+++..++.++.|++.||.|||+ .   +|+||||||+|||++.++.+||+|||+
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCC
Confidence            99999999 45666655443   2578999999999999999999998 5   899999999999999999999999999


Q ss_pred             ccccCCCcceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +.......  ......||+.|+|||++.     ...++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          172 SGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             C----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             chhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            97654322  233456899999999984     56789999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-36  Score=292.63  Aligned_cols=204  Identities=22%  Similarity=0.340  Sum_probs=174.1

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc-CC-CEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc------eeeEeeE
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLLGY  250 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~  250 (424)
                      +..+...++|++.+.||+|+||.||+|.+. ++ ..||+|++... ....+.+.+|+++++.++|++      ++.++++
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            333455679999999999999999999975 34 57999988543 344567888999999997766      9999999


Q ss_pred             eeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEE--------
Q 014466          251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL--------  322 (424)
Q Consensus       251 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl--------  322 (424)
                      +......++||||+ +++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||+        
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence            99999999999999 567777776542  24689999999999999999999998   99999999999999        


Q ss_pred             -----------cCCCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          323 -----------DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       323 -----------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                                 +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                       66789999999999864322    234679999999999999999999999999999999999999997


Q ss_pred             CC
Q 014466          392 YS  393 (424)
Q Consensus       392 ~~  393 (424)
                      ..
T Consensus       241 ~~  242 (355)
T 2eu9_A          241 TH  242 (355)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.4e-37  Score=306.39  Aligned_cols=201  Identities=25%  Similarity=0.342  Sum_probs=158.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      +.|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++.+ +||||+++++++.++...++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            355667899999999998777778999999998653   234577899999876 8999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC-------------Cce
Q 014466          265 DNGNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-------------WNP  328 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~-------------~~~  328 (424)
                      . |+|.+++.........   ..+..++.++.|++.||+|||++   +|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 5999999865322111   12334577999999999999999   99999999999999754             479


Q ss_pred             EEEecCCccccCCCcce---eeecccccccccccccccC-------CCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 014466          329 KLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDYS  393 (424)
Q Consensus       329 kL~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~  393 (424)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||...
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            99999999876543322   1234679999999999865       678999999999999999999 99999753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.1e-36  Score=296.74  Aligned_cols=202  Identities=23%  Similarity=0.309  Sum_probs=170.2

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----------CCceeeEeeE
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRLLGY  250 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~  250 (424)
                      +..++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+.+|++++++++           ||||++++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            45678999999999999999999974 6788999998643 334567888999998886           8999999999


Q ss_pred             eeeCC----eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc---
Q 014466          251 CAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---  323 (424)
Q Consensus       251 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~---  323 (424)
                      +....    ..++||||+ +++|.+++....  ...+++..++.++.|++.||+|||+++  +|+||||||+|||++   
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            98654    788999999 889999998753  245899999999999999999999843  899999999999994   


Q ss_pred             ---CCCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          324 ---KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       324 ---~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                         ..+.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence               4447999999999875432    234578999999999999999999999999999999999999998654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-36  Score=322.29  Aligned_cols=196  Identities=22%  Similarity=0.376  Sum_probs=168.7

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc--CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe--
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--  256 (424)
                      ++..++|++.+.||+|+||.||+|++.  +++.||||++.... ......+.+|++++++++||||+++++++...+.  
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            445679999999999999999999986  57889999986543 3445678899999999999999999999987665  


Q ss_pred             ---eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          257 ---RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       257 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                         .|+||||+++++|.+++..      .+++..++.++.|++.||.|||++   +|+||||||+|||++.+ .+||+||
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence               6999999999999887643      688999999999999999999999   99999999999999986 8999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++.....     ....||+.|+|||++.+.. +.++|||||||++|||++|..||...
T Consensus       226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~  279 (681)
T 2pzi_A          226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR  279 (681)
T ss_dssp             TTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred             ccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence            999876432     3457999999999987654 88999999999999999999998753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=304.29  Aligned_cols=202  Identities=28%  Similarity=0.389  Sum_probs=162.0

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  259 (424)
                      +.+...+|.+.+.||+|+||+||.....+++.||||++......   .+.+|+++++.+ +|||||++++++.++...++
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            35566689999999999999977655667899999998654322   345699999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-----CCceEEEecC
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-----QWNPKLSDFG  334 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kL~DfG  334 (424)
                      ||||+. |+|.+++....   ....+..++.++.|++.||+|||++   +|+||||||+|||++.     ...+||+|||
T Consensus        96 v~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            999997 59999998663   2344445678999999999999999   9999999999999943     2358899999


Q ss_pred             CccccCCCcc--eeeeccccccccccccccc---CCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 014466          335 LAKLLGAERS--YVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVIS-GRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~  392 (424)
                      +++.......  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||..
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            9987643321  2234567999999999987   4667889999999999999999 9999964

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.1e-38  Score=304.47  Aligned_cols=192  Identities=18%  Similarity=0.177  Sum_probs=160.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCC--------chhHHHHHHHHHHHhcCC---------CCceee
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRVR---------HKNLVR  246 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------hpnIv~  246 (424)
                      ..++|++.+.||+|+||+||+|++ +++.||||++....        ....+.+.+|+++++.++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            346799999999999999999998 57899999996542        223467888999988886         666666


Q ss_pred             EeeEe-----------------ee-------------CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 014466          247 LLGYC-----------------AE-------------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA  296 (424)
Q Consensus       247 l~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~  296 (424)
                      +.+++                 .+             +...++||||+++|++.+.+.+     ..+++..++.++.|++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence            66553                 32             6789999999999977666643     3678999999999999


Q ss_pred             HHHHHHH-cCCCCCeeeCCCCCCCEEEcCCC--------------------ceEEEecCCccccCCCcceeeeccccccc
Q 014466          297 KGLTYLH-EGLEPKVVHRDIKSSNILLDKQW--------------------NPKLSDFGLAKLLGAERSYVTTRVMGTFG  355 (424)
Q Consensus       297 ~al~~LH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~  355 (424)
                      .||+||| +.   +|+||||||+|||++.++                    .+||+|||+++.....      ..+||+.
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            9999999 88   999999999999999887                    8999999999865432      3479999


Q ss_pred             ccccccccCCCCCCccchHHHHHH-HHHHHcCCCCCC
Q 014466          356 YVAPEYASTGMLNERSDVYSFGIL-IMEVISGRNPVD  391 (424)
Q Consensus       356 y~aPE~~~~~~~~~~sDiwSlGv~-l~elltg~~Pf~  391 (424)
                      |+|||++.+.. +.++|||||+++ .+++++|..||.
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            99999998776 889999998776 788889999995

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.3e-36  Score=312.76  Aligned_cols=202  Identities=26%  Similarity=0.431  Sum_probs=173.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeee------CCe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH  256 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~  256 (424)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|++++++++||||+++++++..      +..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999974 5888999998654 34455678999999999999999999999765      667


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc---eEEEec
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDF  333 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kL~Df  333 (424)
                      .++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            8999999999999999987532 24688889999999999999999999   9999999999999997765   999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      |++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            9998764332  23456799999999999999999999999999999999999999953

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.4e-35  Score=277.70  Aligned_cols=176  Identities=13%  Similarity=0.097  Sum_probs=153.5

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcC-CCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  258 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  258 (424)
                      +..++|++.+.||+|+||.||+|++.. ++.||+|.+....   ....+.+.+|++.+++++||||+++++++.+++..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            455689999999999999999999864 8889999996553   234467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      +||||+++++|.++++..      .....+..++.|++.||+|||++   +|+||||||+|||++.++.+||+++|    
T Consensus       108 lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred             EEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence            999999999999999542      24556788999999999999999   99999999999999999999997443    


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                                       |++       .++.++|||||||++|||+||+.||.....
T Consensus       175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                             333       368899999999999999999999987554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-35  Score=293.66  Aligned_cols=222  Identities=18%  Similarity=0.225  Sum_probs=165.2

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCC-Ccee------------
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH-KNLV------------  245 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h-pnIv------------  245 (424)
                      .....|...+.||+|+||+||+|++. +|+.||||++.....   ...+.+.+|+.+++.++| +|..            
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34446788899999999999999965 688999998864322   235678999999999987 2211            


Q ss_pred             ---e------EeeEeee-----CCeeeEEEEecCCCCHHHHHccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 014466          246 ---R------LLGYCAE-----GAHRMLVYEYIDNGNLEQWLHGD---VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP  308 (424)
Q Consensus       246 ---~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~  308 (424)
                         .      +..++..     ....+++|+++ +++|.+++...   ......+++..++.++.|+++||+|||++   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---  230 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---  230 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence               1      1111111     12356777765 56999888421   11234678889999999999999999999   


Q ss_pred             CeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeecccccccccccccc----------cCCCCCCccchHHHHH
Q 014466          309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA----------STGMLNERSDVYSFGI  378 (424)
Q Consensus       309 ~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDiwSlGv  378 (424)
                      +|+||||||+|||++.++.+||+|||+++..+..    ....+| +.|+|||++          .+..|+.++|||||||
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            9999999999999999999999999999865322    445677 999999998          5666889999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCC---------CccHHHHHHHHHhhhc
Q 014466          379 LIMEVISGRNPVDYSRPPG---------EVCIPQMNSLMTLSYC  413 (424)
Q Consensus       379 ~l~elltg~~Pf~~~~~~~---------~~~~~~~~~~~~~~~~  413 (424)
                      ++|||++|+.||....+..         .....++..++..||.
T Consensus       306 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  349 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLR  349 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTC
T ss_pred             HHHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHcc
Confidence            9999999999998654311         1123456666666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.1e-34  Score=270.41  Aligned_cols=175  Identities=23%  Similarity=0.357  Sum_probs=150.5

Q ss_pred             CCcccc-eeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHH-hcCCCCceeeEeeEeee----CCeee
Q 014466          186 NGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAI-GRVRHKNLVRLLGYCAE----GAHRM  258 (424)
Q Consensus       186 ~~~~~~-~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~----~~~~~  258 (424)
                      ++|.+. +.||+|+||.||+|.+. +++.||+|.+...     ..+.+|++++ +..+||||+++++++.+    +...+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            356666 78999999999999975 6889999998542     3466788887 66699999999999987    67789


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL  335 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~  335 (424)
                      +||||+++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.   ++.+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999998752  24689999999999999999999999   9999999999999998   78899999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +....                       +..++.++|||||||++|||++|+.||...
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            86532                       234678899999999999999999999653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.2e-33  Score=291.92  Aligned_cols=185  Identities=14%  Similarity=0.078  Sum_probs=131.5

Q ss_pred             eEcccCcEEEEEEE-EcCCCEEEEEEeecCC----------chhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCeeeEE
Q 014466          193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----------GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       193 ~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      .++.|++|.+..++ +-.|+.+++|.+.+..          ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46667777776655 3358889999986541          22345799999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||++|++|.++|...    ++++..   .|+.||+.||+|||++   +||||||||+||||+.+|++||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999999875    456654   4789999999999999   99999999999999999999999999998764


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP  389 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~P  389 (424)
                      ... ......+||+.|+|||++.+. +..++|+||+|+++++|.++..|
T Consensus       391 ~~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          391 QDC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            432 234457899999999998764 66789999999998877665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=9.6e-30  Score=261.29  Aligned_cols=185  Identities=17%  Similarity=0.221  Sum_probs=147.0

Q ss_pred             ccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       189 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ...+.||+|+||.||+|.. .++.+++|+......        ...+.+.+|++++++++||||+++..++.+.+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3467899999999999954 477899998754321        1134588999999999999999666666677778999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++++|.+++..            +..++.|+++||+|||++   +|+||||||+|||++.  ++||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999865            457899999999999999   9999999999999999  99999999999875


Q ss_pred             CCccee------eecccccccccccccccC--CCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          341 AERSYV------TTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       341 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ......      ....+||+.|+|||++..  ..|+...|+|+..+-..+.+.++-+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            432221      235689999999999977  668888999999999999888887773

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=9.5e-26  Score=212.95  Aligned_cols=158  Identities=17%  Similarity=0.105  Sum_probs=125.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc------------------hhHHHHHHHHHHHhcCCCCceeeE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRHKNLVRL  247 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~hpnIv~l  247 (424)
                      ..|.+.+.||+|+||.||+|.+.+|+.||+|.+.....                  .....+.+|++++++++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            34566799999999999999997789999999854321                  13456889999999999  5 666


Q ss_pred             eeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCc
Q 014466          248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN  327 (424)
Q Consensus       248 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~  327 (424)
                      .+++.. +..++||||+++++|.+ +..          .....++.|++.||+|||+.   +|+||||||+|||++ ++.
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTE
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCc
Confidence            665544 55699999999999988 421          12346899999999999999   999999999999999 999


Q ss_pred             eEEEecCCccccCCCcceeeecccccccccccccccC----------CCCCCccchHHH
Q 014466          328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST----------GMLNERSDVYSF  376 (424)
Q Consensus       328 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDiwSl  376 (424)
                      +||+|||+++.              +..+.|||++..          ..|+..+|+|.+
T Consensus       231 vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          231 IWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             EEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             EEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            99999999863              346789998754          456666777653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.2e-21  Score=179.52  Aligned_cols=136  Identities=21%  Similarity=0.161  Sum_probs=105.9

Q ss_pred             cccceeEcccCcEEEEEEEE-cCCCE--EEEEEeecCCch------------------------hHHHHHHHHHHHhcCC
Q 014466          188 FADENVIGEGGYGIVYHGVL-EDNTN--VAVKNLLNNRGQ------------------------AEKEFKVEVEAIGRVR  240 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~  240 (424)
                      |++.+.||+|+||.||+|.+ .+|+.  ||||++......                        ....+.+|++.+.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56789999999999999997 67888  999986432111                        1236788999999998


Q ss_pred             CCce--eeEeeEeeeCCeeeEEEEecCC-C----CHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeee
Q 014466          241 HKNL--VRLLGYCAEGAHRMLVYEYIDN-G----NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVVH  312 (424)
Q Consensus       241 hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-~~~~~~ivH  312 (424)
                      |+++  ..++++    ...+|||||+.+ |    +|.++....       ++..+..++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~-------~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL-------KELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG-------GGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc-------ChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8764  344432    356899999942 3    777765321       23456788999999999999 88   9999


Q ss_pred             CCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          313 RDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       313 rDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.3e-18  Score=169.14  Aligned_cols=138  Identities=13%  Similarity=0.065  Sum_probs=99.2

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc--------------hhHH--------HHHHHHHHHhcCCCCce
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------------QAEK--------EFKVEVEAIGRVRHKNL  244 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~Ei~~l~~l~hpnI  244 (424)
                      -|++.+.||+|+||.||+|...+|+.||||++.....              ....        ....|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3889999999999999999998899999998643210              0001        12346666666654443


Q ss_pred             eeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC
Q 014466          245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK  324 (424)
Q Consensus       245 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~  324 (424)
                      .-..-+...  ..+|||||++|++|.++...          .....++.|++.+|.+||+.   +||||||||.|||+++
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            221111112  23799999999888654321          12346788999999999998   9999999999999988


Q ss_pred             CCc----------eEEEecCCcccc
Q 014466          325 QWN----------PKLSDFGLAKLL  339 (424)
Q Consensus       325 ~~~----------~kL~DfG~a~~~  339 (424)
                      ++.          +.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            763          899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=4e-13  Score=124.57  Aligned_cols=143  Identities=16%  Similarity=0.077  Sum_probs=110.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ..|++...++.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++.+.+..|+||||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            35777888898999999999754 6789999886432222345888999999884 677889999999888999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------------------
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------------------------------  305 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~---------------------------------------  305 (424)
                      +|.+|.+.+..      .   .....++.+++++|+.||+.                                       
T Consensus        93 ~G~~l~~~~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           93 DGVLCSEEYED------E---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             SSEEHHHHCCT------T---TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             CCeehhhccCC------c---ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999876321      1   11246778999999999981                                       


Q ss_pred             -----------------CCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          306 -----------------LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       306 -----------------~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                                       ..+.++|+|+++.|||++++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             013599999999999998765667999997753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=2.8e-12  Score=118.20  Aligned_cols=129  Identities=17%  Similarity=0.121  Sum_probs=96.1

Q ss_pred             cccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEeeEeeeCCeeeEEEEecCCCCHHHH
Q 014466          195 GEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYIDNGNLEQW  272 (424)
Q Consensus       195 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~  272 (424)
                      +.|..+.||++...+|..+++|.....   ....+..|+++++.+.+.+  +.+++++..+++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            455569999998777788999986543   2245677899998885544  566888888878889999999998874  


Q ss_pred             HccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------------
Q 014466          273 LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL----------------------------------------------  306 (424)
Q Consensus       273 l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~----------------------------------------------  306 (424)
                      ..       ....   ..++.++++.|+.||+..                                              
T Consensus       104 ~~-------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 SS-------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TS-------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cC-------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            21       1111   256677888888888641                                              


Q ss_pred             ---------CCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          307 ---------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       307 ---------~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                               .+.++|+|++|.|||+++++.+.|+|||.+..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     11299999999999998876677999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=8.4e-11  Score=114.14  Aligned_cols=141  Identities=11%  Similarity=0.164  Sum_probs=104.9

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEee--cCC-chhHHHHHHHHHHHhcCC--CCceeeEeeEeeeC---CeeeEEEE
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLL--NNR-GQAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEG---AHRMLVYE  262 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~---~~~~lv~e  262 (424)
                      .+.|+.|.++.||++... +..+++|+..  ... ......+.+|.++++.+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999998876 4678888765  222 122346788999999887  45578889888776   34789999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------------------------------------  306 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------------------------------------  306 (424)
                      |++|..+.+..      ...++......++.+++++|+.||+..                                    
T Consensus       122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99997764311      234677888889999999999999720                                    


Q ss_pred             -------------------CCCeeeCCCCCCCEEEcCCCc--eEEEecCCccc
Q 014466          307 -------------------EPKVVHRDIKSSNILLDKQWN--PKLSDFGLAKL  338 (424)
Q Consensus       307 -------------------~~~ivHrDlkp~NILl~~~~~--~kL~DfG~a~~  338 (424)
                                         .+.++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               247999999999999997753  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=3.7e-11  Score=113.94  Aligned_cols=183  Identities=19%  Similarity=0.175  Sum_probs=120.5

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCc--eeeEeeEeeeCC---eeeEEEEec
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKN--LVRLLGYCAEGA---HRMLVYEYI  264 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~e~~  264 (424)
                      .+.++.|....||++.    ..+++|....  ......+.+|.++++.+. +..  +.+++.....+.   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999863    5688887532  234567888999998873 332  345555443333   347899999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------------------
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------------------------------  305 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~---------------------------------------  305 (424)
                      +|.+|.....      ..++...+..++.++++.++.||+.                                       
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9988765332      2356677777888888888888851                                       


Q ss_pred             ----------------CCCCeeeCCCCCCCEEEcC--CCceEEEecCCccccCCCcceeeecccccccc---cccccccC
Q 014466          306 ----------------LEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY---VAPEYAST  364 (424)
Q Consensus       306 ----------------~~~~ivHrDlkp~NILl~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  364 (424)
                                      ..+.++|+|+++.||+++.  ...+.|+||+.+..-+.... ...    ...+   ..|+....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~----~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FIS----LMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHT----TCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHH----HHhhccccCHHHHHH
Confidence                            1246899999999999998  45688999998875322111 000    0011   12221110


Q ss_pred             -----CCC---------CCccchHHHHHHHHHHHcCCCCC
Q 014466          365 -----GML---------NERSDVYSFGILIMEVISGRNPV  390 (424)
Q Consensus       365 -----~~~---------~~~sDiwSlGv~l~elltg~~Pf  390 (424)
                           ...         ....+.|+++.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 011         11258999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.65  E-value=2.7e-07  Score=87.37  Aligned_cols=136  Identities=17%  Similarity=0.172  Sum_probs=94.0

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC---ceeeEeeEee-eCCeeeEEEEecCC
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCA-EGAHRMLVYEYIDN  266 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~e~~~~  266 (424)
                      .+.++.|....||+.    +..+++|..  ........+..|.++|+.+.+.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888988999987    567888874  2334456788999999999652   3556666664 34567899999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-----------------------------------------  305 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-----------------------------------------  305 (424)
                      ..|....-      ..++......++.++++.|+.||+.                                         
T Consensus        98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            87765321      1233444445555555555555532                                         


Q ss_pred             ----------------CCCCeeeCCCCCCCEEEcC---CCc-eEEEecCCccc
Q 014466          306 ----------------LEPKVVHRDIKSSNILLDK---QWN-PKLSDFGLAKL  338 (424)
Q Consensus       306 ----------------~~~~ivHrDlkp~NILl~~---~~~-~kL~DfG~a~~  338 (424)
                                      ..+.++|+|+++.|||++.   ++. ..|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            2335799999999999987   455 48999998865

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=4.8e-07  Score=83.63  Aligned_cols=134  Identities=17%  Similarity=0.112  Sum_probs=94.7

Q ss_pred             EcccCcE-EEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEecCCCCHH
Q 014466          194 IGEGGYG-IVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLE  270 (424)
Q Consensus       194 LG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~  270 (424)
                      +..|..| .||+.... ++..+++|+-..   .....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445555 68987754 456788887532   23456888999988874 333677888888889999999999998877


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 014466          271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--------------------------------------------  306 (424)
Q Consensus       271 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--------------------------------------------  306 (424)
                      +.....        ......+..+++..|+-||+.-                                            
T Consensus       109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            654321        1122345556666677777421                                            


Q ss_pred             -----------CCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          307 -----------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       307 -----------~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                                 .+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       12379999999999999887778999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.39  E-value=3.3e-07  Score=88.43  Aligned_cols=80  Identities=10%  Similarity=0.036  Sum_probs=53.4

Q ss_pred             ceeE-cccCcEEEEEEEEc-------CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCC---CceeeEeeEeeeC--
Q 014466          191 ENVI-GEGGYGIVYHGVLE-------DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRH---KNLVRLLGYCAEG--  254 (424)
Q Consensus       191 ~~~L-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~~--  254 (424)
                      .+.| +.|....+|+....       ++..+++|......   ......+..|..+++.+..   -.+.+++.++.++  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4668 88889999998764       25678888754322   0012356678888877742   3467778777655  


Q ss_pred             -CeeeEEEEecCCCCHH
Q 014466          255 -AHRMLVYEYIDNGNLE  270 (424)
Q Consensus       255 -~~~~lv~e~~~~gsL~  270 (424)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999986543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.15  E-value=1.4e-05  Score=76.04  Aligned_cols=142  Identities=20%  Similarity=0.270  Sum_probs=78.8

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----CCceeeEe-e--EeeeCCeeeEEEEe
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----HKNLVRLL-G--YCAEGAHRMLVYEY  263 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~-~--~~~~~~~~~lv~e~  263 (424)
                      +.|+.|..+.||++...++ .+++|.....    ...+..|.++++.+.     .|.++... +  +...++..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987654 5888987642    123334455554442     34444311 1  12345678899999


Q ss_pred             cCCCCHH--------------HHHccC-CCC--C-------CCCCHHHH-------------------------------
Q 014466          264 IDNGNLE--------------QWLHGD-VGP--H-------SPLTWEIR-------------------------------  288 (424)
Q Consensus       264 ~~~gsL~--------------~~l~~~-~~~--~-------~~l~~~~~-------------------------------  288 (424)
                      ++|..+.              .-++.. ...  .       ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986432              111111 000  0       01122110                               


Q ss_pred             HHHHHHHHHHHHHHHc----------CCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          289 MNIILGTAKGLTYLHE----------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       289 ~~i~~~i~~al~~LH~----------~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ..+...+..++++|++          ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223345666653          0234899999999999998888899999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.15  E-value=6.8e-06  Score=80.46  Aligned_cols=75  Identities=16%  Similarity=0.175  Sum_probs=48.4

Q ss_pred             ceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-------hhHHHHHHHHHHHhcCCC--C-ceeeEeeEeeeCCeeeE
Q 014466          191 ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-------QAEKEFKVEVEAIGRVRH--K-NLVRLLGYCAEGAHRML  259 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--p-nIv~l~~~~~~~~~~~l  259 (424)
                      .+.||.|..+.||++... +++.+++|.......       ...+.+..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 467899997643211       122346678888887632  3 34456544  3445689


Q ss_pred             EEEecCCC
Q 014466          260 VYEYIDNG  267 (424)
Q Consensus       260 v~e~~~~g  267 (424)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.03  E-value=3e-05  Score=72.32  Aligned_cols=77  Identities=21%  Similarity=0.296  Sum_probs=55.5

Q ss_pred             cccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC---ceeeEeeEeeeCCeeeEEEEec
Q 014466          188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ..-.+.+|.|..+.||+.+..+|+.+++|+...........|..|.+.|+.+.-.   -+.+++++  +  ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEee
Confidence            3446789999999999999999999999986554444445677888888877421   24445544  2  237899999


Q ss_pred             CCCC
Q 014466          265 DNGN  268 (424)
Q Consensus       265 ~~gs  268 (424)
                      +++.
T Consensus        93 ~~~~   96 (288)
T 3f7w_A           93 DERP   96 (288)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            8764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.91  E-value=9e-05  Score=70.03  Aligned_cols=139  Identities=14%  Similarity=0.144  Sum_probs=90.9

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC---CCceeeEeeEeeeCCeeeEEEEecCCC
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYIDNG  267 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~g  267 (424)
                      .+.|+.|....+|+... ++..+++|.....   ....+..|.+.|+.+.   ...+.+++.+....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46789999999999875 4677888876432   3556788988888773   356888888888778899999999987


Q ss_pred             CHH--------H---HHccCCC-C----C------------C-CCCHHHHH---HHH----------------HHHHH-H
Q 014466          268 NLE--------Q---WLHGDVG-P----H------------S-PLTWEIRM---NII----------------LGTAK-G  298 (424)
Q Consensus       268 sL~--------~---~l~~~~~-~----~------------~-~l~~~~~~---~i~----------------~~i~~-a  298 (424)
                      .+.        .   -|+.... .    .            . .-+|....   ++.                ..++. .
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            541        1   1232211 0    0            0 01343211   011                11111 1


Q ss_pred             HHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          299 LTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       299 l~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223421 2357899999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.76  E-value=0.00011  Score=72.56  Aligned_cols=77  Identities=8%  Similarity=0.063  Sum_probs=46.2

Q ss_pred             CCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcceeeeccc--ccccccccccccCC---CCCCccchHHHHHHHHH
Q 014466          308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM--GTFGYVAPEYASTG---MLNERSDVYSFGILIME  382 (424)
Q Consensus       308 ~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDiwSlGv~l~e  382 (424)
                      +.++|+|+++.|||++.++ ++|+||+.+..-...- .. ....  -...|.+|+.....   .-....++......+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            4899999999999998876 9999999887532111 10 0011  12345666544311   11123455577777777


Q ss_pred             HHcCC
Q 014466          383 VISGR  387 (424)
Q Consensus       383 lltg~  387 (424)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            66653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.75  E-value=7.8e-05  Score=69.94  Aligned_cols=71  Identities=13%  Similarity=0.067  Sum_probs=42.3

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEEec-CCCC
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYI-DNGN  268 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~-~~gs  268 (424)
                      .+.|+.|....+|++     ..+++|........ ......|..+++.+...++ .+++.+.  .+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            577888999999998     45888876543211 1122446766666632222 3555443  33357899999 6543


Q ss_pred             H
Q 014466          269 L  269 (424)
Q Consensus       269 L  269 (424)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.58  E-value=0.00015  Score=71.76  Aligned_cols=71  Identities=18%  Similarity=0.243  Sum_probs=47.7

Q ss_pred             ceeEcccCcEEEEEEEEcC--------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEE
Q 014466          191 ENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~  261 (424)
                      .+.|+.|....||++...+        +..+++|+.....  ..+.+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888889999998753        4678888774321  12445568888887743333 566766543    3899


Q ss_pred             EecCCC
Q 014466          262 EYIDNG  267 (424)
Q Consensus       262 e~~~~g  267 (424)
                      ||++|.
T Consensus       152 e~l~G~  157 (429)
T 1nw1_A          152 EYIPSR  157 (429)
T ss_dssp             CCCCEE
T ss_pred             EEeCCc
Confidence            999863

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.55  E-value=0.00041  Score=65.86  Aligned_cols=142  Identities=14%  Similarity=0.100  Sum_probs=71.1

Q ss_pred             eeEcccCcEE-EEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC--CceeeEeeEeeeCCeeeEEEEecCCCC
Q 014466          192 NVIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       192 ~~LG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      +.|+.|+... +|+....++..+++|.......   ..+..|+.+++.+..  -.+.+++.+..+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3465555554 6676654466777775433221   223445666655532  23455666543333  78999997766


Q ss_pred             HHHHHccC---------------------CCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHHc--
Q 014466          269 LEQWLHGD---------------------VGP-HSPLTWEIRM-------N-I------------ILGTAKGLTYLHE--  304 (424)
Q Consensus       269 L~~~l~~~---------------------~~~-~~~l~~~~~~-------~-i------------~~~i~~al~~LH~--  304 (424)
                      +.+++...                     ... ...++.....       . +            ...+...++.+.+  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65544221                     000 0112221100       0 0            0011122233311  


Q ss_pred             -CCCCCeeeCCCCCCCEEEcCC----CceEEEecCCccc
Q 014466          305 -GLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL  338 (424)
Q Consensus       305 -~~~~~ivHrDlkp~NILl~~~----~~~kL~DfG~a~~  338 (424)
                       ...+.++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             123489999999999999875    6799999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.54  E-value=0.00057  Score=64.44  Aligned_cols=145  Identities=14%  Similarity=0.133  Sum_probs=78.9

Q ss_pred             ceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEeeE------eeeCCeeeEEEE
Q 014466          191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE  262 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~e  262 (424)
                      .+.|+.|....+|+....++ .+++|.....  .....+..|+++++.+...+  +.+++..      ....+..+++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            45678888899999987655 6888877542  11234555777776663212  2333321      122356789999


Q ss_pred             ecCCCCHH-----H---------HHccCC-CCCC----CCC---HHHHHH------------HHHHHHHHHHHHHcC---
Q 014466          263 YIDNGNLE-----Q---------WLHGDV-GPHS----PLT---WEIRMN------------IILGTAKGLTYLHEG---  305 (424)
Q Consensus       263 ~~~~gsL~-----~---------~l~~~~-~~~~----~l~---~~~~~~------------i~~~i~~al~~LH~~---  305 (424)
                      |++|..+.     .         -++... ....    ...   |.....            +...+...++++++.   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            99985431     0         112110 0000    011   111000            001133445555532   


Q ss_pred             -CCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          306 -LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       306 -~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                       ....++|+|+++.|||++.+..+.|+||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             234799999999999999876568999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.48  E-value=0.00074  Score=63.83  Aligned_cols=143  Identities=15%  Similarity=0.155  Sum_probs=80.1

Q ss_pred             eeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc--eeeEeeE-----eeeCCeeeEEEEec
Q 014466          192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY-----CAEGAHRMLVYEYI  264 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~-----~~~~~~~~lv~e~~  264 (424)
                      ..|+ |....||++...+|+.+++|...... .....+..|..+++.+....  +.+++..     ...++..+++|+|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889999887667779999875332 12345666777777764222  3444432     12245567899999


Q ss_pred             CCCCHH-----HH---------Hcc----CCC-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHcC-
Q 014466          265 DNGNLE-----QW---------LHG----DVG-PHSPLTWEIR----MNI---------------ILGTAKGLTYLHEG-  305 (424)
Q Consensus       265 ~~gsL~-----~~---------l~~----~~~-~~~~l~~~~~----~~i---------------~~~i~~al~~LH~~-  305 (424)
                      +|..+.     .+         ++.    ... .....+....    ..+               ...+...++.+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            874321     11         111    000 0011121110    000               01111223333221 


Q ss_pred             ---CCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          306 ---LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       306 ---~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                         ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234689999999999999 4 899999987754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.40  E-value=0.00036  Score=67.74  Aligned_cols=142  Identities=18%  Similarity=0.170  Sum_probs=80.2

Q ss_pred             eeEcccCcEEEEEEEEc--------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc-eeeEeeEeeeCCeeeEEEE
Q 014466          192 NVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e  262 (424)
                      +.|..|-...+|++...        +++.+++|+.... ......+.+|.++++.+...+ ..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45666888899998864        2467888875332 223455667888888774222 3566666654    28999


Q ss_pred             ecCCCCHHH--------------H---HccCCCC-CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 014466          263 YIDNGNLEQ--------------W---LHGDVGP-HSPLT--WEIRMNIILGTA-------------------KGLTYLH  303 (424)
Q Consensus       263 ~~~~gsL~~--------------~---l~~~~~~-~~~l~--~~~~~~i~~~i~-------------------~al~~LH  303 (424)
                      |++|..|..              .   |+..... .....  +..+.++..++.                   +.++.|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999754421              1   1221111 11122  333444443321                   1223332


Q ss_pred             ----cC-CCCCeeeCCCCCCCEEEcCC----CceEEEecCCccc
Q 014466          304 ----EG-LEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL  338 (424)
Q Consensus       304 ----~~-~~~~ivHrDlkp~NILl~~~----~~~kL~DfG~a~~  338 (424)
                          .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 13479999999999999876    7899999988763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.39  E-value=0.00055  Score=68.15  Aligned_cols=73  Identities=11%  Similarity=0.062  Sum_probs=46.3

Q ss_pred             ceeEcccCcEEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEEecCCCC
Q 014466          191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDNGN  268 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~gs  268 (424)
                      .+.|+.|-...+|++...+ +..+++|+........ -+...|..+++.+...++ .++++.+.+    .+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            4568888889999998865 4678888764322111 112468888888865444 567776632    35999998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.23  E-value=0.00039  Score=67.11  Aligned_cols=72  Identities=14%  Similarity=0.056  Sum_probs=41.9

Q ss_pred             eeEcccCcEEEEEEEEcC---------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc-eeeEeeEeeeCCeeeEEE
Q 014466          192 NVIGEGGYGIVYHGVLED---------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~  261 (424)
                      +.|+.|....+|++...+         +..+++|........ ......|.++++.+...+ ..++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457778888999998754         257778876443221 112356777777774333 34566544  2  26899


Q ss_pred             EecCCCC
Q 014466          262 EYIDNGN  268 (424)
Q Consensus       262 e~~~~gs  268 (424)
                      ||++|..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.09  E-value=0.0031  Score=60.10  Aligned_cols=31  Identities=23%  Similarity=0.327  Sum_probs=27.8

Q ss_pred             CCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       308 ~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=97.09  E-value=0.00051  Score=43.60  Aligned_cols=29  Identities=24%  Similarity=0.276  Sum_probs=15.3

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHhhhhccc
Q 014466           21 RLWVVLGICVGAGIVLVLFLISLWFTSKR   49 (424)
Q Consensus        21 ~~~~ii~I~~g~~~v~~l~~~~~~~~~rr   49 (424)
                      +.-.|+++++|+++++++.+.++++.|||
T Consensus        10 ~~~~Ia~~vVGvll~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           10 PLTSIISAVVGILLVVVLGVVFGILIKRR   38 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhheehh
Confidence            34567888888554444433333333333

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=96.81  E-value=0.0016  Score=40.21  Aligned_cols=32  Identities=16%  Similarity=0.136  Sum_probs=21.5

Q ss_pred             cchhhHHHHHHHHHHHHHHHHH-HHHhhhhccc
Q 014466           18 FGLRLWVVLGICVGAGIVLVLF-LISLWFTSKR   49 (424)
Q Consensus        18 ~gl~~~~ii~I~~g~~~v~~l~-~~~~~~~~rr   49 (424)
                      .||.-..|+||++|+++.++|+ ++.||++|||
T Consensus         6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rrr   38 (38)
T 2k1k_A            6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSRRA   38 (38)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred             CCCCCCceeeeehHHHHHHHHHHHHHHHHeecC
Confidence            4788899999999977644443 4445555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.76  E-value=0.0014  Score=41.71  Aligned_cols=34  Identities=12%  Similarity=0.130  Sum_probs=16.9

Q ss_pred             chhhHHHHHHHHH-HHHHHHHHHHHhhhhcccccc
Q 014466           19 GLRLWVVLGICVG-AGIVLVLFLISLWFTSKRNSN   52 (424)
Q Consensus        19 gl~~~~ii~I~~g-~~~v~~l~~~~~~~~~rr~~~   52 (424)
                      |-+...|++.++| ++++++++++.|+++|||+++
T Consensus         6 ~s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            6 HARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             SCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             CCCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            3445556666665 444444444444444444433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.66  E-value=0.001  Score=42.41  Aligned_cols=25  Identities=24%  Similarity=0.239  Sum_probs=11.6

Q ss_pred             HHHHHHHHHHHHHHHHhhhhccccc
Q 014466           27 GICVGAGIVLVLFLISLWFTSKRNS   51 (424)
Q Consensus        27 ~I~~g~~~v~~l~~~~~~~~~rr~~   51 (424)
                      |++.|++++++++++.|++.|||++
T Consensus        16 gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           16 GMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             ehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            3344455544444444444444443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.15  E-value=0.0095  Score=58.52  Aligned_cols=73  Identities=14%  Similarity=0.125  Sum_probs=45.2

Q ss_pred             ceeEcccCcEEEEEEEEcC--------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc-eeeEeeEeeeCCeeeEEE
Q 014466          191 ENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~  261 (424)
                      .+.|..|-...+|++...+        ++.+++|+...... ..-+..+|..+++.+...+ ..++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3557678888999998753        57788887644321 1112345777777764222 345555332    27899


Q ss_pred             EecCCCC
Q 014466          262 EYIDNGN  268 (424)
Q Consensus       262 e~~~~gs  268 (424)
                      ||++|..
T Consensus       150 efI~G~~  156 (424)
T 3mes_A          150 EFIDGEP  156 (424)
T ss_dssp             ECCCSEE
T ss_pred             EEeCCcc
Confidence            9999865

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=95.80  E-value=0.011  Score=35.08  Aligned_cols=31  Identities=26%  Similarity=0.439  Sum_probs=22.9

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHhhhhcc
Q 014466           18 FGLRLWVVLGICVGAGIVLVLFLISLWFTSK   48 (424)
Q Consensus        18 ~gl~~~~ii~I~~g~~~v~~l~~~~~~~~~r   48 (424)
                      .+++...++||++|.+++.+++.+.+|++.|
T Consensus         2 ~~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r   32 (33)
T 2l34_A            2 STVSPGVLAGIVVGDLVLTVLIALAVYFLGR   32 (33)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             cccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence            3678899999999977766666666555543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.43  E-value=0.039  Score=48.58  Aligned_cols=99  Identities=18%  Similarity=0.125  Sum_probs=65.1

Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      -+|.+.|...   ..+++++.+|.++.|.+++|.-+-...  .-..+=+.|..|++..+|.+-..+ +.+.         
T Consensus        33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence            3799999877   479999999999999999887662110  111233457899999999888764 1110         


Q ss_pred             eecccccccccccccccCCCCCCccchHHHHHHHHHHHc
Q 014466          347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS  385 (424)
Q Consensus       347 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt  385 (424)
                          .....+.|||... ...+.+.=|||||+++|.-+-
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                0122467888753 345678899999999998775

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=95.27  E-value=0.016  Score=36.51  Aligned_cols=27  Identities=30%  Similarity=0.508  Sum_probs=11.3

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHhhhhcc
Q 014466           22 LWVVLGICVGAGIVLVLFLISLWFTSK   48 (424)
Q Consensus        22 ~~~ii~I~~g~~~v~~l~~~~~~~~~r   48 (424)
                      .++++++++|+++++++++++++++||
T Consensus        13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rR   39 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLLVLAGVGFFIHRR   39 (41)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred             EEEEeehhHHHHHHHHHHHHheeEeee
Confidence            334444444544433233333444433

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=94.23  E-value=0.062  Score=35.59  Aligned_cols=26  Identities=31%  Similarity=0.778  Sum_probs=18.6

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHhh
Q 014466           19 GLRLWVVLGICVGAGIVLVLFLISLW   44 (424)
Q Consensus        19 gl~~~~ii~I~~g~~~v~~l~~~~~~   44 (424)
                      +..+|+|++-++|.++++.+++++.|
T Consensus         6 ~vp~WiIi~svl~GLLLL~Lii~~Lw   31 (54)
T 2l8s_A            6 RVPLWVILLSAFAGLLLLMLLILALW   31 (54)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCchHHHHHHHHHHHHHHHHHHHHHH
Confidence            67889988888877666666555544

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=93.78  E-value=0.083  Score=35.12  Aligned_cols=26  Identities=23%  Similarity=0.731  Sum_probs=18.9

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHhh
Q 014466           19 GLRLWVVLGICVGAGIVLVLFLISLW   44 (424)
Q Consensus        19 gl~~~~ii~I~~g~~~v~~l~~~~~~   44 (424)
                      +..+|+|++.++|.++++.++++++|
T Consensus         9 ~vp~wiIi~svl~GLllL~li~~~Lw   34 (54)
T 2knc_A            9 AIPIWWVLVGVLGGLLLLTILVLAMW   34 (54)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence            67899998888877666666555544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.58  E-value=0.24  Score=47.95  Aligned_cols=29  Identities=31%  Similarity=0.439  Sum_probs=24.4

Q ss_pred             CeeeCCCCCCCEEE------cCCCceEEEecCCcc
Q 014466          309 KVVHRDIKSSNILL------DKQWNPKLSDFGLAK  337 (424)
Q Consensus       309 ~ivHrDlkp~NILl------~~~~~~kL~DfG~a~  337 (424)
                      .++|+|+.+.|||+      +++..++++||-.|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      345679999998775

>2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A

Probab=92.67  E-value=0.17  Score=31.74  Aligned_cols=26  Identities=23%  Similarity=0.731  Sum_probs=18.7

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHhh
Q 014466           19 GLRLWVVLGICVGAGIVLVLFLISLW   44 (424)
Q Consensus        19 gl~~~~ii~I~~g~~~v~~l~~~~~~   44 (424)
                      +..+|+|++-++|.++++.++.+..|
T Consensus         7 ~vp~wiIi~s~l~GLllL~li~~~Lw   32 (42)
T 2k1a_A            7 AIPIWWVLVGVLGGLLLLTILVLAMW   32 (42)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence            67899988888876666666555554

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=92.35  E-value=0.07  Score=31.93  Aligned_cols=26  Identities=19%  Similarity=0.415  Sum_probs=11.5

Q ss_pred             HHHHHHHHHHHHHHHHHHHhhhhccc
Q 014466           24 VVLGICVGAGIVLVLFLISLWFTSKR   49 (424)
Q Consensus        24 ~ii~I~~g~~~v~~l~~~~~~~~~rr   49 (424)
                      .|++.++|+++++++.+.+.++.|||
T Consensus         9 sIaagVvglll~vii~l~~~~~iRRr   34 (35)
T 1iij_A            9 FIIATVVGVLLFLILVVVVGILIKRR   34 (35)
T ss_dssp             HHHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred             EeHHHHHHHHHHHHHHHHhheEEeec
Confidence            45556666444433333333333333

>1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A*

Probab=88.76  E-value=0.081  Score=56.88  Aligned_cols=33  Identities=30%  Similarity=0.462  Sum_probs=0.0

Q ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHHhhhhccc
Q 014466           17 IFGLRLWVVLGICVGAGIVLVLFLISLWFTSKR   49 (424)
Q Consensus        17 ~~gl~~~~ii~I~~g~~~v~~l~~~~~~~~~rr   49 (424)
                      .-||.+|+||+|++|++++++++++++++++||
T Consensus       699 ~~~l~~~aii~il~~~~~ll~~~ll~~~~~~~~  731 (880)
T 1q55_A          699 VGGFDLPIILVILGSVLALLILFLLLLLFLKRK  731 (880)
T ss_dssp             ---------------------------------
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence            568999999999999887777766665555444

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=87.74  E-value=0.9  Score=28.73  Aligned_cols=32  Identities=19%  Similarity=0.190  Sum_probs=19.6

Q ss_pred             hhhHHHHHHHHHHHHHHHHHHHHhhhhcccccc
Q 014466           20 LRLWVVLGICVGAGIVLVLFLISLWFTSKRNSN   52 (424)
Q Consensus        20 l~~~~ii~I~~g~~~v~~l~~~~~~~~~rr~~~   52 (424)
                      +-..++.|+++.+ ++++++++++-.++++++|
T Consensus        12 IA~gVVgGv~~v~-ii~~~~~~~~RRRr~~~kr   43 (44)
T 2l2t_A           12 IAAGVIGGLFILV-IVGLTFAVYVRRKSIKKKR   43 (44)
T ss_dssp             HHHHHHHHHHHHH-HHHHHHHHHHHTTCSSCCC
T ss_pred             EEEeehHHHHHHH-HHHHHHHHHhhhhhhhhcc
Confidence            4444555555544 4456668888887776655

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.51  E-value=1.2  Score=38.86  Aligned_cols=116  Identities=11%  Similarity=0.123  Sum_probs=76.4

Q ss_pred             CCCceeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCC
Q 014466          240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN  319 (424)
Q Consensus       240 ~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~N  319 (424)
                      .||+++.. .+-.+++.+.+.++.-+.  ...|-.-     ...+...+++++.+++....+++.     =+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            58888876 566666666666665442  2222211     346778889999999988766653     3688899999


Q ss_pred             EEEcCCCceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCC
Q 014466          320 ILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       320 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      |+++.++.+++.-.|+-..                  ++|.     .+++..=+-.+=+++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999976665322                  2221     11222233456677888888888876

>2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=85.74  E-value=0.67  Score=33.59  Aligned_cols=26  Identities=31%  Similarity=0.502  Sum_probs=14.9

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHhh
Q 014466           19 GLRLWVVLGICVGAGIVLVLFLISLW   44 (424)
Q Consensus        19 gl~~~~ii~I~~g~~~v~~l~~~~~~   44 (424)
                      ..++|.|++.++|++++++|+++++|
T Consensus         7 ~~n~~~Iv~gvi~gilliGllllliw   32 (79)
T 2knc_B            7 GPDILVVLLSVMGAILLIGLAALLIW   32 (79)
T ss_dssp             SSCSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHHHHHHHH
Confidence            45677777666655555555444444

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=83.45  E-value=1.1  Score=27.45  Aligned_cols=27  Identities=22%  Similarity=0.410  Sum_probs=21.1

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHhhh
Q 014466           19 GLRLWVVLGICVGAGIVLVLFLISLWF   45 (424)
Q Consensus        19 gl~~~~ii~I~~g~~~v~~l~~~~~~~   45 (424)
                      |--..++||.++|++++++++++.+..
T Consensus        11 GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           11 GEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CceeeeehHHHHHHHHHHHHHHHHeec
Confidence            555778899999988888887877753

>2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A

Probab=83.34  E-value=1.5  Score=27.67  Aligned_cols=27  Identities=30%  Similarity=0.443  Sum_probs=15.6

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHhhh
Q 014466           19 GLRLWVVLGICVGAGIVLVLFLISLWF   45 (424)
Q Consensus        19 gl~~~~ii~I~~g~~~v~~l~~~~~~~   45 (424)
                      +.+.+.+++-++|++++++++++.+|.
T Consensus         6 ~~n~~~Iv~gvi~~ivliGl~lLliwk   32 (43)
T 2k9j_B            6 GPDILVVLLSVMGAILLIGLAALLIWK   32 (43)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEeehHHHHHHHHHHHHHHHHHHHH
Confidence            346777776666655555555555443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.01  E-value=2.4  Score=37.14  Aligned_cols=83  Identities=7%  Similarity=-0.002  Sum_probs=58.6

Q ss_pred             CCCceeeEeeEeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeeeCCCCCC
Q 014466          240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT-YLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       240 ~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~-~LH~~~~~~ivHrDlkp~  318 (424)
                      .||++  -..+-.+++.+.+.++.-+++.-..-++       ..+...+++++.+++.... +++     .-+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            57877  4444466677777777654443333342       4567888888888777666 454     3477889999


Q ss_pred             CEEEcCCCceEEEecCCc
Q 014466          319 NILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a  336 (424)
                      ||+++.++.+++.-.|+-
T Consensus       114 NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GEEECTTCCEEESCCEET
T ss_pred             eEEEeCCCcEEEEEcCCc
Confidence            999999999999876653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.21  E-value=0.14  Score=50.77  Aligned_cols=60  Identities=5%  Similarity=-0.022  Sum_probs=17.4

Q ss_pred             cceeEcccCcEEEEEEEEcC-CCEEEE------EEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEee
Q 014466          190 DENVIGEGGYGIVYHGVLED-NTNVAV------KNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA  252 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  252 (424)
                      +.+.||   ||.||+|.+.. ..+||+      |......  .+....+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            455676   99999999764 357888      6654322  122346778899999999999999988754

>2kv5_A FST, putative uncharacterized protein RNAI; toxin-antitoxin, bacterial, toxin; NMR {Enterococcus faecalis}

Probab=81.68  E-value=1.8  Score=25.25  Aligned_cols=25  Identities=36%  Similarity=0.404  Sum_probs=15.5

Q ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhccccc
Q 014466           23 WVVLGICVGAGIVLVLFLISLWFTSKRNS   51 (424)
Q Consensus        23 ~~ii~I~~g~~~v~~l~~~~~~~~~rr~~   51 (424)
                      -+|.+|+||+    ++.++--|+-.|+.+
T Consensus         7 ~IIaPivVGv----vl~L~d~WLn~r~~~   31 (33)
T 2kv5_A            7 LVIAPIFVGL----VLEMISRVLDEEDDS   31 (33)
T ss_dssp             HHHHHHHHHH----HHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHH----HHHHHHHHHcccccc
Confidence            3556666665    444667888776643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	424
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-49
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-22

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 7e-63
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 11/224 (4%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           + E+          IG G +G VY G    +  V + N+     Q  + FK EV  + + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           RH N++  +GY        +V ++ +  +L   LH      +       ++I   TA+G+
Sbjct: 62  RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVA 358
            YLH      ++HRD+KS+NI L +    K+ DFGLA +      S+   ++ G+  ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 359 PEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           PE          + +SDVY+FGI++ E+++G+ P        ++
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-62
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 11/213 (5%)

Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 238
           +E+  + F   + +G G  G+V+          +A K + L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
                +V   G         +  E++D G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           LTYL E  + K++HRD+K SNIL++ +   KL DFG++  L           +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMS 171

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           PE       + +SD++S G+ ++E+  GR P+ 
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 7e-62
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 7/220 (3%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
           E EV          +G G +G V+ G    +T VAVK  L     +   F  E   + ++
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQL 65

Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           +H+ LVRL     +     ++ EY++NG+L  +L    G    LT    +++    A+G+
Sbjct: 66  QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGM 122

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            ++ E      +HRD++++NIL+    + K++DFGLA+L+                + AP
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           E  + G    +SDV+SFGIL+ E+++            EV
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 1e-57
 Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 7/208 (3%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
             +G G +G+V +G      +VA+K ++     +E EF  E + +  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +     ++ EY+ NG L  +L            +  + +     + + YL      + +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L++ Q   K+SDFGL++ +  +    +        +  PE       + +S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEV 399
           D+++FG+L+ E+ S            E 
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSET 210

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-57
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 7/208 (3%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
             IG G +G+V+ G   +   VA+K  +     +E++F  E E + ++ H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            E A   LV+E++++G L  +L    G  +    E  + + L   +G+ YL E     V+
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE---ACVI 123

Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
           HRD+ + N L+ +    K+SDFG+ + +  ++   +T       + +PE  S    + +S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEV 399
           DV+SFG+L+ EV S       +R   EV
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEV 211

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 1e-56
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 7/220 (3%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
             E+       E  +G+G +G V+ G     T VA+K  L     + + F  E + + ++
Sbjct: 11  AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKL 69

Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
           RH+ LV+L    +E     +V EY+  G+L  +L G+ G +        +++    A G+
Sbjct: 70  RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGM 126

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
            Y+        VHRD++++NIL+ +    K++DFGLA+L+                + AP
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           E A  G    +SDV+SFGIL+ E+ +            EV
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (468), Expect = 7e-56
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 24/242 (9%)

Query: 176 YTLRELEVSTNGFADE---------NVIGEGGYGIVYHGVLEDNTN----VAVKNL-LNN 221
           +T  +   +   FA E          VIG G +G V  G L+        VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
             +  ++F  E   +G+  H N++ L G   +    M++ E+++NG+L+ +L  + G   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
             T    + ++ G A G+ YL    +   VHRD+ + NIL++     K+SDFGL++ L  
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 342 ERSYVTTR----VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
           + S  T            + APE          SDV+S+GI++ EV+S      +     
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 398 EV 399
           +V
Sbjct: 241 DV 242

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 2e-55
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 8/205 (3%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
             IG G YG         D   +  K  +  +     ++    EV  +  ++H N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 249 GYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
               +  +  L  V EY + G+L   +         L  E  + ++      L   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 307 E--PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
           +    V+HRD+K +N+ LD + N KL DFGLA++L  + S+     +GT  Y++PE  + 
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188

Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              NE+SD++S G L+ E+ +   P
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP 213

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 14/228 (6%)

Query: 179 RELEVSTNGFA-DENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAE-KEFKVEV 233
           ++L +  +     +  +G G +G V  GV    +   +VA+K L     +A+ +E   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
           + + ++ +  +VRL+G C +    MLV E    G L ++L G       +       ++ 
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VM 351
             + G+ YL E      VHRD+ + N+LL  +   K+SDFGL+K LGA+ SY T R    
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
               + APE  +    + RSDV+S+G+ + E +S            EV
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 221

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (458), Expect = 2e-54
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 7/221 (3%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
           + E+       ++ +G G YG VY GV +  +  VAVK L  +  + E EF  E   +  
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
           ++H NLV+LLG C       ++ E++  GNL  +L         ++  + + +    +  
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           + YL +      +HRD+ + N L+ +    K++DFGL++L+  +             + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           PE  +    + +SDV++FG+L+ E+ +            +V
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (457), Expect = 4e-54
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 31/250 (12%)

Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNL-LNNRGQAEKEFK 230
           L  LE   N       IGEG +G V+          E  T VAVK L        + +F+
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--------------- 275
            E   +    + N+V+LLG CA G    L++EY+  G+L ++L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 276 -----DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330
                      PL+   ++ I    A G+ YL E    K VHRD+ + N L+ +    K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181

Query: 331 SDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           +DFGL++ +  A+             ++ PE          SDV+++G+++ E+ S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 390 VDYSRPPGEV 399
             Y     EV
Sbjct: 242 PYYGMAHEEV 251

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-54
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 13/219 (5%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
            ++         IG+G +G V  G       VAVK +        + F  E   + ++RH
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 59

Query: 242 KNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
            NLV+LLG   E    + +V EY+  G+L  +L       S L  +  +   L   + + 
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAME 117

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
           YL        VHRD+ + N+L+ +    K+SDFGL K      S           + APE
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPE 170

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
                  + +SDV+SFGIL+ E+ S         P  +V
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-53
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 25/223 (11%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
           +  IG+G +G V+ G       VAVK + ++R +     + E+     +RH+N++  +  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 251 CAEG----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
             +         LV +Y ++G+L  +L+        +T E  + + L TA GL +LH  +
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 307 -----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---TTRVMGTFGYVA 358
                +P + HRD+KS NIL+ K     ++D GLA    +    +       +GT  Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 359 PEYASTGM------LNERSDVYSFGILIMEVISGRNPVDYSRP 395
           PE     +        +R+D+Y+ G++  E+    +       
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLN---NRGQAEKEFKV 231
           + L + E+          +G+G +G VY     +    +A+K L      +   E + + 
Sbjct: 3   WALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55

Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           EVE    +RH N++RL GY  +     L+ EY   G + + L       S    +     
Sbjct: 56  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATY 111

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
           I   A  L+Y H     +V+HRDIK  N+LL      K++DFG +    + R    T + 
Sbjct: 112 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLC 165

Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           GT  Y+ PE     M +E+ D++S G+L  E + G+ P
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
           F+D   IG G +G VY    + ++  VA+K +        +  ++   EV  + ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
            ++  G         LV EY      +           PL       +  G  +GL YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH 132

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 ++HRD+K+ NILL +    KL DFG A ++           +GT  ++APE   
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 364 T---GMLNERSDVYSFGILIMEVISGRNP 389
               G  + + DV+S GI  +E+   + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP 213

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 15/217 (6%)

Query: 190 DENVIGEGGYGIVYHGVLEDNTN---VAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNL 244
           ++  +G G +G V  G  +       VAVK L N  N    + E   E   + ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           VR++G C E    MLV E  + G L ++L      +  +  +  + ++   + G+ YL E
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYA 362
                 VHRD+ + N+LL  Q   K+SDFGL+K L A+ +Y   +        + APE  
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
           +    + +SDV+SFG+L+ E  S            EV
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 7e-53
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 14/226 (6%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN-----VAVKNLLNNRGQAEK-EFKVEVEA 235
           E+  +    + VIG G +G VY G+L+ ++      VA+K L     + ++ +F  E   
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
           +G+  H N++RL G  ++    M++ EY++NG L+++L          +    + ++ G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119

Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGT 353
           A G+ YL        VHRD+ + NIL++     K+SDFGL+++L    E +Y T+     
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
             + APE  S       SDV+SFGI++ EV++      +     EV
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 7e-53
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 13/204 (6%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
             +G+G +G VY     E +   A K +     +  +++ VE++ +    H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
                +  ++ E+   G ++  +        PLT      +   T   L YLH   + K+
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKI 131

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML--- 367
           +HRD+K+ NIL     + KL+DFG++           + + GT  ++APE          
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190

Query: 368 --NERSDVYSFGILIMEVISGRNP 389
             + ++DV+S GI ++E+     P
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP 214

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 9e-53
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 17/217 (7%)

Query: 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRL 247
           +  IG G +  VY G+  E    VA   L + +      + FK E E +  ++H N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 248 LGYCAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
                         +LV E + +G L+ +L         +  ++  +      KGL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129

Query: 304 EGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
               P ++HRD+K  NI +     + K+ D GLA L  A        V+GT  ++APE  
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMY 185

Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
                +E  DVY+FG+ ++E+ +   P    +   ++
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 221

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 6e-51
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 11/211 (5%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
             +GEG YG V   V       VAVK + +       +  K E+     + H+N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
           +  EG  + L  EY   G L   +     P   +              G+ YLH      
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH---GIG 123

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
           + HRDIK  N+LLD++ N K+SDFGLA +     R  +  ++ GT  YVAPE       +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
            E  DV+S GI++  +++G  P D      +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 7e-51
 Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 31/246 (12%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKE-FKVEVE 234
           E          V+G G +G V +      +       VAVK L      +E+E    E++
Sbjct: 33  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92

Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS------------ 281
            + ++  H+N+V LLG C       L++EY   G+L  +L       S            
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 282 -------PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
                   LT+E  +      AKG+ +L        VHRD+ + N+L+      K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209

Query: 335 LAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
           LA+ + ++ +YV          ++APE    G+   +SDV+S+GIL+ E+ S        
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269

Query: 394 RPPGEV 399
            P    
Sbjct: 270 IPVDAN 275

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-50
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 10/199 (5%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
             IG+G  G VY  + +     VA++ +   +   ++    E+  +   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
              G    +V EY+  G+L   +       + +       +     + L +LH     +V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
           +HRDIKS NILL    + KL+DFG    +  E+S  +T V GT  ++APE  +      +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196

Query: 371 SDVYSFGILIMEVISGRNP 389
            D++S GI+ +E+I G  P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-50
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 15/218 (6%)

Query: 191 ENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 245
             VIG G +G VYHG L DN       AVK+L       E  +F  E   +    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 246 RLLGYCAEG-AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ +L  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEY 361
               K VHRD+ + N +LD+++  K++DFGLA+ +     +  +  T       ++A E 
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
             T     +SDV+SFG+L+ E+++   P        ++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-49
 Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 22/235 (9%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN---TNVAVKNL-LNNRGQAEKEFKVEVEAIG 237
            +  N    ++VIGEG +G V    ++ +    + A+K +         ++F  E+E + 
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 238 RV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLT 284
           ++  H N++ LLG C    +  L  EY  +GNL  +L                   S L+
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
            +  ++     A+G+ YL +    + +HRD+ + NIL+ + +  K++DFGL++       
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182

Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
              T       ++A E  +  +    SDV+S+G+L+ E++S            E+
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-49
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 26/244 (10%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKE-FKV 231
            + E   N  +    +G G +G V           +    VAVK L  +    E+E    
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 232 EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--------------D 276
           E++ +  +  H N+V LLG C  G   +++ EY   G+L  +L                 
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 277 VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
                 L  E  ++     AKG+ +L        +HRD+ + NILL      K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 337 KLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
           + +  + +Y V         ++APE     +    SDV+S+GI + E+ S  +      P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 396 PGEV 399
               
Sbjct: 253 VDSK 256

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 3e-49
 Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
            +G G +G+V+         N A K ++      ++  + E++ +  +RH  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +    +++YE++  G L + +  +   H+ ++ +  +  +    KGL ++HE      V
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146

Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           H D+K  NI+   + +   KL DFGL   L  ++S   T   GT  + APE A    +  
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 204

Query: 370 RSDVYSFGILIMEVISGRNP 389
            +D++S G+L   ++SG +P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-49
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 12/225 (5%)

Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEVE 234
           + E+          IGEG +G V+ G+     N    VA+K   N    + +E F  E  
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
            + +  H ++V+L+G   E     ++ E    G L  +L         L     +     
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQ 116

Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
            +  L YL      + VHRDI + N+L+      KL DFGL++ +     Y  ++     
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
            ++APE  +       SDV+ FG+ + E++             +V
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-48
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 16/217 (7%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN----VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNL 244
             +G+G +G+V  G  +  +     VAVK L   + ++ +A  +F  EV A+  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           +RL G       +M V E    G+L   L    G              +  A+G+ YL  
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES 129

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYA 362
               + +HRD+ + N+LL  +   K+ DFGL + L    +   +       F + APE  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
            T   +  SD + FG+ + E+ +            ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 14/219 (6%)

Query: 188 FADENVIGEGGYGIVYHGVLEDN-----TNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH 241
           F    V+G G +G VY G+           VA+K L      +A KE   E   +  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
            ++ RLLG C       L+ + +  G L  ++            +  +N  +  AKG+ Y
Sbjct: 71  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNY 126

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE 360
           L +    ++VHRD+ + N+L+    + K++DFGLAKLLGA E+ Y          ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
                +   +SDV+S+G+ + E+++  +      P  E+
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 12/204 (5%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 246
             ++GEG +  V     L  +   A+K L       E        E + + R+ H   V+
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
           L     +         Y  NG L +++                         L YLH   
Sbjct: 73  LYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-- 126

Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTG 365
              ++HRD+K  NILL++  + +++DFG AK+L  E +       +GT  YV+PE  +  
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
              + SD+++ G +I ++++G  P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (406), Expect = 4e-46
 Identities = 44/200 (22%), Positives = 85/200 (42%), Gaps = 11/200 (5%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
            +G G +G+V+  V          K +       +   K E+  + ++ H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
            +    +L+ E++  G L   +         ++    +N +    +GL ++H   E  +V
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149

Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           H DIK  NI+ + +     K+ DFGLA  L  +   +      T  + APE      +  
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF 207

Query: 370 RSDVYSFGILIMEVISGRNP 389
            +D+++ G+L   ++SG +P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (402), Expect = 2e-45
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 18/241 (7%)

Query: 184 STNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV 239
           + N F+   +IG GG+G VY     +     A+K L   R    Q E     E   +  V
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 240 R---HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
                  +V +            + + ++ G+L   L      H   +            
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEII 117

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
            GL ++H      VV+RD+K +NILLD+  + ++SD GLA     ++       +GT GY
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGY 171

Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSS 415
           +APE    G+  +  +D +S G ++ +++ G +P    +   +  I +M   M +    S
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231

Query: 416 F 416
           F
Sbjct: 232 F 232

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 7e-45
 Identities = 56/238 (23%), Positives = 106/238 (44%), Gaps = 17/238 (7%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNL-LNNRGQAEKE 228
           Y   E EV+         +G+G +G+VY GV       E  T VA+K +      +   E
Sbjct: 10  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69

Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------GDVGPHSP 282
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L        +    +P
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
            +    + +    A G+ YL+     K VHRD+ + N ++ + +  K+ DFG+ + +   
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 343 RSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
             Y    + +    +++PE    G+    SDV+SFG+++ E+ +            +V
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-44
 Identities = 42/200 (21%), Positives = 87/200 (43%), Gaps = 12/200 (6%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
            +G G +GIV+  V          K  +  +G  +   K E+  +   RH+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
                 ++++E+I   ++ + ++        L     ++ +    + L +LH      + 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           H DI+  NI+   + +   K+ +FG A+ L    ++          Y APE     +++ 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182

Query: 370 RSDVYSFGILIMEVISGRNP 389
            +D++S G L+  ++SG NP
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  153 bits (387), Expect = 4e-44
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
             ++G GG   V+    L  + +VAVK L   L         F+ E +    + H  +V 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 247 LLGYCAE----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           +          G    +V EY+D   L   +H       P+T +  + +I    + L + 
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 127

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
           H+     ++HRD+K +NI++      K+ DFG+A+ +    + V  T  V+GT  Y++PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
            A    ++ RSDVYS G ++ EV++G  P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP 213

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 26/241 (10%)

Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAE-KEFKVE 232
           E+  +       +GEG +G V                T VAVK L ++  + +  +   E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68

Query: 233 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------------GDVGP 279
           +E +  + +HKN++ LLG C +     ++ EY   GNL ++L                 P
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
              L+ +  ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 340 GAERSYVTTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
                Y  T        ++APE     +   +SDV+SFG+L+ E+ +         P  E
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245

Query: 399 V 399
           +
Sbjct: 246 L 246

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 9e-43
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 14/216 (6%)

Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAI 236
           ++ E   + +   +V+G G +  V           VA+K +     +  E   + E+  +
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
            +++H N+V L      G H  L+ + +  G L   +          T      +I    
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVL 117

Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
             + YLH   +  +VHRD+K  N+L    D+     +SDFGL+K+   +   V +   GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172

Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
            GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 13/230 (5%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRV-RHKNLV 245
             ++G+G +G V+     + N   A+K L  +    + +     VE   +     H  L 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            +        +   V EY++ G+L   +                        GL +LH  
Sbjct: 67  HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS- 121

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               +V+RD+K  NILLDK  + K++DFG+ K      +   T   GT  Y+APE     
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178

Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMNSLMTLSYCSS 415
             N   D +SFG+L+ E++ G++P             +M++     +   
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (372), Expect = 6e-42
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 26/216 (12%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNL---------LNNRGQAEKEFKVEVEAIGRVR 240
           + ++G G   +V   +        AVK +              +  +    EV+ + +V 
Sbjct: 8   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67

Query: 241 -HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
            H N+++L           LV++ +  G L  +L         L+ +    I+    + +
Sbjct: 68  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVI 123

Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
             LH+     +VHRD+K  NILLD   N KL+DFG +  L  +       V GT  Y+AP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAP 178

Query: 360 EYASTGMLNER------SDVYSFGILIMEVISGRNP 389
           E     M +         D++S G+++  +++G  P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (374), Expect = 7e-42
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 22/218 (10%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKV 231
           Y+L++ ++          +G G +G V+      +    A+K L   +  R +  +    
Sbjct: 1   YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
           E   +  V H  ++R+ G   +     ++ +YI+ G L   L       +P+       +
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113

Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
                     L       +++RD+K  NILLDK  + K++DFG AK +          + 
Sbjct: 114 -------CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLC 162

Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           GT  Y+APE  ST   N+  D +SFGILI E+++G  P
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-41
 Identities = 64/253 (25%), Positives = 101/253 (39%), Gaps = 25/253 (9%)

Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAE-KE 228
           Y   + E   +       +G G +G V                VAVK L      +E + 
Sbjct: 3   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62

Query: 229 FKVEVEAIGR-VRHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP---- 282
              E++ +     H N+V LLG C + G   M++ E+   GNL  +L        P    
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 283 --------LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
                   LT E  +      AKG+ +L      K +HRD+ + NILL ++   K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 335 LAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
           LA+ +  +  YV          ++APE     +   +SDV+SFG+L+ E+ S        
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239

Query: 394 RPPGEVCIPQMNS 406
               E    ++  
Sbjct: 240 VKIDEEFCRRLKE 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  143 bits (362), Expect = 1e-40
 Identities = 45/200 (22%), Positives = 84/200 (42%), Gaps = 9/200 (4%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
             IGEG YG+VY          A+K   L             E+  +  ++H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
                   +LV+E++D    +            L      + +L    G+ Y H+    +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD---RR 120

Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
           V+HRD+K  N+L++++   K++DFGLA+  G      T  ++  +         +   + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 370 RSDVYSFGILIMEVISGRNP 389
             D++S G +  E+++G   
Sbjct: 181 TIDIWSVGCIFAEMVNGTPL 200

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-39
 Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 9/205 (4%)

Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
           F     IGEG YG+VY          VA+K   L             E+  +  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
           V+LL          LV+E++     +     D    + +   +  + +    +GL + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
               +V+HRD+K  N+L++ +   KL+DFGLA+  G      T  V+  +          
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
              +   D++S G +  E+++ R  
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-39
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 9/210 (4%)

Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHK 242
              + + + IGEG YG+V       +   VA+K +     Q   +    E++ + R RH+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           N++ +           +   Y+    +   L+  +     L+ +     +    +GL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPE 360
           H      V+HRD+K SN+LL+   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 361 YASTGMLNERS-DVYSFGILIMEVISGRNP 389
                    +S D++S G ++ E++S R  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-39
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
           + +GEG +  VY       N  VA+K     +    +    +    E++ +  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            LL      ++  LV+++++                 LT       +L T +GL YLH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
               ++HRD+K +N+LLD+    KL+DFGLAK  G+     T +V  T  Y APE     
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 366 ML-NERSDVYSFGILIMEVISGRNP 389
            +     D+++ G ++ E++     
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPF 200

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-39
 Identities = 50/210 (23%), Positives = 83/210 (39%), Gaps = 17/210 (8%)

Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
           + D  VIG G +G+VY   L +    VA+K +L +    ++    E++ + ++ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77

Query: 247 LLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
           L  +      +       LV +Y+         H        L        +    + L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136

Query: 301 YLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
           Y+H      + HRDIK  N+LLD      KL DFG AK L        + +   +     
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPE 192

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNP 389
                       DV+S G ++ E++ G+  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 7e-39
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 24/222 (10%)

Query: 181 LEVSTNGFAD-----ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
           L++  N   D       V+G G  G V            A+K +L +  +A +E ++   
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 60

Query: 235 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
           A    +  ++VR++       A     ++V E +D G L   +          T      
Sbjct: 61  AS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASE 115

Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVT 347
           I+    + + YLH      + HRD+K  N+L   +      KL+DFG AK   +  S  T
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172

Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
                T  YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 173 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 20/214 (9%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL------LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
            +G G + +V            A K +       + RG + ++ + EV  +  ++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
            L          +L+ E +  G L  +L         LT E     +     G+ YLH  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH-- 130

Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
              ++ H D+K  NI+L  +  P    K+ DFGLA  +     +    + GT  +VAPE 
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 187

Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
            +   L   +D++S G++   ++SG +P      
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-37
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 14/207 (6%)

Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNL 244
             IGEG YG V+      N    VA+K +    G+         E      +    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
           VRL   C            +   +++Q    + D  P   +  E   +++    +GL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
           H     +VVHRD+K  NIL+      KL+DFGLA++   + +   T V+ T  Y APE  
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187

Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
                    D++S G +  E+   +  
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-37
 Identities = 57/211 (27%), Positives = 82/211 (38%), Gaps = 12/211 (5%)

Query: 183 VSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGR 238
           V+ N F    ++G+G +G V            A+K L      A+ E      E   +  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
            RH  L  L            V EY + G L   L          T E            
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSA 117

Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
           L YLH      VV+RDIK  N++LDK  + K++DFGL K   ++ +       GT  Y+A
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173

Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
           PE           D +  G+++ E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-37
 Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 10/201 (4%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
             IGEG YG V+     E +  VA+K   L ++          E+  +  ++HKN+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                     LV+E+ D    + +       +  L  EI  + +    KGL + H     
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---R 120

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
            V+HRD+K  N+L+++    KL++FGLA+  G      +  V+  +           + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 369 ERSDVYSFGILIMEVISGRNP 389
              D++S G +  E+ +   P
Sbjct: 181 TSIDMWSAGCIFAELANAGRP 201

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 5e-37
 Identities = 42/217 (19%), Positives = 78/217 (35%), Gaps = 20/217 (9%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
              IG G +G +Y G  +     VA+K           +  +E +    ++    +  + 
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 250 YC-AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
           +C AEG + ++V E +     + +           + +  + +       + Y+H     
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---K 122

Query: 309 KVVHRDIKSSNIL---LDKQWNPKLSDFGLAKLLGAERSYV------TTRVMGTFGYVAP 359
             +HRD+K  N L     K     + DFGLAK     R++          + GT  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
                   + R D+ S G ++M    G  P    +  
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-36
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE------FKVEVEAIGRVR--HKN 243
           ++G GG+G VY G+ + DN  VA+K++  +R     E        +EV  + +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
           ++RLL +       +L+ E  +          +      L  E+  +      + + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 127

Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
                 V+HRDIK  NIL+D  +   KL DFG   LL   +  V T   GT  Y  PE+ 
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181

Query: 363 STGMLNERS-DVYSFGILIMEVISGRNP 389
                + RS  V+S GIL+ +++ G  P
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  132 bits (333), Expect = 3e-36
 Identities = 40/219 (18%), Positives = 77/219 (35%), Gaps = 22/219 (10%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLL 248
              IGEG +G+++ G  L +N  VA+K     R     + + E      +     +  + 
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
            +  EG H +LV + +     +             + +            +  +HE    
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---K 120

Query: 309 KVVHRDIKSSNILLDKQWNP-----KLSDFGLAKLLGAERS------YVTTRVMGTFGYV 357
            +V+RDIK  N L+ +  +       + DFG+ K      +           + GT  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
           +         + R D+ + G + M  + G  P    +  
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-34
 Identities = 45/221 (20%), Positives = 85/221 (38%), Gaps = 13/221 (5%)

Query: 176 YTLRELEVSTNGFAD----ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKE 228
           +  +E+  +             +G G YG V   V       VA+K            K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
              E+  +  +RH+N++ LL             ++           G +  H  L  +  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
             ++    KGL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   +E    T 
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TG 177

Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
            V+  +        +     +  D++S G ++ E+I+G+  
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (321), Expect = 5e-34
 Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 16/247 (6%)

Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
           AA +  GS  ++V   +           W T  +     + F     +G G +G V    
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFL-KKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 207 -LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262
             E   + A+K L   +    K+      E   +  V    LV+L     + ++  +V E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322
           Y+  G +   L          +                YLH      +++RD+K  N+L+
Sbjct: 122 YVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLI 174

Query: 323 DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 382
           D+Q   +++DFG AK         T  + GT   +APE   +   N+  D ++ G+LI E
Sbjct: 175 DQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 383 VISGRNP 389
           + +G  P
Sbjct: 231 MAAGYPP 237

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-34
 Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 22/213 (10%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
             IG+G +G V+     +    VA+K +L  N +         E++ +  ++H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 249 GYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
             C   A           LV+++ ++       +         T      ++     GL 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131

Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYV 357
           Y+H     K++HRD+K++N+L+ +    KL+DFGLA+     ++      T  + T  Y 
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 358 APEYASTGML-NERSDVYSFGILIMEVISGRNP 389
            PE            D++  G ++ E+ +    
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-31
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 18/218 (8%)

Query: 183 VSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNL----LNNRGQAEKEFKVEVE 234
           V    F    V+G G YG V+        +     A+K L    +  + +  +  + E +
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 235 AIGRVRHK-NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
            +  +R    LV L           L+ +YI+ G L   L          T       + 
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVG 136

Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
                L +LH+     +++RDIK  NILLD   +  L+DFGL+K   A+ +       GT
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193

Query: 354 FGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNP 389
             Y+AP+    G    ++  D +S G+L+ E+++G +P
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (297), Expect = 8e-31
 Identities = 51/244 (20%), Positives = 99/244 (40%), Gaps = 24/244 (9%)

Query: 175 WYTLRELEVSTNGFAD---ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK 230
           ++      V      D      +G G Y  V+  + + +N  V VK L   +   +K+ K
Sbjct: 21  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 77

Query: 231 VEVEAIGRVR-HKNLVRLLGYCAEGAHRM--LVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
            E++ +  +R   N++ L     +   R   LV+E+++N + +Q           LT   
Sbjct: 78  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYD 130

Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYV 346
               +    K L Y H      ++HRD+K  N+++D +    +L D+GLA+     + Y 
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 347 TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVCIPQMN 405
               + +  +  PE      M +   D++S G ++  +I  + P  +     +  +    
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

Query: 406 SLMT 409
            L T
Sbjct: 246 VLGT 249

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 5e-29
 Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 9/201 (4%)

Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
           + +G G YG V      +    VAVK  +         K    E+  +  ++H+N++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
                        +     +L      ++     LT +    +I    +GL Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140

Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
            ++HRD+K SN+ +++    K+ DFGLA+    E    T  V   +        +    N
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYN 197

Query: 369 ERSDVYSFGILIMEVISGRNP 389
           +  D++S G ++ E+++GR  
Sbjct: 198 QTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 21/206 (10%)

Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
            IG G  GIV        + NVA+K  +         K    E+  +  V HKN++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 250 YCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
                    E     LV E +D    +               E    ++     G+ +LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136

Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
                 ++HRD+K SNI++      K+ DFGLA+  G   S++ T  + T  Y APE   
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191

Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
                E  D++S G ++ E++  +  
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (260), Expect = 1e-25
 Identities = 42/216 (19%), Positives = 77/216 (35%), Gaps = 18/216 (8%)

Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
              +G G +  V+    + +NT+VA+K ++       +  + E++ + RV   +  +   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 250 YCAEGAHRMLVYEYIDNGNLEQW------------LHGDVGPHSPLTWEIRMNIILGTAK 297
             A    ++L +      N                       H  +       I      
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAERSYVT-TRVMGTFG 355
           GL Y+H      ++H DIK  N+L++       L    +A L  A       T  + T  
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
           Y +PE          +D++S   LI E+I+G    +
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.2 bits (223), Expect = 9e-22
 Identities = 27/163 (16%), Positives = 52/163 (31%), Gaps = 21/163 (12%)

Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK----------NLLNNRGQAEKEFKVEVEAIGRVRH 241
            ++GEG    V++   E      VK           +   R   +  F V      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
           + L +L G          VY +  N  L + +         +       ++    + +  
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118

Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
            +      +VH D+   N+L+ +     + DF  +  +G E  
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	424
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.64
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.19
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.26
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.87
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.19

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=377.70  Aligned_cols=200  Identities=26%  Similarity=0.407  Sum_probs=181.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            457999999999999999999964 6889999999766555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      |++|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++.+....
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999999988654     689999999999999999999999   99999999999999999999999999999765433


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||...
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  219 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence             2345568999999999999999999999999999999999999999743

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=370.24  Aligned_cols=198  Identities=30%  Similarity=0.497  Sum_probs=179.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++.+..   ....+.+.+|+++++.++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999986 57889999986532   334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |||++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++....
T Consensus        86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999865    5789999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .   .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||+..
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  207 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN  207 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence            2   234567999999999999999999999999999999999999999754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=371.96  Aligned_cols=224  Identities=27%  Similarity=0.474  Sum_probs=181.6

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ..++|++.+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|++.+++..++||||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            346789999999999999999999888899999986543 3456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +++|+|.+++...   ...+++..++.++.|+++||+|||++   +|+||||||+|||++.++++||+|||+++......
T Consensus        82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999998765   35788999999999999999999999   99999999999999999999999999998775554


Q ss_pred             ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHHHHHHHH
Q 014466          344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIPQMNSLM  408 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~~~~~~~  408 (424)
                      ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||....              +.+..+..++.+++
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  235 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence            444455679999999999999999999999999999999999 566665321              23344556777777


Q ss_pred             Hhhhcc
Q 014466          409 TLSYCS  414 (424)
Q Consensus       409 ~~~~~~  414 (424)
                      ..||..
T Consensus       236 ~~cl~~  241 (263)
T d1sm2a_         236 NHCWKE  241 (263)
T ss_dssp             HHHTCS
T ss_pred             HHHccC
Confidence            777753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=375.88  Aligned_cols=203  Identities=31%  Similarity=0.448  Sum_probs=177.3

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999975 68899999986543 2344578999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ||++|+|.+++...    ..+++..++.++.|+++||+|||++   +|+||||||+|||++.++++||+|||+|+.+...
T Consensus        84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999999754    5799999999999999999999999   9999999999999999999999999999876433


Q ss_pred             c-ceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          343 R-SYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       343 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      . ....+..+||+.|+|||++.+..+ +.++|||||||+||||+||+.||+...
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~  210 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  210 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence            2 223455789999999999988776 578999999999999999999997644

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=373.40  Aligned_cols=225  Identities=30%  Similarity=0.475  Sum_probs=184.7

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      +++++.++|++.+.||+|+||+||+|+++  ..||||++...  .....+.|.+|++++++++|||||++++++.+ ...
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            34788899999999999999999999864  46999998543  34556789999999999999999999998765 568


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++|||||++|+|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+||||+.++++||+|||+++
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             EEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccccee
Confidence            9999999999999999765   35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCc-ceeeecccccccccccccccC---CCCCCccchHHHHHHHHHHHcCCCCCCCCCC------------------
Q 014466          338 LLGAER-SYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRP------------------  395 (424)
Q Consensus       338 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~------------------  395 (424)
                      ...... ........||+.|+|||++.+   ..|+.++|||||||+||||+||+.||....+                  
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~  232 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS  232 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence            764332 233455789999999999864   4589999999999999999999999975332                  


Q ss_pred             -CCCccHHHHHHHHHhhhc
Q 014466          396 -PGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       396 -~~~~~~~~~~~~~~~~~~  413 (424)
                       ....+..++.+++..||.
T Consensus       233 ~~~~~~~~~l~~li~~cl~  251 (276)
T d1uwha_         233 KVRSNCPKAMKRLMAECLK  251 (276)
T ss_dssp             GSCTTCCHHHHHHHHHHTC
T ss_pred             hccccchHHHHHHHHHHcC
Confidence             122234566777777775

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=374.19  Aligned_cols=206  Identities=26%  Similarity=0.389  Sum_probs=166.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeee--CCeeeEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV  260 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv  260 (424)
                      ++|++.+.||+|+||+||+|++. +|+.||+|.+....  ....+.+.+|++++++++|||||++++++.+  +..+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            47999999999999999999975 58889999986543  3345678899999999999999999999865  4568899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ||||++|+|.+++.........+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999999764333467999999999999999999999861  01399999999999999999999999999987


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +.... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||..
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence            64432 234457899999999999999999999999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.3e-50  Score=376.28  Aligned_cols=229  Identities=25%  Similarity=0.419  Sum_probs=195.7

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      +++++..++|++.+.||+|+||+||+|++. +++.||||++.... ...++|.+|+++|++++|||||++++++.+++..
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            345788889999999999999999999986 47789999986543 3456799999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ++|||||++|+|.+++....  ...+++..+..++.|+++||+|||++   +|+||||||+||||+.++++||+|||+++
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             EEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence            99999999999999997652  35789999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC---------------CCCCccHH
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR---------------PPGEVCIP  402 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~---------------~~~~~~~~  402 (424)
                      ..............||+.|+|||++.+..|+.++|||||||++|||++|..||....               +.+..+..
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  243 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence            876655555555678999999999999999999999999999999999777654221               22233455


Q ss_pred             HHHHHHHhhhc
Q 014466          403 QMNSLMTLSYC  413 (424)
Q Consensus       403 ~~~~~~~~~~~  413 (424)
                      ++.+++..||.
T Consensus       244 ~l~~li~~cl~  254 (287)
T d1opja_         244 KVYELMRACWQ  254 (287)
T ss_dssp             HHHHHHHHHTC
T ss_pred             HHHHHHHHHcC
Confidence            66666666665

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=373.20  Aligned_cols=227  Identities=28%  Similarity=0.477  Sum_probs=193.8

Q ss_pred             eeeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       180 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      +++++.++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..++
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            4577888999999999999999999999888899999986543 345679999999999999999999998865 56789


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ||||+++|+|.+++....  ...+++..++.++.|+++||.|||++   +|+||||||+||||++++.+||+|||+|+.+
T Consensus        85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence            999999999999886542  23589999999999999999999998   9999999999999999999999999999987


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCC-CCCCC--------------CCCCCccHHHH
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN-PVDYS--------------RPPGEVCIPQM  404 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~-Pf~~~--------------~~~~~~~~~~~  404 (424)
                      ............||+.|+|||++.+..|+.++|||||||++|||+||.. ||...              .+.+..+..++
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL  239 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHH
Confidence            6655555566789999999999999999999999999999999999555 45421              12334456677


Q ss_pred             HHHHHhhhc
Q 014466          405 NSLMTLSYC  413 (424)
Q Consensus       405 ~~~~~~~~~  413 (424)
                      .+++..||.
T Consensus       240 ~~li~~cl~  248 (272)
T d1qpca_         240 YQLMRLCWK  248 (272)
T ss_dssp             HHHHHHHTC
T ss_pred             HHHHHHHcC
Confidence            778877775

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=384.08  Aligned_cols=202  Identities=26%  Similarity=0.426  Sum_probs=180.4

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ++..++|++.+.||+|+||+||+|++. +|+.||+|++... .....+.+.+|+++|++++|||||+++++|.++.+.++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            566789999999999999999999975 5788999998654 33445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++++||+|||+|+.
T Consensus        82 VmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             EEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            99999999999999865    578999999999999999999996 5   899999999999999999999999999986


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +...   .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       155 ~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         155 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             HHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             cCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            5322   234568999999999999999999999999999999999999999754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=374.67  Aligned_cols=202  Identities=24%  Similarity=0.367  Sum_probs=179.5

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .+.|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            356899999999999999999976 5888999999777666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      |++|+|.+++.+.   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+++..... 
T Consensus        91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-  163 (288)
T d2jfla1          91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-  163 (288)
T ss_dssp             CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred             CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence            9999999998654   25799999999999999999999999   9999999999999999999999999999764322 


Q ss_pred             ceeeeccccccccccccccc-----CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .......+||+.|+|||++.     ...|+.++|||||||++|||+||+.||...
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~  218 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL  218 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence            12234567999999999883     566899999999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=373.26  Aligned_cols=201  Identities=24%  Similarity=0.383  Sum_probs=177.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++++.||+|+||+||+|++. +++.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 68899999986532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |||++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999998865    5799999999999999999999999   999999999999999999999999999987654


Q ss_pred             Cc-ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence            32 22344568999999999999999999999999999999999999999753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=362.39  Aligned_cols=223  Identities=22%  Similarity=0.396  Sum_probs=196.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      .++|++.+.||+|+||+||+|++++++.||||++.+... ..++|.+|++++++++|||||+++|++.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            468999999999999999999998888999999876543 4567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++|+|.+++...   ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            999999997665   35788999999999999999999998   999999999999999999999999999987655544


Q ss_pred             eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCC--------------CCCCCCccHHHHHHHHH
Q 014466          345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY--------------SRPPGEVCIPQMNSLMT  409 (424)
Q Consensus       345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~--------------~~~~~~~~~~~~~~~~~  409 (424)
                      .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||+.              ..+.+..+..++.+++.
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence            44556779999999999999999999999999999999998 8999983              23445556677888888


Q ss_pred             hhhcc
Q 014466          410 LSYCS  414 (424)
Q Consensus       410 ~~~~~  414 (424)
                      .||..
T Consensus       236 ~cl~~  240 (258)
T d1k2pa_         236 SCWHE  240 (258)
T ss_dssp             HTTCS
T ss_pred             HHccC
Confidence            88863

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.9e-49  Score=371.71  Aligned_cols=227  Identities=30%  Similarity=0.483  Sum_probs=181.9

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcC-CC---EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLED-NT---NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ++..++|++.+.||+|+||+||+|+++. ++   .||||++... .....+.|.+|+++|++++|||||+++|++.+++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            3455678999999999999999999753 22   4788988654 33455689999999999999999999999999999


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++|||||++|+|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+||||+.++++||+|||++
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccc
Confidence            99999999999999998865   35789999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCccee----eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCC
Q 014466          337 KLLGAERSYV----TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPG  397 (424)
Q Consensus       337 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~  397 (424)
                      +.+.......    .....||+.|+|||++.+..|+.++|||||||+||||+| |+.||...              .|.+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~  255 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP  255 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            8765432221    123457999999999999999999999999999999998 89999732              2344


Q ss_pred             CccHHHHHHHHHhhhcc
Q 014466          398 EVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       398 ~~~~~~~~~~~~~~~~~  414 (424)
                      ..+..++.+++..||..
T Consensus       256 ~~~~~~l~~li~~cl~~  272 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQK  272 (299)
T ss_dssp             TTCCHHHHHHHHHHTCS
T ss_pred             ccchHHHHHHHHHHcCC
Confidence            55667788888888863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=364.75  Aligned_cols=226  Identities=29%  Similarity=0.500  Sum_probs=190.5

Q ss_pred             eecCCCccccee-EcccCcEEEEEEEEc---CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          182 EVSTNGFADENV-IGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       182 ~~~~~~~~~~~~-LG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      -+..++|.+.+. ||+|+||+||+|.++   ++..||||++.... ....++|.+|+++|++++|||||++++++.+ +.
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            455667888885 999999999999864   34469999986543 3456789999999999999999999999975 45


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhh
Confidence            88999999999999998654   35789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccee--eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCc
Q 014466          337 KLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEV  399 (424)
Q Consensus       337 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~  399 (424)
                      +.+.......  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....              +.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~  236 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE  236 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT
T ss_pred             hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            9875543322  234568999999999999999999999999999999998 999997432              23344


Q ss_pred             cHHHHHHHHHhhhcc
Q 014466          400 CIPQMNSLMTLSYCS  414 (424)
Q Consensus       400 ~~~~~~~~~~~~~~~  414 (424)
                      +..++.+++..||..
T Consensus       237 ~~~~l~~li~~cl~~  251 (285)
T d1u59a_         237 CPPELYALMSDCWIY  251 (285)
T ss_dssp             CCHHHHHHHHHTTCS
T ss_pred             CCHHHHHHHHHHcCC
Confidence            567788888888763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=373.55  Aligned_cols=203  Identities=27%  Similarity=0.314  Sum_probs=182.2

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      ..++|++++.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|+++|++++||||++++++++++..+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            3468999999999999999999975 68899999986542   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      |||||++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus        83 v~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             ceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence            99999999999999876    5789999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       156 ~~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         156 ISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             CCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence            432 233456789999999999999999999999999999999999999997543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-48  Score=359.43  Aligned_cols=195  Identities=28%  Similarity=0.460  Sum_probs=169.6

Q ss_pred             cccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee----CCeeeEE
Q 014466          188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV  260 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lv  260 (424)
                      |++.++||+|+||+||+|++. +++.||+|++...  .....+.|.+|+++|++++|||||++++++.+    +...++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356678999999999999976 5778999998654  33445678999999999999999999999865    3467899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeCCCCCCCEEEc-CCCceEEEecCCcc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLD-KQWNPKLSDFGLAK  337 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kL~DfG~a~  337 (424)
                      |||+++|+|.+++.+.    ..+++..++.++.|+++||+|||++   +  |+||||||+|||++ +++.+||+|||+++
T Consensus        91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            9999999999999865    5789999999999999999999998   6  99999999999996 57899999999998


Q ss_pred             ccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....   .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||...
T Consensus       164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence            64332   2345689999999998875 5999999999999999999999999643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-48  Score=370.03  Aligned_cols=200  Identities=25%  Similarity=0.383  Sum_probs=162.7

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ..+.|++.+.||+|+||+||+|++. +++.||||++.+... ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999976 588899999975532 33456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc---CCCceEEEecCCccc
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKL  338 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DfG~a~~  338 (424)
                      |||+||+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||+.   +++.+||+|||+++.
T Consensus        87 E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            999999999999765    5799999999999999999999999   999999999999994   578999999999986


Q ss_pred             cCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      ....  ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..
T Consensus       160 ~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  211 (307)
T d1a06a_         160 EDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD  211 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence            5432  233456899999999999999999999999999999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.1e-48  Score=372.85  Aligned_cols=200  Identities=25%  Similarity=0.428  Sum_probs=181.1

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      ++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999975 68899999998776666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC--CCceEEEecCCccccCCC
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kL~DfG~a~~~~~~  342 (424)
                      ++|+|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999654   35799999999999999999999999   9999999999999954  678999999999976543


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  228 (350)
T d1koaa2         180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  228 (350)
T ss_dssp             S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence            3  234567999999999999999999999999999999999999999653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=370.48  Aligned_cols=230  Identities=27%  Similarity=0.430  Sum_probs=189.0

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCC------CEEEEEEeecC-CchhHHHHHHHHHHHhcC-CCCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDN------TNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  252 (424)
                      ++++.++|++.+.||+|+||+||+|++...      ..||+|.+... .......+.+|+.++.++ +|||||++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            367788999999999999999999997532      25899988654 333446788999999998 8999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeC
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVG-------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR  313 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHr  313 (424)
                      +.+..++|||||++|+|.++++....                   ....+++..++.++.|+++||+|||++   +|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            99999999999999999999976532                   124589999999999999999999999   99999


Q ss_pred             CCCCCCEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCC
Q 014466          314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD  391 (424)
Q Consensus       314 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~  391 (424)
                      ||||+|||++.++++||+|||+|+........ ......||+.|+|||++.+..|+.++|||||||+||||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876443332 2345678999999999999999999999999999999998 899997


Q ss_pred             CCC---------------CCCCccHHHHHHHHHhhhc
Q 014466          392 YSR---------------PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       392 ~~~---------------~~~~~~~~~~~~~~~~~~~  413 (424)
                      ...               +.+..+..++.+++..||.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~  305 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA  305 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcC
Confidence            532               1233445566667776665

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.4e-47  Score=370.97  Aligned_cols=199  Identities=23%  Similarity=0.362  Sum_probs=180.5

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEec
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI  264 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  264 (424)
                      +.|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999975 68899999997776666678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEc--CCCceEEEecCCccccCCC
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DfG~a~~~~~~  342 (424)
                      ++|+|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+||||+  .++.+||+|||+|..+...
T Consensus       109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999987654   35799999999999999999999999   999999999999997  5789999999999987543


Q ss_pred             cceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .  ......||+.|+|||++.+..|+.++|||||||+||||+||+.||..
T Consensus       183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            3  33456799999999999999999999999999999999999999974

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-48  Score=363.37  Aligned_cols=226  Identities=28%  Similarity=0.453  Sum_probs=184.8

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ++++.++|++.+.||+|+||+||+|++++++.||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++|
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            367788999999999999999999999888889999986443 445779999999999999999999999865 567899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|..++....  ...+++..++.++.|++.||+|||++   +|+||||||+||||+.++++||+|||+++.+.
T Consensus        90 ~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence            99999999999987642  24689999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCC-CC--------------CCCCCCccHHHHH
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV-DY--------------SRPPGEVCIPQMN  405 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf-~~--------------~~~~~~~~~~~~~  405 (424)
                      ...........||+.|+|||++....++.++|||||||++|||++|..|| ..              ..+.+..+..++.
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  244 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH  244 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHH
Confidence            55444455577999999999999999999999999999999999966554 31              2234444556777


Q ss_pred             HHHHhhhc
Q 014466          406 SLMTLSYC  413 (424)
Q Consensus       406 ~~~~~~~~  413 (424)
                      +++..||.
T Consensus       245 ~li~~cl~  252 (285)
T d1fmka3         245 DLMCQCWR  252 (285)
T ss_dssp             HHHHHHTC
T ss_pred             HHHHHHcc
Confidence            77777775

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.2e-48  Score=367.24  Aligned_cols=197  Identities=30%  Similarity=0.426  Sum_probs=178.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+.   .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            47899999999999999999975 5889999998653   2234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      |||+||+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus        84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999999876    5678889999999999999999999   999999999999999999999999999987643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .    ....+||+.|+|||++.+..|+.++|||||||+||||+||+.||...
T Consensus       157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  204 (316)
T d1fota_         157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  204 (316)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence            2    34568999999999999999999999999999999999999999753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-47  Score=364.45  Aligned_cols=194  Identities=29%  Similarity=0.435  Sum_probs=173.0

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .|+..+.||+|+||+||+|++. +++.||||++....   ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5889999999999999999975 57789999986543   2334578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ||++|+|..++...    .++++..++.++.|++.||.|||++   +|+||||||+|||++.++++||+|||+++.... 
T Consensus        96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999998777654    5789999999999999999999999   999999999999999999999999999986532 


Q ss_pred             cceeeecccccccccccccccC---CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                          ....+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||..
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~  216 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence                234679999999999854   5689999999999999999999999964

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=358.96  Aligned_cols=226  Identities=30%  Similarity=0.500  Sum_probs=183.3

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCC-----CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ++..+.|+..++||+|+||.||+|.++++     ..||||++.... .....+|.+|++++++++|||||+++|++.+..
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            45667899999999999999999997642     358999986543 334567899999999999999999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+.+|++.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccch
Confidence            999999999999999988765   35789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcc--eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCC---------------CCCCCC
Q 014466          336 AKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY---------------SRPPGE  398 (424)
Q Consensus       336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~---------------~~~~~~  398 (424)
                      ++.+.....  .......||+.|+|||++.+..|+.++|||||||++|||++|..||..               ..+.+.
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~  236 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  236 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch
Confidence            987644322  233445689999999999999999999999999999999996665542               123444


Q ss_pred             ccHHHHHHHHHhhhc
Q 014466          399 VCIPQMNSLMTLSYC  413 (424)
Q Consensus       399 ~~~~~~~~~~~~~~~  413 (424)
                      .+..++.+++..||.
T Consensus       237 ~~~~~l~~li~~cl~  251 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQ  251 (283)
T ss_dssp             TCBHHHHHHHHHHTC
T ss_pred             hhHHHHHHHHHHHCc
Confidence            456777888888876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=357.14  Aligned_cols=214  Identities=31%  Similarity=0.494  Sum_probs=180.0

Q ss_pred             eeEcccCcEEEEEEEEcC---CCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEecCC
Q 014466          192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN  266 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  266 (424)
                      ++||+|+||+||+|.+++   ++.||||++...  .....++|.+|+++|++++|||||++++++.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998653   357999998643  33445689999999999999999999999965 457899999999


Q ss_pred             CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCccee
Q 014466          267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV  346 (424)
Q Consensus       267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~  346 (424)
                      |+|.++++..    ..+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus        92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999999865    5789999999999999999999999   99999999999999999999999999998765443322


Q ss_pred             --eecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCCccHHHHHHHHH
Q 014466          347 --TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGEVCIPQMNSLMT  409 (424)
Q Consensus       347 --~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~~~~~~~~~~~~  409 (424)
                        .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||...              .+.+..+..++.+++.
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~  244 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  244 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence              234578999999999999999999999999999999998 99999742              2234456677888888


Q ss_pred             hhhc
Q 014466          410 LSYC  413 (424)
Q Consensus       410 ~~~~  413 (424)
                      .||.
T Consensus       245 ~cl~  248 (277)
T d1xbba_         245 LCWT  248 (277)
T ss_dssp             HHTC
T ss_pred             HHcC
Confidence            8886

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=357.34  Aligned_cols=227  Identities=26%  Similarity=0.420  Sum_probs=180.3

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA  255 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  255 (424)
                      ++++.++|++.+.||+|+||.||+|++..    +..||||.+.... ....+.|.+|++++++++|||||++++++.+ +
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~   80 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N   80 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            46788899999999999999999998753    2458888885543 3445679999999999999999999999964 6


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..++||||+++|+|.+++...   ...+++..++.++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             eEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence            789999999999999988765   35789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCcc
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVC  400 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~  400 (424)
                      ++..............||+.|+|||++.+..|+.++|||||||++|||+| |..||....              +.+..+
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  234 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  234 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred             heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            98765554555566778999999999999999999999999999999998 899998543              233345


Q ss_pred             HHHHHHHHHhhhcc
Q 014466          401 IPQMNSLMTLSYCS  414 (424)
Q Consensus       401 ~~~~~~~~~~~~~~  414 (424)
                      ..++.+++..||..
T Consensus       235 ~~~~~~li~~cl~~  248 (273)
T d1mp8a_         235 PPTLYSLMTKCWAY  248 (273)
T ss_dssp             CHHHHHHHHHHTCS
T ss_pred             CHHHHHHHHHHcCC
Confidence            56777777777763

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=358.10  Aligned_cols=200  Identities=25%  Similarity=0.394  Sum_probs=178.9

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC------chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+..      ....+.+.+|+++|++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999975 68899999986532      22357899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC----ceEEEec
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDF  333 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kL~Df  333 (424)
                      |||||||++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999765    5799999999999999999999999   999999999999998776    4999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |++.......  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  219 (293)
T d1jksa_         162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  219 (293)
T ss_dssp             TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence            9998764332  234567999999999999999999999999999999999999999754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-47  Score=366.88  Aligned_cols=197  Identities=24%  Similarity=0.298  Sum_probs=178.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  261 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  261 (424)
                      ++|++++.||+|+||.||+|+++ +|+.||||++.+..   ....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            58999999999999999999975 68899999986532   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCC
Q 014466          262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA  341 (424)
Q Consensus       262 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~  341 (424)
                      ||+.+|+|.+++.+.    ..+++..++.++.||+.||.|||++   +||||||||+|||++.++++||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999999765    5789999999999999999999999   999999999999999999999999999997643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .    .....||+.|+|||++.+..|+.++|||||||+||||+||+.||...
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  241 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence            2    23467999999999999999999999999999999999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-46  Score=364.08  Aligned_cols=200  Identities=25%  Similarity=0.351  Sum_probs=174.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---hhHHHH---HHHHHHHhcCCCCceeeEeeEeeeCCee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEF---KVEVEAIGRVRHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  257 (424)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.+...   .....+   ..|+++++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            468999999999999999999976 588999999864321   112223   3457788888999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      |+|||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            9999999999999999875    5788999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcceeeeccccccccccccccc-CCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          338 LLGAERSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .+...   .....+||+.|+|||++. +..|+.++|||||||+||||+||+.||....
T Consensus       156 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         156 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             ECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             ecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence            76443   234567999999999986 4679999999999999999999999997543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=356.69  Aligned_cols=200  Identities=27%  Similarity=0.393  Sum_probs=176.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHh-cCCCCceeeEeeEeeeCCeeeEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIG-RVRHKNLVRLLGYCAEGAHRMLV  260 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~lv  260 (424)
                      ++|++++.||+|+||+||+|++. +++.||||++.+..   ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999976 58889999996532   233445666666654 68999999999999999999999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999865    5789999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .. ....+...||+.|+|||++.+..|+.++|||||||++|||+||+.||...
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~  206 (320)
T d1xjda_         155 LG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  206 (320)
T ss_dssp             CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cc-cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence            33 23345568999999999999999999999999999999999999999753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-46  Score=355.77  Aligned_cols=234  Identities=28%  Similarity=0.440  Sum_probs=195.4

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCceeeEeeE
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGY  250 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~  250 (424)
                      +.++++++++|++.+.||+|+||+||+|+++      +++.||||++..... ...++|.+|++++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            4457889999999999999999999999975      346799999865433 345679999999999999999999999


Q ss_pred             eeeCCeeeEEEEecCCCCHHHHHccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 014466          251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV  310 (424)
Q Consensus       251 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i  310 (424)
                      +.+.+..+++|||+++|+|.+++.....                    ....+++..++.++.|+++||+|||++   +|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence            9999999999999999999999965321                    123588999999999999999999999   99


Q ss_pred             eeCCCCCCCEEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCC-C
Q 014466          311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-N  388 (424)
Q Consensus       311 vHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~-~  388 (424)
                      +||||||+||||+.++++||+|||+++.+..... .......||+.|+|||.+.+..|+.++|||||||++|||++|. .
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999986644332 2334567899999999999999999999999999999999986 5


Q ss_pred             CCCCCC--------------CCCCccHHHHHHHHHhhhcc
Q 014466          389 PVDYSR--------------PPGEVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       389 Pf~~~~--------------~~~~~~~~~~~~~~~~~~~~  414 (424)
                      ||....              +.+..+..++..++..||..
T Consensus       242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~  281 (301)
T d1lufa_         242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSK  281 (301)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCC
Confidence            676322              23445567788888888863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.3e-46  Score=350.41  Aligned_cols=203  Identities=27%  Similarity=0.438  Sum_probs=170.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC----e
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----H  256 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~  256 (424)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....   ....+.+.+|+++++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999975 68899999996543   334567899999999999999999999987654    3


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .|+||||++||+|.+++...    ..+++..++.++.|+++||+|||++   +|+||||||+|||++.++..+|+|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            78999999999999998765    5789999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCc--ceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          337 KLLGAER--SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       337 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .......  .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  218 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  218 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence            7653322  223445689999999999999999999999999999999999999997543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=353.19  Aligned_cols=201  Identities=20%  Similarity=0.319  Sum_probs=178.1

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .++|++++.||+|+||+||+|.+. +++.||||.+.... .....+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999976 57789999986553 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC--CceEEEecCCccccCC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ--WNPKLSDFGLAKLLGA  341 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DfG~a~~~~~  341 (424)
                      |+||+|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+|||++.+  ..+||+|||+++....
T Consensus        83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999765   24689999999999999999999999   99999999999999854  4799999999987643


Q ss_pred             CcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ..  ......||+.|+|||.+.+..|+.++|||||||++|||++|+.||....
T Consensus       157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~  207 (321)
T d1tkia_         157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence            32  2344678999999999999999999999999999999999999997543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-45  Score=345.44  Aligned_cols=200  Identities=26%  Similarity=0.404  Sum_probs=176.9

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc---------hhHHHHHHHHHHHhcCC-CCceeeEeeEeee
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---------QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAE  253 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~  253 (424)
                      .++|++.+.||+|+||+||+|+.. +++.||||++.+...         ...+.+.+|++++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            468999999999999999999975 688899999865432         12345788999999997 9999999999999


Q ss_pred             CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEec
Q 014466          254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF  333 (424)
Q Consensus       254 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~Df  333 (424)
                      ++..|||||||++|+|.++++.+    ..+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence            99999999999999999999765    5799999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCcceeeeccccccccccccccc------CCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      |+++.++...  ......||+.|+|||.+.      ...++.++||||+||+||||++|+.||...
T Consensus       155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~  218 (277)
T d1phka_         155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  218 (277)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence            9999775432  234567999999999874      345789999999999999999999999754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=353.42  Aligned_cols=221  Identities=29%  Similarity=0.493  Sum_probs=182.7

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCC----EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+|+++++||+|+||+||+|.+. +|+    +||+|++... .....++|.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            57999999999999999999975 343    5888888643 334567899999999999999999999999875 4678


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      ++||+.+|+|.+++...   ...+++..++.++.|+++||+|||++   +|+||||||+||||+.++++||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            88999999999988765   36789999999999999999999999   9999999999999999999999999999977


Q ss_pred             CCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------CCCCCccHHH
Q 014466          340 GAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------RPPGEVCIPQ  403 (424)
Q Consensus       340 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~~~~~~~~~~  403 (424)
                      ...... ......||+.|+|||++.+..|+.++|||||||+||||+| |..||+..              .+.+..+..+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~  241 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  241 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            543332 3344578999999999999999999999999999999999 89999843              2344456677


Q ss_pred             HHHHHHhhhc
Q 014466          404 MNSLMTLSYC  413 (424)
Q Consensus       404 ~~~~~~~~~~  413 (424)
                      +..++..||.
T Consensus       242 ~~~li~~cl~  251 (317)
T d1xkka_         242 VYMIMVKCWM  251 (317)
T ss_dssp             HHHHHHHHTC
T ss_pred             HHHHHHHhCC
Confidence            8888888876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=345.67  Aligned_cols=221  Identities=29%  Similarity=0.458  Sum_probs=179.6

Q ss_pred             eecCCCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeee-CCeeeEE
Q 014466          182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLV  260 (424)
Q Consensus       182 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lv  260 (424)
                      ++..++|++.+.||+|+||.||+|+++ |+.||||++.+.  ...+.|.+|++++++++|||||+++|++.+ .+..++|
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            667778999999999999999999986 778999998653  344679999999999999999999998854 4568999


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccC
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG  340 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~  340 (424)
                      |||+++|+|.+++....  ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            99999999999997542  23589999999999999999999998   99999999999999999999999999998653


Q ss_pred             CCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--------------CCCCccHHHHH
Q 014466          341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------------PPGEVCIPQMN  405 (424)
Q Consensus       341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--------------~~~~~~~~~~~  405 (424)
                      ..    .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||+...              +.+..+..++.
T Consensus       155 ~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (262)
T d1byga_         155 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY  230 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred             CC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            32    233568999999999999999999999999999999998 788887432              22233446777


Q ss_pred             HHHHhhhcc
Q 014466          406 SLMTLSYCS  414 (424)
Q Consensus       406 ~~~~~~~~~  414 (424)
                      +++..||..
T Consensus       231 ~li~~cl~~  239 (262)
T d1byga_         231 EVMKNCWHL  239 (262)
T ss_dssp             HHHHHHTCS
T ss_pred             HHHHHHccc
Confidence            777777763

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=348.59  Aligned_cols=233  Identities=27%  Similarity=0.391  Sum_probs=180.5

Q ss_pred             eeeeeecCCCcccceeEcccCcEEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEee
Q 014466          178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLG  249 (424)
Q Consensus       178 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~  249 (424)
                      ..+++++.++|++.+.||+|+||.||+|++..      ++.||||++.... ....+.+..|.+.+.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            34557888899999999999999999999642      3579999986543 34456677888888777 6899999999


Q ss_pred             EeeeC-CeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCC
Q 014466          250 YCAEG-AHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK  316 (424)
Q Consensus       250 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlk  316 (424)
                      ++.+. ...++|||||++|+|.++++....            ....+++..+..++.|+++||+|||++   +|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence            98654 468899999999999999975432            134588999999999999999999999   99999999


Q ss_pred             CCCEEEcCCCceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcC-CCCCCCCC
Q 014466          317 SSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSR  394 (424)
Q Consensus       317 p~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg-~~Pf~~~~  394 (424)
                      |+||||+.++++||+|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||+|| ..||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876443332 33456799999999999999999999999999999999996 56786432


Q ss_pred             C---------------CCCccHHHHHHHHHhhhc
Q 014466          395 P---------------PGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       395 ~---------------~~~~~~~~~~~~~~~~~~  413 (424)
                      .               .+..+..++.+++..||.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  275 (299)
T d1ywna1         242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  275 (299)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcC
Confidence            1               223344566667776665

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=343.72  Aligned_cols=224  Identities=26%  Similarity=0.426  Sum_probs=178.1

Q ss_pred             cCCCcccceeEcccCcEEEEEEEEcC--C--CEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCe
Q 014466          184 STNGFADENVIGEGGYGIVYHGVLED--N--TNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH  256 (424)
Q Consensus       184 ~~~~~~~~~~LG~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  256 (424)
                      ..++|++.+.||+|+||.||+|++..  +  ..||||++.+.   .....++|.+|++++++++|||||+++|++.++ .
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence            44679999999999999999998642  2  25899988653   334557899999999999999999999999764 6


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .++||||+++|+|.+++...   ...+++..++.++.|+++||.|||++   +|+||||||+||||+.++++||+|||++
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             hheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhh
Confidence            78999999999999988765   25689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcce--eeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCC--------------C-CCCC
Q 014466          337 KLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS--------------R-PPGE  398 (424)
Q Consensus       337 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~--------------~-~~~~  398 (424)
                      +.+......  ......||..|+|||++.+..++.++|||||||++|||+| |+.||...              + +...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE  238 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc
Confidence            987544332  2234568889999999999999999999999999999998 89999622              1 2334


Q ss_pred             ccHHHHHHHHHhhhcc
Q 014466          399 VCIPQMNSLMTLSYCS  414 (424)
Q Consensus       399 ~~~~~~~~~~~~~~~~  414 (424)
                      ....++.+++..||..
T Consensus       239 ~~~~~l~~li~~cl~~  254 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAH  254 (273)
T ss_dssp             TCCHHHHHHHHHHTCS
T ss_pred             cccHHHHHHHHHHcCC
Confidence            4456777888888763

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-45  Score=346.34  Aligned_cols=196  Identities=27%  Similarity=0.359  Sum_probs=166.2

Q ss_pred             cceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCch-----hHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          190 DENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       190 ~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      .+++||+|+||+||+|++. +|+.||||++......     ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999975 5889999998544222     124688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +.++++..+....    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9987777665433    5688889999999999999999999   99999999999999999999999999998764432


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ......+||+.|+|||++.. ..|+.++|||||||++|||+||+.||...
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence             22344679999999998864 56899999999999999999999999653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=351.32  Aligned_cols=197  Identities=25%  Similarity=0.346  Sum_probs=169.8

Q ss_pred             CCcccc-eeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhc-CCCCceeeEeeEeee----CCeee
Q 014466          186 NGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAE----GAHRM  258 (424)
Q Consensus       186 ~~~~~~-~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~----~~~~~  258 (424)
                      ++|++. ++||+|+||+||+|++. +++.||||++.+.     +.+.+|++++.+ .+|||||+++++|++    +..+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            478876 46999999999999974 6889999998542     456679988655 489999999999875    45689


Q ss_pred             EEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCC
Q 014466          259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL  335 (424)
Q Consensus       259 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~  335 (424)
                      +|||||+||+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.   ++.+||+|||+
T Consensus        86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence            9999999999999997642  25799999999999999999999999   9999999999999975   55799999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++......  .....+||+.|+|||++.+..|+.++|||||||+||||+||+.||....
T Consensus       161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence            98764432  3345689999999999999999999999999999999999999997543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=344.55  Aligned_cols=233  Identities=24%  Similarity=0.450  Sum_probs=195.2

Q ss_pred             eeeeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEe
Q 014466          179 RELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYC  251 (424)
Q Consensus       179 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  251 (424)
                      ++++++.++|++.+.||+|+||.||+|.+.      +++.||||++.... ......|.+|++++++++|||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            345788899999999999999999999864      25679999996543 34445789999999999999999999999


Q ss_pred             eeCCeeeEEEEecCCCCHHHHHccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          252 AEGAHRMLVYEYIDNGNLEQWLHGDV------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       252 ~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      ..+...++||||+++|+|.+++....      .....+++..+..++.|+++||.|||++   +|+||||||+|||++.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence            99999999999999999999986432      1235678999999999999999999999   99999999999999999


Q ss_pred             CceEEEecCCccccCCCcce-eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcC-CCCCCCCC---------
Q 014466          326 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSR---------  394 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg-~~Pf~~~~---------  394 (424)
                      +++||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||+|| +.||....         
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999876443332 23445789999999999999999999999999999999998 57776322         


Q ss_pred             -----CCCCccHHHHHHHHHhhhcc
Q 014466          395 -----PPGEVCIPQMNSLMTLSYCS  414 (424)
Q Consensus       395 -----~~~~~~~~~~~~~~~~~~~~  414 (424)
                           +.+..+..++.+++..||..
T Consensus       250 ~~~~~~~p~~~~~~l~~li~~cl~~  274 (308)
T d1p4oa_         250 EGGLLDKPDNCPDMLFELMRMCWQY  274 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             hCCCCCCcccchHHHHHHHHHHcCC
Confidence                 23344556788888888763

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=342.41  Aligned_cols=230  Identities=27%  Similarity=0.435  Sum_probs=186.9

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEcC--------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCceeeEeeE
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGY  250 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  250 (424)
                      ++++.++|++.+.||+|+||.||+|+...        +..||||++..... ....++.+|...+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            36778899999999999999999998643        23689999876543 4456788899999888 89999999999


Q ss_pred             eeeCCeeeEEEEecCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCC
Q 014466          251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       251 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~  318 (424)
                      +.++...++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence            9999999999999999999999976531            235689999999999999999999999   9999999999


Q ss_pred             CEEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCC--
Q 014466          319 NILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--  394 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~--  394 (424)
                      |||++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++|||||||++|||++ |+.||....  
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999999999987644332 23345678999999999999999999999999999999998 788886322  


Q ss_pred             ------------CCCCccHHHHHHHHHhhhc
Q 014466          395 ------------PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       395 ------------~~~~~~~~~~~~~~~~~~~  413 (424)
                                  +.+..+..++.+++..||.
T Consensus       245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  275 (299)
T d1fgka_         245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWH  275 (299)
T ss_dssp             HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTC
T ss_pred             HHHHHHHcCCCCCCCccchHHHHHHHHHHcc
Confidence                        2233344566666666665

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=342.78  Aligned_cols=201  Identities=25%  Similarity=0.441  Sum_probs=171.0

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++++.||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++|||||++++++.++.+.|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999975 68899999985442  2234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      |+.+ ++.+++....  ...+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9976 5555554331  35799999999999999999999999   9999999999999999999999999999876433


Q ss_pred             cceeeecccccccccccccccCCC-CCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                       ........||+.|+|||++.... ++.++|+|||||++|||++|+.||...
T Consensus       156 -~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         156 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             -SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence             23344567999999999876655 578999999999999999999999653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=343.25  Aligned_cols=226  Identities=26%  Similarity=0.428  Sum_probs=183.9

Q ss_pred             ecCCCcccceeEcccCcEEEEEEEEcC-CC--EEEEEEeecC-CchhHHHHHHHHHHHhcC-CCCceeeEeeEeeeCCee
Q 014466          183 VSTNGFADENVIGEGGYGIVYHGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  257 (424)
Q Consensus       183 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  257 (424)
                      +..++|++.+.||+|+||.||+|++++ +.  .||||++... .....++|.+|+++|+++ +|||||++++++.+++..
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            355789999999999999999999764 43  3678887543 333456799999999999 799999999999999999


Q ss_pred             eEEEEecCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCC
Q 014466          258 MLVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ  325 (424)
Q Consensus       258 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~  325 (424)
                      ++||||+++|+|.++++...            .....+++..++.++.|+++||.|||++   +|+||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence            99999999999999997652            2346799999999999999999999999   99999999999999999


Q ss_pred             CceEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCC-CCCCCCC----------
Q 014466          326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-NPVDYSR----------  394 (424)
Q Consensus       326 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~-~Pf~~~~----------  394 (424)
                      +.+||+|||+++.....  .......||..|+|||.+.+..|+.++|||||||++|||++|. .||....          
T Consensus       164 ~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CceEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            99999999999864322  2223456899999999999999999999999999999999965 5675321          


Q ss_pred             ----CCCCccHHHHHHHHHhhhc
Q 014466          395 ----PPGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       395 ----~~~~~~~~~~~~~~~~~~~  413 (424)
                          +.+..+..++.+++..||.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~  264 (309)
T d1fvra_         242 GYRLEKPLNCDDEVYDLMRQCWR  264 (309)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTC
T ss_pred             cCCCCCCccCCHHHHHHHHHHcC
Confidence                2233455677778877775

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=342.66  Aligned_cols=230  Identities=27%  Similarity=0.401  Sum_probs=191.3

Q ss_pred             eeecCCCcccceeEcccCcEEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCceeeEeeEee
Q 014466          181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA  252 (424)
Q Consensus       181 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  252 (424)
                      ++++.++|++.+.||+|+||.||+|++.      +++.||||++.... .....+|.+|+.+++++ +|||||++++++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            4677889999999999999999999863      34579999997643 34456789999999999 6999999999999


Q ss_pred             eCCeeeEEEEecCCCCHHHHHccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCC
Q 014466          253 EGAHRMLVYEYIDNGNLEQWLHGDVG--------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS  318 (424)
Q Consensus       253 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~  318 (424)
                      ++...++|||||++|+|.+++++...              ....+++..+..++.||++||+|||++   +++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence            99999999999999999999976532              234689999999999999999999999   9999999999


Q ss_pred             CEEEcCCCceEEEecCCccccCCCcc-eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHc-CCCCCCCCCC-
Q 014466          319 NILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP-  395 (424)
Q Consensus       319 NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~ellt-g~~Pf~~~~~-  395 (424)
                      |||++.++.+||+|||+++....... ......+||+.|+|||++.+..++.++|||||||++|||+| |..||..... 
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999997754433 33445789999999999999999999999999999999999 5555654322 


Q ss_pred             --------------CCCccHHHHHHHHHhhhc
Q 014466          396 --------------PGEVCIPQMNSLMTLSYC  413 (424)
Q Consensus       396 --------------~~~~~~~~~~~~~~~~~~  413 (424)
                                    .+.....++..++..||.
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~  286 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD  286 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcC
Confidence                          122334566666666664

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-45  Score=339.96  Aligned_cols=198  Identities=28%  Similarity=0.448  Sum_probs=170.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCC--CCceeeEeeEeeeCC
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEGA  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~  255 (424)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+...      .....+.+|++++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999975 688999999865321      11234667999999986  899999999999999


Q ss_pred             eeeEEEEecCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-CCceEEEec
Q 014466          256 HRMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDF  333 (424)
Q Consensus       256 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kL~Df  333 (424)
                      ..++||||+.+ +++.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 6888888765    5789999999999999999999999   9999999999999985 579999999


Q ss_pred             CCccccCCCcceeeecccccccccccccccCCCC-CCccchHHHHHHHHHHHcCCCCCCC
Q 014466          334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      |+++.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||..
T Consensus       156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence            999865332   2345689999999999987665 5678999999999999999999974

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=339.58  Aligned_cols=218  Identities=29%  Similarity=0.458  Sum_probs=181.9

Q ss_pred             ceeEcccCcEEEEEEEEcCC----CEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCceeeEeeEeee-CCeeeEEEEec
Q 014466          191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYEYI  264 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~  264 (424)
                      .++||+|+||+||+|++.++    ..||||++.+. .....++|.+|+++|++++|||||+++|++.+ +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997542    24899998643 44556789999999999999999999999865 45789999999


Q ss_pred             CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCcc
Q 014466          265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS  344 (424)
Q Consensus       265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~  344 (424)
                      ++|+|.+++...   ....++..++.++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999998865   35678888999999999999999998   999999999999999999999999999987644322


Q ss_pred             e---eeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC---------------CCCCccHHHHHH
Q 014466          345 Y---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR---------------PPGEVCIPQMNS  406 (424)
Q Consensus       345 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~---------------~~~~~~~~~~~~  406 (424)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||+||..||....               +.+..+..++.+
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~  265 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE  265 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence            2   2233578999999999999999999999999999999999888875321               123345567888


Q ss_pred             HHHhhhcc
Q 014466          407 LMTLSYCS  414 (424)
Q Consensus       407 ~~~~~~~~  414 (424)
                      ++..||..
T Consensus       266 li~~cl~~  273 (311)
T d1r0pa_         266 VMLKCWHP  273 (311)
T ss_dssp             HHHHHTCS
T ss_pred             HHHHHcCC
Confidence            88888864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.8e-44  Score=337.84  Aligned_cols=200  Identities=24%  Similarity=0.385  Sum_probs=172.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||+||+|++++|+.||||++....  ....+.+.+|+++|++++|||||++++++.+++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999999999999996543  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCCc
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER  343 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~  343 (424)
                      +.++.+..+....    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+...... 
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-  153 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-  153 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC-
Confidence            9887776666544    6799999999999999999999998   9999999999999999999999999999876433 


Q ss_pred             ceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            223344568999999998865 55789999999999999999999999653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=336.15  Aligned_cols=198  Identities=27%  Similarity=0.411  Sum_probs=162.5

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC----eeeEEEE
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVYE  262 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~lv~e  262 (424)
                      +|.+.+.||+|+||.||+|+++ |+.||||++.... .....+..|+..+..++|||||++++++.+++    ..++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            5777889999999999999975 7899999885432 22222344566667889999999999997654    5789999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ||++|+|.+++++.     .+++..++.++.|++.||+|||+..     +++|+||||||+||||+.++++||+|||+++
T Consensus        82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999864     6889999999999999999999621     2399999999999999999999999999998


Q ss_pred             ccCCCcce---eeecccccccccccccccCCC------CCCccchHHHHHHHHHHHcCCCCCC
Q 014466          338 LLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRNPVD  391 (424)
Q Consensus       338 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlGv~l~elltg~~Pf~  391 (424)
                      ........   .....+||+.|+|||++.+..      ++.++|||||||+||||+||..||.
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            77543322   234568999999999987543      6778999999999999999998874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=336.90  Aligned_cols=201  Identities=28%  Similarity=0.390  Sum_probs=167.0

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-C-CCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCceeeEeeEeee----
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-D-NTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAE----  253 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~----  253 (424)
                      .++|++++.||+|+||+||+|++. + ++.||||++.....  .....+.+|+++++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 45689999854321  2223455677776655   89999999999853    


Q ss_pred             -CCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEe
Q 014466          254 -GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD  332 (424)
Q Consensus       254 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  332 (424)
                       ....+++|||++++++.......   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             34678999999987766554443   35789999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       333 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ||+++.....  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            9999864322  2345578999999999999999999999999999999999999999754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-43  Score=335.05  Aligned_cols=203  Identities=27%  Similarity=0.361  Sum_probs=176.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCC-CceeeEeeEeeeCC
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGA  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~  255 (424)
                      .++|++++.||+|+||+||+|+..    +|+.||||.+.+..    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            367999999999999999999863    47889999985432    2234567889999999976 89999999999999


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ..+++|||+.+|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999999876    4678889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccCC--CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ++.+............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||....
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~  236 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  236 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            987765555555567899999999988654  47889999999999999999999997654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=333.60  Aligned_cols=201  Identities=24%  Similarity=0.390  Sum_probs=168.6

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC----eeeE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRML  259 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~l  259 (424)
                      ++|++++.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            47999999999999999999975 78999999996543 344567889999999999999999999987643    2345


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCcccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL  339 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~  339 (424)
                      +++|+.+|+|.+++...     .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            56677799999999753     689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcc--eeeecccccccccccccc-cCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERS--YVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      .....  ......+||+.|+|||++ ....++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            44322  223456799999999988 45567899999999999999999999997543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.9e-42  Score=325.08  Aligned_cols=202  Identities=20%  Similarity=0.279  Sum_probs=173.6

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC-CceeeEeeEeeeCCeeeEEEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e  262 (424)
                      .++|++.+.||+|+||+||+|++. +|+.||||.+....  ....+.+|++.++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999976 57889999875432  22346778889999865 899999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC-----CCceEEEecCCcc
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-----QWNPKLSDFGLAK  337 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kL~DfG~a~  337 (424)
                      |+ +++|.+++...   ...++...+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|+
T Consensus        82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 67999998765   24689999999999999999999999   9999999999999964     5789999999998


Q ss_pred             ccCCCcc------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          338 LLGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       338 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      .+.....      ......+||+.|+|||.+.+..+++++|||||||++|||+||+.||.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~  218 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  218 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence            7643211      123346799999999999999999999999999999999999999986554

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-42  Score=332.38  Aligned_cols=196  Identities=27%  Similarity=0.408  Sum_probs=165.8

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCC------
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------  255 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  255 (424)
                      .++|++++.||+|+||+||+|++. +|+.||||++...  .....+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            578999999999999999999975 5888999999654  3344567889999999999999999999997654      


Q ss_pred             eeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCC
Q 014466          256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL  335 (424)
Q Consensus       256 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~  335 (424)
                      ++++||||+ +.+|..+.+.     ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            568999999 5588887754     3689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      ++.....    .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            9876432    345679999999998876 45789999999999999999999999754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-42  Score=328.79  Aligned_cols=200  Identities=22%  Similarity=0.347  Sum_probs=166.9

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeee--------C
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G  254 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------~  254 (424)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...  .....+.+.+|+++|++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            58999999999999999999975 6889999998543  23345678899999999999999999998855        3


Q ss_pred             CeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecC
Q 014466          255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG  334 (424)
Q Consensus       255 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG  334 (424)
                      ...++||||+.++.+..+....    ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            4578999999887666554433    5788899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCcc---eeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          335 LAKLLGAERS---YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       335 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      +++.+.....   ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            9987643221   122335799999999998765 689999999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-42  Score=332.59  Aligned_cols=197  Identities=27%  Similarity=0.354  Sum_probs=163.3

Q ss_pred             CcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCceeeEeeEeeeC------CeeeE
Q 014466          187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AHRML  259 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~~~l  259 (424)
                      +|+..++||+|+||+||+|++. +|+.||||++......    +.+|+++|++++||||++++++|...      .+.+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999999986 5889999999665322    34699999999999999999998532      35789


Q ss_pred             EEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCccc
Q 014466          260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKL  338 (424)
Q Consensus       260 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~~  338 (424)
                      |||||+++. ...+.........+++..++.++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999998754 333332212246799999999999999999999998   999999999999999775 899999999987


Q ss_pred             cCCCcceeeecccccccccccccccC-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +....  ......||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||...
T Consensus       173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            64332  2344679999999998764 57899999999999999999999999654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=319.36  Aligned_cols=199  Identities=25%  Similarity=0.379  Sum_probs=174.8

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCceeeEeeEeeeCCeeeEEEE
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  262 (424)
                      ++|++++.||+|+||+||+|++. +++.||||++...  .....+.+.+|+++++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999975 6788999998544  23446788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCccccCCC
Q 014466          263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE  342 (424)
Q Consensus       263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~  342 (424)
                      ++.+++|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999998887655    5788999999999999999999999   9999999999999999999999999999876443


Q ss_pred             cceeeecccccccccccccccCCC-CCCccchHHHHHHHHHHHcCCCCCCC
Q 014466          343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDY  392 (424)
Q Consensus       343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGv~l~elltg~~Pf~~  392 (424)
                      .. ......+++.|+|||++.... ++.++|||||||++|||++|+.||..
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            22 233456788999999887654 68999999999999999999999743

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.7e-41  Score=323.49  Aligned_cols=195  Identities=23%  Similarity=0.363  Sum_probs=167.7

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeC--CeeeEE
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRMLV  260 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~lv  260 (424)
                      .++|++++.||+|+||+||+|++. +|+.||||++....   .+.+.+|+++|+.++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            357999999999999999999975 68889999986432   456888999999995 99999999999743  468899


Q ss_pred             EEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCC-ceEEEecCCcccc
Q 014466          261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLL  339 (424)
Q Consensus       261 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DfG~a~~~  339 (424)
                      |||+.+++|..+.       ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++..
T Consensus       111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            9999999987653       3689999999999999999999999   999999999999998755 5999999999876


Q ss_pred             CCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          340 GAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       340 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                      ....  ......||+.|+|||.+.+. .|+.++||||+||++|||++|+.||....
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            4332  23456789999999987664 58999999999999999999999996543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-41  Score=318.25  Aligned_cols=201  Identities=21%  Similarity=0.267  Sum_probs=167.3

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCc-eeeEeeEeeeCCeeeEEEEe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEY  263 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~  263 (424)
                      ++|++.+.||+|+||+||+|++. +|+.||||.+.....  .+++..|+++++.++|+| |+.+.+++.++...++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            47999999999999999999975 588899998765432  235778999999998766 55556666788888999999


Q ss_pred             cCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcC---CCceEEEecCCccccC
Q 014466          264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLAKLLG  340 (424)
Q Consensus       264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DfG~a~~~~  340 (424)
                      +. ++|...+...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..+||+|||+|+.+.
T Consensus        85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 LG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             cC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            95 4776666544   35789999999999999999999999   9999999999999854   5579999999999765


Q ss_pred             CCcc------eeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q 014466          341 AERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP  395 (424)
Q Consensus       341 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~~  395 (424)
                      ....      .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~  218 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  218 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence            4322      123456799999999999999999999999999999999999999976554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=322.71  Aligned_cols=196  Identities=29%  Similarity=0.355  Sum_probs=160.2

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeee------CCe
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH  256 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~  256 (424)
                      ++|+++++||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++|||||+++++|..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999976 58899999996542  3445678899999999999999999999963      367


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .|+||||+.++ +.+.+.      ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            89999999775 444443      3578999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      +....  ....+..+||+.|+|||++.+..+++++||||+||++|||++|+.||...
T Consensus       167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hcccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            86533  23345567999999999999999999999999999999999999999643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=322.98  Aligned_cols=197  Identities=25%  Similarity=0.373  Sum_probs=166.4

Q ss_pred             CCCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCceeeEeeEeeeC-----Ce
Q 014466          185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH  256 (424)
Q Consensus       185 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  256 (424)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+..  ....+.+.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999975 68899999996543  33456788999999999999999999998643     34


Q ss_pred             eeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceEEEecCCc
Q 014466          257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA  336 (424)
Q Consensus       257 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DfG~a  336 (424)
                      .+++++|+.+|+|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            4677788889999999964     3689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcceeeecccccccccccccccCC-CCCCccchHHHHHHHHHHHcCCCCCCCC
Q 014466          337 KLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS  393 (424)
Q Consensus       337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~elltg~~Pf~~~  393 (424)
                      .....    ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            75432    23446789999999986654 5688999999999999999999999643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-35  Score=286.83  Aligned_cols=199  Identities=22%  Similarity=0.259  Sum_probs=159.4

Q ss_pred             CCcccceeEcccCcEEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----------CCceeeEeeEeee
Q 014466          186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRLLGYCAE  253 (424)
Q Consensus       186 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~~~~  253 (424)
                      .+|+++++||+|+||+||+|++. +|+.||||++.+.. ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999975 68899999986543 33456778999888775           5789999998864


Q ss_pred             C--CeeeEEEEecCCCCH-HHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeCCCCCCCEEEcCCCc--
Q 014466          254 G--AHRMLVYEYIDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWN--  327 (424)
Q Consensus       254 ~--~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivHrDlkp~NILl~~~~~--  327 (424)
                      .  ...+++++++..+.. .......  ....+++..+..++.|+++||+|||+ .   +|+||||||+|||++.++.  
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             ccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence            3  455677777655443 2322222  24678889999999999999999997 6   8999999999999986653  


Q ss_pred             ----eEEEecCCccccCCCcceeeecccccccccccccccCCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 014466          328 ----PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR  394 (424)
Q Consensus       328 ----~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~elltg~~Pf~~~~  394 (424)
                          +|++|||.+.....    .....+||+.|+|||++....|+.++|+||+||+++||++|+.||....
T Consensus       167 ~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             TEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ccceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence                99999999986432    2345679999999999999999999999999999999999999997544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.2e-25  Score=197.84  Aligned_cols=163  Identities=17%  Similarity=0.166  Sum_probs=120.2

Q ss_pred             cccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCc------------------hhHHHHHHHHHHHhcCCCCceeeEee
Q 014466          188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRHKNLVRLLG  249 (424)
Q Consensus       188 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~hpnIv~l~~  249 (424)
                      +.+.+.||+|+||+||+|++.+|+.||||.+.....                  .....+..|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            356899999999999999998899999997642210                  01123456888999999999998886


Q ss_pred             EeeeCCeeeEEEEecCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeCCCCCCCEEEcCCCceE
Q 014466          250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK  329 (424)
Q Consensus       250 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  329 (424)
                      +..    .+++|||++++.+.+           ++......++.|++++++|||++   +|+||||||+|||++++ .++
T Consensus        82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence            632    379999998865432           22333467889999999999999   99999999999999975 499


Q ss_pred             EEecCCccccCCCcceeeeccccccccccc------ccccCCCCCCccchHHHHHH
Q 014466          330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAP------EYASTGMLNERSDVYSFGIL  379 (424)
Q Consensus       330 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDiwSlGv~  379 (424)
                      |+|||+|.........         .|...      +. ..+.|+.++|+||+.--
T Consensus       143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             ECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred             EEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence            9999999765322211         11111      11 13568889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.64  E-value=6.6e-08  Score=86.81  Aligned_cols=142  Identities=15%  Similarity=0.078  Sum_probs=95.6

Q ss_pred             CcccceeEcccCcEEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCceeeEeeEeeeCCeeeEEEEecC
Q 014466          187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYID  265 (424)
Q Consensus       187 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  265 (424)
                      .|+..+..+-+..+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+..+++..++||++++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~   93 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence            445555443344468998764 46678888876554444445677888877663 3335677888888888999999999


Q ss_pred             CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 014466          266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL---------------------------------------  306 (424)
Q Consensus       266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~---------------------------------------  306 (424)
                      |.++.+.....      ..   ...++.++++.++.||+..                                       
T Consensus        94 G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          94 GVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             ccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            98876543211      11   1234455666666666421                                       


Q ss_pred             -----------------CCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          307 -----------------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       307 -----------------~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                                       .+.++|+|+.|.|||+++++...|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                             12379999999999999876677999998763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.19  E-value=3.5e-06  Score=74.76  Aligned_cols=130  Identities=17%  Similarity=0.147  Sum_probs=82.9

Q ss_pred             EcccCc-EEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC--CceeeEeeEeeeCCeeeEEEEecCCCCHH
Q 014466          194 IGEGGY-GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNGNLE  270 (424)
Q Consensus       194 LG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~gsL~  270 (424)
                      +..|.. ..||+....++..+++|......   ...+..|.+.++.+..  -.+.+++.+..+++..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344543 68999988777778888754332   2245667777776632  33567788888888889999999885542


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 014466          271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-----------------------------------------------  303 (424)
Q Consensus       271 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-----------------------------------------------  303 (424)
                      +.         .....   .++.++++.|+-||                                               
T Consensus        95 ~~---------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          95 SS---------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TS---------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cc---------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            20         01111   11122333333333                                               


Q ss_pred             ----cCC----CCCeeeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          304 ----EGL----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       304 ----~~~----~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                          +..    .+.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                211    22489999999999999876678999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=5.4e-05  Score=71.65  Aligned_cols=76  Identities=16%  Similarity=0.179  Sum_probs=46.9

Q ss_pred             ceeEcccCcEEEEEEEEcC-CCEEEEEEeecC-------CchhHHHHHHHHHHHhcCC---CCceeeEeeEeeeCCeeeE
Q 014466          191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNN-------RGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML  259 (424)
Q Consensus       191 ~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l  259 (424)
                      .+.||.|....||++...+ ++.+++|.-.+.       ..........|.+.|+.+.   ...+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999998654 567888864321       1112233455777776652   2345666654  4455689


Q ss_pred             EEEecCCCC
Q 014466          260 VYEYIDNGN  268 (424)
Q Consensus       260 v~e~~~~gs  268 (424)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.26  E-value=0.00043  Score=63.42  Aligned_cols=136  Identities=13%  Similarity=0.139  Sum_probs=76.6

Q ss_pred             EEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce--eeEe-----eEeeeCCeeeEEEEecCCCCH---
Q 014466          200 GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRLL-----GYCAEGAHRMLVYEYIDNGNL---  269 (424)
Q Consensus       200 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI--v~l~-----~~~~~~~~~~lv~e~~~~gsL---  269 (424)
                      -.||++..++|+.+++|...+. ....+++..|.+.+..|...++  +..+     ..+..++..+.++++++|..+   
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5899999999999999986543 2345667778888877743222  1111     123445667889999976322   


Q ss_pred             --HHH---------H----ccCCCC-CCCCCH-------------------HHHHHHHHHHHHHHHHHHc----CCCCCe
Q 014466          270 --EQW---------L----HGDVGP-HSPLTW-------------------EIRMNIILGTAKGLTYLHE----GLEPKV  310 (424)
Q Consensus       270 --~~~---------l----~~~~~~-~~~l~~-------------------~~~~~i~~~i~~al~~LH~----~~~~~i  310 (424)
                        ..+         +    ...... ....+.                   .....+...+.+.++.+..    ....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence              111         0    111000 011111                   1111122222223333322    224579


Q ss_pred             eeCCCCCCCEEEcCCCceEEEecCCccc
Q 014466          311 VHRDIKSSNILLDKQWNPKLSDFGLAKL  338 (424)
Q Consensus       311 vHrDlkp~NILl~~~~~~kL~DfG~a~~  338 (424)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  46899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.87  E-value=0.0017  Score=60.98  Aligned_cols=71  Identities=18%  Similarity=0.251  Sum_probs=46.8

Q ss_pred             eeEcccCcEEEEEEEEcCC--------CEEEEEEeecCCchhHHHHHHHHHHHhcCCCCce-eeEeeEeeeCCeeeEEEE
Q 014466          192 NVIGEGGYGIVYHGVLEDN--------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYE  262 (424)
Q Consensus       192 ~~LG~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e  262 (424)
                      +.|+-|-.-.+|++...++        ..|.+++.. .. .......+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5687788899999987543        345555544 22 223345678888888743344 477777754    58999


Q ss_pred             ecCCCC
Q 014466          263 YIDNGN  268 (424)
Q Consensus       263 ~~~~gs  268 (424)
                      |++|..
T Consensus       122 fi~g~~  127 (395)
T d1nw1a_         122 YIPSRP  127 (395)
T ss_dssp             CCCEEE
T ss_pred             Eecccc
Confidence            998743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.19  E-value=0.006  Score=54.92  Aligned_cols=31  Identities=26%  Similarity=0.278  Sum_probs=27.6

Q ss_pred             CCCeeeCCCCCCCEEEcCCCceEEEecCCcc
Q 014466          307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAK  337 (424)
Q Consensus       307 ~~~ivHrDlkp~NILl~~~~~~kL~DfG~a~  337 (424)
                      ..++||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999988777899999876